Citrus Sinensis ID: 038422
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 634 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LPT1 | 686 | Probably inactive leucine | no | no | 0.944 | 0.873 | 0.521 | 1e-166 | |
| C0LGU0 | 662 | Probable LRR receptor-lik | no | no | 0.930 | 0.891 | 0.489 | 1e-166 | |
| C0LGR9 | 676 | Probable LRR receptor-lik | no | no | 0.925 | 0.868 | 0.438 | 1e-154 | |
| Q3E991 | 659 | Probable inactive leucine | no | no | 0.929 | 0.893 | 0.346 | 1e-103 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.929 | 0.879 | 0.352 | 3e-93 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.946 | 0.917 | 0.342 | 6e-87 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.941 | 0.932 | 0.324 | 1e-85 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.916 | 0.897 | 0.341 | 3e-85 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.872 | 0.884 | 0.343 | 3e-85 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.910 | 0.880 | 0.330 | 7e-84 |
| >sp|Q9LPT1|Y1061_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At1g50610 OS=Arabidopsis thaliana GN=At1g50610 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 587 bits (1512), Expect = e-166, Method: Compositional matrix adjust.
Identities = 334/641 (52%), Positives = 425/641 (66%), Gaps = 42/641 (6%)
Query: 15 VLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGS 74
VL ++ V SD + LL+FK +L + S +W+ L +PC N NW GVLC N
Sbjct: 32 VLCPVAMSQVVVPDSDADCLLRFKDTLANGSE-FRSWDPLSSPCQGNTANWFGVLCSN-Y 89
Query: 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
VWGL+LE M L+G + + L + +LR +SFMNN F GP+P +++ LKS+YLS+N FS
Sbjct: 90 VWGLQLEGMGLTGKLNLDPLVPMKNLRTISFMNNNFNGPMPQVKRFTSLKSLYLSNNRFS 149
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEM 194
G I DAF GM LKK+ +ANN GTIPSSL LP L+ELRL N+FQGQ+P +Q ++
Sbjct: 150 GEIPADAFLGMPLLKKILLANNAFRGTIPSSLASLPMLLELRLNGNQFQGQIPSFQQKDL 209
Query: 195 RSLGLANNELEGPIPESLSKMDPSTFAGNKNLC-GPPLDPCVLPKHPEIPNNVSQPPKGQ 253
+ NN+L+GPIPESL MDP +FAGNK LC P + PK
Sbjct: 210 KLASFENNDLDGPIPESLRNMDPGSFAGNKGLCDAPLSPCSSSSPGVPVVPVSPVDPKST 269
Query: 254 PPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSS 313
P P KK S + +I++V+G+ L IIA + R+R S
Sbjct: 270 SP------PTGKKAGSFYTLAIILIVIGIILVIIALVFCFVQSRRRNFL----------S 313
Query: 314 KLPTSFGSSKVEP-----------EPIEIKKKADYG-------KLSFVRDDMEPFDLQDM 355
P+S G ++E +P E G +L FVRDD++ FDLQD+
Sbjct: 314 AYPSSAGKERIESYNYHQSTNKNNKPAESVNHTRRGSMPDPGGRLLFVRDDIQRFDLQDL 373
Query: 356 LRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
LRASAEVLGSGTFGASYK IS+GQ VVKRYK MNNVGR++F EH++RLGRL HPN+LP
Sbjct: 374 LRASAEVLGSGTFGASYKAAISSGQTLVVKRYKHMNNVGRDEFHEHMRRLGRLNHPNILP 433
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L A+YYR+EEKLL+ EF+ N SLA LHAN++ GLDW TRLKIIKGV KG++YL +E
Sbjct: 434 LVAYYYRREEKLLVTEFMPNSSLASHLHANNSA---GLDWITRLKIIKGVAKGLSYLFDE 490
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY--AHNGKI 533
LP IPHGH+KSSN++LD SFEPLLTDYALRP+++ ++AH M AYKSPEY + I
Sbjct: 491 LPTLTIPHGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHAHNFMTAYKSPEYRPSKGQII 550
Query: 534 SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593
+KK+DVW G+LILE+LTG++PENYL QGYDS SL WVN+MVKEK+TGDVFDKEMKG
Sbjct: 551 TKKTDVWCFGVLILEVLTGRFPENYLTQGYDSNMSLVTWVNDMVKEKKTGDVFDKEMKGK 610
Query: 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634
K K+EMINLLKIGL CCEE+ RM+++EV+E +E L+EG
Sbjct: 611 KNCKAEMINLLKIGLRCCEEEEERRMDMREVVEMVEMLREG 651
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGU0|RLK_ARATH Probable LRR receptor-like serine/threonine-protein kinase RLK OS=Arabidopsis thaliana GN=RLK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 585 bits (1508), Expect = e-166, Method: Compositional matrix adjust.
Identities = 314/641 (48%), Positives = 421/641 (65%), Gaps = 51/641 (7%)
Query: 15 VLVLISFVGVTFGLSDTEILLQFKSSLN-DSSSALVNWNALRNPCTFNYPNWNGVLCLNG 73
V +L+ F T GLSD+E +L+FK SL +AL +WNA PCT W+GVLC G
Sbjct: 19 VCLLLFFSTPTHGLSDSEAILKFKESLVVGQENALASWNAKSPPCT-----WSGVLCNGG 73
Query: 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF 133
SVW L++E + LSG+I E+L L+SLR +SFMNNKFEGP PD +K+ LKS+YLS+N F
Sbjct: 74 SVWRLQMENLELSGSIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLAALKSLYLSNNQF 133
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE 193
G+I DAFEGM LKK+++A N+ TG IPSS+ +LPKL+ELRL+ N+F G++PE +++
Sbjct: 134 GGDIPGDAFEGMGWLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEF-EHQ 192
Query: 194 MRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDP-CVLPKHPEIPNNVSQP-PK 251
+ L L+NN L GPIPESLS DP F GNK L G PL+ C P P + ++P
Sbjct: 193 LHLLNLSNNALTGPIPESLSMTDPKVFEGNKGLYGKPLETECDSPYIEHPPQSEARPKSS 252
Query: 252 GQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYL-RKRKTQIERASSYE 310
+ P+++ +++ + I+++LGV IF L R K + R +
Sbjct: 253 SRGPLVI---------TAIVAALTILIILGV----------IFLLNRSYKNKKPRLAVET 293
Query: 311 DSSKLPTSFGSSKVEPEPIEIKKKADY------------------GKLSFVRDDMEPFDL 352
S L G + + + +KKAD+ KLSF+R+D E FDL
Sbjct: 294 GPSSLQKKTGIREAD-QSRRDRKKADHRKGSGTTKRMGAAAGVENTKLSFLREDREKFDL 352
Query: 353 QDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN 412
QD+L+ASAE+LGSG FGASYK V+S+GQ VVKR+KQMNN GR++FQEH+KRLGRL H N
Sbjct: 353 QDLLKASAEILGSGCFGASYKAVLSSGQMMVVKRFKQMNNAGRDEFQEHMKRLGRLMHHN 412
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
LL + A+YYRKEEKLL+ +F E GSLA LH+N + +P LDW TRLKI+KGV KG+ YL
Sbjct: 413 LLSIVAYYYRKEEKLLVCDFAERGSLAINLHSNQSLGKPSLDWPTRLKIVKGVAKGLFYL 472
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGK 532
H +LP + PHGHLKSSNVLL ++FEPLLTDY L PLIN + A M AY+SPEY + +
Sbjct: 473 HQDLPSLMAPHGHLKSSNVLLTKTFEPLLTDYGLIPLINQEKAQMHMAAYRSPEYLQHRR 532
Query: 533 ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592
I+KK+DVW LGILILE+LTGK+P N+ S+ L++WVN+ +FDK M
Sbjct: 533 ITKKTDVWGLGILILEILTGKFPANF---SQSSEEDLASWVNSGFHGVWAPSLFDKGMGK 589
Query: 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+ + +++ LL IGL+CCE DV R+++ + +EKIE LKE
Sbjct: 590 TSHCEGQILKLLTIGLNCCEPDVEKRLDIGQAVEKIEELKE 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1404), Expect = e-154, Method: Compositional matrix adjust.
Identities = 288/657 (43%), Positives = 404/657 (61%), Gaps = 70/657 (10%)
Query: 15 VLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNY---PNWNGVLCL 71
+L+++ FV +G D + LL+FKSSL ++SS L W++ PC+ + W GV+C
Sbjct: 14 LLIVLLFVSPIYGDGDADALLKFKSSLVNASS-LGGWDSGEPPCSGDKGSDSKWKGVMCS 72
Query: 72 NGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSD 130
NGSV+ L+LE M+LSG + ++LG + L+++SFM N FEG +P + + L +YL+
Sbjct: 73 NGSVFALRLENMSLSGELDVQALGSIRGLKSISFMRNHFEGKIPRGIDGLVSLAHLYLAH 132
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK 190
N F+G I D F GM +L K+++ NR +G IP SL +LPKL EL LE N F G++P K
Sbjct: 133 NQFTGEIDGDLFSGMKALLKVHLEGNRFSGEIPESLGKLPKLTELNLEDNMFTGKIPAFK 192
Query: 191 QNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPP 250
Q + ++ +ANN+LEG IP +L M+ + F+GNK LCG PL PC +
Sbjct: 193 QKNLVTVNVANNQLEGRIPLTLGLMNITFFSGNKGLCGAPLLPCRYTR------------ 240
Query: 251 KGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRK---------- 300
PP V LL + ++ +V+ +I L + L +R+
Sbjct: 241 ---PPFFT---------VFLLALTILAVVV-----LITVFLSVCILSRRQGKGQDQIQNH 283
Query: 301 -------------TQIERASSYEDSSKLPTSFGSSKVEPEPIEIK-------------KK 334
Q + + SK+ + V+ + K+
Sbjct: 284 GVGHFHGQVYGQPEQQQHSEKSSQDSKVYRKLANETVQRDSTATSGAISVGGLSPDEDKR 343
Query: 335 ADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG 394
D KL FVR+D E F LQDMLRASAEVLGSG FG+SYK +S+G+A VVKR++ M+N+G
Sbjct: 344 GDQRKLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIG 403
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD 454
RE+F +H+K++GRL HPNLLPL AFYYRKEEKLL+ ++ NGSLA LHAN T + LD
Sbjct: 404 REEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLD 463
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514
W RLKI++GV +G+AYL+ P +PHGHLKSSNVLLD +FEPLLTDYAL P++N D
Sbjct: 464 WPIRLKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQ 523
Query: 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVN 574
+ MVAYK+PE+ + S++SDVWSLGILILE+LTGK+P NYL QG + L+ WV
Sbjct: 524 SQQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGADDELAAWVE 583
Query: 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
++ + + T DVFDKEMK K +++M+ LLKIGL CC+ D+ R+EL E +++IE +
Sbjct: 584 SVARTEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEV 640
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E991|Y5269_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At5g20690 OS=Arabidopsis thaliana GN=At5g20690 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 377 bits (967), Expect = e-103, Method: Compositional matrix adjust.
Identities = 224/647 (34%), Positives = 362/647 (55%), Gaps = 58/647 (8%)
Query: 28 LSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNG-SVWGLKLEQMNLS 86
+S++E L++FK+S+ + L +W +PC+ W G+ C G +V G+ + ++ LS
Sbjct: 28 VSESEPLVRFKNSVKITKGDLNSWREGTDPCS---GKWFGIYCQKGLTVSGIHVTRLGLS 84
Query: 87 GTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMT 146
GTI + L L +L+ + NN GPLP K+ LKS+ LS+N FSG I DD F+ M+
Sbjct: 85 GTITVDDLKDLPNLKTIRLDNNLLSGPLPHFFKLRGLKSLMLSNNSFSGEIRDDFFKDMS 144
Query: 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNEL 204
LK+L++ +N+ G+IPSS+ QLP+L EL +++N G++P ++ L L+ N L
Sbjct: 145 KLKRLFLDHNKFEGSIPSSITQLPQLEELHMQSNNLTGEIPPEFGSMKNLKVLDLSTNSL 204
Query: 205 EGPIPESLS--KMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENP 262
+G +P+S++ K N+ LCGP +D V ++ E+ + P +GQPP +
Sbjct: 205 DGIVPQSIADKKNLAVNLTENEYLCGPVVD--VGCENIEL----NDPQEGQPPSKPSSSV 258
Query: 263 NQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIER------ASSYE-DSSKL 315
+ + + IM VS+ ++ II + KR+ + + A++ E D ++
Sbjct: 259 PETSNKAAINAIM------VSISLLLLFFIIVGVIKRRNKKKNPDFRMLANNRENDVVEV 312
Query: 316 PTSFGSSKVEPEPIEIKKK----ADYGK--------------------------LSFVRD 345
S SS + +K +D G + V
Sbjct: 313 RISESSSTTAKRSTDSSRKRGGHSDDGSTKKGVSNIGKGGNGGGGGALGGGMGDIIMVNT 372
Query: 346 DMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRL 405
D F L D+++A+AEVLG+G+ G++YK V++ G + VVKR + MN + RE F ++R
Sbjct: 373 DKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLAREPFDVEMRRF 432
Query: 406 GRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGV 465
G+L HPN+L A++YR+EEKL++ E++ SL LH + L W TRLKII+GV
Sbjct: 433 GKLRHPNILTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWATRLKIIQGV 492
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSP 525
GM +LH E +PHG+LKSSNVLL ++EPL++DYA PL+ P NA + A+K+P
Sbjct: 493 AHGMKFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNASQALFAFKTP 552
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585
E+A ++S KSDV+ LGI+ILE+LTGK+P YL G + WV + V E++ ++
Sbjct: 553 EFAQTQQVSHKSDVYCLGIIILEILTGKFPSQYLNNG-KGGTDIVQWVQSSVAEQKEEEL 611
Query: 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
D E+ S +M+ LL++G +C + R++++E + +IE++K
Sbjct: 612 IDPEIVNNTESMRQMVELLRVGAACIASNPDERLDMREAVRRIEQVK 658
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 221/627 (35%), Positives = 344/627 (54%), Gaps = 38/627 (6%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT 88
+D+E LL FK + DS+ L +WN NPC W GV C V L LE +NL+G+
Sbjct: 30 TDSETLLNFKLTA-DSTGKLNSWNTTTNPC-----QWTGVSCNRNRVTRLVLEDINLTGS 83
Query: 89 IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSL 148
I++ + L+SLR +S +N GP+P+L + LK ++LS+N FSGN + +T L
Sbjct: 84 ISSLTS--LTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPT-SITSLTRL 140
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPI 208
+L ++ N +G IP L L L+ LRLE+N+F GQ+P I ++++ ++ N G I
Sbjct: 141 YRLDLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQI 200
Query: 209 PESLSKMDPSTFAGNKNLCGPPLDPCVL----PKHPEIPNNVSQPPKGQPPIIVQ----- 259
P SLS+ S F N +LCG PL C P P P+ P +P +
Sbjct: 201 PNSLSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSI 260
Query: 260 ---ENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSSKL- 315
+ N +S + +I I+L + L ++ +L + R+ ++ S + K+
Sbjct: 261 HGGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIV 320
Query: 316 ------PTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFG 369
PTS ++ + + + D GK+ F + F+L+D+LRASAE+LG G FG
Sbjct: 321 YSSNPYPTSTQNNNNQNQQV-----GDKGKMVFF-EGTRRFELEDLLRASAEMLGKGGFG 374
Query: 370 ASYKTVISNGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLL 428
+YK V+ +G VKR K V G+++F++ ++ LGRL H NL+ L A+Y+ +EEKLL
Sbjct: 375 TAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLL 434
Query: 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKS 488
+Y+++ NGSL LH N R LDW TRLKI G +G+A++H + HG +KS
Sbjct: 435 VYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKS 494
Query: 489 SNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILE 548
+NVLLDRS ++D+ L + P Y++PE K ++KSDV+S G+L+LE
Sbjct: 495 TNVLLDRSGNARVSDFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLE 553
Query: 549 LLTGKYPENYLLQGYDSKA-SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIG 607
+LTGK P N + G+ A L WV ++V+E+ T +VFD E+ K + EM+ LL+I
Sbjct: 554 ILTGKCP-NMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIA 612
Query: 608 LSCCEEDVLARMELKEVIEKIERLKEG 634
++C R ++ V++ IE ++ G
Sbjct: 613 MACTAVAADHRPKMGHVVKLIEDIRGG 639
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 219/640 (34%), Positives = 332/640 (51%), Gaps = 40/640 (6%)
Query: 7 RPARNVLH-VLVLISFVGVTFGL-------SDTEILLQFKSSLNDSSSALVNWNALRNPC 58
RP++ L LV FV TF SD + LL F +S+ +NWN+ + C
Sbjct: 17 RPSKGFLSTCLVSFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRR--LNWNSTNHIC 74
Query: 59 TFNYPNWNGVLCLNG--SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP- 115
+W GV C + SV L+L + L G I +LG L SLR +S +N G LP
Sbjct: 75 K----SWVGVTCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPP 130
Query: 116 DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMEL 175
D+ + L IYL N FSG + L L ++ N TG IP++ L +L L
Sbjct: 131 DIHSLPSLDYIYLQHNNFSGEVPSFVSR---QLNILDLSFNSFTGKIPATFQNLKQLTGL 187
Query: 176 RLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCV 235
L+ NK G VP + +R L L+NN L G IP +L S+F+GN LCG PL PC
Sbjct: 188 SLQNNKLSGPVPNLDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCA 247
Query: 236 LPK-HPEIPNNVSQPPKGQPPIIVQENPNQKKEVS-LLKIIMIVLVLGVSLGIIAAILII 293
P + ++S PP PP +E +K VS ++ I L + + +I I
Sbjct: 248 TSSPPPSLTPHISTPP--LPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCI 305
Query: 294 FYLRKRKTQIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQ 353
KR+ I + + + +K FGS EPE KL F FDL+
Sbjct: 306 KKKDKREDSIVKVKTLTEKAK--QEFGSGVQEPE---------KNKLVFFNGCSYNFDLE 354
Query: 354 DMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPN 412
D+LRASAEVLG G++G +YK V+ VVKR K++ G+ +F++ ++ + R+ HP+
Sbjct: 355 DLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV-AAGKREFEQQMEIISRVGNHPS 413
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++PL A+YY K+EKL++ ++ G+L+ LH N ++ LDW +R+KI KG+A+L
Sbjct: 414 VVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHL 473
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGK 532
H G HG++KSSNV++ + + ++D+ L PL+ A Y++PE K
Sbjct: 474 H-AAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRK 532
Query: 533 ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592
+ KSDV+S G+LILE+LTGK P D L WV ++V+E+ T +VFD E+
Sbjct: 533 HTHKSDVYSFGVLILEMLTGKSPVQS--PSRDDMVDLPRWVQSVVREEWTSEVFDIELMR 590
Query: 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
+ + EM+ +L+I ++C + R + +V+ IE ++
Sbjct: 591 FQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 211/650 (32%), Positives = 347/650 (53%), Gaps = 53/650 (8%)
Query: 4 HIGRPARNVLHVLVLISFVGVTFGL-SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNY 62
H A + +L+ + V V+ L SD + LL F +S+ +NWN + C+
Sbjct: 5 HTAFVAASFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPK--LNWNKNLSLCS--- 59
Query: 63 PNWNGVLCLNGS----VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DL 117
+W G+ C + V ++L + L G+I +LG L +L+ +S +N G LP D+
Sbjct: 60 -SWIGITCDESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDI 118
Query: 118 RKMGPLKSIYLSDNGFSGNISDDAFEGMT-SLKKLYMANNRLTGTIPSSLVQLPKLMELR 176
+ L+ +YL N FSG ++ ++ ++ L L ++ N L+G IPS L L ++ L
Sbjct: 119 LSLPSLEYLYLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLY 178
Query: 177 LEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVL 236
L+ N F G + + ++ + L+ N L GPIPE L K +F GN LCGPPL+ C
Sbjct: 179 LQNNSFDGPIDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNAC-- 236
Query: 237 PKHPEIPNNVSQPPKGQP-PIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFY 295
P P P+ +P ++++ K +I +V+G S+ ++ ++
Sbjct: 237 ------SGGAISPSSNLPRPLTENLHPVRRRQS---KAYIIAIVVGCSVAVLFLGIVFLV 287
Query: 296 LRKRKTQIE-------RASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDME 348
+KT+ E R +SK P FGS +PE KL F
Sbjct: 288 CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEK---------NKLFFFERCNH 338
Query: 349 PFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL 408
FDL+D+L+ASAEVLG G+FG +YK V+ + A VVKR +++ +++F++ ++ +G++
Sbjct: 339 NFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREV-VASKKEFEQQMEIVGKI 397
Query: 409 -EHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
+H N +PL A+YY K+EKLL+Y+++ GSL G +H N + G+DW+TR+KI G K
Sbjct: 398 NQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDR--GVDWETRMKIATGTSK 455
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY 527
++YLH+ HG +KSSN+LL EP L+D +L L N + Y +PE
Sbjct: 456 AISYLHS----LKFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEV 511
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYPENYL-LQGYDSKASLSNWVNNMVKEKRTGDVF 586
++S++SDV+S G++ILE+LTGK P L+ L WV ++V+E+ T +VF
Sbjct: 512 IETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVF 571
Query: 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEV---IEKIERLKE 633
D E+ + + EM+ +L++ L+C + +R +++EV IE + RL +
Sbjct: 572 DVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQ 621
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 216/632 (34%), Positives = 337/632 (53%), Gaps = 51/632 (8%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALR-NPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSG 87
+D LL F+S++ + + W+ + +PC NW GVLC G V L+L LSG
Sbjct: 33 ADKSALLSFRSAVGGRT---LLWDVKQTSPC-----NWTGVLCDGGRVTALRLPGETLSG 84
Query: 88 TIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMT 146
I G L+ LR +S N G LP DL L+ +YL N FSG I + F ++
Sbjct: 85 HIPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFS-LS 143
Query: 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206
+L +L +A N +G I S L +L L LE NK G + ++ + + ++NN L G
Sbjct: 144 NLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQ-FNVSNNLLNG 202
Query: 207 PIPESLSKMDPSTFAGNKNLCGPPLDPC----VLPKHPEIPNNVSQPPKGQPPIIVQENP 262
IP+SL K D +F G +LCG PL C +P P N+ +G E
Sbjct: 203 SIPKSLQKFDSDSFVGT-SLCGKPLVVCSNEGTVPSQPISVGNIPGTVEGS------EEK 255
Query: 263 NQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRK---RKTQIERASSYEDSSKLPTSF 319
++K++S I IV+ V L +I IL++ + +K R I+ A+ ++P
Sbjct: 256 KKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEK 315
Query: 320 GSSKV--------EPEPIEIKK----KADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGT 367
+ + E P +K + KL F + + FDL+D+LRASAEVLG GT
Sbjct: 316 AAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGT 375
Query: 368 FGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKL 427
FG +YK V+ VKR K + RE F+E I+ +G ++H NL+PL A+YY +EKL
Sbjct: 376 FGTAYKAVLDAVTLVAVKRLKDVTMADRE-FKEKIEVVGAMDHENLVPLRAYYYSGDEKL 434
Query: 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLK 487
L+Y+F+ GSL+ LH N RP L+W+ R I G +G+ YLH++ P S HG++K
Sbjct: 435 LVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLS--SHGNVK 492
Query: 488 SSNVLLDRSFEPLLTDYALRPLINPDNAH-TLMVAYKSPEYAHNGKISKKSDVWSLGILI 546
SSN+LL S + ++D+ L L++ + Y++PE ++S+K+DV+S G+++
Sbjct: 493 SSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVL 552
Query: 547 LELLTGKYPENYLL--QGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKS---EMI 601
LELLTGK P N ++ +G D L+ WV+++ +E+ +VFD E+ + S EM
Sbjct: 553 LELLTGKAPSNSVMNEEGMD----LARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMA 608
Query: 602 NLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+L++G+ C E+ R + EV+ +I+ L++
Sbjct: 609 EMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQ 640
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 205/596 (34%), Positives = 323/596 (54%), Gaps = 43/596 (7%)
Query: 51 WNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKF 110
WN PCT W GV C +G V L+L + LSG + ++G L+ L +SF N
Sbjct: 46 WNLTAPPCT-----WGGVQCESGRVTALRLPGVGLSGPLPI-AIGNLTKLETLSFRFNAL 99
Query: 111 EGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQL 169
GPLP D + L+ +YL N FSG I F + ++ ++ +A N G IP ++
Sbjct: 100 NGPLPPDFANLTLLRYLYLQGNAFSGEIPSFLFT-LPNIIRINLAQNNFLGRIPDNVNSA 158
Query: 170 PKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGP 229
+L L L+ N+ G +PEIK +++ +++N+L G IP+ LS M + F GN LCG
Sbjct: 159 TRLATLYLQDNQLTGPIPEIKI-KLQQFNVSSNQLNGSIPDPLSGMPKTAFLGNL-LCGK 216
Query: 230 PLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAA 289
PLD C + N + P G+ + ++S I+ IV+ V L ++
Sbjct: 217 PLDACPVNGT----GNGTVTPGGK---------GKSDKLSAGAIVGIVIGCFVLLLVLFL 263
Query: 290 ILIIFYLRKRKTQIERASSYEDSSKLPTSFGSSKVE---PEPIEIKKKADYG-------- 338
I+ +K+K Q+ ++ S E ++ +PTS + E P + ++ G
Sbjct: 264 IVFCLCRKKKKEQVVQSRSIE-AAPVPTSSAAVAKESNGPPAVVANGASENGVSKNPAAV 322
Query: 339 --KLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE 396
L+F FDL +L+ASAEVLG GTFG+SYK +G VKR + + V +
Sbjct: 323 SKDLTFFVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDVV-VPEK 381
Query: 397 DFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQ 456
+F+E ++ LG + H NL+ L A+Y+ ++EKL+++E++ GSL+ LH N R L+W+
Sbjct: 382 EFREKLQVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWE 441
Query: 457 TRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH 516
TR I G + ++YLH+ + HG++KSSN+LL SFE ++DY L P+I+P +
Sbjct: 442 TRANIALGAARAISYLHSR--DATTSHGNIKSSNILLSESFEAKVSDYCLAPMISPTSTP 499
Query: 517 TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM 576
+ Y++PE KIS+K+DV+S G+LILELLTGK P + L ++ L WV+++
Sbjct: 500 NRIDGYRAPEVTDARKISQKADVYSFGVLILELLTGKSPTHQQL--HEEGVDLPRWVSSI 557
Query: 577 VKEKRTGDVFDKEMKGAKYSKSE-MINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
+++ DVFD E+ + +E MI LL IG+SC + +R + EV IE +
Sbjct: 558 TEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEV 613
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 210/636 (33%), Positives = 334/636 (52%), Gaps = 59/636 (9%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALR-NPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSG 87
+D LL +S++ + WN + +PC NW GV C + V L+L + LSG
Sbjct: 35 ADRTALLSLRSAVGGRT---FRWNIKQTSPC-----NWAGVKCESNRVTALRLPGVALSG 86
Query: 88 TIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMT 146
I G L+ LR +S N G LP DL L+ +YL N FSG I + F ++
Sbjct: 87 DIPEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFS-LS 145
Query: 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206
L +L +A+N TG I S L KL L LE N+ G +P++ + ++NN L G
Sbjct: 146 HLVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDL-PLVQFNVSNNSLNG 204
Query: 207 PIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKG--QPPIIVQENPNQ 264
IP++L + + +F +LCG PL C P +P SQP G + P V+ + +
Sbjct: 205 SIPKNLQRFESDSFL-QTSLCGKPLKLC--PDEETVP---SQPTSGGNRTPPSVEGSEEK 258
Query: 265 KKEVSLLKIIMIVLVLGVSLGIIAAILIIFYL-----RKRKTQIERASSYEDSSKLPTS- 318
KK+ L + +V+G +G +LI+ L KR ++ ++ + ++P
Sbjct: 259 KKKNKLSGGAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDK 318
Query: 319 --------FGSSKVEPEPIEIKKKADYG------KLSFVRDDMEPFDLQDMLRASAEVLG 364
+ S + KA G KL F + + FDL+D+LRASAEVLG
Sbjct: 319 EAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLG 378
Query: 365 SGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE 424
GTFG +YK V+ VKR K + +E F+E I+ +G ++H NL+PL A+Y+ ++
Sbjct: 379 KGTFGTAYKAVLDAVTVVAVKRLKDVMMADKE-FKEKIELVGAMDHENLVPLRAYYFSRD 437
Query: 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHG 484
EKLL+Y+F+ GSL+ LH N R L+W R +I G +G+ YLH++ G+ HG
Sbjct: 438 EKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQ--GTSTSHG 495
Query: 485 HLKSSNVLLDRSFEPLLTDYALRPLI-----NPDNAHTLMVAYKSPEYAHNGKISKKSDV 539
++KSSN+LL +S + ++D+ L L+ NP+ A Y++PE ++S+K DV
Sbjct: 496 NIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRA----TGYRAPEVTDPKRVSQKGDV 551
Query: 540 WSLGILILELLTGKYPENYLL--QGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSK 597
+S G+++LEL+TGK P N ++ +G D L WV ++ +++ +VFD E+ +
Sbjct: 552 YSFGVVLLELITGKAPSNSVMNEEGVD----LPRWVKSVARDEWRREVFDSELLSLATDE 607
Query: 598 SEMI-NLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
EM+ ++++GL C + R E+ EV+ K+E L+
Sbjct: 608 EEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 634 | ||||||
| 255544478 | 651 | receptor protein kinase, putative [Ricin | 0.919 | 0.895 | 0.575 | 0.0 | |
| 224122728 | 653 | predicted protein [Populus trichocarpa] | 0.965 | 0.937 | 0.561 | 0.0 | |
| 224095141 | 625 | predicted protein [Populus trichocarpa] | 0.933 | 0.947 | 0.562 | 0.0 | |
| 225443433 | 636 | PREDICTED: probable LRR receptor-like se | 0.922 | 0.919 | 0.535 | 0.0 | |
| 42565049 | 679 | leucine-rich repeat protein kinase-like | 0.933 | 0.871 | 0.546 | 0.0 | |
| 297830704 | 679 | hypothetical protein ARALYDRAFT_479539 [ | 0.933 | 0.871 | 0.546 | 1e-180 | |
| 359484945 | 633 | PREDICTED: probable LRR receptor-like se | 0.930 | 0.932 | 0.507 | 1e-178 | |
| 147866686 | 633 | hypothetical protein VITISV_017867 [Viti | 0.930 | 0.932 | 0.507 | 1e-178 | |
| 449524728 | 643 | PREDICTED: probable LRR receptor-like se | 0.916 | 0.903 | 0.515 | 1e-176 | |
| 224090562 | 612 | predicted protein [Populus trichocarpa] | 0.914 | 0.947 | 0.511 | 1e-173 |
| >gi|255544478|ref|XP_002513300.1| receptor protein kinase, putative [Ricinus communis] gi|223547208|gb|EEF48703.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/619 (57%), Positives = 469/619 (75%), Gaps = 36/619 (5%)
Query: 21 FVGVTFG--LSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGL 78
FV + FG +D+ LL+FK +L +SS AL NWN + PC ++ NW GVLCLNGS+WGL
Sbjct: 34 FVHMAFGENATDSVALLKFKDALGNSS-ALYNWNPIFPPCEWDRSNWIGVLCLNGSIWGL 92
Query: 79 KLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNIS 138
KLE M+L+G+I +SL L R +S M+N +GP PD++K+G LK++YLS+N FSG I
Sbjct: 93 KLEHMSLAGSIDVDSLLPLPFFRTLSLMDNDLDGPFPDIKKLGKLKALYLSNNRFSGQIP 152
Query: 139 DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLG 198
DDAF+GM SLK+++MANN TG IP SL LP+LMELRLE N+F+G +P+ +Q+ ++++
Sbjct: 153 DDAFQGMGSLKRVFMANNMFTGNIPLSLATLPRLMELRLEGNQFKGLIPDFQQHVLKTVN 212
Query: 199 LANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIV 258
LA+N+L GPIP SLSK+DP +F+GNK LCGPPLDPC PE +NV
Sbjct: 213 LASNQLVGPIPTSLSKLDPDSFSGNKELCGPPLDPC---SSPENKSNV------------ 257
Query: 259 QENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYE-DSSKLP- 316
LKII+ V+V+ + + +A L + + + R +Q+ER SS +S+K+
Sbjct: 258 ------------LKIIITVMVVLLIVAAVAFALAVLWRKSRGSQLERTSSLSANSNKIAP 305
Query: 317 -TSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV 375
T G + P+E +++D +LSFVR+D+E FDL D+LRASAEVLGSGTFG+SYK
Sbjct: 306 NTYVGDQEQIQMPVEQLRRSD--RLSFVREDVEKFDLNDLLRASAEVLGSGTFGSSYKAS 363
Query: 376 ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435
+ +G A VVKRY+ MNNVGRE+F EH++RLGRL+HPNLL L A+YYR+EEKLL+YE+VE+
Sbjct: 364 VGSGVALVVKRYRHMNNVGREEFHEHMRRLGRLQHPNLLRLAAYYYRREEKLLVYEYVEH 423
Query: 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR 495
GSLA +LH+N++ + GLDW TRL++IKGV KG+AYL+ ELP ++PHGHLKSSNVLLD
Sbjct: 424 GSLASRLHSNNSLEGQGLDWHTRLRVIKGVAKGLAYLYGELP-ILVPHGHLKSSNVLLDP 482
Query: 496 SFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
S EPLLTDYALRP+INP AH LM+AYKSPEYA NG+ S K+D+WS GILILE+LTGK+P
Sbjct: 483 SLEPLLTDYALRPVINPQQAHNLMIAYKSPEYAQNGRTSNKTDIWSFGILILEILTGKFP 542
Query: 556 ENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDV 615
ENYL GYD+ A L++WVN MVKEKRT +VFDK+MKGAKYSK EMIN+LKIGLSCCEEDV
Sbjct: 543 ENYLTAGYDTSADLASWVNKMVKEKRTSEVFDKDMKGAKYSKGEMINVLKIGLSCCEEDV 602
Query: 616 LARMELKEVIEKIERLKEG 634
+R+++++V+EK+E+LKEG
Sbjct: 603 ESRVDIEQVVEKLEQLKEG 621
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122728|ref|XP_002330454.1| predicted protein [Populus trichocarpa] gi|222871866|gb|EEF08997.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/643 (56%), Positives = 468/643 (72%), Gaps = 31/643 (4%)
Query: 1 MGRHIGRPARNVLHVLVLI-----SFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALR 55
M H+ + AR LVL+ S V +FG D++ LL+FK L ++ A+ +WN
Sbjct: 3 MAAHVAKFARATTSSLVLVLAFVLSIVVTSFGSPDSDALLKFKDQLANNG-AINSWNPSV 61
Query: 56 NPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP 115
PC + NW GVLCLNGS+ GL+LE M LSG I ++L L S R +S M+N F+GPLP
Sbjct: 62 KPCEWERSNWVGVLCLNGSIRGLQLEHMALSGDIDLDALAPLPSFRTLSLMDNNFDGPLP 121
Query: 116 DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMEL 175
D +K+G LK++YLS+N FSG+I D+AFEGM SLK+LY+ANN LTG IPSSL L KLMEL
Sbjct: 122 DFKKLGKLKALYLSNNRFSGDIPDNAFEGMGSLKRLYLANNLLTGKIPSSLATLSKLMEL 181
Query: 176 RLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCV 235
+LE N+FQGQ+P +Q M+++ +A+NELEGPIPE+LS++ P +FAGNK LCGPPL PC+
Sbjct: 182 KLEGNQFQGQIPNFQQKSMKTVNVASNELEGPIPEALSRLSPHSFAGNKGLCGPPLGPCI 241
Query: 236 LPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFY 295
P P P + K+ S+L I++I+L++ + L IA ++F
Sbjct: 242 -PSPPSTPK------------------SNGKKFSILYIVIIILIVLLMLAAIAFAFLLFS 282
Query: 296 LRKRKTQIERASSY--EDSSKLPTSF--GSSKVEPEPIEIKKKADYGKLSFVRDDMEPFD 351
+K K++I+R +S E+S+K+ S+ + E KKAD+GKL+F++DD+E FD
Sbjct: 283 RKKCKSRIQRTASSPEENSNKMVASYYRDVHRELSETSSHAKKADHGKLTFLKDDIEKFD 342
Query: 352 LQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHP 411
LQD+L ASAEVLGSGTFG+SYK V+ Q VVKRY+ M+NVGRE+F EH++RLGRL+HP
Sbjct: 343 LQDLLTASAEVLGSGTFGSSYKAVVVG-QPVVVKRYRHMSNVGREEFHEHMRRLGRLKHP 401
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
NLLPL A+Y R++EKLL+ EF ENGSLA LH NH+ + GL W RLKI+KGV +G+A+
Sbjct: 402 NLLPLAAYYNRRDEKLLVTEFAENGSLASHLHGNHSPEEDGLHWHIRLKIVKGVARGLAF 461
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNG 531
L+NELP I PHGHLKSSNVLLD SFEPLLTDYALRP++NP++AH M+AYKSPEYA
Sbjct: 462 LYNELP-IIAPHGHLKSSNVLLDESFEPLLTDYALRPVVNPEHAHMFMMAYKSPEYAQQS 520
Query: 532 KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591
+ S K+D+WS GILILE+LTGK+PENYL Y+S A L+ WVNNMVKEKRT +VFDKE+
Sbjct: 521 RTSNKTDIWSFGILILEMLTGKFPENYLTPCYNSDADLATWVNNMVKEKRTSEVFDKEIV 580
Query: 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634
G KYSK EMI LLKIGLSCCEEDV R+++KEV+EKI+ LKEG
Sbjct: 581 GTKYSKGEMIKLLKIGLSCCEEDVERRLDIKEVVEKIDVLKEG 623
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224095141|ref|XP_002310352.1| predicted protein [Populus trichocarpa] gi|222853255|gb|EEE90802.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/617 (56%), Positives = 456/617 (73%), Gaps = 25/617 (4%)
Query: 20 SFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLK 79
S V +FG D++ LL+FK L ++ + NWN NPC + NW GVLC NG +WGL+
Sbjct: 26 SIVVTSFGSPDSDALLKFKEQLVNNE-GISNWNVSVNPCERDRSNWVGVLCFNGGIWGLQ 84
Query: 80 LEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD 139
LE M L+G I ++L L S R +S M+N F+GPLPD +K+G LK++YLS+N FSG+I D
Sbjct: 85 LEHMGLAGNIDLDALAPLPSFRTLSLMDNNFDGPLPDFKKLGKLKALYLSNNRFSGDIPD 144
Query: 140 DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGL 199
AFEGM SLK+L++ANN LTG I SSL LPKL EL+L+ N+F+GQ+P +Q M++ +
Sbjct: 145 KAFEGMGSLKRLFLANNLLTGKIASSLAILPKLTELKLDGNQFEGQIPNFQQKGMKTANV 204
Query: 200 ANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQ 259
ANNELEGPIPE+LS++ P++FAGNK LCGPPL PC+ P P P
Sbjct: 205 ANNELEGPIPEALSRLSPNSFAGNKGLCGPPLGPCI-PSPPSTPK--------------- 248
Query: 260 ENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSSKLPTSF 319
K+ S+L I++I+L++ + L IA ++F ++ K + +R +S E+S+++ +S+
Sbjct: 249 ---AHGKKFSILYIVIIILIVLLILAAIAFAFLLFSRKESKRRTQRRAS-ENSNRIMSSY 304
Query: 320 --GSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVIS 377
+ PE + D+GKLSF++DD+E FDLQD+LRASAEVLGSGT+G+SYK V+
Sbjct: 305 YRDVHREMPETNSHSRITDHGKLSFLKDDIEKFDLQDLLRASAEVLGSGTYGSSYKAVVG 364
Query: 378 NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437
GQ VVKRY+ MNNV RE+F EH++R+GRL+HPNLLPL A+YYR++EKLL+ F ENGS
Sbjct: 365 -GQPVVVKRYRHMNNVEREEFHEHMRRIGRLKHPNLLPLAAYYYRRDEKLLVTVFAENGS 423
Query: 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497
LA LH NH+ + GLDW+ RLKI+KGV +G+A+L+N+LP I PHGHLKSSNVLLD SF
Sbjct: 424 LASHLHGNHSLEEDGLDWRIRLKIVKGVARGLAFLYNQLP-IIAPHGHLKSSNVLLDESF 482
Query: 498 EPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557
EPLLTDYALRP+INP++AH M+AYKSPEYA +G+ S K+D+WS GILILE+LTGK+PEN
Sbjct: 483 EPLLTDYALRPVINPEHAHVFMMAYKSPEYAQHGRSSNKTDIWSFGILILEILTGKFPEN 542
Query: 558 YLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLA 617
YL GY+S A L+ WVNNMVKEKRT +VFDKEM G K SK EMI LLKIGLSCCE++V
Sbjct: 543 YLTPGYNSDADLATWVNNMVKEKRTSEVFDKEMLGTKNSKGEMIKLLKIGLSCCEQEVER 602
Query: 618 RMELKEVIEKIERLKEG 634
R ++KEV++KIE LKEG
Sbjct: 603 RSDIKEVVDKIEELKEG 619
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443433|ref|XP_002267926.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/622 (53%), Positives = 444/622 (71%), Gaps = 37/622 (5%)
Query: 15 VLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPC-TFNYPNWNGVLCLNG 73
+L+L+S + +SD +ILL+F+ SL +++ AL +WN R+ C T +WNGV C NG
Sbjct: 22 ILILVSITS-SEAVSDADILLKFRVSLGNAT-ALGDWNTSRSVCSTDQTESWNGVRCWNG 79
Query: 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF 133
SVWGL+LE + L+G I +SL L LR +SFMNN FEGPLP+++K+ LKS+YLS+N F
Sbjct: 80 SVWGLRLEGLGLNGAIDLDSLSSLRYLRTISFMNNSFEGPLPEIKKLVALKSVYLSNNHF 139
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE 193
SG+I DDAF GM LKK+++ANN+ TG IPSSL LP+L+ LRL+ NKF+GQ+P+ +Q
Sbjct: 140 SGDIPDDAFSGMAYLKKVHLANNKFTGKIPSSLATLPRLLVLRLDGNKFEGQIPDFQQKH 199
Query: 194 MRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQ 253
+ ++ ++NN L GPIP SLS++ S+F+GNK+LCG PLD C
Sbjct: 200 LANVNISNNMLGGPIPASLSRISSSSFSGNKDLCGKPLDSC------------------- 240
Query: 254 PPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSS 313
K+ S + + +IV+ + + L I +L++ + R Q+ A+ ++ S
Sbjct: 241 ----------SSKKPSAVIVALIVVAIALILVTIGLLLLVLHRNIRTVQLGGAAPVDNHS 290
Query: 314 KLPTSFGSSKVEPEPIEIK---KKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGA 370
+ SS VE E+ K+A+ GKL+FVRDD E FDLQD+LRASAEVLGSG FG+
Sbjct: 291 MSEVAH-SSLVECGTSEMSGHSKRAEQGKLTFVRDDRERFDLQDLLRASAEVLGSGNFGS 349
Query: 371 SYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLY 430
SYK V+ +G+A V KRYKQMNNVGRE+FQEH++RLGRL HPNLLPL A+YYRKEEKLL+
Sbjct: 350 SYKAVLLSGEAMVAKRYKQMNNVGREEFQEHMRRLGRLAHPNLLPLVAYYYRKEEKLLVS 409
Query: 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSN 490
E+VENGSLA LH NH+ +PGL+W TRL+IIKGV KG+AYL+NELP I+ HGHLKSSN
Sbjct: 410 EYVENGSLASHLHGNHSIDQPGLNWPTRLRIIKGVAKGLAYLYNELPSLIVAHGHLKSSN 469
Query: 491 VLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELL 550
VLLD SF P+LTDYAL P+INP++A LMVAYKSPE+A + + +KK+DVW LGILILE+L
Sbjct: 470 VLLDESFNPVLTDYALLPVINPEHARQLMVAYKSPEFAQHSRTTKKTDVWGLGILILEIL 529
Query: 551 TGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSC 610
TGK+P NYL G +S+ ++ WVN++ ++ +VFDKEM G + SK EM+ LLKIGL+C
Sbjct: 530 TGKFPTNYLTVGNNSEEGIT-WVNSIANQEWMMEVFDKEMGGTENSKGEMLKLLKIGLAC 588
Query: 611 CEEDVLARMELKEVIEKIERLK 632
CEEDV R +LKE I+ IE L+
Sbjct: 589 CEEDVERRWDLKEAIKHIEELE 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42565049|ref|NP_188654.2| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|9293975|dbj|BAB01878.1| receptor protein kinase [Arabidopsis thaliana] gi|209529801|gb|ACI49795.1| At3g20190 [Arabidopsis thaliana] gi|224589571|gb|ACN59319.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332642824|gb|AEE76345.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/613 (54%), Positives = 440/613 (71%), Gaps = 21/613 (3%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT 88
SD + LL+FK +L ++S + +W+ +PC N NW GVLC+ G+VWGL+LE M L+G
Sbjct: 51 SDADCLLRFKDTLVNAS-FISSWDPSISPCKRNSENWFGVLCVTGNVWGLQLEGMGLTGK 109
Query: 89 IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSL 148
+ E L + +LR +SFMNNKF G +P ++ G LKS+YLS+N F+G I DAF+GM L
Sbjct: 110 LDLEPLAAIKNLRTLSFMNNKFNGSMPSVKNFGALKSLYLSNNRFTGEIPADAFDGMHHL 169
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPI 208
KKL +ANN G+IPSSL LP L+ELRL N+F G++P KQ +++ NN+LEGPI
Sbjct: 170 KKLLLANNAFRGSIPSSLAYLPMLLELRLNGNQFHGEIPYFKQKDLKLASFENNDLEGPI 229
Query: 209 PESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEV 268
PESLS MDP +F+GNKNLCGPPL ++ S P ++N NQ
Sbjct: 230 PESLSNMDPVSFSGNKNLCGPPL---------SPCSSDSGSSPDLPSSPTEKNKNQ---- 276
Query: 269 SLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSSKLPTSFGSSKVEPEP 328
S I ++++V+G+ L II+ ++ I + R+RK+ S+ +D ++ S+ +
Sbjct: 277 SFFIIAIVLIVIGIILMIISLVVCILHTRRRKSLSAYPSAGQDRTEKYNYDQSTDKDKAA 336
Query: 329 IEIKKKA-------DYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQA 381
+ D KL F++DD++ FDLQD+LRASAEVLGSG+FG+SYKT I++GQ
Sbjct: 337 DSVTSYTSRRGAVPDQNKLLFLQDDIQRFDLQDLLRASAEVLGSGSFGSSYKTGINSGQM 396
Query: 382 YVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGK 441
VVKRYK MNNVGR++F EH++RLGRL+HPNLLP+ A+YYR+EEKLL+ EF+ N SLA
Sbjct: 397 LVVKRYKHMNNVGRDEFHEHMRRLGRLKHPNLLPIVAYYYRREEKLLIAEFMPNRSLASH 456
Query: 442 LHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501
LHANH+ +PGLDW TRLKII+GV KG+ YL NEL IPHGHLKSSNV+LD SFEPLL
Sbjct: 457 LHANHSVDQPGLDWPTRLKIIQGVAKGLGYLFNELTTLTIPHGHLKSSNVVLDESFEPLL 516
Query: 502 TDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQ 561
TDYALRP++N + +H LM++YKSPEY+ G ++KK+DVW LG+LILELLTG++PENYL Q
Sbjct: 517 TDYALRPVMNSEQSHNLMISYKSPEYSLKGHLTKKTDVWCLGVLILELLTGRFPENYLSQ 576
Query: 562 GYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621
GYD+ SL WV+NMVKEK+TGDVFDKEM G K K+EM+NLLKIGLSCCEED RME+
Sbjct: 577 GYDANMSLVTWVSNMVKEKKTGDVFDKEMTGKKNCKAEMLNLLKIGLSCCEEDEERRMEM 636
Query: 622 KEVIEKIERLKEG 634
++ +EKIERLKEG
Sbjct: 637 RDAVEKIERLKEG 649
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297830704|ref|XP_002883234.1| hypothetical protein ARALYDRAFT_479539 [Arabidopsis lyrata subsp. lyrata] gi|297329074|gb|EFH59493.1| hypothetical protein ARALYDRAFT_479539 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1646), Expect = e-180, Method: Compositional matrix adjust.
Identities = 335/613 (54%), Positives = 438/613 (71%), Gaps = 21/613 (3%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT 88
SD + LL+FK +L ++S + +W+ +PC N NW GVLC+ G+VWGL+LE M L+G
Sbjct: 51 SDADCLLKFKDTLVNAS-FISSWDPSISPCKRNSENWFGVLCVTGNVWGLQLEGMGLTGK 109
Query: 89 IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSL 148
+ E L + +LR +SFMNNKF G +P ++ +G LKS+YLS+N F+G I DAF+GM L
Sbjct: 110 LDLEPLAPIKNLRTLSFMNNKFNGSMPSVKNLGALKSLYLSNNRFTGEIPADAFDGMHHL 169
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPI 208
KKL +ANN G IPSSL LP L+ELR+ N+F GQ+P+ KQ +++ NN+LEGPI
Sbjct: 170 KKLLLANNAFRGNIPSSLASLPMLLELRVNGNQFHGQIPDFKQKDLKLASFENNDLEGPI 229
Query: 209 PESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEV 268
P SLS MDP +F+GNKNLCGPPL ++ S P ++N NQ
Sbjct: 230 PGSLSNMDPGSFSGNKNLCGPPL---------SPCSSDSGSSPDLPSSPTEKNKNQ---- 276
Query: 269 SLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSSKLPTSFGSSKVEPEP 328
S I ++++V+G+ L II+ ++ I RKRK+ S+ +D ++ S+ +
Sbjct: 277 SFFTIAIVLIVIGIILMIISLVVCILDTRKRKSLSAYPSAGQDRTEKYNYDQSTDKDKAA 336
Query: 329 IEIKKKA-------DYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQA 381
+ D KL F++DD++ FDLQD+LRASAEVLGSG+FGASYKT I++GQ
Sbjct: 337 DSVTSYTSRRGAVPDQNKLLFLQDDIQRFDLQDLLRASAEVLGSGSFGASYKTGINSGQT 396
Query: 382 YVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGK 441
VVKRYK MNNVGRE+F +H++RLGRL HPNLLP+ A+YYR+EEKLL+ EF+ N SLA
Sbjct: 397 LVVKRYKHMNNVGREEFHDHMRRLGRLNHPNLLPIVAYYYRREEKLLIAEFMPNRSLASH 456
Query: 442 LHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501
LHANH+ +PGLDW TR+KII+GV KG+ YL NEL IPHGHLKSSNV+LD SFEPLL
Sbjct: 457 LHANHSVDQPGLDWPTRVKIIQGVAKGLGYLFNELTTLTIPHGHLKSSNVVLDESFEPLL 516
Query: 502 TDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQ 561
TDYALRP++N + +H LM++YKSPEY+ G ++KK+DVW LG+LILELLTG++PENYL Q
Sbjct: 517 TDYALRPVMNSEQSHNLMISYKSPEYSLKGHLTKKTDVWCLGVLILELLTGRFPENYLSQ 576
Query: 562 GYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621
GYD+ SL WV+NMVKEK+TGDVFDKEM G K K+EM+NLLKIGLSCCEED RME+
Sbjct: 577 GYDANMSLVTWVSNMVKEKKTGDVFDKEMTGKKNCKAEMLNLLKIGLSCCEEDEERRMEM 636
Query: 622 KEVIEKIERLKEG 634
++ +EKIERLKEG
Sbjct: 637 RDAVEKIERLKEG 649
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484945|ref|XP_002266187.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Vitis vinifera] gi|297736026|emb|CBI24064.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-178, Method: Compositional matrix adjust.
Identities = 318/626 (50%), Positives = 422/626 (67%), Gaps = 36/626 (5%)
Query: 13 LHVLVLISFVGVTFGL----SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGV 68
L LV+IS V + S +EILL+FK+SL + + AL +WN PC + W GV
Sbjct: 10 LIFLVIISVVHINVASGAKPSQSEILLEFKNSLRNVT-ALGSWNTSTTPCGGSPGGWVGV 68
Query: 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYL 128
+C+NG VWGL+LE M L GTI ++L L LR +SFMNN F+G +P ++K+ LKS++L
Sbjct: 69 ICINGDVWGLQLEGMGLMGTIDMDTLAKLPHLRGISFMNNHFDGAIPKIKKLSALKSVFL 128
Query: 129 SDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188
S+N FSG I DDAF GM SLKK+++A+N+ +G +P SL LP+++ELRLE N F+GQ+PE
Sbjct: 129 SNNQFSGEIEDDAFSGMVSLKKVHLAHNKFSGGVPESLALLPRILELRLEGNHFKGQIPE 188
Query: 189 IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQ 248
+ +++S ++NN LEGPIPESL KM+ ++F+GNKNLCG PL C PK P
Sbjct: 189 FRATQLQSFNISNNNLEGPIPESLRKMELTSFSGNKNLCGAPLGSCPRPKKPTT------ 242
Query: 249 PPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASS 308
++M+V+ + V+L + A I+ LR K Q
Sbjct: 243 ------------------------LMMVVVGIVVALALSAIIVAFILLRCSKCQTTLVQV 278
Query: 309 YEDSSKLPT-SFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGT 367
SK+ K++ E KK + GKL ++R+D DL+D+L+ASAE+LGSG
Sbjct: 279 ETPPSKVTCRELDKVKLQESNTESGKKVEQGKLYYLRNDENKCDLKDLLKASAEILGSGY 338
Query: 368 FGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKL 427
FG+SYK V+ NG + VVKR++ MNNVG+E+FQEH++RLGRL HPNLLP A+YYR+EEKL
Sbjct: 339 FGSSYKAVLVNGSSVVVKRFRHMNNVGKEEFQEHMRRLGRLNHPNLLPFVAYYYREEEKL 398
Query: 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLK 487
L+ +F++NGSLA LH NH + +P LDW TRLKIIKG+ KG+AYL+ ELP I PH HLK
Sbjct: 399 LVTDFIDNGSLAIHLHGNHARDQPRLDWATRLKIIKGIAKGLAYLYTELPTLIAPHSHLK 458
Query: 488 SSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILIL 547
SSNVLL +SF PLLTDY L PLIN + A LMVAYKSPEY +G+I+KK+DVWS G LIL
Sbjct: 459 SSNVLLSKSFTPLLTDYGLVPLINQEIAQALMVAYKSPEYKQHGRITKKTDVWSFGTLIL 518
Query: 548 ELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIG 607
E+LTGK+P L QG S L++WVN++ +E+ +VFDKEM G SK EM+ LLKIG
Sbjct: 519 EILTGKFPTQNLQQGQASDTDLASWVNSVSQEEWEDEVFDKEMGGTTNSKWEMVKLLKIG 578
Query: 608 LSCCEEDVLARMELKEVIEKIERLKE 633
L+CCE DV R ++KE +EKIE LKE
Sbjct: 579 LACCEGDVGKRWDMKEAVEKIEELKE 604
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147866686|emb|CAN83670.1| hypothetical protein VITISV_017867 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1628), Expect = e-178, Method: Compositional matrix adjust.
Identities = 318/626 (50%), Positives = 421/626 (67%), Gaps = 36/626 (5%)
Query: 13 LHVLVLISFVGVTFGL----SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGV 68
L LV+IS V + S +EILL+FK+SL + + AL +WN PC + W GV
Sbjct: 10 LIFLVIISVVHINVASGAKPSQSEILLEFKNSLRNVT-ALGSWNTSTTPCGGSPGGWVGV 68
Query: 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYL 128
+C+NG VWGL+LE M L GTI ++L L LR +SFMNN F+G +P ++K+ LKS++L
Sbjct: 69 ICINGDVWGLQLEGMGLMGTIDMDTLAKLPHLRGISFMNNHFDGAIPKIKKLSALKSVFL 128
Query: 129 SDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188
S+N FSG I DDAF GM SLKK+++A+N+ +G +P SL LP+++ELRLE N F+GQ+PE
Sbjct: 129 SNNQFSGEIEDDAFSGMVSLKKVHLAHNKFSGGVPESLALLPRILELRLEGNHFKGQIPE 188
Query: 189 IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQ 248
+ +++S ++NN LEGPIPESL KM+ ++F+GNKNLCG PL C PK P
Sbjct: 189 FRATQLQSFNISNNNLEGPIPESLRKMELTSFSGNKNLCGAPLGSCPRPKKPTT------ 242
Query: 249 PPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASS 308
++M+V+ + V+L + A I+ LR K Q
Sbjct: 243 ------------------------LMMVVVGIVVALALSAIIVAFILLRCSKCQTTLVQV 278
Query: 309 YEDSSKLPT-SFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGT 367
SK+ K++ E KK + GKL ++R+D DL+D+L+ASAE+LGSG
Sbjct: 279 ETPPSKVTCRELDKVKLQESNTESGKKVEQGKLYYLRNDENKCDLKDLLKASAEILGSGY 338
Query: 368 FGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKL 427
FG+SYK V+ NG + VVKR++ MNNVG+E+FQEH++RLGRL HPNLLP A+YYR+EEKL
Sbjct: 339 FGSSYKAVLVNGSSVVVKRFRHMNNVGKEEFQEHMRRLGRLNHPNLLPFVAYYYREEEKL 398
Query: 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLK 487
L+ +F++NGSLA LH NH + +P LDW TRLKIIKG+ KG+AYL+ ELP I PH HLK
Sbjct: 399 LVTDFIDNGSLAIHLHGNHARDQPRLDWATRLKIIKGIAKGLAYLYTELPTLIAPHSHLK 458
Query: 488 SSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILIL 547
SSNVLL SF PLLTDY L PLIN + A LMVAYKSPEY +G+I+KK+DVWS G LIL
Sbjct: 459 SSNVLLSXSFTPLLTDYGLVPLINQEIAQALMVAYKSPEYKQHGRITKKTDVWSFGTLIL 518
Query: 548 ELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIG 607
E+LTGK+P L QG S L++WVN++ +E+ +VFDKEM G SK EM+ LLKIG
Sbjct: 519 EILTGKFPTQNLQQGQASDTDLASWVNSVSQEEWEDEVFDKEMGGTTNSKWEMVKLLKIG 578
Query: 608 LSCCEEDVLARMELKEVIEKIERLKE 633
L+CCE DV R ++KE +EKIE LKE
Sbjct: 579 LACCEGDVGKRWDMKEAVEKIEELKE 604
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449524728|ref|XP_004169373.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1613), Expect = e-176, Method: Compositional matrix adjust.
Identities = 327/634 (51%), Positives = 424/634 (66%), Gaps = 53/634 (8%)
Query: 24 VTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQM 83
V F +SD E LLQFK SL S++AL NW PC + NW GVLCLNG V GL+LE M
Sbjct: 38 VVFSVSDAETLLQFKRSLT-SATALNNWKPSVPPCEHHKSNWAGVLCLNGHVRGLRLENM 96
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAF 142
L G + SL L+ LR +SFMNN G P + K+G L+S+YLS N FSG I DDAF
Sbjct: 97 GLKGEVDMNSLVSLTRLRTLSFMNNTLVGSWPPVISKLGSLRSVYLSYNHFSGEIPDDAF 156
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANN 202
GM LKK+++ NN G IPSSL L +LMELRL+ NKF+GQVP ++ + + L ++NN
Sbjct: 157 TGMKFLKKVFLTNNEFKGPIPSSLASLSRLMELRLDGNKFKGQVPPLQIHTLTKLNVSNN 216
Query: 203 ELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENP 262
EL+GPIP SLS MDPS F+GN +LCG PL C G+ P+
Sbjct: 217 ELDGPIPTSLSHMDPSCFSGNIDLCGDPLPEC-----------------GKAPM------ 253
Query: 263 NQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERA--------------SS 308
LLKI +IV+++G++L ++AAI II LR + ++ +
Sbjct: 254 ---SSSGLLKIAVIVIIVGLTLAVLAAIFIILNLRNQPAALQLGKENAGMINMEDQDQNK 310
Query: 309 YEDSSKLPTSFGSS--KVEPEPIEIKKK-----ADYGKLSFVRDDMEPFDLQDMLRASAE 361
Y ++ ++ G +E + + A++GKL FVRDD E FDLQD+LRASAE
Sbjct: 311 YVNAKQVTAGVGDGYRSIESSSSSVAQATRRGGAEHGKLLFVRDDRERFDLQDLLRASAE 370
Query: 362 VLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+LGSG+FG+SYK T++SN A VVKRYK MNNVGRE+F EH++RLGRL HPNLLPL A+Y
Sbjct: 371 ILGSGSFGSSYKATILSN--AVVVKRYKHMNNVGREEFHEHMRRLGRLTHPNLLPLVAYY 428
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
YRKEEKLL+ +FV+NGSLA LH NH + GLDW TRLKII+G+ +G++YL+ LP +
Sbjct: 429 YRKEEKLLISDFVDNGSLASHLHGNHNLEEAGLDWATRLKIIRGIARGLSYLYTSLPNVL 488
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVW 540
HGHLKSSNVLLD S EPLLTDY L P+ N + +LM+AYKSPEYA G+I+KK+DVW
Sbjct: 489 AAHGHLKSSNVLLDESMEPLLTDYGLSPVANLEQGQSLMMAYKSPEYAQMGRITKKTDVW 548
Query: 541 SLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK-YSKSE 599
S GI+ILE+LTG++PENYL + +D KA L+ WVNNM+KEK+T VFD E+ A+ SK E
Sbjct: 549 SFGIVILEMLTGRFPENYLTRNHDPKADLAAWVNNMIKEKKTPLVFDPELGRARESSKGE 608
Query: 600 MINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
++ +LKI LSCCEEDV R++L +V +IE L +
Sbjct: 609 LLKMLKIALSCCEEDVDRRLDLNQVAAEIEDLND 642
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090562|ref|XP_002309026.1| predicted protein [Populus trichocarpa] gi|222855002|gb|EEE92549.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 323/631 (51%), Positives = 435/631 (68%), Gaps = 51/631 (8%)
Query: 24 VTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCT-FNYPNWNGVLCLNGSVWGLKLEQ 82
+ GL+D+EILL+FK SL+++S AL +W+ PCT N NW GV+C++G +WGL+LE
Sbjct: 2 ASLGLTDSEILLKFKGSLSNAS-ALSDWSDKTTPCTKNNATNWAGVICVDGILWGLQLEN 60
Query: 83 MNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAF 142
M L+G I E+L L L+ +S MNN F+GP+P+ +K+ L+++YLS+N FSG I DAF
Sbjct: 61 MGLAGKIDMETLQALPDLKTLSIMNNNFDGPMPEFKKIVSLRALYLSNNHFSGVIPLDAF 120
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANN 202
+GM LKK+Y+A N TG IPSSL+ LPKL++LRLE N+F GQ+P++ QN + S ++NN
Sbjct: 121 DGMLKLKKVYLAQNEFTGAIPSSLIALPKLLDLRLEGNQFTGQLPDLTQN-LLSFSVSNN 179
Query: 203 ELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENP 262
LEGPIP LSKMD S+F+GNK LCGPPL C + N
Sbjct: 180 ALEGPIPAGLSKMDSSSFSGNKGLCGPPLKECN---------------------TINSNS 218
Query: 263 NQKKEVSLLKIIMIVLVLGVSLG-IIAAILIIFYLRKRK-------------TQIERASS 308
+ KK LL I++I V+G+ LG I+AA L + +R+ + +++ +
Sbjct: 219 DSKKPPVLL-IVIIAAVVGLLLGAIVAAFLFLRRQSQRQPLASIEAPPPPIPSNLKKKTG 277
Query: 309 YEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTF 368
+++ ++ P+S P+ KK + KLSFVRDD E FDL D+L+ASAE+LGSG F
Sbjct: 278 FKEENQSPSS------SPDHSVGSKKGEPPKLSFVRDDREKFDLPDLLKASAEILGSGCF 331
Query: 369 GASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLL 428
G+SYK +++G VVKR+KQMNNVGRE+FQEH++RLGRL+H NLLPL A+YYRKEEKLL
Sbjct: 332 GSSYKAALNSGTMMVVKRFKQMNNVGREEFQEHMRRLGRLKHSNLLPLVAYYYRKEEKLL 391
Query: 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKS 488
+ +FVE GSLA LH + +P LDW +RLKI+KGVV+G+AYL+ +LP I HGHLKS
Sbjct: 392 ITDFVEKGSLAVHLHGHQALGQPSLDWPSRLKIVKGVVRGLAYLYKDLPNIIAAHGHLKS 451
Query: 489 SNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILE 548
SNVLL +S EPLLTDY L P+IN +NA LMVAYKSPEY H+G+I+KK+DVWSLGILILE
Sbjct: 452 SNVLLTQSNEPLLTDYGLVPVINQENAQELMVAYKSPEYLHHGRITKKTDVWSLGILILE 511
Query: 549 LLTGKYPENYLLQGYDS-KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSK-----SEMIN 602
+L+ K P N++ QG S + L+NWVN++ E+ T V DK+M + SE+I
Sbjct: 512 ILSAKLPANFVPQGKGSEEEDLANWVNSVPHEEWTNVVIDKDMTNGPTKQNGGGESEVIK 571
Query: 603 LLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
LLKIGLSCCE DV R++LKE +E+IE +KE
Sbjct: 572 LLKIGLSCCEADVEKRIDLKEAVERIEEIKE 602
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 634 | ||||||
| TAIR|locus:2087595 | 679 | PRK4 "pollen receptor like kin | 0.930 | 0.868 | 0.551 | 1.5e-179 | |
| TAIR|locus:2008061 | 686 | PRK5 "pollen receptor like kin | 0.962 | 0.889 | 0.531 | 4e-170 | |
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.941 | 0.922 | 0.475 | 2.5e-145 | |
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.466 | 0.437 | 0.587 | 2.1e-143 | |
| TAIR|locus:2180409 | 659 | PRK6 "pollen receptor like kin | 0.463 | 0.446 | 0.420 | 6.5e-104 | |
| TAIR|locus:2078546 | 633 | PRK3 "AT3G42880" [Arabidopsis | 0.933 | 0.935 | 0.369 | 3.7e-103 | |
| TAIR|locus:2193942 | 644 | AT1G72460 [Arabidopsis thalian | 0.938 | 0.923 | 0.380 | 8.8e-102 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.963 | 0.911 | 0.353 | 5.2e-97 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.947 | 0.918 | 0.339 | 2.4e-85 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.936 | 0.902 | 0.330 | 2.7e-84 |
| TAIR|locus:2087595 PRK4 "pollen receptor like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1743 (618.6 bits), Expect = 1.5e-179, P = 1.5e-179
Identities = 339/615 (55%), Positives = 439/615 (71%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT 88
SD + LL+FK +L ++S + +W+ +PC N NW GVLC+ G+VWGL+LE M L+G
Sbjct: 51 SDADCLLRFKDTLVNASF-ISSWDPSISPCKRNSENWFGVLCVTGNVWGLQLEGMGLTGK 109
Query: 89 IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSL 148
+ E L + +LR +SFMNNKF G +P ++ G LKS+YLS+N F+G I DAF+GM L
Sbjct: 110 LDLEPLAAIKNLRTLSFMNNKFNGSMPSVKNFGALKSLYLSNNRFTGEIPADAFDGMHHL 169
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPI 208
KKL +ANN G+IPSSL LP L+ELRL N+F G++P KQ +++ NN+LEGPI
Sbjct: 170 KKLLLANNAFRGSIPSSLAYLPMLLELRLNGNQFHGEIPYFKQKDLKLASFENNDLEGPI 229
Query: 209 PESLSKMDPSTFAGNKNLCGPPLDPCVLPK--HPEIPNNVSQPPKGQPPIIVQENPNQKK 266
PESLS MDP +F+GNKNLCGPPL PC P++P S P ++N NQ
Sbjct: 230 PESLSNMDPVSFSGNKNLCGPPLSPCSSDSGSSPDLP---SSP--------TEKNKNQ-- 276
Query: 267 EVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQI-------ERASSYEDSSKLPTSF 319
S I ++++V+G+ L II+ ++ I + R+RK+ +R Y
Sbjct: 277 --SFFIIAIVLIVIGIILMIISLVVCILHTRRRKSLSAYPSAGQDRTEKYNYDQSTDKDK 334
Query: 320 GSSKVXXXXXXXXXXADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNG 379
+ V D KL F++DD++ FDLQD+LRASAEVLGSG+FG+SYKT I++G
Sbjct: 335 AADSVTSYTSRRGAVPDQNKLLFLQDDIQRFDLQDLLRASAEVLGSGSFGSSYKTGINSG 394
Query: 380 QAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439
Q VVKRYK MNNVGR++F EH++RLGRL+HPNLLP+ A+YYR+EEKLL+ EF+ N SLA
Sbjct: 395 QMLVVKRYKHMNNVGRDEFHEHMRRLGRLKHPNLLPIVAYYYRREEKLLIAEFMPNRSLA 454
Query: 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499
LHANH+ +PGLDW TRLKII+GV KG+ YL NEL IPHGHLKSSNV+LD SFEP
Sbjct: 455 SHLHANHSVDQPGLDWPTRLKIIQGVAKGLGYLFNELTTLTIPHGHLKSSNVVLDESFEP 514
Query: 500 LLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYL 559
LLTDYALRP++N + +H LM++YKSPEY+ G ++KK+DVW LG+LILELLTG++PENYL
Sbjct: 515 LLTDYALRPVMNSEQSHNLMISYKSPEYSLKGHLTKKTDVWCLGVLILELLTGRFPENYL 574
Query: 560 LQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM 619
QGYD+ SL WV+NMVKEK+TGDVFDKEM G K K+EM+NLLKIGLSCCEED RM
Sbjct: 575 SQGYDANMSLVTWVSNMVKEKKTGDVFDKEMTGKKNCKAEMLNLLKIGLSCCEEDEERRM 634
Query: 620 ELKEVIEKIERLKEG 634
E+++ +EKIERLKEG
Sbjct: 635 EMRDAVEKIERLKEG 649
|
|
| TAIR|locus:2008061 PRK5 "pollen receptor like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1654 (587.3 bits), Expect = 4.0e-170, P = 4.0e-170
Identities = 337/634 (53%), Positives = 430/634 (67%)
Query: 13 LHVLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN 72
+ VL ++ V SD + LL+FK +L + S +W+ L +PC N NW GVLC N
Sbjct: 30 ISVLCPVAMSQVVVPDSDADCLLRFKDTLANGSE-FRSWDPLSSPCQGNTANWFGVLCSN 88
Query: 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNG 132
VWGL+LE M L+G + + L + +LR +SFMNN F GP+P +++ LKS+YLS+N
Sbjct: 89 -YVWGLQLEGMGLTGKLNLDPLVPMKNLRTISFMNNNFNGPMPQVKRFTSLKSLYLSNNR 147
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
FSG I DAF GM LKK+ +ANN GTIPSSL LP L+ELRL N+FQGQ+P +Q
Sbjct: 148 FSGEIPADAFLGMPLLKKILLANNAFRGTIPSSLASLPMLLELRLNGNQFQGQIPSFQQK 207
Query: 193 EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVL--PKHPEIPNNVSQPP 250
+++ NN+L+GPIPESL MDP +FAGNK LC PL PC P P +P + P
Sbjct: 208 DLKLASFENNDLDGPIPESLRNMDPGSFAGNKGLCDAPLSPCSSSSPGVPVVPVSPVDPK 267
Query: 251 KGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRK--------TQ 302
PP KK S + +I++V+G+ L IIA + R+R
Sbjct: 268 STSPP-------TGKKAGSFYTLAIILIVIGIILVIIALVFCFVQSRRRNFLSAYPSSAG 320
Query: 303 IERASSYEDSSKLPTSFGSSKVXXXXXXXXXXADYGKLSFVRDDMEPFDLQDMLRASAEV 362
ER SY + ++ G+L FVRDD++ FDLQD+LRASAEV
Sbjct: 321 KERIESYNYHQSTNKNNKPAESVNHTRRGSMPDPGGRLLFVRDDIQRFDLQDLLRASAEV 380
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LGSGTFGASYK IS+GQ VVKRYK MNNVGR++F EH++RLGRL HPN+LPL A+YYR
Sbjct: 381 LGSGTFGASYKAAISSGQTLVVKRYKHMNNVGRDEFHEHMRRLGRLNHPNILPLVAYYYR 440
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
+EEKLL+ EF+ N SLA LHAN++ GLDW TRLKIIKGV KG++YL +ELP IP
Sbjct: 441 REEKLLVTEFMPNSSLASHLHANNSA---GLDWITRLKIIKGVAKGLSYLFDELPTLTIP 497
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHN-GKI-SKKSDVW 540
HGH+KSSN++LD SFEPLLTDYALRP+++ ++AH M AYKSPEY + G+I +KK+DVW
Sbjct: 498 HGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHAHNFMTAYKSPEYRPSKGQIITKKTDVW 557
Query: 541 SLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEM 600
G+LILE+LTG++PENYL QGYDS SL WVN+MVKEK+TGDVFDKEMKG K K+EM
Sbjct: 558 CFGVLILEVLTGRFPENYLTQGYDSNMSLVTWVNDMVKEKKTGDVFDKEMKGKKNCKAEM 617
Query: 601 INLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634
INLLKIGL CCEE+ RM+++EV+E +E L+EG
Sbjct: 618 INLLKIGLRCCEEEEERRMDMREVVEMVEMLREG 651
|
|
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
Identities = 300/631 (47%), Positives = 400/631 (63%)
Query: 16 LVLISFVGVTF----GLSDTEILLQFKSSLN-DSSSALVNWNALRNPCTFNYPNWNGVLC 70
L+ +S V V F G+S+TE LL+FK+SL ++AL +WN PC W GVLC
Sbjct: 6 LMFVSIVSVFFMVVNGVSETETLLKFKNSLVIGRANALESWNRRNPPC-----KWTGVLC 60
Query: 71 LNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSD 130
G VWGL+LE + LSG+I E+L L+SLR++SF+NNKF+GP P+ +K+ LKS+YLS+
Sbjct: 61 DRGFVWGLRLENLELSGSIDIEALMGLNSLRSLSFINNKFKGPFPEFKKLVALKSLYLSN 120
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK 190
N F I DAF+GM LKKL++ N G IP+SLV+ PKL+ELRL+ N+F GQ+PE +
Sbjct: 121 NQFDLEIPKDAFDGMGWLKKLHLEQNNFIGEIPTSLVKSPKLIELRLDGNRFTGQIPEFR 180
Query: 191 QNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDP-CVLPKHPEIPNNVSQP 249
+ L L+NN L G IP S S MDP F GNK LCG PLD C P N S
Sbjct: 181 HHP-NMLNLSNNALAGQIPNSFSTMDPKLFEGNKGLCGKPLDTKC------SSPYNHSSE 233
Query: 250 PKGQPPIIVQENPNQKKEVSLLKIIMI-VLVLGVSLGIIAAILIIFYLRKRKTQIERASS 308
PK +K L I+ V L SL II ++ + RK+K + A
Sbjct: 234 PKSS---------TKKTSSKFLYIVAAAVAALAASLIIIGVVIFLIRRRKKKQPLLSAEP 284
Query: 309 YEDSSKLPTSF-----GSSKVXXXXXXXXXXADYGKLSFVRDDMEPFDLQDMLRASAEVL 363
S ++ G KLSF+RDD F+LQD+L+ASAE+L
Sbjct: 285 GPSSLQMRAGIQESERGQGSYHSQNRAAKKMIHTTKLSFLRDDKGKFELQDLLKASAEIL 344
Query: 364 GSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK 423
GSG FGASYKT++SNG VVKR+K MN+ G ++FQEH+KRLGRL H NLLP+ A+YY+K
Sbjct: 345 GSGCFGASYKTLLSNGSVMVVKRFKHMNSAGIDEFQEHMKRLGRLNHENLLPIVAYYYKK 404
Query: 424 EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPH 483
EEKL + +FV NGSLA LH + + +P LDW TR I+KGV +G+ YLH LP + PH
Sbjct: 405 EEKLFVSDFVANGSLAAHLHGHKSLGQPSLDWPTRFNIVKGVGRGLLYLHKNLPSLMAPH 464
Query: 484 GHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLG 543
GHLKSSNVLL FEPLL DY L P+IN ++A LMVAYKSPEY +++KK+DVW LG
Sbjct: 465 GHLKSSNVLLSEKFEPLLMDYGLIPMINEESAQELMVAYKSPEYVKQSRVTKKTDVWGLG 524
Query: 544 ILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINL 603
+LILE+LTGK E++ +S+ L++WV + K + T ++FD+EM ++ ++NL
Sbjct: 525 VLILEILTGKLLESFSQVDKESEEDLASWVRSSFKGEWTQELFDQEMGKTSNCEAHILNL 584
Query: 604 LKIGLSCCEEDVLARMELKEVIEKIERL-KE 633
++IGLSCCE DV R++++E +EK+E L KE
Sbjct: 585 MRIGLSCCEVDVEKRLDIREAVEKMEDLMKE 615
|
|
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 2.1e-143, Sum P(2) = 2.1e-143
Identities = 174/296 (58%), Positives = 226/296 (76%)
Query: 336 DYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGR 395
D KL FVR+D E F LQDMLRASAEVLGSG FG+SYK +S+G+A VVKR++ M+N+GR
Sbjct: 345 DQRKLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGR 404
Query: 396 EDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDW 455
E+F +H+K++GRL HPNLLPL AFYYRKEEKLL+ ++ NGSLA LHAN T + LDW
Sbjct: 405 EEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDW 464
Query: 456 QTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515
RLKI++GV +G+AYL+ P +PHGHLKSSNVLLD +FEPLLTDYAL P++N D +
Sbjct: 465 PIRLKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQS 524
Query: 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNN 575
MVAYK+PE+ + S++SDVWSLGILILE+LTGK+P NYL QG + L+ WV +
Sbjct: 525 QQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTGKFPANYLRQGKGADDELAAWVES 584
Query: 576 MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
+ + + T DVFDKEMK K +++M+ LLKIGL CC+ D+ R+EL E +++IE +
Sbjct: 585 VARTEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEV 640
|
|
| TAIR|locus:2180409 PRK6 "pollen receptor like kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 6.5e-104, Sum P(2) = 6.5e-104
Identities = 124/295 (42%), Positives = 190/295 (64%)
Query: 338 GKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRED 397
G + V D F L D+++A+AEVLG+G+ G++YK V++ G + VVKR + MN + RE
Sbjct: 365 GDIIMVNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMTTGLSVVVKRIRDMNQLAREP 424
Query: 398 FQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQT 457
F ++R G+L HPN+L A++YR+EEKL++ E++ SL LH + L W T
Sbjct: 425 FDVEMRRFGKLRHPNILTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGIYHSELTWAT 484
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT 517
RLKII+GV GM +LH E +PHG+LKSSNVLL ++EPL++DYA PL+ P NA
Sbjct: 485 RLKIIQGVAHGMKFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPSNASQ 544
Query: 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMV 577
+ A+K+PE+A ++S KSDV+ LGI+ILE+LTGK+P YL G + WV + V
Sbjct: 545 ALFAFKTPEFAQTQQVSHKSDVYCLGIIILEILTGKFPSQYLNNGKGG-TDIVQWVQSSV 603
Query: 578 KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
E++ ++ D E+ S +M+ LL++G +C + R++++E + +IE++K
Sbjct: 604 AEQKEEELIDPEIVNNTESMRQMVELLRVGAACIASNPDERLDMREAVRRIEQVK 658
|
|
| TAIR|locus:2078546 PRK3 "AT3G42880" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1022 (364.8 bits), Expect = 3.7e-103, P = 3.7e-103
Identities = 239/647 (36%), Positives = 366/647 (56%)
Query: 15 VLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNG- 73
+L+ SF +S++E L++FK S+N + L +W +PC W G+ C G
Sbjct: 10 LLICFSFTPSLQNVSESEPLVRFKRSVNITKGDLNSWRTGTDPCN---GKWFGIYCQKGQ 66
Query: 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF 133
+V G+ + ++ LSGTI E L L +LR + NN GPLP K+ LKS+ LS+N F
Sbjct: 67 TVSGIHVTRLGLSGTINIEDLKDLPNLRTIRLDNNLLSGPLPPFFKLPGLKSLLLSNNSF 126
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE 193
SG I+DD F+ LK++++ NNRL+G IP+SL+QL L EL ++ N+F G++P +
Sbjct: 127 SGEIADDFFKETPQLKRVFLDNNRLSGKIPASLMQLAGLEELHMQGNQFTGEIPPLTDGN 186
Query: 194 --MRSLGLANNELEGPIPESLS--KMDPSTFAGNKNLCGPPLD-PCVLPKHPEIPNNVSQ 248
++SL L+NN+LEG IP ++S K F GN+ LCG PL+ C E P++
Sbjct: 187 KVLKSLDLSNNDLEGEIPITISDRKNLEMKFEGNQRLCGSPLNIEC-----DEKPSSTGS 241
Query: 249 PPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQI----- 303
G E N K I M++L L + L ++A +I + +KR+ +
Sbjct: 242 ---GN------EKNNTAKA-----IFMVILFLLIFLFVVA--IITRWKKKRQPEFRMLGK 285
Query: 304 ERASSYE-------DSSKLP--------TSFGSSKVXXXXXXXXXX----ADYGKLSFVR 344
+ S E DS K P + GSSK + G + V
Sbjct: 286 DHLSDQESVEVRVPDSIKKPIDSSKKRSNAEGSSKKGSSHNGKGAGGGPGSGMGDIIMVN 345
Query: 345 DDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR 404
+ F L D+++A+AEVLG+G+ G++YK V++NG + VVKR + MN + RE F ++R
Sbjct: 346 SEKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMANGLSVVVKRIRDMNKLAREAFDTEMQR 405
Query: 405 LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG 464
G+L HPN+L A++YR+EEKL++ E++ SL LH + L W TRLKII+G
Sbjct: 406 FGKLRHPNVLTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGVYHSELTWATRLKIIQG 465
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKS 524
V +GM +LH E +PHG+LKSSNVLL ++EPL++DYA PL+ P+NA + A+KS
Sbjct: 466 VARGMDFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPNNASQALFAFKS 525
Query: 525 PEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584
PE+ N ++S KSDV+ LGI++LE++TGK+P YL G + WV + + + + +
Sbjct: 526 PEFVQNQQVSPKSDVYCLGIIVLEVMTGKFPSQYLNTGKGG-TDIVEWVQSSIAQHKEEE 584
Query: 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
+ D E+ S +M+ LL+IG +C + R +KE++ +IER+
Sbjct: 585 LIDPEIASNTDSIKQMVELLRIGAACIASNPNERQNMKEIVRRIERV 631
|
|
| TAIR|locus:2193942 AT1G72460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
Identities = 243/638 (38%), Positives = 364/638 (57%)
Query: 17 VLISFVGVTFG-LSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSV 75
+++S ++ ++++E LL+FK SLN++ S L +W PC + W G+LC SV
Sbjct: 10 IVLSLTALSANSITESESLLKFKKSLNNTKS-LDSWTPESEPCGASQ-RWIGLLCNKNSV 67
Query: 76 WGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSG 135
+GL++EQM LSG + L L SLR +S MNN F G +P+ ++ LKS+Y+S N FSG
Sbjct: 68 FGLQIEQMGLSGKVDVAPLKDLPSLRTISIMNNSFSGDIPEFNRLTALKSLYISGNRFSG 127
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ-LPKLMELRLEANKFQGQVPEIKQNEM 194
NI D FE M SLKK +++NN +G IP SL LP L+ELRLE N+F G +P Q +
Sbjct: 128 NIPSDYFETMVSLKKAWLSNNHFSGLIPISLATTLPNLIELRLENNQFIGSIPNFTQTTL 187
Query: 195 RSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLD-PCVLPKHPEIPNNVSQPPKGQ 253
+ L+NN+L G IP L K D TFAGN LCG L PC PK+ + S +G
Sbjct: 188 AIVDLSNNQLTGEIPPGLLKFDAKTFAGNSGLCGAKLSTPCPQPKN----STASITIEG- 242
Query: 254 PPIIVQENPNQKK---EVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYE 310
++ N+ K S L +++IV++ VSL + R+T E+ +S +
Sbjct: 243 ----TMKDANKSKYFLAFSTLGVLLIVVL--VSLAFRKKKKKRRRKKARRTS-EQDNS-D 294
Query: 311 DSSKLPTSFGSSKVXXXXXXXXXXADYG-----KLSFVRDDMEPFDLQDMLRASAEVLG- 364
D T GS+ + G L V + F L D+++A+A VLG
Sbjct: 295 DQQIQVTVEGSNSSRQSRSSRSGELNKGVAGTSDLVMVNKEKGVFRLSDLMKAAAHVLGN 354
Query: 365 ----------SGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
SG G++YK V+SNG VVKR MN V + F + I++LG L+H N+L
Sbjct: 355 PGGGSNRPRSSGGVGSAYKAVLSNGVTVVVKRVTVMNQVSVDVFDKEIRKLGSLQHKNVL 414
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
A+++R++EKLL++EFV N +L +LH +H + + LDW +RLKII+G+ +GM YLH
Sbjct: 415 TPLAYHFRQDEKLLVFEFVPNLNLLHRLHGDHEEFQ--LDWPSRLKIIQGIARGMWYLHR 472
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKIS 534
EL +PHG+LKSSN+ L EPL++++ L+ LINPD +VA+KSPE +G +S
Sbjct: 473 ELGFLNLPHGNLKSSNIFLAEDGEPLISEFGLQKLINPDAQSQSLVAFKSPEADRDGTVS 532
Query: 535 KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA- 593
KSDV+S G+++LE+LTGK+P Y A+L W+ + +++ D+ + A
Sbjct: 533 AKSDVFSFGVVVLEILTGKFPSQYAGLNRAGGANLVEWLGSALEQGGWMDLLHPMVVTAA 592
Query: 594 ---KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628
K + E+ N+L+IG+ C ED R + EV++++
Sbjct: 593 AEDKIMEEEIENVLRIGVRCTREDPDQRPNMTEVVDEL 630
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
Identities = 226/640 (35%), Positives = 348/640 (54%)
Query: 12 VLHVLVLISFVGVTFGLS-DTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLC 70
+L +L+L+ ++ S D+E LL FK + DS+ L +WN NPC W GV C
Sbjct: 12 LLSLLILLQSCLLSSSSSTDSETLLNFKLTA-DSTGKLNSWNTTTNPC-----QWTGVSC 65
Query: 71 LNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSD 130
V L LE +NL+G+I+ SL L+SLR +S +N GP+P+L + LK ++LS+
Sbjct: 66 NRNRVTRLVLEDINLTGSIS--SLTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSN 123
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK 190
N FSGN + +T L +L ++ N +G IP L L L+ LRLE+N+F GQ+P I
Sbjct: 124 NQFSGNFPT-SITSLTRLYRLDLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNIN 182
Query: 191 QNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVL----PKHPEIPNNV 246
++++ ++ N G IP SLS+ S F N +LCG PL C P P P+
Sbjct: 183 LSDLQDFNVSGNNFNGQIPNSLSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEA 242
Query: 247 SQPPKGQP------PIIVQ--ENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRK 298
P +P P + + N +S + +I I+L + L ++ +L + R+
Sbjct: 243 KASPLNKPETVPSSPTSIHGGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQ 302
Query: 299 RKTQIERASSYEDSSKLPTSFGS--SKVXXXXXXXXXXADYGKLSFVRDDMEPFDLQDML 356
++ S + K+ S + D GK+ F + F+L+D+L
Sbjct: 303 YAVNKKKHSKILEGEKIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFF-EGTRRFELEDLL 361
Query: 357 RASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLP 415
RASAE+LG G FG +YK V+ +G VKR K V G+++F++ ++ LGRL H NL+
Sbjct: 362 RASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVS 421
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L A+Y+ +EEKLL+Y+++ NGSL LH N R LDW TRLKI G +G+A++H
Sbjct: 422 LKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGS 481
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISK 535
+ HG +KS+NVLLDRS ++D+ L + P Y++PE K ++
Sbjct: 482 CKTLKLTHGDIKSTNVLLDRSGNARVSDFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQ 540
Query: 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKA-SLSNWVNNMVKEKRTGDVFDKEMKGAK 594
KSDV+S G+L+LE+LTGK P N + G+ A L WV ++V+E+ T +VFD E+ K
Sbjct: 541 KSDVYSFGVLLLEILTGKCP-NMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYK 599
Query: 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634
+ EM+ LL+I ++C R ++ V++ IE ++ G
Sbjct: 600 DIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGG 639
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 217/639 (33%), Positives = 335/639 (52%)
Query: 7 RPARNVLHV-LVLISFVGVTF------GL-SDTEILLQFKSSLNDSSSALVNWNALRNPC 58
RP++ L LV FV TF L SD + LL F +S+ +NWN+ + C
Sbjct: 17 RPSKGFLSTCLVSFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRR--LNWNSTNHIC 74
Query: 59 TFNYPNWNGVLCLNG--SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP- 115
+W GV C + SV L+L + L G I +LG L SLR +S +N G LP
Sbjct: 75 K----SWVGVTCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPP 130
Query: 116 DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMEL 175
D+ + L IYL N FSG + +F L L ++ N TG IP++ L +L L
Sbjct: 131 DIHSLPSLDYIYLQHNNFSGEVP--SFVSR-QLNILDLSFNSFTGKIPATFQNLKQLTGL 187
Query: 176 RLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCV 235
L+ NK G VP + +R L L+NN L G IP +L S+F+GN LCG PL PC
Sbjct: 188 SLQNNKLSGPVPNLDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCA 247
Query: 236 LPKHP-EIPNNVSQPPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIF 294
P + ++S PP PP +E +K VS I+ + G +L ++ ++I+
Sbjct: 248 TSSPPPSLTPHISTPPL--PPFPHKEGSKRKLHVST---IIPIAAGGAALLLLITVIILC 302
Query: 295 YLRKRKTQIERASSYEDSSKLPTSFGSSKVXXXXXXXXXXADYGKLSFVRDDMEPFDLQD 354
K+K + E + K+ T + K + KL F FDL+D
Sbjct: 303 CCIKKKDKRE-----DSIVKVKTL--TEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLED 355
Query: 355 MLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNL 413
+LRASAEVLG G++G +YK V+ VVKR K++ G+ +F++ ++ + R+ HP++
Sbjct: 356 LLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVA-AGKREFEQQMEIISRVGNHPSV 414
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+PL A+YY K+EKL++ ++ G+L+ LH N ++ LDW +R+KI KG+A+LH
Sbjct: 415 VPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLH 474
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKI 533
G HG++KSSNV++ + + ++D+ L PL+ A Y++PE K
Sbjct: 475 -AAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKH 533
Query: 534 SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593
+ KSDV+S G+LILE+LTGK P D L WV ++V+E+ T +VFD E+
Sbjct: 534 THKSDVYSFGVLILEMLTGKSPVQS--PSRDDMVDLPRWVQSVVREEWTSEVFDIELMRF 591
Query: 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
+ + EM+ +L+I ++C + R + +V+ IE ++
Sbjct: 592 QNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 209/633 (33%), Positives = 332/633 (52%)
Query: 11 NVLHVLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLC 70
++ +L+L V + ++ + LL F + + + WN + C NW GV C
Sbjct: 10 SLFSILLLTQRVN-SESTAEKQALLTFLQQIPHENR--LQWNESDSAC-----NWVGVEC 61
Query: 71 LNG--SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIY 127
+ S+ L+L L G I + SLG L+ LR +S +N+ G +P D + L+S+Y
Sbjct: 62 NSNQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLY 121
Query: 128 LSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP 187
L N FSG +F + +L +L +++N TG+IP S+ L L L L N F G +P
Sbjct: 122 LQHNEFSGEFPT-SFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLP 180
Query: 188 EIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVS 247
I + ++NN L G IP SLS+ +F GN +LCG PL PC +
Sbjct: 181 SISLG-LVDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPC---------KSFF 230
Query: 248 QPPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLG--IIAAILIIFYLRKRKTQIER 305
P P +I N K+ L K ++ +++ +L ++ A+L+ LRKR+ E
Sbjct: 231 VSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEA 290
Query: 306 ASSYEDSS-------KLPTSFGSSK--VXXXXXXXXXXADYGKLSFVRDDMEPFDLQDML 356
+ + LP SSK V + KL F + FDL+D+L
Sbjct: 291 RTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLL 350
Query: 357 RASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
RASAEVLG G+ G SYK V+ G VVKR K + +++F+ ++ +G+++HPN++PL
Sbjct: 351 RASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVM-ASKKEFETQMEVVGKIKHPNVIPL 409
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
A+YY K+EKLL+++F+ GSL+ LH + R LDW R++I +G+A+LH +
Sbjct: 410 RAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLH--V 467
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKK 536
++ HG++K+SN+LL + + ++DY L L + + + Y +PE K++ K
Sbjct: 468 SAKLV-HGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFK 526
Query: 537 SDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYS 596
SDV+S G+L+LELLTGK P L G + L WV ++V+E+ T +VFD E+
Sbjct: 527 SDVYSFGVLLLELLTGKSPNQASL-GEEG-IDLPRWVLSVVREEWTAEVFDVELMRYHNI 584
Query: 597 KSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629
+ EM+ LL+I ++C R ++EV+ IE
Sbjct: 585 EEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIE 617
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01350071 | hypothetical protein (653 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 634 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-29 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-22 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.001 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.001 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.002 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.002 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.003 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.003 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.003 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.003 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.004 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.004 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 148/598 (24%), Positives = 256/598 (42%), Gaps = 121/598 (20%)
Query: 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
V+ L + NL G I + + SL+ +S NKF G LPD L+++ LS N FS
Sbjct: 430 VYFLDISNNNLQGRINSRKWDM-PSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFS 488
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEM 194
G + ++ L +L ++ N+L+G IP L KL+ L L N+ GQ+P +EM
Sbjct: 489 GAVPR-KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA-SFSEM 546
Query: 195 RSLG---LANNELEGPIPESLSKMD----------------PST----------FAGNKN 225
L L+ N+L G IP++L ++ PST AGN +
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 226 LCGPPLDPCVLPKHPEIPNNVSQPPKGQPPI-IVQENPNQKKEVSLLKIIMIVLVLGVSL 284
LCG G PP V++ P+ ++ +VL L
Sbjct: 607 LCG------------------GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLAL---- 644
Query: 285 GIIAAILIIFYLRKRKTQIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVR 344
A +F + +++R + ED + F SKV
Sbjct: 645 ---VAFGFVFIRGRNNLELKRVEN-EDGT-WELQFFDSKV-------------------- 679
Query: 345 DDMEPFDLQDMLRASAE--VLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEH 401
+ + D+L + E V+ G GASYK I NG +VVK +N++ + +
Sbjct: 680 --SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD- 736
Query: 402 IKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI 461
+G+L+HPN++ L ++ L++E++E +L+ L L W+ R KI
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKI 785
Query: 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA 521
G+ K + +LH +++ G+L +++D EP L +L L+ D + A
Sbjct: 786 AIGIAKALRFLHCRCSPAVVV-GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA 843
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDS-----KASLSN----- 571
Y +PE I++KSD++ G++++ELLTGK P + + S + S+
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 572 WVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629
W++ ++ +++E++ ++ + L C D AR +V++ +E
Sbjct: 904 WIDPSIRGD------------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKRY-KQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
LG G FG Y G+ +K K+ ++ E+ I+ L +L HPN++ L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+ L+ E+ E GSL L + L L+I+ +++G+ YLH+ I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 481 IPHGHLKSSNVLLD-RSFEPLLTDYAL-RPLINPDNAHTLMV---AYKSPEYAHN-GKIS 534
I H LK N+LLD + + L D+ L + L + + +V AY +PE G S
Sbjct: 114 I-HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 535 KKSDVWSLGILILEL 549
+KSD+WSLG+++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK---RYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
LGSG+FG YK G+ VK + + + + +E I+ L RL HPN++ L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARRE-IRILRRLSHPNIVRL 63
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ K+ L+ E+ E G L L + L KI +++G+ YLH+
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLHSN- 117
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALRPLINPDNAHTLMV--AYKSPE-YAHNG 531
II H LK N+LLD + + D+ A + L + + T + Y +PE
Sbjct: 118 --GII-HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 532 KISKKSDVWSLGILILELLTGKYP 555
K DVWSLG+++ ELLTGK P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 36/274 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLP 415
E LG G+FG Y G+ +K + + +E I R L +L+HPN++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKV---IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + +++ L+ E+ E G L L K+R L ++ ++ + YLH++
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV---AYKSPEYAHNGK 532
I+ H LK N+LLD L D+ L ++P T V Y +PE
Sbjct: 117 ---GIV-HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 533 ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592
K D+WSLG+++ ELLTGK P + L + K K
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP-------FPGDDQLLELFKKIGKPK-----PPFPPPE 220
Query: 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
S E +L++ +D R+ +E ++
Sbjct: 221 WDISP-EAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLP 415
+ LG G FG K VK K+ + R+DF + + + +L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHAN----HTKQRPGLDWQTRLKIIKGVVKGMAY 471
L +E L+ E++E G L L + + ++ L + L + KGM Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSP 525
L ++ + H L + N L+ ++D+ L + D+ + + + +P
Sbjct: 121 LASK---KFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 526 EYAHNGKISKKSDVWSLGILILELLT-GKYP 555
E +G + KSDVWS G+L+ E+ T G P
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLL 414
+ LG G FG + K + V VK K+ + RE+F E + +L HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L + E ++ E++ G L L K L + L++ + KGM YL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPEYA 528
+ + + H L + N L+ + ++D+ L I D+ + + + +PE
Sbjct: 121 K---NFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 529 HNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
+GK + KSDVWS G+L+ E+ T G+ YP L GY
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE---HPNLLPL 416
E +G G FG YK G+ +K + +E ++ I + L+ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKV---IKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
Y +K+E ++ EF GSL L + + L + K ++KG+ YLH+
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT----LTESQIAYVCKELLKGLEYLHSN- 117
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV---AYKSPEYAHNGKI 533
II H +K++N+LL E L D+ L ++ A MV + +PE +
Sbjct: 118 --GII-HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 534 SKKSDVWSLGILILELLTGKYP 555
K+D+WSLGI +EL GK P
Sbjct: 175 DYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E+LG G+FG+ Y G+ VK + E + I+ L L+HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63
Query: 418 AFYY---RKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
YY R EEK L E+V GSL+ L K+ L K + +++G+AY
Sbjct: 64 --YYGSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQILEGLAY 116
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY----ALRPLINPDNAHTLM--VAYKSP 525
LH+ I+ H +K +N+L+D L D+ L + + ++ + +P
Sbjct: 117 LHSN---GIV-HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E + + +D+WSLG ++E+ TGK P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 362 VLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPL 416
VLG G+ G YK G+ Y +K+ ++ G E+F++ + R L E P ++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKK---IHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+Y++ E ++ E+++ GSLA L K+ + I + ++KG+ YLH +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--DNAHTLM--VAYKSPEYAHNGK 532
II H +K SN+L++ E + D+ + ++ D +T + V Y SPE
Sbjct: 120 --HII-HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 533 ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASL 569
S +D+WSLG+ +LE GK+P +L G S L
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFEL 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGRE--DFQEHIKRLGRLEHPNLLPLT 417
+++G G FG YK + + G +K+ + I L L+HPN++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRL--KIIKGVVKGMAYLHNE 475
+ ++ E+ ENGSL + + L + V++G+AYLH +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFG-------PFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHNG 531
+I H +K++N+L + L D+ + +N + V + +PE
Sbjct: 119 ---GVI-HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 532 KISKKSDVWSLGILILELLTGKYP 555
S SD+WSLG ++ELLTG P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 37/205 (18%)
Query: 32 EILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGS-VWGLKLEQMNLSGTIA 90
E+LL FKSS+ND L NWN+ + C W G+ C N S V + L N+SG I+
Sbjct: 32 ELLLSFKSSINDPLKYLSNWNSSADVC-----LWQGITCNNSSRVVSIDLSGKNISGKIS 86
Query: 91 AESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150
+ L P +++I LS+N SG I DD F +SL+
Sbjct: 87 SAIFRL----------------PY--------IQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP-EIKQ-NEMRSLGLANNELEGPI 208
L ++NN TG+IP +P L L L N G++P +I + ++ L L N L G I
Sbjct: 123 LNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 209 PES---LSKMDPSTFAGNKNLCGPP 230
P S L+ ++ T A N+ + P
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIP 205
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 29/224 (12%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQM-NNVGREDFQEHIKRLGRLEHPNLL 414
+ LG G FG K + V VK K+ + E+F + + +L+HPN++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L +E ++ E++E G L L N RP L L + +GM YL +
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIARGMEYLES 120
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAH 529
+ + I H L + N L+ + ++D+ L + D+ + + + +PE
Sbjct: 121 K---NFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 530 NGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
GK + KSDVWS G+L+ E+ T G+ YP YL GY
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY 220
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+ +G G+FG Y S+G+ YV+K M+ RED +K L +L HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII--- 62
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRP-----GLDWQTRLKIIKGVVKGM 469
+Y EEK L E+ + G L+ K+ + +P LDW +L +
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLAL 116
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMV---AYKSP 525
YLH+ I H +K N+ L + L D+ + + L + + +V Y SP
Sbjct: 117 KYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E N + KSD+WSLG ++ EL T K+P
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQM-NNVGREDFQEHIKRLGRLEHPNLL 414
+ LG G FG + K + V VK K+ + E+F + + +L+HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L +E +++ E++ G L L + L L + +GM YL +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDL---LDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAH 529
+ + I H L + N L+ + ++D+ L + D+ + + + + +PE
Sbjct: 122 K---NFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 530 NGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
GK + KSDVWS G+L+ E+ T G+ YP YL +GY
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY 221
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LGSG FG ++ + N +K K + + ++DFQ+ ++ L RL H +L+ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
E ++ E +E GSL L + + L + + + V +GMAYL + + I
Sbjct: 74 GEPVYIITELMEKGSL---LAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI- 126
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NAHTLMVAYKSPEYAHNGKISKKSD 538
H L + N+L+ + D+ L LI D + + + +PE A +G S KSD
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 539 VWSLGILILELLT-GKYP 555
VWS GIL+ E+ T G+ P
Sbjct: 187 VWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+G G+FG +K V ++ + Y +K+ +MN RE+ + + L +L+ ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRP-GLDWQTRLKIIKGVVKGMAYLHNEL 476
+ K + ++ E+ ENG L L + P W+ ++I+ G +A+LH++
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHSKK 121
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--AHTLMVA--YKSPEYAHNGK 532
I H +KS N+ LD + D + L++ + A+T++ Y SPE +
Sbjct: 122 ----ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
++KSDVW+LG+++ E TGK+P
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-17
Identities = 56/141 (39%), Positives = 81/141 (57%), Gaps = 11/141 (7%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP----DLRKMGPLKSIYLSDNGF 133
L L NL+G I + SLG L +L+ + NK GP+P L+K L S+ LSDN
Sbjct: 241 LDLVYNNLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK---LISLDLSDNSL 296
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQ 191
SG I + + + +L+ L++ +N TG IP +L LP+L L+L +NKF G++P+ K
Sbjct: 297 SGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 192 NEMRSLGLANNELEGPIPESL 212
N + L L+ N L G IPE L
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGL 376
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG+G FG ++ + +N VK K + +DF + + +L HP L+ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
+E ++ E ++ GSL L + L + + V GMAYL E I
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYL--EAQNYI-- 125
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NAHT---LMVAYKSPEYAHNGKISKKS 537
H L + NVL+ + + D+ L +I D A + + +PE A + S KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 538 DVWSLGILILELLT-GKYP 555
DVWS GIL+ E++T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 362 VLGSGTFGASYKTV-ISNGQAYVVKR-YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG+G G K + G+ VK ++N ++ + L + P ++
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+Y + + E+++ GSL K+ + P + KI V+KG+ YLH +
Sbjct: 68 FYNNGDISICMEYMDGGSLD-KILKEVQGRIPE---RILGKIAVAVLKGLTYLHEKH--K 121
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP---DNAHTLMVAYKSPEYAHNGKISK 535
II H +K SN+L++ + L D+ + L+N T Y +PE S
Sbjct: 122 II-HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS--YMAPERIQGNDYSV 178
Query: 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595
KSD+WSLG+ ++EL TG++P D L ++ N + F +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF----- 233
Query: 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627
+ +NL C +D R KE++E
Sbjct: 234 --QDFVNL------CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
+GSG FG + + +K ++ + EDF E + + +L HP L+ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
+ L++EF+E+G L+ L A QR +T L + V +GMAYL + S +
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES----SNVI 122
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPD-----NAHTLMVAYKSPEYAHNGKISKKS 537
H L + N L+ + ++D+ + + D V + SPE K S KS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 538 DVWSLGILILELLT-GKYP 555
DVWS G+L+ E+ + GK P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 26/172 (15%)
Query: 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIY 127
LC +G+++ L L +L G I +SLG SLR V +N F G LP + K+ + +
Sbjct: 376 LCSSGNLFKLILFSNSLEGEIP-KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 128 LSDNGFSGNISDDAFE----------------------GMTSLKKLYMANNRLTGTIPSS 165
+S+N G I+ ++ G L+ L ++ N+ +G +P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494
Query: 166 LVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNELEGPIPESLSKM 215
L L +LM+L+L NK G++P+ + ++ SL L++N+L G IP S S+M
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 49/287 (17%)
Query: 362 VLGSGTFGASYKTV-ISNGQ----AYVVKRYKQMNNVGREDFQE---HIKRLGRLEHPNL 413
VLGSG FG YK V I G+ +K + + +E + ++HP++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMASVDHPHV 71
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ L + L+ + + G L + + + Q L + KGM+YL
Sbjct: 72 VRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN----IGSQYLLNWCVQIAKGMSYL- 125
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSP------EY 527
E + H L + NVL+ +TD+ L L++ D K P E
Sbjct: 126 -EEKRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 528 AHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586
+ + KSDVWS G+ + EL+T G P Y+ ++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP-------YEG--------------IPAVEIP 221
Query: 587 DKEMKGAKYSKSEM--INLLKIGLSCCEEDVLARMELKEVIEKIERL 631
D KG + + + I++ + + C D +R KE+I + ++
Sbjct: 222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRY--KQMNNVGREDFQEHIKR----LGRLE-HPN 412
+++G G+F + Y +K +Q+ +E +++K L RL HP
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI---KEKKVKYVKIEKEVLTRLNGHPG 63
Query: 413 LLPLTAFY-YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
++ L +Y ++ EE L + E+ NG L + ++ LD + ++ +
Sbjct: 64 IIKL--YYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLALE 116
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NAHTLMVA------- 521
YLH++ II H LK N+LLD+ +TD+ +++P+ A
Sbjct: 117 YLHSK---GII-HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 522 ---------------YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y SPE + K SD+W+LG +I ++LTGK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 361 EVLGSGTFGASYKTVIS-NGQAYV---VKRYK-QMNNVGREDFQEHIKRLGRLEHPNLLP 415
+V+G G FG + + G+ + +K K ++ R DF +G+ +HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + +++ E++ENGSL L N K + +++G+ GM YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM-----VAYKSPEYAH 529
+ H L + N+L++ + ++D+ L R L + + +T + + +PE
Sbjct: 126 --NYV--HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 530 NGKISKKSDVWSLGILILELLT 551
K + SDVWS GI++ E+++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKRYKQMN--NVGREDFQEHIKR----LGRLEHPNLLP 415
LG G+FG G+ Y +K + + + EH L R+ HP ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMK---VLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 416 LTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLD-WQTRLKIIKGVVKGMAYLH 473
L + ++ EEKL L+ E+ G L +H + + R +V + YLH
Sbjct: 58 L-HYAFQTEEKLYLVLEYAPGGELF-----SHLSKEGRFSEERARF-YAAEIVLALEYLH 110
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYAH 529
+ II + LK N+LLD LTD+ L + L + + Y +PE
Sbjct: 111 SL---GII-YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
K D WSLG+L+ E+LTGK P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-15
Identities = 53/134 (39%), Positives = 72/134 (53%), Gaps = 5/134 (3%)
Query: 85 LSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFE 143
L G I SL L+SL ++ +N+ G +P +L +M LK IYL N SG I +
Sbjct: 176 LVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE-IG 233
Query: 144 GMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE--IKQNEMRSLGLAN 201
G+TSL L + N LTG IPSSL L L L L NK G +P ++ SL L++
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 202 NELEGPIPESLSKM 215
N L G IPE + ++
Sbjct: 294 NSLSGEIPELVIQL 307
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG+G FG + + VK K + E F + + + +L H L+ L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
+E ++ E++ GSL L + K+ L + + + +GMAYL E I
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYL--ESRNYI-- 125
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NAHT---LMVAYKSPEYAHNGKISKKS 537
H L + N+L+ + + D+ L LI D A + + +PE A+ G+ + KS
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 538 DVWSLGILILELLT-GKYP 555
DVWS GIL+ E++T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 75.9 bits (185), Expect = 1e-14
Identities = 63/285 (22%), Positives = 107/285 (37%), Gaps = 35/285 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRL-EHPNLLP 415
LG G+FG Y + + +K + + E R L L PN++
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAK-KLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L F+ + L+ E+V+ GSL + ++ L L I+ ++ + YLH+
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSL--EDLLKKIGRKGPLSESEALFILAQILSALEYLHS- 119
Query: 476 LPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINPDNAHTLM----------VAYKS 524
I H +K N+LLDR L D+ L L+ + + + Y +
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 525 PEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581
PE S SD+WSLGI + ELLTG P +G + ++ S + +++
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSATSQTLKIILELPT 232
Query: 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
+ +LLK +D R+ +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E +G G+FG K S+G+ V K Y M ++ + L L+HPN++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 418 AFYY-----RKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
YY R + L + E+ E G LA +L K+R ++ + +I+ ++ +
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 472 LHN-ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--AHTLMVA--YKSPE 526
HN PG+ + H LK +N+ LD + L D+ L ++ D+ A T + Y SPE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
++ +KSD+WSLG LI EL P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 361 EVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNL 413
E LG G FG YK + + + +K K+ +++F++ + + L+HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-----------LDWQTRLKII 462
+ L +++ +L+E++ +G L L N G LD L I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 463 KGVVKGMAYL--HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM- 519
+ GM YL H+ H L + N L+ ++D+ L I + + +
Sbjct: 131 IQIAAGMEYLSSHH------FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 520 -----VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGY 563
V + PE GK + +SD+WS G+++ E+ + Y LQ Y
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS------YGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 62/203 (30%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLT 417
LG G FG V S + + +K K+ ++ QEHI L HP ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK-RHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGL--DWQTRLKIIKGVVKGMAYLHNE 475
+ K+ +L E+ G L L GL ++ R I VV YLHN
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR------GLFDEYTARF-YIACVVLAFEYLHNR 112
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM--VAYKSPEYAHNGK 532
II + LK N+LLD + L D+ + L + T Y +PE N
Sbjct: 113 ---GII-YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
D WSLGIL+ ELLTG+ P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ LG+G FG + + +K KQ ++ E F + +L+HP L+ L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+E ++ E++ENGSL L + L + + + +GMA++ E I
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEGIK---LTINKLIDMAAQIAEGMAFI--ERKNYI 124
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKIS 534
H L+++N+L+ + + D+ L LI DN +T + + +PE + G +
Sbjct: 125 --HRDLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 535 KKSDVWSLGILILELLT-GKYP 555
KSDVWS GIL+ E++T G+ P
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 363 LGSGTFG--------ASYKTVISNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPN 412
LGSG FG A K I K +N + EDF E K + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAI-----------KAINEGAMSEEDFIEEAKVMMKLSHPK 60
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAY 471
L+ L +++ ++ EF+ENG L N+ +QR G L L + + V +GM Y
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLL-----NYLRQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-----AHTLMVAYKSPE 526
L S I H L + N L+ + ++D+ + + D V + PE
Sbjct: 116 LERN---SFI-HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 527 YAHNGKISKKSDVWSLGILILELLT-GKYP-ENY 558
+ K S KSDVWS G+L+ E+ T GK P E
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 47/126 (37%), Positives = 66/126 (52%), Gaps = 10/126 (7%)
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR-PLINPDNAHTL 518
KI VV+G+ YL+N I H +K SN+L++ + L D+ + LIN A T
Sbjct: 107 KIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-SIADTF 162
Query: 519 M--VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP---ENYLLQGYDSKASLSNWV 573
+ Y SPE GK + KSDVWSLGI I+EL GK+P N G D + + +
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222
Query: 574 NNMVKE 579
+V+E
Sbjct: 223 QQIVQE 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 361 EVLGSGTFGASYKTVISN-GQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPL 416
++G G++G K GQ +K++ + + V + +E I+ L +L H NL+ L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE-IRMLKQLRHENLVNL 65
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ RK+ L++EFV++ L + GLD K + +++G+ + H+
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSH- 119
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEY-AHNG 531
+II H +K N+L+ +S L D+ R L P +T VA Y++PE +
Sbjct: 120 --NII-HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 532 KISKKSDVWSLGILILELLTG 552
K + D+W++G L+ E+LTG
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKR-YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+GSG G YK + G+ Y +K Y + R I+ L + HPN++ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
E +L EF++ GSL G H + + Q ++ G+AYLH
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGT-HIADEQFLADVARQ--------ILSGIAYLHRRH---- 188
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLIN----PDNAHTLMVAYKSPEY--------A 528
I H +K SN+L++ + + D+ + ++ P N+ +AY SPE A
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
++G D+WSLG+ ILE G++P
Sbjct: 249 YDGY---AGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQM--NNVGREDFQE---HIKRLGRLEHPNLL 414
++LGSG FG +K + I G + + + + GR+ FQE H+ +G L+H ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAYLH 473
L +L+ + GSL +H +Q LD Q L + KGM YL
Sbjct: 73 RLLGICPGASLQLVT-QLSPLGSLL-----DHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSP------EY 527
+ H +L + N+LL + D+ + L+ PD+ +K+P E
Sbjct: 127 EHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 528 AHNGKISKKSDVWSLGILILELLT 551
G+ + +SDVWS G+ + E+++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG+G FG K GQ V + + ++ ++F E K + +L H L+ L +
Sbjct: 12 LGTGQFGV-VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
+ ++ E++ NG L L + L++ K V +GMAYL ++
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLESKQ----FI 122
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAHNGKISKKS 537
H L + N L+D ++D+ L + D + + V + PE K S KS
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 538 DVWSLGILILELLT-GKYP 555
DVW+ G+L+ E+ + GK P
Sbjct: 183 DVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LGSG FG + +K ++ + +DF E K + +L HPNL+ L +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAYLHNELPGSII 481
+ ++ E++ NG L N+ ++R G L + L + V + M YL E G I
Sbjct: 71 QRPIFIVTEYMANGCLL-----NYLRERKGKLGTEWLLDMCSDVCEAMEYL--ESNGFI- 122
Query: 482 PHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKISK 535
H L + N L+ ++D+ L + D+ +T V + PE + S
Sbjct: 123 -HRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 536 KSDVWSLGILILELLT-GKYP 555
KSDVWS G+L+ E+ + GK P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 342 FVRDDMEPFDLQDMLRASAEVLGSGTFGASY-KTVISNGQAYVVKRYKQMNNVGREDFQE 400
F +DD E L + +G G+FGA Y + N + +K+ E +Q+
Sbjct: 8 FFKDDPEK------LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 401 HIKR---LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQT 457
IK L +L HPN + Y R+ L+ E+ GS A L H K ++
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS-ASDLLEVHKKPLQEVEIAA 119
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT 517
+ G ++G+AYLH+ ++I H +K+ N+LL L D+ ++ P N
Sbjct: 120 ---VTHGALQGLAYLHSH---NMI-HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172
Query: 518 LMVAYKSPEY---AHNGKISKKSDVWSLGILILELLTGKYP 555
+ +PE G+ K DVWSLGI +EL K P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 54/199 (27%), Positives = 81/199 (40%), Gaps = 15/199 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRED-FQEHIKRLGRLEHPNLLPLTAF 419
+G G FG GQ VK K ++ F + L HPNL+ L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ ++ E++ GSL L ++ R + +L V +GM YL
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLR---SRGRAVITLAQQLGFALDVCEGMEYLE----EK 121
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTLMVAYKSPEYAHNGKISKKS 537
H L + NVL+ ++D+ L D+ L V + +PE K S KS
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK-LPVKWTAPEALREKKFSTKS 180
Query: 538 DVWSLGILILELLT-GKYP 555
DVWS GIL+ E+ + G+ P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG+G FG + +N VK K + + F E + L+H L+ L A +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTK--QRPGL-DWQTRLKIIKGVVKGMAYLHNELPGS 479
+E ++ E++ GSL L ++ P L D+ + + +GMAY+ E
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYI--ERKNY 124
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKI 533
I H L+++NVL+ S + D+ L +I DN +T + + +PE + G
Sbjct: 125 I--HRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 534 SKKSDVWSLGILILELLT-GKYP 555
+ KSDVWS GIL+ E++T GK P
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 342 FVRDDMEPF--DLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE--- 396
F ++D E DL++ +G G+FGA Y + + V K+M+ G++
Sbjct: 18 FFKEDPEKLFTDLRE--------IGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 397 ---DFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGL 453
D + +K L R++HPN + Y R+ L+ E+ GS A L H K +
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GS-ASDLLEVHKKPLQEV 125
Query: 454 DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513
+ I G ++G+AYLH+ + H +K+ N+LL + L D+ + +P
Sbjct: 126 EIAA---ITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 514 NAHTLMVAYKSPEY---AHNGKISKKSDVWSLGILILELLTGKYP 555
N+ + +PE G+ K DVWSLGI +EL K P
Sbjct: 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 362 VLGSGTFGAS--YKTVISNGQAYVVKRYKQMN-----NVGREDFQEHIKRLGRLEHPNLL 414
VLG G FG + Y+ + VV +K++N R D I L L+HPN++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSL--VV--WKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62
Query: 415 PLTAFY--YRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
A+Y + + LL+ E+ G+L K+ K + + + L + +V ++Y
Sbjct: 63 ---AYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQL-FEEEMVLWYLFQIVSAVSY 116
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEY 527
+H I H +K+ N+ L ++ L D+ + ++ + + V Y SPE
Sbjct: 117 IHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587
K + KSD+W+LG ++ ELLT L + +D+ + N V +V+ T
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLT-------LKRTFDA-TNPLNLVVKIVQGNYT----- 219
Query: 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
+ YS SE+I+L+ S ++D R EV++
Sbjct: 220 --PVVSVYS-SELISLVH---SLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 23/204 (11%)
Query: 363 LGSGTFGASYK---TVISNGQAYVV--KRYK-QMNNVGREDFQEHIKRLGRLEHPNLLPL 416
LG G FG + + V K R DF+ I+ L L+H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 417 TAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
+ + L+ E++ +GSL L + R ++ + L + KGM YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQ----RHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-------NAHTLMVAYKSPEY 527
+ I H L + N+L++ ++D+ L ++ D + + +PE
Sbjct: 128 Q--RYI--HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 528 AHNGKISKKSDVWSLGILILELLT 551
K S SDVWS G+ + EL T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 51/221 (23%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGR-------LEHPN 412
E+LGSG+FG+ Y+ + + +G + VK ++ QE +K+L + L+HPN
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ--TGQEAVKQLEQEIALLSKLQHPN 63
Query: 413 LLPLTAFYY---RKEEKLLLY-EFVENGSLAGKLH----------ANHTKQRPGLDWQTR 458
++ Y R+E+ L ++ E V GSLA L +T+Q
Sbjct: 64 IVQ----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--------- 110
Query: 459 LKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL 518
++ G+ YLH+ H +K +N+L+D + L D+ + + +
Sbjct: 111 ------ILLGLEYLHDRN----TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160
Query: 519 MVA---YKSPEY-AHNGKISKKSDVWSLGILILELLTGKYP 555
+ +PE A G +D+WSLG +LE+ TGK P
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK----------RYKQMNNVGREDFQEHIKRLGRLE 409
E++G GT+G Y + ++ G+ VK R+ + + I+ L L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 410 HPNLLPLTAFYYRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKG 468
H N++ F EE L ++ E+V GS+ G + + L R + V++G
Sbjct: 67 HLNIVQYLGFE-TTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQL---VRF-FTEQVLEG 120
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL---INPDNAHTLM---VAY 522
+AYLH++ I H LK+ N+L+D ++D+ + I ++ + M V +
Sbjct: 121 LAYLHSKG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 523 KSPEYAHNGK--ISKKSDVWSLGILILELLTGKYP 555
+PE H+ S K D+WSLG ++LE+ G+ P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 46/134 (34%), Positives = 72/134 (53%), Gaps = 5/134 (3%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAF 142
NLSG I E +G L+SL + + N GP+P L + L+ ++L N SG I F
Sbjct: 223 NLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLA 200
+ L L +++N L+G IP ++QL L L L +N F G++P + ++ L L
Sbjct: 282 -SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340
Query: 201 NNELEGPIPESLSK 214
+N+ G IP++L K
Sbjct: 341 SNKFSGEIPKNLGK 354
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG G FG + NG V + + + E F + + + +L H L+PL A
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
+E ++ EF+ GSL L K L + + + GMAY+ E I
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYI--ERMNYI-- 124
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKISKK 536
H L+++N+L+ + + D+ L LI DN +T + + +PE A G+ + K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 537 SDVWSLGILILELLT-GKYP 555
SDVWS GIL+ EL+T G+ P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG+G FG + NG V + + + E F E + + +L H L+ L A
Sbjct: 14 LGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
E ++ E++ GSL L + L + + V GMAY+ E I
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMAYI--ERMNYI-- 124
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKISKK 536
H L+S+N+L+ + D+ L LI DN +T + + +PE A G+ + K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 537 SDVWSLGILILELLT-GKYP 555
SDVWS GIL+ EL+T G+ P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 361 EVLGSGTFGASYKT-VISNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLT 417
V+G G +G K + G+ +K++K+ + ++ +K L +L H N++ L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ RK L++E+VE L GL I +++ +AY H
Sbjct: 67 EAFRRKGRLYLVFEYVER-----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---- 117
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLI-NPDNAHTLMVA---YKSPE-YAHNG 531
I H +K N+L+ S L D+ R L P + T VA Y++PE +
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 532 KISKKSDVWSLGILILELLTG 552
K DVW++G ++ ELL G
Sbjct: 178 NYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE------DFQEHIKRLGRLEHPNLLPL 416
+G G+FGA Y +N V K+M+ G++ D + +K L +L+HPN +
Sbjct: 29 IGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
Y ++ L+ E+ GS + L + ++P L I G ++G+AYLH+
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVH---KKP-LQEVEIAAITHGALQGLAYLHSH- 140
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY---AHNGKI 533
+ H +K+ N+LL + L D+ +P N+ + +PE G+
Sbjct: 141 ---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 534 SKKSDVWSLGILILELLTGKYP 555
K DVWSLGI +EL K P
Sbjct: 198 DGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 46/213 (21%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGR------EDFQEHIKRLGRLEHPNL 413
+ LG+G F + Y+ + G VK+ + N E ++ I+ + RL HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ + L E++ GS++ L + + + +++G++YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLLRGLSYLH 120
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLM--------VAYKS 524
I H +K +N+L+D + + L + D+ + +A+ +
Sbjct: 121 ENQ----IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 525 PEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557
PE + + DVWS+G +I+E+ T K P N
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGRED--------FQEHIKRLGRLEHPNL 413
+G G++G +K GQ +K++ V ED +E I+ L +L+HPNL
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALRE-IRMLKQLKHPNL 62
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRP-GLDWQTRLKIIKGVVKGMAYL 472
+ L + RK + L++E+ ++ L N ++ P G+ KII ++ + +
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVL------NELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEY- 527
H I H +K N+L+ + + L D+ R L P + +T VA Y++PE
Sbjct: 117 HKH--NCI--HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 528 AHNGKISKKSDVWSLGILILELLTG 552
+ + DVW++G + ELLTG
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 7e-11
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG G FG + NG V + + + E F + + + +L H L+ L A
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTK--QRPGL-DWQTRLKIIKGVVKGMAYLHNELPGS 479
+E ++ E++ GSL L K + P L D ++ V+ M Y+H +L
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL--- 128
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKI 533
+++N+L+ + + D+ L LI DN +T + + +PE A G+
Sbjct: 129 -------RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 534 SKKSDVWSLGILILELLT-GKYP 555
+ KSDVWS GIL+ EL T G+ P
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE---HPNLLPL 416
E LG G++G+ YK + GQ +K + ED QE IK + L+ P ++
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIK---VVPV--EEDLQEIIKEISILKQCDSPYIVKY 63
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHA-NHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
Y++ + ++ E+ GS++ + N T L + I+ +KG+ YLH+
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGLEYLHSN 118
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHNG 531
I H +K+ N+LL+ + L D+ + + A V + +PE
Sbjct: 119 ---KKI-HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 532 KISKKSDVWSLGILILELLTGKYP 555
+ K+D+WSLGI +E+ GK P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 40/212 (18%)
Query: 363 LGSGTFGASYKTVI----SNGQAYVVKRY--KQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
+G G+FG K ++ +G+ YV+K +M+ RE+ ++ + L ++HPN++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 417 TAFYYRKEEKLLLY---EFVENGSLAGKLHANHT---KQRPGLDWQTRLKIIKGVVKGMA 470
+ EE LY ++ E G L K++A + LDW ++ + +
Sbjct: 65 QESF---EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALK 115
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA--------Y 522
++H+ I H +KS N+ L + L D+ + ++N T+ +A Y
Sbjct: 116 HVHDRK----ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN----STVELARTCIGTPYY 167
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKY 554
SPE N + KSD+W+LG ++ E+ T K+
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422
LG+G FG + + VK K ++ E F + L+H L+ L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 423 KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIP 482
E ++ EF+ GSL L ++ ++P + + +GMA++ + I
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFIEQR---NYI- 124
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKISKK 536
H L+++N+L+ S + D+ L +I DN +T + + +PE + G + K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 537 SDVWSLGILILELLT-GKYP 555
SDVWS GIL++E++T G+ P
Sbjct: 184 SDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 45/173 (26%), Positives = 89/173 (51%), Gaps = 24/173 (13%)
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTK----QR 450
R DF +G+ +HPN++ L + + +++ E++ENGSL L + + Q
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL 108
Query: 451 PGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510
G +++G+ GM YL + G + H L + N+L++ + ++D+ L ++
Sbjct: 109 VG--------MLRGIASGMKYLSDM--GYV--HRDLAARNILVNSNLVCKVSDFGLSRVL 156
Query: 511 --NPDNAHT-----LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+P+ A+T + + + +PE K + SDVWS GI++ E+++ G+ P
Sbjct: 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVK-------RYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
+G GTFG Y V + G+ VK K + + E +K L L+HPNL+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE-----MKVLELLKHPNLV 62
Query: 415 PLTAFYYRKE---EKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
YY E EK+ ++ E+ G+L L H + LD +++G+A
Sbjct: 63 K----YYGVEVHREKVYIFMEYCSGGTLEELLE--HGRI---LDEHVIRVYTLQLLEGLA 113
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALRPLINPDNAHTLMV------AY 522
YLH+ I H +K +N+ LD + L D+ A++ N + AY
Sbjct: 114 YLHS----HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 523 KSPEYAHNGKISKK---SDVWSLGILILELLTGKYP 555
+PE GK +D+WSLG ++LE+ TGK P
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQA------YVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNL 413
LG G FG + + + VK K+ +N R+DF+ + L +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN--------HTKQRPG-LDWQTRLKIIKG 464
+ + ++++E++E+G L L ++ G L L+I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM 519
+ GM Y L H L + N L+ + D+ + R + D HT++
Sbjct: 131 IASGMVY----LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 520 -VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+ + PE K + +SDVWS G+++ E+ T GK P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE--DFQEHIKRLGRLEHPNLLPLTA 418
E +G G+FG +K + + Q V + + E D Q+ I L + + P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAYLHNELP 477
Y + + ++ E++ GS L PG LD I++ ++KG+ YLH+E
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALR-PLINPDNAHTLMVA---YKSPEYAHNGKI 533
H +K++NVLL E L D+ + L + V + +PE
Sbjct: 123 ----IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 534 SKKSDVWSLGILILELLTGKYPENYL 559
K+D+WSLGI +EL G+ P + L
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 10/200 (5%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYK--QMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG G++G+ YK +S+ Q Y +K M+ RED I+ L + HPN++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ + ++ E+ G L+ K + K+R + Q +I +++G+ LH +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA--YKSPEYAHNGKISKKS 537
I H LKS+N+LL + + D + ++ + A T + Y +PE S KS
Sbjct: 124 -ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS 182
Query: 538 DVWSLGILILELLTGKYPEN 557
D+WSLG L+ E+ T P
Sbjct: 183 DIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 359 SAEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMNNVGREDF--QEHIKRLGRLEHP 411
+++L GTFG + ++ + VK K + + QE G L H
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQ 68
Query: 412 NLLPLTAFYYRKEEK-LLLYEFVENGSLAGKLHANHTKQRPGLDWQ---TRLKIIKG--V 465
N+LP+ E +LY ++ G+L KL + + Q T+ + +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNL--KLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL------M 519
GM+YLH +I H + + N ++D + +TD AL + P + H L
Sbjct: 127 ACGMSYLHKR---GVI-HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP---------ENYLLQGY 563
V + + E N + S SDVWS G+L+ EL+T G+ P YL GY
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLP 415
EV+G+G FG + + + +V +K K R DF +G+ +HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + +++ EF+ENG+L L N + + +++G+ GM YL +E
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV----IQLVGMLRGIAAGMKYL-SE 124
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH---------TLMVAYKSPE 526
+ H L + N+L++ + ++D+ L + D + + + + +PE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 527 YAHNGKISKKSDVWSLGILILELLT-GKYP 555
K + SDVWS GI++ E+++ G+ P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 60/219 (27%), Positives = 80/219 (36%), Gaps = 57/219 (26%)
Query: 28 LSDTEILLQFKSSLNDSSSAL-----VNWNALRNPCTFNYPNWNGVLCL---NGSVW--- 76
++++ LL+ S+L S+L WN +PC W+G C W
Sbjct: 364 TAESKTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFID 421
Query: 77 GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
GL L+ L G I D+ K+ L+SI LS N GN
Sbjct: 422 GLGLDNQGLRGFIPN------------------------DISKLRHLQSINLSGNSIRGN 457
Query: 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRS 196
I + +TSL+ L ++ N G+IP SL QL L L L N G+VP
Sbjct: 458 IPP-SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA-------- 508
Query: 197 LGLANNELEGPIPESLSKMDPSTFAGNKNLCG-PPLDPC 234
L L F N LCG P L C
Sbjct: 509 -ALGGRLLHRAS---------FNFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 362 VLGSGTFGASY--------------KTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGR 407
++GSG+FG+ Y + + + A R + M + I L
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSM----LDALAREIALLKE 62
Query: 408 LEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
L+H N++ + + E+V GS+A L+ + + ++ ++K
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILK 117
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-------- 519
G+ YLHN I H +K +N+L+D ++D+ + + ++ T
Sbjct: 118 GLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 520 --VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
V + +PE ++K+D+WSLG L++E+LTGK+P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLP 415
E +G G+FG YK + Q +K ++ ED Q+ I+ L + P +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYI-- 61
Query: 416 LTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAY 471
T +Y + K KL ++ E+ GS L +PG LD I++ V+ G+ Y
Sbjct: 62 -TKYYGSFLKGSKLWIIMEYCGGGSCLDLL-------KPGKLDETYIAFILREVLLGLEY 113
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI--NPDNAHTLMVA---YKSPE 526
LH E G I H +K++N+LL + L D+ + + +T V + +PE
Sbjct: 114 LHEE--GKI--HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPE 168
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
+K+D+WSLGI +EL G+ P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 49/208 (23%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQM----NNVGREDFQEHIKRLGRLEHPNLLP 415
+V+G+G FG ++ ++ G+ V K + R+DF +G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + + +++ E++ENG+L L + + +Q + +++G+ GM YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS---YQL-VGMLRGIAAGMKYLSD- 125
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI--NPDNAHT-----LMVAYKSPEYA 528
H L + N+L++ + E ++D+ L ++ +P+ +T + + + +PE
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 529 HNGKISKKSDVWSLGILILELLT-GKYP 555
K + SDVWS GI++ E+++ G+ P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 363 LGSGTFGASY-KTVISNGQAYVVKRYKQMNNVGR---EDFQEHIKR---LGRLEHPNLLP 415
+G G+FGA Y + + +K+ M+ G+ E +Q+ IK L +L HPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKK---MSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
Y R+ L+ E+ GS + L H K L I G ++G+AYLH+
Sbjct: 80 YKGCYLREHTAWLVMEYCL-GSASDILEV-HKK---PLQEVEIAAICHGALQGLAYLHSH 134
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY---AHNGK 532
I H +K+ N+LL L D+ L++P N+ + +PE G+
Sbjct: 135 --ERI--HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
K DVWSLGI +EL K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 362 VLGSGTFGASYKTVISNGQAYVVKR---YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
V+G G FG + Q V+ + +QM R Q + L L HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ + +++ E+ G+LA + + LD T L ++ + ++H +L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQ---KRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 479 SIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMVA---YKSPEYAHNGKIS 534
I H LK+ N+LLD+ + + D+ + +++ + +V Y SPE +
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 535 KKSDVWSLGILILELLTGK 553
+KSD+W+LG ++ EL + K
Sbjct: 180 QKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
E++G G FGA + + GQ VK K +V + F E + +L H NL+ L
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+++ E + G+L L T+ R + L+ V +GM YL ++
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFLR---TRGRALVSVIQLLQFSLDVAEGMEYLESKK---- 120
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT--LMVAYKSPEYAHNGKISKKSD 538
+ H L + N+L+ ++D+ L + L V + +PE + K S KSD
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179
Query: 539 VWSLGILILELLT-GKYP 555
VWS G+L+ E+ + G+ P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 361 EVLGSGTFGASYK-----TVISNGQAYVVKRYKQMNNVGR-EDFQEHIKRLGRLEHPNLL 414
E LG FG YK + + Q +K K +NN + +FQ+ + L HPN++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKL--HANHT----------KQRPGLDWQTRLKII 462
L +++ +L+E++ G L L + H+ + LD L I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHT 517
+ GM YL + H L + N+L+ ++D L R + + D +
Sbjct: 131 IQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 518 LM-VAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
L+ + + PE GK S SD+WS G+++ E+ +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQ----EHIKRLGRLEHPNLLPLT 417
+G GT+G YK G+ +K+ + M N +E F IK L +L HPN++ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MEN-EKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 418 AFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK-IIKGVVKGMAYLHN 474
K + +++E++++ L G L + K ++K +K +++G+ YLH+
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-----QIKCYMKQLLEGLQYLHS 118
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH-------TLMVAYKSPE- 526
I+ H +K SN+L++ L D+ L N+ TL Y+ PE
Sbjct: 119 N---GIL-HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW--YRPPEL 172
Query: 527 ------YAHNGKISKKSDVWSLGILILELLTGK 553
Y + D+WS+G ++ EL GK
Sbjct: 173 LLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKR---YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+G G F Y+ T + +G +K+ + M+ R D + I L +L HPN++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ E ++ E + G L+ ++ + KQ+ + +T K + + ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-- 126
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--AHTLMVA--YKSPEYAHNGKIS 534
+ H +K +NV + + L D L + AH+L+ Y SPE H +
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 535 KKSDVWSLGILILELLTGKYP 555
KSD+WSLG L+ E+ + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYK-QMNNV-----GREDFQEHIKRLGRLEHPNLL 414
EVLG G +G Y + + GQ VK+ + +NV E QE + L L+H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
+ EFV GS++ L+ P K K ++ G+AYLHN
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHN 120
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALR-PLINPDNAHTLMVA-------YKS 524
+ + H +K +NV+L + L D+ A R + H+ M+ + +
Sbjct: 121 ----NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 525 PEYAHNGKISKKSDVWSLGILILELLTGKYP 555
PE + +KSD+WS+G + E+ TGK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKR---YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+G G F Y+ T + + + +K+ ++ M+ R+D + I L +L HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ E ++ E + G L+ ++ KQ+ + +T K + + ++H+
Sbjct: 70 SFIEDNELNIVLELADAGDLS-QMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-- 126
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--AHTLMVA--YKSPEYAHNGKIS 534
+ H +K +NV + + L D L + AH+L+ Y SPE H +
Sbjct: 127 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 535 KKSDVWSLGILILELLTGKYP 555
KSD+WSLG L+ E+ + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 362 VLGSGTFG-ASYKTVISNGQAYVVKRYKQMNNVGRED--FQEHIKRLGRLEHPNLLPLTA 418
V+G G++G S ++G+ YV+K+ N RE ++ + L +L+HPN++
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA--- 63
Query: 419 FYYRKE---EKLLLY---EFVENGSLAGKLHANHTKQRPG---LDWQTRLKIIKGVVKGM 469
YR+ E LLY F E G L KL K P ++W ++ + +
Sbjct: 64 --YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM------AL 115
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP-DNAHTLMVA--YKSP 525
YLH + I H LK+ NV L R+ + D + R L N D A TL+ Y SP
Sbjct: 116 QYLHEKH----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYPEN 557
E N + KSDVW+LG + E+ T K+ N
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE--DFQEHIKRLGRLEHPNLLPLTA 418
E +G G+FG +K + + Q V + + E D Q+ I L + + P +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
Y + + ++ E++ GS L A P ++Q ++K ++KG+ YLH+E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG-----PFDEFQIA-TMLKEILKGLDYLHSEKK- 122
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALR-PLINPDNAHTLMVA---YKSPEYAHNGKIS 534
H +K++NVLL + L D+ + L + V + +PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 535 KKSDVWSLGILILELLTGKYPEN 557
K+D+WSLGI +EL G+ P +
Sbjct: 180 SKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLTA 418
+G+GTFG + + Y + + V R ++H+ L + HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ + +L E+V G L L + T L +V + YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEYLH----S 119
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTL--MVAYKSPEYAHNGKISK 535
I + LK N+LLD+ LTD+ + L D TL Y +PE + +K
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 536 KSDVWSLGILILELLTGKYP 555
D W+LGILI E+L G P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 363 LGSGTFGA----SYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
LG G FG+ Y + N G+ VK+ + DF+ I+ L L+H N++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 418 AFYY---RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
Y R+ +L++ E++ GSL L K R LD + L + KGM YL
Sbjct: 72 GVCYSAGRRNLRLVM-EYLPYGSLRDYLQ----KHRERLDHRKLLLYASQICKGMEYLG- 125
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA--------YKSPE 526
H L + N+L++ + D+ L ++ P + V + +PE
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPE 181
Query: 527 YAHNGKISKKSDVWSLGILILELLT 551
K S SDVWS G+++ EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGR-EDFQEHIKRLGRLEHPNLLPLTAFYY 421
LG G FG YK + + Q+ + EDF I L +HPN++ L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 422 RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSII 481
+ + +L EF + G+L + +R + Q R + + +++ + +LH+ +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRY-VCRQMLEALNFLHSHK----V 124
Query: 482 PHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL----------------MVA---Y 522
H LK+ N+LL + L D+ ++ N TL +VA +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFG----VSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYL 559
K Y + K+D+WSLGI ++EL + P + L
Sbjct: 181 KDNPYDY------KADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 44/213 (20%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 378 NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKL----LLY 430
N + +++ +K+ + V + + IK L R++ N+L + F + L L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSN 490
E+ G L L L ++T+L + KG+ L+ P+ +L S +
Sbjct: 102 EYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVS 153
Query: 491 VLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILIL 547
L+ +++ + + L + L +P + + Y S + ++ + + K D++SLG+++
Sbjct: 154 FLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLW 213
Query: 548 ELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580
E+ TGK P + +K +N K
Sbjct: 214 EIFTGKIP----FENLTTKEIYDLIINKNNSLK 242
|
Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE--DFQEHIKRLGRLEHPNLLPLTA 418
E +G G+FG YK + + + V + + E D Q+ I L + + P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAYLHNELP 477
Y + + ++ E++ GS L +PG L+ I++ ++KG+ YLH+E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-------KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NAHTLMVAYKSPEYAHNGKI 533
H +K++NVLL + L D+ + + N + +PE
Sbjct: 123 ----IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 534 SKKSDVWSLGILILELLTGKYPENYL 559
K+D+WSLGI +EL G+ P + L
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 363 LGSGTFGA-----SYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
LG G FG Y + + V VK K R+DFQ + L L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTR-----------LKIIKGV 465
+ ++++E++++G L L A+ +D Q R L I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM- 519
GM YL ++ H L + N L+ + + D+ + R + + D HT++
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+ + PE K + +SDVWS G+++ E+ T GK P
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 5e-09
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQ-MNNVG------REDFQEHIKRLGRLEHPN 412
E LG GT+G YK G+ +K+ + G RE I L L+HPN
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE-----ISLLKELKHPN 59
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L + + + L++E+ + L L K+ L I+ +++G+AY
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLD----KRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE-- 526
H+ I+ H LK N+L++R L D+ L R P +T V Y++PE
Sbjct: 115 HS---HRIL-HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 527 -----YAHNGKISKKSDVWSLGILILELLTGK 553
Y S D+WS+G + E++TGK
Sbjct: 171 LGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 56/243 (23%), Positives = 91/243 (37%), Gaps = 57/243 (23%)
Query: 361 EVLGSGTFGASYKTVISNG----QAYVVKRYKQMNNVGR--EDFQEHIKRLGRLEHPNLL 414
++LG G FG+ + +S VK K + E+F + +HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 415 PLTAFYYRKEEK------LLLYEFVENGSLAGKLHANHTKQRP-GLDWQTRLKIIKGVVK 467
L + +++ F+++G L L + P L QT LK + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY 527
GM YL N + I H L + N +L + D+ L I S +Y
Sbjct: 125 GMEYLSNR---NFI-HRDLAARNCMLREDMTVCVADFGLSKKI------------YSGDY 168
Query: 528 AHNGKISK------------------KSDVWSLGILILELLT-GKYP---------ENYL 559
G+I+K KSDVW+ G+ + E+ T G+ P +YL
Sbjct: 169 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228
Query: 560 LQG 562
G
Sbjct: 229 RHG 231
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
+ +G G FG Y+ G VK K N+ + F + +L H NL+ L
Sbjct: 12 QTIGKGEFGDVMLGDYR-----GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 417 TAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
EEK LY E++ GSL L ++ R L LK V + M YL
Sbjct: 65 LGVIV--EEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHNGK 532
+ H L + NVL+ ++D+ L + + + L V + +PE K
Sbjct: 120 ----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 175
Query: 533 ISKKSDVWSLGILILELLT-GKYP 555
S KSDVWS GIL+ E+ + G+ P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 27/207 (13%)
Query: 363 LGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPL- 416
LG G G+ K + + G + +K N D Q+ I R + P ++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDLQKQILRELEINKSCKSPYIVKYY 65
Query: 417 TAFYYRKEEKL-LLYEFVENGSLAG-----KLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
AF + + E+ E GSL K ++ KI + V+KG++
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV------LGKIAESVLKGLS 119
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR-PLINP-DNAHTLMVAYKSPEYA 528
YLH+ II H +K SN+LL R + L D+ + L+N T Y +PE
Sbjct: 120 YLHSR---KII-HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERI 175
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
S SDVWSLG+ +LE+ ++P
Sbjct: 176 QGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+ +GSGT+G YK I+ G+ +K K E Q+ I L HPN++ A+
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AY 65
Query: 420 Y--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ Y + +KL ++ E+ GSL + P L + + +KG+AYLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGP-LSELQIAYVCRETLKGLAYLHET- 120
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKS---------PEY 527
G I H +K +N+LL + L D+ + + T + KS PE
Sbjct: 121 -GKI--HRDIKGANILLTEDGDVKLADFGVSAQLT----AT-IAKRKSFIGTPYWMAPEV 172
Query: 528 A---HNGKISKKSDVWSLGILILELLTGKYP 555
A G K D+W+LGI +EL + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDF-----QEHIKRLGRLEH---P 411
E++G G +GA Y+ + G+ +K + N+ D Q + L +L P
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALK----IINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSL-----AGKLHANHTKQRPGLDWQTRLKIIKGVV 466
N+ Y + ++ E+ E GS+ AG + + II+ V+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----------IIREVL 111
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-HTLMVA---Y 522
+ Y+H +I H +K++N+L+ + L D+ + L+N +++ + V +
Sbjct: 112 VALKYIHKV---GVI-HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 523 KSPEYAHNGKI-SKKSDVWSLGILILELLTGKYP 555
+PE GK K+D+WSLGI I E+ TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 363 LGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421
LG G +G Y+ V VK K+ + + E+F + + ++HPNL+ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 422 RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSII 481
R+ ++ EF+ G+L L R ++ L + + M YL + + I
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 482 PHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NAHT---LMVAYKSPEYAHNGKISKK 536
H L + N L+ + + D+ L L+ D AH + + +PE K S K
Sbjct: 127 -HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 537 SDVWSLGILILELLT---GKYPENYLLQGYD 564
SDVW+ G+L+ E+ T YP L Q Y+
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 390 MNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN---- 445
+ R DF + IK + RL++PN++ L + ++ E++ENG L L
Sbjct: 56 VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES 115
Query: 446 ---HTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI-IPHGHLKSSNVLLDRSFEPLL 501
H P + L + + GM YL S+ H L + N L+ + +
Sbjct: 116 TFTHANNIPSVSIANLLYMAVQIASGMKYL-----ASLNFVHRDLATRNCLVGNHYTIKI 170
Query: 502 TDYAL-RPLINPD-----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
D+ + R L + D L + + + E GK + SDVW+ G+ + E+ T
Sbjct: 171 ADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKR---YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+G G F YK + + +G+ +K+ ++ M+ R+D + I L +L+HPN++ A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ E ++ E + G L+ ++ + KQ+ + +T K + + ++H++
Sbjct: 70 SFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-- 126
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--AHTLMVA--YKSPEYAHNGKIS 534
I H +K +NV + + L D L + AH+L+ Y SPE H +
Sbjct: 127 --IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 535 KKSDVWSLGILILEL 549
KSD+WSLG L+ E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 362 VLGSGTFG-ASYKTVISNGQAYVVKRY---KQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
V+G G+FG A +++ Q Y +K K + V ED ++ L +++HPN++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRKEAVLLAKMKHPNIVAFK 64
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ ++ E+ + G L K+ K P T L+ + G+ ++H +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE---DTILQWFVQMCLGVQHIHEKR- 120
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDY-ALRPLINPDNAHTLMVA---YKSPEYAHNGKI 533
+ H +KS N+ L ++ + L D+ + R L +P V Y PE N
Sbjct: 121 ---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 534 SKKSDVWSLGILILELLTGKYP 555
+ KSD+WSLG ++ EL T K+P
Sbjct: 178 NNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 14/197 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E+LG G FG +K + + VK K+ + + F + L + +HPN++ L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+++ ++ E V G L K++ L + +K GMAYL E
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLR----KKKDELKTKQLVKFALDAAAGMAYL--ESKNC 114
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRP-----LINPDNAHTLMVAYKSPEYAHNGKIS 534
I H L + N L+ + ++D+ + + + + + + +PE + G+ S
Sbjct: 115 I--HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 535 KKSDVWSLGILILELLT 551
+SDVWS GIL+ E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 46/200 (23%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G G G + ++ GQ +K+ +E I + L++PN++
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ +E ++ E++ GSL + +D + + ++ + +LH +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLH----AN 134
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-HTLMVA---YKSPEYAHNGKISK 535
+ H +KS NVLL LTD+ I P+ + + MV + +PE
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 536 KSDVWSLGILILELLTGKYP 555
K D+WSLGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 39/104 (37%), Positives = 62/104 (59%), Gaps = 12/104 (11%)
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM 519
KI +VK + YLH++L S+I H +K SNVL++R+ + L D+ + + A T+
Sbjct: 107 KIAVSIVKALEYLHSKL--SVI-HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 520 VA---YKSPEYAHNGKISK-----KSDVWSLGILILELLTGKYP 555
Y +PE N ++++ KSDVWSLGI ++EL TG++P
Sbjct: 164 AGCKPYMAPERI-NPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G G G Y + ++ GQ +K+ +E I + +HPN++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
Y +E ++ E++ GSL + +D + + ++ + +LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS----N 134
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-NAHTLMVA---YKSPEYAHNGKISK 535
+ H +KS N+LL LTD+ I P+ + + MV + +PE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 536 KSDVWSLGILILELLTGKYP 555
K D+WSLGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 361 EVLGSGTFGASYKT-VISNGQAYVVKRYKQMNNVG-REDFQEHIKRLG-----------R 407
E LGSG FG YK +NGQ + + ++N +D +E K +G +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 408 LEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRL-KIIKGVV 466
L HPN++ + + ++ + +E L H N K++ + R+ I +V
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YK 523
+ YLH E I H L +N++L + +TD+ L P++ T +V Y
Sbjct: 124 LALRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLT 551
PE N +K+DVW+ G ++ ++ T
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 63/230 (27%), Positives = 95/230 (41%), Gaps = 40/230 (17%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL----EHPNLLP 415
V+G G FG Y T+I + + K +N + + E + G + HPN+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 416 LTAFYYRKE-EKLLLYEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
L E L++ ++++G L + H K G Q V KGM
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ--------VAKGME 112
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL------RPLINPDNAH--TLMVAY 522
YL ++ H L + N +LD SF + D+ L + + N L V +
Sbjct: 113 YLASKK----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT---GKYPE-------NYLLQG 562
+ E K + KSDVWS G+L+ EL+T YP+ YLLQG
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG 218
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLP 415
EV+G G Y + + N + +KR ++ ++ ++ ++ + + HPN++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ +E L+ ++ GSL + + R GLD ++K V+KG+ YLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYA-----LRPLINPDNAHTLMVA---YKSPEY 527
G I H +K+ N+LL + D+ V + +PE
Sbjct: 122 --GQI--HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 528 AHNGK-ISKKSDVWSLGILILELLTGKYP 555
K+D+WS GI +EL TG P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 361 EVLGSGTFGASY--KTVISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
+ +G G+FG Y K + V+K +M +E ++ + L +++HPN++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHT---KQRPGLDWQTRLKIIKGVVKGMAYLH 473
A + ++ E+ + G L +++ + L W ++ + G+ ++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118
Query: 474 NELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINP--DNAHTLMVA--YKSPEYA 528
+ I H +KS N+ L ++ L D+ + +N + A+T + Y SPE
Sbjct: 119 DRK----ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
N + K+D+WSLG ++ EL T K+P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 3e-08
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 49/217 (22%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPN 412
+ LG+G+FG +K +G+ Y +K + + + EH+ L + HP
Sbjct: 7 KTLGTGSFGRVMLVRHK---GSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 413 LLPLTAFYYRKEEKLL--LYEFVENGSL------AGKLHANHTK----QRPGLDWQTRLK 460
L+ L + +++ L + E+V G L +G+ + Q
Sbjct: 63 LVNLYGSF--QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----------- 109
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL-- 518
VV + YLH+ I+ + LK N+LLD +TD+ + +TL
Sbjct: 110 ----VVLALEYLHSL---DIV-YRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLCG 160
Query: 519 MVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE + K D W+LGILI E+L G YP
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG-YP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 46/206 (22%), Positives = 73/206 (35%), Gaps = 21/206 (10%)
Query: 363 LGSGTFGASYKTVISNGQA---YVVKRYKQMNNVGRED-FQEHIKRLGRLEHPNLLPLTA 418
+G+G FG G + VVK + + F + ++ L HPN+L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
LL+ EF G L L +N ++ V G+ +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---- 118
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYAL------RPLINPDNAHTLMVAYKSPEYAHN-- 530
+ H L N L + DY L + H + + + +PE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 531 -----GKISKKSDVWSLGILILELLT 551
+KKS++WSLG+ + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 41/221 (18%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVG--REDFQEHIKRLGRL-EHPNLLPL 416
EV+G GT+G YK GQ +K M+ + E+ +E L + HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSNHPNIATF 68
Query: 417 TAFYYRK-----EEKL-LLYEFVENGS---LAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
+ +K +++L L+ E GS L L +R +W I++ ++
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAY--ILRETLR 124
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDN------------ 514
G+AYLH +I H +K N+LL ++ E L D+ + L +
Sbjct: 125 GLAYLHENK---VI-HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
A ++ + P+ +++ +SDVWSLGI +EL GK P
Sbjct: 181 APEVIACDEQPDASYD----ARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 15/199 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G G FG YK V+ VK + + + F + + L + +HPN++ L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+K+ ++ E V GSL L K++ L + L++ GM YL E
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR----KKKNRLTVKKLLQMSLDAAAGMEYL--ESKNC 114
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRP------LINPDNAHTLMVAYKSPEYAHNGKI 533
I H L + N L+ + ++D+ + D + + + +PE + G+
Sbjct: 115 I--HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 534 SKKSDVWSLGILILELLTG 552
+ +SDVWS GIL+ E +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR-PLINP-DNAHT 517
KI V++G+ YL + I+ H +K SN+L++ E L D+ + LI+ N+
Sbjct: 103 KISIAVLRGLTYLREKH--KIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159
Query: 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+Y SPE + +SD+WSLG+ ++E+ G+YP
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM 519
K+ +VK + YL + +I H +K SN+LLD S L D+ + + A T
Sbjct: 118 KMTVAIVKALHYLKEK--HGVI-HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174
Query: 520 V---AYKSPEY----AHNGKISKKSDVWSLGILILELLTGKYP 555
AY +PE N K ++DVWSLGI ++EL TG++P
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G G G Y + I+ GQ +K+ +E I + ++PN++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
Y +E ++ E++ GSL + +D + + ++ + +LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHS----N 134
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-HTLMVA---YKSPEYAHNGKISK 535
+ H +KS N+LL LTD+ I P+ + + MV + +PE
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 536 KSDVWSLGILILELLTGKYP 555
K D+WSLGI+ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 362 VLGSGTFGASY----KTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGR--LEHPNLLP 415
VLG+G +G + G+ Y +K K+ V + EH R R LE P
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH-TRTERQVLEAVRRCP 65
Query: 416 --LTAFY-YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
+T Y ++ + KL L+ ++V G L H QR I +V + +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELF-----THLYQREHFTESEVRVYIAEIVLALDH 120
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---AHTL--MVAYKSPE 526
LH II + +K N+LLD +LTD+ L + A++ + Y +PE
Sbjct: 121 LHQL---GII-YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 527 YAHNGKI--SKKSDVWSLGILILELLTGKYP 555
G K D WSLG+L ELLTG P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 363 LGSGTFGASYKTVISN------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
LG G FG + N VK K ++ R+DF + L L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHAN------HTKQRP--GLDWQTRLKIIKGVVKG 468
+ ++++E++++G L L A+ + L L I + + G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM-VAY 522
M YL ++ H L + N L+ + + D+ + R + + D HT++ + +
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
PE K + +SDVWSLG+++ E+ T GK P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 34/210 (16%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVK--------RYKQMNNVGREDFQEHIKRLGRLE 409
V+G G FG + + + +K + NV E + L L
Sbjct: 7 VIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNE-----RRILQELN 58
Query: 410 HPNLLPLTAFY-YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKG 468
HP L+ L +Y ++ EE + L V + L G L + +++ + Q + I +V
Sbjct: 59 HPFLVNL--WYSFQDEENMYL---VVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLA 112
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV---AYKSP 525
+ YLH++ I H +K N+LLD +TD+ + + PD T Y +P
Sbjct: 113 LEYLHSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E S D WSLG+ E L GK P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDF----QEHIKRLGRLEHPNLLPLT 417
LG GTFG YK I G+ +K K + + ++ F IK L +L+HPN++PL
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 418 AFYYRK-----EEKLLLY--EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
+ ++ +Y + L+G L K Q + + +++G+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES---QIKC-YMLQLLEGIN 129
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP-----------DNAHTL 518
YLH I H +K++N+L+D + D+ L RP P +T
Sbjct: 130 YLHENH----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 519 MVA---YKSPEY-AHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
+V Y+ PE + + D+W +G + E+ T + P +LQG
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-P---ILQG 229
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 363 LGSGTFGASYKTVISN------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
LG G FG + N VK K+ + R+DFQ + L L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 417 TAFYYRKEEKLLLYEFVENGSLA---------GKLHANHTKQRPG-LDWQTRLKIIKGVV 466
L+++E++ +G L K+ A PG L L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM-V 520
GM Y L H L + N L+ + + D+ + R + + D T++ +
Sbjct: 133 SGMVY----LASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 521 AYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+ PE K + +SD+WS G+++ E+ T GK P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 31/232 (13%)
Query: 361 EVLGSGTFGASYK----TVISNGQAYVVK-RYKQMNNVGR---EDFQEHIKRLGRLEHPN 412
E LG GTF +K V G+ + + K ++ R E F E + +L H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ +E +++ E+V+ GSL L N + W+ V K +A+
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN--ISWKLE------VAKQLAWA 112
Query: 473 HNELPGSIIPHGHLKSSNVLLDR------SFEPL--LTDYALRPLINPDNAHTLMVAYKS 524
+ L + HG++ + NVLL R P L+D + + P + +
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172
Query: 525 PEYAHNGK-ISKKSDVWSLGILILELLTG-KYPENYL-----LQGYDSKASL 569
PE N + +S +D WS G + E+ +G P + L LQ Y+ + L
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 344 RDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDF---Q 399
R+ E F+L + +GSGT+G YK ++ G+ +K K EDF Q
Sbjct: 5 RNPQEDFEL-------IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQ 54
Query: 400 EHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRL 459
+ I + +H N++ Y R+++ + EF GSL H + + +R
Sbjct: 55 QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR- 113
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM 519
++G+ YLH++ G + H +K +N+LL + L D+ + I A
Sbjct: 114 ----ETLQGLYYLHSK--GKM--HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165
Query: 520 VA----YKSPEYA---HNGKISKKSDVWSLGILILEL 549
+ +PE A G ++ D+W++GI +EL
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 453 LDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512
LD + L V KGM++L ++ + I H L + N+LL + D+ L I
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 513 DNAHT------LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDS 565
D+ + L V + +PE N + +SDVWS GIL+ E+ + G P Y DS
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMPVDS 324
Query: 566 KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVI 625
K M+KE M + + SEM +++K SC + D L R K+++
Sbjct: 325 K------FYKMIKE-------GYRMLSPECAPSEMYDIMK---SCWDADPLKRPTFKQIV 368
Query: 626 EKIER 630
+ IE+
Sbjct: 369 QLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 26/206 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVV-------KRYKQMNNVGREDFQEHIKRLGRLEHPNL 413
+ LG G+FG + S V+ K K + + +DF + + L+H NL
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENL 58
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRP-GLDWQTRLKIIKGVVKGMAYL 472
+ L ++ E GSL +L + ++I GM YL
Sbjct: 59 IRLYGVVLTHPLMMV-TELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYL 113
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHT------LMVAYKSP 525
++ I H L + N+LL + + D+ L R L ++ + + A+ +P
Sbjct: 114 ESK---RFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 526 EYAHNGKISKKSDVWSLGILILELLT 551
E S SDVW G+ + E+ T
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 351 DLQDMLRASAEVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLE 409
DL+D+ +G G FG K + + VKR + +E KRL ++
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQ-----KRL-LMD 52
Query: 410 H---------PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK 460
P ++ +R+ + + E ++ SL + + + + K
Sbjct: 53 LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGK 111
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV 520
I VK + YL EL II H +K SN+LLDR+ L D+ + + A T
Sbjct: 112 IAVATVKALNYLKEEL--KII-HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA 168
Query: 521 A---YKSPEYAHNGKISK---KSDVWSLGILILELLTGKYP 555
Y +PE +SDVWSLGI + E+ TGK+P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQ-------MNNVGREDFQEHIKRLGRLEHPNLL 414
+G GT+G YK G+ +K+ K RE IK L L HPN++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE-----IKLLKELNHPNII 61
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK-IIKGVVKGMAYLH 473
L + K + L++EF++ +QR L ++ +K + +++G+A+ H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRG-LP-ESLIKSYLYQLLQGLAFCH 115
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYAH 529
+ I H LK N+L++ L D+ L R +P +T V Y++PE
Sbjct: 116 S----HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 530 NGKI-SKKSDVWSLGILILELLTGK 553
K S D+WS+G + ELL+ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 30/213 (14%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEH---IKRLGRLEHPNLLPLTAF 419
LG G FG YK N + V+ K ++ E+ +++ I L +HPN++ L
Sbjct: 13 LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+Y + +L EF G++ + +RP + Q R+ + K ++ + YLH +
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRV-VCKQTLEALNYLHE----N 122
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA--------YKSPEY---- 527
I H LK+ N+L + L D+ ++ N T+ + +PE
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 528 -AHNGKISKKSDVWSLGILILELLTGKYPENYL 559
+ + K+DVWSLGI ++E+ + P + L
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 361 EVLGSGTFGASY----KTVISNGQAYVVKRYKQMNNVGREDFQEHIK-RLGRLEH----P 411
+VLG+G +G + T G+ Y +K ++ V + EH + LEH P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 412 NLLPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGM 469
L+ L + ++ E KL L+ ++V G + H QR + ++ G ++ +
Sbjct: 66 FLVTL-HYAFQTEAKLHLILDYVSGGEMF-----THLYQRDNFS-EDEVRFYSGEIILAL 118
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTL----MVAYKS 524
+LH I + +K N+LLD +LTD+ L + ++ + T + Y +
Sbjct: 119 EHLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 525 PEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQG 562
PE G K D WSLGILI ELLTG P + L+G
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEG 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-07
Identities = 21/44 (47%), Positives = 25/44 (56%), Gaps = 7/44 (15%)
Query: 29 SDTEILLQFKSSLN-DSSSALVNWNA-LRNPCTFNYPNWNGVLC 70
D + LL FKSSLN D S AL +WN +PC +W GV C
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPC-----SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 30/217 (13%)
Query: 363 LGSGTFGASY----KTVISNG---QAYVVKRYKQMNNVGREDFQEHIKR---LGRLEHPN 412
LGSG FG Y ++ G VK ++ ++ +E +K + HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPN 60
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANH--TKQRPGLDWQTRLKIIKGVVKGMA 470
++ L E + ++ E +E G L L P L + L I V KG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 471 YLHNELPGSIIPHGHLKSSNVLL-----DRSFEPLLTDYAL-RPLINPD-----NAHTLM 519
YL H L + N L+ D + D+ L R + D L
Sbjct: 121 YLEQ----MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
V + +PE +GK + +SDVWS G+L+ E+LT G+ P
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 50/227 (22%), Positives = 90/227 (39%), Gaps = 43/227 (18%)
Query: 354 DMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE-----HIKRLGRL 408
++L + K VK+ +++ +ED + R +L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSR--QL 56
Query: 409 EHPNLLP-LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
+HPN+LP +T+F E ++ + GS L H + GL I+K V+
Sbjct: 57 QHPNILPYVTSFIV-DSELYVVSPLMAYGS-CEDLLKTHFPE--GLPELAIAFILKDVLN 112
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA-LRPLINPDNAHTLMVAYK--- 523
+ Y+H++ G I H +K+S++LL + +L+ +I ++ +
Sbjct: 113 ALDYIHSK--GFI--HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 524 -------SPE--------YAHNGKISKKSDVWSLGILILELLTGKYP 555
SPE Y ++KSD++S+GI EL G P
Sbjct: 169 VKNLPWLSPEVLQQNLQGY------NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G G G Y + ++ GQ +++ +E I + ++PN++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
Y +E ++ E++ GSL + +D + + ++ + +LH+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS----N 135
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-HTLMVA---YKSPEYAHNGKISK 535
+ H +KS N+LL LTD+ I P+ + + MV + +PE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 536 KSDVWSLGILILELLTGKYP 555
K D+WSLGI+ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/152 (28%), Positives = 64/152 (42%), Gaps = 24/152 (15%)
Query: 419 FYY--RKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
YY + ++ L L+ E++ G LA L + LD I +V + YLH+
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLALEYLHSN 112
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--------RPLINPDNAHTLMVA----YK 523
II H LK N+L+D + LTD+ L + +N D + Y
Sbjct: 113 ---GII-HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE SK D WSLG ++ E L G P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 32/232 (13%)
Query: 343 VRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEH 401
VR D++P ++ +++ LG G FG YK G K + + ED+
Sbjct: 4 VRRDLDPNEVWEIIGE----LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE 59
Query: 402 IKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL-AGKLHANHTKQRPGLDWQTRLK 460
I+ L HP ++ L +Y + ++ EF G++ A L + P Q ++
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP----QIQV- 114
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV 520
I + +++ + YLH+ I H LK+ NVLL + L D+ ++ N TL
Sbjct: 115 ICRQMLEALQYLHSMK----IIHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQR 166
Query: 521 A--------YKSPEYA-----HNGKISKKSDVWSLGILILELLTGKYPENYL 559
+ +PE + K+D+WSLGI ++E+ + P + L
Sbjct: 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 3e-07
Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
LKS+ LS+N + I D AF+G+ +LK L ++ N LT P + LP L L L N
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 361 EVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNL 413
E LG FG YK + QA +K K RE+F+ RL+HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSL------------AGKLHANHTKQRPGLDWQTRLKI 461
+ L +++ +++ + + L G + T + L+ + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT-VKSTLEPADFVHI 129
Query: 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-- 519
+ + GM +L + + H L + NVL+ ++D L + + + LM
Sbjct: 130 VTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 520 ----VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGY 563
+ + SPE GK S SD+WS G+++ E+ + Y LQ Y
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS------YGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 361 EVLGSGTFGASY--KTVI--SNGQAYVVKRYKQMNNVGREDFQEHIKR--LGRLEHPNLL 414
+VLG G+FG + + + GQ Y +K K+ R+ + ++R L + HP ++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 415 PLTAFYYRKEEKL-LLYEFVENGSLAGKLHAN--HTKQRPGLDWQTRLKIIKGVVKGMAY 471
L + ++ E KL L+ +F+ G L +L T++ +K + +A
Sbjct: 62 KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----------VKFYLAELAL 109
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEY 527
+ L I + LK N+LLD LTD+ L + + A++ V Y +PE
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLS 570
+ ++ +D WS G+L+ E+LTG P QG D K +++
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMT 208
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK-RYKQMNNV----GREDFQEHIKRLGRLEHPNLL 414
+VLGSG FG YK + + G+ + K +N +F + + ++HP+L+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L +L+ + + +G L +H + + + Q L + KGM YL
Sbjct: 73 RLLGVCLSPTIQLVT-QLMPHGCLLDYVH----EHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD------NAHTLMVAYKSPEYA 528
+ H L + NVL+ +TD+ L L+ D + + + + + E
Sbjct: 128 RR----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 529 HNGKISKKSDVWSLGILILELLT 551
H K + +SDVWS G+ I EL+T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQE------HIKRLGRLEHPN 412
++LG G FG Y + G+ K+ Q + E +E I+ L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQV-QFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 413 LLPLTAFYYRKEEKLL--LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
++ + EK L E++ GS+ +L K L K + +++GM+
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMS 120
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY-ALRPLINPDNAHTLMVA------YK 523
YLH ++I H +K +N+L D + L D+ A + L + T + + +
Sbjct: 121 YLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
SPE +K+DVWSLG ++E+LT K P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 48/137 (35%), Positives = 68/137 (49%), Gaps = 11/137 (8%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGN 136
L L N +G I +L L L+ + +NKF G +P +L K L + LS N +G
Sbjct: 313 LHLFSNNFTGKIP-VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 137 ISDDAFEGMTS---LKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE--IKQ 191
I EG+ S L KL + +N L G IP SL L +RL+ N F G++P K
Sbjct: 372 IP----EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 192 NEMRSLGLANNELEGPI 208
+ L ++NN L+G I
Sbjct: 428 PLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKR---YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG+G G +K V ++ R + ++ R ++ L P ++
Sbjct: 13 LGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+Y E + E ++ GSL L K+ + Q K+ V+KG+ YL +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLREK---H 123
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPEYAHNGKISKKS 537
I H +K SN+L++ E L D+ + + A++ + +Y SPE S +S
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 538 DVWSLGILILELLTGKYP 555
D+WS+G+ ++E+ G+YP
Sbjct: 184 DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 409 EHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKG 468
++PN + L + +L+ +++++G L L L KII+ +V+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-----LSEAEVKKIIRQLVEA 121
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMVAYKSPEY 527
+ LH +II H +K NVL DR+ + + L DY L +I + + + Y SPE
Sbjct: 122 LNDLHKH---NII-HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPE- 176
Query: 528 AHNGKISKKS-----DVWSLGILILELLTGKYP 555
KI + D W++G+L ELLTGK+P
Sbjct: 177 ----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 361 EVLGSGTFGASY--KTVISN--GQAYVVKRYKQMNNVGREDFQEHIKRLGR-LEH----P 411
+VLG+G +G + + V + G+ Y +K K+ V + EH + + LEH P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 412 NLLPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
L+ L + ++ + KL L+ +++ G L H QR Q +V +
Sbjct: 66 FLVTL-HYAFQTDTKLHLILDYINGGELF-----THLSQRERFKEQEVQIYSGEIVLALE 119
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---AHTL--MVAYKSP 525
+LH I + +K N+LLD + +LTD+ L + D A++ + Y +P
Sbjct: 120 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 526 EYAHNGKI--SKKSDVWSLGILILELLTGKYP 555
+ G K D WS+G+L+ ELLTG P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 39/230 (16%)
Query: 342 FVRDDMEPFDLQDMLRASAEVLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGRED 397
F + D + L D E LG+G+FG A +K G+ Y +K K+ + +
Sbjct: 7 FTKPDTSSWKLSDF--EMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKK-REILKMK 60
Query: 398 FQEHIKR----LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL------AGKLHANHT 447
+H+ + L L HP ++ + + + L EFV G L AG+ +
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 448 KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507
K +V YLH++ I + LK N+LLD +TD+
Sbjct: 121 KFYHA-----------ELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 508 PLINPDNAHTL--MVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ PD TL Y +PE + K D W++G+L+ E + G YP
Sbjct: 166 KKV-PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG-YP 213
|
Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 10/163 (6%)
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD 454
R ++ L P ++ +Y E + E ++ GSL L K+ +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KEAKRIP 101
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514
+ K+ V++G+AYL + I H +K SN+L++ E L D+ + +
Sbjct: 102 EEILGKVSIAVLRGLAYLREK---HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158
Query: 515 AHTLM--VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
A++ + +Y SPE S +SD+WS+G+ ++EL G+YP
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 361 EVLGSGTFGASYKTVI----SNGQAYVVKRYKQMNNVGREDFQEHI---KRLGRLEHPNL 413
++LG GTFG K ++ ++G+ Y +K K+ + +++ + + L HP L
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L + K+ + E+V G L L +++R + +TR + +V + YLH
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAE-IVSALDYLH 112
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEYAH 529
+ G I+ + LK N++LD+ +TD+ L + + T Y +PE
Sbjct: 113 S---GKIV-YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
+ + D W LG+++ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 34/210 (16%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRY----KQMNNVGREDFQEHIKRLGRLEHPNLLP 415
E +G G G YK T + G+ +K+ + + E I + +HPN++
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINE-----ILIMKDCKHPNIVD 79
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK------IIKGVVKGM 469
Y +E ++ E+++ GSL + N R+ + + V++G+
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQN----------FVRMNEPQIAYVCREVLQGL 129
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH-TLMV---AYKSP 525
YLH+ ++I H +KS N+LL + L D+ + + + +V + +P
Sbjct: 130 EYLHS---QNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E K D+WSLGI+ +E+ G+ P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 50/172 (29%), Positives = 70/172 (40%), Gaps = 17/172 (9%)
Query: 388 KQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHT 447
Q+ NV E I+ E P + L + K+ L+ E++ G A +
Sbjct: 38 NQVTNVKAERAIMMIQG----ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI----- 88
Query: 448 KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507
K GL + I VV G+ LH I H +K N+L+D++ LTD+ L
Sbjct: 89 KTLGGLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144
Query: 508 P--LINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557
L N T Y +PE K SD WSLG +I E L G P +
Sbjct: 145 RNGLENKKFVGT--PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEH-----IKRLGRLEHPNLLPL 416
+G G G +K G+ +K+ + E + IK L +HP ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKK---VALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ +L+ E++ L+ L ++RP + Q + ++ ++KG+AY+H
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLR---DEERPLPEAQVK-SYMRMLLKGVAYMH--- 116
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDN-AHTLMVA---YKSPEYAHNG 531
+ I H LK +N+L+ + D+ L R + ++ VA Y++PE +
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 532 -KISKKSDVWSLGILILELLTG 552
K D+W++G + ELL G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 347 MEPFDLQDMLRASAEVLGSGTFG-ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRL 405
+ P D ++ L S +G G+ G T G+ VK+ RE + +
Sbjct: 15 VSPGDPREYL-DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIM 73
Query: 406 GRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGV 465
H N++ + Y +E ++ EF+E G+L + HT+ ++ + + V
Sbjct: 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTR----MNEEQIATVCLSV 127
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN---PDNAHTLMVAY 522
++ ++YLHN+ G I H +KS ++LL L+D+ ++ P + Y
Sbjct: 128 LRALSYLHNQ--GVI--HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 523 -KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE + D+WSLGI+++E++ G+ P
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 40/228 (17%)
Query: 352 LQDMLRASAEVLGSGTFGASYKTVISN---GQAYVVKRYKQMNNVGRE----DFQEHIKR 404
LQ++ LG G FG + + K + E +F+ +
Sbjct: 7 LQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 405 LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTK----QRPGLDWQTRLK 460
+L H N++ L E ++ E+ + G L L A +K + P L + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE-----PLLTD-------YALRP 508
+ + GM +L N + H L + N L+ E L+ Y LR
Sbjct: 122 LCTQIALGMDHLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 509 LINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+ P + + +PE S KSDVWS G+L+ E+ T G+ P
Sbjct: 178 ALIP-------LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 36/232 (15%)
Query: 356 LRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLL- 414
LRAS E + S + + KR K + + + I LGRL H N+L
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILK 227
Query: 415 -------PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
+ ++ LY F+ + + K RP L QTR I+K ++
Sbjct: 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAF-------DWKDRPLL-KQTR-AIMKQLLC 278
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA-LRPLINPDNAHTL----MVAY 522
+ Y+H++ + H +K N+ L+ + +L D+ P A VA
Sbjct: 279 AVEYIHDKK----LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT---------GKYPENYLLQGYDS 565
SPE + +D+WS G+++L++L+ G P LL+ DS
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386
|
Length = 501 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 33/210 (15%)
Query: 361 EVLGSGTFG--ASYKTVISN---GQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLL 414
VLG G FG + Y +N G+ VK K+ +++ I L L H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 415 PLTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ K L+ E+V GSL L + L+ L + + +GMAYL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAYL 123
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI-----------NPDNAHTLMVA 521
H++ H L + NVLLD + D+ L + + D+ V
Sbjct: 124 HSQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VF 175
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLT 551
+ + E K S SDVWS G+ + ELLT
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 20/175 (11%)
Query: 391 NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQR 450
N R DF + IK + RL+ PN++ L A + ++ E++ENG L + + H Q
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQE 117
Query: 451 PGLD-------WQTRLKIIKGVVKGMAYLHNELPGSI-IPHGHLKSSNVLLDRSFEPLLT 502
+ T + + + GM YL S+ H L + N L+ +++ +
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYL-----SSLNFVHRDLATRNCLVGKNYTIKIA 172
Query: 503 DYAL-RPLINPD-----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
D+ + R L + D L + + S E GK + SDVW+ G+ + E+LT
Sbjct: 173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 362 VLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
VLG GT+G Y +S +K + ++ + E I L+H N++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKII-KGVVKGMAYLHNELPGS 479
+ E V GSL+ L +K P D + + K +++G+ YLH+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLR---SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--- 128
Query: 480 IIPHGHLKSSNVLLDR-SFEPLLTDYALRPL---INP-DNAHTLMVAYKSPEYAHNGK-- 532
I H +K NVL++ S ++D+ INP T + Y +PE G
Sbjct: 129 -IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+D+WSLG I+E+ TGK P
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 45/186 (24%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 374 TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433
T S G+ VK+ RE + + +HPN++ + + Y +E ++ EF+
Sbjct: 39 TDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98
Query: 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL 493
E G+L + HT+ ++ + + V+K +++LH + G I H +KS ++LL
Sbjct: 99 EGGALTDIV--THTR----MNEEQIATVCLAVLKALSFLHAQ--GVI--HRDIKSDSILL 148
Query: 494 DRSFEPLLTDYALRPLIN---PDNAHTLMVAY-KSPEYAHNGKISKKSDVWSLGILILEL 549
L+D+ ++ P + Y +PE + D+WSLGI+++E+
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 550 LTGKYP 555
+ G+ P
Sbjct: 209 VDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 34/164 (20%)
Query: 405 LGRLEHPNLLPLTAFYYRKEEKLL--------LYEFVENGSLAGKLHANHTKQRPGLDWQ 456
L + HP+++ + + LY ++ S RP L
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------------RP-LPID 157
Query: 457 TRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALRPLINPDN 514
L I K +++G+ YLH I H +K+ N+ ++ + + D A P++ P
Sbjct: 158 QALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
A T V +PE K + K+D+WS GI++ E+L YP
Sbjct: 214 LGLAGT--VETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 6/98 (6%)
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP-DNAHT 517
+I VVKG+ YL I H +K SN+L++ + L D+ + L+N +
Sbjct: 99 RIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154
Query: 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
AY +PE + SDVWSLGI +EL G++P
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQE------HIKRLGRLEHPNLLP 415
LG G FG Y + G+ VK+ + E +E I+ L L+H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQV-PFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 416 LTAFYY---RKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
YY R +E L ++ E++ GS+ + K L K + +++G+ Y
Sbjct: 69 ----YYGCLRDDETLSIFMEYMPGGSVK-----DQLKAYGALTETVTRKYTRQILEGVEY 119
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA-------YKS 524
LH+ + I H +K +N+L D + L D+ + + + + S
Sbjct: 120 LHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 525 PEYAHNGKISKKSDVWSLGILILELLTGKYP 555
PE +K+DVWS+G ++E+LT K P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 14/167 (8%)
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD 454
R F LG+ +H N++ L R +++ E++ NG+L L H Q L
Sbjct: 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQ---LV 105
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514
+ ++ G+ GM YL +E+ G + H L + VL++ ++ + +
Sbjct: 106 AGQLMGMLPGLASGMKYL-SEM-GYV--HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161
Query: 515 AHTLM-----VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+T M V + +PE S SDVWS GI++ E+++ G+ P
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 48/216 (22%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVK------RYKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
LG GT+ YK G+ +K R + + + +E IK L L+HPN++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALRE-IKLLQELKHPNIIG 66
Query: 416 LTAFYYRKEEKLLLYEF--------VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
L + K L++EF +++ S+ L K + ++
Sbjct: 67 LLDVFGHKSNINLVFEFMETDLEKVIKDKSI--VLTPADIKS-----------YMLMTLR 113
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YK 523
G+ YLH+ + I H LK +N+L+ L D+ L R +P+ T V Y+
Sbjct: 114 GLEYLHS----NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169
Query: 524 SPE------YAHNGKISKKSDVWSLGILILELLTGK 553
+PE + G D+WS+G + ELL
Sbjct: 170 APELLFGARHYGVG-----VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 363 LGSGTFGASYKTV--ISNGQ--AYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLT 417
LG G FG+ K V + +G+ VK KQ + G+++F + +L+HP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 418 AFYYRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
K E L+L E G L L K+R + ++ V GMAYL
Sbjct: 62 -IGVCKGEPLMLVMELAPLGPLLKYL-----KKRREIPVSDLKELAHQVAMGMAYLE--- 112
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-------AHTLMVAYKSPEYAH 529
H L + NVLL + ++D+ + + + A + + +PE +
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 530 NGKISKKSDVWSLGILILELLT 551
GK S KSDVWS G+ + E +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 363 LGSGTFG-ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421
+G G+ G TV S+G+ VK+ RE + + +H N++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 422 RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSII 481
+E ++ EF+E G+L + HT+ ++ + + V+K ++ LH + G I
Sbjct: 88 VGDELWVVMEFLEGGALTDIV--THTR----MNEEQIAAVCLAVLKALSVLHAQ--GVI- 138
Query: 482 PHGHLKSSNVLLDRSFEPLLTDYALRPLIN---PDNAHTLMVAY-KSPEYAHNGKISKKS 537
H +KS ++LL L+D+ ++ P + Y +PE +
Sbjct: 139 -HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 538 DVWSLGILILELLTGKYP 555
D+WSLGI+++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNN-------VGREDFQEHIKRLGRLEHPNLL 414
+G G +G YK +G +K + N RE +KRL +HPN++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE--VALLKRLEAFDHPNIV 65
Query: 415 PL-----TAFYYRKEEKLLLYEFVENGSLAGKLHANHTK-QRPGLDWQTRLKIIKGVVKG 468
L T+ R+ + L++E V+ L K PGL +T +++ ++G
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-----DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YKSP 525
+ +LH + I H LK N+L+ + L D+ L + + A T +V Y++P
Sbjct: 121 LDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGK 553
E + D+WS+G + E+ K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421
+GSGT+G YK + G+ VK K Q+ I + +H N++ Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 422 RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSII 481
+E+ + E+ GSL H + + R ++G+AYLH++ G +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSK--GKM- 128
Query: 482 PHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYA---HNGKIS 534
H +K +N+LL + + L D+ + I A + +PE A NG +
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 535 KKSDVWSLGILILEL 549
+ D+W++GI +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 361 EVLGSGTFGASYKTVIS----NGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHP 411
+V+G G+FG K +++ +G+ Y VK ++ + R++ Q+HI L ++HP
Sbjct: 1 KVIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHP 56
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
L+ L + E+ + +FV G L L + P + R + + + Y
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP----RARFYAAE-IASALGY 111
Query: 472 LHNELPGSI-IPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE 526
LH SI I + LK N+LLD +LTD+ L + I + T Y +PE
Sbjct: 112 LH-----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE 166
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
D W LG ++ E+L G P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 16/202 (7%)
Query: 362 VLGSGTFGASYK-TVISNGQAYVVKRY--KQMNNVGREDFQEHIKR-LGRLEHPNLLPLT 417
VLG G FG V + G+ Y K+ K++ E + K+ L ++ ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
Y K+ L+ + G L K H + PG D + + + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDL--KFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER- 122
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----AHTLMVAYKSPEYAHNGKI 533
I + LK N+LLD ++D L I P+ V Y +PE N +
Sbjct: 123 ---IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 534 SKKSDVWSLGILILELLTGKYP 555
+ D W LG LI E++ GK P
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 40/224 (17%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG------------------REDFQEHI 402
E LG G FG + Q + K + + +N REDF + +
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 403 KRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHA------NHTKQRPGLDWQ 456
K L RL PN+ L ++ E++ENG L L L +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 457 TRLKIIKGVVKGMAYL--HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD 513
T L + + GM YL N + H L + N L+ +++ + D+ + R L + D
Sbjct: 131 TLLYMATQIASGMRYLESLNFV------HRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 514 ------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
A L + + + E GK + KSDVW+ G+ + E+LT
Sbjct: 185 YYRVQGRA-PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQE------HIKRLGRLEHPN 412
++LG G FG Y G+ VK+ Q + E +E I+ L L H
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQV-QFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 413 LLPLTAFYYRKEEKLL--LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
++ E+ L E + GS+ +L K L K + +++G++
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILEGVS 120
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY-ALRPLINPDNAHTLMVA------YK 523
YLH+ ++I H +K +N+L D L D+ A + L + T M + +
Sbjct: 121 YLHS----NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
SPE +K+D+WS+G ++E+LT K P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 9e-06
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVKRYKQMNN-------VGREDFQEHI---KRLGRLEHP 411
+G G +G YK ++ G+ +K+ + + RE I K+L EHP
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-----IALLKQLESFEHP 61
Query: 412 N---LLPLTAFYYRKEEKL--LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
N LL + E L++E V+ LA L + K PGL +T +++ ++
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPK--PGLPPETIKDLMRQLL 117
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YK 523
+G+ +LH+ I H LK N+L+ + + D+ L + + + A T +V Y+
Sbjct: 118 RGVDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173
Query: 524 SPEYAHNGKISKKSDVWSLGILILEL 549
+PE + D+WS+G + EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 38/236 (16%)
Query: 340 LSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDF 398
LS +RD F+L EV+G+GT+G YK + GQ +K + E+
Sbjct: 8 LSALRDPAGIFEL-------VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEI 59
Query: 399 QEHIKRLGRL-EHPNLLPLTAFYYRK------EEKLLLYEFVENGS---LAGKLHANHTK 448
+ I L + H N+ + +K ++ L+ EF GS L N K
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA--- 505
+ DW I + +++G+A+LH + H +K NVLL + E L D+
Sbjct: 120 E----DWIAY--ICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169
Query: 506 -LRPLINPDNAHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYP 555
L + N + +PE + +SD+WSLGI +E+ G P
Sbjct: 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 362 VLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQ----EHIKRLGRLEHPNLLPL- 416
+G GT+G YK + V + +++N +E F IK L +L H N++ L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 417 ---------TAFYYRKEEKLLLYEFVEN---GSL-AGKLHANHTKQRPGLDWQTRLKIIK 463
F K L++E++++ G L +G +H + + +K
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK---------SFMK 123
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH-----TL 518
+++G+ Y H + H +K SN+LL+ + L D+ L L N + + +
Sbjct: 124 QLLEGLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 519 MVAYKSPE-YAHNGKISKKSDVWSLGILILELLTGK 553
+ Y+ PE + DVWS G ++ EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 33/230 (14%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGR--EDFQEHIKRLGRLEHPNLLP 415
+LG G FG A K+ + Q VK K E+F + +HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 416 LTAFYYRKEEK------LLLYEFVENGSLAGKLHANHTKQRP-GLDWQTRLKIIKGVVKG 468
L R K +++ F+++G L L + + P L QT ++ + + G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN------AHTLMVAY 522
M YL ++ + I H L + N +L+ + + D+ L I + A L V +
Sbjct: 126 MEYLSSK---NFI-HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT-GKYP---------ENYLLQG 562
+ E + + SDVW+ G+ + E++T G+ P NYL++G
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 409 EHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK------II 462
+H N++ + Y EE +L EF++ G+L + QTRL +
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS------------QTRLNEEQIATVC 123
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA- 521
+ V++ + YLH++ G I H +KS ++LL L+D+ I+ D +
Sbjct: 124 ESVLQALCYLHSQ--GVI--HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179
Query: 522 ---YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ +PE + D+WSLGI+++E++ G+ P
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRY----------KQMNNVGREDFQEHIKRLGRL 408
++LG G FG Y G+ VK+ K++N + E I+ L L
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECE-----IQLLKNL 61
Query: 409 EHPNLLPLTAFYYRKEEKLL--LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
H ++ EEK L E++ GS+ +L K L + + ++
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQIL 116
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-------NAHTLM 519
+G++YLH ++I H +K +N+L D + L D+ I + T
Sbjct: 117 QGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ SPE +K+DVWS+ ++E+LT K P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNN--VGREDFQEHIKR------LGRLEHPNLL 414
LG G+FG Y ++ + +A +R K + VG + E ++ L +L+HP ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKL----HANHTKQRPGL-DWQTRLKIIKGVVKGM 469
A + ++ ++ E+ E L KL H T + +W +L + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI--NPDNAHTLMVA--YKSP 525
Y+H I H LK+ N+ L + + D+ + L+ + D A T Y SP
Sbjct: 120 HYMHQRR----ILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 526 EYAHNGKISKKSDVWSLGILILEL 549
E + KSD+WSLG ++ E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 358 ASAEVLGSGTFGASYKTVISNGQAYVVKRYKQM-----NNVGREDFQEHIKRLGRLEHPN 412
A + LG G FG+ + ++ + + K M EDF + +HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 413 LLPLTAFYYRKEEK------LLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGV 465
++ L + E +++ F+++G L L + P L Q +K + +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD-----NAHTLM 519
GM YL ++ S I H L + N +L+ + + D+ L + + N D +
Sbjct: 122 ASGMEYLSSK---SFI-HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP----EN-----YLLQG 562
V + + E + + KSDVWS G+ + E+ T G+ P EN YL QG
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTAFYY 421
+G GT+G YK +G+ KQ+ G I L L+HPN++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 422 RKEEK--LLLYEFVENGSL-AGKLH-ANHTKQRPGLDWQTRLK-IIKGVVKGMAYLHNEL 476
++ LL+++ E+ K H A+ ++P ++ +K ++ ++ G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--- 125
Query: 477 PGSIIPHGHLKSSNVLL-------------DRSFEPLLTDYALRPLINPDNAHTLMVAYK 523
+ + H LK +N+L+ D F L L+PL + D + Y+
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS-PLKPLADLDPV-VVTFWYR 182
Query: 524 SPEYAHNGK-ISKKSDVWSLGILILELLTGK 553
+PE + +K D+W++G + ELLT +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHP 411
+V+G G+FG A K S+G Y VK Q + ++ Q HI L L+HP
Sbjct: 1 KVIGKGSFGKVLLAKRK---SDGSFYAVKVL-QKKTILKKKEQNHIMAERNVLLKNLKHP 56
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
L+ L + E+ + ++V G L L ++R L+ + R + V + Y
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAAE-VASAIGY 111
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEY 527
LH+ +II + LK N+LLD +LTD+ L + + P+ + Y +PE
Sbjct: 112 LHSL---NII-YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV 167
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
+ D W LG ++ E+L G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 363 LGSGTFGASYKTVISNGQ-AYVVKRYKQMNNVGREDFQEHIKR---LGRLEHPNLLPLTA 418
+G G+FG + + Q Y +K ++ + V R + + L ++ P ++PL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 419 FYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI-IKGVVKGMAYLHNEL 476
F ++ EKL L+ F+ G L H QR G +R + ++ + LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELF------HHLQREGRFDLSRARFYTAELLCALENLHK-- 111
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL--INPDNAHTL--MVAYKSPEYAHNGK 532
+ + LK N+LLD L D+ L L + D +T Y +PE
Sbjct: 112 --FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+K D W+LG+L+ E+LTG P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPNLLP 415
+V+G G+FG + + + Q + ++ ++HI L ++HP L+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L F ++ +KL NG G+L + ++R L+ + R + + + YLH+
Sbjct: 61 L-HFSFQTADKLYFVLDYING---GELFYHLQRERCFLEPRARFYAAE-IASALGYLHS- 114
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYAHNG 531
I + LK N+LLD +LTD+ L + I + + Y +PE H
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 532 KISKKSDVWSLGILILELLTGKYP 555
+ D W LG ++ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 44/229 (19%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRY------------------KQMNNVGREDFQEHI 402
E LG G FG + + N Q ++ N R DF + +
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 403 KRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQR------------ 450
K L RL+ PN++ L ++ ++ E++ENG L L ++H +
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 451 --PGLDWQTRLKIIKGVVKGMAYLHNELPGSI-IPHGHLKSSNVLLDRSFEPLLTDYAL- 506
P + + + L + + GM YL S+ H L + N L+ + + D+ +
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYL-----SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 507 RPLINPD-----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELL 550
R L D L + + + E GK + SDVW+ G+ + E+L
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 361 EVLGSGTFGASYKTVIS----NGQAYVVKRYKQMNNVGREDFQEHI--KRLGRL--EHPN 412
+VLG G+FG K +++ G+ + VK K+ + +D + + KR+ L E+P
Sbjct: 1 KVLGKGSFG---KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L L + KE + EF+ G L H + + D +V G+ +L
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQFL 112
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYA 528
H++ G I + LK NV+LDR + D+ + + + DN + Y +PE
Sbjct: 113 HSK--GII--YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
K + D WS G+L+ E+L G+ P
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQ----EHIKRLGRLEHPNLLPL- 416
+G GTFG +K Q +K+ M N +E F IK L L+H N++ L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL-MEN-EKEGFPITALREIKILQLLKHENVVNLI 77
Query: 417 -------TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
T + K L++EF E+ LAG L + K K++K ++ G+
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS----EIKKVMKMLLNGL 132
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNA----HTLMVA--- 521
Y+H + I H +K++N+L+ + L D+ L R N+ +T V
Sbjct: 133 YYIHR----NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 522 YKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPENYLLQG 562
Y+ PE + D+W G ++ E+ T + P ++QG
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP---IMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G GT+G YK T +G VK +++V E E+ HPN++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 420 YYRKEEKL-----LLYEFVENGSLA----GKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
+Y+ ++ + L+ E GS+ G L + + I+ G + G+
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-----ILYGALLGLQ 142
Query: 471 YLHNELPGSIIPHGHLKSSNVLL---------DRSFEPLLTDYALRPLINPDNAHTLMVA 521
+LHN + I H +K +N+LL D LT LR + +
Sbjct: 143 HLHN----NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ E ++ + DVWSLGI +EL G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 14/201 (6%)
Query: 362 VLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN---LLPLT 417
VLG G FG V + G+ Y KR ++ R+ + LE N ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
Y K+ L+ + G L K H + PG + + L ++ G+ LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDL--KFHI-YNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALR---PLINPDNAHTLMVAYKSPEYAHNGKIS 534
+ LK N+LLD ++D L P V Y +PE +N + +
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 535 KKSDVWSLGILILELLTGKYP 555
D W LG LI E++ G+ P
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD 454
+ F + + L + HPN++ L +K+ ++ E V+ G L + P L
Sbjct: 37 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT----EGPRLK 92
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD 513
+ +++++ GM YL ++ H L + N L+ ++D+ + R +
Sbjct: 93 VKELIQMVENAAAGMEYLESKH----CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148
Query: 514 NAHT-----LMVAYKSPEYAHNGKISKKSDVWSLGILILE 548
A T + V + +PE + G+ S +SDVWS GIL+ E
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 13/133 (9%)
Query: 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSN 490
E+++ GSL KL+A G+ +I VVKG+ +L E +II H +K +N
Sbjct: 79 EYMDAGSL-DKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEH--NII-HRDVKPTN 133
Query: 491 VLLDRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPEY------AHNGKISKKSDVWSL 542
VL++ + + L D+ + + A T + +Y +PE N + +SDVWSL
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193
Query: 543 GILILELLTGKYP 555
G+ ILE+ G+YP
Sbjct: 194 GLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE--------HIKRLGRLEHPN 412
E +G GT+G YK V M + E +E I L L+HPN
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVA-----MKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L ++ L++EF+ S+ K + + + +D + + +++G+ +
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYA 528
H+ + H LK N+L+D L D+ L R P +T V Y++PE
Sbjct: 118 HSRR----VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 529 HNG-KISKKSDVWSLGILILELLTGK 553
+ S D+WS+G + E+ T K
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 15/136 (11%)
Query: 427 LLLYEFVENGSLAGKLHANHTK--QRPGLDWQTRLKIIK---GVVKGMAYLHNELPGSII 481
L++ E + G L L + + PGL T K I+ + GMAYL
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKK---F 140
Query: 482 PHGHLKSSNVLLDRSFEPLLTDYALRPLIN------PDNAHTLMVAYKSPEYAHNGKISK 535
H L + N ++ + D+ + I L V + +PE +G +
Sbjct: 141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 536 KSDVWSLGILILELLT 551
KSDVWS G+++ E+ T
Sbjct: 201 KSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 39/212 (18%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQ--------MNNVGREDFQEHIKRLGRL-EH 410
+ LG GTFG+ Y G+ +K+ K+ MN RE +K L +L EH
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL--RE-----VKSLRKLNEH 57
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK-IIKGVVKGM 469
PN++ L + +E ++E++E G L+ ++ ++ ++ II +++G+
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-----GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 470 AYLHNELPGSIIPHG--H--LKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---Y 522
A++H HG H LK N+L+ + D+ L I +T V+ Y
Sbjct: 113 AHIHK--------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWY 164
Query: 523 KSPE-YAHNGKISKKSDVWSLGILILELLTGK 553
++PE + S D+W+LG ++ EL T +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 361 EVLGSGTFGASYKTV--ISNGQAYVVK-RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E +G GT+G YK ++N + K R +Q + I L ++H N++ L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG----VVKGMAYLH 473
+ ++ L++E+++ L K H + + D+ ++IK +++G+AY H
Sbjct: 68 DVVHSEKRLYLVFEYLD---LDLKKHMDSSP-----DFAKNPRLIKTYLYQILRGIAYCH 119
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYAL-RPLINPDNAHTLMVA---YKSPEYA 528
+ + H LK N+L+DR L L D+ L R P T V Y++PE
Sbjct: 120 SHR----VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 529 HNGK-ISKKSDVWSLGILILELLTGK 553
+ S D+WS+G + E++ K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHI--KRL----GRLEHP 411
VLG G FG A YK G+ Y +K K+ + + R++ + + KR+ HP
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGMA 470
L+ L A + ++ + E+ G L +H + + R VV G+
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-------RAVFYAACVVLGLQ 115
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE 526
YLH I+ + LK N+LLD + D+ L + + + + + +PE
Sbjct: 116 YLHEN---KIV-YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
++ D W LG+LI E+L G+ P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 41/190 (21%), Positives = 69/190 (36%), Gaps = 33/190 (17%)
Query: 397 DFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQ------- 449
DFQ + +HPN++ L + LL+E++ G L L +
Sbjct: 54 DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113
Query: 450 ----------RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499
L +L I K V GMAYL H L + N L+ +
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVV 169
Query: 500 LLTDYALRPLI------NPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK 553
+ D+ L I + + + PE + + +SDVW+ G+++ E+ +
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-- 227
Query: 554 YPENYLLQGY 563
Y +Q Y
Sbjct: 228 ----YGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 28/206 (13%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRED----------FQEHIKRLGRLEHPN 412
LG GTF YK V+ + Q +V + F E + +L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ L R E ++ E+V+ G L LH K L W +L + K + + YL
Sbjct: 63 LVKLYGVCVRDENIMVE-EYVKFGPLDVFLHRE--KNNVSLHW--KLDVAKQLASALHYL 117
Query: 473 HNELPGSIIPHGHLKSSNVLLDR-----SFEPL--LTDYALRPLINPDNAHTLMVAYKSP 525
++ + HG++ N+L+ R + P L+D + + + + +P
Sbjct: 118 EDKK----LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAP 173
Query: 526 EYAHNG--KISKKSDVWSLGILILEL 549
E NG ++ +D WS G +LE+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDF-----QEHIKRLGRLEHPN 412
VLG G+FG A K + Y VK K+ + +D ++ + L +HP
Sbjct: 2 VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPF 57
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L L + + K+ + E+V G L + + P + R + +V G+ +L
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP----RARFYAAE-IVLGLQFL 112
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYA 528
H II + LK NVLLD + D+ + + I + Y +PE
Sbjct: 113 HER---GII-YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP-----ENYLLQ 561
D W+LG+L+ E+L G+ P E+ L Q
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 40/218 (18%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTAFYY 421
+G GT+G YK +G+ KQ+ G I L L+HPN++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 422 RKEEK--LLLYEFVENGSL-AGKLH-ANHTKQRPGLDWQTRLKIIKGVVK--------GM 469
++ LL+++ E+ K H A+ ++P +++ +G+VK G+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP-------VQLPRGMVKSLLYQILDGI 121
Query: 470 AYLHNELPGSIIPHGHLKSSNVLL-------------DRSFEPLLTDYALRPLINPDNAH 516
YLH + + H LK +N+L+ D F L L+PL + D
Sbjct: 122 HYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS-PLKPLADLDPV- 175
Query: 517 TLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGK 553
+ Y++PE + +K D+W++G + ELLT +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHI--KRLGRL--EHPNLLP 415
++LG G+FG + + Q + +K K+ + +D + + KR+ L EHP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + KE + E++ G L + + H P + ++ G+ +LH++
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYA-----AEIICGLQFLHSK 115
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHNG 531
I + LK N+LLD + D+ + +A T Y +PE
Sbjct: 116 G----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 532 KISKKSDVWSLGILILELLTGKYP 555
K + D WS G+L+ E+L G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 27/207 (13%)
Query: 362 VLGSGTFGASYKTV------ISNGQAYVVKRYKQMNNVGREDFQE----HIKRLGRL-EH 410
LG+G FG K V +S A + K + +E +K + L H
Sbjct: 42 TLGAGAFG---KVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
N++ L L++ E+ G L L K+ L + L V KGMA
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMA 155
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKS 524
+L ++ + I H L + NVLL + D+ L I D+ + L V + +
Sbjct: 156 FLASK---NCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 525 PEYAHNGKISKKSDVWSLGILILELLT 551
PE N + +SDVWS GIL+ E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 362 VLGSGTFGASYK-TVISNGQAYVVKRY--KQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
VLG G FG V + G+ Y K+ K++ E + KR+ + + A
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ Y ++ L L + NG K H + PG D Q + + G+ L E
Sbjct: 67 YAYETKDALCLVLTIMNGGDL-KFHI-YNMGNPGFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----AHTLMVAYKSPEYAHNGKIS 534
I + LK N+LLD ++D L I P+ V Y +PE +N K +
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 535 KKSDVWSLGILILELLTGKYP 555
D W LG LI E++ G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 17/132 (12%)
Query: 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS-IIPHGHL 486
L+ EF+ +GSL L N K ++ + +LK + KGM YL GS H L
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYL-----GSRQYVHRDL 135
Query: 487 KSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-------VAYKSPEYAHNGKISKKSDV 539
+ NVL++ + + D+ L I D + + V + +PE K SDV
Sbjct: 136 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDV 195
Query: 540 WSLGILILELLT 551
WS G+ + ELLT
Sbjct: 196 WSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 50/201 (24%), Positives = 80/201 (39%), Gaps = 14/201 (6%)
Query: 362 VLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN---LLPLT 417
VLG G FG V + G+ Y K+ ++ R+ + LE N ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
Y K+ L+ + G L K H H + G + + + G+ LH E
Sbjct: 67 YAYETKDALCLVLTLMNGGDL--KFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER- 122
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---AHTLMVAYKSPEYAHNGKIS 534
I + LK N+LLD ++D L + V Y +PE N + +
Sbjct: 123 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 535 KKSDVWSLGILILELLTGKYP 555
D W+LG L+ E++ G+ P
Sbjct: 180 FSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 38/223 (17%)
Query: 362 VLGSGTFGASYK---TVISNGQAYV---VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLL 414
LG G FG K + Y VK K+ ++ D L ++ HP+++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHAN--------------------HTKQRPGLD 454
L + LL+ E+ + GSL L + + +R L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA-LT 125
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514
+ + +GM YL E+ + H L + NVL+ + ++D+ L + ++
Sbjct: 126 MGDLISFAWQISRGMQYL-AEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 515 AHT------LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
++ + V + + E + + +SDVWS G+L+ E++T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 29/214 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVG--REDFQEHIKRLGRL-EHPNLLPL 416
E++G+GT+G YK + GQ +K M+ G E+ ++ I L + H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEIKQEINMLKKYSHHRNIATY 68
Query: 417 TAFYYRK------EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
+ +K ++ L+ EF GS+ L N +W I + +++G++
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA----LRPLINPDNAHTLMVAYKSPE 526
+LH + H +K NVLL + E L D+ L + N + +PE
Sbjct: 126 HLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181
Query: 527 YAH-----NGKISKKSDVWSLGILILELLTGKYP 555
+ KSD+WSLGI +E+ G P
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-------HPNL 413
+V+G G FG K I + K+M +D +H G LE HPN+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNI 70
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLH-------------ANHTKQRPGLDWQTRLK 460
+ L + L E+ +G+L L AN T L Q L
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLH 128
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL---RPLINPDNAHT 517
V +GM YL + H L + N+L+ ++ + D+ L + +
Sbjct: 129 FAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
L V + + E + + SDVWS G+L+ E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G GT+G +K + NG VK ++++ E E+ +HPN++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 420 YYRKEEK-----LLLYEFVENGSLA----GKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
YY+K+ K L+ E GS+ G L + P + + I+ + G+
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQ 138
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NAHTLMVAYKSPE 526
+LH + H +K +N+LL L D+ + + N + +PE
Sbjct: 139 HLHV----NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 527 YAH-----NGKISKKSDVWSLGILILELLTGKYP 555
+ + DVWSLGI +EL G P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 363 LGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHI----KRLGRLEHPNLL 414
LG+G+FG A+YK + +KR+++ + + ++ +H+ K L + HP +
Sbjct: 38 LGTGSFGRVILATYKN--EDFPPVAIKRFEK-SKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRP---GLDWQTRLKIIKGVVKGMAY 471
L + + L+ EFV G L N K+ P G + ++ +I ++ +
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL--MVAYKSPEYAH 529
++ +L K N+LLD+ +TD+ +++ +TL Y +PE
Sbjct: 153 VYRDL----------KPENLLLDKDGFIKMTDFGFAKVVD-TRTYTLCGTPEYIAPEILL 201
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
N K +D W+LGI I E+L G P
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 361 EVLGSGTFGASYKTVI----SNGQAYVVKRYKQMNNVGREDFQEHI---KRLGRLEHPNL 413
++LG GTFG K ++ + G+ Y +K K+ V +++ + + L HP L
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L + ++ ++L NG G+L + +++R + + R + +V + YLH
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANG---GELFFHLSRERVFSEDRARFYGAE-IVSALDYLH 112
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAH 529
+E + + LK N++LD+ +TD+ L D A Y +PE
Sbjct: 113 SE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
+ + D W LG+++ E++ G+ P
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYK---QMNNVGREDFQEHIKRLGRLEHPNLLPL 416
E +G GT+G YK G+ +K+ + + V +E I L L HPN++ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE-ISLLKELNHPNIVKL 64
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ + + L++EF LH + K +D I ++K +YL L
Sbjct: 65 LDVIHTENKLYLVFEF---------LHQDLKKF---MDASPLSGIPLPLIK--SYLFQLL 110
Query: 477 PGSIIPHGH------LKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE 526
G H H LK N+L++ L D+ L R P +T V Y++PE
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 527 YAHNGKI-SKKSDVWSLGILILELLTGK 553
K S D+WSLG + E++T +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE--------HIKRLGRLEHPN 412
E LG GT+ YK G+ + + D +E I + L+H N
Sbjct: 6 EKLGEGTYATVYK-----GRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHEN 59
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L + + + +L++E+++ K H + LD T ++KG+A+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFC 116
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYA 528
H + + H LK N+L+++ E L D+ L R P N + V Y++P+
Sbjct: 117 HE----NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 529 HNGKISKKS-DVWSLGILILELLTGK 553
+ S D+WS+G ++ E++TG+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 56/124 (45%)
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-------------RSF--------EP 499
I+ ++K + Y+H+ G++I H LK SN+LL+ RS P
Sbjct: 112 IMYQLLKALKYIHS---GNVI-HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 500 LLTDYALRPLINPDNAHTLMVA---YKSPE-------YAHNGKISKKSDVWSLGILILEL 549
+LTDY VA Y++PE Y +K D+WS+G ++ E+
Sbjct: 168 VLTDY---------------VATRWYRAPEILLGSTRY------TKGVDMWSVGCILGEM 206
Query: 550 LTGK 553
L GK
Sbjct: 207 LLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 13/215 (6%)
Query: 410 HPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
HP L+ L + + + + E+V G L H ++ P + R + + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLP--EEHARFYSAE-ISLAL 109
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSP 525
YLH I + LK NVLLD LTDY + + + P + + Y +P
Sbjct: 110 NYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 165
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585
E D W+LG+L+ E++ G+ P + + + + +++ ++ EK+
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 225
Query: 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME 620
+K A KS + K L C + A ++
Sbjct: 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 260
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 363 LGSGTFGASYKTV-ISNGQAYV-VKRYK-QMNNVG------REDFQEHIKRLGRLEHPNL 413
+G G +G +K + NG +V +KR + Q G RE ++ L EHPN+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 66
Query: 414 LPL----TAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKG 468
+ L T +E KL L++E V+ L L PG+ +T ++ +++G
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD---KVPEPGVPTETIKDMMFQLLRG 122
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YKSP 525
+ +LH+ + H LK N+L+ S + L D+ L + + A T +V Y++P
Sbjct: 123 LDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGK 553
E + D+WS+G + E+ K
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 361 EVLGSGTFG-ASYKTVISNGQAYVVKRYK-----QMNNVGREDFQEHIKRLGRLEHPNLL 414
VLG G+FG + +G+ Y VK K Q ++V ++ I L R HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 59
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGMAYLH 473
L + + + EFV G L H ++ D + R + + + +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLM-----FHIQKSRRFD-EARARFYAAEITSALMFLH 113
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTLMVA--YKSPEYAH 529
++ II + LK NVLLD L D+ + + N T Y +PE
Sbjct: 114 DK---GII-YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
D W++G+L+ E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 363 LGSGTFGASYKTV--ISNGQAYV-VKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTA 418
LGSG FG K V + Q V +K K N R++ + + +L++P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ E L+L V + G L+ + ++ + ++++ V GM YL G
Sbjct: 63 VC--EAEALML---VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----G 113
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYK------SPEYAHNG 531
H L + NVLL ++D+ L + L D+ + A K +PE +
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 532 KISKKSDVWSLGILILELLT-GKYP 555
K S +SDVWS GI + E + G+ P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYK---QMNNVGREDFQEHIKRLGRLEHPNLLPL 416
E +G GT+G YK G+ +K+ + + V +E I L L HPN++ L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE-ISLLKELNHPNIVRL 63
Query: 417 TAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ E KL L++EF++ L K + + + GLD + +++G+AY H
Sbjct: 64 LDVVH-SENKLYLVFEFLD---LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCH-- 116
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYAHNG 531
+ H LK N+L+DR L D+ L R P +T V Y++PE
Sbjct: 117 --SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 532 K-ISKKSDVWSLGILILELLTGK 553
+ S D+WS+G + E++ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YK 523
G+A+LH+ I H LK+SN+LL+ + D+ L R +P +T +V Y+
Sbjct: 118 GVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173
Query: 524 SPEYAHNGKI-SKKSDVWSLGILILELLTGK 553
+PE K S D+WS+G + ELLT K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 30/208 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQ--EHIKR-------LGRLEH 410
+GSG +G + V +K+ FQ H KR L ++H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKL-------SRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
N++ L + + L G N K + D + ++ +++G+
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLK 132
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE 526
Y+H+ II H LK SN+ ++ E + D+ L R D+ T VA Y++PE
Sbjct: 133 YIHS---AGII-HRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPE 185
Query: 527 YAHN-GKISKKSDVWSLGILILELLTGK 553
N ++ D+WS+G ++ ELLTGK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 8e-04
Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNEL 204
+LK L ++NNRLT + LP L L L N PE +RSL L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 28/176 (15%)
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLL-LYEFVENGSLAGKLHANHTKQRPGL 453
R F+ RL HPN++ L L ++E+V +L L A+ L
Sbjct: 22 RARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGA-----L 76
Query: 454 DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL----DRSFEPLLTDYALRPL 509
+++ V+ +A HN+ G I H LK N+++ R +L D+ + L
Sbjct: 77 PAGETGRLMLQVLDALACAHNQ--G--IVHRDLKPQNIMVSQTGVRPHAKVL-DFGIGTL 131
Query: 510 INPD---------NAHTLMV---AYKSPEYAHNGKISKKSDVWSLGILILELLTGK 553
+ P T ++ Y +PE ++ SD+++ G++ LE LTG+
Sbjct: 132 L-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHPNLL 414
+G GT+G Y+ + V + +M+N RE I L L HPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE-----ITLLLNLRHPNIV 69
Query: 415 PL--TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L + L+ E+ E LA L P + Q + ++ +++G+ YL
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM---PTPFSESQVKC-LMLQLLRGLQYL 124
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYA 528
H I H LK SN+LL + D+ L R P T V Y++PE
Sbjct: 125 HENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180
Query: 529 HNGKISKKS-DVWSLGILILELLTGK 553
+ D+W++G ++ ELL K
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYK-QMNNVG------RE-------DFQEHIKRL 405
E +G GT+G YK + G+ +K+ + +M+ G RE +I RL
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 406 GRLEHPNLLPLTAFYYRKEEKLLLYEFVE--NGSLAGKLHANHTKQRPGLDWQTRLKIIK 463
+EH K K LY E + L + +N L +T +
Sbjct: 67 LDVEHVE---------EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYAL-RPLINPDNAHTLMVA 521
++KG+A+ H + H LK N+L+D+ L + D L R P ++T +
Sbjct: 118 QLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 522 ---YKSPEYAHNGK-ISKKSDVWSLGILILELLTG 552
Y++PE S D+WS+G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 10/97 (10%)
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV 520
+I +++G+ Y+H+ + I H LK SN+ ++ E + D+ L + D+ T V
Sbjct: 125 LIYQILRGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV 178
Query: 521 A---YKSPEYAHNG-KISKKSDVWSLGILILELLTGK 553
A Y++PE N ++ D+WS+G ++ ELLTG+
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 32/212 (15%)
Query: 363 LGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN---------- 412
LG G+FG Y+ G A V + + V + E R+E N
Sbjct: 14 LGQGSFGMVYE-----GIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 68
Query: 413 --LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHA--NHTKQRPGLDWQTRLKIIK---GV 465
++ L + + L++ E + G L L + + P + K+I+ +
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHT-----LM 519
GMAYL+ + H L + N ++ F + D+ + R + D L
Sbjct: 129 ADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
V + SPE +G + SDVWS G+++ E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 363 LGSGTFG--ASYKTVISNGQAYVVKRYKQMNN-----VGREDFQEHIKRLGRLEHPNLLP 415
+G G FG S + ++ GQ +K K M + + ++E +K L L H N++
Sbjct: 18 VGMGAFGLVCSARDQLT-GQNVAIK--KIMKPFSTPVLAKRTYRE-LKLLKHLRHENIIS 73
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L+ + E + + L L + RP L+ Q + +++G+ Y+H+
Sbjct: 74 LSDIFISPLEDIYFVTELLGTDLHRLLTS-----RP-LEKQFIQYFLYQILRGLKYVHS- 126
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKI-- 533
G + H LK SN+L++ + + + D+ L + +P M Y S Y +I
Sbjct: 127 -AGVV--HRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIML 178
Query: 534 -----SKKSDVWSLGILILELLTGK 553
+ D+WS G + E+L GK
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 25/168 (14%)
Query: 410 HPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
+P L+ L + + L+ E+V G L H ++ P + R + + +
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLP--EEHARFYAAE-ICIAL 109
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSP 525
+LH II + LK NVLLD LTDY + + + P + + Y +P
Sbjct: 110 NFLHER---GII-YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP------------ENYLLQ 561
E + D W+LG+L+ E++ G+ P E+YL Q
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGRED-------FQEHIKRLGRLEH 410
VLG G+FG A K + + +K K+ +V ED + + L EH
Sbjct: 2 VLGKGSFGKVMLAELK---GTNEFFAIKALKK--DVVLEDDDVECTMVERRVLALA-WEH 55
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
P L L + KE + E++ G L H + D ++ G+
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLM-----FHIQSSGRFDEARARFYAAEIICGLQ 110
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE 526
+LH + G I + LK NVLLD+ + D+ + + +N + + Y +PE
Sbjct: 111 FLHKK--GII--YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
K ++ D WS G+L+ E+L G+ P
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 27/212 (12%)
Query: 361 EVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNL 413
+V+G G FG + +I N ++K + N+ DF ++ L +L HPN+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND--HRDFAGELEVLCKLGHHPNI 65
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLH-----------ANHTKQRPGLDWQTRLKII 462
+ L + + E+ G+L L A L Q L+
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL---RPLINPDNAHTLM 519
V GM YL + H L + NVL+ + + D+ L + L
Sbjct: 126 SDVATGMQYLSEKQ----FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
V + + E + + KSDVWS G+L+ E+++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 362 VLGSGTFGASYKTVISNGQAYV-VKRYK--QMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
V+G G +G K + V +K++K + N +E +K L L+ N++ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH-NELP 477
+ R+ + L++E+VE L +L P ++ I ++K + + H N+
Sbjct: 68 AFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRS---YIYQLIKAIHWCHKND-- 120
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNA-HTLMVA---YKSPEYAHNGK 532
I H +K N+L+ + L D+ R L NA +T VA Y+SPE
Sbjct: 121 ---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 533 ISKKSDVWSLGILILELLTGK 553
K D+WS+G ++ EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 10/83 (12%)
Query: 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAH----------NGK 532
H +K NVLLD++ L D+ + D VA +P+Y G+
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+ D WSLG+ + E+L G+ P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 29/97 (29%), Positives = 56/97 (57%), Gaps = 12/97 (12%)
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM----V 520
+++G+ Y+H + + H LK SN+LL+ + + + D+ L + +P++ HT V
Sbjct: 115 ILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 521 A---YKSPEYAHNGK-ISKKSDVWSLGILILELLTGK 553
A Y++PE N K +K D+WS+G ++ E+L+ +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 363 LGSGTFGASYKTV--ISNGQAYV-VKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLT 417
LGSG FG K + + + V VK K NN +++ + +L++P ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHAN-HTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
E +L+ E E G L L N H ++ +++ V GM YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEK------NITELVHQVSMGMKYLEE-- 113
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH-------TLMVAYKSPEYAH 529
+ H L + NVLL ++D+ L + D + V + +PE +
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 530 NGKISKKSDVWSLGILILE 548
K S KSDVWS G+L+ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 44/206 (21%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 361 EVLGSGTFGASYKTVI----SNGQAYVVKRYKQMNNVGREDFQEHI---KRLGRLEHPNL 413
++LG GTFG K ++ + G+ Y +K ++ + +++ + + L HP L
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L + + + E+ G L L +++R + + R + +V + YLH
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH 112
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAH 529
+ + + +K N++LD+ +TD+ L D A Y +PE
Sbjct: 113 SR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
+ + D W LG+++ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 23/204 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQ------AYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL 413
+VLGSG FG YK + I G+ A R +E E + +++P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MASVDNPHV 71
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L +L+ + + G L + + K G + L + KGM YL
Sbjct: 72 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREH--KDNIGSQYL--LNWCVQIAKGMNYLE 126
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSP------EY 527
+ H L + NVL+ +TD+ L L+ D K P E
Sbjct: 127 ERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 528 AHNGKISKKSDVWSLGILILELLT 551
+ + +SDVWS G+ + EL+T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 361 EVLGSGTFGASYKTVI----SNGQAYVVKRYKQMNNVGREDFQEHI---KRLGRLEHPNL 413
++LG GTFG K ++ + G+ Y +K K+ + +++ + + L HP L
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L + + + E+ NG G+L + +++R + + R + +V + YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYA-NG---GELFFHLSRERVFSEDRARFYGAE-IVSALGYLH 112
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAH 529
+ ++ + LK N++LD+ +TD+ L D A Y +PE
Sbjct: 113 S---CDVV-YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
+ + D W LG+++ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 362 VLGSGTFGASYK----TVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
VLG G +G ++ T G+ + +K K+ V + H K L ++HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 414 LPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQ-TRLKIIKGVVKGMAY 471
+ L + ++ KL L+ E++ G L L +R G+ + T + + + +
Sbjct: 63 VDL-IYAFQTGGKLYLILEYLSGGELFMHL------EREGIFMEDTACFYLSEISLALEH 115
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEY 527
LH + II + LK N+LLD LTD+ L + HT + Y +PE
Sbjct: 116 LHQQ---GII-YRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
K D WSLG L+ ++LTG P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 43/200 (21%), Positives = 75/200 (37%), Gaps = 14/200 (7%)
Query: 363 LGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHI---KRLGRLEHPNLLPLTA 418
LG G FG + G+ Y K+ + R+ Q + K L ++ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ K++ L+ + G L K H + + PG + ++ G+ +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDL--KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALR---PLINPDNAHTLMVAYKSPEYAHNGKISK 535
I + LK NVLLD ++D L Y +PE
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 536 KSDVWSLGILILELLTGKYP 555
D ++LG + E++ G+ P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 49/220 (22%)
Query: 364 GSGTFGASYKTVISN---GQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHPN 412
G GT+G YK N G+ Y +K++K RE I L L+H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE-----IALLRELKHEN 63
Query: 413 LLPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
++ L F ++ + LL+++ E+ L + + +R + ++ ++ G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 471 YLHNELPGSIIPHGHLKSSNVL-----------------LDRSF-EPLLTDYALRPLINP 512
YLH+ + + H LK +N+L L R F PL L P++
Sbjct: 123 YLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV-- 176
Query: 513 DNAHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLT 551
+ + Y++PE + +K D+W++G + ELLT
Sbjct: 177 -----VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 27/212 (12%)
Query: 361 EVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNL 413
+V+G G FG K I + +K Y ++ DF ++ L +L HPN+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNI 58
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLH-----------ANHTKQRPGLDWQTRLKII 462
+ L + L E+ +G+L L A L Q L
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL---RPLINPDNAHTLM 519
V +GM YL + H L + N+L+ ++ + D+ L + + L
Sbjct: 119 ADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLT 551
V + + E + + SDVWS G+L+ E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 22/168 (13%)
Query: 401 HIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK 460
H+ +L HPN++P A + E ++ F+ GS A L H G+
Sbjct: 51 HVSKL--FNHPNIVPYRATFIADNELWVVTSFMAYGS-AKDLICTHFMD--GMSELAIAY 105
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD----------RSFEPLLTDYALRPLI 510
I++GV+K + Y+H+ G + H +K+S++L+ RS ++ ++
Sbjct: 106 ILQGVLKALDYIHHM--GYV--HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161
Query: 511 NPDNAHTLMV-AYKSPEYAHNG--KISKKSDVWSLGILILELLTGKYP 555
+ +++ V + SPE KSD++S+GI EL G P
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 16/201 (7%)
Query: 363 LGSGTFGASYKTVISN-GQAYVVKRY--KQMNNVGREDFQEHIKR-LGRLEHPNLLPLTA 418
LG G FG + N G+ Y K+ K++ E K L ++ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ K L+ + G L K H + +R GL+ + + + G+ +LH+
Sbjct: 61 AFESKTHLCLVMSLMNGGDL--KYHIYNVGER-GLEMERVIHYSAQITCGILHLHS---- 113
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHNGKIS 534
I + +K NVLLD L+D L + D A Y +PE S
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 535 KKSDVWSLGILILELLTGKYP 555
D +++G I E++ G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 361 EVLGSGTFGASYKTVIS----NGQAYVVKRYK-----QMNNVGREDFQEHIKRLGRLEHP 411
+VLG G+FG K +++ + Y +K K Q ++V ++ I L +HP
Sbjct: 1 KVLGKGSFG---KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP 56
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
L L + K+ + E+V G L ++ + R + ++R + V + +
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAAE-VTLALMF 111
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEY 527
LH G I + LK N+LLD L D+ + + I T Y +PE
Sbjct: 112 LHRH--GVI--YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI 167
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
+ D W+LG+L+ E++ G+ P
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 12/103 (11%)
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV 520
+I +++G+ Y+H+ + I H LK SNV ++ E + D+ L D+ T V
Sbjct: 123 LIYQLLRGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYV 176
Query: 521 A---YKSPEYAHNG-KISKKSDVWSLGILILELLTGK--YPEN 557
A Y++PE N ++ D+WS+G ++ ELL GK +P N
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVG------REDFQEHIKRLGRLEHPNL 413
E LG G++ YK + NGQ +K G RE L L+H N+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIRE-----ASLLKGLKHANI 65
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG--LDWQTRLKIIKGVVKGMAY 471
+ L + KE ++E++ A + Q PG + RL + + +++G+AY
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDL------AQYMIQHPGGLHPYNVRLFMFQ-LLRGLAY 118
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEY 527
+H G I H LK N+L+ E L D+ L R P ++ V Y+ P+
Sbjct: 119 IH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174
Query: 528 AHNG-KISKKSDVWSLGILILELLTGK 553
S D+W G + +E+L G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 459 LKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALRPL-INPDNA 515
L I + V++ + YLH II H +K+ N+ ++ + L D+ A P+ IN +
Sbjct: 185 LAIERSVLRAIQYLHEN---RII-HRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 516 HTL--MVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK 553
+ +A +PE D+WS GI++ E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 26/207 (12%)
Query: 363 LGSGTFGASYKTVI---SNGQAYVVKRYK-QMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+G+G FG + I + VVK K ++ + +F + L+HPN+L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH--NEL 476
LL++E+ E G L L + R ++ + G+ ++H N L
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL-SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP------LINPDNAHTLMVAYKSPEYA-- 528
H L N L + DY + P I ++ + + + +PE
Sbjct: 122 ------HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 529 -HNGKIS----KKSDVWSLGILILELL 550
H G I+ K S+VW+LG+ + EL
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 634 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.32 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.3 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.15 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.12 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.81 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.79 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.71 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.68 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.63 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.6 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.58 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.57 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.34 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.27 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.09 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.07 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.07 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.05 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.91 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.9 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.83 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-63 Score=590.47 Aligned_cols=491 Identities=26% Similarity=0.476 Sum_probs=337.7
Q ss_pred EEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
+..|+|++|++.|.+|. ...+++|+.|+|++|.++|.+| .+.++++|+.|+|++|+++|.+|.. ++++++|++|+|
T Consensus 454 L~~L~L~~n~~~~~~p~--~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L 530 (968)
T PLN00113 454 LQMLSLARNKFFGGLPD--SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE-LSSCKKLVSLDL 530 (968)
T ss_pred CcEEECcCceeeeecCc--ccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChH-HcCccCCCEEEC
Confidence 33444444444444442 1233556666666666666666 3666777777788888777777765 777888888888
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCcc--ccCCCCCcccCCCCCCCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPES--LSKMDPSTFAGNKNLCGP 229 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~--~~~~~~~~~~gn~~lcg~ 229 (634)
++|+++|.+|..+.++++|+.|+|++|+++|.+|.. ...+|+.|++++|+++|.+|.. +..+....+.||+.+||.
T Consensus 531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 610 (968)
T PLN00113 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610 (968)
T ss_pred CCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCC
Confidence 888888888888888888888888888888888875 3457888888888888888854 445666778888888875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCcccchhhhhHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhhhhcccc
Q 038422 230 PLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSY 309 (634)
Q Consensus 230 p~~~c~~~~~~~~p~~~s~pp~~~~p~~~~~~~~~~~~~s~~~i~vi~~v~~v~l~il~~~~~~~~~r~~~~~~~~~~~~ 309 (634)
+...- .+|+.. .. + ...+.+++ ++++++++++++++++++++|+|+....+. .
T Consensus 611 ~~~~~------------------~~~c~~----~~-~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 663 (968)
T PLN00113 611 DTTSG------------------LPPCKR----VR-K-TPSWWFYI-TCTLGAFLVLALVAFGFVFIRGRNNLELKR--V 663 (968)
T ss_pred ccccC------------------CCCCcc----cc-c-cceeeeeh-hHHHHHHHHHHHHHHHHHHHHhhhcccccc--c
Confidence 32100 001100 00 0 01111222 222222222222222333333332211110 0
Q ss_pred cCCCCCCCCCCCCCCCCChhhhcccccCCCcccccCCCCCCCHHHHHHhh--ccccCccCceeEEEEEE-cCCcEEEEEE
Q 038422 310 EDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRAS--AEVLGSGTFGASYKTVI-SNGQAYVVKR 386 (634)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~ 386 (634)
+... +. ... ..+.......++++++.... .++||+|+||.||+|+. .++..||+|+
T Consensus 664 ~~~~------~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 664 ENED------GT--WEL-------------QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred cccc------cc--ccc-------------cccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 0000 00 000 00000011223444444332 35799999999999996 5789999999
Q ss_pred ecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHH
Q 038422 387 YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466 (634)
Q Consensus 387 ~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 466 (634)
++..... ...|++++++++|||||+++|+|.+++..++|||||++|+|.++++. ++|.++.+|+.|||
T Consensus 723 ~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia 790 (968)
T PLN00113 723 INDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIA 790 (968)
T ss_pred ccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHH
Confidence 8654322 23568899999999999999999999999999999999999999852 89999999999999
Q ss_pred HHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCccccccccCcccccCCCCCcchhHHHHHHHH
Q 038422 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILI 546 (634)
Q Consensus 467 ~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl 546 (634)
+||+|||+.+.+ +|+||||||+||+++.++.+++. ||.+..........++..|+|||++.+..++.|+|||||||++
T Consensus 791 ~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl 868 (968)
T PLN00113 791 KALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLIL 868 (968)
T ss_pred HHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHH
Confidence 999999966433 69999999999999999988876 6766554444445667899999999999999999999999999
Q ss_pred HHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC-CCCHHHHHHHHHHHhcccccCccCCCCHHHHH
Q 038422 547 LELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA-KYSKSEMINLLKIGLSCCEEDVLARMELKEVI 625 (634)
Q Consensus 547 ~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 625 (634)
|||+||+.|++.. .+....+.+|++..........++|+.+... ....+++.++.+++.+||+.||++||+|+||+
T Consensus 869 ~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 869 IELLTGKSPADAE---FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred HHHHhCCCCCCcc---cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 9999999998632 2234567888876655544556667766432 23456788899999999999999999999999
Q ss_pred HHHHhhhc
Q 038422 626 EKIERLKE 633 (634)
Q Consensus 626 ~~L~~i~~ 633 (634)
++|+++.+
T Consensus 946 ~~L~~~~~ 953 (968)
T PLN00113 946 KTLESASR 953 (968)
T ss_pred HHHHHhhc
Confidence 99998754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-56 Score=461.61 Aligned_cols=281 Identities=35% Similarity=0.648 Sum_probs=245.6
Q ss_pred CCCCCCHHHHHHhhc-----cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEE
Q 038422 346 DMEPFDLQDMLRASA-----EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420 (634)
Q Consensus 346 ~~~~~~~~~~~~~~~-----~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 420 (634)
....|++.++..++. +.||+|+||.||+|.+.+|..||||++.........+|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 356689999988873 689999999999999999999999988765433145699999999999999999999999
Q ss_pred EeCC-ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCe
Q 038422 421 YRKE-EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499 (634)
Q Consensus 421 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 499 (634)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+++ .|+||||||+|||||+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCE
Confidence 9998 499999999999999999875432 599999999999999999999999876 49999999999999999999
Q ss_pred EEeccccCCccCC-CCCc----cccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHH
Q 038422 500 LLTDYALRPLINP-DNAH----TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVN 574 (634)
Q Consensus 500 kl~DfGla~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~ 574 (634)
||+|||+|+.... .... .+|.+|+||||+..+..+.|+|||||||+|+|++||+.|.+... ......+.+|+.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHH
Confidence 9999999977654 3221 67899999999999999999999999999999999999876322 123356999999
Q ss_pred HHHHhccCCcccccccccCCCCH-HHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 575 NMVKEKRTGDVFDKEMKGAKYSK-SEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 575 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
..+.+++..+++|+++....+.. +++.+++.+|++|++.+|.+||+|.||+++|+.+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999889999999997444544 78999999999999999999999999999997764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=398.51 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=202.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccC--hhHHHHHHHHHhcCCCCccccceeEEEeCC-ceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG--REDFQEHIKRLGRLEHPNLLPLTAFYYRKE-EKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45599999999999999765559999998654322 569999999999999999999999999887 799999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-ccccCCCCCCEEeCCCC-CeEEeccccCCccCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI-IPHGHLKSSNVLLDRSF-EPLLTDYALRPLINP-- 512 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~-- 512 (634)
+|.++++... ...+++..+++++.|||+||.|||+. . ||||||||+|||++.++ ++||+|||+++....
T Consensus 126 sL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 126 SLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred cHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999998741 23499999999999999999999998 5 99999999999999997 999999999976553
Q ss_pred --CCCccccccccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 513 --DNAHTLMVAYKSPEYAH--NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 513 --~~~~~~~~~y~aPE~~~--~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
.....+|..|||||++. ...|+.|+|||||||+||||+||+.||... .-..-+......+....+-+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~--------~~~~~~~~v~~~~~Rp~~p~- 269 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL--------APVQVASAVVVGGLRPPIPK- 269 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcCCCCCCCc-
Confidence 22357889999999999 568999999999999999999999998732 11222333333332222211
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.....+ ..++.+||..||++||++.|++..|+.+..
T Consensus 270 ------~~~~~l---~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 ------ECPPHL---SSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ------cCCHHH---HHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 122334 444458999999999999999999997753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=394.80 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=207.7
Q ss_pred hhccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 358 ASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
...+.||+|-||.||.|.+.....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 455789999999999999988889999999875 4456789999999999999999999999999889999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC--
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 515 (634)
|.+||+.... ..+...+.+.++.|||+||+||+++ .+|||||.++|||++++..+||+|||+|+...++..
T Consensus 288 Ll~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 288 LLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred HHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999987322 3489999999999999999999998 799999999999999999999999999996554432
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++.|.|||.+..++++.|||||||||+||||+| |+.|+. +....+.+. .+..+. ++.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--------~msn~ev~~-~le~Gy-------Rlp 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--------GMSNEEVLE-LLERGY-------RLP 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--------CCCHHHHHH-HHhccC-------cCC
Confidence 234578999999999999999999999999999999 898875 233333332 233332 222
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+...++++.++ |..||+.+|++|||++.+...|+++.+
T Consensus 425 ~P~~CP~~vY~l---M~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCPDEVYEL---MKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCHHHHHH---HHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 223334555554 559999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=414.97 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=207.4
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|... +.+.||||.++..... .+++|++|+++++.++|||||+|+|+|..++..+||+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 467999999999999854 3568999999977655 788999999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEec
Q 038422 433 VENGSLAGKLHANHTKQ---------RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 503 (634)
|..|||.+||....... ..+|+..+.+.||.|||.||+||-++ .+|||||..+|||+.++..+||+|
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhceeccceEEEecc
Confidence 99999999998654322 23489999999999999999999998 699999999999999999999999
Q ss_pred cccCCccCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHH
Q 038422 504 YALRPLINPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNM 576 (634)
Q Consensus 504 fGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~ 576 (634)
||+++.....+. ...+++|||||.+..++||++||||||||+|||++| |+.||.... -+.|-+.
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---------n~EVIe~ 717 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---------NQEVIEC 717 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---------hHHHHHH
Confidence 999986544332 234688999999999999999999999999999999 999985211 1122233
Q ss_pred HHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 577 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
++.+..-+ ..+.+..++-+||+.||+.+|++||+++||-..|+...+
T Consensus 718 i~~g~lL~----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQLLS----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCccc----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 44443311 122333455666679999999999999999999997643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=363.31 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=208.4
Q ss_pred CCHHHHHHhhccccCccCceeEEEEEEc-CCcEEEEEEecc-cCccChhHHHHHHHHHhcCCCCccccceeEEEeCC-ce
Q 038422 350 FDLQDMLRASAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-EK 426 (634)
Q Consensus 350 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~ 426 (634)
+++.|+.+ ...||+|..|+|||++++ +++.+|+|.+.. .+...++++.+|++++++++||+||++||.|+.++ +.
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 45555543 467999999999999975 578899999853 34455678999999999999999999999999999 49
Q ss_pred EEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 427 LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 427 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
.|+||||.+|+|.+++.... .+++...-+|+.+|++||.|||+.. .||||||||+|||++..+++||+|||.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence 99999999999999997653 3899999999999999999999742 699999999999999999999999999
Q ss_pred CCccCCC--CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 507 RPLINPD--NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 507 a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
++.+..+ .+..||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .....+.+.+...+.+.
T Consensus 226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~p---- 298 (364)
T KOG0581|consen 226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEP---- 298 (364)
T ss_pred cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCC----
Confidence 9877655 45678999999999999999999999999999999999999986331 11234444444444322
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.|++... .-.+++..|++ .|++.||.+||+++|+++.
T Consensus 299 --pP~lP~~-~fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 --PPRLPEG-EFSPEFRSFVS---CCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --CCCCCcc-cCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence 1222221 12467777887 9999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=361.85 Aligned_cols=188 Identities=26% Similarity=0.413 Sum_probs=171.0
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.||+|+||+||+|++. ++..||||.+... .....+.+..|+++|+.++|||||++++++++++..|||||||.+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 45999999999999964 5789999999765 45556778999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC------CCeEEeccccCCccC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS------FEPLLTDYALRPLIN 511 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~------~~~kl~DfGla~~~~ 511 (634)
|.+|++.... +++...+.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 96 Ls~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 96 LSDYIRRRGR-----LPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred HHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999987653 99999999999999999999999 79999999999999865 458999999999988
Q ss_pred CCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+.. ...|++-|||||++...+|+.|+|+||.|+++||++||+.||+
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 653 3467888999999999999999999999999999999999997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=371.13 Aligned_cols=239 Identities=24% Similarity=0.368 Sum_probs=200.4
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+|+.||.++. ..|+.||+|++.+. +...++...+||++.++|+|||||+++++|++.++.|||.|+|+
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence 357899999999999996 88999999999763 35567889999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|..++.... ++++.++..+++||+.||.|||+. +|+|||||..|++|++++++||+|||||..+..+
T Consensus 102 ~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 102 RGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred CccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999987432 499999999999999999999998 8999999999999999999999999999887644
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
.+.+||+.|+|||++....++..+||||+||+||-|++|++||+. ..+.+-. ..++. .+..-|.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety-~~Ik~---~~Y~~P~- 239 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETY-NKIKL---NEYSMPS- 239 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHH-HHHHh---cCccccc-
Confidence 345688999999999999999999999999999999999999961 2222221 22211 1111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....++.+++. ..++.||.+|||+++|+.
T Consensus 240 ----~ls~~A~dLI~---~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 ----HLSAEAKDLIR---KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----ccCHHHHHHHH---HHhcCCcccCCCHHHHhc
Confidence 22344555555 899999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=355.43 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=192.5
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEecccCcc-------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNV-------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.|-+|+ ..+|+.||||++.+.... ......+|+++|++++|||||+++++|...+..||||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 35789999999999998 567999999999754321 1234579999999999999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccC
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALR 507 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla 507 (634)
|||+||+|.+++..+.. +.+..-+.++.|++.|+.|||+. +|+||||||+|||+..+ ..+||+|||+|
T Consensus 256 E~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999976543 77888899999999999999998 89999999999999766 78999999999
Q ss_pred CccCCC---CCccccccccCcccccCCCC---CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 508 PLINPD---NAHTLMVAYKSPEYAHNGKI---SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 508 ~~~~~~---~~~~~~~~y~aPE~~~~~~~---~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
+..... ...+||+.|.|||++.+..+ ..|.|+||+||+||-+++|.+||.... . ...+.+. +..++
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~---~-~~sl~eQ----I~~G~ 398 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY---T-DPSLKEQ----ILKGR 398 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc---C-CccHHHH----HhcCc
Confidence 987654 45678999999999986543 348899999999999999999997321 1 1223332 22222
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. +-+.. +....++...+++ +++..||++|||++|+++
T Consensus 399 y~--f~p~~--w~~Iseea~dlI~---~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 YA--FGPLQ--WDRISEEALDLIN---WMLVVDPENRPSADEALN 436 (475)
T ss_pred cc--ccChh--hhhhhHHHHHHHH---HhhEeCcccCcCHHHHhc
Confidence 11 11000 0112344445555 999999999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=380.03 Aligned_cols=246 Identities=22% Similarity=0.439 Sum_probs=206.7
Q ss_pred ccccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||.|.||.||+|+++- ...||||.+|... +..+.+|..|+.||.+++||||++|.|+.......+||.|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 5789999999999999753 3579999998653 5567899999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
||+|+.||+.+..+ +++.+...+.++||.||.||.+. +.|||||.++|||++.+...||+|||+++.+.++.
T Consensus 714 NGsLDsFLR~~DGq----ftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 714 NGSLDSFLRQNDGQ----FTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred CCcHHHHHhhcCCc----eEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999887643 99999999999999999999998 79999999999999999999999999999886654
Q ss_pred Cc-c------ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 515 AH-T------LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 515 ~~-~------~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. . .+++|.|||.+...++|.+||||||||||||.++ |..||... +.+ +.++ .+.++-
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-----SNQ---dVIk-aIe~gy----- 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQ---DVIK-AIEQGY----- 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-----chH---HHHH-HHHhcc-----
Confidence 21 1 2367999999999999999999999999999998 99997622 112 2222 222211
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
++ +...++...+-+||+.||+.|-..||.+.+|+..|+++.
T Consensus 852 --RL---PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 852 --RL---PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred --CC---CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 11 122345567788899999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=337.29 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=199.5
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEec--ccCccChhHHHHHHHHHhcCCCCcccccee-EEEeCCc-eEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYK--QMNNVGREDFQEHIKRLGRLEHPNLLPLTA-FYYRKEE-KLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lv~e~~ 433 (634)
..++||+|.||+|||+. +.+|..+|.|.++ ..+...+++...|+.+|++|+|||||++++ -+.++.+ .+||||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 34679999999999998 6789999999886 234455678999999999999999999998 4444444 88999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
..|||...++..... ...++++.+++++.|++.||..+|...+...|+||||||.||+|+.++.+|++|||+++.+...
T Consensus 103 ~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred cccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 999999998765443 4459999999999999999999999654435899999999999999999999999999988765
Q ss_pred C----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 N----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. +..||+.||+||.+.+..|+.||||||+||++|||+.-+.||. +.++.+... .+..+....+.|
T Consensus 182 ~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~--------g~n~~~L~~-KI~qgd~~~~p~-- 250 (375)
T KOG0591|consen 182 TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY--------GDNLLSLCK-KIEQGDYPPLPD-- 250 (375)
T ss_pred hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc--------cccHHHHHH-HHHcCCCCCCcH--
Confidence 3 4568999999999999999999999999999999999999986 124433322 233332221211
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
.. -.+++ -+|+..|+..||..||+...++..++
T Consensus 251 ---~~-YS~~l---~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 ---EH-YSTDL---RELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---HH-hhhHH---HHHHHHHccCCcccCCCcchHHHHHH
Confidence 11 12334 44555999999999999655555544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=390.30 Aligned_cols=251 Identities=26% Similarity=0.451 Sum_probs=203.7
Q ss_pred hccccCccCceeEEEEEEcC--Cc----EEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN--GQ----AYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|.+.+ |. .||+|.+++.. .....+|.+|..+|++++|||||+++|+|.+.+..+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35689999999999999754 33 48899887653 4456799999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 432 FVENGSLAGKLHANHTKQ--RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
||++|||..||++.+... ...++..+.+.++.|||+|+.||+++ .+|||||.++||||++...+||+|||+|+.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999874322 34599999999999999999999998 699999999999999999999999999984
Q ss_pred cCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 510 INPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 510 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
+.... ....+++|||||++.++.+|.|+|||||||++||++| |..||.. .+-.+.+......+
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~--------~~n~~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS--------RSNFEVLLDVLEGG-- 921 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC--------cchHHHHHHHHhCC--
Confidence 33221 2234578999999999999999999999999999999 8899751 11111111122222
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
++..+.+-.+.++ +++..||+.+|++||++..++++++.+.
T Consensus 922 ------RL~~P~~CP~~ly---~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLY---QLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ------ccCCCCCCChHHH---HHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 3333344445444 6666999999999999999999998875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=366.07 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=201.9
Q ss_pred ccccCccCceeEEEEEEcCC----cE-EEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISNG----QA-YVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~----~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
.++||+|+||.||+|++..+ .. ||+|..+.. ......+|.+|+++|++++|||||++||++.....+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 37899999999999996542 23 899988753 34456789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
+|.||+|.++|..... .++..+++.++.+.|.||+|||++ .++||||.++|||++.+..+||+|||+++...
T Consensus 242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999987653 399999999999999999999998 79999999999999999999999999987654
Q ss_pred CC---C-CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 512 PD---N-AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 512 ~~---~-~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.- . ....++.|+|||.+..+.|+.++|||||||++||+++ |..||.. ....+........+.....
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g--------~~~~~v~~kI~~~~~r~~~- 384 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG--------MKNYEVKAKIVKNGYRMPI- 384 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC--------CCHHHHHHHHHhcCccCCC-
Confidence 21 1 2235678999999999999999999999999999999 8889762 2222222222222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+...+.++..+++ .||..+|++||+|.+|.+.|+.+..
T Consensus 385 ------~~~~p~~~~~~~~---~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 385 ------PSKTPKELAKVMK---QCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred ------CCCCHHHHHHHHH---HhccCChhhccCHHHHHHHHHHHHh
Confidence 1234566666666 9999999999999999999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=352.69 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=207.4
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccC-hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.+.||+|.||.|..+....+..||||.++...... +.+|.+|+++|.+++|||||+|+|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 468899999999999999888999999999765544 5899999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCcc
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT 517 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 517 (634)
|.+|+.++.... +.-...++|+.|||.||+||.+. .+|||||.++|||+|+++++||+|||+++-+.....+.
T Consensus 622 LnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 622 LNQFLSAHELPT---AETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999998765432 45556678999999999999997 79999999999999999999999999998665554433
Q ss_pred ------ccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 518 ------LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT--GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 518 ------~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt--g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.+++|||||.+.-+++|+++|||+|||+|||+++ ...||....+ ..+.+-...+.+.+....+
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~~---- 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQVV---- 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCccee----
Confidence 3588999999999999999999999999999987 7788763221 2333333333332222111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+..+ .-+-..+.+++++||..|.++||+++++...|++..
T Consensus 766 l~~P---~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 LSRP---PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ccCC---CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1111 123345668888999999999999999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=342.62 Aligned_cols=257 Identities=18% Similarity=0.323 Sum_probs=201.5
Q ss_pred CCCHHHHHHhhccccCccCceeEEEEEEcCCcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEe---
Q 038422 349 PFDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYR--- 422 (634)
Q Consensus 349 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~--- 422 (634)
.++.+++.......||+|++|.||+|.. +|+.||+|+++...... .+.|.+|+++|++++|||||+++|++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 4455555444456799999999999998 68899999987654333 3678899999999999999999999977
Q ss_pred -CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEE
Q 038422 423 -KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501 (634)
Q Consensus 423 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 501 (634)
....++||||+++|+|.+++.... .++|.....++.|++.||.|||+.. +++||||||+|||+++++.+||
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEE
Confidence 346789999999999999997542 3899999999999999999999742 5789999999999999999999
Q ss_pred eccccCCccCCCC-CccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 502 TDYALRPLINPDN-AHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 502 ~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.. ....++......
T Consensus 165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~--------~~~~~~~~~i~~ 236 (283)
T PHA02988 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN--------LTTKEIYDLIIN 236 (283)
T ss_pred cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHh
Confidence 9999988654432 3346778999999976 6899999999999999999999999862 122222222222
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+... .+ +....+++.++ +.+||+.||++|||++||++.|+++.
T Consensus 237 ~~~~~-----~~--~~~~~~~l~~l---i~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 KNNSL-----KL--PLDCPLEIKCI---VEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCCCC-----CC--CCcCcHHHHHH---HHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 21110 11 11123445444 45999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=342.80 Aligned_cols=243 Identities=27% Similarity=0.434 Sum_probs=195.8
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC--ceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE--EKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~~~~g 436 (634)
.+.||+|+||+||.+...+ |...|||.+...+....+.+.+|+++|++++|||||+++|.....+ .+++.|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 4789999999999999654 8999999987653333567899999999999999999999865555 588999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINP--- 512 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~--- 512 (634)
+|.+++..... .|++..++.+.+||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 102 sL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 102 SLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999986543 399999999999999999999998 8999999999999999 79999999999886652
Q ss_pred ----CCCccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 513 ----DNAHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 513 ----~~~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
.....+|+.|||||++..+. ...++|||||||++.||+||+.||... .....++.....+...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC-----
Confidence 12356788999999998643 345999999999999999999999721 1222333222222211
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
|.+. ..-.++..+++. .|++.||++|||++|+++.
T Consensus 242 P~ip--~~ls~~a~~Fl~---~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 242 PEIP--DSLSDEAKDFLR---KCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCC--cccCHHHHHHHH---HHhhcCcccCcCHHHHhhC
Confidence 1221 123467778887 9999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.75 Aligned_cols=232 Identities=26% Similarity=0.372 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||+||.++.. +++.+|+|++++.... ..+....|..+|.+++||.||+++..|++.+..|+|+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 478999999999999954 5889999999876433 345678999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|.|..+|..... +++..+.-++.+|+.||.|||+. +||||||||+|||||++++++|+|||+++.....
T Consensus 110 GeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 110 GELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred ccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999976543 89999999999999999999998 8999999999999999999999999999864433
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....||+.|||||++.+..|+..+|.||+||++|||+||.+||. ..+..++.....+.. . ..
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--------~~~~~~~~~~I~~~k-~-------~~ 244 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--------AEDVKKMYDKILKGK-L-------PL 244 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--------CccHHHHHHHHhcCc-C-------CC
Confidence 23467889999999999999999999999999999999999986 244555555544332 0 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCC
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARM 619 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP 619 (634)
.+.+...++.++++ .-+..||++|-
T Consensus 245 ~p~~ls~~ardll~---~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEARDLLK---KLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHHHHHHH---HHhccCHHHhc
Confidence 12223456666766 88899999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.85 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=194.8
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|.||+||+|++.. .||||+++.... ...+.|+.|+..+++-+|.||+-+.|||..++. .||..+|++-
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 46789999999999999853 689999976543 345789999999999999999999999987766 9999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|+.+|+....+ |+..+.+.||.|||+||.|||.+ .|||||||..||++.+++++||+|||++......
T Consensus 473 SLY~hlHv~etk----fdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 473 SLYTHLHVQETK----FDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hhhhhccchhhh----hhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 999999876643 99999999999999999999999 7999999999999999999999999997543211
Q ss_pred ---CCccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 ---NAHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
....+.+.|||||++.. ..|+..+||||||||+|||+||..||. ... .+.+-.++..+.. -
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~--------~dqIifmVGrG~l----~ 611 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQN--------RDQIIFMVGRGYL----M 611 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCC--------hhheEEEeccccc----C
Confidence 22345577999999974 478999999999999999999999986 111 1111111111111 1
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+++.. .....-+++.+|+..||..++++||.+.+|+..|+++..
T Consensus 612 pd~s~--~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSK--IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchh--hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11111 011222344455559999999999999999998887643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.76 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=194.8
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeCC-ceEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKE-EKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~lv 429 (634)
..+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|++++.++ +|||||+++++|...+ ..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 457899999999999974 2356899999875432 2345788999999999 8999999999987644 57899
Q ss_pred EEcCCCCChhhHHhhccCC---------------------------------------------------------CCCC
Q 038422 430 YEFVENGSLAGKLHANHTK---------------------------------------------------------QRPG 452 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~ 452 (634)
|||+++|+|.+++...... ....
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999999753210 0134
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC------CccccccccCcc
Q 038422 453 LDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPE 526 (634)
Q Consensus 453 l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE 526 (634)
+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...++..|+|||
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 88999999999999999999998 79999999999999999999999999997653321 122346799999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHH
Q 038422 527 YAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLK 605 (634)
Q Consensus 527 ~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 605 (634)
++.+..++.++|||||||++|||+| |+.||... . ....+......+... .. .....+ .+.+
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~----~----~~~~~~~~~~~~~~~-----~~--~~~~~~---~l~~ 308 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV----Q----INEEFCQRLKDGTRM-----RA--PENATP---EIYR 308 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC----C----ccHHHHHHHhcCCCC-----CC--CCCCCH---HHHH
Confidence 9999899999999999999999997 99998521 1 111111122222111 11 111122 3455
Q ss_pred HHhcccccCccCCCCHHHHHHHHHhhhcC
Q 038422 606 IGLSCCEEDVLARMELKEVIEKIERLKEG 634 (634)
Q Consensus 606 l~~~C~~~~P~~RPs~~evl~~L~~i~~~ 634 (634)
++.+||+.||++||++.||++.|+++.++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 66699999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=339.35 Aligned_cols=189 Identities=26% Similarity=0.450 Sum_probs=167.3
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.++||+|+||.||+|+ ..+|+.||+|++.-.. ........+||.+|++|+||||++|.+...++ ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 3679999999999999 6679999999987554 34445678999999999999999999999887 68999999998
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+ ||..++..... .++..+++.|+.|++.||+|+|++ +|+|||||.+|||||.++.+||+|||||+++....
T Consensus 202 h-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 202 H-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred c-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 7 88888865443 399999999999999999999998 89999999999999999999999999999876654
Q ss_pred C-----ccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 A-----HTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ~-----~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
. ...|.+|+|||.+.+. .|+...|+||.||||.||++|++.+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 2 3467899999999875 79999999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=345.47 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=203.3
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+.|.||.++ ..+++.||||++.......++-+..|+.+|+..+|+|||+++..|..+++.|+|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3579999999999998 567899999999887777778889999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.|.+.... +++.++..|+++++.||+|||.+ +|+|||||.+|||++.++.+||+|||++..+... .
T Consensus 358 TDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 358 TDVVTKTR------MTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhccc------ccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 99986542 89999999999999999999998 8999999999999999999999999998776554 3
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...||+.|||||++....|++|.||||||++.+||+-|.+||-. +..+... ..+..... +.+....
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-------E~PlrAl--yLIa~ng~-----P~lk~~~ 493 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-------ENPLRAL--YLIATNGT-----PKLKNPE 493 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-------CChHHHH--HHHhhcCC-----CCcCCcc
Confidence 45688999999999999999999999999999999999999741 1222211 11222222 2332222
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
-...++.+|++ +|++.|+.+||+++|+++.
T Consensus 494 klS~~~kdFL~---~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLD---RCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHH---HHhhcchhcCCCHHHHhcC
Confidence 33467888888 9999999999999999863
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.79 Aligned_cols=235 Identities=26% Similarity=0.440 Sum_probs=190.5
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 440 (634)
+-||+|+-|.||.|+++ ++.||||+++..+ ..+|+-|++|+||||+.|.|+|....-++||||||+.|-|..
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 56999999999999985 6789999887543 246778999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---CCcc
Q 038422 441 KLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---NAHT 517 (634)
Q Consensus 441 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~ 517 (634)
.|+.... ++-.....+..+||.||.|||.+ .|||||||+-||||..+..+||+|||.++...+. ....
T Consensus 202 VLka~~~-----itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 202 VLKAGRP-----ITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHhccCc-----cCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence 9986543 77788889999999999999998 6999999999999999999999999999876654 3456
Q ss_pred ccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCH
Q 038422 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSK 597 (634)
Q Consensus 518 ~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 597 (634)
+|+.|||||++.....++|+||||||||||||+||..||.... ....+ | .+.. ..+. +.-+....
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----ssAII--w---GVGs----NsL~--LpvPstcP 337 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----SSAII--W---GVGS----NSLH--LPVPSTCP 337 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc----hheeE--E---eccC----Cccc--ccCcccCc
Confidence 8999999999999999999999999999999999999986211 10000 1 0000 1110 11111123
Q ss_pred HHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 598 SEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 598 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
+.++-+++ .||+..|..||++++++..|+-
T Consensus 338 ~GfklL~K---qcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 338 DGFKLLLK---QCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred hHHHHHHH---HHHhcCCCCCccHHHHHHHHhh
Confidence 44444444 9999999999999999998873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.76 Aligned_cols=254 Identities=18% Similarity=0.246 Sum_probs=195.2
Q ss_pred HhhccccCccCceeEEEEE-EcCCcEEEEEEecccCccChh-HHHHHHHHHhcCC-CCccccceeEEEeCC-ceEEEEEc
Q 038422 357 RASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGRE-DFQEHIKRLGRLE-HPNLLPLTAFYYRKE-EKLLLYEF 432 (634)
Q Consensus 357 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lv~e~ 432 (634)
+...+.||.|+||.||+|+ ..+|+.||||++++.-....+ .=.+|++.|+++. |||||++.+++.+.+ ..++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 3455789999999999999 567999999999875433222 2368999999998 999999999999988 89999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|.. +|++.+..+. ..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+..
T Consensus 92 Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 92 MDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred hhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEeccccccccccc
Confidence 975 8999997663 3599999999999999999999998 899999999999999999999999999998876
Q ss_pred CCC---ccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHH---HHHhccCCcc
Q 038422 513 DNA---HTLMVAYKSPEYAH-NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNN---MVKEKRTGDV 585 (634)
Q Consensus 513 ~~~---~~~~~~y~aPE~~~-~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~~ 585 (634)
... +..|-+|+|||++. .+-|+.+.||||+|||++|+.+-++-|. +.. -.+.++. .+......+.
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP----G~s----E~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP----GAS----EIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC----CCc----HHHHHHHHHHHhCCCccccc
Confidence 644 44677899999886 4678999999999999999999887664 222 1222222 1211111111
Q ss_pred cc------------cccccCCC---CHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 586 FD------------KEMKGAKY---SKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 586 ~d------------~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. +...+... ......+.++++..|+++||.+|||++|.++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00 00000000 01123456666779999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=318.71 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=189.4
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.++|+|+||+|||++.+ +|+.||||++.... ..-.+-..+|+++|++++|||+|.++.+|..+...+||+|||...
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT- 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT- 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH-
Confidence 46899999999999965 59999999997643 333567789999999999999999999999999999999999874
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC-CCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP-DNA- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-~~~- 515 (634)
+.+-|..... .++...+.+|+.|+++|+.|+|++ .++||||||+|||++.++.+|++|||+|+.+.. ...
T Consensus 87 vL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 87 VLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 4444443322 388999999999999999999998 799999999999999999999999999998873 332
Q ss_pred --ccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHH-----------H-hc
Q 038422 516 --HTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMV-----------K-EK 580 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~-----------~-~~ 580 (634)
+..|-+|+|||.+.+ .+|+..+||||.||++.||+||.+-|.. ..+ .+....+...+ . .+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG----~SD-iDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG----RSD-IDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC----cch-HHHHHHHHHHHcccCHHHHHHhccCC
Confidence 345778999999987 7899999999999999999999987751 111 11111111111 0 01
Q ss_pred cCCccccccccc-----CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 581 RTGDVFDKEMKG-----AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 581 ~~~~~~d~~~~~-----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+.-|.... ..+ ..-..-+++++..|++.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111110011100 001 011225677778999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.14 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=206.4
Q ss_pred hhccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 358 ASAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
....+||-|.||.||.|+++. .-.||||.++.+ ....++|..|+.+|+.++|||+|+|+|+|......|||.|||.+|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 345789999999999999765 668999999875 456789999999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCc
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH 516 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 516 (634)
+|.+||++.... .++--..+.++.||+.||+||..+ .+|||||.++|||+.++..+||+|||+++++..+...
T Consensus 349 NLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 349 NLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999876543 377778899999999999999998 6999999999999999999999999999998776432
Q ss_pred -----cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 517 -----TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 517 -----~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
...+.|.|||.+....++.|+|||+|||+|||+.| |..||. +.++. .|+..+..+.. +
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------GidlS-qVY~LLEkgyR-------M 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------GIDLS-QVYGLLEKGYR-------M 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------CccHH-HHHHHHhcccc-------c
Confidence 23577999999999999999999999999999999 999975 13332 34444444322 2
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.++.. +..++.+|++.||+++|++||++.|+-+.++.+
T Consensus 486 ~~PeG---CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 486 DGPEG---CPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cCCCC---CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 22222 233556666799999999999999999988865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=327.46 Aligned_cols=248 Identities=20% Similarity=0.322 Sum_probs=195.1
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..++||.|.-++||+|+ .+.++.||||++.-.+.. +.+.+.+|+..|+.++||||++++..|..+...|+||.||.+|
T Consensus 30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence 35789999999999999 566899999999754433 3578999999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
++.+++......+ +++..+..|.+++++||.|||++ |-||||||+.||||+++|.+||+|||.+..+...
T Consensus 110 S~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 110 SLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred cHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999998776653 99999999999999999999998 8999999999999999999999999986554432
Q ss_pred -----CCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc-C--C
Q 038422 514 -----NAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR-T--G 583 (634)
Q Consensus 514 -----~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~-~--~ 583 (634)
....+++.|||||++.. ..|+.|+||||||++..||.+|..||....+ .+.....++... . .
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHhcCCCCCccc
Confidence 23457788999999653 4689999999999999999999999873211 111111111110 0 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...|..... .+ ...+.+++. .|++.||++|||++++++
T Consensus 255 ~~~~~d~~k-~~-~ksf~e~i~---~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDK-KF-SKSFREMIA---LCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhh-hh-cHHHHHHHH---HHhhcCcccCCCHHHHhc
Confidence 111111111 11 124444444 999999999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.22 Aligned_cols=255 Identities=22% Similarity=0.389 Sum_probs=193.4
Q ss_pred ccccCccCceeEEEEEEcC-----------------CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEE
Q 038422 360 AEVLGSGTFGASYKTVISN-----------------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 421 (634)
.+.||+|+||.||++...+ +..||+|.+.... .....+|.+|++++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 4679999999999997532 3469999887542 223467999999999999999999999999
Q ss_pred eCCceEEEEEcCCCCChhhHHhhccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCC
Q 038422 422 RKEEKLLLYEFVENGSLAGKLHANHTK--------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLK 487 (634)
Q Consensus 422 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk 487 (634)
+.+..++||||+++|+|.+++...... ....++|..+.+++.||+.||+|||+. +|+|||||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ivH~dlk 165 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHRDLA 165 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----CccccCcc
Confidence 999999999999999999998653211 113478999999999999999999998 79999999
Q ss_pred CCCEEeCCCCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCcccc
Q 038422 488 SSNVLLDRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT--GKYPENYL 559 (634)
Q Consensus 488 ~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt--g~~P~~~~ 559 (634)
|+|||+++++.+||+|||+++...... ...++..|+|||++..+.++.++|||||||++|||++ +..|+...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999987654322 1223567999999988899999999999999999997 45666421
Q ss_pred cccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 560 LQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 560 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
........+......... ... ......... .+.+++.+||+.||++||||+||.+.|++
T Consensus 246 -----~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~---~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 -----TDEQVIENAGEFFRDQGR-QVY---LFRPPPCPQ---GLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred -----CHHHHHHHHHHHhhhccc-ccc---ccCCCCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 112233333222222111 010 000111122 45566669999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=335.27 Aligned_cols=239 Identities=21% Similarity=0.359 Sum_probs=191.9
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEeccc---CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
+++.||+|+|++||+|+ ...++.+|||++.+. .+...+-...|-..|.+| .||.||+|+.-|.+...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 46789999999999999 456899999998653 222334567788889988 8999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.++|...+. |++...+.++.+|+.||+|||+. +||||||||+|||+|+||++||+|||-|+.+.+.
T Consensus 157 ~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 157 PNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred CCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999986543 99999999999999999999998 8999999999999999999999999999876532
Q ss_pred -----------------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHH
Q 038422 514 -----------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM 576 (634)
Q Consensus 514 -----------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 576 (634)
....||..|.+||++.++..++.+|+|+|||++|+|+.|++||.. ..+..+.+ ..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-----~NeyliFq---kI 299 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-----ANEYLIFQ---KI 299 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-----ccHHHHHH---HH
Confidence 123567789999999999999999999999999999999999962 11111111 11
Q ss_pred HHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 577 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+. +|-.+ +..-.+.+.++++ +-+..||++|++.+||-+
T Consensus 300 ~~-------l~y~f--p~~fp~~a~dLv~---KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 300 QA-------LDYEF--PEGFPEDARDLIK---KLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HH-------hcccC--CCCCCHHHHHHHH---HHHccCccccccHHHHhh
Confidence 10 01111 1111245555555 888999999999987754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=304.09 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=193.3
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+++|+|.||.||+|+ ..+|+.||||+++..+.. -.....+|++.|+.++|+||+.++++|-..+..-||+|||+.
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 34689999999999999 567999999999865332 234678999999999999999999999999999999999975
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
+|...++.... .++-.++..++.++.+|++|+|.+ .|+||||||.|+|++.++.+||+|||+|+.+.+...
T Consensus 86 -dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 86 -DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred -cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 89988875543 499999999999999999999998 799999999999999999999999999998765432
Q ss_pred ----ccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHH--HHHHHHhccCCcc---
Q 038422 516 ----HTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNW--VNNMVKEKRTGDV--- 585 (634)
Q Consensus 516 ----~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~--~~~~~~~~~~~~~--- 585 (634)
...|-.|+|||.+.+. .|+...||||.|||+.||+-|.+-+. +. .++.+. +...+......++
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~---sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GD---SDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CC---chHHHHHHHHHHcCCCCcccCccc
Confidence 2457789999999875 69999999999999999998875543 21 222221 1122211111111
Q ss_pred ------cccc-----cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 586 ------FDKE-----MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 586 ------~d~~-----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
++-. ....-+ ...-.+.++++..++..||.+|.+++|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000 000000 1122345677779999999999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=327.96 Aligned_cols=243 Identities=29% Similarity=0.507 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEEc-----CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-----NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|.||.||+|.+. .+..|+||.++.... ...++|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999987 257899999965332 23678999999999999999999999999888899999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.++|..... ..+++..+..|+.|||+||+|||+. +++|+||+++||++++++.+||+|||+++.....
T Consensus 84 ~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccc
Confidence 99999999987622 2499999999999999999999998 7999999999999999999999999998766322
Q ss_pred ------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 ------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
........|+|||.+....++.++||||||+++||++| |+.|+.. ....++.... .++.....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~--------~~~~~~~~~~-~~~~~~~~- 226 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD--------YDNEEIIEKL-KQGQRLPI- 226 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT--------SCHHHHHHHH-HTTEETTS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccc-ccccccee-
Confidence 22334567999999998889999999999999999999 6788651 2233333333 22211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
. ......+. +++..||+.+|++||+|+|+++.|
T Consensus 227 ~------~~~~~~~~---~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 P------DNCPKDIY---SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp B------TTSBHHHH---HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c------cchhHHHH---HHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 11123444 455599999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=335.53 Aligned_cols=237 Identities=25% Similarity=0.387 Sum_probs=192.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc----Cc-cChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM----NN-VGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||.|+. .++..||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 46799999999999984 56899999977653 11 23456778999999999 99999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~ 511 (634)
+.+|+|.+++.... ++.+.++..++.|++.|++|+|+. +|+||||||+|||+|.+ +.+||+|||++....
T Consensus 102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999998732 388899999999999999999998 89999999999999999 999999999998772
Q ss_pred -C---CCCccccccccCcccccCCC-CC-cchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 512 -P---DNAHTLMVAYKSPEYAHNGK-IS-KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 512 -~---~~~~~~~~~y~aPE~~~~~~-~~-~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
. .....|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. ......... +..+ +.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~k-i~~~---~~ 240 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRK-IRKG---EF 240 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHH-HhcC---Cc
Confidence 2 24567889999999999877 85 789999999999999999999972 222222222 1111 11
Q ss_pred cccccccCCCC-HHHHHHHHHHHhcccccCccCCCCHHHHH
Q 038422 586 FDKEMKGAKYS-KSEMINLLKIGLSCCEEDVLARMELKEVI 625 (634)
Q Consensus 586 ~d~~~~~~~~~-~~~~~~~~~l~~~C~~~~P~~RPs~~evl 625 (634)
.-+ ..- ..+...++. +|+..||.+|+++.||+
T Consensus 241 ~~p-----~~~~S~~~~~Li~---~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 KIP-----SYLLSPEARSLIE---KMLVPDPSTRITLLEIL 273 (370)
T ss_pred cCC-----CCcCCHHHHHHHH---HHcCCCcccCCCHHHHh
Confidence 111 111 344445555 99999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.78 Aligned_cols=237 Identities=22% Similarity=0.373 Sum_probs=199.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||||+. .+.+.||+|.+.+... .+.+.+.+|++++++++|||||.++++|+...+.++|.||+.+
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 46799999999999994 4688999999876533 3345789999999999999999999999999999999999976
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|..+|..... +++..+..|+.|+..||.|||+. +|+|||+||.|||++.++.+|++|||+|+.+....
T Consensus 86 ~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 99999976543 99999999999999999999998 89999999999999999999999999999877653
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...||+.|||||.+.+..|+..+|.||+||++||+++|++||- ...+.+.++....+....
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--------a~si~~Lv~~I~~d~v~~--------- 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--------ARSITQLVKSILKDPVKP--------- 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--------HHHHHHHHHHHhcCCCCC---------
Confidence 3457889999999999999999999999999999999999985 245666666655443211
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.....++..+++ .-+..||.+|-+-.+++.
T Consensus 220 p~~~S~~f~nfl~---gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQ---GLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHH---HHhhcChhhcccHHHHhc
Confidence 1112345555665 888999999999887764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=340.41 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=194.6
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+++++.+ +|||||+++++|.+.+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 457899999999999973 235689999987543 23346788999999999 8999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCC--------------------------------------------------------------
Q 038422 431 EFVENGSLAGKLHANHTK-------------------------------------------------------------- 448 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 448 (634)
|||++|+|.+++......
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999753210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-----
Q 038422 449 --------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA----- 515 (634)
Q Consensus 449 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 515 (634)
....++|..+.+++.||+.||+|||+. +|+||||||+|||++++..+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 012488999999999999999999998 799999999999999999999999999876543221
Q ss_pred -ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 516 -HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 516 -~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...+..|+|||++.+..++.++|||||||++|||+| |..||.... ....+.++ +..+.... ..
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~----~~~~~~~~----~~~~~~~~-------~~ 339 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP----VDSKFYKM----IKEGYRML-------SP 339 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC----chHHHHHH----HHhCccCC-------CC
Confidence 123456999999999999999999999999999998 888875211 11112222 22211100 01
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.....+ +.+++..||+.||++||+|+||++.|++.
T Consensus 340 ~~~~~~---l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSE---MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 112233 44555699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.21 Aligned_cols=246 Identities=20% Similarity=0.337 Sum_probs=193.1
Q ss_pred hccccCccCceeEEEEEEc----CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|++. .+..||+|.++.... ...+.|.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 4578999999999999853 356899998875422 23457899999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999987542 2489999999999999999999998 7999999999999999999999999987543222
Q ss_pred C-----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 N-----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ~-----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
. ....+..|+|||++.+..++.++|||||||++||+++ |+.||... ...+.+.. +.++....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--------~~~~~~~~-~~~~~~~~--- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--------SGQDVIKA-VEDGFRLP--- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHH-HHCCCCCC---
Confidence 1 1223467999999999999999999999999999875 99998621 11122211 12211100
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
. ...... .+.+++..||+.+|.+||+++|+.+.|+++
T Consensus 229 --~--~~~~~~---~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --A--PRNCPN---LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --C--CCCCCH---HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 111123 345555699999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.28 Aligned_cols=259 Identities=20% Similarity=0.336 Sum_probs=205.9
Q ss_pred CCCCCHHHHHHhhccccCccCceeEEEEEEcC---C--cEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEE
Q 038422 347 MEPFDLQDMLRASAEVLGSGTFGASYKTVISN---G--QAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420 (634)
Q Consensus 347 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 420 (634)
...+.++.-.....+.||+|-||.||+|.+.+ | -.||||..+.. ...+.+.|..|..+|++++|||||+|+|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 34444444444567889999999999999643 2 36888888764 445578999999999999999999999999
Q ss_pred EeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeE
Q 038422 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL 500 (634)
Q Consensus 421 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~k 500 (634)
.+ ...|+|||.++-|.|..||+.... .|+......++.||+.+|+|||+. .+|||||..+|||+.....+|
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceee
Confidence 64 578999999999999999987643 388999999999999999999998 799999999999999999999
Q ss_pred EeccccCCccCCCCCccc-----cccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHH
Q 038422 501 LTDYALRPLINPDNAHTL-----MVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVN 574 (634)
Q Consensus 501 l~DfGla~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 574 (634)
++|||+++.+.++..+.. ++.|||||.+...+++.++|||-|||.|||++. |..||...... ..+
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----DVI----- 602 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----DVI----- 602 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----ceE-----
Confidence 999999999887654433 467999999999999999999999999999998 99998632111 000
Q ss_pred HHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 575 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..++.+ .++..+. .+.-.+-.|+-+||+.||.+||.+.|+...|+++.+
T Consensus 603 ~~iEnG-------eRlP~P~---nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENG-------ERLPCPP---NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCC-------CCCCCCC---CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 000111 1221122 222234456669999999999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.67 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=194.6
Q ss_pred hhccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 358 ASAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
...+.||+|+||.||+++.. ++..||+|+++... ....+.+.+|+++++.+ +|||||+++++|...+..++|
T Consensus 41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv 120 (374)
T cd05106 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVI 120 (374)
T ss_pred eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEe
Confidence 44678999999999998742 23579999987543 22345688999999999 899999999999999999999
Q ss_pred EEcCCCCChhhHHhhccC--------------------------------------------------------------
Q 038422 430 YEFVENGSLAGKLHANHT-------------------------------------------------------------- 447 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~-------------------------------------------------------------- 447 (634)
|||+++|+|.+++.....
T Consensus 121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (374)
T cd05106 121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE 200 (374)
T ss_pred HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence 999999999999864321
Q ss_pred ---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC------ccc
Q 038422 448 ---KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA------HTL 518 (634)
Q Consensus 448 ---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~------~~~ 518 (634)
....++++.++.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..+
T Consensus 201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 0112478999999999999999999998 899999999999999999999999999876543221 123
Q ss_pred cccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCH
Q 038422 519 MVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSK 597 (634)
Q Consensus 519 ~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 597 (634)
+..|+|||++.+..++.++|||||||++|||+| |+.||.... .... .......+. .... .....
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~----~~~~----~~~~~~~~~-----~~~~--~~~~~ 341 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL----VNSK----FYKMVKRGY-----QMSR--PDFAP 341 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc----ccHH----HHHHHHccc-----CccC--CCCCC
Confidence 456999999998899999999999999999998 999986211 0011 111111111 0000 11112
Q ss_pred HHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 598 SEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 598 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.++ .+++.+||+.||++||+++||+++|+++.
T Consensus 342 ~~l---~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEI---YSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 344 45555999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.41 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=194.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++...++..+|+|.+... ....+++.+|++++++++||||+++++++..++..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 4679999999999999888888999987643 344578999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 88 NYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99875432 389999999999999999999998 79999999999999999999999999987653321
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....+..|+|||++.+..++.++||||||+++|||+| |+.||.. ....+.+.... .+.. ...+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~--------~~~~~~~~~i~-~~~~--~~~~~---- 224 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK--------KSNYEVVEMIS-RGFR--LYRPK---- 224 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHH-CCCC--CCCCC----
Confidence 1223457999999988889999999999999999999 8989752 11122222221 1111 11111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
.... .+.+++.+||+.+|++||+|+|+++.|.
T Consensus 225 -~~~~---~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -LASM---TVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCH---HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1123 3556666999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.63 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=201.2
Q ss_pred hhccccCccCceeEEEEEE-cCC----cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 358 ASAEVLGSGTFGASYKTVI-SNG----QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
...++||+|+||+||+|.+ ++| .+||+|++.... .....++.+|+-+|.+++|||+++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999985 444 367888886553 334578999999999999999999999998765 889999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
||+.|+|.||++..+. .+--+..+.+..|||+||.|||.+ ++|||||.++|||+.+-..+||+|||+++.+.
T Consensus 778 ~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred hcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999988654 388899999999999999999988 89999999999999999999999999999987
Q ss_pred CCCCc------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PDNAH------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~~~~------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
.+... ...+.|||-|.+....|++++|||||||++||++| |..|++.. . .+-+...++.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--------~-~~eI~dlle~ge--- 917 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--------P-AEEIPDLLEKGE--- 917 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--------C-HHHhhHHHhccc---
Confidence 76432 23467999999999999999999999999999999 99998621 1 112222333221
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
++. ..+-...++--++.+||..|++.||+++++.+.+.+..
T Consensus 918 ----RLs---qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 ----RLS---QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ----cCC---CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 121 22233455666777999999999999999999987754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.42 Aligned_cols=257 Identities=25% Similarity=0.435 Sum_probs=192.4
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHh--cCCCCccccceeEEEeCC----ceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLG--RLEHPNLLPLTAFYYRKE----EKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~lv~e~~~ 434 (634)
++||+|.||.||||.+. ++.||||++.. ...+.|+.|-+|.+ .++|+||++++++-.... +++||+||.+
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 57999999999999985 49999999864 34567888888765 468999999999976655 7899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----CCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP-----GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
+|+|.+||..+. ++|....+|+.-+++||+|||+..+ ++.|+|||||++|||+..|+++-|+|||+|..
T Consensus 292 kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999997653 8999999999999999999998643 34699999999999999999999999999987
Q ss_pred cCCCC------CccccccccCcccccCCC-CC-----cchhHHHHHHHHHHHHhCCCCcc------cc--cccCCCCCcH
Q 038422 510 INPDN------AHTLMVAYKSPEYAHNGK-IS-----KKSDVWSLGILILELLTGKYPEN------YL--LQGYDSKASL 569 (634)
Q Consensus 510 ~~~~~------~~~~~~~y~aPE~~~~~~-~~-----~k~DVwSfGvvl~elltg~~P~~------~~--~~~~~~~~~l 569 (634)
+.... ...||.+|||||++.+.. +. .+.||||+|.|||||+++-.-.+ |. +...-+...-
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 65432 246788999999997642 22 36899999999999999643321 11 0000011112
Q ss_pred HHHHHHHH-HhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 570 SNWVNNMV-KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 570 ~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+-++..+ +++....+-| ...+. .....+.+.++ .||..||+.|-|+.=|-+++.++.
T Consensus 446 ~e~mq~~VV~kK~RP~~p~-~W~~h-~~~~~l~et~E---eCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPD-AWRKH-AGMAVLCETIE---ECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHHHHHHhhccCCCChh-hhhcC-ccHHHHHHHHH---HHcCCchhhhhhhHHHHHHHHHHh
Confidence 22333333 3332323322 22221 23344555555 999999999999999999888764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.13 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=190.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999985 568999999886432 12234678899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 85 g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 85 GDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999988864322 2489999999999999999999998 79999999999999999999999999987654322
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||.... . ....+-+........ . ..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~----~-~~~~~~~~~~~~~~~--~----~~-- 224 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK----E-RVKREEVDRRVKEDQ--E----EY-- 224 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC----c-chhHHHHHHHhhccc--c----cC--
Confidence 2346788999999999999999999999999999999999986211 1 111111111111110 0 01
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
.....+++.+ ++..||+.||.+||+ ++|+++
T Consensus 225 ~~~~s~~~~~---li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKS---ICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHH---HHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111234444 555999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.32 Aligned_cols=237 Identities=21% Similarity=0.299 Sum_probs=188.9
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
++||+|+||.||+++. .+|+.+|+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999987542 222346788999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999986543 389999999999999999999998 8999999999999999999999999998753222
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ........... .+. ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~--------~~~~~~~~~~~-~~~------~~~-- 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELIL-MEE------IRF-- 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC--------CCHHHHHHHHH-cCC------CCC--
Confidence 223467889999999999999999999999999999999999851 11111111111 111 011
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
.....+++.++++ .|++.||++|| +++|+++
T Consensus 215 p~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLA---GLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHH---HHccCCHHHcCCCCCCCHHHHHc
Confidence 1112344555555 99999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.26 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=199.8
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++.||+|+-|.|..|+ ..+|+.+|||++.+..+ .....+.+|+-+|+-++||||+++|+++.++.++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 4579999999999999 56799999999976532 2335688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|.|.+++...+. +++.++.+++.||..|+.|+|.. +|+||||||+|+|||.+..+||+|||+|.+-.++
T Consensus 97 GELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 97 GELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred chhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 999999987543 99999999999999999999998 7999999999999999999999999999876555
Q ss_pred -CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+|.+-|.|||++.+..| +.++||||.|||||.|+||+.||+ ++++..... .++.|.. +
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------DdNir~LLl-KV~~G~f-~------- 230 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------DDNIRVLLL-KVQRGVF-E------- 230 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------CccHHHHHH-HHHcCcc-c-------
Confidence 35677888999999999998 579999999999999999999997 234444332 2223221 1
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
-+.....++.+++. +++..||++|-|++||++.
T Consensus 231 MPs~Is~eaQdLLr---~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 MPSNISSEAQDLLR---RMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCCcCCHHHHHHHH---HHhccCccccccHHHHhhC
Confidence 11223455666666 9999999999999999863
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.85 Aligned_cols=249 Identities=23% Similarity=0.422 Sum_probs=194.4
Q ss_pred ccccCccCceeEEEEEEcCC------cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVISNG------QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|..... ..+++|.++... ......|.+|++++++++||||+++++++.+.+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 46799999999999986432 578999886442 22345789999999999999999999999998999999999
Q ss_pred CCCCChhhHHhhccCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEE
Q 038422 433 VENGSLAGKLHANHTKQR-----------PGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 501 (634)
+++|+|.+++........ ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCCCcEEE
Confidence 999999999976432111 3588999999999999999999998 7999999999999999999999
Q ss_pred eccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHH
Q 038422 502 TDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVN 574 (634)
Q Consensus 502 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 574 (634)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |..||... ...+..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~--------~~~~~~- 236 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF--------SNQEVI- 236 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHH-
Confidence 9999987643321 2233567999999998899999999999999999998 99997521 111211
Q ss_pred HHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 575 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
..+..+..... ...... .+.+++.+||+.||++||+++||++.|+.+
T Consensus 237 ~~i~~~~~~~~-------~~~~~~---~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 EMIRSRQLLPC-------PEDCPA---RVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCcCCC-------cccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11222211111 011123 345555699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.30 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=192.6
Q ss_pred ccccCccCceeEEEEEEc-CCc----EEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQ----AYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++|+||+
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 467999999999999853 343 38899886532 23456788999999999999999999999764 578999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 91 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999975432 388999999999999999999998 7999999999999999999999999999876533
Q ss_pred CC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 NA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. ...+..|+|||++.+..++.++|||||||++|||+| |+.||+. ....++. .....+....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~--------~~~~~~~-~~~~~~~~~~-- 231 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------IPASEIS-SILEKGERLP-- 231 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CCHHHHH-HHHhCCCCCC--
Confidence 21 123457999999999999999999999999999998 9999752 1111211 1111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
... ....++.+++..||+.+|++||++.|++..|.++..
T Consensus 232 -----~~~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 -----QPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -----CCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 001 111245667779999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=327.70 Aligned_cols=235 Identities=22% Similarity=0.317 Sum_probs=186.9
Q ss_pred cCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||.||+++.. +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 57899999987532 23345678899999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99997532 389999999999999999999998 7999999999999999999999999998754322 1
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+......... . .+ ..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~--------~~~~~~~~~~~~~~-~------~~--~~ 214 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD--------ENVNEMYRKILQEP-L------RF--PD 214 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC--------CCHHHHHHHHHcCC-C------CC--CC
Confidence 23467889999999999999999999999999999999999851 22223222222111 0 11 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCC---HHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARME---LKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs---~~evl~ 626 (634)
...+++.+++ ..||+.||++||+ +.|+++
T Consensus 215 ~~~~~~~~li---~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLL---IGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHH---HHHcCCCHHHcCCCCCHHHHHc
Confidence 1224444554 4999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.85 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=200.4
Q ss_pred hhccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 358 ASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
...+.||+|+||.||+|...++..+++|.+.........++.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred HHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCC
Confidence 34578999999999999988899999999887655566789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 89 L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 89 LLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred HHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 9999975432 2489999999999999999999998 79999999999999999999999999987654332
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....+..|+|||++....++.++|||||||++|||++ |+.||... ...+...... ..... ..
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~-----~~-- 225 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--------NNHEVYDQIT-AGYRM-----PC-- 225 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC--------CHHHHHHHHH-hCCcC-----CC--
Confidence 1223567999999988889999999999999999999 89998521 1111111111 11110 00
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.....+ .+.+++.+||+.+|++|||++|+++.|+.+
T Consensus 226 ~~~~~~---~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQ---EIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011122 345666699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.99 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=196.6
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||.||+|...++..|++|.+... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 34679999999999999888889999987653 23467899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 89 LDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 999975432 2388999999999999999999997 79999999999999999999999999997654322
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++....++.++|||||||++|||+| |+.||... .......+ ....... +..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~----~~~~~~~----~~~-- 226 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-----SNSDVMSA----LQRGYRM----PRM-- 226 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-----CHHHHHHH----HHcCCCC----CCC--
Confidence 1223467999999988889999999999999999999 99998521 11112111 1111110 111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
. ...++ +.+++.+|++.+|++||+++++.+.|+++
T Consensus 227 ~-~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 E-NCPDE---LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C-CCCHH---HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1 11233 45566699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.78 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=196.2
Q ss_pred hccccCccCceeEEEEEEcC------CcEEEEEEecccC-ccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.||+|+... +..||+|+++... ....+.+.+|+++++++. |||||+++++|.+.+..++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 35789999999999998532 3469999987543 233467899999999996 999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCC--------------------------------------------------------------
Q 038422 431 EFVENGSLAGKLHANHTK-------------------------------------------------------------- 448 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 448 (634)
|||++|+|.+++......
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999998753210
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCe
Q 038422 449 -----------------------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499 (634)
Q Consensus 449 -----------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 499 (634)
....+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEEEeCCCEE
Confidence 012488999999999999999999998 79999999999999999999
Q ss_pred EEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHH
Q 038422 500 LLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNW 572 (634)
Q Consensus 500 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~ 572 (634)
||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+.
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~--------~~~~ 348 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI--------VDST 348 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc--------hhHH
Confidence 999999987653322 1223467999999998899999999999999999997 999975211 1111
Q ss_pred HHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 573 VNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 573 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.......+.... ... .....+.+++.+||+.+|++||++.+|+++|+++.+
T Consensus 349 ~~~~~~~~~~~~-------~~~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGYRMA-------KPD---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCCCCC-------CCc---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 112222211100 001 112345566679999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=327.29 Aligned_cols=190 Identities=25% Similarity=0.363 Sum_probs=166.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 467999999999999965 57888999886532 2334679999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--CC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 515 (634)
|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 999986543 3889999999999999999999852 5999999999999999999999999998765432 23
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 346788999999998899999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.12 Aligned_cols=249 Identities=23% Similarity=0.406 Sum_probs=196.0
Q ss_pred hccccCccCceeEEEEEEcC------CcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN------GQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 34679999999999998643 478999998765433 35689999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 432 FVENGSLAGKLHANHT---------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
|+++|+|.+++..... .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCCeEEEC
Confidence 9999999999976432 1223489999999999999999999998 79999999999999999999999
Q ss_pred ccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHH
Q 038422 503 DYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNN 575 (634)
Q Consensus 503 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 575 (634)
|||+++...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||... ...+.+..
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--------~~~~~~~~ 236 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--------SNEEVIEC 236 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHH
Confidence 999987543221 2223567999999999999999999999999999999 99997521 11122211
Q ss_pred HHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 576 MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 576 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
. ..+..... . ..... .+.+++.+||+.||++||+++||+++|++
T Consensus 237 ~-~~~~~~~~-~------~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 I-TQGRLLQR-P------RTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H-HcCCcCCC-C------CCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 11111110 0 01123 34555669999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=315.59 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=186.7
Q ss_pred cccCccCceeEEEEEEcC-------------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceE
Q 038422 361 EVLGSGTFGASYKTVISN-------------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKL 427 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 427 (634)
+.||+|+||.||+|+... ...+++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2257888876554444567889999999999999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC-------eE
Q 038422 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE-------PL 500 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-------~k 500 (634)
+||||+++|+|..++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +|
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999998886432 2389999999999999999999998 7999999999999987654 89
Q ss_pred EeccccCCccCCCCCccccccccCccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 501 LTDYALRPLINPDNAHTLMVAYKSPEYAH-NGKISKKSDVWSLGILILELL-TGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 501 l~DfGla~~~~~~~~~~~~~~y~aPE~~~-~~~~~~k~DVwSfGvvl~ell-tg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
++|||++..........++..|+|||++. +..++.++|||||||++|||+ +|+.|+.. ....+. ....
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~--------~~~~~~-~~~~- 222 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD--------KTLAEK-ERFY- 222 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------cchhHH-HHHH-
Confidence 99999987766555556778899999887 456899999999999999998 58888652 111111 0111
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
.... . . .....++ +.+++.+||+.||.+||+++||++.|+
T Consensus 223 ~~~~-~-----~--~~~~~~~---~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-M-----L--VTPSCKE---LADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-c-----C--CCCChHH---HHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1100 0 0 0111233 445566999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.83 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=195.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|... .++.+++|.++.. ....+++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 467999999999999965 4788999988643 33456789999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--- 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 515 (634)
.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 90 LDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred HHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 999865432 2489999999999999999999998 799999999999999999999999999876544321
Q ss_pred --ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 --HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...+..|+|||++.+..++.++|||||||++|||+| |..|+.. ....++... ...... ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~--------~~~~~~~~~-~~~~~~-----~~~-- 226 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVYEL-LEKGYR-----MER-- 226 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHH-HHCCCC-----CCC--
Confidence 122457999999998899999999999999999998 8888751 122222211 111110 011
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
......++ .+++.+||+.+|++||++.|++++|+.+
T Consensus 227 ~~~~~~~~---~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKV---YELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHH---HHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01112344 4455599999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.86 Aligned_cols=252 Identities=22% Similarity=0.401 Sum_probs=198.2
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
..+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 3467999999999999842 3456889988765555567899999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 433 VENGSLAGKLHANHT--------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
+++++|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEeccC
Confidence 999999999975432 1123489999999999999999999998 7999999999999999999999999
Q ss_pred ccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHH
Q 038422 505 ALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMV 577 (634)
Q Consensus 505 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~ 577 (634)
|+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+.. ..+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~--------~~~~~~-~~i 235 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNNEVI-ECI 235 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHH-HHH
Confidence 9987553321 1223457999999998889999999999999999999 88887521 111111 111
Q ss_pred HhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 578 KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 578 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+.... . .... .. .+.+++.+||+.+|.+||+++||++.|+++..
T Consensus 236 ~~~~~~~-----~-~~~~-~~---~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 TQGRVLQ-----R-PRTC-PK---EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HcCCcCC-----C-CCCC-CH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1211110 0 0111 12 35666669999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=325.64 Aligned_cols=237 Identities=21% Similarity=0.306 Sum_probs=188.1
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999995 468999999987532 223356778999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9998886532 389999999999999999999998 8999999999999999999999999998753222
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... ............. . .+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--------~~~~~~~~~~~~~-~------~~p- 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILMEE-I------RFP- 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcCC-C------CCC-
Confidence 1234678899999999999999999999999999999999998521 1111111111110 0 111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
....+++.++++ .|++.||++|| ++.|+++
T Consensus 216 -~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 -RTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CCCCHHHHHHHH---HHccCCHHHhCCCCCCCHHHHHc
Confidence 112244555555 99999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.14 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=196.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 47899999999999998788889999987543 44678999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA---- 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 515 (634)
+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 9997543 12489999999999999999999998 799999999999999999999999999876543211
Q ss_pred -ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 516 -HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 516 -~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...+..|+|||++.+..++.++|||||||++|||+| |+.||... .... +........... .
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~-~~~~~~~~~~~~-----~--- 225 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--------TNAE-VLQQVDQGYRMP-----C--- 225 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--------CHHH-HHHHHHcCCCCC-----C---
Confidence 112346999999998899999999999999999999 99887521 1111 111111111000 0
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.......+.+++.+|++.+|.+||+++++++.|+++
T Consensus 226 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 --PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001123455666699999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=297.69 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=201.9
Q ss_pred hhccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEE
Q 038422 358 ASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYE 431 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e 431 (634)
.+.+.+|+|+|+.||.++ ..+++.+|+|++.-.+..+.+..++|++..++++||||+++++++..+. +.||+++
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 345789999999999998 6788999999998777778889999999999999999999999886543 5899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|...|+|.+.+.....++ ..+++.+++.|+.+|++||++||+..+ ...||||||.|||+.+.+.+++.|||.+....
T Consensus 104 yy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred hhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEeccCccccc
Confidence 999999999998765543 359999999999999999999999854 48999999999999999999999999875432
Q ss_pred C-------------CCCccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHH
Q 038422 512 P-------------DNAHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNN 575 (634)
Q Consensus 512 ~-------------~~~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~ 575 (634)
- ......|..|+|||.+. +..+++++|||||||+||+|+.|..||++..+..++ ..+
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-laL------ 253 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-LAL------ 253 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-EEE------
Confidence 1 11223467899999986 346789999999999999999999999866543222 111
Q ss_pred HHHhccCCcccccccc--cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 576 MVKEKRTGDVFDKEMK--GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 576 ~~~~~~~~~~~d~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+..+.+. ......+.+.++++ +|++.||.+||++.|++..++.+.
T Consensus 254 --------Av~n~q~s~P~~~~yse~l~~lik---~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 --------AVQNAQISIPNSSRYSEALHQLIK---SMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------eeeccccccCCCCCccHHHHHHHH---HHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111111 11112344555555 999999999999999999998763
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.17 Aligned_cols=239 Identities=19% Similarity=0.278 Sum_probs=184.3
Q ss_pred ccCccCceeEEEEEEcC-------------------------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccc
Q 038422 362 VLGSGTFGASYKTVISN-------------------------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 416 (634)
.||+|+||.||+|+... ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998521 13578888765433344678899999999999999999
Q ss_pred eeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 417 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
+++|.+....++||||+++|+|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+|||+++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEecc
Confidence 999999999999999999999999886532 2388999999999999999999998 79999999999999764
Q ss_pred C-------CeEEeccccCCccCCCCCccccccccCcccccC-CCCCcchhHHHHHHHHHHHH-hCCCCcccccccCCCCC
Q 038422 497 F-------EPLLTDYALRPLINPDNAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELL-TGKYPENYLLQGYDSKA 567 (634)
Q Consensus 497 ~-------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~ell-tg~~P~~~~~~~~~~~~ 567 (634)
+ .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++||++ +|+.|+.... ..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-----PS 228 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-----hH
Confidence 3 379999999865544444456778999998875 56899999999999999995 6898875211 01
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
....+ ..... .+.. .... .+.+++.+||+.+|++||+|++|++.|.
T Consensus 229 ~~~~~----~~~~~-------~~~~--~~~~---~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERF----YEKKH-------RLPE--PSCK---ELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH----HHhcc-------CCCC--CCCh---HHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 11100 0100 0112 3556666999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.30 Aligned_cols=191 Identities=25% Similarity=0.376 Sum_probs=166.0
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||++++++|.+++..++||||+++|
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence 3467999999999999965 5788888887653 2233467899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--C
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--N 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~ 514 (634)
+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++...... .
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 160 (333)
T cd06650 89 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (333)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence 9999996532 3889999999999999999999752 5999999999999999999999999998755332 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 3356778999999998889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=326.39 Aligned_cols=246 Identities=19% Similarity=0.275 Sum_probs=191.6
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+++.. +++.||+|.++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999964 58899999997532 22335678899999888 799999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99998886432 389999999999999999999998 8999999999999999999999999998753211
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||+.............++....+..... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~- 224 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC-
Confidence 223467889999999999999999999999999999999999963322111122333444444333211 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCC------HHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARME------LKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs------~~evl~ 626 (634)
+.....++. +++..|++.||.+||+ ++|+++
T Consensus 225 -p~~~~~~~~---~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKAS---SVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHH---HHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111123344 4555999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=321.77 Aligned_cols=238 Identities=22% Similarity=0.251 Sum_probs=190.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 467999999999999965 58899999986432 12345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 99999997543 389999999999999999999998 89999999999999999999999999987664432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ........... .+.. .+. .
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~--------~~~~~~~~~i~-~~~~------~~~--~ 219 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD--------DNPFGIYEKIL-AGKL------EFP--R 219 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHH-hCCc------CCC--c
Confidence 33467889999999988899999999999999999999999852 11122222221 1111 110 1
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
....++.+ ++.+|++.||.+||+ ++|+++
T Consensus 220 ~~~~~~~~---li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 220 HLDLYAKD---LIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred cCCHHHHH---HHHHHcCCCHHHccCCccCCHHHHhc
Confidence 11234444 445999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.05 Aligned_cols=251 Identities=23% Similarity=0.405 Sum_probs=197.5
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+++.. ++..+++|.++.......+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 467999999999999843 34568888887655555578999999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 434 ENGSLAGKLHANHT-----------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 434 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
++++|.+++..... .....++|..++.++.||+.|++|||++ +|+||||||+||++++++.+||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEEC
Confidence 99999999975432 1122489999999999999999999998 79999999999999999999999
Q ss_pred ccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHH
Q 038422 503 DYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNN 575 (634)
Q Consensus 503 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 575 (634)
|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+.+.
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~- 236 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--------SNTEVIE- 236 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHH-
Confidence 999987553321 1223567999999998899999999999999999999 99997521 1111111
Q ss_pred HHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 576 MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 576 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+..... ...... .+.+++.+||+.+|++||++++|+++|+++.+
T Consensus 237 ~~~~~~~~~~-------~~~~~~---~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER-------PRVCPK---EVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC-------CccCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1112111111 001122 35566669999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=319.18 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEE-----cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||+||.+.. .++..||+|.++... ....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 46799999999988653 357789999987543 23456788999999999999999999998764 35789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999998642 289999999999999999999998 79999999999999999999999999987654
Q ss_pred CCCC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PDNA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
.... ...+..|+|||.+....++.++|||||||++|||+||+.|+....... .....+...........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccccccchhhhhh
Confidence 3221 123456999999988889999999999999999999999975221100 000000000000000001
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+..... .........+.+++..||+.+|++||++++|++.|+++.+
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 236 LLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred hhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 11111100 0011112345556669999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=309.47 Aligned_cols=243 Identities=21% Similarity=0.363 Sum_probs=190.7
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.||+|+||.||+|+.. +++.+|+|...... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 68899999876432 23346789999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--- 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 515 (634)
.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99986533 2389999999999999999999998 799999999999999999999999999875443211
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+..|+|||.+.++.++.++|||||||++|||++ |..|+.... - .............. .
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--------~-~~~~~~~~~~~~~~-----~- 217 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--------N-QQTREAIEQGVRLP-----C- 217 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--------H-HHHHHHHHcCCCCC-----C-
Confidence 112346999999998899999999999999999998 888875211 0 11111111110000 0
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
...... .+.+++.+|++.+|++||+++||.++|++
T Consensus 218 -~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 -PELCPD---AVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred -cccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 001123 34556669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.03 Aligned_cols=239 Identities=24% Similarity=0.390 Sum_probs=198.3
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.||+|+||.||+|.. ..++.||+|++.... ....+++++|+.++.+++++||.++||.|..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6799999999999994 568899999997543 34457899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+.|..... +++.++.-|++++..|+.|||.+ +.+|||||+.|||+..++.+|++|||.+-.+... .
T Consensus 99 ~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 99 LDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhccCCC-----CccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999975432 47778888999999999999998 7899999999999999999999999998765443 4
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+|+.|||||++....|+.|+||||+|++.+||++|.+|+....+ +... --+.+-..|.+.+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----mrvl---------flIpk~~PP~L~~-- 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----MRVL---------FLIPKSAPPRLDG-- 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----ceEE---------EeccCCCCCcccc--
Confidence 56788999999999988999999999999999999999999863221 1000 0112223344433
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....+++|++ .|++.||+.||+++++++.
T Consensus 234 ~~S~~~kEFV~---~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 DFSPPFKEFVE---ACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCHHHHHHHH---HHhhcCcccCcCHHHHhhh
Confidence 22355777777 9999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.73 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=190.2
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||.||+++.. +++.+|+|.++... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 57899999987542 22334577888888776 899999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99998886532 389999999999999999999998 7999999999999999999999999998753221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||..............+++......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC-
Confidence 223467889999999999999999999999999999999999863222111122333444443332211 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCC------HHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARME------LKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs------~~evl~ 626 (634)
+.....++ .+++.+|++.||++||+ +.|+++
T Consensus 225 -p~~~~~~~---~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 225 -PRSLSVKA---ASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCCCCHHH---HHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11112334 44555999999999998 466643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.75 Aligned_cols=238 Identities=22% Similarity=0.312 Sum_probs=189.3
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999987532 223457788999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9998886532 389999999999999999999998 8999999999999999999999999998754322
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+........ + ..+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~--------~~~~~~~~~~~~~----~---~~~p- 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILME----D---IKFP- 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC--------CCHHHHHHHhccC----C---ccCC-
Confidence 123467889999999988999999999999999999999999852 1111221111111 0 0111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~~ 627 (634)
.....++.++++ +|++.||++|| +++|+++.
T Consensus 216 -~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 -RTLSADAKSLLS---GLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCHHHHHHHH---HHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112244555555 99999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=310.49 Aligned_cols=239 Identities=20% Similarity=0.350 Sum_probs=198.6
Q ss_pred hhccccCccCceeEEEEEE-cCCcEEEEEEecccCccChh---HHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 358 ASAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGRE---DFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.+.||+|.||.|-+++. ..|+.||||.+++....+.+ .+.+|++||+.++||||+.++.+|..++.+.|||||.
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYa 135 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYA 135 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEec
Confidence 3456799999999999984 67999999999876554444 5789999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|.|+||+.+.+. |++.+...+++||..|+.|+|.+ +++|||||.+|||+|.++.+||+|||++-++...
T Consensus 136 S~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 136 SGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred CCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999987653 99999999999999999999998 8999999999999999999999999999887766
Q ss_pred C---CccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 N---AHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ~---~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. ..++++-|.+||.+.+..| ++..|.||+||+||-|+.|..||+ +.+....+++.... ...++.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD--------G~Dhk~lvrQIs~G----aYrEP~ 274 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD--------GRDHKRLVRQISRG----AYREPE 274 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC--------CchHHHHHHHhhcc----cccCCC
Confidence 4 4567788999999999888 588999999999999999999997 13333333333211 121221
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....... |+.+++..+|+.|-|+++|..
T Consensus 275 ------~PSdA~g---LIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 275 ------TPSDASG---LIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ------CCchHHH---HHHHHHhcCcccchhHHHHhh
Confidence 1222333 444889999999999999975
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=339.60 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=198.8
Q ss_pred hhccccCccCceeEEEEEEcCC-cEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeE-EEeC------CceEE
Q 038422 358 ASAEVLGSGTFGASYKTVISNG-QAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAF-YYRK------EEKLL 428 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~~------~~~~l 428 (634)
...++|.+|||+.||.+....+ ..+|+|++-..++...+.+.+||++|++|+ |+|||.+++. .... -+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3457899999999999997766 999999998777777889999999999997 9999999993 3221 25789
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
.||||++|.|-|++..+... .|++.++++|+.|+++|+++||...+ +|||||||-+||||+.++..||||||-+.
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred ehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 99999999999999865433 39999999999999999999999754 49999999999999999999999999874
Q ss_pred ccCCC--C-----------CccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHH
Q 038422 509 LINPD--N-----------AHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNW 572 (634)
Q Consensus 509 ~~~~~--~-----------~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~ 572 (634)
-.... . ....|+-|+|||++. +..+++|+||||+||+||-|+....||+. .+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~-----sg------- 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE-----SG------- 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc-----Cc-------
Confidence 32111 1 123467899999874 66899999999999999999999999861 11
Q ss_pred HHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 573 VNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 573 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...+++..+.-+.+ ...-..+.+|+..||+.||.+||++-+|+..+.++++
T Consensus 263 ---------~laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ---------ceeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 11222222222211 2233445556669999999999999999999998875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.09 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||+||+|...++..+|+|.++.. ....+++.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 4679999999999999877778999988743 344578999999999999999999999999888899999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA---- 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 515 (634)
+++..... .+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 88 ~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 88 NYLREHGK----RFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99875432 389999999999999999999998 799999999999999999999999999876543321
Q ss_pred -ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 516 -HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 516 -~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
..++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+...... .+.... .+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~~--~~----- 223 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--------NNSETVEKVS-QGLRLY--RP----- 223 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHHHh-cCCCCC--CC-----
Confidence 123457999999988889999999999999999999 99997521 1111111111 111100 00
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
....+ .+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~~~~~---~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASE---KVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCH---HHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01123 4455666999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=326.39 Aligned_cols=239 Identities=21% Similarity=0.281 Sum_probs=190.8
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||.||+++.. +++.||+|.++... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 3578999999999999965 58899999987532 2234578899999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 102 GGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999997543 388999999999999999999998 79999999999999999999999999987664432
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+.. ..+.++.. .+ .
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~--------~~~~~~~-~~i~~~~~------~~--p 235 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD--------DTPFRIY-EKILAGRL------KF--P 235 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC--------CCHHHHH-HHHhcCCc------CC--C
Confidence 34567889999999998999999999999999999999999851 1111111 11222111 01 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
......+.+ ++..||+.||++||+ ++|+++
T Consensus 236 ~~~~~~~~~---li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 NWFDGRARD---LVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCHHHHH---HHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111234444 445999999999996 677664
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.28 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=192.7
Q ss_pred ccccCccCceeEEEEEEc-----CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-----NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~ 432 (634)
.+.||+|+||.||++... ++..|++|+++.......+.+.+|++++++++||||+++++++... ...++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 467999999999999753 4789999998766555566889999999999999999999987643 468899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 89 ~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 89 LPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred cCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999965432 389999999999999999999998 899999999999999999999999999886643
Q ss_pred CCC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccC----CCC---CcHHHHHHHHHH
Q 038422 513 DNA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGY----DSK---ASLSNWVNNMVK 578 (634)
Q Consensus 513 ~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~----~~~---~~l~~~~~~~~~ 578 (634)
... ...+..|+|||++.+..++.++|||||||++|||++|..|+....... +.. ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 321 112345999999988889999999999999999999877653111000 000 001111111111
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.... ......... .+.+++.+||+.+|++||||+||+++|+.++
T Consensus 241 ~~~~-------~~~~~~~~~---~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNGR-------LPAPPGCPA---EIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCCc-------CCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1100 000011123 3555666999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=312.27 Aligned_cols=245 Identities=23% Similarity=0.425 Sum_probs=194.2
Q ss_pred ccccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+|+... ...|++|.++... .....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 4679999999999998743 3578999886543 2334678999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++......
T Consensus 89 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 89 NGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999975432 489999999999999999999997 79999999999999999999999999988764221
Q ss_pred C------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 515 A------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 515 ~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
. ...+..|+|||.+.+..++.++||||||+++|||+| |..||... ....+.+. ........
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-----~~~~~~~~----~~~~~~~~--- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-----SNQDVIKA----VEDGYRLP--- 228 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH----HHcCCCCC---
Confidence 1 123457999999998899999999999999999998 99997521 11111111 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.. ....+ .+.+++..||+.+|++||+++||++.|+++
T Consensus 229 -~~---~~~~~---~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -PP---MDCPS---ALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CC---CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01122 355666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.67 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=193.9
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeC-CceEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRK-EEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~lv 429 (634)
..+.||+|+||.||+|+.. +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3578999999999999742 247899998874322 2234677899999999 899999999988754 467899
Q ss_pred EEcCCCCChhhHHhhccCC--------------------------------------------------------CCCCC
Q 038422 430 YEFVENGSLAGKLHANHTK--------------------------------------------------------QRPGL 453 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l 453 (634)
|||+++|+|.+++...... ....+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998643210 01258
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC------CccccccccCccc
Q 038422 454 DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPEY 527 (634)
Q Consensus 454 ~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~ 527 (634)
+|..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+.... ...++..|+|||+
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 9999999999999999999998 79999999999999999999999999998654322 1223467999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHH
Q 038422 528 AHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKI 606 (634)
Q Consensus 528 ~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l 606 (634)
+.+..++.++|||||||++|||+| |+.||.... ..+........+... .. .. ....++.++
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~-~~------~~---~~~~~~~~l 308 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--------IDEEFCRRLKEGTRM-RA------PE---YATPEIYSI 308 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC--------ccHHHHHHHhccCCC-CC------Cc---cCCHHHHHH
Confidence 999999999999999999999998 999985211 111111122221111 00 01 112346677
Q ss_pred HhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 607 GLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 607 ~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+.+||+.+|++||+++||++.|+++.+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 779999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=320.19 Aligned_cols=189 Identities=24% Similarity=0.325 Sum_probs=166.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+||+|+||.||.++. .+|+.+|+|++++..... .+....|-.+|...++|+||+|+..|++.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 46899999999999995 459999999998765433 34677899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC---
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--- 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 512 (634)
||+..+|..... |++..+..++.+++.|++-+|+. +++||||||+|+|||..|++|++||||+.-+..
T Consensus 226 GD~mTLL~~~~~-----L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 226 GDMMTLLMRKDT-----LTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred ccHHHHHHhcCc-----CchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999976543 99999999999999999999998 899999999999999999999999999742110
Q ss_pred -------------------C--C---------------------------CccccccccCcccccCCCCCcchhHHHHHH
Q 038422 513 -------------------D--N---------------------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGI 544 (634)
Q Consensus 513 -------------------~--~---------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGv 544 (634)
. . +..||+-|||||++.+..|+..+|.||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 0 113567799999999999999999999999
Q ss_pred HHHHHHhCCCCcc
Q 038422 545 LILELLTGKYPEN 557 (634)
Q Consensus 545 vl~elltg~~P~~ 557 (634)
|||||+.|.+||.
T Consensus 377 ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 377 IMYEMLVGYPPFC 389 (550)
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999996
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.79 Aligned_cols=244 Identities=17% Similarity=0.195 Sum_probs=192.4
Q ss_pred hccccCccCceeEEEEEEc-C-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-N-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||+++++|..++..++||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 4578999999999999853 3 5678888765544444456788999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++..... ...++++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99998865322 123589999999999999999999998 7999999999999999999999999999865432
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+.+..... +... + .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~--------~~~~~~~~~~~~-~~~~----~-~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG--------PSQREIMQQVLY-GKYD----P-F 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHh-CCCC----C-C
Confidence 123467889999999999999999999999999999999999852 122222222221 1111 0 0
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
......++. +++..||+.+|++||+++|+++
T Consensus 292 --~~~~s~~~~---~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMK---ALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHH---HHHHHHhccChhhCcCHHHHHh
Confidence 011123444 4555999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.92 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=195.3
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccCcc-ChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.||+|+.. .+..||+|+++..... ..+.+.+|++++.++. |||||+++++|...+..++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 4578999999999999853 2468999999754322 2357889999999997 999999999999999999999
Q ss_pred EcCCCCChhhHHhhccC---------------------------------------------------------------
Q 038422 431 EFVENGSLAGKLHANHT--------------------------------------------------------------- 447 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~--------------------------------------------------------------- 447 (634)
||+++|+|.++++....
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 448 ------------------------------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 448 ------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
.....+++..++.++.|++.||+|||+. +|+||||||+|||++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCcceEEEeCCC
Confidence 0113478889999999999999999987 799999999999999999
Q ss_pred CeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~ 570 (634)
.+|++|||+++...... ...++..|+|||.+....++.++|||||||++|||++ |+.||... ...
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~--------~~~ 348 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL--------PMN 348 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC--------Cch
Confidence 99999999987643221 1234567999999998889999999999999999998 88887521 111
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+.....+..+.... .......++ .+++..||..+|.+||+++||++.|+++.
T Consensus 349 ~~~~~~~~~~~~~~-------~p~~~~~~l---~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKRGYRMA-------KPAHASDEI---YEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHcCCCCC-------CCCCCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112222211100 011112344 44555999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.24 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=187.3
Q ss_pred ccCccCceeEEEEEEcC---CcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVISN---GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.||+|+||.||+|...+ +..+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 35788998765432 233578899999999999999999999999889999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++...........++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999764432233467888899999999999999998 79999999999999999999999999986543321
Q ss_pred ---CccccccccCcccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 515 ---AHTLMVAYKSPEYAHNG-------KISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~-------~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
...++..|+|||++... .++.++|||||||++|||++ |+.||.... ....... ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~~---~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-----DEQVLTY---TVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHH---Hhh-cccC
Confidence 12345679999998642 35789999999999999997 999986211 1111111 111 1111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
...++.+.. ...+.+.++++ .|| .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~~--~~~~~~~~l~~---~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL--PLSDRWYEVMQ---FCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC--CCChHHHHHHH---HHh-cCcccCCCHHHHHHHhc
Confidence 222222211 12234445554 898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.50 Aligned_cols=246 Identities=20% Similarity=0.177 Sum_probs=192.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999965 48899999987532 22345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-C
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-N 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 514 (634)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 99999996532 388999999999999999999998 7999999999999999999999999998765432 3
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc-C
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG-A 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~ 593 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||... ...+........... .-.+.... .
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~--~~~~~~~~~~ 226 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------TPNETWENLKYWKET--LQRPVYDDPR 226 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC--------CHHHHHHHHHhcccc--ccCCCCCccc
Confidence 345788899999999989999999999999999999999998621 111111111110000 00011000 0
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....+++.+++ ..|+..+|.+||+++|+++.
T Consensus 227 ~~~s~~~~~li---~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLI---TKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHH---HHHhhChhhhcCCHHHHHhC
Confidence 01124444444 49999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.79 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=187.5
Q ss_pred cccCccCceeEEEEEE----cCCcEEEEEEecccC----ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
+.||+|+||.||+++. .+++.||+|.++... ......+..|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999985 357899999987532 22335678899999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++.... .+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999986543 378889999999999999999998 799999999999999999999999999864322
Q ss_pred C----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 513 D----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 513 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
. ....++..|+|||++.+..++.++|||||||++|||+||+.||.. ......+.... .+..
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~--------~~~~~~~~~~~-~~~~------ 217 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA--------ENRKKTIDKIL-KGKL------ 217 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC--------CCHHHHHHHHH-cCCC------
Confidence 2 123467889999999988899999999999999999999999862 11122222221 1111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
.+ .....+++.++ +.+|++.+|++|| +++++++
T Consensus 218 ~~--~~~~~~~~~~l---i~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NL--PPYLTPEARDL---LKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CC--CCCCCHHHHHH---HHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01 11122344444 4599999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=309.94 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=188.7
Q ss_pred cccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~ 434 (634)
+.||+|+||.||+|...+ +..+|+|++.... ....+.+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 3578999875432 2335678899999999999999999998764 456889999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999975432 267888899999999999999998 79999999999999999999999999987543221
Q ss_pred --------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 515 --------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK-YPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 515 --------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~-~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
....+..|+|||++.+..++.++|||||||++|||+||. .|+.. ....+...... .+....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~- 222 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--------VDSFDITVYLL-QGRRLL- 222 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHh-cCCCCC-
Confidence 122355799999998889999999999999999999965 45431 12222222221 111000
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......+ .+.+++..||+.+|++||++.||++.|+++..
T Consensus 223 ------~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 ------QPEYCPD---PLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ------CCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011112 45566679999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.43 Aligned_cols=189 Identities=22% Similarity=0.326 Sum_probs=162.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccC--hhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVG--REDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
-+.|++|+||.||+|+. ++++.||+|+++-..... .-.-.+||.+|.+++|||||.+..+.... +..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 36799999999999995 568899999997543221 22457999999999999999999888654 47999999998
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+ ||...+.... .++...+.+.++.|+++|++|||++ .|+|||||++|+|+.+.+.+||+|||+|+.+...
T Consensus 161 h-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 161 H-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred h-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 7 8999887654 2499999999999999999999998 7999999999999999999999999999987665
Q ss_pred ---CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ---NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.....|.+|+|||.+.+. .|++..|+||+|||+.||+++++-|.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 234568899999999875 58999999999999999999997764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.79 Aligned_cols=238 Identities=23% Similarity=0.354 Sum_probs=187.3
Q ss_pred cccCccCceeEEEEEEcCCc-----------EEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEE
Q 038422 361 EVLGSGTFGASYKTVISNGQ-----------AYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 429 (634)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999976533 4677776544332 6789999999999999999999999988 788999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-------CeEEe
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-------EPLLT 502 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-------~~kl~ 502 (634)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+|++
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999976432 389999999999999999999997 799999999999999887 79999
Q ss_pred ccccCCccCCCCCccccccccCcccccCC--CCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 503 DYALRPLINPDNAHTLMVAYKSPEYAHNG--KISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 503 DfGla~~~~~~~~~~~~~~y~aPE~~~~~--~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
|||++..........++..|+|||++... .++.++|||||||++|||++ |..|+.... ...+.... ..
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--------~~~~~~~~-~~ 221 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--------SSEKERFY-QD 221 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--------chhHHHHH-hc
Confidence 99998876554444556789999999876 78999999999999999999 566764211 11111111 11
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
.. .... ... ..+.+++..||..+|.+||++.||++.|+
T Consensus 222 ~~-------~~~~--~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH-------RLPM--PDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-------CCCC--CCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0000 011 34556666999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=309.52 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=198.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999995 468899999876432 22235688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 87 GDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999988643221 23488999999999999999999998 79999999999999999999999999987654432
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||++.+..++.++||||||+++|||+||+.|+... .....++..... .... +...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~------~~~~~~~~~~~~-~~~~-----~~~~ 229 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLFSLCQKIE-QCDY-----PPLP 229 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc------cccHHHHHHHHh-cCCC-----CCCC
Confidence 234567899999998888999999999999999999999997521 122233322211 1111 1110
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.......+.+++.+||+.+|++||+++||++.|++++
T Consensus 230 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 ----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0111133455566999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.35 Aligned_cols=246 Identities=22% Similarity=0.433 Sum_probs=194.4
Q ss_pred hccccCccCceeEEEEEEcC-C---cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISN-G---QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|+... + ..+++|.++... ....+.+..|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 35789999999999999653 3 368888886542 333567899999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999986543 2389999999999999999999998 7999999999999999999999999998765432
Q ss_pred CCc-------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 514 NAH-------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 514 ~~~-------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
... ..+..|+|||++....++.++|||||||++||++| |+.||... ...++..... ......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~--------~~~~~~~~i~-~~~~~~- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--------SNHEVMKAIN-DGFRLP- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC--------CHHHHHHHHh-cCCCCC-
Confidence 211 12346999999988889999999999999999998 99998521 1122222221 111000
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
. ..+....+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 231 ---~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ---A------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---C------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 001123456777799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=310.39 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEEcCCc---EEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEE
Q 038422 360 AEVLGSGTFGASYKTVISNGQ---AYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 428 (634)
.+.||+|+||.||+|+..+.. .+|+|.++... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 467999999999999975532 58888876432 23346788999999999999999999988542 24689
Q ss_pred EEEcCCCCChhhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 429 LYEFVENGSLAGKLHANHTK-QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
||||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988543321 223489999999999999999999997 7999999999999999999999999998
Q ss_pred CccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 508 PLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 508 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
+...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||... .-.+. ...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~-~~~~~~~ 230 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--------ENSEI-YDYLRQG 230 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHH-HHHHHcC
Confidence 8764322 1223457999999998899999999999999999999 78887521 11111 1222222
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
..... .....+ .+.+++.+||+.+|++|||+.||++.|+++
T Consensus 231 ~~~~~-------~~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQ-------PPDCLD---GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC-------CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110 011122 345666699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.76 Aligned_cols=239 Identities=24% Similarity=0.415 Sum_probs=183.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999964 68999999986532 2234678999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 159 LEGTH---------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ccccc---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 86432 256778889999999999999998 7999999999999999999999999998765432
Q ss_pred CCccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 NAHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....++..|+|||++.. ...+.++|||||||++|||++|+.||... ....+...+....... . +
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~-----~~~~~~~~~~~~~~~~-~-----~ 294 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG-----RQGDWASLMCAICMSQ-P-----P 294 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CCccHHHHHHHHhccC-C-----C
Confidence 23456788999998743 23456899999999999999999998621 1111211111111000 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. ......++.+ ++..||+.||++||+++|+++.
T Consensus 295 ~~--~~~~~~~l~~---li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EA--PATASREFRH---FISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC--CCccCHHHHH---HHHHHccCChhhCcCHHHHhcC
Confidence 00 0111234444 4559999999999999999864
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=310.17 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=192.7
Q ss_pred cccCccCceeEEEEEEcC-Cc--EEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISN-GQ--AYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+|+..+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 46788776432 23346788999999999 899999999999999999999999999
Q ss_pred CChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 436 GSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 436 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
|+|.+++...... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 9999999754321 123488999999999999999999997 8999999999999999999999999
Q ss_pred ccCCccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 505 ALRPLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 505 Gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
|+++..... .....+..|+|||++....++.++|||||||++|||+| |..||.. ....+..... ..+
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~--------~~~~~~~~~~-~~~ 227 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELYEKL-PQG 227 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc--------cCHHHHHHHH-hCC
Confidence 998633211 11223456999999988889999999999999999997 9999852 1112222111 111
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...+ . ...... .+.+++.+||+.+|.+||++.|+++.|+++.+
T Consensus 228 ~~~~-----~--~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 228 YRLE-----K--PLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CCCC-----C--CCcCCH---HHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 1100 0 011112 35566669999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.98 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=190.5
Q ss_pred hccccCccCceeEEEEEEcC--CcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISN--GQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 34 ~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 34689999999999998543 3689999886432 233457889999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 114 IGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999997543 389999999999999999999998 8999999999999999999999999999876443
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.||... .. ......+..+.. .+
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-------~~--~~~~~~i~~~~~--~~------ 247 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-------EP--LLIYQKILEGII--YF------ 247 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC-------CH--HHHHHHHhcCCC--CC------
Confidence 2345778899999999888999999999999999999999998621 11 111112212111 01
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
+....+++.++++ +|++.||++|+ +++|+++
T Consensus 248 p~~~~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 248 PKFLDNNCKHLMK---KLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCCHHHHHHHH---HHcccCHHHcCCCCCCCHHHHHc
Confidence 1112244555555 99999999995 8888865
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=308.13 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=188.7
Q ss_pred ccCccCceeEEEEEEc---CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVIS---NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 355789998875432 23467899999999999999999999885 457899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC--
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 515 (634)
|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.+..+|++|||+++.......
T Consensus 81 L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999865332 489999999999999999999998 799999999999999999999999999875543221
Q ss_pred -----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 516 -----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 516 -----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...+..|+|||++....++.++|||||||++||+++ |+.||... .-.++. ..+..+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~-~~~~~~~~~~----- 218 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--------KGPEVM-SFIEQGKRLD----- 218 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--------CHHHHH-HHHHCCCCCC-----
Confidence 112457999999988889999999999999999997 99998621 111221 1122211111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
. .....+++.+ ++..||+.+|++||++.+|.+.|+.+
T Consensus 219 ~--~~~~~~~l~~---li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 C--PAECPPEMYA---LMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C--CCCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1 1112344444 55599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=305.95 Aligned_cols=242 Identities=21% Similarity=0.352 Sum_probs=192.7
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
++||+|+||.||+|...++..+|+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999998875432 22347889999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .+++..+..++.|++.||.|||+. +++||||||+||++++++.+|++|||++.......
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKKD----ELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99865432 389999999999999999999998 79999999999999999999999999986543321
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....+..|+|||++.+..++.++|||||||++||+++ |..||... .... .......+..... .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--------~~~~-~~~~~~~~~~~~~-------~ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--------TNQQ-AREQVEKGYRMSC-------P 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--------CHHH-HHHHHHcCCCCCC-------C
Confidence 1223456999999998899999999999999999999 99998521 1111 1111111111110 0
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
. .....+.+++.+|++.+|++||++.|++++|.
T Consensus 217 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 Q---KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred C---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1 11234566666999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.07 Aligned_cols=197 Identities=25% Similarity=0.364 Sum_probs=174.0
Q ss_pred CCHHHHHHhhccccCccCceeEEEEEEc-CCcEEEEEEecccCccCh---hHHHHHHHHHhcCCCCccccceeEEEeCCc
Q 038422 350 FDLQDMLRASAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGR---EDFQEHIKRLGRLEHPNLLPLTAFYYRKEE 425 (634)
Q Consensus 350 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 425 (634)
+.+++.. +...||.|+||.|..++.+ +|..+|+|++++..-... +....|..+|+.+.||.++++++.|.+.+.
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 4444432 3467999999999999954 588999999976543333 456789999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
.+|||||++||.|..+|+..+. +++..++.+|.||+.||+|||+. .|++|||||+|||+|.++.+||+|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999987543 99999999999999999999998 79999999999999999999999999
Q ss_pred cCCccCCCC-CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 506 LRPLINPDN-AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 506 la~~~~~~~-~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+|+...... ..+||+-|+|||.++...|+..+|.|||||++|||+.|.+||.
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 999876653 3468899999999999999999999999999999999999985
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=307.23 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=189.0
Q ss_pred ccCccCceeEEEEEE---cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 362 VLGSGTFGASYKTVI---SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3578899998864432 23467899999999999999999999885 45678999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 515 (634)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999986432 389999999999999999999998 799999999999999999999999999876543321
Q ss_pred ------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 516 ------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 516 ------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
..++..|+|||.+....++.++|||||||++|||+| |+.||... ...++.. .+..+...+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~-~i~~~~~~~---- 218 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--------KGNEVTQ-MIESGERME---- 218 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHH-HHHCCCCCC----
Confidence 112357999999988889999999999999999998 99998621 1112222 222221111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
. .....+++.+ ++..||+.||++||++.+|++.|+..
T Consensus 219 -~--~~~~~~~l~~---li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -C--PQRCPPEMYD---LMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -C--CCCCCHHHHH---HHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 0112244444 55599999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.11 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEEcC----CcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCc------eE
Q 038422 360 AEVLGSGTFGASYKTVISN----GQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE------KL 427 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 427 (634)
.+.||+|+||.||+|.... +..+|+|+++.... ...+.+.+|++.+++++||||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999998643 36799999875322 223578999999999999999999999876554 78
Q ss_pred EEEEcCCCCChhhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 428 LLYEFVENGSLAGKLHANHTK-QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
+|+||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECCccc
Confidence 999999999999998654321 123589999999999999999999998 799999999999999999999999999
Q ss_pred CCccCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++....... ...+..|+|||++.+..++.++|||||||++|||++ |..||... ....+.++ .. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-----~~~~~~~~---~~-~ 230 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-----ENHEIYDY---LR-H 230 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH---HH-c
Confidence 876543321 223467999999988889999999999999999999 88887521 11112221 11 1
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
+.... . . ......+.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~~~~-----~--~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK-----Q--P---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC-----C--C---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 1 0 11123456666699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.94 Aligned_cols=249 Identities=20% Similarity=0.335 Sum_probs=192.1
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|... .+..+|+|++.... .....++.+|+.+++.++||||+++++++..+...++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 3467999999999998753 24679999876432 2234578899999999999999999999998899999999
Q ss_pred cCCCCChhhHHhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 432 FVENGSLAGKLHANHTK-----QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEEECCCCC
Confidence 99999999999754321 123478899999999999999999997 799999999999999999999999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ...++..|+|||++.+..++.++|||||||++|||+| |..||... ...+...... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--------~~~~~~~~~~-~ 236 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--------SNEQVLRFVM-E 236 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHH-c
Confidence 87543321 1233567999999998899999999999999999999 68887521 1112211111 1
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
...... .....+ .+.+++.+|++.+|++||++.|+++.|++
T Consensus 237 ~~~~~~-------~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDK-------PDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCC-------CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 011123 34556669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=315.36 Aligned_cols=240 Identities=21% Similarity=0.335 Sum_probs=186.5
Q ss_pred cccCccCceeEEEEEEcC--------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVISN--------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234777777554444456788999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC--------eEEecc
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--------PLLTDY 504 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--------~kl~Df 504 (634)
+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||+++.+.. +|++||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999975432 389999999999999999999998 8999999999999987765 599999
Q ss_pred ccCCccCCCCCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC-CCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 505 ALRPLINPDNAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGK-YPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 505 Gla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~-~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
|++..........++..|+|||++.+. .++.++|||||||++|||++|. .|+.. ........ .... .
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~--------~~~~~~~~-~~~~-~- 221 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA--------LDSQKKLQ-FYED-R- 221 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh--------ccHHHHHH-HHHc-c-
Confidence 998766555555667889999999864 5799999999999999999985 45431 11111111 1111 0
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
. .+.. .... ++.+++..||+.+|++|||++|+++.|+
T Consensus 222 ~-----~~~~--~~~~---~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H-----QLPA--PKWT---ELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-----cCCC--CCcH---HHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 1100 1112 3455666999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=314.30 Aligned_cols=243 Identities=17% Similarity=0.235 Sum_probs=186.8
Q ss_pred cCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||+||++... +++.+|+|.+...... ..+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 6889999998653222 234677899999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 988754322 223589999999999999999999998 79999999999999999999999999987654332
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||... .............. . ....-..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~-~--------~~~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR----GEKVENKELKQRIL-N--------DSVTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----CcchhHHHHHHhhc-c--------cCCCCcc
Confidence 234677899999999999999999999999999999999998621 11011111111111 0 0000001
Q ss_pred CCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
....++ .+++..|++.||++|| +++|+++
T Consensus 223 ~~~~~~---~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPAS---KSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHH---HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 112334 4455599999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.50 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=191.9
Q ss_pred ccccCccCceeEEEEEE-----cCCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|.. ..+..+++|.++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 46799999999999984 2457899999875332 22357889999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEE
Q 038422 434 ENGSLAGKLHANHT------------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501 (634)
Q Consensus 434 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 501 (634)
++|+|.+++..... .....+++.+.+.++.|++.||+|||+. +|+||||||+||++++++.+|+
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCCCcEEe
Confidence 99999999864321 0123488999999999999999999998 7999999999999999999999
Q ss_pred eccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHH
Q 038422 502 TDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVN 574 (634)
Q Consensus 502 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 574 (634)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |..||... ....+.
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~-----~~~~~~---- 236 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF-----SNQEVI---- 236 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHH----
Confidence 9999987653321 2223457999999988889999999999999999999 88887411 111111
Q ss_pred HHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 575 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
..+....... . .....+.+ .+++.+||+.+|++||++.+|.++|..
T Consensus 237 ~~~~~~~~~~-----~--~~~~~~~~---~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLLP-----C--SEDCPPRM---YSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCC-----C--CCCCCHHH---HHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1221111111 0 01112334 445559999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.70 Aligned_cols=246 Identities=22% Similarity=0.393 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEEc-CCc----EEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQ----AYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+.. +++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 467999999999999863 344 366776653322 12356778888999999999999999875 45678999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .++|..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 91 PLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999975432 389999999999999999999998 7999999999999999999999999999765432
Q ss_pred C------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 N------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
. ...++..|+|||++.+..++.++|||||||++||++| |+.||... ....+.++ +..+.. ..
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~----~~~~~~--~~ 231 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-----RPHEVPDL----LEKGER--LA 231 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH----HHCCCc--CC
Confidence 2 1224567999999998899999999999999999998 99998521 11112222 222111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+.. ... .+.+++.+||..+|++||++.|+++.|+.+.+
T Consensus 232 ~~~~-----~~~---~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-----CTI---DVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-----CCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 112 34556669999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.76 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=196.0
Q ss_pred hhccccCccCceeEEEEEEc--------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceE
Q 038422 358 ASAEVLGSGTFGASYKTVIS--------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKL 427 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 427 (634)
...+.||+|+||.||+++.. ++..+|+|.++... ....+++.+|+.+++.+ +||||+++++++......+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 34578999999999999742 24578999886432 23346789999999999 8999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 428 LLYEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
+||||+++|+|.+++...... ....++|.+++.++.||+.||+|||+. +|+||||||+||+++++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Nili~~~ 173 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARNVLVTEN 173 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----CeeecccccceEEEcCC
Confidence 999999999999999764321 123488999999999999999999998 89999999999999999
Q ss_pred CCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcH
Q 038422 497 FEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASL 569 (634)
Q Consensus 497 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l 569 (634)
+.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++||++| |..|+.. ...
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~--------~~~ 245 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--------IPV 245 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc--------CCH
Confidence 999999999987654322 1223457999999988889999999999999999999 7777641 222
Q ss_pred HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 570 SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.++.... ..+..... ......+ +.+++.+||+.+|++||+|.||++.|+++.
T Consensus 246 ~~~~~~~-~~~~~~~~-------~~~~~~~---~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 246 EELFKLL-KEGHRMDK-------PANCTNE---LYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHH-HcCCcCCC-------CCCCCHH---HHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 3332222 22111110 1111233 444555999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.46 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=192.8
Q ss_pred ccccCccCceeEEEEEEcC-Cc--EEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQ--AYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||+|+||.||+|+..+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 4679999999999998754 33 46788776432 23346789999999999 79999999999999999999999999
Q ss_pred CCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEec
Q 038422 435 NGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503 (634)
Q Consensus 435 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 503 (634)
+|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~d 162 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIAD 162 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCeEEECC
Confidence 99999999754311 112489999999999999999999997 899999999999999999999999
Q ss_pred cccCCccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 504 YALRPLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 504 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
||++...... .....+..|+|||++.+..++.++|||||||++|||+| |+.||.. ....++.... ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~--------~~~~~~~~~~-~~ 233 (297)
T cd05089 163 FGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG--------MTCAELYEKL-PQ 233 (297)
T ss_pred cCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHH-hc
Confidence 9998643221 11222456999999988889999999999999999998 9999852 1222222221 11
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+... .. ......+ +.+++.+||+.+|.+||+++++++.|+.+.+
T Consensus 234 ~~~~-----~~--~~~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 234 GYRM-----EK--PRNCDDE---VYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCC-----CC--CCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1100 00 0111233 4456669999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.85 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=192.5
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||.||++...++..+|+|.+... ....+++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 34679999999999999877788999988643 23456788999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--- 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 515 (634)
.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 87 LNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999975432 389999999999999999999998 799999999999999999999999999876543221
Q ss_pred --ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 --HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...+..|+|||++.+..++.++|||||||++||++| |+.||... . ...... ...... ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~-~~~~~~----~~~~~~-----~~~~-- 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF----S-NSEVVE----SVSAGY-----RLYR-- 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC----C-HHHHHH----HHHcCC-----cCCC--
Confidence 122346999999998899999999999999999999 88887521 1 111111 111110 0010
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
...... .+.+++.+||..+|++||+|+||++.|
T Consensus 223 ~~~~~~---~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPT---EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111123 355566699999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.17 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=193.2
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||.||++...++..+|+|.++... ...+++.+|+.++++++|+|++++++++. ....++||||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 346799999999999998888889999987543 34578999999999999999999999874 4568999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--- 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 515 (634)
.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 88 LDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999975432 2389999999999999999999998 799999999999999999999999999876543221
Q ss_pred --ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 --HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+...... ..... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~-----~~-- 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------NNREVLEQVE-RGYRM-----PC-- 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHH-cCCCC-----CC--
Confidence 123457999999988889999999999999999999 88887521 1112221111 11000 00
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
...... .+.+++.+|++.+|++|||+.++.+.|++
T Consensus 225 ~~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPI---SLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCH---HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122 35556669999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.80 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=194.4
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|+.. ....+++|.+.... ....+++.+|+++++.++||||+++++.|...+..++|+||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 467999999999999853 23568888776432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe
Q 038422 433 VENGSLAGKLHANHT-------------------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 493 (634)
+.+|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~nill 160 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAARNVLV 160 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----CeehhhhhhheEEE
Confidence 999999999865321 1123488999999999999999999998 79999999999999
Q ss_pred CCCCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCC
Q 038422 494 DRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSK 566 (634)
Q Consensus 494 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~ 566 (634)
++++.+||+|||+++...... ....+..|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------- 233 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI------- 233 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-------
Confidence 999999999999987643321 1223567999999988889999999999999999999 99997521
Q ss_pred CcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 567 ASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...++ ........... . .....+ .+.+++..|++.+|++||+++|+++.|+++.+
T Consensus 234 -~~~~~-~~~~~~~~~~~-----~--~~~~~~---~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 -APERL-FNLLKTGYRME-----R--PENCSE---EMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -CHHHH-HHHHhCCCCCC-----C--CCCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 12222111100 0 011123 34556669999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.38 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=193.4
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||.||+|+..+...|++|+++.. ....+.+.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcH
Confidence 35679999999999999877778999998753 334568999999999999999999999874 4568999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 88 LDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred HHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999975322 2489999999999999999999998 79999999999999999999999999987654332
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||+..+..++.++|||||||++|||+| |+.||... . .............. .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~--------~-~~~~~~~~~~~~~~-----~--- 223 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------V-NREVLDQVERGYRM-----P--- 223 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------C-hHHHHHHHhcCCCC-----C---
Confidence 1223457999999988899999999999999999999 78887521 1 11111111111100 0
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
...+....+.+++.+|++.+|++||+++++++.|++.
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0112223456677799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=313.10 Aligned_cols=189 Identities=20% Similarity=0.327 Sum_probs=162.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||+. |+
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 467999999999999864 57899999987543 2234577899999999999999999999999889999999997 59
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 89 LKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9998865432 378999999999999999999998 8999999999999999999999999998754322
Q ss_pred CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||.+.+ ..++.++||||+||++|||+||+.||.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12345778999998875 568999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=312.37 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=193.3
Q ss_pred hccccCccCceeEEEEEEcC------CcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN------GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|...+ ++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 34679999999999998632 47899999875432 224578899999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeE
Q 038422 432 FVENGSLAGKLHANHT-----------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL 500 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~k 500 (634)
|+.+++|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCCceE
Confidence 9999999999863211 1123488999999999999999999998 799999999999999999999
Q ss_pred EeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHH
Q 038422 501 LTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWV 573 (634)
Q Consensus 501 l~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~ 573 (634)
|+|||+++...... ....+..|+|||++.++.++.++|||||||++|||+| |..||.. ....++.
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~ 236 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--------YSNQDVI 236 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHH
Confidence 99999987653322 1223567999999988889999999999999999998 8888752 1122222
Q ss_pred HHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 574 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
... ..+..... . ....++ +.+++..||+.+|++||+++||++.|+.
T Consensus 237 ~~i-~~~~~~~~-----~--~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMI-RNRQVLPC-----P--DDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-HcCCcCCC-----C--CCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222 22111111 0 111233 4455669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.94 Aligned_cols=255 Identities=20% Similarity=0.349 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEEcC---------------CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC
Q 038422 360 AEVLGSGTFGASYKTVISN---------------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK 423 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 423 (634)
.+.||+|+||.||+++..+ ...||+|.++... ....+.|.+|++++++++||||+++++++...
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4679999999999987542 2358899886532 23345789999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 424 EEKLLLYEFVENGSLAGKLHANHTK-------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 424 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRNCLVGNH 165 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhhEEEcCC
Confidence 9999999999999999998653211 112478999999999999999999998 79999999999999999
Q ss_pred CCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCcccccccCCCCCc
Q 038422 497 FEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT--GKYPENYLLQGYDSKAS 568 (634)
Q Consensus 497 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt--g~~P~~~~~~~~~~~~~ 568 (634)
+.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| +..||.... ...
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-----~~~ 240 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-----DEQ 240 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-----hHH
Confidence 999999999987643322 1123467999999998899999999999999999998 556664211 111
Q ss_pred HHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 569 LSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
+...+.............. ...... ..+.+++.+||+.+|++||+|++|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~----~~~~~~---~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLS----QTPLCP---SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccccCC----CCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2111111111111100000 001111 246667779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.60 Aligned_cols=237 Identities=19% Similarity=0.286 Sum_probs=186.2
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999965 47899999987532 23345677888888865 799999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999886543 389999999999999999999998 7999999999999999999999999998753322
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... ...+......... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~--------~~~~~~~~i~~~~----~~~p--- 216 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD--------NEDDLFESILHDD----VLYP--- 216 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC----CCCC---
Confidence 1234678899999999889999999999999999999999998621 1122222222111 1001
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCC-------CHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARM-------ELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-------s~~evl~ 626 (634)
.....++.+ ++..|++.||++|| +++++++
T Consensus 217 --~~~~~~~~~---ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 --VWLSKEAVS---ILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CCCCHHHHH---HHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111234444 44599999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.42 Aligned_cols=238 Identities=21% Similarity=0.305 Sum_probs=187.6
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||+|+||.||+++. .+++.||+|.++... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999987532 223356778999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++.... .+++..+..++.||+.||+|||+.. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9998886432 3899999999999999999999731 7999999999999999999999999998753222
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ............. .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~--------~~~~~~~~~i~~~-~~------~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILME-EI------RF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC--------CCHHHHHHHHhcC-CC------CC--
Confidence 123467889999999988999999999999999999999999852 1111211111111 00 11
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
......++.++++ +|++.||++|+ +++|+++
T Consensus 216 p~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTLSPEAKSLLS---GLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCHHHHHHHH---HHhhcCHHHhCCCCCCCHHHHhc
Confidence 1112244555555 99999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.85 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=183.8
Q ss_pred ccCccCceeEEEEEEcCC---cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVISNG---QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.||+|+||+||+|...++ ..+++|.+.... ......+.+|+++++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999975443 467777665432 2223568899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++...........++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999765433233467888899999999999999998 7999999999999999999999999998653222
Q ss_pred --CCccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 --NAHTLMVAYKSPEYAHN-------GKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~-------~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.....+..|+|||++.. ..++.++|||||||++|||++ |..||... .. .+-........ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-------~~-~~~~~~~~~~~-~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-------SD-EQVLKQVVREQ-DI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC-------CH-HHHHHHHhhcc-Cc
Confidence 12234567999998743 356889999999999999999 77787521 11 11111222221 11
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
...++.+.. ........ +...|| .||++||+++||++.|.
T Consensus 229 ~~~~~~~~~--~~~~~~~~---~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDL--KYSDRWYE---VMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccc--cCCHHHHH---HHHHHh-cCcccccCHHHHHHHhc
Confidence 222222211 11233333 444788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.44 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=197.0
Q ss_pred hccccCccCceeEEEEEEcC-----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN-----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 431 (634)
..++||+|+||.||+|...+ +..|++|+++... ....+.+.+|+.++++++||||+++++++.. +...++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 35789999999999999765 6888999886432 2334678899999999999999999999876 467899999
Q ss_pred cCCCCChhhHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 432 FVENGSLAGKLHANHTK---QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999999998754321 113589999999999999999999998 79999999999999999999999999998
Q ss_pred ccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 509 LINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 509 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
.+.... ...++..|+|||++.+..++.++|||||||++||++| |+.||... ....+..++ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~----~~~~ 236 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-----DPFEMAAYL----KDGY 236 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-----CHHHHHHHH----HcCC
Confidence 654332 1223567999999988889999999999999999999 99998621 111222221 1111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
... ......++ +.+++.+||+.+|++||++.||+++|+.+.+
T Consensus 237 ~~~-------~~~~~~~~---~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 RLA-------QPINCPDE---LFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCC-------CCCcCCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 00011233 4556669999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.06 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=195.5
Q ss_pred hccccCccCceeEEEEEEcC------CcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.||++.... ...+|+|.+.... .....++.+|+++++++ +||||+++++++..++..+++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 34679999999999998642 3678999887532 22335688999999999 8999999999999999999999
Q ss_pred EcCCCCChhhHHhhccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCe
Q 038422 431 EFVENGSLAGKLHANHT-----------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 499 (634)
||+++|+|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEEcCCCeE
Confidence 99999999999975321 1223589999999999999999999998 79999999999999999999
Q ss_pred EEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHH
Q 038422 500 LLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNW 572 (634)
Q Consensus 500 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~ 572 (634)
|++|||+++.+.... ....+..|+|||++.+..++.++|||||||++||+++ |..||.. ....+.
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~ 243 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG--------IPVEEL 243 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC--------CCHHHH
Confidence 999999988654322 1123457999999988899999999999999999998 8888751 111111
Q ss_pred HHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 573 VNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 573 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
......+...+ .. ......+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 244 -~~~~~~~~~~~-------~~---~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 -FKLLKEGYRME-------KP---QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHcCCcCC-------CC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111100 00 111234556777999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.43 Aligned_cols=232 Identities=21% Similarity=0.307 Sum_probs=183.4
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||+||+++.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 57899999987532 23345677888888776 699999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999886543 389999999999999999999998 7999999999999999999999999998753221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... ... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~--------~~~~~~~~~i~-~~~---~~~~--- 216 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA--------ENEDDLFEAIL-NDE---VVYP--- 216 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHh-cCC---CCCC---
Confidence 223467889999999988999999999999999999999999862 11122222221 111 1001
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
.....++.+++ ..|++.||++||++
T Consensus 217 --~~~~~~~~~li---~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 --TWLSQDAVDIL---KAFMTKNPTMRLGS 241 (320)
T ss_pred --CCCCHHHHHHH---HHHcccCHHHCCCC
Confidence 11224444444 49999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.95 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=195.9
Q ss_pred hhccccCccCceeEEEEEEc--------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceE
Q 038422 358 ASAEVLGSGTFGASYKTVIS--------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKL 427 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 427 (634)
...+.||+|+||.||+++.. +...+|+|.++... .....++.+|+++++++ +||||++++++|...+..+
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 34578999999999999752 23468999887542 23345788899999999 7999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 428 LLYEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
+||||+++|+|.+++...... ....++|.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED 176 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheEEcCC
Confidence 999999999999999764321 123489999999999999999999997 89999999999999999
Q ss_pred CCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcH
Q 038422 497 FEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASL 569 (634)
Q Consensus 497 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l 569 (634)
+.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.. ...
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~--------~~~ 248 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPV 248 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc--------CCH
Confidence 999999999987654321 1122357999999988889999999999999999998 8888751 222
Q ss_pred HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 570 SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+.... .......+. ...... .+.+++.+|+..+|++||+|.||++.|+++.+
T Consensus 249 ~~~~~~-~~~~~~~~~-------~~~~~~---~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 EELFKL-LKEGHRMDK-------PSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHH-HHcCCCCCC-------CCcCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 222222 222111110 111123 44455669999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.77 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=192.8
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCc-cccceeEEEeCC------ceEEEE
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPN-LLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~~lv~ 430 (634)
+.||+|+||+||+|+ ..+|+.||+|++..... .......+|+.++++++|+| ||++++++.+.. ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 569999999999999 45689999999975433 34456789999999999999 999999998877 788999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+.. +|.+++....... ..++...++.+++||++||+|||++ +|+||||||.|||+++++.+||+|||+|+..
T Consensus 97 e~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred Eeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 99965 9999998765321 2477789999999999999999999 8999999999999999999999999999865
Q ss_pred C-CCC---CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC---
Q 038422 511 N-PDN---AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT--- 582 (634)
Q Consensus 511 ~-~~~---~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~--- 582 (634)
. +.. ...+|..|+|||++.+. .|++..||||+||++.||++++.-|. +..+ .+...-+...+.....
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp----G~se-~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP----GDSE-IDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC----CCcH-HHHHHHHHHHcCCCCccCC
Confidence 5 222 33467889999999987 78999999999999999999887765 2111 1111111111111100
Q ss_pred Ccc-----cccccccCC---CCHHH----HHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 583 GDV-----FDKEMKGAK---YSKSE----MINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 583 ~~~-----~d~~~~~~~---~~~~~----~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+ .+..+.... ....+ ..+..+++..|++.+|++|.|++.+++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 111111100 00110 1356677779999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.51 Aligned_cols=189 Identities=22% Similarity=0.286 Sum_probs=165.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +++.+|+|+++... ......+.+|++++.+++||||+++++.+.+....++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 467999999999999854 58899999987532 22335678899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 86 GDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999997542 389999999999999999999998 8999999999999999999999999998754321
Q ss_pred -------------------------------------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 514 -------------------------------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 514 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
....+|..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1124678899999999999999999999999999999999998
Q ss_pred c
Q 038422 557 N 557 (634)
Q Consensus 557 ~ 557 (634)
.
T Consensus 237 ~ 237 (363)
T cd05628 237 C 237 (363)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.27 Aligned_cols=188 Identities=22% Similarity=0.407 Sum_probs=159.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e 431 (634)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++.... ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46899999999999995 468999999987432 223456889999999999999999999986533 4799999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
||. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 85 LME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred cCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 995 68998886432 389999999999999999999998 79999999999999999999999999987543
Q ss_pred CC-------CCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD-------NAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~-------~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 22 12346778999999865 678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.22 Aligned_cols=243 Identities=19% Similarity=0.259 Sum_probs=187.3
Q ss_pred cCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||.||+++.. +|+.+|+|.+.... ......+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---A 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 515 (634)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 988865432 2389999999999999999999998 89999999999999999999999999987654332 2
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++|||||||++|||++|+.||.... ......+........ .+. ......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~-----~~~--~~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTLED-----EVK--FEHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhhcc-----ccc--cccccC
Confidence 346778999999998889999999999999999999999985211 101111111111110 000 000111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.+++ .+++..||+.||++||+++|+++.
T Consensus 223 -~~~~---~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 -TEES---KDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred -CHHH---HHHHHHHhccCHhhCCCCccchhh
Confidence 2334 445559999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.71 Aligned_cols=189 Identities=22% Similarity=0.336 Sum_probs=163.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +++.+|+|+++... ....+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999975 57889999987542 233467889999999999999999999999999999999999987
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
.+..+.. .. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~l~~~~~-~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 86 MLELLEE-MP----NGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred HHHHHHh-cC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 7664432 21 2389999999999999999999998 79999999999999999999999999987654321
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 2346778999999998889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.42 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=199.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|... +++.+++|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 467999999999999976 78999999886432 22356789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++++|||+++......
T Consensus 87 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 87 GDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999865322 223489999999999999999999998 89999999999999999999999999987654322
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.|+.. ......++..... .+..... .
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~------~~~~~~~~~~~~~-~~~~~~~-----~ 229 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG------DKMNLYSLCKKIE-KCDYPPL-----P 229 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc------CCccHHHHHhhhh-cCCCCCC-----C
Confidence 23456779999999888899999999999999999999999751 1123333322211 1111111 0
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
. ......+.+++.+||..+|++||++.+|+++|++++
T Consensus 230 ~----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 A----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred h----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 011123445556999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=316.12 Aligned_cols=189 Identities=23% Similarity=0.365 Sum_probs=161.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+.. +++.+|+|+++.... .....+.+|++++++++||||+++++++.+++..++||||+. ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 467999999999999965 688999999875432 233467889999999999999999999999999999999995 68
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 89 LCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 8888865432 388999999999999999999998 7999999999999999999999999998654322
Q ss_pred CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 22345678999999865 457899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.80 Aligned_cols=244 Identities=22% Similarity=0.352 Sum_probs=197.7
Q ss_pred hhccccCccCceeEEEEEEcC--Cc--EEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 358 ASAEVLGSGTFGASYKTVISN--GQ--AYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
...++||+|.||+|++|.+.. |+ .||||.++..... ...+|.+|+.+|.+|+|||+++|||+..+ ....||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 346789999999999999753 43 6899999876544 66899999999999999999999999987 678899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
++.|+|.+.|+... +..|-......|+.|||.||+||..+ ++|||||.++|+|+.....+||+||||.+.+..
T Consensus 192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999998732 23488888899999999999999998 799999999999999999999999999987765
Q ss_pred CCCcc-------ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 513 DNAHT-------LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 513 ~~~~~-------~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
..... ..+.|.|||.+...+++.++|||+|||++|||+| |..||-.. .-.+.+. .+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qIL~-~iD~----- 330 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQILK-NIDA----- 330 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHHHH-hccc-----
Confidence 54332 2467999999999999999999999999999999 88898521 1111111 1111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
-+++.+..+..+.++.+ +..||..+|++||++.++.+.+
T Consensus 331 --~erLpRPk~csedIY~i---mk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 --GERLPRPKYCSEDIYQI---MKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --cccCCCCCCChHHHHHH---HHHhccCCccccccHHHHHHhH
Confidence 12344455555555555 4599999999999999998554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=325.56 Aligned_cols=183 Identities=20% Similarity=0.280 Sum_probs=159.7
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+++. .+++.||+|... ...+.+|++++++++|||||++++++..+...++|+||+. ++
T Consensus 96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 346899999999999995 457889999643 3457899999999999999999999999999999999995 78
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 169 L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 169 LYCYLAAKR-----NIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 988886532 389999999999999999999998 7999999999999999999999999998754321
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 12357889999999999899999999999999999999998864
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.95 Aligned_cols=244 Identities=26% Similarity=0.409 Sum_probs=196.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++... ++.|++|.++.... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 467999999999999874 78899999876543 5678899999999999999999999999889999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-ccc
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-HTL 518 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~ 518 (634)
+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.++....... ...
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 161 (256)
T cd05039 89 DYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL 161 (256)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccccCCC
Confidence 99975432 2489999999999999999999998 799999999999999999999999999887643322 223
Q ss_pred cccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCH
Q 038422 519 MVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSK 597 (634)
Q Consensus 519 ~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 597 (634)
+..|+|||++....++.++||||||+++||+++ |+.||... ...+ +............ .....
T Consensus 162 ~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~-~~~~~~~~~~~~~-------~~~~~ 225 (256)
T cd05039 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKD-VVPHVEKGYRMEA-------PEGCP 225 (256)
T ss_pred cccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--------CHHH-HHHHHhcCCCCCC-------ccCCC
Confidence 457999999988889999999999999999998 99997521 1111 1112211111110 01112
Q ss_pred HHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 598 SEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 598 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
++ +.+++.+||..+|++||+++|++++|+.+
T Consensus 226 ~~---~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PE---VYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HH---HHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 33 44556699999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=317.33 Aligned_cols=236 Identities=22% Similarity=0.337 Sum_probs=182.8
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhc-CCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGR-LEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57889999987532 2233455666777664 4899999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99999886543 389999999999999999999998 7999999999999999999999999998754322
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||++|+.||... ...+...... ... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~-~~~--~~~~---- 216 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE--------DEDELFDSIL-NDR--PHFP---- 216 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-cCC--CCCC----
Confidence 2234678899999999889999999999999999999999998621 1111111111 110 0111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHH-HHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELK-EVI 625 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 625 (634)
.....++.++++ .||+.+|++||++. +++
T Consensus 217 --~~~~~~~~~ll~---~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 --RWISKEAKDCLS---KLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --CCCCHHHHHHHH---HHccCCHHHcCCChHHHH
Confidence 112234445554 99999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.63 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=193.1
Q ss_pred cccCccCceeEEEEEEcC--C--cEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISN--G--QAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+|.+.+ + ..+|+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3689999876554 445689999999999999999999999988 889999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999976542 2489999999999999999999998 79999999999999999999999999987664421
Q ss_pred ------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 515 ------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 515 ------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+...........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~--------~~~~~~~~~~~~~~~~----- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG--------LSGSQILKKIDKEGER----- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHhcCCc-----
Confidence 1234567999999998899999999999999999999 9999852 1112222222111110
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
......... .+.+++.+|++.+|++||++.||++.|.+
T Consensus 220 --~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 220 --LERPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred --CCCCccCCH---HHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 000111123 34556669999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.73 Aligned_cols=246 Identities=24% Similarity=0.462 Sum_probs=193.0
Q ss_pred hccccCccCceeEEEEEEcC-C---cEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISN-G---QAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|.... + ..|++|.++.. .....++|..|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 35689999999999999643 3 36999988754 2334568999999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 88 ~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 88 ENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred CCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999875432 389999999999999999999998 8999999999999999999999999998765432
Q ss_pred CCc---------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 NAH---------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 ~~~---------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
... ..+..|+|||++.+..++.++|||||||++||+++ |..||... ....+.+++ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-----~~~~~~~~i----~~~~-- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQDVINAI----EQDY-- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-----CHHHHHHHH----HcCC--
Confidence 211 11346999999998999999999999999999987 99998521 111222222 1110
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.......... .+.+++..||+.+|++||+|++|+..|+++
T Consensus 229 -----~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -----RLPPPMDCPT---ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----cCCCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000011122 345566699999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.42 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=194.0
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||++... ++..+++|.++.......+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 467999999999999742 35678899887665556678999999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEec
Q 038422 434 ENGSLAGKLHANHTK----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 503 (634)
++|+|.+++...... ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCCEEECC
Confidence 999999999754321 113489999999999999999999998 799999999999999999999999
Q ss_pred cccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHH
Q 038422 504 YALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNM 576 (634)
Q Consensus 504 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~ 576 (634)
||+++...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||... .-.+.+...
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~~~ 237 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL--------SNTEAIECI 237 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC--------CHHHHHHHH
Confidence 99987543221 1223467999999998899999999999999999999 88887521 111111111
Q ss_pred HHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 577 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
. .+..... .......+. +++..||+.||++||+++||++.|++
T Consensus 238 ~-~~~~~~~-------~~~~~~~~~---~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 T-QGRELER-------PRTCPPEVY---AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H-cCccCCC-------CCCCCHHHH---HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1 1111000 011123344 45559999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.22 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=194.0
Q ss_pred hhccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 358 ASAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
...+.||+|+||.||++... .+..+|+|+++... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 34578999999999999742 24578999887543 22345789999999999 799999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++++..+|++|||+++.
T Consensus 118 ~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999975332 2389999999999999999999998 799999999999999999999999999876
Q ss_pred cCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 510 INPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 510 ~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
...... ..++..|+|||++.+..++.++|||||||++|||+| |+.||... ....-.......+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~ 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--------PVDSKFYKLIKEGYR 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC--------CchHHHHHHHHcCCc
Confidence 543221 123457999999998899999999999999999998 99997521 111111111211111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.. . .....++ +.+++.+|++.+|++||++.||++.|+++
T Consensus 263 ~~-----~--~~~~~~~---~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MA-----Q--PEHAPAE---IYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-----C--CCCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 0 0111233 45555599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.10 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=186.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCc-----eEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE-----KLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lv~e~~ 433 (634)
.+++|+|+||.||+|++. +++.||||+..+... --.+|+++|++++|||||+|..+|....+ ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999965 468999999876533 22478999999999999999988875432 34899999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINP 512 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~ 512 (634)
+. +|.+.++.... .+..++...++-++.||.+||.|||+. +|+||||||.|+|+|.+ +.+||+|||.|+.+..
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 87 89988875322 223478888899999999999999997 89999999999999977 8899999999998866
Q ss_pred CCCc---cccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC------
Q 038422 513 DNAH---TLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT------ 582 (634)
Q Consensus 513 ~~~~---~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~------ 582 (634)
.... ..+-.|+|||.+.+. .|+.+.||||.|||+.||+-|++-|. +..+...+...++ .+.....
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp----G~s~~dQL~eIik-~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP----GDSSVDQLVEIIK-VLGTPTREDIKSM 253 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC----CCCHHHHHHHHHH-HhCCCCHHHHhhc
Confidence 5443 345679999999874 79999999999999999999998775 2222223333322 1111100
Q ss_pred ----CcccccccccCC----CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 583 ----GDVFDKEMKGAK----YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 583 ----~~~~d~~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.+.-.+.+.... .....-.+.++++.++++.+|.+|.++.|++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 011112222111 011112345556669999999999999998853
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.56 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEEcC------CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVISN------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|...+ +..|++|.+.... .....+|.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 4679999999999999753 5678888876443 22345789999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC---CeEEeccccC
Q 038422 433 VENGSLAGKLHANHTK--QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF---EPLLTDYALR 507 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla 507 (634)
+++|+|.+++...... ....++|..++.++.||+.||+|||+. +++||||||+||+++.++ .+|++|||++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999765421 123489999999999999999999998 799999999999998654 5999999998
Q ss_pred CccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 508 PLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 508 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
+...... ....+..|+|||++.+..++.++|||||||++|||+| |+.||... ...+.+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~--------~~~~~~~~~~~~~ 238 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--------TNQEVMEFVTGGG 238 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHcCC
Confidence 8653321 1112357999999998899999999999999999997 99998621 1112221111111
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.. . . ...... .+.+++.+|++.+|++||++.||++.|++
T Consensus 239 ~~-~-----~--~~~~~~---~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 RL-D-----P--PKGCPG---PVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cC-C-----C--CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 10 0 0 011123 34556669999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.75 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=193.5
Q ss_pred ccccCccCceeEEEEEEcC-----------------CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEE
Q 038422 360 AEVLGSGTFGASYKTVISN-----------------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 421 (634)
.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++++++||||++++++|.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4679999999999988543 2457889887543 234567899999999999999999999999
Q ss_pred eCCceEEEEEcCCCCChhhHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC
Q 038422 422 RKEEKLLLYEFVENGSLAGKLHANHTK------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR 495 (634)
Q Consensus 422 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 495 (634)
.++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+||++++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~Nili~~ 165 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCLVGK 165 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----CccccccchhceeecC
Confidence 999999999999999999999765421 122589999999999999999999998 7999999999999999
Q ss_pred CCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCcccccccCCCCC
Q 038422 496 SFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT--GKYPENYLLQGYDSKA 567 (634)
Q Consensus 496 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt--g~~P~~~~~~~~~~~~ 567 (634)
++.++++|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ +..|+... ...
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~-----~~~ 240 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL-----TDQ 240 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc-----ChH
Confidence 9999999999987643322 1223567999999988899999999999999999998 66676411 111
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.+...+.............+ ...... .++.+++..|++.||++||++.||++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLP----RPPNCP---KDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHhccccccccccCC----CccCCC---HHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 12121111111111111110 011111 346667779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.58 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEEc-----------------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-----------------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 421 (634)
.+.||+|+||.||++... ++..+|+|+++... ....+++.+|++++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 467999999999998532 23468899887542 233568999999999999999999999999
Q ss_pred eCCceEEEEEcCCCCChhhHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC
Q 038422 422 RKEEKLLLYEFVENGSLAGKLHANHTKQ------RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR 495 (634)
Q Consensus 422 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 495 (634)
..+..++||||+++|+|.+++....... ...+++.++..++.|++.||+|||+. +++||||||+||++++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~Nili~~ 165 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVGK 165 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChheEEEcC
Confidence 9999999999999999999997643211 12488899999999999999999998 7999999999999999
Q ss_pred CCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCcccccccCCCCC
Q 038422 496 SFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT--GKYPENYLLQGYDSKA 567 (634)
Q Consensus 496 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt--g~~P~~~~~~~~~~~~ 567 (634)
++.+|++|||+++.+.... ....+..|+|||+...+.++.++|||||||++|||+| |..|+... . ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~----~-~~ 240 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL----S-DE 240 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc----C-hH
Confidence 9999999999987653322 1122467999999888889999999999999999998 66776521 1 11
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.+...+............. +. ..... ..+.+++.+||+.||++||+|+||++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~-~~---~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYL-PK---PALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhccccccC-CC---CCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111111110 11 11111 345566679999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.27 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=197.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++.. .+++.+++|.+..... ...+++.+|+++++.++||||+++++++.+++..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 46799999999999995 5789999998765322 2345788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++..... ....+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 87 GDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999998864322 223489999999999999999999998 79999999999999999999999999987654332
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||++.+..++.++||||||+++|||++|..||... ......+..... .. ..+...
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~-~~-----~~~~~~ 229 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIE-QC-----DYPPLP 229 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc------cchHHHHhhhhh-cC-----CCCCCC
Confidence 234567899999998888999999999999999999999998521 112222221111 10 011111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.. ...++ +.+++.+||+.+|.+||||++|++.++++.
T Consensus 230 ~~-~~~~~---~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 SD-HYSEE---LRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cc-cccHH---HHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11 11233 444555999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.69 Aligned_cols=236 Identities=21% Similarity=0.311 Sum_probs=183.8
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhc-CCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGR-LEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||+||+|+.. +++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 47899999987542 2233456677778775 4999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999986532 388999999999999999999998 8999999999999999999999999998643221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... ...+.... +.... +.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~-i~~~~------~~~~ 216 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--------DEEELFQS-IRMDN------PCYP 216 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--------CHHHHHHH-HHhCC------CCCC
Confidence 1234678899999999889999999999999999999999998621 11111111 11111 1110
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHH-HHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELK-EVI 625 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 625 (634)
.....++.+ +..+|++.||++||++. ++.
T Consensus 217 --~~~~~~~~~---li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 --RWLTREAKD---ILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --ccCCHHHHH---HHHHHhccCHhhcCCChHHHH
Confidence 111234444 44599999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.33 Aligned_cols=234 Identities=23% Similarity=0.325 Sum_probs=185.5
Q ss_pred cccCccCceeEEEEEE----cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
+.||+|+||.||+++. .+|+.+|+|+++... ......+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 357899999987542 2234567789999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999986532 389999999999999999999998 79999999999999999999999999987654331
Q ss_pred ----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 515 ----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
...++..|+|||.+.+..++.++|||||||++|||+||+.||... ...+...... .... . +
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--------~~~~~~~~i~-~~~~-~-----~ 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--------DRKETMTMIL-KAKL-G-----M 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--------CHHHHHHHHH-cCCC-C-----C
Confidence 234677899999999888999999999999999999999998621 1111111111 1111 0 1
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKE 623 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~e 623 (634)
......++.+++ ..||+.||++||++.+
T Consensus 218 --p~~~~~~~~~li---~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 --PQFLSPEAQSLL---RALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCHHHHHHH---HHHhhcCHhHcCCCCC
Confidence 111123444444 5999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.96 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=191.7
Q ss_pred cccCccCceeEEEEEEcC----CcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISN----GQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||.||+|+... +..+|+|.+...... ..+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999998533 268999988755432 3467899999999999999999999875 4568999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999997543 389999999999999999999998 799999999999999999999999999876543321
Q ss_pred c-------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 516 H-------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 516 ~-------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
. .++..|+|||.+.+..++.++|||||||++|||+| |+.||... ....+..++ .......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-----~~~~~~~~~----~~~~~~~--- 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-----KGAEVIAML----ESGERLP--- 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHH----HcCCcCC---
Confidence 1 12356999999998899999999999999999998 99998621 112222222 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....... .+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus 219 ----~~~~~~~---~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 219 ----RPEECPQ---EIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred ----CCCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 0011112 44556669999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.06 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEEc-CCc--EEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQ--AYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 467999999999999964 344 45677665432 22345788999999999 89999999999999999999999999
Q ss_pred CCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEec
Q 038422 435 NGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503 (634)
Q Consensus 435 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 503 (634)
+|+|.+++...... ....+++.+++.++.|++.|++|||+. +|+||||||+|||+++++.+||+|
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCcEEeCc
Confidence 99999999754321 123589999999999999999999998 899999999999999999999999
Q ss_pred cccCCccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 504 YALRPLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 504 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
||+++..... .....+..|+|||++.+..++.++|||||||++|||+| |..||... ...+.... ...
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~-~~~ 238 (303)
T cd05088 168 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYEK-LPQ 238 (303)
T ss_pred cccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC--------ChHHHHHH-Hhc
Confidence 9998643211 11223457999999988889999999999999999998 99998521 11122111 111
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+ . ...... .+.+++.+||+.+|++||+++++++.|+++.+
T Consensus 239 ~~~~~-----~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 239 GYRLE-----K--PLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred CCcCC-----C--CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 10000 0 011123 34556669999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.20 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=194.1
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..++||+|+||.||+|...+++.+|+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..++||||+++|+|
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L 87 (260)
T cd05067 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSL 87 (260)
T ss_pred eeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCH
Confidence 346899999999999998889999999987543 3457899999999999999999999986 45678999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 88 VDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 999865432 2489999999999999999999987 79999999999999999999999999987654221
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....+..|+|||++....++.++|||||||++||++| |+.||... .-.+.+... ....... .
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~-~~~~~~~-----~-- 224 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--------TNPEVIQNL-ERGYRMP-----R-- 224 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC--------ChHHHHHHH-HcCCCCC-----C--
Confidence 1223467999999988889999999999999999999 99998521 111111111 1111101 0
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.....++ +.+++.+|++.+|++||+++++++.|+.+
T Consensus 225 ~~~~~~~---~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 225 PDNCPEE---LYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0111233 45555599999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.63 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=191.8
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||++... +..+++|..+.. ...+.+.+|+.++++++|+|++++++++.. ++..++||||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 467999999999999764 778899988643 335678999999999999999999998654 4578999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-Ccc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-AHT 517 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 517 (634)
.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++...... ...
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 160 (256)
T cd05082 88 VDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160 (256)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence 999875432 2489999999999999999999998 79999999999999999999999999987543322 223
Q ss_pred ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCC
Q 038422 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYS 596 (634)
Q Consensus 518 ~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 596 (634)
.+..|+|||++.+..++.++|||||||++|||++ |+.|+.. ....+..... ..+.... .. ...
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~-~~~~~~~-----~~--~~~ 224 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRV-EKGYKMD-----AP--DGC 224 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHH-hcCCCCC-----CC--CCC
Confidence 4567999999988889999999999999999998 9988751 2222322221 1111111 10 111
Q ss_pred HHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 597 KSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 597 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
... +.+++.+|++.+|++||+++++++.|+++
T Consensus 225 ~~~---~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 225 PPV---VYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CHH---HHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 233 44555599999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.10 Aligned_cols=244 Identities=24% Similarity=0.307 Sum_probs=190.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||+||++... +++.||+|++..... .....+.+|++++++++||||+++++.+.+++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 467999999999999954 688999999865321 2234578899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 85 GDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999988864322 2489999999999999999999998 79999999999999999999999999987654332
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.||... .. ....+.+...+.... ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~----~~-~~~~~~~~~~~~~~~--~~~~----- 225 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR----KE-KVKREEVERRVKEDQ--EEYS----- 225 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC----ch-hhHHHHHHHHhhhcc--cccC-----
Confidence 234678899999999889999999999999999999999998621 11 111111211111110 0000
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
....+.+ .+++..||+.||++|| +++++++
T Consensus 226 -~~~~~~~---~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 226 -EKFSEAA---RSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccCHHH---HHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0112333 4555599999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.22 Aligned_cols=236 Identities=23% Similarity=0.315 Sum_probs=184.1
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhc-CCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGR-LEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+++.. +|+.||+|.++... ....+.+..|.+++.. .+||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 57899999987532 2234456777887765 4899999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC---
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--- 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 512 (634)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999886532 388999999999999999999998 899999999999999999999999999864321
Q ss_pred -CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 513 -DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 513 -~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
.....++..|+|||++.+..++.++|||||||++|||++|+.||... ........ ..... +.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--------~~~~~~~~-~~~~~------~~~~ 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--------DEDELFES-IRVDT------PHYP 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHH-HHhCC------CCCC
Confidence 12234678899999999999999999999999999999999998621 11111111 11110 1111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHH-HHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELK-EVI 625 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 625 (634)
.....++.++++ .|++.||++||++. ++.
T Consensus 217 --~~~~~~~~~li~---~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 --RWITKESKDILE---KLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCHHHHHHHH---HHccCCHHHcCCChHHHH
Confidence 112234445554 99999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.95 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=186.7
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||+||+++.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 47899999987542 23345677888888877 799999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999886543 389999999999999999999998 7999999999999999999999999998653221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... .......... .... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--------~~~~~~~~i~-~~~~------~~- 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--------DEDELFQSIL-EDEV------RY- 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--------CHHHHHHHHH-cCCC------CC-
Confidence 1224677899999999999999999999999999999999998621 1111111111 1111 01
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCH-----HHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMEL-----KEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~-----~evl~ 626 (634)
.....+++.+ ++.+||+.||++||++ .++++
T Consensus 216 -~~~~~~~~~~---li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 -PRWLSKEAKS---ILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCcCCHHHHH---HHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0111234444 4559999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.02 Aligned_cols=244 Identities=17% Similarity=0.238 Sum_probs=187.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+++.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 46799999999999985 4578999999875422 2335688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999987543 388999999999999999999998 8999999999999999999999999997532100
Q ss_pred -------------------------------------------------CCccccccccCcccccCCCCCcchhHHHHHH
Q 038422 514 -------------------------------------------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGI 544 (634)
Q Consensus 514 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGv 544 (634)
....+|..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 1124678899999999888999999999999
Q ss_pred HHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHH
Q 038422 545 LILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEV 624 (634)
Q Consensus 545 vl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~ev 624 (634)
++|||+||+.||.... -.+........... . .+........+..+++.- +.|+..+|..||+++|+
T Consensus 237 il~elltG~~Pf~~~~--------~~~~~~~i~~~~~~--~---~~~~~~~~s~~~~dli~~-ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPT--------PTETQLKVINWENT--L---HIPPQVKLSPEAVDLITK-LCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCC--------HHHHHHHHHccccc--c---CCCCCCCCCHHHHHHHHH-HccCcccccCCCCHHHH
Confidence 9999999999986211 11111111110000 0 010001112444555541 23777888889999999
Q ss_pred HH
Q 038422 625 IE 626 (634)
Q Consensus 625 l~ 626 (634)
++
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.09 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=184.7
Q ss_pred ccCccCceeEEEEEEcCCc---EEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVISNGQ---AYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.||+|+||.||++...++. .+++|.++... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999865443 45566655432 2345689999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC-----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP----- 512 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~----- 512 (634)
|.+++...... ...+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999764322 22367788889999999999999997 799999999999999999999999999764321
Q ss_pred -CCCccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 513 -DNAHTLMVAYKSPEYAHN-------GKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 513 -~~~~~~~~~y~aPE~~~~-------~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.. ....+.......+ ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~--------~~~~~~~~~~~~~-~~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH--------LSDREVLNHVIKD-QQV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHhh-ccc
Confidence 122345678999998753 245789999999999999998 4667641 1112222222222 222
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
...++.+... ..+.+.+++ ..|| .+|++||+++||++.|.
T Consensus 228 ~~~~~~~~~~--~~~~~~~l~---~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP--YSERWYEVL---QFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC--CcHHHHHHH---HHHh-hCcccCCCHHHHHHHhc
Confidence 3334443221 123444444 4899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=318.93 Aligned_cols=233 Identities=21% Similarity=0.312 Sum_probs=181.7
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHH-HHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIK-RLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||+||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999964 68999999986532 122234445544 56889999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999886532 388999999999999999999998 8999999999999999999999999998753222
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+........ .. .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~-~~------~~~ 216 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RDTAEMYDNILNK-PL------RLK 216 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC--------CCHHHHHHHHHcC-CC------CCC
Confidence 123467889999999999999999999999999999999999852 1222222222211 10 110
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELK 622 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~ 622 (634)
.....++.++++ +|++.||++||+++
T Consensus 217 --~~~~~~~~~li~---~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 --PNISVSARHLLE---GLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCHHHHHHHH---HHhhcCHHhCCCCC
Confidence 111344444444 99999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.69 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=193.7
Q ss_pred hhccccCccCceeEEEEEE------cCCcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeC-CceEE
Q 038422 358 ASAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRK-EEKLL 428 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~l 428 (634)
...+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.++.++ +||||++++++|... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 3457899999999999973 3467899999875432 2235688999999999 689999999988654 46789
Q ss_pred EEEcCCCCChhhHHhhccCC------------------------------------------------------------
Q 038422 429 LYEFVENGSLAGKLHANHTK------------------------------------------------------------ 448 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------ 448 (634)
||||+++|+|.+++......
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 99999999999998753210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC------Cccccc
Q 038422 449 --QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN------AHTLMV 520 (634)
Q Consensus 449 --~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~ 520 (634)
....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++...... ...++.
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 012378999999999999999999998 89999999999999999999999999987643221 122345
Q ss_pred cccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHH
Q 038422 521 AYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSE 599 (634)
Q Consensus 521 ~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 599 (634)
.|+|||.+.+..++.++|||||||++|||++ |..||... ............+..... .....+
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~~~~~~~-------~~~~~~- 309 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDEEFCRRLKEGTRMRA-------PDYTTP- 309 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc--------cccHHHHHHHhccCCCCC-------CCCCCH-
Confidence 6999999988899999999999999999997 88887521 111111112222211110 011112
Q ss_pred HHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 600 MINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 600 ~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
++.+++..||+.+|++||++.||++.|+.+.+
T Consensus 310 --~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 --EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 45667779999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.86 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=193.9
Q ss_pred hccccCccCceeEEEEEEcC------CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+++++.++||||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 34679999999999998643 3689999986443 2234578899999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 432 FVENGSLAGKLHANHTK-----QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
|+++|+|.+++...... ....++|..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEECCccc
Confidence 99999999999754321 122478999999999999999999997 799999999999999999999999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ...++..|+|||.+.+..++.++|||||||++||++| |+.||.. .....+.+++ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-----~~~~~~~~~~----~~ 236 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-----LSNEEVLKFV----ID 236 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-----CCHHHHHHHH----hc
Confidence 87543321 2234568999999988889999999999999999999 8888751 1111222211 11
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
+..... . ..... .+.+++..||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~~~-----~--~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHLDL-----P--ENCPD---KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCC-----C--CCCCH---HHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 0 11123 44556669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.99 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=192.8
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
++||+|+||.||++...+++.|++|.+...... ..+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877999999988754333 4568899999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99865432 388999999999999999999998 79999999999999999999999999987554221
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....+..|+|||.+.+..++.++|||||||++|||+| |..||... ........ ..... ....
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~--------~~~~~~~~-~~~~~-------~~~~ 216 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM--------SNQQTRER-IESGY-------RMPA 216 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC--------CHHHHHHH-HhcCC-------CCCC
Confidence 1122456999999988899999999999999999999 88887521 11111111 11110 0000
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
...... .+.+++.+|++.+|++||+++||++.|++
T Consensus 217 ~~~~~~---~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPE---EIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCH---HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 011123 45556669999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.41 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=200.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCc-eEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE-KLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~e~~~~ 435 (634)
.+++|+|+||.++..+.+ ++..+++|.+.-. ....++....|+.++++++|||||.+.+.|..++. .+|||+||+|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 468999999999988743 5678999988644 34445678899999999999999999999999888 9999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|++.+.+..... ..+++..+..++.|++.|++|||++ .|+|||||+.||+++.+..+||+|||+|+.+.+..
T Consensus 89 g~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 89 GDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999987652 2489999999999999999999987 79999999999999999999999999999988764
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+|+.||.||.+.+..|+.|+||||+||++|||++-+.+|. ..+....+....+.. +++.-
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~--------a~~m~~Li~ki~~~~-----~~Plp- 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK--------ASNMSELILKINRGL-----YSPLP- 227 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC--------ccchHHHHHHHhhcc-----CCCCC-
Confidence 3457889999999999999999999999999999999999986 234444444443221 12111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....++..+++ .|+..+|..||++.+++.+
T Consensus 228 --~~ys~el~~lv~---~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 --SMYSSELRSLVK---SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccccHHHHHHHH---HHhhcCCccCCCHHHHhhC
Confidence 122345555555 9999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.51 Aligned_cols=190 Identities=23% Similarity=0.371 Sum_probs=158.2
Q ss_pred ccccCccCceeEEEEEEc--CCcEEEEEEecccC--ccChhHHHHHHHHHhcC---CCCccccceeEEEe-----CCceE
Q 038422 360 AEVLGSGTFGASYKTVIS--NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRL---EHPNLLPLTAFYYR-----KEEKL 427 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~~ 427 (634)
.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 467999999999999863 46789999886533 22234566777777665 69999999999863 34588
Q ss_pred EEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
+||||+. ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred EEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 9999996 699999865432 2389999999999999999999998 8999999999999999999999999998
Q ss_pred CccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 508 PLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 508 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+..... ....++..|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 765433 22346788999999988899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.18 Aligned_cols=243 Identities=24% Similarity=0.377 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++....+..+++|.+... ....+.+.+|++++++++|||++++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 4679999999999999877778999987643 234567899999999999999999999874 45689999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 89 DFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 99975432 2489999999999999999999998 79999999999999999999999999987654322
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....+..|+|||+..+..++.++|||||||++|||+| |+.||.... ......+ ....... .. .
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~----~~~~~~~-----~~--~ 225 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NREVLEQ----VERGYRM-----PC--P 225 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH----HHcCCCC-----CC--C
Confidence 1234567999999988899999999999999999999 898975211 1111111 1111100 00 0
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.....+ +.+++.+||+.+|++||++++|++.|++
T Consensus 226 ~~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPES---LHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHH---HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111233 4445559999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=324.69 Aligned_cols=241 Identities=19% Similarity=0.288 Sum_probs=188.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 467999999999999964 58899999997532 22335678899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 86 GDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred cHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999987532 389999999999999999999998 79999999999999999999999999986542210
Q ss_pred -----------------------------------------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 038422 515 -----------------------------------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK 553 (634)
Q Consensus 515 -----------------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~ 553 (634)
...+|+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 123678899999999989999999999999999999999
Q ss_pred CCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCC---HHHHHH
Q 038422 554 YPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME---LKEVIE 626 (634)
Q Consensus 554 ~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~evl~ 626 (634)
.||... ...+.......... .. .+.......+++.++++ +|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~--------~~~~~~~~i~~~~~--~~---~~~~~~~~s~~~~~li~---~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSD--------NPQETYRKIINWKE--TL---QFPDEVPLSPEAKDLIK---RLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCC--------CHHHHHHHHHcCCC--cc---CCCCCCCCCHHHHHHHH---HHcc-CHhhcCCCCCHHHHhc
Confidence 998621 11111111111100 00 00011112345555555 6775 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.65 Aligned_cols=246 Identities=27% Similarity=0.466 Sum_probs=195.5
Q ss_pred cccCccCceeEEEEEEcC----CcEEEEEEecccCccC-hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISN----GQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||.||++.... +..+++|.++...... .+.+.+|++.++.++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999654 7889999987654333 67899999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 436 GSLAGKLHANHTK----QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 436 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
++|.+++...... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999765211 023489999999999999999999998 79999999999999999999999999988765
Q ss_pred CCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
... ...++..|+|||.+....++.++||||+||++|||++ |+.||... ...+.... ...+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~-~~~~~~~~ 227 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEY-LRKGYRLP 227 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHH-HHcCCCCC
Confidence 432 2335678999999988889999999999999999999 69998621 11122211 11111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
....... ++.+++.+||+.+|++||+++|+++.|+
T Consensus 228 -------~~~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 -------KPEYCPD---ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCccCCh---HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011123 4455666999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.24 Aligned_cols=237 Identities=22% Similarity=0.313 Sum_probs=183.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHH---hcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRL---GRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++ ++++||||+++++++.+++..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 467999999999999854 58899999987542 22334566676654 567899999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|..++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999887532 389999999999999999999998 899999999999999999999999999865322
Q ss_pred C----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 513 D----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 513 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
. ....++..|+|||.+.+..++.++|||||||++|||+||+.||.. ....+......... .
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~--------~~~~~~~~~i~~~~-~------ 218 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG--------DDEEEVFDSIVNDE-V------ 218 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCC-C------
Confidence 2 223467889999999998999999999999999999999999862 11122222221111 0
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
.. ......++. +++.+|++.||.+||+ ++++++
T Consensus 219 ~~--p~~~~~~~~---~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RY--PRFLSREAI---SIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC--CCCCCHHHH---HHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01 111123344 4555999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.37 Aligned_cols=245 Identities=20% Similarity=0.249 Sum_probs=191.6
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC--------ceE
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE--------EKL 427 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~ 427 (634)
..+.||+|+||+||+++. .+++.||+|++.... ......+.+|+..+..++|+||++++..+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 356899999999999984 568999999986542 233456889999999999999999888775432 367
Q ss_pred EEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 999999999999999754332 23589999999999999999999998 7999999999999999999999999998
Q ss_pred CccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 508 PLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 508 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
+..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+.+...... .
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~--------~~~~~~~~~~~~~-~ 261 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG--------ENMEEVMHKTLAG-R 261 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHhcC-C
Confidence 765432 223467889999999998999999999999999999999999862 2333333322211 1
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. .+. ....+++. +++..||+.||.+||++.++++.
T Consensus 262 ~~-~~~------~~~~~~l~---~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YD-PLP------PSISPEMQ---EIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC-CCC------CCCCHHHH---HHHHHHcccChhhCcCHHHHHhC
Confidence 11 011 11123444 45559999999999999999863
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.01 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=193.7
Q ss_pred hhccccCccCceeEEEEEE-----cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEE
Q 038422 358 ASAEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLL 429 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 429 (634)
...+.||+|+||.||.++. .++..||+|.++... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence 3456799999999999974 347889999987543 33346789999999999999999999999875 568899
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||+++++|.+++..... .++|.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 87 ~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 87 MEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999865422 389999999999999999999998 899999999999999999999999999876
Q ss_pred cCCCC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCccccccc-------CCCCCcHHHHHHH
Q 038422 510 INPDN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG-------YDSKASLSNWVNN 575 (634)
Q Consensus 510 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~-------~~~~~~l~~~~~~ 575 (634)
..... ...++..|+|||++.+..++.++|||||||++|||+|++.|....... .........++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence 54322 122345699999998888999999999999999999987764211000 001111222221
Q ss_pred HHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 576 MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 576 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
....+..... .. .....+.+++.+|++.+|++||+++|+++.|+++
T Consensus 238 ~~~~~~~~~~-------~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPR-------PP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCC-------CC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111110 00 1122455566699999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.34 Aligned_cols=190 Identities=25% Similarity=0.360 Sum_probs=164.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||++... ++..+++|.++... ....+++.+|++++++++||||++++++|.+++..++||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 467999999999999854 57788888876432 2234568899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--CC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 515 (634)
|.+++.... .+++..+..++.|++.||.|||+.+ +++||||||+||++++++.+||+|||++...... ..
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (308)
T cd06615 86 LDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 157 (308)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence 999997542 3899999999999999999999742 6999999999999999999999999998765432 23
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..++..|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 345678999999988889999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=286.83 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=198.8
Q ss_pred CCCHHHHHHhhccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCC
Q 038422 349 PFDLQDMLRASAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE 424 (634)
Q Consensus 349 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 424 (634)
.+++++. ...+.||+|.||.||.|+.+ ++-.||+|++.+.. .....++.+|+++-+.|+||||+++|++|.+..
T Consensus 18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 3444443 34678999999999999964 46789999986542 233468899999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 425 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
..||++||.++|++...|.+.... .+++.....++.|+|.|+.|+|.. .|+||||||+|+|++.++..|++||
T Consensus 96 riyLilEya~~gel~k~L~~~~~~---~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMK---RFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccc---cccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCC
Confidence 999999999999999999865443 378888889999999999999998 7999999999999999999999999
Q ss_pred ccCCccCC--CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 505 ALRPLINP--DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 505 Gla~~~~~--~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
|-+-.... ....++|.-|.+||...+..++.+.|+|++||+.||++.|.+||.... .+-.+..+. .
T Consensus 169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---------~~etYkrI~---k 236 (281)
T KOG0580|consen 169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---------HSETYKRIR---K 236 (281)
T ss_pred CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---------hHHHHHHHH---H
Confidence 98755432 234567888999999999999999999999999999999999996321 111111111 1
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.+..+|. ....++. +++..|+..+|.+|.+..||++.
T Consensus 237 ~~~~~p~-----~is~~a~---dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDLKFPS-----TISGGAA---DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccccCCc-----ccChhHH---HHHHHHhccCccccccHHHHhhh
Confidence 2232332 1223344 45559999999999999999863
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.49 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=193.9
Q ss_pred hccccCccCceeEEEEEEc--------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEE
Q 038422 359 SAEVLGSGTFGASYKTVIS--------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 428 (634)
..+.||+|+||.||+++.. ....+|+|.++... .....++..|+++++++ +||||++++++|.+.+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 4578999999999999742 24578889877432 22345688999999999 69999999999999889999
Q ss_pred EEEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 429 LYEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
||||+++|+|.+++...... ....++|.+++.++.|++.||+|||+. +|+||||||+||++++++
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeEEEcCCC
Confidence 99999999999999764321 123489999999999999999999998 899999999999999999
Q ss_pred CeEEeccccCCccCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~ 570 (634)
.+||+|||+++....... ...+..|+|||++.+..++.++|||||||++|||+| |..||.. ....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~--------~~~~ 243 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG--------IPVE 243 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC--------CCHH
Confidence 999999999976543211 122356999999988889999999999999999999 8888751 1111
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+.. .....+...+. ......+ +.+++.+||+.+|++||++.|+++.|+++.
T Consensus 244 ~~~-~~~~~~~~~~~-------~~~~~~~---l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 ELF-KLLREGHRMDK-------PSNCTHE---LYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHH-HHHHcCCCCCC-------CCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 12222111111 0111233 445666999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=305.55 Aligned_cols=246 Identities=21% Similarity=0.379 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEE-cCCc----EEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQ----AYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+. .+++ .||+|.++... ....+.+.+|+.+++.++||||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 46799999999999984 3454 47889886432 2334678899999999999999999999975 4578999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 91 PYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999875432 389999999999999999999998 7999999999999999999999999998866432
Q ss_pred CC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 NA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. ...+..|+|||...+..++.++|||||||++|||+| |..||+.. ....+..++ ..+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~----~~~~~~~~- 232 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-----PAREIPDLL----EKGERLPQ- 232 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH----HCCCcCCC-
Confidence 21 123457999999998899999999999999999999 88997521 112222222 11111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...... .+.+++..||+.||++||++.|+++.|+++..
T Consensus 233 ------~~~~~~---~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 233 ------PPICTI---DVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------CccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001112 34556669999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.69 Aligned_cols=239 Identities=20% Similarity=0.289 Sum_probs=186.5
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||.||+++.. +++.+|+|+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 57899999997542 22335678899999888 699999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99998886432 389999999999999999999998 8999999999999999999999999998753221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||...... ......+++......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~------~~- 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN--PDMNTEDYLFQVILEKPI------RI- 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC--cccccHHHHHHHHHhCCC------CC-
Confidence 2234678899999999999999999999999999999999999632211 112233333333322211 01
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
.......+.+ ++.+|++.||++||++
T Consensus 223 -p~~~~~~~~~---li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 -PRFLSVKASH---VLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCCCCHHHHH---HHHHHhccCHHHcCCC
Confidence 1111233444 4459999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.89 Aligned_cols=238 Identities=22% Similarity=0.290 Sum_probs=183.4
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHH-HHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIK-RLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||+||+++. .+|+.+|+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999985 468899999986532 122334555554 57789999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99998886432 389999999999999999999998 8999999999999999999999999998753221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+....... ... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~--------~~~~~~~~~~~~-~~~------~~- 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC--------RDVAEMYDNILH-KPL------VL- 215 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC--------CCHHHHHHHHHc-CCc------cC-
Confidence 223467889999999999999999999999999999999999852 122222222211 110 01
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
. .....++.+ ++..|++.+|.+||++++.+++
T Consensus 216 ~-~~~~~~~~~---ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 216 R-PGASLTAWS---ILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred C-CCCCHHHHH---HHHHHhccCHHhcCCCCCCHHH
Confidence 1 112233444 4559999999999998654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.16 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=196.0
Q ss_pred HhhccccCccCceeEEEEEEcC--------CcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCce
Q 038422 357 RASAEVLGSGTFGASYKTVISN--------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEK 426 (634)
Q Consensus 357 ~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 426 (634)
....+.||+|+||.||+++... ...+|+|.++... ....+++.+|+++++++ +||||++++++|...+..
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 3445789999999999997421 2368899876432 22346789999999999 899999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC
Q 038422 427 LLLYEFVENGSLAGKLHANHT-----------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR 495 (634)
Q Consensus 427 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 495 (634)
+++|||+++|+|.+++..... .....++|.+++.++.|++.||+|||+. +|+||||||+||++++
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Nill~~ 169 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAARNVLVTE 169 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcC
Confidence 999999999999999975431 1123489999999999999999999998 8999999999999999
Q ss_pred CCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCc
Q 038422 496 SFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKAS 568 (634)
Q Consensus 496 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~ 568 (634)
++.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||.. ..
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~ 241 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG--------IP 241 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC--------CC
Confidence 9999999999987654321 1122356999999998899999999999999999999 8888751 22
Q ss_pred HHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 569 LSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
..++..... .+...+. ...... .+.+++.+||+.+|++||+|.|+++.|+++.
T Consensus 242 ~~~~~~~~~-~~~~~~~-------~~~~~~---~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 VEELFKLLK-EGHRMDK-------PANCTH---ELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHHH-cCCCCCC-------CCCCCH---HHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 333332221 1111111 001122 4556666999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.78 Aligned_cols=244 Identities=22% Similarity=0.274 Sum_probs=189.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+. .+++.+|+|++........+.+.+|+.++++++||||+++++++..++..++||||+++++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 46799999999999995 56889999998765444556788999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 94 QDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99886432 389999999999999999999998 7999999999999999999999999998765332 2
Q ss_pred CccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 AHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||.+. ...++.++|||||||++|||+||+.|+...... .....+ .. .....+...
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~----~~~~~~-----~~---~~~~~~~~~ 232 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFLM-----SK---SNFQPPKLK 232 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----hhheee-----ec---CCCCCCCCc
Confidence 234567899999884 345788999999999999999999997521100 000000 00 000011111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.......+ +.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~---~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 233 DKTKWSST---FHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cccccCHH---HHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11111233 4455559999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.32 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=187.0
Q ss_pred ccccCccCceeEEEEEE----cCCcEEEEEEecccC----ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
.+.||+|+||.||+++. .+++.+|+|+++... ....+.+..|+++++++ +||||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46899999999999885 357899999986432 22335678899999999 5999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999986543 389999999999999999999998 7999999999999999999999999998764
Q ss_pred CCCC-----CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 511 NPDN-----AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 511 ~~~~-----~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
.... ...++..|+|||++.+. .++.++|||||||++|||+||+.||.... . ......+.......
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~-~~~~~~~~~~~~~~---- 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG----E-RNTQSEVSRRILKC---- 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC----C-CCCHHHHHHHHhcC----
Confidence 3321 23467889999999865 47889999999999999999999986221 1 11112221111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
++.+. .....++.+++ .+|++.||++|| +++|+++
T Consensus 227 --~~~~~--~~~~~~~~~li---~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 --DPPFP--SFIGPEAQDLL---HKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCC--CCCCHHHHHHH---HHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 11223444444 499999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=301.06 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +++.+++|.+... .....+++.+|++++++++||||+++++++.+++..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 467999999999999964 5889999988643 2344568899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+|++|||+++......
T Consensus 85 ~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 85 DLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred cHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999976422 2489999999999999999999997 79999999999999999999999999987654432
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||... .-...... ...+..... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~~~~-----~~ 223 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--------NQGALILK-IIRGVFPPV-----SQ 223 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--------CHHHHHHH-HHcCCCCCC-----cc
Confidence 224567799999999988999999999999999999999998621 11111111 111111111 00
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....+.+++.+||+.+|++||+|.|+++.
T Consensus 224 -----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 -----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111235556669999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=322.18 Aligned_cols=233 Identities=23% Similarity=0.329 Sum_probs=185.3
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
+..+||+|.||+|+.+..+ +++.+|||++++.... +.+..+.|.+++... +||.++.++..|+++++.|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 4578999999999999964 5789999999987543 345677888887766 5999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC-C
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN-P 512 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~-~ 512 (634)
.||++..+.+. ..+++..+..|+.+|+.||+|||++ +||+||||.+|||||.+|++||+|||+++..- .
T Consensus 452 ~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 452 AGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 99995444332 2399999999999999999999999 89999999999999999999999999998543 1
Q ss_pred ---CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 ---DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ---~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
..+..||+-|||||++.+..|+..+|.|||||+||||++|..||. ++++ ..+.+ ..+.+ ++ .
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~----gddE-ee~Fd---sI~~d----~~---~ 586 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP----GDDE-EEVFD---SIVND----EV---R 586 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC----CCCH-HHHHH---HHhcC----CC---C
Confidence 234567889999999999999999999999999999999999986 2222 22211 11111 11 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
|...--.+.++|+.+.+..+|++|--+
T Consensus 587 -----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 -----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111222344555559999999999876
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.34 Aligned_cols=249 Identities=19% Similarity=0.323 Sum_probs=192.1
Q ss_pred ccccCccCceeEEEEEEcC------CcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVISN------GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|...+ +..||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 4689999999999997532 45789998764432 2234688899999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 433 VENGSLAGKLHANHTK-----QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
+++|+|.+++...... .....++..+..++.|++.||.|||+. +|+||||||+||++++++.+|++|||++
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999753221 123467888999999999999999998 7999999999999999999999999998
Q ss_pred CccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 508 PLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 508 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
+...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.. ....++..... .+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~--------~~~~~~~~~~~-~~ 237 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------LSNEQVLKFVM-DG 237 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHH-cC
Confidence 7543321 1223467999999998899999999999999999999 7888752 11222222221 11
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.... . .....+ .+.+++.+|++.+|++||++.|+++.|++.
T Consensus 238 ~~~~-----~--~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 238 GYLD-----Q--PDNCPE---RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCC-----C--CCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1110 0 011123 445555599999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.88 Aligned_cols=255 Identities=21% Similarity=0.322 Sum_probs=194.3
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhc--CCCCccccceeEEEeCC----ceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGR--LEHPNLLPLTAFYYRKE----EKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e~~ 433 (634)
.+.||+|.||.||+|.+ .|+.||||++... +.+.+.+|.+++.. |+|+||+.+++.-..+. +.+||.+|-
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 57899999999999998 5889999998753 44577788888765 59999999998865443 579999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL----PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
++|||.|||... .++-...++++.-+|.||+|||... ..+.|.|||||+.|||+..++..-|+|+|||-.
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999763 3889999999999999999999742 234699999999999999999999999999854
Q ss_pred cCC--------CCCccccccccCcccccCCC----C--CcchhHHHHHHHHHHHHhC----------CCCcccccccCCC
Q 038422 510 INP--------DNAHTLMVAYKSPEYAHNGK----I--SKKSDVWSLGILILELLTG----------KYPENYLLQGYDS 565 (634)
Q Consensus 510 ~~~--------~~~~~~~~~y~aPE~~~~~~----~--~~k~DVwSfGvvl~elltg----------~~P~~~~~~~~~~ 565 (634)
... .+...||.+|||||++.... + -..+||||||.|+||++-+ +.||....+.+.+
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 332 24567899999999997532 1 2468999999999999863 3455433333222
Q ss_pred CCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 566 KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+ +-++..+-..+....++.+ ..+.+.+..+.+|+..||..+|..|-|+=-+-+.|.++.
T Consensus 446 ---~-eeMrkVVCv~~~RP~ipnr----W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 446 ---F-EEMRKVVCVQKLRPNIPNR----WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ---H-HHHhcceeecccCCCCCcc----cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1 1112222122222222222 235578889999999999999999999988888887764
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.94 Aligned_cols=245 Identities=22% Similarity=0.429 Sum_probs=192.2
Q ss_pred ccccCccCceeEEEEEEc-C---CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-N---GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. + +..+|+|.++... ....+.+..|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 468999999999999863 2 3378898886432 2234678999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 89 ~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 89 NGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999975432 389999999999999999999998 79999999999999999999999999987654432
Q ss_pred Cc-------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 515 AH-------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 515 ~~-------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. ..+..|+|||++.+..++.++|||||||++||+++ |+.||... ........+ .++...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-----~~~~~~~~~----~~~~~~--- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-----SNQDVIKAI----EEGYRL--- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-----CHHHHHHHH----hCCCcC---
Confidence 11 12346999999998899999999999999999887 99998521 011121111 111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
+. .....+. +.+++.+|++.+|.+||+|.++++.|+++
T Consensus 229 -~~---~~~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PA---PMDCPAA---LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CC---CCCCCHH---HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 0111233 44556699999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.54 Aligned_cols=241 Identities=21% Similarity=0.345 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+. .+++.+++|.+........+.+.+|+.++++++||||+++++++..+...++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 36799999999999985 46889999998765555567889999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 9998542 278999999999999999999998 79999999999999999999999999987543322
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||... ... .+.......+ ... +...
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~-------~~~-~~~~~~~~~~-~~~-----~~~~- 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-------NPL-RALYLIATNG-TPE-----LQNP- 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC-------CHH-HhHHHHhcCC-CCC-----CCCc-
Confidence 234567899999999888999999999999999999999998521 111 1111111111 000 1000
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
......+.+++.+||..+|++||+++|+++.
T Consensus 240 --~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 --EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1111234556669999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.86 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 357999999999999863 46789999886532 22346789999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC
Q 038422 433 VENGSLAGKLHANHT-----------------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR 495 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 495 (634)
+++|+|.+++..... .....+++.+++.++.|++.||+|||+. +++||||||+||++++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~nil~~~ 165 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGE 165 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHhheEecC
Confidence 999999999975321 1123478999999999999999999998 7999999999999999
Q ss_pred CCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCc
Q 038422 496 SFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKAS 568 (634)
Q Consensus 496 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~ 568 (634)
++.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||.. ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~--------~~ 237 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG--------MA 237 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------CC
Confidence 9999999999987543221 1223457999999988899999999999999999998 8888741 12
Q ss_pred HHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 569 LSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
..++... +..+..... ...... .+.+++.+|++.+|++||+++|+++.|++
T Consensus 238 ~~~~~~~-~~~~~~~~~-------~~~~~~---~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYY-VRDGNVLSC-------PDNCPL---ELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHH-HhcCCCCCC-------CCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2222222 222211110 011123 35556669999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.53 Aligned_cols=242 Identities=21% Similarity=0.277 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 467999999999999965 68999999987542 23345788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 86 GDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999997642 389999999999999999999997 89999999999999999999999999987654332
Q ss_pred --------------------------------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCccccccc
Q 038422 515 --------------------------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562 (634)
Q Consensus 515 --------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~ 562 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~--- 233 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD--- 233 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC---
Confidence 234678899999999999999999999999999999999998621
Q ss_pred CCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCC-HHHHHHH
Q 038422 563 YDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME-LKEVIEK 627 (634)
Q Consensus 563 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~evl~~ 627 (634)
............. ....-+.. ....+++.+++. .|+. ||.+||+ ++|+++.
T Consensus 234 -----~~~~~~~~i~~~~--~~~~~p~~---~~~~~~~~~li~---~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 -----TLQETYNKIINWK--ESLRFPPD---PPVSPEAIDLIC---RLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----CHHHHHHHHhccC--CcccCCCC---CCCCHHHHHHHH---HHcc-ChhhcCCCHHHHhcC
Confidence 1111111111100 00000000 001344455554 8997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.67 Aligned_cols=238 Identities=20% Similarity=0.287 Sum_probs=183.3
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHH-HHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHI-KRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||+||+++.. +++.+|+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 56789999986532 12223444444 457889999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999986533 378888899999999999999998 8999999999999999999999999998754222
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+......... . .+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~-~--~~~~--- 217 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RNTAEMYDNILNKP-L--QLKP--- 217 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC--------CCHHHHHHHHHhCC-c--CCCC---
Confidence 223467889999999999999999999999999999999999852 12222222222111 0 0111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....++.++++ +|++.+|.+||++.+.+.+
T Consensus 218 ---~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 ---NITNSARHLLE---GLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ---CCCHHHHHHHH---HHcccCHHHCCCCCCCHHH
Confidence 12344555555 9999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.86 Aligned_cols=246 Identities=24% Similarity=0.416 Sum_probs=190.6
Q ss_pred ccCccCceeEEEEEEcC-------CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 362 VLGSGTFGASYKTVISN-------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|++++++++||||++++++|...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2578888876432 234567899999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-----CeEEecccc
Q 038422 434 ENGSLAGKLHANHTK--QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-----EPLLTDYAL 506 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-----~~kl~DfGl 506 (634)
++|+|.+++...... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999754321 123488999999999999999999987 799999999999999877 899999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ....+..|+|||++.++.++.++|||||||++|||+| |+.||... .-.+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--------~~~~~~~~-~~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--------NNQEVLQH-VTA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc--------CHHHHHHH-Hhc
Confidence 87543221 1223567999999999999999999999999999998 99997521 11111111 111
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
+.. ........+. +.+++.+||+.+|.+||++++|++.|++
T Consensus 229 ~~~-------~~~~~~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGR-------LQKPENCPDK---IYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCc-------cCCcccchHH---HHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 110 1111112233 4455559999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=303.40 Aligned_cols=248 Identities=20% Similarity=0.326 Sum_probs=192.9
Q ss_pred hccccCccCceeEEEEEEcCC----cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISNG----QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|...+. ..+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 356899999999999986442 468888876543 3345689999999999999999999999865 5678999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 89 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 89 PLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999965432 389999999999999999999997 7999999999999999999999999998765433
Q ss_pred CC-----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 NA-----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ~~-----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
.. ...+..|+|||.+....++.++|||||||++||+++ |+.||.... ......++ ..+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~~----~~~~~~~--- 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NNDVIGRI----ENGERLP--- 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHH----HcCCcCC---
Confidence 21 122356999999988889999999999999999996 999986211 11111111 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhcC
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~~ 634 (634)
. ......++.+ ++.+|+..+|++||++.|+++.|+++.++
T Consensus 229 --~--~~~~~~~~~~---li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 --M--PPNCPPTLYS---LMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --C--CCCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 1111234444 55599999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.81 Aligned_cols=240 Identities=24% Similarity=0.391 Sum_probs=199.1
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||.|+||.||-++ ..+.+.||||++.-... ....++..|++.|.+++|||+|.+.|+|......|||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 459999999999999 45678999999864332 234588999999999999999999999999999999999995 5
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCc
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH 516 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 516 (634)
+-.|++..... ++.+.++..|+.+.+.||+|||+. ..||||||+.|||+++.+.+|++|||.|.++.+.++.
T Consensus 111 SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF 182 (948)
T KOG0577|consen 111 SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF 182 (948)
T ss_pred cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence 88888865543 489999999999999999999998 6899999999999999999999999999999999999
Q ss_pred cccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 517 TLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 517 ~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
.||+.|||||++. .+.|+-|+||||+||+..|+...++|... ++-..-++.+-... .|.+. .
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--------MNAMSALYHIAQNe------sPtLq-s 247 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNE------SPTLQ-S 247 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--------chHHHHHHHHHhcC------CCCCC-C
Confidence 9999999999986 57899999999999999999999999641 22222222222111 12232 2
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....+.+..|++ .|++.-|.+|||.+++++.
T Consensus 248 ~eWS~~F~~Fvd---~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 NEWSDYFRNFVD---SCLQKIPQERPTSEELLKH 278 (948)
T ss_pred chhHHHHHHHHH---HHHhhCcccCCcHHHHhhc
Confidence 344567777888 9999999999999998763
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.20 Aligned_cols=242 Identities=25% Similarity=0.427 Sum_probs=193.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++...++..+++|.++.. .....+|.+|++++++++||||+++++++......++||||+++|+|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 4679999999999999877889999988643 334568999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 88 DYLRAQRG----KFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99875432 388999999999999999999998 79999999999999999999999999987543321
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....+.+|+|||++.+..++.++|||||||++|||++ |+.||.. ......+... ..+ .....+..
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~~~~-~~~--~~~~~~~~--- 225 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN--------RSNSEVVETI-NAG--FRLYKPRL--- 225 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc--------CCHHHHHHHH-hCC--CCCCCCCC---
Confidence 1223467999999998899999999999999999998 8999752 1112222221 111 01111111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
..+ .+.+++.+||+.+|++||+++||+++|+
T Consensus 226 --~~~---~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 --ASQ---SVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCH---HHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 123 4555666999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.83 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=196.0
Q ss_pred ccccCccCceeEEEEEEc-----CCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-----NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e 431 (634)
.+.||+|+||.||++++. ++..+|+|.++..... ..+.|.+|++++++++||||+++++++.. ....++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 367999999999999854 3678999998755432 35689999999999999999999999887 557899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++....
T Consensus 89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999975432 389999999999999999999998 79999999999999999999999999988765
Q ss_pred CCCC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCC-------CCcHHHHHHHHH
Q 038422 512 PDNA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDS-------KASLSNWVNNMV 577 (634)
Q Consensus 512 ~~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~-------~~~l~~~~~~~~ 577 (634)
.... ...+..|+|||++.+..++.++||||||+++|||+||+.|+......... ......+. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHH
Confidence 3211 12234599999998889999999999999999999999997532111000 00111111 111
Q ss_pred HhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 578 KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 578 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
..... .... ......+.+++.+||+.+|++||+|.||+++|+.|+
T Consensus 240 ~~~~~-------~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGER-------LPRP---PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCCc-------CCCC---ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11100 0000 011134666777999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.56 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=195.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++...++..+++|.+... ....+++.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 4679999999999999888888999988753 345678999999999999999999999999888999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++.+|++|||+++......
T Consensus 90 ~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 90 DFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred HHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 99976432 2489999999999999999999998 79999999999999999999999999987654321
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....+..|+|||.+.+..++.++|||||||++||++| |+.||... .-............. .. .
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~~~~~~~~~~~~--~~------~ 226 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--------TNREVLEQVERGYRM--PR------P 226 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCCC--CC------C
Confidence 1223457999999998889999999999999999999 99997521 111111111111000 00 0
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
....+ .+.+++.+|++.+|++||+++|+.+.|+.+
T Consensus 227 ~~~~~---~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 227 PNCPE---ELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 01123 345566699999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.20 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=189.2
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++|+
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 3467999999999999965 477888888866554455678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++......
T Consensus 89 l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 89 VDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 998876432 2489999999999999999999998 8999999999999999999999999998654322
Q ss_pred CCccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 NAHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....++..|+|||++. +..++.++|||||||++|||++|+.||... .-.+.+....... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~-~~~~--- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSE-PPTL--- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc--------CHHHHHHHHhhcC-CCCC---
Confidence 2234567899999984 345788999999999999999999997521 1111111111111 1011
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
........++. +++..||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~---~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFK---DFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHH---HHHHHHccCChhhCcCHHHHhcC
Confidence 01111123444 45559999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.67 Aligned_cols=240 Identities=22% Similarity=0.318 Sum_probs=183.3
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--------------cChhHHHHHHHHHhcCCCCccccceeEEEeC-
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--------------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK- 423 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 423 (634)
.+.||+|.||.|-+|+. .+++.||+|++.+... ...+...+||.+|++++|||||+|+.+..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 45699999999999994 5689999999864321 1125789999999999999999999998764
Q ss_pred -CceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 424 -EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 424 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
+..|||+|||..|.+...=. ....++..++++|++++..||+|||.+ +|+||||||+|+||++++++||+
T Consensus 182 s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred cCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCCcEEee
Confidence 47899999999998764321 122389999999999999999999998 89999999999999999999999
Q ss_pred ccccCCccCCC---------CCccccccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcH
Q 038422 503 DYALRPLINPD---------NAHTLMVAYKSPEYAHNGK----ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASL 569 (634)
Q Consensus 503 DfGla~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l 569 (634)
|||.+...... ....||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.. ...
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--------~~~ 324 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--------DFE 324 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--------chH
Confidence 99998755221 1256889999999987632 35788999999999999999999861 122
Q ss_pred HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 570 SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+.... ++...+.-+.. .+.-.++-+|+.+.++.||.+|.+..||..
T Consensus 325 ~~l~~K---------Ivn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 LELFDK---------IVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHHH---------HhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 222212 22222211111 122223344555999999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.17 Aligned_cols=242 Identities=18% Similarity=0.260 Sum_probs=188.3
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 3468999999999999964 58899999986432 2234567889999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999988642 278888899999999999999998 7999999999999999999999999998765432
Q ss_pred ----CCccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 514 ----NAHTLMVAYKSPEYAHNG----KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 514 ----~~~~~~~~y~aPE~~~~~----~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
....+++.|+|||++.+. .++.++|||||||++|||+||+.||.. ............... ..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~--~~ 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMDHKN--SL 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC--------CCHHHHHHHHHcCCC--cC
Confidence 233467889999998653 478999999999999999999999862 112221222221110 01
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccC--CCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLA--RMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~ 626 (634)
.+........++.++++ .|++.+|.+ ||+++|+++
T Consensus 267 ---~~~~~~~~s~~~~~li~---~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 ---TFPDDIEISKQAKDLIC---AFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ---CCCCcCCCCHHHHHHHH---HHccChhhccCCCCHHHHhc
Confidence 01111112344555555 999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=319.14 Aligned_cols=242 Identities=21% Similarity=0.275 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +++.+|+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 467999999999999854 688999999875422 2345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 86 GDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999976422 389999999999999999999998 79999999999999999999999999997654432
Q ss_pred ----CccccccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 515 ----AHTLMVAYKSPEYAH------NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~------~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
...++..|+|||++. ...++.++|||||||++|||+||+.||.. ..................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~--------~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE--------GTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC--------CCHHHHHHHHHcCCCccC
Confidence 224678899999986 45678999999999999999999999862 111222222221111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ........++.++++ .|++ +|++||+++++++
T Consensus 230 ~-----~~~~~~~~~~~~li~---~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 F-----PEDPKVSSDFLDLIQ---SLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-----CCCCCCCHHHHHHHH---HHcc-ChhhCCCHHHHhC
Confidence 0 011112344555555 8887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=309.71 Aligned_cols=246 Identities=24% Similarity=0.417 Sum_probs=190.1
Q ss_pred ccccCccCceeEEEEEEc-CCc----EEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQ----AYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++||||++++|+|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 467999999999999853 444 467887764332 2234688999999999999999999998754 567999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 91 PHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999875432 389999999999999999999998 7999999999999999999999999999765432
Q ss_pred CC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 NA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. ...+..|+|||++.+..++.++|||||||++||++| |+.||... ....+.+++ ..+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-----~~~~~~~~~----~~~~~~~-- 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-----PTREIPDLL----EKGERLP-- 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH----HCCCCCC--
Confidence 21 223467999999998899999999999999999998 88997521 111222221 1111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
... ....++.+++..||..+|++||+|+|+++.|+++.+
T Consensus 232 -----~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 232 -----QPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -----CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 111345566779999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=298.13 Aligned_cols=242 Identities=19% Similarity=0.322 Sum_probs=199.9
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..++||+|+||.||++.++ .|+.+|+|++.. ..+.+++..|+.+|.+++.|++|++||.|......|+|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 3467999999999999864 589999998765 3466789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC----C
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP----D 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~----~ 513 (634)
+.|.++.+.. +|++.++..++++.++||+|||.. .-+|||||+.|||++.++.+|++|||.+..+.+ .
T Consensus 115 iSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 115 ISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred HHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999987654 499999999999999999999998 578999999999999999999999999876544 3
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
+...+|+.|||||++..-.|+.++||||+|++..||..|++||....+... .+ .+.-.-.+.++++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----------IF---MIPT~PPPTF~KP 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----------IF---MIPTKPPPTFKKP 252 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----------eE---eccCCCCCCCCCh
Confidence 556788999999999999999999999999999999999999863321100 00 0111123344443
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....+++.++++ .|+-..|++|-|+.++++.
T Consensus 253 E~WS~~F~DFi~---~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIR---SCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHH---HHhcCCHHHHHHHHHHhhh
Confidence 334455555555 9999999999999888763
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=304.35 Aligned_cols=246 Identities=22% Similarity=0.385 Sum_probs=193.2
Q ss_pred ccccCccCceeEEEEEEcC-Cc----EEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQ----AYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|...+ |. .+++|....... .....+.+|+.++++++||||++++++|.. ...++||||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 4679999999999998643 33 588888765432 234678899999999999999999999987 7889999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 91 PLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999975432 389999999999999999999997 7999999999999999999999999999766533
Q ss_pred CC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 NA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. ...+..|+|||.+....++.++|||||||++||++| |+.||+. ....++... +..+.. .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~--------~~~~~~~~~-~~~~~~--~- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG--------IPAVEIPDL-LEKGER--L- 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC--------CCHHHHHHH-HhCCCC--C-
Confidence 22 112456999999988889999999999999999999 9999862 122222221 111111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....... .++.+++.+||..+|++||++.++++.|+++.+
T Consensus 231 ----~~~~~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 ----PQPPICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----CCCCCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0001111 234556669999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.76 Aligned_cols=189 Identities=21% Similarity=0.292 Sum_probs=164.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 46799999999999985 468899999986432 22235678899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 86 GDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999986532 388999999999999999999998 8999999999999999999999999998632110
Q ss_pred -------------------------------------------------CCccccccccCcccccCCCCCcchhHHHHHH
Q 038422 514 -------------------------------------------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGI 544 (634)
Q Consensus 514 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGv 544 (634)
....+|..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0124677899999999889999999999999
Q ss_pred HHHHHHhCCCCcc
Q 038422 545 LILELLTGKYPEN 557 (634)
Q Consensus 545 vl~elltg~~P~~ 557 (634)
++|||+||+.||.
T Consensus 237 il~elltG~~Pf~ 249 (377)
T cd05629 237 IMFECLIGWPPFC 249 (377)
T ss_pred hhhhhhcCCCCCC
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.02 Aligned_cols=233 Identities=22% Similarity=0.289 Sum_probs=180.2
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHH-HHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHI-KRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+|+||.||+++.. +++.+|+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57899999986432 12233455555 467889999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99998886432 388889999999999999999998 7999999999999999999999999998753221
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ............. .. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~-~~------~~- 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RDVSQMYDNILHK-PL------QL- 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC--------CCHHHHHHHHhcC-CC------CC-
Confidence 123467889999999988999999999999999999999999852 1222222222111 00 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELK 622 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~ 622 (634)
......++ .+++..|++.||.+||+..
T Consensus 216 -~~~~~~~~---~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -PGGKTVAA---CDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCHHH---HHHHHHHccCCHhhcCCCC
Confidence 11112334 4455599999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.81 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=189.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.++||+|+||.||+|+. .+++.+|+|.+.... ....+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 36799999999999985 568899999886432 2234578899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--CC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 515 (634)
|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ..
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 97542 278888999999999999999998 8999999999999999999999999998765433 23
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++|||||||++|||+||+.||......... .....+........ .+.+.....
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~ 225 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDED------PPVLPVGQF 225 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccC------CCCCCCCcC
Confidence 35677899999999889999999999999999999999998632211111 11111111111110 111111111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+ +.+++.+|++.+|++||+++|+++.
T Consensus 226 -~~~---~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 -SEK---FVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CHH---HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 233 4555669999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=321.91 Aligned_cols=183 Identities=21% Similarity=0.247 Sum_probs=158.9
Q ss_pred hccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+++... ++.||+|... ...+.+|++++++++|||||++++++..++..++||||+. ++
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 35679999999999999654 7789998532 2346789999999999999999999999999999999995 78
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... .++|.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 246 L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 246 LYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9988865322 499999999999999999999998 79999999999999999999999999987654321
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
...+|..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 234688899999999999999999999999999999988764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.29 Aligned_cols=190 Identities=22% Similarity=0.317 Sum_probs=159.9
Q ss_pred cccCcc--CceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSG--TFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
++||+| +|++||+++. .+|+.||+|+++... ....+.+.+|+++++.++||||++++++|..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 579999 6789999985 568999999987542 22235677899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+........
T Consensus 84 ~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 84 GSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999998654322 389999999999999999999998 7999999999999999999999999864322111
Q ss_pred ---------CCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ---------NAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ---------~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 11234566999999976 458999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.61 Aligned_cols=233 Identities=20% Similarity=0.240 Sum_probs=181.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCC-ccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHP-NLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..++|+ +|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 467999999999999965 46789999987532 23345678899999999765 58889999998999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999886543 388999999999999999999998 8999999999999999999999999998643211
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... .-.+...... .... .+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--------~~~~~~~~i~-~~~~------~~ 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--------DEDELFQSIM-EHNV------SY 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-cCCC------CC
Confidence 1234678899999999989999999999999999999999998621 1111111111 1110 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
. .....++ .+++.+|+..||.+|++.
T Consensus 221 ~--~~~~~~~---~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 P--KSLSKEA---VSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C--CCCCHHH---HHHHHHHhhcCHHHcCCC
Confidence 0 1112334 445559999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=311.54 Aligned_cols=233 Identities=20% Similarity=0.250 Sum_probs=182.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. +++.+|+|.++... ....+.+..|..++..+ +|++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 467999999999999865 47799999987542 22234566778887777 58999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999886542 389999999999999999999998 7999999999999999999999999998754321
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... .... .+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~--------~~~~~~~~~i~-~~~~------~~ 220 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIM-EHNV------AY 220 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC--------CCHHHHHHHHH-hCCC------CC
Confidence 223467889999999999999999999999999999999999862 11111111111 1111 01
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
.....+++ .+++.+|++.+|.+|++.
T Consensus 221 --p~~~s~~~---~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 --PKSMSKEA---VAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCcCCHHH---HHHHHHHcccCHHhcCCC
Confidence 01112334 455559999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=305.50 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=188.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||++.. .+++.+|+|.+..... ...+.+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 36799999999999986 4688999999865321 2234578899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 85 GDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 999988865322 2499999999999999999999998 79999999999999999999999999986653322
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||... .. .....-+...+.... ..+.+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~----~~-~~~~~~~~~~~~~~~--~~~~~---- 226 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR----KE-KVKREEVDRRVLETE--EVYSA---- 226 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC----CH-HHHHHHHHHhhhccc--cccCc----
Confidence 234678899999999889999999999999999999999998621 10 111111111111110 01111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
....++ .+++..|++.||++||+ ++|+++
T Consensus 227 --~~~~~~---~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 --KFSEEA---KSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cCCHHH---HHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 112333 45555999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.52 Aligned_cols=191 Identities=23% Similarity=0.392 Sum_probs=157.1
Q ss_pred ccccCccCceeEEEEEEc---CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS---NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 434 (634)
...||+|+||+||+|+.. +++.+|+|.+... .....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 4578999988653 234567899999999999999999999865 346789999996
Q ss_pred CCChhhHHhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe----CCCCCeEEecccc
Q 038422 435 NGSLAGKLHANHTK----QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL----DRSFEPLLTDYAL 506 (634)
Q Consensus 435 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl 506 (634)
++|.+++...... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5888887543211 122489999999999999999999998 79999999999999 4567899999999
Q ss_pred CCccCCC-------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 507 RPLINPD-------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 507 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
++..... ....+|..|+|||++.+. .++.++||||+||++|||+||+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9765432 123457789999998764 58999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.70 Aligned_cols=241 Identities=21% Similarity=0.331 Sum_probs=188.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc-----cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN-----VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||++.. .+++.+++|.+..... ...+.+.+|++++++++||||+++++++.+++..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 46899999999999985 4588999998864321 12346888999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.....
T Consensus 87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999986542 388999999999999999999998 7999999999999999999999999998754332
Q ss_pred -------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 -------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 -------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
....++..|+|||++.+..++.++|||||||++|||++|+.||... ..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~-~~~~~~~~~~---- 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-------EAMAA-IFKIATQPTN---- 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc-------chHHH-HHHHhccCCC----
Confidence 1223456799999999988999999999999999999999998521 11111 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+. ....+++. +++..||..+|.+||++.|+++.
T Consensus 226 -~~~~--~~~~~~~~---~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -PQLP--SHVSPDAR---NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCC--ccCCHHHH---HHHHHHhhcCcccCCCHHHHhhC
Confidence 1111 11123344 45559999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.27 Aligned_cols=189 Identities=19% Similarity=0.252 Sum_probs=163.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+++.+|+|++..... ...+.+.+|++++++++|||||++++++.+++..++|||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 46799999999999995 4578999999875322 2235688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC---
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--- 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 512 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 86 GDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999986542 388899999999999999999998 799999999999999999999999999743210
Q ss_pred ------------------------------------------------CCCccccccccCcccccCCCCCcchhHHHHHH
Q 038422 513 ------------------------------------------------DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGI 544 (634)
Q Consensus 513 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGv 544 (634)
.....+|..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00124677899999999999999999999999
Q ss_pred HHHHHHhCCCCcc
Q 038422 545 LILELLTGKYPEN 557 (634)
Q Consensus 545 vl~elltg~~P~~ 557 (634)
++|||+||+.||.
T Consensus 237 il~elltG~~Pf~ 249 (382)
T cd05625 237 ILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.44 Aligned_cols=188 Identities=21% Similarity=0.364 Sum_probs=160.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e 431 (634)
.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46799999999999995 468999999886432 223457889999999999999999999998776 7899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 996 57888775432 389999999999999999999998 79999999999999999999999999987654
Q ss_pred CCC-----CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PDN-----AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~~-----~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ...++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 322 22346779999998874 47899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.51 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=188.9
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+|+. .+++.+|+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 346799999999999985 4588999999876544445678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.... .+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 93 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 93 LQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999986533 389999999999999999999998 7999999999999999999999999998654322
Q ss_pred CCccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 NAHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++. ...++.++|||||||++|||++|+.|+.... .. ..+......... .+..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~-------~~-~~~~~~~~~~~~----~~~~ 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH-------PM-RALFLMTKSNFQ----PPKL 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc-------ch-hhHHhhhccCCC----CCcc
Confidence 2234677899999874 4568899999999999999999999974211 00 001111111101 1111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.......+.+ .+++.+|++.+|++||++++|++
T Consensus 232 ~~~~~~~~~~---~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSF---HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHH---HHHHHHHccCCchhCcCHHHHhc
Confidence 1100112334 44555999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.55 Aligned_cols=240 Identities=20% Similarity=0.351 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++||||+++++++.++...++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4579999999999999765 78999999875432 67899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99986533 2489999999999999999999998 79999999999999999999999999987654432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.|+..... ..... .... ...+.+....
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-------~~~~~--~~~~-----~~~~~~~~~~ 223 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-------MRAIF--MIPN-----KPPPTLSDPE 223 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-------hhhhh--hhcc-----CCCCCCCchh
Confidence 22356789999999988999999999999999999999999862111 00000 0000 0001111110
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.... .+.+++.+||+.+|++||+++||++
T Consensus 224 ~~~~---~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSP---EFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCH---HHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112 3455555999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.99 Aligned_cols=189 Identities=18% Similarity=0.264 Sum_probs=164.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999954 58899999986432 22345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC---
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--- 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 512 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 86 GDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999996542 388899999999999999999998 899999999999999999999999999742210
Q ss_pred --------------------------------------------CCCccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 038422 513 --------------------------------------------DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILE 548 (634)
Q Consensus 513 --------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~e 548 (634)
.....+|..|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 001246788999999999999999999999999999
Q ss_pred HHhCCCCcc
Q 038422 549 LLTGKYPEN 557 (634)
Q Consensus 549 lltg~~P~~ 557 (634)
|+||+.||.
T Consensus 237 ll~G~~Pf~ 245 (376)
T cd05598 237 MLVGQPPFL 245 (376)
T ss_pred hhhCCCCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.92 Aligned_cols=243 Identities=25% Similarity=0.319 Sum_probs=186.9
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
..||+|+||.||+|+.. ++..|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999954 57789999887655555678999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccCCCC----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~---- 514 (634)
+++...... ...++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.......
T Consensus 94 ~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 94 ALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred HHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 999754321 0127888999999999999999998 8999999999999986 6789999999987553321
Q ss_pred CccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 AHTLMVAYKSPEYAHNGK--ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~--~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.... ++.++|||||||++|||++|+.|+.... ......|..... .. .+.+.
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~-----~~~~~~~~~~~~---~~----~~~~~- 234 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG-----EPQAAMFKVGMF---KI----HPEIP- 234 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc-----ChhhhHhhhhhh---cc----CCCCC-
Confidence 234567899999987643 7899999999999999999999985211 011111110000 00 01111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++. +++.+||+.+|++||+++|+++
T Consensus 235 -~~~~~~~~---~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 -ESLSAEAK---NFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -cccCHHHH---HHHHHHcCCCchhCCCHHHHHh
Confidence 11123444 4455999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.45 Aligned_cols=188 Identities=20% Similarity=0.303 Sum_probs=163.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+|+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 57899999986432 22345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999998642 278889999999999999999998 7999999999999999999999999998765432
Q ss_pred ---CCccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ---NAHTLMVAYKSPEYAHNG----KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~----~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 233478899999998754 37889999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=296.37 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=192.4
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++...++..+++|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 4679999999999999877888999987653 2345678999999999999999999999877 7789999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA---- 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 515 (634)
+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 89 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred HHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 99975432 2488999999999999999999997 799999999999999999999999999875543221
Q ss_pred -ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 516 -HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 516 -~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
..++..|+|||++....++.++|||||||++||++| |+.||... ....+..++ ........ .
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~----~~~~~~~~-------~ 225 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRAL----ERGYRMPR-------P 225 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH----hCCCCCCC-------c
Confidence 123456999999998889999999999999999999 89897521 111122211 11111000 0
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.....+ +.+++.+|++.+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~---~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 226 ENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ccCCHH---HHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111233 44555699999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.91 Aligned_cols=189 Identities=19% Similarity=0.340 Sum_probs=161.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+.. +++.+|+|.++... ......+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 467999999999999864 57889999987543 22345678899999999999999999999999999999999975 8
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 90 l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 90 LKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 8888765432 388999999999999999999998 89999999999999999999999999987543221
Q ss_pred -CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2345678999998865 468999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.15 Aligned_cols=252 Identities=18% Similarity=0.254 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999964 588999999875322 2245789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 436 GSLAGKLHANHTK------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 436 gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999998643211 122367888999999999999999998 799999999999999999999999999876
Q ss_pred cCCC----------------------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCC
Q 038422 510 INPD----------------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKA 567 (634)
Q Consensus 510 ~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~ 567 (634)
.... ....+|..|+|||++.+..++.++|||||||++|||+||+.||... . ..
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~----~-~~ 237 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK----K-GR 237 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc----c-hh
Confidence 5210 1124678899999999999999999999999999999999998621 0 01
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCC-CHHHHHHHHHhhh
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM-ELKEVIEKIERLK 632 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~ 632 (634)
.+.. . ....... .......... .+.+++.+|++.||++|| +++++.+.|+...
T Consensus 238 ki~~---~----~~i~~P~--~~~p~~~iP~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 238 KISY---R----DVILSPI--EVAPYREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhh---h----hhccChh--hccccccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1100 0 0000000 0000001122 344566699999999995 7788888887653
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=298.35 Aligned_cols=241 Identities=22% Similarity=0.369 Sum_probs=185.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeC------CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRK------EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~lv~e 431 (634)
.+.||+|+||.||+|... +++.+|+|.+... ......+..|+.+++++ +||||+++++++... ...++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 357999999999999864 5788999988654 34456788999999998 799999999998753 35789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 90 ~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 90 FCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999875432 2489999999999999999999998 79999999999999999999999999987653
Q ss_pred CC----CCccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 512 PD----NAHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
.. ....++..|+|||++. +..++.++|||||||++|||++|+.|+... .....+. .......
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~-------~~~~~~~--~~~~~~~ 233 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-------HPMRALF--LIPRNPA 233 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc-------CHHHHHH--HHhcCCC
Confidence 32 2234567899999986 345788999999999999999999998521 1111111 1111111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....... ...+ +.+++.+||..+|.+||+++||++
T Consensus 234 -----~~~~~~~-~~~~---~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 -----PRLKSKK-WSKK---FQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCCCCCC-cCHH---HHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111111 1233 445555999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=301.41 Aligned_cols=242 Identities=21% Similarity=0.305 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+.. +++.+++|.+........+.+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 467999999999999965 4889999998766555567888999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
..++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 97 DAIMLELDR----GLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 888765332 389999999999999999999997 7999999999999999999999999987654322 2
Q ss_pred CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...++..|+|||++. ...++.++|||||||++|||+||+.|+... .....+.... .... +.
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~--------~~~~~~~~~~-~~~~-----~~ 234 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIA-KSEP-----PT 234 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc--------cHHHHHHHHh-cCCC-----cc
Confidence 233567899999985 345688999999999999999999997521 1111111111 1111 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
......... ++.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 LSQPSKWSM---EFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCCcccCH---HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 101111112 3455566999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.96 Aligned_cols=189 Identities=21% Similarity=0.346 Sum_probs=155.0
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeC--------CceEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--------EEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lv 429 (634)
..+.||+|+||.||+|+.. +++.||+|++... .....+|+.++++++|||||++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 3578999999999999964 5889999988543 23345799999999999999999987542 135689
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCC
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRP 508 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~ 508 (634)
|||+++ +|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.+. .+||+|||+++
T Consensus 146 mE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 999985 77777654322 123489999999999999999999998 799999999999999664 69999999998
Q ss_pred ccCCCC---CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 509 LINPDN---AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...... ...++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 654332 23457789999998764 68999999999999999999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.82 Aligned_cols=240 Identities=21% Similarity=0.310 Sum_probs=196.8
Q ss_pred ccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhh
Q 038422 362 VLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 440 (634)
.||.|+||.||++..++ +-..|.|++...+....++|.-||+||..++||+||+|++.|+..+..+|+.|||.||-...
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 48999999999999655 44567788887777788999999999999999999999999999999999999999999998
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc----CCCCCc
Q 038422 441 KLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI----NPDNAH 516 (634)
Q Consensus 441 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~----~~~~~~ 516 (634)
.+.+... .|+..++..+++|++.||.|||+. .|+|||||+.|||++-+|.++++|||.+... ...+..
T Consensus 119 imlEL~r----~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 119 IMLELGR----VLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred HHHHhcc----ccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 8876543 499999999999999999999998 7999999999999999999999999997433 234567
Q ss_pred cccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 517 TLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 517 ~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
.||+.|||||+.. ..+|+.++||||||++|.||..+.+|.... +....+... ...-.|.+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--------npMRVllKi------aKSePPTLl 256 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKI------AKSEPPTLL 256 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--------chHHHHHHH------hhcCCCccc
Confidence 8999999999875 468999999999999999999999996521 111111111 111123444
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+......+.++++ .|+..||..||++.++++
T Consensus 257 qPS~Ws~~F~DfLk---~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLK---RCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHH---HHHhcCCccCCCHHHHhh
Confidence 44444556666766 999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.92 Aligned_cols=242 Identities=21% Similarity=0.303 Sum_probs=192.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 468999999999999854 68899999886432 3345678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... ..+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+.......
T Consensus 85 l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 85 LMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9998865332 2388999999999999999999998 89999999999999999999999999987654322
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.. .......... ..+..... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~--------~~~~~~~~~~-~~~~~~~~-~~----- 222 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA--------NSWKNLILKV-CQGSYKPL-PS----- 222 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC--------CCHHHHHHHH-hcCCCCCC-Cc-----
Confidence 23456779999999888899999999999999999999999862 1222222111 11111111 10
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..... +.+++.+||+.||++||+++|++.+
T Consensus 223 -~~~~~---~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 -HYSYE---LRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -ccCHH---HHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11233 4455559999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.73 Aligned_cols=244 Identities=22% Similarity=0.295 Sum_probs=189.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||.||++... +++.+|+|.+...... ..+.+.+|+.++++++|+||+.+++.+.+++..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 367999999999999854 5889999988653222 224577899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 85 GDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999998865332 2389999999999999999999997 79999999999999999999999999987654332
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... .....-........ . ....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~-----~~~~~~~~~~~~~~--~----~~~~- 225 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-----KIKREEVERLVKEV--Q----EEYS- 225 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc-----cchHHHHHhhhhhh--h----hhcC-
Confidence 23467889999999998999999999999999999999999862110 10011111111110 0 0110
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
.....++. +++..||+.||++||+ ++|+++
T Consensus 226 -~~~~~~~~---~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 -EKFSPDAR---SLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -ccCCHHHH---HHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01123344 4555999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.21 Aligned_cols=239 Identities=23% Similarity=0.370 Sum_probs=189.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 356999999999999854 57889999886432 2334578999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 89 ALDLLKPG------PLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99988532 389999999999999999999997 79999999999999999999999999987654432
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.|+..... ..... ...... .+.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~~~~----~~~~~~-----~~~~~~- 223 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-----MRVLF----LIPKNS-----PPTLEG- 223 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-----hhHHh----hhhcCC-----CCCCCc-
Confidence 12356679999999988899999999999999999999999752110 11111 111111 111111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....+.+++.+||+.+|++||+|.||++.
T Consensus 224 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 ----QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112334556669999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=297.15 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=189.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCcc------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|...+++.+|+|.++..... ..+.+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 4679999999999999888999999988643211 1246888999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999996532 388999999999999999999998 7999999999999999999999999998654211
Q ss_pred ----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 ----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 ----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... ....... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-------~~~~~~~-~~~~~~~~- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-------DRLAAMF-YIGAHRGL- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC-------ChHHHHH-HhhhccCC-
Confidence 1233567899999999888999999999999999999999998521 1111111 11000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+.+.. ...+++.+++ .+||+.+|++||++.|+++
T Consensus 227 ---~~~~~~--~~~~~~~~~i---~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPD--SFSAAAIDFV---TSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCC--CCCHHHHHHH---HHHhcCCcccCCCHHHHhc
Confidence 111111 1224444444 4999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.28 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=190.1
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||.||++.. +++.+|+|..+.. ...+.+.+|+.++++++||||+++++++... ..++||||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L 85 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence 357899999999999875 6788999988653 2456789999999999999999999998654 57999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-CCcc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-NAHT 517 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 517 (634)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++..... ....
T Consensus 86 ~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (254)
T cd05083 86 VNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158 (254)
T ss_pred HHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCC
Confidence 999975432 2489999999999999999999997 8999999999999999999999999998754332 1222
Q ss_pred ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCC
Q 038422 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYS 596 (634)
Q Consensus 518 ~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 596 (634)
.+..|+|||++.+..++.++|||||||++|||++ |+.||.. ....++.. ....+...+. ....
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~~-~~~~~~~~~~-------~~~~ 222 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK--------MSLKEVKE-CVEKGYRMEP-------PEGC 222 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc--------CCHHHHHH-HHhCCCCCCC-------CCcC
Confidence 3457999999988899999999999999999998 9999752 12222222 1111111110 0011
Q ss_pred HHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 597 KSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 597 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.++ +.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~---~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PAD---VYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHH---HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 233 4455569999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=301.52 Aligned_cols=240 Identities=22% Similarity=0.349 Sum_probs=191.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||.|+||.||+|+. .+++.|++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 35799999999999984 56899999998765555567889999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9988532 389999999999999999999998 89999999999999999999999999987654332
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||.+.+..++.++|||||||++|||+||+.||... .. .+....... ..... +....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~-------~~-~~~~~~~~~-~~~~~-----~~~~~ 239 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-------NP-LRALYLIAT-NGTPE-----LQNPE 239 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CH-HHHHHHHHh-cCCcc-----cCCcc
Confidence 224567899999999888999999999999999999999998521 11 111111111 11111 10111
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+ .+++.+||..||.+||++.+|+.
T Consensus 240 ~~~~~~---~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIF---RDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHH---HHHHHHHhhcChhhCCCHHHHhh
Confidence 112333 44555999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=284.07 Aligned_cols=242 Identities=22% Similarity=0.343 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc--------ChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV--------GREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
.+++|.|..++|.++.. .+|+.+|+|++...... -++.-.+|+.+|+++ .||+|+.+.++|..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 46799999999988874 46889999988643211 123456799999998 699999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
+|.|+.|.|.|+|...- .+++++..+|++|+..|++|||.+ .||||||||+|||+|+++.+||+|||++..
T Consensus 102 Fdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999997654 389999999999999999999998 799999999999999999999999999998
Q ss_pred cCCCC---CccccccccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 510 INPDN---AHTLMVAYKSPEYAHN------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 510 ~~~~~---~~~~~~~y~aPE~~~~------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
+.++. ..+||++|.|||.+.- ..|+...|+||.||+||-++.|.+||..- .. -.+..++.++
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQ--mlMLR~ImeG 243 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQ--MLMLRMIMEG 243 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HH--HHHHHHHHhc
Confidence 87764 3578999999998853 35788999999999999999999998511 11 1122334444
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+. +.-.+.+ .+-...+.+++.+|++.||.+|-|.+|+++
T Consensus 244 ky-qF~speW------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 244 KY-QFRSPEW------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc-ccCCcch------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 32 1111111 111223444555999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.84 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=201.3
Q ss_pred hhccccCccCceeEEEEEEcC--------CcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceE
Q 038422 358 ASAEVLGSGTFGASYKTVISN--------GQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKL 427 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 427 (634)
...+.||+|+||.|++|.... ...||||.++... ....+++..|+++|+.+ +|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 445689999999999998431 4578999988543 34567899999999998 6999999999999999999
Q ss_pred EEEEcCCCCChhhHHhhcc---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 428 LLYEFVENGSLAGKLHANH---------TKQR--PGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
+|+||+..|+|.++|+..+ .... ..++..+.+.++.|||.||+||++. .+|||||.++|||+.++
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----CccchhhhhhhEEecCC
Confidence 9999999999999998876 1111 1389999999999999999999998 69999999999999999
Q ss_pred CCeEEeccccCCccCCCCCc-------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCc
Q 038422 497 FEPLLTDYALRPLINPDNAH-------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKAS 568 (634)
Q Consensus 497 ~~~kl~DfGla~~~~~~~~~-------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~ 568 (634)
..+||+|||+++........ ..++.|||||.+....|+.|+|||||||+|||++| |..||.. -..
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-------~~~ 527 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-------IPP 527 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-------CCc
Confidence 99999999999865443222 13567999999999999999999999999999999 8888741 011
Q ss_pred HHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 569 LSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 569 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
..+. ...++++.. +..+.+..++++ ++|..||+.+|++||++.|+++.++..
T Consensus 528 ~~~l-~~~l~~G~r-------~~~P~~c~~eiY---~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEEL-LEFLKEGNR-------MEQPEHCSDEIY---DLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHH-HHHHhcCCC-------CCCCCCCCHHHH---HHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2222 234444432 222233345555 555599999999999999999999874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.13 Aligned_cols=250 Identities=21% Similarity=0.371 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEEc----CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceE
Q 038422 360 AEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKL 427 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 427 (634)
.++||+|+||.||+|... +++.+|+|.+.... ....+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 357999999999999853 36789999886532 223457889999999999999999999986542 247
Q ss_pred EEEEcCCCCChhhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 428 LLYEFVENGSLAGKLHANHTK-QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
+++||+++|+|.+++...... ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+|++|||+
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECcccc
Confidence 899999999999888643322 122488999999999999999999998 799999999999999999999999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ....+..|++||.+....++.++|||||||++|||++ |+.|+... ....+..+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~-----~~~~~~~~----~~~ 230 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-----ENSEIYNY----LIK 230 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC-----CHHHHHHH----HHc
Confidence 87654321 1223457999999988889999999999999999999 88887521 11112111 111
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
... +.... .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 231 ~~~-------~~~~~---~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 231 GNR-------LKQPP---DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CCc-------CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 110 00001 11235666777999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.82 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=195.2
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++||||+++|
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence 3467999999999999954 58889999876432 334568899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--C
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--N 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~ 514 (634)
+|.+++.... .+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++...... .
T Consensus 89 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 89 SLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 9999886532 3899999999999999999999742 6999999999999999999999999998654322 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCC---CCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYD---SKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||++.+..++.++|||||||++||++||+.||.......+ ....+.+++.....+. .+.+.
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 234 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRLP 234 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCCC
Confidence 23467789999999888899999999999999999999999873321100 0112233333322211 01110
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
. .+....+.+++.+|++.||++||+++||++..
T Consensus 235 ~----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 235 S----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred c----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 01112345566699999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.31 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=188.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 467999999999999964 58899999986422 22345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 86 GDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999965322 389999999999999999999998 79999999999999999999999999986554322
Q ss_pred ----CccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 515 ----AHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
...++..|+|||++.. ..++.++|||||||++|||++|+.||.. ....+..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~--------~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC--------CCHHHHHHHHHcCCCcccC
Confidence 1346788999999863 4578899999999999999999999852 2222222222211111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.+.. ....+++.++++=+ .|...++..||+++++++.
T Consensus 230 -~~~~---~~~~~~~~~li~~l-l~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 -PPDV---TDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCcc---CCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence 1111 11234566666522 2555566668999998764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.31 Aligned_cols=240 Identities=19% Similarity=0.331 Sum_probs=190.0
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
..||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999864 58899999987654455667899999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----CC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 515 (634)
+++... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++...... ..
T Consensus 108 ~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 108 DIVTHT------RMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 987432 388999999999999999999998 7999999999999999999999999998654322 12
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++|||||||++|||++|+.||... ... .-+.. .... +.+.......
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-------~~~-~~~~~-~~~~-----~~~~~~~~~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-------PPL-QAMRR-IRDN-----LPPRVKDSHK 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHH-HHHHH-HHhc-----CCCccccccc
Confidence 34567899999998888999999999999999999999998521 111 11111 1111 1111111111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+.+..+++ .|+..||++|||++|+++.
T Consensus 244 ~~~~~~~li~---~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLD---LMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHH---HHccCChhHCcCHHHHhhC
Confidence 2234445544 9999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.07 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEEcC--CcEEEEEEecccC----------ccChhHHHHHHHHHhc-CCCCccccceeEEEeCCce
Q 038422 360 AEVLGSGTFGASYKTVISN--GQAYVVKRYKQMN----------NVGREDFQEHIKRLGR-LEHPNLLPLTAFYYRKEEK 426 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~ 426 (634)
.+.||+|+||.||++.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..++..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 3579999999999999765 6789999875321 1122456778887765 7999999999999999999
Q ss_pred EEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 427 LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 427 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.. +++|+||||+||++++++.+||+|||+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999988643221 234899999999999999999999642 699999999999999999999999999
Q ss_pred CCccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 507 RPLINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 507 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
+....... ...++..|+|||++.+..++.++|||||||++|||++|+.||.. ........... +....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~--------~~~~~~~~~~~-~~~~~ 231 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--------TNMLSLATKIV-EAVYE 231 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc--------cCHHHHHHHHh-hccCC
Confidence 87655432 23456779999999988899999999999999999999999751 12222222211 11111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
... ... ...++ .+++.+||+.||++||++.||.+++++
T Consensus 232 ~~~-----~~~-~~~~l---~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 PLP-----EGM-YSEDV---TDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCC-----ccc-CCHHH---HHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 110 001 12334 445559999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=294.59 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.++||+|+||.||.++. .+++.+++|.+... +.....++.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 46899999999998884 45889999987643 2344567889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 85 TLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999875432 2489999999999999999999997 79999999999999999999999999987654332
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+.+.... .+..... .
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--------~~~~~~~~~~~-~~~~~~~-~----- 222 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA--------TNPLNLVVKIV-QGNYTPV-V----- 222 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHH-cCCCCCC-c-----
Confidence 23456789999999888899999999999999999999999852 12222222222 1111111 0
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....++ .+++..||+.+|.+||+++|+++.
T Consensus 223 -~~~~~~~---~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 -SVYSSEL---ISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -cccCHHH---HHHHHHHcccCcccCCCHHHHhhC
Confidence 1112334 445559999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=295.68 Aligned_cols=239 Identities=25% Similarity=0.415 Sum_probs=188.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccC---------hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVG---------REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 429 (634)
...||+|+||.||+|... +++.+++|.+....... .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 457999999999999854 57899999886543221 14688899999999999999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999996542 388999999999999999999998 799999999999999999999999999876
Q ss_pred cCCCC----------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 510 INPDN----------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 510 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
..... ...++..|+|||.+.+..++.++|||||||++|||+||+.||... ..... +... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~-~~~~-~~ 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC-------TQLQA-IFKI-GE 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc-------cHHHH-HHHH-hc
Confidence 64211 123466799999999888999999999999999999999998621 11111 1111 11
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ..+.+.. ...+++.++++ +||+.||.+||++.||++
T Consensus 227 ~-----~~~~~~~--~~~~~~~~li~---~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 N-----ASPEIPS--NISSEAIDFLE---KTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-----CCCcCCc--ccCHHHHHHHH---HHccCCchhCcCHHHHhh
Confidence 1 1111111 12244455554 999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.08 Aligned_cols=186 Identities=21% Similarity=0.327 Sum_probs=158.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||.||+++. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 46899999999999985 45889999998643 2233457889999999999999999999986543 469999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+.+ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 99975 56666532 278899999999999999999998 8999999999999999999999999998765
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 332 22346778999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.09 Aligned_cols=233 Identities=20% Similarity=0.246 Sum_probs=182.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+++.. +++.||+|++.... ....+.+..|.+++..+. |++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 467999999999999854 58899999987532 223356778888888885 5778889999999899999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999886532 389999999999999999999998 7999999999999999999999999998754322
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... .-......... ... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--------~~~~~~~~i~~-~~~------~~ 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--------DEDELFQSIME-HNV------SY 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHh-CCC------CC
Confidence 2234678899999999889999999999999999999999998621 11111222211 111 01
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
......+ +.+++.+|++.+|.+|++.
T Consensus 221 --p~~~~~~---~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 --PKSLSKE---AVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CccCCHH---HHHHHHHHcccCHhhCCCC
Confidence 0111233 4455559999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=284.53 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=193.3
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..++||+|.|+.||++. .++|+.+|+|.+... +..+-+++.+|++|.+.++|||||+|...+...+..|||+|+|.|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 45689999999999987 456899999887533 344667899999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccCCccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 512 (634)
|+|..-+..+. .+++..+-.+++||+.+|.|+|.+ +|||||+||+|+|+... .-+|++|||+|..+..
T Consensus 95 ~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 95 GELFEDIVARE-----FYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred hHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99987665542 278888999999999999999999 89999999999999543 4589999999988774
Q ss_pred CC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 DN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.. ...+|++|||||++...+|+..+|||+.||+||-++.|..||.. .+...+ ++.+..+.. ++-.+.
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-----~~~~rl----ye~I~~g~y-d~~~~~ 235 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-----EDQHRL----YEQIKAGAY-DYPSPE 235 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-----ccHHHH----HHHHhcccc-CCCCcc
Confidence 43 34578999999999999999999999999999999999999861 111122 222222211 111111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+ ....++.+.+++ +++..||++|-|+.|.++
T Consensus 236 w---~~is~~Ak~Lvr---rML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 236 W---DTVTPEAKSLIR---RMLTVNPKKRITADEALK 266 (355)
T ss_pred c---CcCCHHHHHHHH---HHhccChhhhccHHHHhC
Confidence 1 123456666666 999999999999998764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.91 Aligned_cols=186 Identities=18% Similarity=0.288 Sum_probs=158.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||.||+++.. .++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.... ..++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 467999999999999854 58899999987532 223457788999999999999999999986543 468999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+.+ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 99975 67666642 278899999999999999999998 8999999999999999999999999999865
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 443 22356788999999998899999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=294.20 Aligned_cols=187 Identities=24% Similarity=0.420 Sum_probs=161.4
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecc--cCccChhHHHHHHHHHhcCCCCccccceeEEEe-----CCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-----KEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lv~e~ 432 (634)
+.||+|+||.|..++. .+|+.||+|++.. ......+.-.+|+++|+.++|+||+.+++++.. -...|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5799999999999984 5689999999873 344556778899999999999999999999876 2368999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|+ -+|...++... .|+......++.|+++||.|+|+. +|+||||||+|+|++.+...||+|||+|+....
T Consensus 108 Me-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 108 ME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred Hh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccceeeccc
Confidence 94 58888886543 389999999999999999999998 799999999999999999999999999998853
Q ss_pred C------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 D------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
. .....|-+|+|||.+.. ..||...||||.|||+.||++|++-|.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 2 23456778999998865 579999999999999999999998764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=298.90 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=190.6
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||++... ++..+++|.++.......+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 3457999999999999964 588999999876555555689999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 89 L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 89 LDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred HHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999865432 389999999999999999999998 79999999999999999999999999876543321
Q ss_pred -CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 515 -AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
...++..|+|||.+. ...++.++|||||||++|||++|+.||... .....+... ..... +
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~--------~~~~~~~~~-~~~~~-----~ 226 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL--------NPMRVLLKI-LKSEP-----P 226 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC--------CHHHHHHHH-hcCCC-----C
Confidence 224567899999875 345678999999999999999999998621 111111111 11111 0
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.+........++ .+++..||+.+|.+||++++|++.
T Consensus 227 ~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQPSKWSSSF---NDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCCcccCCHHH---HHHHHHHhccChhhCcCHHHHhcC
Confidence 111111112334 445559999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.41 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=192.2
Q ss_pred cccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
-+||+|.||+||.|+..+ ...+|||.+...+....+-+.+||.+-++++|.|||+++|.|..++..-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999554 4578999988766666677889999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEeccccCCccCCC---
Q 038422 440 GKLHANHTKQRPGL--DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 440 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~--- 513 (634)
+.|+..... + .+..+-.+..||++||.|||++ .|||||||-+|||++ -.+.+||+|||.++.+..-
T Consensus 661 sLLrskWGP----lKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 661 SLLRSKWGP----LKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred HHHHhccCC----CccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999876542 4 6778888999999999999998 699999999999996 5789999999998776543
Q ss_pred -CCccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNG--KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~--~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
...+||..|||||++..+ .|+.++|||||||++.||.||++||-..- + .+- .+++-+.. .+-
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg----s-pqA-----AMFkVGmy--KvH--- 797 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG----S-PQA-----AMFKVGMY--KVH--- 797 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC----C-hhH-----hhhhhcce--ecC---
Confidence 345678889999999865 58899999999999999999999986321 1 000 11111110 011
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+....+--.+.-..+++|..+||.+||+++++++
T Consensus 798 --P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 --PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1122222334455666999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.73 Aligned_cols=183 Identities=19% Similarity=0.254 Sum_probs=157.0
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+..++|+||+. |+
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 4578999999999999965 4678888874322 23568999999999999999999999999999999995 68
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---C
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---N 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---~ 514 (634)
|.+++..... .+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 143 l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 143 LYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9888865432 489999999999999999999998 7999999999999999999999999998754322 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
...++..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 234678899999999999999999999999999999966654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=315.72 Aligned_cols=189 Identities=22% Similarity=0.298 Sum_probs=165.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +++.||+|+++... ......+.+|++++.+++||||+++++.+.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 367999999999999864 58899999987432 22345678899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999986543 389999999999999999999998 8999999999999999999999999998644211
Q ss_pred -------------------------------------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 514 -------------------------------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 514 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0224678899999999999999999999999999999999998
Q ss_pred c
Q 038422 557 N 557 (634)
Q Consensus 557 ~ 557 (634)
.
T Consensus 237 ~ 237 (360)
T cd05627 237 C 237 (360)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.21 Aligned_cols=240 Identities=20% Similarity=0.311 Sum_probs=190.2
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
..||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999864 68899999987655555678889999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----CC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 515 (634)
+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 107 DIVSQT------RLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 877432 389999999999999999999998 7999999999999999999999999998654332 22
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++|||||||++|||++|+.||... .. .+-+. .+..... +.......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-------~~-~~~~~-~~~~~~~-----~~~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-------SP-VQAMK-RLRDSPP-----PKLKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CH-HHHHH-HHhccCC-----CCccccCC
Confidence 34567899999999888999999999999999999999998521 11 11111 1111110 00101111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+.+.+ ++..|++.+|.+||+++|+++.
T Consensus 243 ~~~~l~~---~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRD---FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHH---HHHHHhcCCcccCcCHHHHhhC
Confidence 1233444 4459999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=297.19 Aligned_cols=248 Identities=22% Similarity=0.357 Sum_probs=191.6
Q ss_pred cccCccCceeEEEEEEc------CCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 361 EVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
+.||+|+||.||+|+.. +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence 56999999999999964 2457888887654332 3467999999999999999999999999888999999999
Q ss_pred CCCChhhHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 434 ENGSLAGKLHANHTKQ----RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 9999999997554211 12489999999999999999999998 799999999999999999999999999865
Q ss_pred cCCC-----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 510 INPD-----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 510 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.... ....++..|+|||.+.+..++.++|||||||++|||++ |..||... .-.+.+. ....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~--------~~~~~~~-~~~~~~~~ 237 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL--------SDEEVLN-RLQAGKLE 237 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--------chHHHHH-HHHcCCcC
Confidence 4322 12234567999999988888999999999999999999 77887421 1111111 11111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.... .. ..+ .+.+++.+||+.+|++||++.|+++.|++
T Consensus 238 ~~~~-----~~-~~~---~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LPVP-----EG-CPS---RLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCC-----CC-CCH---HHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1100 11 123 34455569999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.19 Aligned_cols=184 Identities=19% Similarity=0.275 Sum_probs=159.5
Q ss_pred hccccCccCceeEEEEEEc---CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS---NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||.||++... .+..|++|.+... +.+.+|++++++++|||||++++++......++||||+.
T Consensus 96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 3467999999999999753 3567888887542 345689999999999999999999999999999999996
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 170 CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 6888888432 2489999999999999999999998 79999999999999999999999999987654322
Q ss_pred -----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 2346788999999999999999999999999999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.74 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 46799999999999995 57899999998765555567788999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 104 TDVVTET------CMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 9998542 378999999999999999999998 79999999999999999999999999987654332
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||.+.+..++.++|||||||++||++||+.||.... ... ........+ .. ......
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~-------~~~-~~~~~~~~~-~~-----~~~~~~ 239 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLR-ALYLIATNG-TP-----ELQNPE 239 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------cch-heeeeccCC-CC-----CCCCcc
Confidence 2345678999999998889999999999999999999999985211 000 000000000 00 000001
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+ .+++.+||+.+|++||+++||++
T Consensus 240 ~~~~~~---~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVF---RDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHH---HHHHHHHccCChhhCcCHHHHhc
Confidence 112333 44555999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.87 Aligned_cols=239 Identities=23% Similarity=0.350 Sum_probs=190.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|... ++..+|+|.++... ....+.+.+|++++++++||||+++++++.++...++||||+++|+
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 356999999999999964 58899999886432 2334678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++... .+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 89 L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 89 ALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99988632 388999999999999999999998 79999999999999999999999999986654322
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.|+.... -..... ....... +.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--------~~~~~~-~~~~~~~-----~~---- 220 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH--------PMRVLF-LIPKNNP-----PT---- 220 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--------hHhHhh-hhhcCCC-----CC----
Confidence 2235667999999988889999999999999999999999986211 011111 1111100 11
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
........+.+++..||+.+|++||+++|+++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 -LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111223455666679999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.86 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=191.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 367999999999999964 5788999998766555667899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++...... .
T Consensus 88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 99887542 2389999999999999999999998 7999999999999999999999999998765432 2
Q ss_pred CccccccccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 AHTLMVAYKSPEYAHNG---KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~---~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||.+... .++.++|||||||++|||+||+.|+.... -.+-.... ...... ...+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~--------~~~~~~~~-~~~~~~---~~~~~ 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMRALFLI-SKSNFP---PPKLK 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-HhccCC---Ccccc
Confidence 23456679999999776 88999999999999999999999985211 01111111 111000 01111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. .......+.+++.+||+.+|.+||+++||+.
T Consensus 228 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 D---KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c---hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 1111234555666999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.40 Aligned_cols=191 Identities=23% Similarity=0.408 Sum_probs=156.4
Q ss_pred ccccCccCceeEEEEEEcC---CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN---GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 434 (634)
...||+|+||+||+|+..+ +..+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999653 4689999886532 33567899999999999999999999864 456789999987
Q ss_pred CCChhhHHhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe----CCCCCeEEecccc
Q 038422 435 NGSLAGKLHANHT----KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL----DRSFEPLLTDYAL 506 (634)
Q Consensus 435 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl 506 (634)
+ +|.+++..... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 4 78877753221 1123488999999999999999999998 79999999999999 5667899999999
Q ss_pred CCccCCC-------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 507 RPLINPD-------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 507 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 9765432 123457789999998764 57999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=296.14 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=183.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-----cChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-----VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||.||++... ++..+++|++..... ...+.+.+|++++++++||||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 467999999999999864 588999998864321 1234688899999999999999999998763 56789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999996532 388999999999999999999987 79999999999999999999999999987543
Q ss_pred CC-------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PD-------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||... ... ..+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-------~~~-~~~~~~~~~~---- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-------EAM-AAIFKIATQP---- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-------chH-HHHHHHhcCC----
Confidence 21 1123567899999999888999999999999999999999998621 111 1111111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+.+. ..+...++.++.||..+|++||+|+||++
T Consensus 226 -~~~~~~------~~~~~~~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLP------SHISEHARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCc------hhcCHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 011111 11112223333699999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.37 Aligned_cols=186 Identities=17% Similarity=0.289 Sum_probs=159.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.+.||+|+||.||+++.. .++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 467999999999999854 57889999987532 23345788999999999999999999988643 2479999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+.+ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 99975 67777642 278899999999999999999998 8999999999999999999999999999865
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 443 22356788999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=298.35 Aligned_cols=246 Identities=21% Similarity=0.349 Sum_probs=188.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||++... ++..+|+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 467999999999999975 6899999988643 22234578899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--CC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 515 (634)
|..++..... ...+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (286)
T cd06622 86 LDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT 160 (286)
T ss_pred HHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence 9988865321 224899999999999999999999742 6999999999999999999999999998765332 22
Q ss_pred ccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 516 HTLMVAYKSPEYAHNG------KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~------~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
..++..|+|||.+.+. .++.++|||||||++|||+||+.||... .......-+.... .+... .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~-~~~~~-----~ 229 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE-----TYANIFAQLSAIV-DGDPP-----T 229 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc-----chhhHHHHHHHHh-hcCCC-----C
Confidence 3456689999998654 3588999999999999999999998521 1111111111111 11111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.. ...+++ .+++.+||+.+|++||+++|+++
T Consensus 230 ~~~--~~~~~~---~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 230 LPS--GYSDDA---QDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCc--ccCHHH---HHHHHHHcccCcccCCCHHHHhc
Confidence 100 012334 44555999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.53 Aligned_cols=189 Identities=21% Similarity=0.298 Sum_probs=163.5
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 47 i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 47 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 3578999999999999965 57889999986422 2234567899999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999998642 278888999999999999999998 8999999999999999999999999998765432
Q ss_pred ----CCccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ----NAHTLMVAYKSPEYAHNG----KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ----~~~~~~~~y~aPE~~~~~----~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++... .++.++|||||||++|||++|+.||.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 233478889999998753 37899999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.67 Aligned_cols=236 Identities=22% Similarity=0.268 Sum_probs=179.3
Q ss_pred cCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcC---CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 363 LGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRL---EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
||+|+||+||+|+.. +++.||+|++...... ....+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999964 5889999998643211 223445566666655 699999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999886532 389999999999999999999998 7999999999999999999999999998754322
Q ss_pred --CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.. ....+... .+..+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~--------~~~~~~~~-~i~~~~~------~~ 216 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA--------EDTQQMYR-NIAFGKV------RF 216 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC--------CCHHHHHH-HHHcCCC------CC
Confidence 233467889999998764 479999999999999999999999851 12222211 1111111 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCC----HHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARME----LKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs----~~evl~ 626 (634)
.... ..++..++++ .|++.||.+||+ ++|+++
T Consensus 217 ~~~~-~~~~~~~li~---~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNV-LSDEGRQFVK---GLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCcc-CCHHHHHHHH---HHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 1244445555 999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=293.79 Aligned_cols=241 Identities=20% Similarity=0.338 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++. .+++.+++|.+... .....+++.+|++++++++||||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 46899999999999985 46889999998643 2334467899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ..+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 85 DLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999875432 2378999999999999999999997 79999999999999999999999999987654432
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||+..+..++.++|||||||++|||+||+.|+.. ....+.+...... .... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--------~~~~~~~~~~~~~-~~~~-----~-- 221 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--------GNMKNLVLKIIRG-SYPP-----V-- 221 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC--------CCHHHHHHHHhcC-CCCC-----C--
Confidence 22356779999999988899999999999999999999999752 2222333222211 1110 0
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
......+ +.+++.+||+.+|++||+|+||++
T Consensus 222 ~~~~~~~---~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYD---LRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHH---HHHHHHHHhhCChhhCcCHHHHhh
Confidence 0011233 445555999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.53 Aligned_cols=191 Identities=24% Similarity=0.365 Sum_probs=162.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 367999999999999964 68899999886432 2234678899999999999999999999999999999999997 6
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 89888865432 23489999999999999999999998 7999999999999999999999999998754322
Q ss_pred -CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 122346779999988654 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.20 Aligned_cols=241 Identities=21% Similarity=0.369 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEE--Eeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCc--eEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVK--RYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE--KLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK--~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~ 432 (634)
.++||+|+|-+||||... +|..||=- ++... +....+.|..|+.+|+.|+|||||++|.++.+... .-+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999964 46666522 12221 23345789999999999999999999999987665 6789999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~ 511 (634)
|..|+|..|+...+. ++.+.++++++||++||.|||++.| +|+|||||.+||+|+.+ +.+||+|.|||..+.
T Consensus 125 ~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999987654 7888999999999999999999865 49999999999999876 789999999998877
Q ss_pred CCCC--ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 512 PDNA--HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 512 ~~~~--~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.... ..||+-|||||++. ..|++..||||||..|+||+|+.+||... .+- ..++..+-.|.....+.+
T Consensus 198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~-AQIYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNP-AQIYKKVTSGIKPAALSK- 267 (632)
T ss_pred ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCH-HHHHHHHHcCCCHHHhhc-
Confidence 6543 46899999999987 78999999999999999999999998732 222 233444444433322221
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....++.++++ +|+.. .++|||+.|+++
T Consensus 268 -----V~dPevr~fIe---kCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 -----VKDPEVREFIE---KCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----cCCHHHHHHHH---HHhcC-chhccCHHHHhh
Confidence 12456777777 99999 999999999986
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=297.58 Aligned_cols=190 Identities=24% Similarity=0.389 Sum_probs=158.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcC---CCCccccceeEEEeC-----CceEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRL---EHPNLLPLTAFYYRK-----EEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~~~~l 428 (634)
.+.||+|+||+||+|+.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 367999999999999865 588999998875322 2234566777777665 799999999998652 35789
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 999997 489888865432 2389999999999999999999998 79999999999999999999999999988
Q ss_pred ccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 509 LINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 664332 2345778999999998899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.89 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.|++|.+...... ..+++.+|++++++++||||++++++|.+++..++||||+.
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 367999999999999864 5889999988644322 23468899999999999999999999999999999999997
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++........
T Consensus 99 g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 678777754322 389999999999999999999998 799999999999999999999999999987766555
Q ss_pred ccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 HTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||++. ...++.++|||||||++|||+||+.|+... .......... .... +.+..
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~--------~~~~~~~~~~-~~~~-----~~~~~ 236 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIA-QNDS-----PTLSS 236 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHh-cCCC-----CCCCc
Confidence 56777899999874 356889999999999999999999997521 1111111111 1101 01100
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
......+.+++.+||+.+|++||+|.+|+..
T Consensus 237 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 237 ----NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111234555569999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.57 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc----------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV----------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 428 (634)
.+.||+|+||.||+|.. .+++.+|+|.++..... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46799999999999985 46889999987532110 12467889999999999999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +++||||+|+||+++.++.+|++|||+++
T Consensus 86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999987542 389999999999999999999998 79999999999999999999999999987
Q ss_pred ccCCC------CCccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 509 LINPD------NAHTLMVAYKSPEYAHNGK--ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 509 ~~~~~------~~~~~~~~y~aPE~~~~~~--~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
..... ....++..|+|||++.... ++.++||||||+++||+++|+.|+... .....+. .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------~~~~~~~-~~~~-~ 227 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------EAIAAMF-KLGN-K 227 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-------chHHHHH-Hhhc-c
Confidence 65322 1223567899999987654 789999999999999999999998511 1111111 1111 1
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+++.... ....+ +.+++..||..+|++||+++||++
T Consensus 228 ~~~~~~~~~~~~--~~~~~---~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSAPPIPPDVSM--NLSPV---ALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCcCCccccc--cCCHH---HHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111221111 11233 444555999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.97 Aligned_cols=245 Identities=29% Similarity=0.412 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccCh--hHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGR--EDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+++... ++.+|+|.+........ ....+|+.++++++||||+++++++.+....++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 4689999999999999655 56899999987643322 23456999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC----
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP---- 512 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~---- 512 (634)
+|.+++.... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||.+.....
T Consensus 84 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 84 SLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp BHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc-----cccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 9999998332 389999999999999999999998 899999999999999999999999999865311
Q ss_pred CCCccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 513 DNAHTLMVAYKSPEYAH-NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 513 ~~~~~~~~~y~aPE~~~-~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
.....++..|+|||++. +..++.++||||+|+++|||++|+.|+... ............... .. .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~----~~-~~~~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKR----PL-PSSSQ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHT----HH-HHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhcccc----cc-ccccc
Confidence 12344677899999998 788999999999999999999999998622 001111111111110 00 00110
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...... ..+.+++..|++.||++||+++|+++
T Consensus 225 ~~~~~~---~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKS---EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSH---HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhH---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112 34555555999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.62 Aligned_cols=239 Identities=24% Similarity=0.382 Sum_probs=190.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||.|+||.||+|+.. +++.+++|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 357999999999999965 58899999886543 2334578899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.....
T Consensus 86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99998643 389999999999999999999998 7999999999999999999999999998766433
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.... -..... ....... +.+...
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--------~~~~~~-~~~~~~~-----~~~~~~ 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--------PMRVLF-LIPKNNP-----PSLEGN 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--------hHHHHH-HhhhcCC-----CCCccc
Confidence 22345667999999998889999999999999999999999985211 111111 1111111 111111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+ .++ +.+++..||..+|++||+++++++
T Consensus 222 ~~-~~~---~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KF-SKP---FKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc-CHH---HHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 223 444555999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.76 Aligned_cols=240 Identities=24% Similarity=0.355 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-----cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-----VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 367999999999999976 789999998865331 23357889999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999986532 388999999999999999999998 7999999999999999999999999998765433
Q ss_pred C---CccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 N---AHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ~---~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. ...++..|+|||.+.... ++.++|+|||||++|||++|+.||.... -.+............. +.+
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~-~~~- 225 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKELPP-IPD- 225 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccCCC-cCC-
Confidence 2 334567799999987766 8999999999999999999999986211 1111111111111111 111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++. +++.+||+.+|++||+++|+++
T Consensus 226 -----~~~~~~~---~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 -----HLSDEAK---DFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----CcCHHHH---HHHHHHhhcCcccCcCHHHHhc
Confidence 1123344 4555999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.97 Aligned_cols=189 Identities=23% Similarity=0.388 Sum_probs=162.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 357999999999999975 58899999886432 223456889999999999999999999999999999999999998
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
.|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 86 VLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 8877764322 389999999999999999999997 79999999999999999999999999988765433
Q ss_pred --CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 --AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 2335667999999876 457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.41 Aligned_cols=241 Identities=24% Similarity=0.342 Sum_probs=189.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC-ceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-EKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+++|++.... ....+.+.+|++++++++|+|++++++.+...+ ..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 468999999999999954 47889999986432 233457889999999999999999998876444 57899999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
++|.+++..... ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 85 ~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 85 GDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred CcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999975322 2489999999999999999999998 7999999999999999999999999998765432
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .....+..... .+.... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~--------~~~~~~~~~~~-~~~~~~-----~~ 223 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA--------KDMNSLVYRII-EGKLPP-----MP 223 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHH-hcCCCC-----Cc
Confidence 123356789999999998999999999999999999999999751 22233332222 111111 10
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....++ +.+++.+|++.+|++||++.|+++
T Consensus 224 --~~~~~~---~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 --KDYSPE---LGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --cccCHH---HHHHHHHHhccCcccCCCHHHHhc
Confidence 011233 445555999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=304.08 Aligned_cols=241 Identities=22% Similarity=0.343 Sum_probs=197.4
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCcc---ChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNV---GREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|.||.||+++... |+.+|+|.+.+.... +.+.+.+|+++|+++. |||||.++++|.+....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 4679999999999999655 999999999765443 3468999999999998 9999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC----CCeEEeccccCCcc
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS----FEPLLTDYALRPLI 510 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~~ 510 (634)
+|.|.+.+... .+++..+..++.||+.++.|||+. +|+||||||+|+|+... +.+|++|||++...
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999866 189999999999999999999997 89999999999999644 47999999999887
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
... ....+|+.|+|||++....|+..+||||.||++|.|+.|..||... ...... ..+..+.. +.-+
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-------~~~~~~--~~i~~~~~-~f~~ 259 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE-------TEFEIF--LAILRGDF-DFTS 259 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC-------ChhHHH--HHHHcCCC-CCCC
Confidence 763 3456789999999999999999999999999999999999998621 111111 12222221 1212
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+. ...+.+.++++ .++..||.+|+++.++++
T Consensus 260 ~~w~---~is~~akd~i~---~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 260 EPWD---DISESAKDFIR---KLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCcc---ccCHHHHHHHH---HhcccCcccCCCHHHHhc
Confidence 2221 12355666666 999999999999999987
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=306.39 Aligned_cols=187 Identities=22% Similarity=0.344 Sum_probs=158.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 46799999999999985 467899999986532 22345677899999999999999999988643 3468999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
|++ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 998 78898877431 389999999999999999999998 8999999999999999999999999998765
Q ss_pred CCC-CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 443 23456788999999876 568999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.32 Aligned_cols=189 Identities=20% Similarity=0.343 Sum_probs=161.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||++ ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 367999999999999864 57899999986443 2334567899999999999999999999999999999999997 58
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 90 l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 90 LKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 9988865432 388999999999999999999998 79999999999999999999999999987543221
Q ss_pred -CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||.+.+. .++.++|||||||++|||+||+.||.
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 22346789999988653 57889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.99 Aligned_cols=243 Identities=27% Similarity=0.452 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEEcC-----CcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN-----GQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+++..+ +..+|+|.++..... ..+.+..|++++++++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999999754 378999998755433 4678999999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++++|.+++...... .+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 84 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 84 EGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred CCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999998754321 189999999999999999999998 7999999999999999999999999998765443
Q ss_pred CC-----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 NA-----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ~~-----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
.. ..++..|+|||.+.+..++.++||||+|+++|||++ |+.|+.. ....+...... .......
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~-~~~~~~~-- 225 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG--------MSNEEVLEYLK-KGYRLPK-- 225 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHh-cCCCCCC--
Confidence 11 224578999999988889999999999999999999 7888752 12222222211 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
......+ +.+++.+|+..+|++|||+.|+++.|
T Consensus 226 -----~~~~~~~---~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -----PENCPPE---IYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCcCCHH---HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011233 44555699999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.64 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~~ 435 (634)
.+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+. ...++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 367999999999999974 578899998875432 2346789999999999999999999998654 368999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999998764322 123488999999999999999999998 79999999999999999999999999987543322
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++|||||||++|||+||+.|+............+..|+.. ...... .......
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~ 235 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-KDEPGNG 235 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-ccCCCCC
Confidence 2334667999999998899999999999999999999999986321110111122222211 111111 1111000
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+ .+.+++..||+.+|++|||+.||++
T Consensus 236 ~~~~~---~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 236 IKWSE---EFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchHH---HHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11123 3455666999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.10 Aligned_cols=247 Identities=20% Similarity=0.283 Sum_probs=186.8
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++... ++.+|+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 4679999999999999654 6789999986422 22334588899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 86 GDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999975322 389999999999999999999998 79999999999999999999999999986543321
Q ss_pred ----CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 515 ----AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
...++..|+|||++. ...++.++|||||||++|||++|+.||.. ....+.............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~~- 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKERFQ- 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC--------CCHHHHHHHHhCCCcccc-
Confidence 234678899999986 34688999999999999999999999861 222232222221111000
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
+.... ....+++.++++-+ .|...++..|++++|+++.
T Consensus 229 ~p~~~---~~~s~~~~~li~~l-l~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQV---TDVSEDAKDLIRRL-ICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCcc---ccCCHHHHHHHHHH-ccChhhhcCCCCHHHHhCC
Confidence 11111 11234556666521 2445555668899998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.38 Aligned_cols=241 Identities=22% Similarity=0.348 Sum_probs=190.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||++.. .+++.+++|.+.... ....+.+.+|++++++++||||+++++.+..++..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 46799999999999985 467889999886532 233567899999999999999999999999899999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~- 514 (634)
+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++++ ..+|++|||++.......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 85 TLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999976432 2389999999999999999999998 79999999999999855 468999999987654332
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||.+.+..++.++|||||||++|||++|+.|++. ......+...... ......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~----- 223 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA--------ANLPALVLKIMSG-TFAPISD----- 223 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc--------CchHHHHHHHHhc-CCCCCCC-----
Confidence 23456789999999988899999999999999999999999852 1222222222111 1111100
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+ +.+++..||+.+|++|||++|+++
T Consensus 224 --~~~~~---l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 --RYSPD---LRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CcCHH---HHHHHHHHccCChhhCCCHHHHhh
Confidence 01233 445555999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=319.24 Aligned_cols=189 Identities=21% Similarity=0.259 Sum_probs=154.5
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCC------CccccceeEEEeC-CceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEH------PNLLPLTAFYYRK-EEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~-~~~~lv~ 430 (634)
..++||+|+||+||+|+.. .++.||||+++... ....++..|++++++++| .+++++++++... ...++||
T Consensus 133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 3468999999999999864 57889999986532 223456677777777655 4588888888764 4688999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-------------
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF------------- 497 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~------------- 497 (634)
|++ +++|.+++.... .+++..+..|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 212 ~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 212 PKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred ecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCC
Confidence 988 778998886542 3899999999999999999999742 799999999999998765
Q ss_pred ---CeEEeccccCCccCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 498 ---EPLLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 498 ---~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.+||+|||.+...... ....+|..|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 283 ~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987643322 23457889999999999999999999999999999999999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.25 Aligned_cols=190 Identities=24% Similarity=0.301 Sum_probs=164.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+|+|.+.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999965 57889999986432 22334578899999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 86 GDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999975322 389999999999999999999998 89999999999999999999999999987654332
Q ss_pred ----CccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ----AHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 2346788999999875 467899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=296.39 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=189.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++. .++..+|+|.+...... ..+.+..|++++++++|||++++++++.++...++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 46799999999999995 46889999988643222 23468889999999999999999999999999999999997
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|+|.+.+.... ..++|.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++........
T Consensus 109 g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 58887775432 2389999999999999999999998 799999999999999999999999999887666556
Q ss_pred ccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 HTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||++. .+.++.++|||||||++|||++|+.|+... ............... ....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~~------~~~~ 246 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNESP------TLQS 246 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhccCC------CCCC
Confidence 66778899999974 456889999999999999999999997521 111111111111110 0000
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
....+. +.+++.+||+.+|.+||++.||++.+
T Consensus 247 -~~~~~~---l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 247 -NEWSDY---FRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -ccccHH---HHHHHHHHccCCcccCcCHHHHHhCh
Confidence 111233 44555599999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.41 Aligned_cols=244 Identities=20% Similarity=0.240 Sum_probs=188.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++... .++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 367999999999999964 478999998875432 2345788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999996542 389999999999999999999998 7999999999999999999999999998642110
Q ss_pred -----------------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHH
Q 038422 514 -----------------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM 576 (634)
Q Consensus 514 -----------------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 576 (634)
....++..|+|||++....++.++|||||||++||++||+.||.. ....++....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~--------~~~~~~~~~~ 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--------DTPEELFGQV 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHH
Confidence 012345679999999888899999999999999999999999851 1122222222
Q ss_pred HHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 577 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
.... ...+... .....++.+ ++.+||+.+|++||++.++.+.|+
T Consensus 229 ~~~~----~~~~~~~--~~~~~~~~~---li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 229 ISDD----IEWPEGD--EALPADAQD---LISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred Hhcc----cCCCCcc--ccCCHHHHH---HHHHHhccChhhccCccCHHHHHh
Confidence 2111 1111110 111234444 455999999999999766666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.46 Aligned_cols=247 Identities=19% Similarity=0.303 Sum_probs=186.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+++.. .+..+|+|.+.... ......|..|+.++++++|||||+++++|.+. ...+|||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 467999999999999964 46788888876432 23346789999999999999999999998654 46899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---CCCccccCCCCCCEEeCC----------------
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP---GSIIPHGHLKSSNVLLDR---------------- 495 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~ivHrdlk~~NILl~~---------------- 495 (634)
+|+|.++|...... ...+++..++.|+.||+.||+|||+... ..+|+||||||+|||++.
T Consensus 98 gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 99999999754321 2249999999999999999999998531 125999999999999964
Q ss_pred -CCCeEEeccccCCccCCC---CCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcH
Q 038422 496 -SFEPLLTDYALRPLINPD---NAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASL 569 (634)
Q Consensus 496 -~~~~kl~DfGla~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l 569 (634)
...+||+|||+++.+... ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||.. ....
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~-------~~~~ 249 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK-------ANNF 249 (1021)
T ss_pred CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc-------CCcH
Confidence 234899999999765433 23356788999999864 4588999999999999999999999852 1222
Q ss_pred HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 570 SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+.. +.... .+.... ...++. +++..||+.+|.+||++.|++.
T Consensus 250 ~qli~~-lk~~p-------~lpi~~-~S~eL~---dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 SQLISE-LKRGP-------DLPIKG-KSKELN---ILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHH-HhcCC-------CCCcCC-CCHHHH---HHHHHHhcCChhHCcCHHHHhc
Confidence 222222 11111 110011 123444 4555999999999999999984
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.48 Aligned_cols=189 Identities=25% Similarity=0.413 Sum_probs=161.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|... +++.+|+|++...... ..+.+.+|++++++++||||+++++++.+++..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 467999999999999975 5889999987653322 3467889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.++..... .++|.+++.++.||+.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 86 VLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred HHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 8887664321 389999999999999999999998 79999999999999999999999999987654322
Q ss_pred --CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 --AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 1235677999999875 457889999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=293.04 Aligned_cols=239 Identities=19% Similarity=0.308 Sum_probs=190.8
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
+.||+|+||.||++.. .+++.+++|+++.......+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5799999999999985 468899999887555455667889999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----CC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 515 (634)
+++... .+++.++..++.|++.||+|||+. +|+||||+|+||++++++.++++|||++...... ..
T Consensus 105 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 105 DIVTHT------RMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred HHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 998651 288999999999999999999998 7999999999999999999999999987654332 12
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||.+.+..++.++|||||||++|||++|+.||.. ........... .... +.......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~--------~~~~~~~~~~~-~~~~-----~~~~~~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN--------EPPLQAMKRIR-DNLP-----PKLKNLHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC--------CCHHHHHHHHH-hcCC-----CCCccccc
Confidence 3456789999999888899999999999999999999999752 11122222211 1111 11111111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.... +.+++.+||+.+|++||+++|+++
T Consensus 241 ~~~~---l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPR---LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHH---HHHHHHHHcccChhhCcCHHHHcc
Confidence 1233 445555999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=288.75 Aligned_cols=242 Identities=26% Similarity=0.370 Sum_probs=189.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|... +++.+++|.++..... ..+.+.+|++++++++|+||+++++++.+.+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 467999999999999864 6889999998765433 4568899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 515 (634)
+|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999987532 378999999999999999999998 799999999999999999999999999876543321
Q ss_pred -------ccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 516 -------HTLMVAYKSPEYAHNGK---ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 516 -------~~~~~~y~aPE~~~~~~---~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
..++..|+|||++.+.. ++.++||||||+++||+++|+.||.... .-...... .... .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~~~~~~~~-~~~~-~--- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFH-VGAG-H--- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------chHHHHHH-HhcC-C---
Confidence 23456899999998766 8899999999999999999999986211 11111111 1111 0
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+.+.........+. +++..||+.+|.+||+++|++.
T Consensus 224 -~~~~~~~~~~~~~~~---~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSLQLSPEGK---DFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCcccccCHHHH---HHHHHHccCCcccCCCHHHHhc
Confidence 111111111123344 4555999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=306.28 Aligned_cols=190 Identities=25% Similarity=0.361 Sum_probs=162.6
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CC-----ccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HP-----NLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~lv~e 431 (634)
..++||+|+||.|-+|.. .+++.||||+++.... --.+-..|+.+|..|+ |. |+|+++++|..+++.|||+|
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 457899999999999994 5699999999986532 2345567899999997 43 89999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC--CCeEEeccccCCc
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS--FEPLLTDYALRPL 509 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGla~~ 509 (634)
.+.. +|.++|..+... +++...+..|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.|..
T Consensus 269 LL~~-NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 269 LLST-NLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred hhhh-hHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9965 999999887654 499999999999999999999998 89999999999999654 3699999999987
Q ss_pred cCCCC-CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 510 INPDN-AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 510 ~~~~~-~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..... .+..+..|+|||++.+.+|+.+.||||||||+.||+||.+-|.
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 65443 2334567999999999999999999999999999999976553
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=290.49 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 467999999999999954 57889999886433 2245688999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC--
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 515 (634)
|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++........
T Consensus 86 l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 86 LLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred HHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999764331 2489999999999999999999998 799999999999999999999999999865544322
Q ss_pred ------ccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 516 ------HTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 516 ------~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
..++..|+|||++... .++.++|||||||++|||+||+.||.... ....+.+. .... .+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~----~~~~~~~~----~~~~------~~ 225 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP----PMKVLMLT----LQND------PP 225 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC----hhhhHHHH----hcCC------CC
Confidence 2356779999998876 78999999999999999999999986211 11111111 1110 01
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+........-...+.+++..|++.||++||+++||++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11100000011123445555999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.46 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=182.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-----cChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-----VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||.||+++.. ++..|++|.+..... ...+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 468999999999999964 588999998753221 1234688899999999999999999988764 45789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999986432 278889999999999999999998 79999999999999999999999999987543
Q ss_pred C-------CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 P-------DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~-------~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||... ..... +........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-------~~~~~-~~~~~~~~~--- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-------EAMAA-IFKIATQPT--- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-------chHHH-HHHHhcCCC---
Confidence 2 11234567899999998888999999999999999999999998521 11111 111111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+.. .......+.++..+|+ .+|++||+++||++
T Consensus 227 --~~~~-----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 227 --NPVL-----PPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred --CCCC-----chhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 1111 1111123334444787 49999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=290.74 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|.. .++..+|+|...... ....+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 45799999999999985 467899999876432 2234578899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 89 l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 89 ALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 99988532 389999999999999999999998 79999999999999999999999999987654322
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.|+... .-..+... ...... +.+..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~-----~~~~~- 223 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL--------HPMKVLFL-IPKNNP-----PTLEG- 223 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc--------chHHHHHH-HhcCCC-----CCCCc-
Confidence 223566799999998888999999999999999999999998521 11111111 111111 11111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....+ +.+++.+||+.+|.+||+++|+++.
T Consensus 224 -~~~~~---~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 -NYSKP---LKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -ccCHH---HHHHHHHHccCChhhCcCHHHHHhC
Confidence 11233 4445559999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=288.57 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=189.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|+||.||++.. .+++.+++|.+.... ....+.+..|++++++++||||+++++++... ...+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 35799999999999985 467889999886432 23345788899999999999999999988643 45789999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH-----NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
+++|.+++..... ....+++..++.++.|++.||+||| +. +++|+||||+||++++++.+|++|||++..
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999976432 2235999999999999999999999 55 799999999999999999999999999887
Q ss_pred cCCCC----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 510 INPDN----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 510 ~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
..... ...++..|+|||++.+..++.++||||||+++|+|++|+.||... ....+. .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~-~~~~~~~~~-- 228 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR--------NQLQLA-SKIKEGKFR-- 228 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc--------CHHHHH-HHHhcCCCC--
Confidence 65433 234567899999999888999999999999999999999998621 111111 111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+ .......+.+++.+|++.+|++||+++||++
T Consensus 229 ---~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 ---RI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11 0111234555666999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.78 Aligned_cols=189 Identities=22% Similarity=0.348 Sum_probs=160.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +|+.+++|+++... ......+.+|++++++++||||+++++++.+....++|+||+. +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 367999999999999964 68899999986432 2233567889999999999999999999999999999999997 5
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... .+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 84 DLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 88888764322 389999999999999999999998 79999999999999999999999999987654321
Q ss_pred --CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 --AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+. .++.++|||||||++|||+||+.|+.
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 22346789999998764 47899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.61 Aligned_cols=189 Identities=25% Similarity=0.378 Sum_probs=162.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|... +++.|++|.++.. .....+.+.+|++++++++|+||+++++++..++..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 467999999999999965 5789999988653 2334568899999999999999999999999999999999999987
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
.+..+.... ..+++.++..++.||+.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 86 LLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 666554322 2389999999999999999999998 79999999999999999999999999987655433
Q ss_pred ---CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ---AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22345679999999887 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.09 Aligned_cols=241 Identities=22% Similarity=0.344 Sum_probs=190.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++||||++++++|...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 46799999999999985 46789999998755555567889999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 104 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 9998642 278999999999999999999998 79999999999999999999999999876554332
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++....++.++|||||||++||+++|+.||..... .+.+......+ . +.+..
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~-----~~~~~-- 237 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-T-----PELQN-- 237 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------hhheeehhcCC-C-----CCCCC--
Confidence 22456679999999888899999999999999999999999862110 00000000000 0 00000
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.......+.+++..||+.+|.+||+++|++..
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 -PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111234455569999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=290.12 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||++... +++.+++|.+.... ....+++.+|++++++++||||+++++++..+...++|+||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 357999999999999975 58899999887543 2344678999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--C
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN-ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--N 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~ 514 (634)
|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+...... .
T Consensus 86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999987543 248999999999999999999999 6 7999999999999999999999999998654322 1
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++||||||+++|||++|+.|+..... ......+.+....... . +.+....
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~-~-----~~~~~~~ 228 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEP-P-----PRLPSGK 228 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCC-C-----CCCChhh
Confidence 24456789999999988999999999999999999999999863211 1122233332222111 0 0110000
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
...+ +.+++..||..+|++||++.|+++.
T Consensus 229 -~~~~---~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 -FSPD---FQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -cCHH---HHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1233 4455559999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.75 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=187.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc-----ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV-----GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|... +++.|++|.++..... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 357999999999999964 5889999998754322 2345678999999999999999999999989999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
+|+|.+++.... ..+++..+..++.||++||+|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999999986543 2489999999999999999999998 7999999999999999999999999998765443
Q ss_pred C----CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh---------
Q 038422 514 N----AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE--------- 579 (634)
Q Consensus 514 ~----~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~--------- 579 (634)
. ....+..|+|||.+.+ ..++.++|||||||++|||++|..||... .....+.... .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD----SDIDQLGKIF-EALGTPTEENWPGV 230 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC----ccHHHHHHHH-HHcCCCchhhhhhc
Confidence 2 1234567999998865 45789999999999999999997776421 1101111110 00000
Q ss_pred ccCCcccccccccCCCC-----HHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYS-----KSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
........... ..... ...-..+.+++.+||+.+|++||+++||++.
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccc-cCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 00000 0112345566669999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.15 Aligned_cols=245 Identities=21% Similarity=0.352 Sum_probs=184.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEe-----CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYR-----KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~lv~e~ 432 (634)
.+.||+|+||.||+++.. +++.+++|.++... .....+..|+.+++++ +||||+++++++.. ++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 357999999999999864 57889999876432 2345788899999999 69999999999853 3468999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+|++|||+++....
T Consensus 102 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 102 CNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred cCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 9999999988643221 23488999999999999999999998 799999999999999999999999999876543
Q ss_pred C----CCccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 513 D----NAHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 513 ~----~~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
. ....++..|+|||++.. ..++.++|||||||++|||+||+.|+... .....+. . .......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~-------~~~~~~~-~-~~~~~~~ 247 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-------HPMRALF-K-IPRNPPP 247 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC-------chhHHHh-h-ccccCCC
Confidence 2 22346778999998853 45788999999999999999999998521 1111111 0 0000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
...++ ..... .+.+++.+||+.+|++||+++||++.
T Consensus 248 ~~~~~-----~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 248 TLHQP-----ELWSN---EFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCC-----CCcCH---HHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111 11112 34556669999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=283.70 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=196.4
Q ss_pred ccccCccCceeEEEEEEcC------CcEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeC-CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISN------GQAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e 431 (634)
..++-+|.||.||+|.+.+ .+.|.+|.++.. +......+..|.-.+..+.|||+..+.+++.+. +..+++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 4568899999999997643 345667766543 344456788899999999999999999999764 56789999
Q ss_pred cCCCCChhhHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 432 FVENGSLAGKLHANH---TKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
++..|+|..||...+ ......++-.+...++.|++.||+|||++ +|||.||.++|++||+..++|++|-.+++
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----CcccchhhhhcceehhheeEEeccchhcc
Confidence 999999999998332 22234588889999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCCc------cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 509 LINPDNAH------TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 509 ~~~~~~~~------~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
.+.+.+.+ ..++.||+||.+....|+..+|||||||+||||+| |+.|+.... ..-+...+.++.
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID---------PfEm~~ylkdGy 515 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID---------PFEMEHYLKDGY 515 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC---------HHHHHHHHhccc
Confidence 77665433 34678999999999999999999999999999999 999975221 112333344432
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
++..+...++|+ ..++.-||...|++||+++|++.-|.+..
T Consensus 516 -------RlaQP~NCPDeL---f~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 516 -------RLAQPFNCPDEL---FTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -------eecCCCCCcHHH---HHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 122222234444 45555999999999999999999888753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.79 Aligned_cols=189 Identities=22% Similarity=0.341 Sum_probs=163.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+.. +++.+++|++.... ....+.+.+|+.++++++||||+++++++..+...++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 467999999999999964 68899999987543 233468999999999999999999999999999999999999 99
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++.... ..+++.++..++.||+.||+|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9999987543 2489999999999999999999998 79999999999999999999999999987664432
Q ss_pred ---CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ---AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+. .++.++||||+||++|||+||+.|+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 23456789999998754 46899999999999999999977764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=289.50 Aligned_cols=243 Identities=21% Similarity=0.365 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||++.. .+++.+|+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 36799999999999984 56889999988643211 235788999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~ 511 (634)
+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||.+....
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999986532 388999999999999999999998 799999999999998775 59999999987654
Q ss_pred CCC--------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 512 PDN--------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 512 ~~~--------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
... ...++..|+|||.+.+..++.++||||+||++|||++|+.||... .................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~-- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE-----KHSNHLALIFKIASATT-- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC-----CCcchHHHHHHHhccCC--
Confidence 321 123567899999998888999999999999999999999998521 11111111111111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+.+ ....-.++.+++..|+..+|++||++.|+++
T Consensus 229 ---~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---APSI-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCC-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111 1111133455666999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.46 Aligned_cols=241 Identities=20% Similarity=0.323 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999965 57889999886532 234567889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPDN- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~- 514 (634)
+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++++. .+|++|||.+.......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 85 DLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999875432 2489999999999999999999998 799999999999999875 56999999987654432
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.|+.. ....+++...... ..... .+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~-~~~~~-~~--- 224 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG--------NNLHQLVLKICQG-YFAPI-SP--- 224 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHhcc-cCCCC-CC---
Confidence 12356779999999888899999999999999999999999751 2233343332211 11111 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+ +.+++.+|++.+|++||+++||++
T Consensus 225 ---~~~~~---~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 ---NFSRD---LRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCHH---HHHHHHHHhccChhhCcCHHHHhh
Confidence 11233 444555999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=292.00 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=185.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCC-----ceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKE-----EKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-----~~~lv~e~ 432 (634)
.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++...+ ..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 35799999999999996 468899999886532 2346778899999998 8999999999987543 57999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 106 ~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 106 CNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred CCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 9999999988643221 23489999999999999999999998 799999999999999999999999999876543
Q ss_pred C----CCccccccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 513 D----NAHTLMVAYKSPEYAHNG-----KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 513 ~----~~~~~~~~y~aPE~~~~~-----~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
. ....++..|+|||++... .++.++|||||||++|||+||+.|+.... ....+.+ .......
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~----~~~~~~~-----~~~~~~~ 251 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH----PVKTLFK-----IPRNPPP 251 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc----HHHHHHH-----HhcCCCC
Confidence 2 223456779999998643 36889999999999999999999985211 0011111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...++ .+....+.+++.+||+.+|++||++.|+++
T Consensus 252 ~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 252 TLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 111224556666999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.40 Aligned_cols=189 Identities=22% Similarity=0.286 Sum_probs=158.1
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455566666666655 6899999998754 233446899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----- 513 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----- 513 (634)
.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+......
T Consensus 87 ~~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 87 EDLLKTHFPE---GLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999765332 388999999999999999999998 7999999999999999999999999987544221
Q ss_pred ------CCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ------NAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ------~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 11234567999999875 358899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=295.02 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++...+ ++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+....++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 3579999999999999654 899999998754322 345788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 86 GELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999864322 2489999999999999999999998 79999999999999999999999999876542211
Q ss_pred --------------------------------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCccccccc
Q 038422 515 --------------------------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562 (634)
Q Consensus 515 --------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~ 562 (634)
...++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--- 235 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS--- 235 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC---
Confidence 113456799999999888999999999999999999999998521
Q ss_pred CCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCC----HHHHHH
Q 038422 563 YDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME----LKEVIE 626 (634)
Q Consensus 563 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs----~~evl~ 626 (634)
. ....+ ....... . .........+++.++++ +|++.+|++||+ ++|+++
T Consensus 236 -~---~~~~~-~~~~~~~-~------~~~~~~~~~~~~~~li~---~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 -N---RDETF-SNILKKE-V------TFPGSPPVSSSARDLIR---KLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -c---hHHHH-HHHhcCC-c------cCCCccccCHHHHHHHH---HHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 1111110 0 01000011344445544 999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=290.11 Aligned_cols=240 Identities=22% Similarity=0.346 Sum_probs=191.1
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
+.||+|+||.||++... +++.+++|+++.... ..+.+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 57999999999999976 588999999876543 5677899999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----CC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 515 (634)
+++.... ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++...... ..
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 9997653 2499999999999999999999997 8999999999999999999999999987654432 12
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++|||||||++|||+||+.|+... .-........ ........+ ...
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~--------~~~~~~~~~~-~~~~~~~~~-----~~~ 241 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--------PPLRALFLIT-TKGIPPLKN-----PEK 241 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-hcCCCCCcc-----hhh
Confidence 23456799999998888999999999999999999999997511 1111111111 111111101 110
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...++. +++.+|++.+|.+||++.+|++
T Consensus 242 ~~~~l~---~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFK---DFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHH---HHHHHHhccChhhCcCHHHHhh
Confidence 123444 4555999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=292.24 Aligned_cols=189 Identities=22% Similarity=0.356 Sum_probs=160.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||+. ++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence 367999999999999965 678999999865432 223457789999999999999999999999999999999998 49
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 89 LKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9998865432 389999999999999999999998 7999999999999999999999999998654221
Q ss_pred CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11234677999999875 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=291.21 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=184.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHH-HhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKR-LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +|+.||+|+++.... ....++..|+.+ ++..+||||+++++++..++..++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 367999999999999965 589999999875422 223455566665 667799999999999999999999999996 6
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 515 (634)
+|.+++...... ...+++..+..++.||+.||+|||+++ +++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 898888654322 245899999999999999999999863 699999999999999999999999999876543221
Q ss_pred --ccccccccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 516 --HTLMVAYKSPEYAHN----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ..... ....... .. +.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~-~~~~~~~-~~-----~~ 227 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK------TPFQQ-LKQVVEE-PS-----PQ 227 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc------cCHHH-HHHHHhc-CC-----CC
Confidence 235677999998865 456889999999999999999999985211 11111 1111111 11 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+....+ .+++ .+++..||+.+|++||+++||++
T Consensus 228 ~~~~~~-~~~l---~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPAEKF-SPEF---QDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcccc-CHHH---HHHHHHHccCChhhCcCHHHHhc
Confidence 111111 2334 44555999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=290.45 Aligned_cols=190 Identities=24% Similarity=0.382 Sum_probs=161.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+.. +++.+++|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 357999999999999864 58899999886432 2233578899999999999999999999999999999999996 6
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|++|||+++......
T Consensus 84 ~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 84 DLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred CHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 89888865432 2489999999999999999999998 79999999999999999999999999987654321
Q ss_pred --CccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 --AHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+.. ++.++|||||||++|||+||+.||.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 123456799999887644 5889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.87 Aligned_cols=239 Identities=18% Similarity=0.296 Sum_probs=189.0
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+||+|+||.||++.. .+++.+|+|++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 468899999886544445567899999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----CC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 515 (634)
+++... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++...... ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 887432 378999999999999999999998 7999999999999999999999999987654332 12
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+.+.. .... . .+.+.....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~--------~~~~~~~~~-~~~~-~----~~~~~~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKM-IRDN-L----PPKLKNLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHH-HHhh-C----CcccCCccc
Confidence 3456789999999888899999999999999999999999752 111111111 1111 0 111111011
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+.+ ++.+||+.+|.+||++.||++
T Consensus 242 ~~~~l~~---li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKG---FLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHH---HHHHHHhCCcccCcCHHHHhc
Confidence 1233444 445999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=285.70 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=183.9
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccC---hhHHHHHHHH-HhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVG---REDFQEHIKR-LGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||.||+|... +++.||+|.+....... ...+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 58899999986543211 1234445444 4556899999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence 99999986542 388999999999999999999998 799999999999999999999999999876555444
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||.+.+..++.++||||||+++|||+||..||... ......... ...... ...... ..
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~-~~~~~~--~~~~~~--~~ 219 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE--------TPDAVFDNI-LSRRIN--WPEEVK--EF 219 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH-HhcccC--CCCccc--cc
Confidence 55677899999998888999999999999999999999998521 111211111 111110 011110 01
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
...++ .+++.+||+.+|++||++.++.+.|
T Consensus 220 ~~~~~---~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 220 CSPEA---VDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCHHH---HHHHHHHccCCHHHccCCCcHHHHH
Confidence 12344 4455599999999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.39 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=194.0
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+++... ++.+++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 3679999999999999764 89999999876543 345789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN-ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 515 (634)
|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++........
T Consensus 86 L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 86 LADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999754 238999999999999999999999 7 799999999999999999999999999876654332
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||.+.+..++.++||||||+++|||+||+.|+....+ ....+...... .... +.+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~-~~~~-----~~~~~ 225 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAIC-DGPP-----PSLPA 225 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHh-cCCC-----CCCCc
Confidence 2356779999999988899999999999999999999999863211 12222221111 1111 11111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....+. +.+++..|++.+|++||++.|+++.
T Consensus 226 -~~~~~~---l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 -EEFSPE---FRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -ccCCHH---HHHHHHHHccCChhhCCCHHHHHhC
Confidence 001233 4445559999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.79 Aligned_cols=189 Identities=24% Similarity=0.353 Sum_probs=159.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|.. .+++.+++|.+..... .....+.+|++++++++|+||+++++++.+++..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 36799999999999985 4688999999865432 223467899999999999999999999999999999999996 68
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
+.+++.... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 877765432 2378889999999999999999998 7999999999999999999999999998754322
Q ss_pred CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 222346789999998754 57889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=289.90 Aligned_cols=240 Identities=20% Similarity=0.286 Sum_probs=180.0
Q ss_pred ccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHH---HhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 362 VLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKR---LGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 588999998865322 112234444433 334579999999999999899999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999886532 389999999999999999999998 7999999999999999999999999998654332
Q ss_pred -CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..... ... ..+...... ....+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~-~~~~~~~~~------~~~~~~ 219 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDK-HEIDRMTLT------VNVELP 219 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC-----cCH-HHHHHHhhc------CCcCCc
Confidence 22346788999999864 5689999999999999999999999863211 111 111111110 011111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~~ 627 (634)
. ....++.++++ .|+..||++|| +++|+++.
T Consensus 220 ~--~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 D--SFSPELKSLLE---GLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c--ccCHHHHHHHH---HHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 11244455554 99999999999 59988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.02 Aligned_cols=238 Identities=22% Similarity=0.334 Sum_probs=194.5
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.||+|.|++|-.++ ..+|..||||++.+. +......+.+|++.|+-++|||||+||.+......+|||+|.=.+|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 569999999999998 568999999999764 34455678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccCCCC--
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~-- 514 (634)
|+||+..... .+.+....+++.||..|+.|+|+. .+|||||||+||.+-+ -+-+|++|||++-.+.+..
T Consensus 104 l~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 104 LFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred HHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 9999986654 399999999999999999999998 6999999999997754 5789999999998776654
Q ss_pred -CccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKIS-KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~-~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..+++..|.|||.+.+..|+ ++.||||+|||||-|+.|+.||+... ++ . .+..++|=...-
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN---DS-E-------------TLTmImDCKYtv 238 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN---DS-E-------------TLTMIMDCKYTV 238 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc---ch-h-------------hhhhhhcccccC
Confidence 45677889999999999886 67899999999999999999997321 11 1 122233323222
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.....+..+++ ..++..||++|.+.+||+.
T Consensus 239 PshvS~eCrdLI---~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 PSHVSKECRDLI---QSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred chhhhHHHHHHH---HHHHhcCchhhccHHHHhc
Confidence 222234444444 4999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=276.35 Aligned_cols=263 Identities=22% Similarity=0.371 Sum_probs=203.8
Q ss_pred CCCCHHHHHHhhccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCc
Q 038422 348 EPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEE 425 (634)
Q Consensus 348 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 425 (634)
..-+++|+.+-+.++||+|+|+.|-.++ +.+|..+|||++.+.....+....+|++++.+++ |+||++|+.||.++..
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3446889999999999999999999988 7889999999999888888999999999999984 9999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC---eEEe
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE---PLLT 502 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~ 502 (634)
.|||||-|.||+|..+++... .+++.++.++..+||.||.|||.+ +|.||||||+|||-.+... +||+
T Consensus 151 FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred EEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeee
Confidence 999999999999999998654 399999999999999999999998 8999999999999976544 7999
Q ss_pred ccccCCccCCCC-----------CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCccccccc---C
Q 038422 503 DYALRPLINPDN-----------AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQG---Y 563 (634)
Q Consensus 503 DfGla~~~~~~~-----------~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~---~ 563 (634)
||-+..-+...+ ...++..|||||+.. ...|+.++|.||+|||+|-|+.|..||...-.. +
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 998865433221 112344599999864 346899999999999999999999998632111 1
Q ss_pred CCCC-c--HHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 564 DSKA-S--LSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 564 ~~~~-~--l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+. . -.+-+...++++.. +.-|+.+ ....++.++++. .-+..|+..|-++.+|++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkY-eFPdkdW---ahIS~eakdlis---nLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKY-EFPDKDW---AHISSEAKDLIS---NLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCC-cCChhhh---HHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence 1111 0 11112233344322 2223332 122345556655 556699999999988876
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=288.72 Aligned_cols=240 Identities=22% Similarity=0.362 Sum_probs=188.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc-CccChhHHHHHHHHHhcCC---CCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM-NNVGREDFQEHIKRLGRLE---HPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|.. .+++.+++|.++.. .....+++.+|++++++++ |||++++++++..+...++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 36799999999999995 56889999988653 2334567889999999986 9999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+++|.+++... .+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++++|||++.......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999988542 389999999999999999999998 79999999999999999999999999987654432
Q ss_pred ----CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 ----AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...++..|+|||++.++ .++.++|||||||++|||++|+.||... ....++... .. ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~--------~~~~~~~~~-~~-----~~~~~ 221 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV--------DAFRAMMLI-PK-----SKPPR 221 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC--------Chhhhhhcc-cc-----CCCCC
Confidence 22356679999998754 4689999999999999999999998621 111111110 00 01111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
+.... ....+.+++.+||+.||++||++.|+++.
T Consensus 222 ~~~~~----~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDNG----YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCccc----CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 21111 12245556669999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.98 Aligned_cols=241 Identities=23% Similarity=0.357 Sum_probs=187.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.+++|.+..... ...+++.+|+++++.++|+|++++++++......++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 467999999999999964 578899998864322 223467889999999999999999999999999999999996
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|++.+++.... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.+|++|||++........
T Consensus 99 ~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 99 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 68888775432 2389999999999999999999998 799999999999999999999999999887766555
Q ss_pred ccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 HTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||++. ...++.++|||||||++|||+||+.|+... .-........ ..... ....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~-~~~~~-----~~~~ 236 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIA-QNESP-----ALQS 236 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc--------cHHHHHHHHh-hcCCC-----CcCc
Confidence 66778899999975 356788999999999999999999997521 1111111111 11111 1111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. ...++ .+++.+||+.+|++||++++|++.
T Consensus 237 ~~-~~~~~---~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 237 GH-WSEYF---RNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cc-ccHHH---HHHHHHHhhCCcccCCCHHHHhhC
Confidence 11 12334 445559999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=286.89 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=187.9
Q ss_pred cCccCceeEEEEEEcC-CcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVISN-GQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999875433 3446788999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++.... .+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99987543 389999999999999999999998 79999999999999999999999999986543321
Q ss_pred --------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 515 --------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 515 --------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
...++..|+|||.......+.++||||||+++||++||+.||.. ....+...... .+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~--------~~~~~~~~~~~-~~~~~--- 219 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG--------ETPEEIFQNIL-NGKIE--- 219 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHh-cCCcC---
Confidence 12345679999999888899999999999999999999999862 11122221111 11110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
.........++ .+++..|++.+|++||++.+|.+.|+
T Consensus 220 ---~~~~~~~~~~~---~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 ---WPEDVEVSDEA---IDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCccccCCHHH---HHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000012344 44555999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.68 Aligned_cols=189 Identities=22% Similarity=0.293 Sum_probs=157.6
Q ss_pred ccCcc--CceeEEEEEE-cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 362 VLGSG--TFGASYKTVI-SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 362 ~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.||+| +||+||+++. .+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|..++..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999996 4689999999875322 22367889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+........
T Consensus 85 ~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 85 SANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998765332 389999999999999999999987 7999999999999999999999999754222110
Q ss_pred --------CCccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 --------NAHTLMVAYKSPEYAHNG--KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 --------~~~~~~~~y~aPE~~~~~--~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 011234569999999763 47899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=295.45 Aligned_cols=193 Identities=23% Similarity=0.403 Sum_probs=162.4
Q ss_pred ccccCccCceeEEEEEEc---CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS---NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 457999999999999965 47899999987633 33346778899999999999999999999988 78999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC----CCCeEEeccccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR----SFEPLLTDYALR 507 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGla 507 (634)
|+++ ++.+++..........+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9975 777777544333333589999999999999999999998 7999999999999999 899999999998
Q ss_pred CccCCCC-------CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 508 PLINPDN-------AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 508 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+...... ...++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 7653321 22346779999988764 57899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.24 Aligned_cols=189 Identities=23% Similarity=0.326 Sum_probs=160.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|... +++.+++|.++..... ....+.+|+.++++++||||+++++++... ...++||||+.
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 367999999999999975 5889999998754322 234577899999999999999999999877 78999999997
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
++|.+++..... .+++.++..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 599988865432 489999999999999999999998 79999999999999999999999999987654431
Q ss_pred ----CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ----AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 22346679999998764 46899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.03 Aligned_cols=239 Identities=25% Similarity=0.289 Sum_probs=188.3
Q ss_pred cCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 488999999865432 2346789999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---A 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 515 (634)
.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+|++|||+++...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99997542 288999999999999999999997 79999999999999999999999999988765432 2
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ....+............ .. +..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~-----~~--~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD------EDPMEIYNDILKGNGKL-----EF--PNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC------CCHHHHHHHHhccCCCC-----CC--Ccc
Confidence 335677999999988889999999999999999999999986221 11222222222111000 00 111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
..+++.. ++..||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~---~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKD---LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHH---HHHHHccCChhhCcCCcccCHHHHhc
Confidence 1234444 455999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=280.91 Aligned_cols=242 Identities=25% Similarity=0.388 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||++... +++.+++|++........+.+.+|++++++++|+||+++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 367999999999999975 6889999998765554567899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---A 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 515 (634)
.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+....... .
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 99987542 2489999999999999999999997 79999999999999999999999999987765542 3
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|+|||++.+..++.++||||||+++|||++|+.|+... ........... ...... .....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~-~~~~~~-----~~~~~ 222 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL--------PPMKALFKIAT-NGPPGL-----RNPEK 222 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------chHHHHHHHHh-cCCCCc-----Ccccc
Confidence 34567799999998888999999999999999999999998621 11121111111 111111 11111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...++. +++..||+.||++|||+.|+++
T Consensus 223 ~~~~~~---~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFK---DFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHH---HHHHHHccCChhhCCCHHHHhc
Confidence 123444 4455999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.81 Aligned_cols=234 Identities=25% Similarity=0.312 Sum_probs=180.3
Q ss_pred cCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhc-CCCCccccceeEEEeCCceEEEEEcCCCCChhh
Q 038422 363 LGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGR-LEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440 (634)
Q Consensus 363 lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 440 (634)
||+|+||.||+++. .++..+++|.......... |+..... .+||||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 69999999999985 4578889988765321111 2222221 279999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCCCCCcccc
Q 038422 441 KLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPDNAHTLM 519 (634)
Q Consensus 441 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~ 519 (634)
++.... .+++.++..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++.........++
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 997543 389999999999999999999998 799999999999999998 9999999998877665556678
Q ss_pred ccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHH
Q 038422 520 VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSE 599 (634)
Q Consensus 520 ~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 599 (634)
..|+|||++.+..++.++|||||||++|||+||+.||.... ........|.... .. .... . ......
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~--~~-~~~~----~---~~~~~~ 236 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQ--QK-KLPF----I---KNVSKN 236 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhh--cc-cCCc----c---cccCHH
Confidence 89999999998899999999999999999999999986221 1111223332221 10 0000 0 112234
Q ss_pred HHHHHHHHhcccccCccCCCC-HHHHHH
Q 038422 600 MINLLKIGLSCCEEDVLARME-LKEVIE 626 (634)
Q Consensus 600 ~~~~~~l~~~C~~~~P~~RPs-~~evl~ 626 (634)
+.+++. .|++.+|.+||+ ++|+++
T Consensus 237 ~~~li~---~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 237 ANDFVQ---SMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHH---HHhccChhhCCchHHHHhc
Confidence 445554 999999999995 688874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=287.09 Aligned_cols=190 Identities=24% Similarity=0.394 Sum_probs=161.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|++|.||+|... +|..|++|++.... ....+.+.+|++++++++|||++++++++.+++..++||||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 367999999999999864 68999999886443 2233578899999999999999999999999999999999995 6
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++......
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 89998865432 2489999999999999999999998 79999999999999999999999999987653221
Q ss_pred --CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 --AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 12346779999988664 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=290.77 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=184.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 357999999999999954 57899999887532 233457889999999996 99999999999999999999999864
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
++.++...........+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 6555433211111234899999999999999999999753 6999999999999999999999999998754432
Q ss_pred CCccccccccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 NAHTLMVAYKSPEYAHNG---KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~---~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++.+. .++.++|||||||++|||+||+.||... ....+-+...... . .+.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~-~-----~~~~ 231 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW-------NSVFDQLTQVVKG-D-----PPIL 231 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc-------chHHHHHhhhcCC-C-----CCcC
Confidence 223456789999999876 6899999999999999999999998621 1111111111110 0 0111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
... ........+.+++.+||+.+|++||+++||++.
T Consensus 232 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 000111234555559999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=287.01 Aligned_cols=240 Identities=22% Similarity=0.288 Sum_probs=190.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++++.++...++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 468999999999999965 588999999875432 2356889999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
++|.+++... ..+++.++..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 85 GDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 9999998654 2389999999999999999999998 7999999999999999999999999998765443
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....++....... ....+.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~--~~~~~~~---- 223 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS------RTIRDQIRAKQET--ADVLYPA---- 223 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC------ccHHHHHHHHhcc--ccccCcc----
Confidence 22345667999999988889999999999999999999999986221 1122222222111 0011111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCH--HHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMEL--KEVI 625 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~--~evl 625 (634)
....++. +++.+||+.||.+||++ +|++
T Consensus 224 --~~~~~~~---~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 --TWSTEAI---DAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cCcHHHH---HHHHHHccCChhHcCCccHHHHh
Confidence 1123444 44559999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=289.11 Aligned_cols=240 Identities=23% Similarity=0.357 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+++.+++|++...... ..+.+.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 35699999999999985 45889999988653322 22467889999999999999999999999999999999996
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|++.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++........
T Consensus 105 ~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~ 176 (313)
T cd06633 105 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176 (313)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence 67888775432 2389999999999999999999998 799999999999999999999999999876555555
Q ss_pred ccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 HTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||++. ...++.++|||||||++|||++|+.|+.. ..-...+....... ..... .
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~--------~~~~~~~~~~~~~~-~~~~~-----~ 242 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQND-SPTLQ-----S 242 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhcC-CCCCC-----c
Confidence 56778899999984 35688999999999999999999999752 11122222221111 11111 1
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... ...+. +++.+||+.+|.+||++.|+++
T Consensus 243 ~~~-~~~l~---~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 243 NEW-TDSFR---GFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ccc-CHHHH---HHHHHHccCChhhCcCHHHHhc
Confidence 111 12344 4555999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.21 Aligned_cols=237 Identities=22% Similarity=0.305 Sum_probs=188.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 467999999999999965 58899999886532 22346788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++.... .+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++......
T Consensus 86 ~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 86 GELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 99999987542 389999999999999999999997 89999999999999999999999999987764432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||.+.+..++.++||||||+++|||+||+.||... .. .........+.. .+ ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~-~~~~~~~~~~~~------~~--~~ 219 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD--------NP-IQIYEKILEGKV------RF--PS 219 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------CH-HHHHHHHhcCCc------cC--Cc
Confidence 234567899999998888899999999999999999999998521 11 111111111110 11 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCC-----CHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARM-----ELKEVI 625 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl 625 (634)
.....+.++++ +||+.+|.+|| +++|++
T Consensus 220 ~~~~~l~~li~---~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 220 FFSPDAKDLIR---NLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred cCCHHHHHHHH---HHccCCHHHccCcccCCHHHHH
Confidence 11344555555 99999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.47 Aligned_cols=247 Identities=17% Similarity=0.242 Sum_probs=172.4
Q ss_pred ccccCccCceeEEEEEEcCC----cEEEEEEecccCccC-h----------hHHHHHHHHHhcCCCCccccceeEEEeCC
Q 038422 360 AEVLGSGTFGASYKTVISNG----QAYVVKRYKQMNNVG-R----------EDFQEHIKRLGRLEHPNLLPLTAFYYRKE 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 424 (634)
.+.||+|+||+||+|...++ ..+++|......... . .....+...+..++|+|++++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 46799999999999996553 455555433221111 0 11223334566779999999999776543
Q ss_pred ----ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeE
Q 038422 425 ----EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL 500 (634)
Q Consensus 425 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~k 500 (634)
..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 97 CRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred CCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCcEE
Confidence 34678887743 6666654321 257888899999999999999998 799999999999999999999
Q ss_pred EeccccCCccCCC-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcH
Q 038422 501 LTDYALRPLINPD-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASL 569 (634)
Q Consensus 501 l~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l 569 (634)
|+|||+++..... ....+|..|+|||+..+..++.++|||||||++|||+||+.||..... ...+
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~----~~~~ 242 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH----NGNL 242 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc----chHH
Confidence 9999998765321 123467889999999999999999999999999999999999963211 1111
Q ss_pred HHHHH-HHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 570 SNWVN-NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 570 ~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
..-.. ..... +......- .....++.++++ .|++.+|++||+++++.+.|+
T Consensus 243 ~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKR-----LHEGKIKI-KNANKFIYDFIE---CVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHH-----hhhhhhcc-CCCCHHHHHHHH---HHHhCCCCCCCCHHHHHHhhC
Confidence 11111 11100 00001100 112345555555 999999999999999998763
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.44 Aligned_cols=241 Identities=22% Similarity=0.371 Sum_probs=183.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEe------CCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYR------KEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~lv~e 431 (634)
.+.||+|+||.||+|+. .+++.+|+|.+... .....++..|+.+++++ +||||+++++++.. ....+++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 36799999999999996 45788999987543 23345788899999998 79999999999863 356799999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 100 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 100 FCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred eCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999875432 2378888999999999999999998 79999999999999999999999999987543
Q ss_pred CC----CCccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 512 PD----NAHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
.. ....++..|+|||.+. ...++.++|||||||++|||+||+.||.... .... ... .....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-------~~~~-~~~-~~~~~- 242 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-------PMRA-LFL-IPRNP- 242 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-------HHhh-hhh-HhhCC-
Confidence 21 2234567899999876 3467889999999999999999999985211 0000 000 11110
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+...... ...+ +.+++.+||+.||.+||++.|+++
T Consensus 243 ----~~~~~~~~-~~~~---~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 ----PPKLKSKK-WSKK---FIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----CCCCcccc-cCHH---HHHHHHHHhCCChhhCcCHHHHhc
Confidence 11111111 1233 445555999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.39 Aligned_cols=188 Identities=21% Similarity=0.329 Sum_probs=162.8
Q ss_pred cCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||+||++.. .+|+.+++|.+.... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 458899999886432 22344677899999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---A 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 515 (634)
.+++..... ..+++.++..++.|++.||.|||+. +++||||+|+||++++++.+|++|||++....... .
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 999875432 2489999999999999999999998 79999999999999999999999999987654321 2
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 195 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 234567999999988889999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.65 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=187.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. +++.+++|++.... ......+.+|++++++++|||++++++++.+. +..++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 357999999999999965 48899999998653 33345788999999999999999999999888 78999999997
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+ +|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 4 8888886442 2489999999999999999999998 79999999999999999999999999987654432
Q ss_pred -----CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc---cCC--
Q 038422 515 -----AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK---RTG-- 583 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~---~~~-- 583 (634)
....+..|+|||.+.+ ..++.++||||||+++|||+||+.||.... . ......+....... ...
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST----E-LEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC----h-HHHHHHHHHHhCCCchhhcccc
Confidence 1234567999998765 457899999999999999999999985211 0 11111111110000 000
Q ss_pred -c-----------ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 -D-----------VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 -~-----------~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+ .....+.. .........+++++..||+.+|.+||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLRE-FFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHH-HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000 000001345667777999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.98 Aligned_cols=193 Identities=21% Similarity=0.274 Sum_probs=160.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCC-CCccccceeEEEeCCc-----eEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEE-----KLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~~lv~ 430 (634)
.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++ ||||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999964 588999998765322 23457888999999995 6999999999987665 89999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPL 509 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~ 509 (634)
||+++ +|.+++..........+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 99985 899988765433234589999999999999999999998 7999999999999998 88999999999875
Q ss_pred cCCC----CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 510 INPD----NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 510 ~~~~----~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 4322 11234567999998865 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.83 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=184.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCC-CCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|.. .+++.+|+|+++... ........+|+.++.++. |+||+++++++.++ +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 46799999999999995 468899999887542 222334557888899885 99999999999987 88999999997
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
|+|.+++.... ..++|.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 58888886533 2489999999999999999999998 7999999999999999 999999999987654332
Q ss_pred ---CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHH-----------Hh
Q 038422 515 ---AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMV-----------KE 579 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~-----------~~ 579 (634)
...++..|+|||++.. ..++.++|||||||++|||++|+.||.... ......+..... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-----ELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-----HHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 2235678999997654 557899999999999999999999985211 111111111111 00
Q ss_pred ccCCcccccccccCC---CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 KRTGDVFDKEMKGAK---YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
........+...... ........+.+++.+||+.+|++||+++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 00011245566667999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.56 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=191.8
Q ss_pred HHHHHHhhccccCccCceeEEEEEEcCCcEEEEEEecc--cCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEE
Q 038422 352 LQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 352 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 428 (634)
+..-.+...+.||+||.+.||++...+.+.+|+|++.. .+......|..|+..|.+++ |.+||+|++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 33334445578999999999999988888999988753 34455578999999999994 9999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||= .-||..+|...... ...| .++.|..|++.++.++|.+ +|||.||||.|.|+-+ |.+||+|||+|.
T Consensus 438 vmE~G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred Eeecc-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence 99986 46999999765443 2345 7889999999999999998 8999999999999975 689999999999
Q ss_pred ccCCCC------CccccccccCcccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHH-
Q 038422 509 LINPDN------AHTLMVAYKSPEYAHNG-----------KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLS- 570 (634)
Q Consensus 509 ~~~~~~------~~~~~~~y~aPE~~~~~-----------~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~- 570 (634)
.+..+. ...||+.||+||.+... +++.++||||+|||||+|+.|+.||. ++.
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~----------~~~n 577 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG----------QIIN 577 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH----------HHHH
Confidence 887764 35689999999998642 35689999999999999999999985 222
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.|.+ ...+.|+.-.-+.....+-.+++++|..|++.||++||+..|+++
T Consensus 578 ~~aK-------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 QIAK-------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHH-------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2221 122223311000000011122666777999999999999999986
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.09 Aligned_cols=238 Identities=19% Similarity=0.341 Sum_probs=195.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
...||+|.|++|..|+. .++..||+|.+++.. ...+..+.+|+++|+.++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 46799999999999995 458999999998653 334466899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
.+++|+...+. ....++..++.|+..+++|+|++ .|+|||||++||||+.++.+||+|||++..+...
T Consensus 141 e~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 141 ELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred hhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeecccccc
Confidence 99999987654 55688889999999999999999 6999999999999999999999999999877654
Q ss_pred CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....+++.|.|||++.+..| ++++|+||+||++|-|+.|..||+. ..+... ...++-..++-
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG--------~~lk~L---------r~rvl~gk~rI 274 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG--------QNLKEL---------RPRVLRGKYRI 274 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC--------cccccc---------cchheeeeecc
Confidence 34567788999999998877 5899999999999999999999971 222111 01112222222
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+...+...+++ +.+..+|.+|++++++.+
T Consensus 275 p~~ms~dce~lLr---k~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 275 PFYMSCDCEDLLR---KFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cceeechhHHHHH---HhhccCccccCCHHHhhh
Confidence 2233444555555 888899999999999865
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=289.46 Aligned_cols=189 Identities=24% Similarity=0.357 Sum_probs=156.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCc--------eEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE--------KLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--------~~l 428 (634)
.+.||+|+||.||+++.. +++.||+|.+..... .....+.+|++++++++||||++++++|...+. .++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 467999999999999964 588999998864322 223456789999999999999999999876543 499
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||+. ++|.+++.... ..+++.++..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 97 v~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 999997 48888876432 2389999999999999999999998 79999999999999999999999999987
Q ss_pred ccCCCC--------CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 509 LINPDN--------AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 509 ~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...... ...++..|+|||.+.+. .++.++||||||+++|||+||+.|+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 653321 12345679999988764 47889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=293.64 Aligned_cols=188 Identities=21% Similarity=0.319 Sum_probs=158.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccC--------------hhHHHHHHHHHhcCCCCccccceeEEEeCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVG--------------REDFQEHIKRLGRLEHPNLLPLTAFYYRKE 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 424 (634)
.+.||+|+||+||+|+.. +++.||+|.++...... ...+.+|++++++++||||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999954 68899999886532211 125778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 425 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
..++||||+. |+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEECCc
Confidence 9999999997 68998886432 389999999999999999999998 7999999999999999999999999
Q ss_pred ccCCccCCC------------------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 505 ALRPLINPD------------------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 505 Gla~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
|+++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 998755411 111235679999998764 46899999999999999999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=283.39 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=186.3
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCc--cChhHHHHHHHHHhcC---CCCccccceeEEEeCCc-----eEE
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNN--VGREDFQEHIKRLGRL---EHPNLLPLTAFYYRKEE-----KLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~~l 428 (634)
.+.||+|+||.||+|+... ++.+|+|+++.... .....+.+|+.+++++ +||||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 4679999999999999764 89999999874322 2234566787776655 69999999999998776 899
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
+|||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999997 489988865432 2489999999999999999999998 79999999999999999999999999987
Q ss_pred ccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC--
Q 038422 509 LINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG-- 583 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~-- 583 (634)
...... ...++..|+|||++.+..++.++|||||||++|||+||+.||... ...+........-...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT--------SEADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC--------ChHHHHHHHHHHcCCCCh
Confidence 654332 223566799999999889999999999999999999999887521 1112222111110000
Q ss_pred -----------cccccccccC--CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 -----------DVFDKEMKGA--KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 -----------~~~d~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+....... ....+....+.+++.+||+.||++||+++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 000111244556777999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=282.87 Aligned_cols=244 Identities=24% Similarity=0.396 Sum_probs=185.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCC------ceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKE------EKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------~~~lv~e 431 (634)
.+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|+++++++ +|+||+++++++.... ..++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 467999999999999974 57789999886543 3456789999999999 7999999999997654 4899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||++....
T Consensus 90 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 90 LCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred cCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999998754311 23489999999999999999999998 79999999999999999999999999986543
Q ss_pred CC----CCccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 512 PD----NAHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
.. ....++..|+|||++.. ..++.++|||||||++|||+||+.||... . .. .-..... ....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~---~~-~~~~~~~-~~~~ 235 (275)
T cd06608 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM----H---PM-RALFKIP-RNPP 235 (275)
T ss_pred cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc----c---hH-HHHHHhh-ccCC
Confidence 32 22345678999998753 34678999999999999999999998521 1 11 1111111 1111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+.......++ +.+++.+||..||++|||++||++
T Consensus 236 -----~~~~~~~~~~~~---~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 -----PTLKSPENWSKK---FNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----CCCCchhhcCHH---HHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111101133 445555999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.62 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=196.2
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEEEc
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~e~ 432 (634)
+.||+|+||.||+|+ ...|+.||||.++... ...++...+|+++|++++|||||+++++-.+.. ...+||||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 579999999999999 5679999999998643 445678889999999999999999999865543 56899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC----CCCCeEEeccccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD----RSFEPLLTDYALRP 508 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~----~~~~~kl~DfGla~ 508 (634)
|.+|||...|..-. ....|++.+.+.+..+++.||.|||++ +|+||||||.||++- .....||+|||.|+
T Consensus 99 C~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred cCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999996533 345699999999999999999999988 899999999999983 33357999999999
Q ss_pred ccCCCC---CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc--C
Q 038422 509 LINPDN---AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR--T 582 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~--~ 582 (634)
.+.++. +..||..|.+||.+.. ..|+..+|.|||||++||.+||..||.+... .....+.++....... .
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~----pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG----PKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC----ccccchhhhhhhccCCCce
Confidence 987765 3457888999999985 7889999999999999999999999974322 1222222222221111 1
Q ss_pred CcccccccccCC-----------CCHHHHHHHHHHHhcccccCccCCC--CHHHHHHHHHhhh
Q 038422 583 GDVFDKEMKGAK-----------YSKSEMINLLKIGLSCCEEDVLARM--ELKEVIEKIERLK 632 (634)
Q Consensus 583 ~~~~d~~~~~~~-----------~~~~~~~~~~~l~~~C~~~~P~~RP--s~~evl~~L~~i~ 632 (634)
.-..++...++- ........+-++....+..+|++|- ...+....+..|.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 111122221110 1122334444555577788899998 6666666666553
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.62 Aligned_cols=192 Identities=19% Similarity=0.314 Sum_probs=152.1
Q ss_pred hccccCccCceeEEEEEEcC--CcEEEEEEe---------------cc--cCccChhHHHHHHHHHhcCCCCccccceeE
Q 038422 359 SAEVLGSGTFGASYKTVISN--GQAYVVKRY---------------KQ--MNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~---------------~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 419 (634)
..+.||+|+||+||++..+. +...++|.+ +. ........+.+|++++++++|||||+++++
T Consensus 152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 45789999999999987543 222222211 00 111123468899999999999999999999
Q ss_pred EEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCe
Q 038422 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499 (634)
Q Consensus 420 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 499 (634)
+.+.+..++|+|++. ++|.+++..............++..|+.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCE
Confidence 999999999999985 5788877654322222244567788999999999999998 79999999999999999999
Q ss_pred EEeccccCCccCCCC-----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 038422 500 LLTDYALRPLINPDN-----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 500 kl~DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P 555 (634)
||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999998664432 23578889999999999999999999999999999998764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=293.19 Aligned_cols=186 Identities=19% Similarity=0.318 Sum_probs=158.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.+.||+|+||.||+++. .+++.||+|.+... .....+.+.+|++++++++||||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46799999999999995 46889999998643 222345677899999999999999999998643 2469999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+. ++|.+.+... +++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 101 ELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred eccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 9996 5888877431 78889999999999999999998 7999999999999999999999999999765
Q ss_pred CCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.... ...++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 4432 2335677999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.43 Aligned_cols=245 Identities=21% Similarity=0.327 Sum_probs=183.4
Q ss_pred hccccCccCceeEEEEEEcC-CcEEEEEEecccCc-cChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||.||+|+..+ ++.+|+|.++.... .....+.+|+.++.+.. ||||++++++|.++...++||||+.
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS- 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence 35789999999999999765 88999999875432 23455677787776664 9999999999999999999999985
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
+++.+++..... .+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++........
T Consensus 98 ~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 98 TCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 477776654322 4899999999999999999999742 699999999999999999999999999876543222
Q ss_pred ---ccccccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGK----ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~----~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
..++..|+|||++.+.. ++.++|||||||++|||++|+.||.... .-.+......... ...
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~-~~~---- 238 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-------TEFEVLTKILQEE-PPS---- 238 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch-------hHHHHHHHHhcCC-CCC----
Confidence 23456799999987554 7899999999999999999999985210 1111111111111 100
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
+.......+ ++.+++.+||+.||.+||+++++++.
T Consensus 239 -~~~~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -LPPNEGFSP---DFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100000123 34555569999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=279.32 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=192.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++. .+++.+++|.+.... .....++.+|++++++++|+||+++++++.+....++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46799999999999985 467899999987532 233457889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++...... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+|++|||+++......
T Consensus 85 ~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 85 DLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 999998764321 23489999999999999999999998 79999999999999999999999999987664432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||.+.+..++.++|+||||+++|||++|+.||... ...... ...........
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~-~~~~~~~~~~~--------- 221 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR--------SMQDLR-YKVQRGKYPPI--------- 221 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHH-HHHhcCCCCCC---------
Confidence 233567899999999888999999999999999999999998621 111111 11111111111
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
......++.+++.+|++.+|++||++.|+++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 -PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111233555666999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=286.41 Aligned_cols=189 Identities=24% Similarity=0.366 Sum_probs=158.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. +|+.||+|.++..... ....+.+|++++++++|+||+++++++... +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 367999999999999964 5899999998643322 233567899999999999999999998765 46899999997
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 48888886543 2489999999999999999999998 79999999999999999999999999987654321
Q ss_pred ----CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ----AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 1223567999999875 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=274.32 Aligned_cols=193 Identities=25% Similarity=0.421 Sum_probs=163.1
Q ss_pred ccccCccCceeEEEEEEcC-----CcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISN-----GQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 431 (634)
...||+|+||.||+|+-.+ ...+|+|+++..+. .-.....+|+.+++.++|||||.|..++.. +...++++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 4579999999999996432 23789999876532 223567799999999999999999999987 678899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC----CCeEEeccccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS----FEPLLTDYALR 507 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla 507 (634)
|.+. +|...++-.+......++-...++|+.||+.|+.|||++ -|+||||||.|||+..+ +.+||+|+|++
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9987 899888766555455688899999999999999999999 69999999999999877 89999999999
Q ss_pred CccCC-------CCCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 508 PLINP-------DNAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 508 ~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+++.. .+....|+.|+|||.+.+. .||.+.||||.|||+.||+|-++-|.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 87653 3445678999999999875 58999999999999999999876654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=283.56 Aligned_cols=188 Identities=25% Similarity=0.381 Sum_probs=162.6
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.||+|++|.||++... +++.+++|.++.... .....+.+|++++++++|+||+++++++.+++..++|+||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 56999999999999964 688999998875432 2356788999999999999999999999999999999999975 8
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 84 l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 84 LYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred HHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 888886543 2489999999999999999999998 79999999999999999999999999987654432
Q ss_pred -CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||.+.+. .++.++||||||+++|||+||+.||.
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 22345679999998876 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=276.91 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=191.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 367999999999999976 688999999875432 3456889999999999999999999999988 78999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+++|.+++.... .+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999987543 489999999999999999999997 79999999999999999999999999987655432
Q ss_pred ------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 515 ------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 515 ------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... .....+...........
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~---- 224 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEPPE---- 224 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCCcC----
Confidence 2345677999999988889999999999999999999999986211 11111111110000100
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+. .....+ +.+++.+|++.+|++||++.|+++
T Consensus 225 -~~--~~~~~~---l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 -IP--EHLSEE---AKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CC--cccCHH---HHHHHHHhCcCChhhCCCHHHHhh
Confidence 10 011233 444555999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=278.23 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=191.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++|||++++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999865 578999999876543 34467899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 515 (634)
+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 85 SLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999987542 389999999999999999999998 799999999999999999999999999876654332
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||...+..++.++||||+|+++|||++|+.|+... ....... ... .. ....+.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~-------~~~~~~~-~~~-~~-~~~~~~~---- 221 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL-------NPMAALF-RIV-QD-DHPPLPE---- 221 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHH-HHh-cc-CCCCCCC----
Confidence 34567799999998878899999999999999999999997521 1111111 111 11 1111111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++. +++.+|+..+|++||++.|++.
T Consensus 222 --~~~~~~~---~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 --GISPELK---DFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCHHHH---HHHHHHHhCChhhCcCHHHHhc
Confidence 1123344 4555999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.98 Aligned_cols=239 Identities=19% Similarity=0.276 Sum_probs=179.7
Q ss_pred ccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHH---HHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 362 VLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHI---KRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
+||+|+||.||+++.. +++.||+|.+...... ....+..|. +.++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5889999988653211 112233443 34555689999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999998886432 389999999999999999999997 7999999999999999999999999998754332
Q ss_pred -CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.++ .++.++|||||||++|||++|+.||..... ..... ....... .+..+.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~~~------~~~~~~ 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHE-IDRMTLT------MAVELP 219 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc-----cchHH-HHHHhhc------cCCCCC
Confidence 233567889999998754 689999999999999999999999862211 11111 1111111 011111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
. ....++ .+++.+|+..+|.+|| +++|+++
T Consensus 220 ~--~~s~~~---~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 D--SFSPEL---RSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C--cCCHHH---HHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 112334 4444599999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=291.20 Aligned_cols=187 Identities=21% Similarity=0.385 Sum_probs=156.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~ 432 (634)
.+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 46799999999999985 468899999986432 223456888999999999999999999876543 47999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+. ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 90 ME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 97 4888777432 389999999999999999999998 799999999999999999999999999876533
Q ss_pred CC-------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 DN-------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 1235677999998754 468999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.13 Aligned_cols=191 Identities=23% Similarity=0.389 Sum_probs=162.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|++|.||+|+.. +|+.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 367999999999999975 588999999875432 2345778899999999999999999999999999999999985 8
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++.....
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9888865432 23489999999999999999999998 7999999999999999999999999998754322
Q ss_pred CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|++||++.+. .++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 123346779999988654 56889999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=285.15 Aligned_cols=189 Identities=26% Similarity=0.403 Sum_probs=158.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC----------ce
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE----------EK 426 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----------~~ 426 (634)
.+.||+|+||.||+|... +++.|++|.++... ......+.+|++++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 467999999999999975 58899999987543 223356788999999999999999999987654 78
Q ss_pred EEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 427 LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 427 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 999999986 7777765432 2489999999999999999999998 799999999999999999999999999
Q ss_pred CCccCCCCC-----ccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 507 RPLINPDNA-----HTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 507 a~~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+........ ...+..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 876543321 223567999998865 357899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=283.35 Aligned_cols=190 Identities=24% Similarity=0.361 Sum_probs=161.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+.. +++.+++|++..... .......+|+..+++++ ||||+++++++.+++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 367999999999999975 478899998865422 23334567999999999 999999999999999999999999 88
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ..+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 83 NLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 99998876541 2489999999999999999999998 79999999999999999999999999987665432
Q ss_pred -CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.. ..++.++||||||+++|||+||+.||.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 2345677999998854 457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.01 Aligned_cols=239 Identities=29% Similarity=0.429 Sum_probs=191.9
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
...||.|.||.||.|. ..+|+..|+|-++-.. ....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 3579999999999998 6678999999876443 233457789999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+.+...+. .++.....+..|++.|++|||+. +||||||||.||+|+.++.+|.+|||.|..+....
T Consensus 1320 sLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999875443 56667777899999999999998 89999999999999999999999999998765542
Q ss_pred ------CccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHH-HHHhccCCc
Q 038422 515 ------AHTLMVAYKSPEYAHNGK---ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNN-MVKEKRTGD 584 (634)
Q Consensus 515 ------~~~~~~~y~aPE~~~~~~---~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~ 584 (634)
...||+.|||||++.+.. ...+.||||+|||+.||+||+.||... +. +|.-. .+.-+....
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~----dn-----e~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL----DN-----EWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc----cc-----hhHHHhHHhccCCCC
Confidence 345788999999998643 456899999999999999999999722 11 33322 222222222
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+- .+ ...+-.++++ .|++.||+.|-++.|+++
T Consensus 1462 ~P-~~------ls~~g~dFle---~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IP-ER------LSSEGRDFLE---HCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred Cc-hh------hhHhHHHHHH---HHHhcCchhhhHHHHHHH
Confidence 21 11 2345567888 999999999998887765
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=281.92 Aligned_cols=190 Identities=21% Similarity=0.356 Sum_probs=158.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+.. +++.+++|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 367999999999999965 688999998865322 234578899999999999999999999999999999999996 5
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~-- 513 (634)
+|.+++..... ..+++..+..++.||+.||+|||+. +++||||||+||++++ +..+||+|||++......
T Consensus 86 ~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 86 DLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 88888754332 2367888889999999999999998 7999999999999985 567899999998754322
Q ss_pred --CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 --NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 122346789999988764 57899999999999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=277.50 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++|||++++++.+..++..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 467999999999999965 588999999875432 45567899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..... ....+++.++..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 85 DLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999976532 123599999999999999999999998 89999999999999999999999999987654432
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||...+..++.++||||+|+++|+|++|+.|+.. ....+....... ..... +.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~--------~~~~~~~~~~~~-~~~~~-----~~- 224 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG--------ENLLELALKILK-GQYPP-----IP- 224 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC--------CcHHHHHHHHhc-CCCCC-----CC-
Confidence 23456679999999888899999999999999999999999852 112222222211 11111 10
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....++ +.+++..||..+|++||++.|+++
T Consensus 225 -~~~~~~---~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 -SQYSSE---LRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCHH---HHHHHHHHcCCChhhCcCHHHHhc
Confidence 011233 445555999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.24 Aligned_cols=188 Identities=25% Similarity=0.396 Sum_probs=157.7
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcC-CCCccccceeEEEeCC--ceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKE--EKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--~~~lv~e~ 432 (634)
..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||++++++|...+ ..++||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 3467999999999999965 5789999988542 223345677899999999 9999999999986543 57999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
++ ++|.+++... .++|..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 97 5998888643 388999999999999999999998 899999999999999999999999999876543
Q ss_pred CC---------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 DN---------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~~---------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 22 1235667999998765 457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=284.50 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=188.6
Q ss_pred ccccCccCceeEEEEEE----cCCcEEEEEEecccC----ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
.+.||+|+||.||+++. .+++.+|+|.++... ....+.+..|++++.++ +||||+++++.+..+...++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999884 356789999887432 22345688999999999 5999999999999888999999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||+++..
T Consensus 85 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 85 DYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred ecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999986432 388999999999999999999997 7999999999999999999999999998765
Q ss_pred CCCC-----CccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 511 NPDN-----AHTLMVAYKSPEYAHNGK--ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 511 ~~~~-----~~~~~~~y~aPE~~~~~~--~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.... ...++..|+|||.+.+.. .+.++||||||+++|||+||+.||... +......++........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~--- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD----GEQNSQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC----cccchHHHHHHHHHccC---
Confidence 4322 123567899999987655 788999999999999999999998521 11111122221111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
+... .....++. +++.+||+.+|++|||+++|.+.|+.
T Consensus 229 ----~~~~--~~~~~~l~---~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ----PPFP--KTMSAEAR---DFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCC--cccCHHHH---HHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0110 01123344 44559999999999999988877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=275.64 Aligned_cols=241 Identities=21% Similarity=0.258 Sum_probs=187.8
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccCh---hHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGR---EDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||.|.-|+||.+.+.+ +..+|+|++.+..-..+ ...+.|-+||+.++||.++.||+.+..++..|+|||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 3579999999999999765 58999999987544333 3567789999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC----
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN---- 511 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~---- 511 (634)
|+|...++.+.. ..++...+..++.+|+.||+|||-. |||.|||||+|||+-+++++-++||-|+....
T Consensus 162 GdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 162 GDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred ccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999988876544 3499999999999999999999998 89999999999999999999999998753210
Q ss_pred ---C--------------------------C-C--------------------------CccccccccCcccccCCCCCc
Q 038422 512 ---P--------------------------D-N--------------------------AHTLMVAYKSPEYAHNGKISK 535 (634)
Q Consensus 512 ---~--------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~~~ 535 (634)
. . . ...||-.|.|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0 011233499999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCc
Q 038422 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDV 615 (634)
Q Consensus 536 k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P 615 (634)
++|.|+|||++|||+.|..||. +.+..+.+.+.+.+ +..+.+.. +....+-+|+..-+..||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFK----G~~~~~Tl~NIv~~-----------~l~Fp~~~---~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFK----GSNNKETLRNIVGQ-----------PLKFPEEP---EVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcC----CCCchhhHHHHhcC-----------CCcCCCCC---cchhHHHHHHHHHhccCh
Confidence 9999999999999999999986 23332333333211 11222211 222334445558999999
Q ss_pred cCCCC----HHHHH
Q 038422 616 LARME----LKEVI 625 (634)
Q Consensus 616 ~~RPs----~~evl 625 (634)
++|-- +.||-
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99987 55553
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=277.25 Aligned_cols=239 Identities=21% Similarity=0.315 Sum_probs=184.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-----ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-----NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||.||+|.. .+++.+++|.+.... ....+.+.+|++++++++||||+++++++.+. ...++|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 46899999999999985 458899999875321 12235788999999999999999999998764 35789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999986532 378999999999999999999998 79999999999999999999999999987543
Q ss_pred CC-------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PD-------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
.. ....++..|+|||++.+..++.++|||||||++||+++|+.||... ..... +....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~-~~~~~~~~-~~- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-------EAMAA-IFKIATQP-TK- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-------CHHHH-HHHHHcCC-CC-
Confidence 21 1123567899999999888999999999999999999999998521 11111 11111111 11
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+ .....+++.++++ .|+. +|..||+..++++
T Consensus 228 ---~~~--p~~~~~~~~~~i~---~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ---PML--PDGVSDACRDFLK---QIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCC--CcccCHHHHHHHH---HHhc-CcccCccHHHHhc
Confidence 111 1112344555655 9998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=283.01 Aligned_cols=242 Identities=23% Similarity=0.325 Sum_probs=185.7
Q ss_pred ccccCccCceeEEEEEE----cCCcEEEEEEecccC----ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
.+.||+|+||.||+++. .+|+.||+|+++... ....+.+.+|+++++++ +|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999985 368899999987532 22346788899999999 5999999999999888999999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999997542 388999999999999999999998 7999999999999999999999999998765
Q ss_pred CCCC-----CccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 511 NPDN-----AHTLMVAYKSPEYAHNG--KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 511 ~~~~-----~~~~~~~y~aPE~~~~~--~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.... ...++..|+|||++... .++.++|||||||++|||+||+.|+... ........+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~----~~~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD----GEKNSQAEISRRILKSE--- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC----CccccHHHHHHHhhccC---
Confidence 4322 22356789999998753 4678999999999999999999998521 11122222222221111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
+... ......+. +++.+|++.+|++|| +.+++++
T Consensus 229 ----~~~~--~~~~~~~~---~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----PPYP--QEMSALAK---DIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCC--ccCCHHHH---HHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0110 01123344 455599999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=290.44 Aligned_cols=188 Identities=19% Similarity=0.350 Sum_probs=158.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 432 (634)
.+.||+|+||.||++... +++.|++|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 467999999999999954 58999999987542 2334567889999999999999999998864 3467999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 90 ME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 96 68988885432 389999999999999999999998 799999999999999999999999999876533
Q ss_pred CC--------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 DN--------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~~--------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 21 1245667999998865 468899999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=288.65 Aligned_cols=188 Identities=24% Similarity=0.411 Sum_probs=163.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e 431 (634)
.+.||+|+||.||+++.. +++.+++|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 467999999999999965 48899999987643 334567899999999999999999999998775 7899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 85 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 85 LME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred chh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 998 58888886432 489999999999999999999998 79999999999999999999999999987654
Q ss_pred CCC-------CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PDN-------AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~~-------~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ...++..|+|||++.+. .++.++||||||+++|||+||+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 432 22346679999999887 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=278.43 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=184.0
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccC-----ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMN-----NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+++... +..+++|.++... ......+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 4679999999999998643 4445556554322 223346778999999999999999999999989999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++++|.+++...... ...+++.+++.++.|++.||.|||+. +++|+||||+||++++ ..+|++|||+++.....
T Consensus 85 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 85 EGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred CCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999988753222 23599999999999999999999998 8999999999999986 46999999998765433
Q ss_pred C----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 N----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. ...++..|+|||++.+..++.++||||||+++|||++|..|+.. ........... .+.. +.
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~--------~~~~~~~~~~~-~~~~-----~~ 224 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG--------QNFLSVVLRIV-EGPT-----PS 224 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHH-cCCC-----CC
Confidence 2 23356679999999888889999999999999999999999751 12222222211 1111 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+. ..... .+.+++.+||..+|++||++.|+++
T Consensus 225 ~~--~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 LP--ETYSR---QLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred Cc--chhcH---HHHHHHHHHhcCChhhCcCHHHHhh
Confidence 10 01123 3445555999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=287.34 Aligned_cols=190 Identities=25% Similarity=0.370 Sum_probs=169.9
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
++||+|+||.||-+.. .+|+.+|.|++.+.. .........|-.+|.+++.+.||.+-..|.+++..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 6899999999999985 458999999886432 233446678999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
||.-+|.+... +.+++..++.++.+|+.||++||+. +||.|||||+|||+|++++++|+|.|+|..+....
T Consensus 271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999876553 4599999999999999999999998 89999999999999999999999999998776553
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...||.+|||||++..+.|+...|.||+||++|||+.|+.||.
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 3468999999999999999999999999999999999999986
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=279.71 Aligned_cols=188 Identities=27% Similarity=0.397 Sum_probs=163.0
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.||+|.||.||+|+.. +++.+++|.+.... ....+.+..|++++++++|+||+++++++.+.+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 56999999999999965 48999999987653 3334678889999999999999999999999999999999998 59
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++......
T Consensus 84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 999997643 2389999999999999999999998 79999999999999999999999999987654332
Q ss_pred -CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 -AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+..|+|||.+.+. .++.++|||||||++||+++|+.||.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 12235669999998776 78999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=285.10 Aligned_cols=189 Identities=23% Similarity=0.379 Sum_probs=155.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCC--------ceEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKE--------EKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~~~l 428 (634)
.+.||+|+||.||+|+.. +++.+++|++...... ....+.+|++++++++||||+++++++.+.. ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 467999999999999964 5889999988644322 2346788999999999999999999886543 3689
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
|+||+.. ++...+.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 9999975 6777665432 2499999999999999999999998 79999999999999999999999999987
Q ss_pred ccCCCCC---------------ccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 509 LINPDNA---------------HTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 509 ~~~~~~~---------------~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....... ..++..|+|||.+.+. .++.++|||||||++|||+||+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 5432211 1235569999987654 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.95 Aligned_cols=188 Identities=21% Similarity=0.382 Sum_probs=158.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e 431 (634)
.+.||+|+||+||+++. .+++.||+|.++.. .......+.+|+.+++.++||||+++++++.... ..++|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 45799999999999985 46889999998753 2233456778999999999999999999886542 4799999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 90 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 90 LMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred CCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 996 68988876432 389999999999999999999998 79999999999999999999999999987654
Q ss_pred CC----CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD----NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 33 22345677999998865 468899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=285.61 Aligned_cols=186 Identities=20% Similarity=0.354 Sum_probs=155.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46799999999999995 468999999886432 223456889999999999999999999987543 468999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+.. +|.++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++..
T Consensus 100 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 100 PYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 99964 6766542 1389999999999999999999998 7999999999999999999999999998765
Q ss_pred CCCC-CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPDN-AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 4332 2345677999999876 468899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.64 Aligned_cols=187 Identities=22% Similarity=0.378 Sum_probs=156.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeC--------------C
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--------------E 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------------~ 424 (634)
.+.||+|+||.||+|+. .+++.|++|++........+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 46799999999999996 45889999998766555567789999999999999999999877654 2
Q ss_pred ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEec
Q 038422 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTD 503 (634)
Q Consensus 425 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~D 503 (634)
..++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++ ++..+|++|
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEECC
Confidence 4789999997 5888887532 388999999999999999999998 799999999999997 456789999
Q ss_pred cccCCccCCCC-------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 504 YALRPLINPDN-------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 504 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
||+++...... ...++..|+|||.+.. ..++.++|||||||++|||++|+.||.
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99987653221 1234667999998754 567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=270.59 Aligned_cols=232 Identities=25% Similarity=0.331 Sum_probs=184.8
Q ss_pred cCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 363 LGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
||+|+||.||++... +++.+++|.+...... ..+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 4889999988754322 345788999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 99997543 389999999999999999999997 7999999999999999999999999998765442 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||...+...+.++|+||||+++||+++|+.||... ........... ... .+ ..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~-~~~------~~--~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE--------DRKEIYEKILK-DPL------RF--PE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHhc-CCC------CC--CC
Confidence 234567899999998888899999999999999999999998521 11111111111 100 11 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKE 623 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~e 623 (634)
....++. +++.+|+..||++||++.+
T Consensus 215 ~~~~~l~---~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEAR---DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHH---HHHHHHhcCCHhhCCCccc
Confidence 1123444 4555999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=259.70 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=187.4
Q ss_pred CCCHHHHHHhhccccCccCceeEEEEEEc-CCcEEEEEEecccCcc-ChhHHHHHHHHHhcC-CCCccccceeEEEeCCc
Q 038422 349 PFDLQDMLRASAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEE 425 (634)
Q Consensus 349 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 425 (634)
+.++.|+.. ...||+|+.|.|++++.. .|...|||.+.+..+. ..+.+...++++.+- +.|.||+.+|||..+..
T Consensus 88 ~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 344555532 356999999999999965 5889999999765433 345566667766555 47999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
.++.||.|.. .+...+.... .++++..+-++...+.+||.||-++. +|+|||+||+|||+|+.+.+|++|||
T Consensus 166 V~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeeccc
Confidence 9999999853 4444444332 24888888899999999999998874 89999999999999999999999999
Q ss_pred cCCccCCCCC---ccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 506 LRPLINPDNA---HTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 506 la~~~~~~~~---~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++..+.++.+ ..+...|||||.+.- ..|+.++|||||||+++||.||+.||.... .++.- +.....+
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdFe~-ltkvln~ 310 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDFEV-LTKVLNE 310 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccHHH-HHHHHhc
Confidence 9987766543 346678999999863 468899999999999999999999986221 22211 1111111
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
. .|.+.....-..++.++++ .|+..|+.+||...++++.
T Consensus 311 e------PP~L~~~~gFSp~F~~fv~---~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 E------PPLLPGHMGFSPDFQSFVK---DCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred C------CCCCCcccCcCHHHHHHHH---HHhhcCcccCcchHHHhcC
Confidence 1 1233222111244555555 9999999999999988763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=268.51 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=186.5
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCc-cChhHHHHHHHH-HhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN-VGREDFQEHIKR-LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..||.|+||+|+|-.+ +.|+..|||+++.... .+.+++..|.+. ++.=+-||||++||.+..++..|+-||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 4699999999999885 4589999999986543 455678888876 445578999999999999999999999995 46
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|..+-......+...+++.-.-.|.....+||.||-+.. .|+|||+||+|||+|..+.+|++|||++..+..+-
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 655443322223345888888889999999999998874 69999999999999999999999999987765543
Q ss_pred CccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 AHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...|...|||||.+.. ..|+-+|||||+|++|||+.||+.|+.. + .++.+.+...+... . .++......
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----w---~svfeql~~Vv~gd-p-p~l~~~~~~ 296 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----W---DSVFEQLCQVVIGD-P-PILLFDKEC 296 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----H---HHHHHHHHHHHcCC-C-CeecCcccc
Confidence 2345567999999974 3489999999999999999999999852 1 23334333333221 1 111111111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
- .....+..+++ .|+..|-++||+.+++.+
T Consensus 297 ~-~~s~~~~~fin---tCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 297 V-HYSFSMVRFIN---TCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred c-ccCHHHHHHHH---HHhhcccccCcchhhhhc
Confidence 1 12245666666 899999999999998865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=281.70 Aligned_cols=187 Identities=24% Similarity=0.393 Sum_probs=158.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|++++++++||||++++++|.. ....++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 467999999999999854 7889999987642 22335678899999999999999999999876 45788999998 5
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-C
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-N 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 514 (634)
++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...... .
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 6888887532 378888899999999999999998 7999999999999999999999999998765433 2
Q ss_pred CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2345677999998766 568999999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=284.03 Aligned_cols=187 Identities=21% Similarity=0.353 Sum_probs=158.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||.||++.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 36799999999999984 468899999986432 223456889999999999999999999987653 358999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++...
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 999 67898887531 389999999999999999999998 7999999999999999999999999998765
Q ss_pred CCCC-CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPDN-AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.... ...++..|+|||.+.+ ..++.++|||||||++||+++|+.||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4432 2345678999999876 458899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=275.90 Aligned_cols=238 Identities=21% Similarity=0.333 Sum_probs=187.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+++.. +++.+++|.+.... ....+.+.+|++++++++ ||||+++++++.+++..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 467999999999999965 68999999886532 223457889999999998 9999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999997543 399999999999999999999998 79999999999999999999999999987554322
Q ss_pred C------------------------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHH
Q 038422 515 A------------------------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 515 ~------------------------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~ 570 (634)
. ..++..|+|||......++.++||||||++++|+++|+.|+... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-------~~-~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-------NE-Y 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc-------cH-H
Confidence 1 12356799999998888999999999999999999999998621 10 0
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCH----HHHHH
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMEL----KEVIE 626 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~----~evl~ 626 (634)
.-..... .. .. .+ .....+.+ .+++.+|++.+|.+||++ +|+++
T Consensus 229 ~~~~~~~-~~--~~----~~--~~~~~~~~---~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKIL-KL--EY----SF--PPNFPPDA---KDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHH-hc--CC----CC--CCccCHHH---HHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1011111 10 00 00 01112334 445559999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=284.16 Aligned_cols=188 Identities=22% Similarity=0.307 Sum_probs=155.4
Q ss_pred ccccCccCceeEEEEEEc-C--CcEEEEEEecccC--ccChhHHHHHHHHHhcC-CCCccccceeEEEeC----CceEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-N--GQAYVVKRYKQMN--NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRK----EEKLLL 429 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~~lv 429 (634)
.+.||+|+||.||+++.. + +..+|+|++.... ....+.+.+|+++++++ +||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999964 3 6789999886432 22345678899999999 599999999876432 357889
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
+||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 85 EELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred Eeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 99986 68988885432 389999999999999999999998 899999999999999999999999999875
Q ss_pred cCCCC--------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 510 INPDN--------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 510 ~~~~~--------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 43221 1245678999998765 468999999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=302.37 Aligned_cols=140 Identities=25% Similarity=0.327 Sum_probs=124.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.||+|+++..... ....+..|+.+++.++||||+++++++...+..++||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999965 6889999998754322 235788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
++|.+++.... .+++..++.|+.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999986532 388999999999999999999998 79999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=267.72 Aligned_cols=178 Identities=20% Similarity=0.287 Sum_probs=152.0
Q ss_pred cCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhhHHhh
Q 038422 366 GTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHA 444 (634)
Q Consensus 366 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 444 (634)
|.||.||+++. .+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 468899999987543 234455556666799999999999999999999999999999999865
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-Ccccccccc
Q 038422 445 NHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-AHTLMVAYK 523 (634)
Q Consensus 445 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~ 523 (634)
.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....+..|+
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence 42 389999999999999999999998 79999999999999999999999999876554322 223355699
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 524 SPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 524 aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
|||...+..++.++||||+||++|||++|+.|+.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 9999988889999999999999999999998864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=280.92 Aligned_cols=187 Identities=21% Similarity=0.355 Sum_probs=156.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 36799999999999985 568899999987532 22345688899999999999999999988643 2467888
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
+++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 877 78998877532 389999999999999999999998 7999999999999999999999999998765
Q ss_pred CCCC-CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPDN-AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4332 2345678999998866 468899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=279.71 Aligned_cols=187 Identities=21% Similarity=0.366 Sum_probs=158.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCc------eEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE------KLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lv~ 430 (634)
...||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 467999999999999965 57899999886431 2233567789999999999999999998876654 89999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+ +++|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 100 e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 100 HLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 999 5699988864 2389999999999999999999998 7999999999999999999999999998765
Q ss_pred CCC-CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||.+.+ ..++.++|||||||++||++||+.||.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 433 23345677999998865 367899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=299.28 Aligned_cols=240 Identities=22% Similarity=0.334 Sum_probs=175.9
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC---------------
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--------------- 423 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------------- 423 (634)
++||+||||.||+++ .-||+.+|||++.-.. ...-..+.+|++.+++|+|||||+++..+.+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 679999999999999 4489999999997542 22335688999999999999999998765310
Q ss_pred --------------------------------------------------------------------------------
Q 038422 424 -------------------------------------------------------------------------------- 423 (634)
Q Consensus 424 -------------------------------------------------------------------------------- 423 (634)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ------------------------CceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 038422 424 ------------------------EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479 (634)
Q Consensus 424 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 479 (634)
...||-||||+.-.+.++++.+.... .-....+++++|+.||.|+|+.
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~---- 716 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQ---- 716 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhC----
Confidence 01367789998888888877654321 3456788999999999999998
Q ss_pred CccccCCCCCCEEeCCCCCeEEeccccCCccC----------------------CCCCccccccccCcccccCC---CCC
Q 038422 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN----------------------PDNAHTLMVAYKSPEYAHNG---KIS 534 (634)
Q Consensus 480 ~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~----------------------~~~~~~~~~~y~aPE~~~~~---~~~ 534 (634)
+||||||||.||++|++..+||+|||+|.... ......||.-|+|||.+.+. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 89999999999999999999999999987621 00123467779999999865 499
Q ss_pred cchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccC
Q 038422 535 KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEED 614 (634)
Q Consensus 535 ~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~ 614 (634)
.|+|+||+|||++||+. ||.. .+.-+.- -..++.+.+..- +.+ ..+++..-.+++.++++.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~T-------sMERa~i-L~~LR~g~iP~~--~~f-----~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGT-------SMERASI-LTNLRKGSIPEP--ADF-----FDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCc-------hHHHHHH-HHhcccCCCCCC--ccc-----ccccchHHHHHHHHHhcCC
Confidence 99999999999999985 3431 1111111 122233333222 111 1222233345555899999
Q ss_pred ccCCCCHHHHHH
Q 038422 615 VLARMELKEVIE 626 (634)
Q Consensus 615 P~~RPs~~evl~ 626 (634)
|++|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=260.89 Aligned_cols=244 Identities=20% Similarity=0.301 Sum_probs=185.5
Q ss_pred hhccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEe----CCceEEEEE
Q 038422 358 ASAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYR----KEEKLLLYE 431 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lv~e 431 (634)
...++||-|-.|.|..+.. .+++.+|+|++.. .....+|+++--+. .|||||.++++|.+ ....++|||
T Consensus 65 is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 65 ISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred ehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 3457899999999999885 4588899998754 34556788764444 69999999999864 345679999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRP 508 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~ 508 (634)
+|+||.|...++.++.. .+++.++-.|+.||+.|+.|||+. .|.||||||+|+|... |...|++|||+|+
T Consensus 140 ~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred cccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEeccccccc
Confidence 99999999999876543 499999999999999999999998 7999999999999964 4579999999998
Q ss_pred ccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 509 LINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
...... ....|+.|.|||++...+|+..+|+||+||+||-|+.|.+||... . +..+.--++..+..+.. +.
T Consensus 213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~-h----g~aispgMk~rI~~gqy-~F 286 (400)
T KOG0604|consen 213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN-H----GLAISPGMKRRIRTGQY-EF 286 (400)
T ss_pred ccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc-C----CccCChhHHhHhhccCc-cC
Confidence 766432 334578899999999999999999999999999999999998521 1 12233223333332211 11
Q ss_pred cccccccCCCCHHHH-HHHHHHHhcccccCccCCCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEM-INLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~-~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
-++++ .++ .+..+++...+..+|++|.|++|+++
T Consensus 287 P~pEW-------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 287 PEPEW-------SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChhH-------hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11121 122 23333444778999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=269.94 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=186.3
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccCcc-------ChhHHHHHHHHHhcCCCCccccceeEEE-eCCceEEEEE
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNV-------GREDFQEHIKRLGRLEHPNLLPLTAFYY-RKEEKLLLYE 431 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e 431 (634)
.+||+|+|+.||++. +...+.||+|+-...... ..+...+|.+|-+.|+||.||++|+|+. +.+..|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 579999999999999 445667777765322111 1134568999999999999999999985 5678899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRP 508 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~ 508 (634)
||+|.+|.-||..... ++++++..|+.||+.||.||.+..+ +|+|-||||.|||+.+ .+.+||+|||+++
T Consensus 549 YceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999976543 8999999999999999999999865 4999999999999954 4679999999999
Q ss_pred ccCCCCC-----------ccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHH
Q 038422 509 LINPDNA-----------HTLMVAYKSPEYAHNG----KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWV 573 (634)
Q Consensus 509 ~~~~~~~-----------~~~~~~y~aPE~~~~~----~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~ 573 (634)
++..+.. ..+|.+|++||.+.-+ +++.|+||||.|||+|+.+.|+.||... ..-.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn-------qsQQ--- 691 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN-------QSQQ--- 691 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc-------hhHH---
Confidence 9876532 2467889999998754 5789999999999999999999998521 1111
Q ss_pred HHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHH
Q 038422 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVI 625 (634)
Q Consensus 574 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 625 (634)
..+.+..+...-+..+...+....+...+++ +|++..-++|-...++.
T Consensus 692 -dILqeNTIlkAtEVqFP~KPvVsseAkaFIR---RCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -DILQENTILKATEVQFPPKPVVSSEAKAFIR---RCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HHHhhhchhcceeccCCCCCccCHHHHHHHH---HHHHhhhhhhhhHHHHc
Confidence 1222333322222233222334456777777 99999988888777664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=257.66 Aligned_cols=235 Identities=25% Similarity=0.341 Sum_probs=187.6
Q ss_pred CceeEEEEEEcC-CcEEEEEEecccCccC-hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhhHHhh
Q 038422 367 TFGASYKTVISN-GQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHA 444 (634)
Q Consensus 367 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 444 (634)
+||.||+|+..+ ++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8999999987655444 68899999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---CCcccccc
Q 038422 445 NHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---NAHTLMVA 521 (634)
Q Consensus 445 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~~~~~ 521 (634)
... +++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+...... ....++..
T Consensus 81 ~~~-----~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 RGR-----LSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred ccC-----CCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 432 88999999999999999999998 7999999999999999999999999998776543 23345677
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHH
Q 038422 522 YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMI 601 (634)
Q Consensus 522 y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 601 (634)
|++||......++.++||||||+++||+++|..||... ........ ........ . ...... ...
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~-~~~~~~~~-~---~~~~~~----~~~ 215 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFK-KIGKPKPP-F---PPPEWK----ISP 215 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHH-HHhccCCC-C---cccccc----CCH
Confidence 99999998888999999999999999999999998521 11111111 11111110 0 000000 113
Q ss_pred HHHHHHhcccccCccCCCCHHHHHH
Q 038422 602 NLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 602 ~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
++.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 4555666999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.05 Aligned_cols=231 Identities=23% Similarity=0.328 Sum_probs=183.1
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+|.|+|+.|-++.. .+++..++|++.+. ..+-.+|+.++... +||||+++.+.|.+..+.|+|||++.+|-+
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 4599999999999884 55788999998764 23345677665555 799999999999999999999999999998
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe-CCCCCeEEeccccCCccCCCC-Cc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL-DRSFEPLLTDYALRPLINPDN-AH 516 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl-~~~~~~kl~DfGla~~~~~~~-~~ 516 (634)
.+.+..... .. .++..|+.+|+.++.|||++ +||||||||+|||+ ++.++++|+|||.++...... ..
T Consensus 404 l~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp 473 (612)
T KOG0603|consen 404 LRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTP 473 (612)
T ss_pred HHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchhhccc
Confidence 888765432 33 77888999999999999998 89999999999999 588999999999998877662 22
Q ss_pred cccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCC
Q 038422 517 TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYS 596 (634)
Q Consensus 517 ~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 596 (634)
..|..|.|||++....|++.+|+|||||+||||++|+.|+... ..+.. +...+..+... ...
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~----P~~~e----i~~~i~~~~~s----------~~v 535 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH----PAGIE----IHTRIQMPKFS----------ECV 535 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC----CchHH----HHHhhcCCccc----------ccc
Confidence 4567899999999999999999999999999999999998621 11111 11222222111 112
Q ss_pred HHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 597 KSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 597 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.++.+++++ .|++.||.+||+|.++..
T Consensus 536 S~~AKdLl~---~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 SDEAKDLLQ---QLLQVDPALRLGADEIGA 562 (612)
T ss_pred CHHHHHHHH---HhccCChhhCcChhhhcc
Confidence 355666666 999999999999999864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=258.92 Aligned_cols=189 Identities=23% Similarity=0.350 Sum_probs=167.2
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHH---HHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDF---QEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|.||+|-.++ ...++.+|+|++++.-...+++. ..|-++|...+||.+..|...|+..+..++||||..|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 4689999999999998 45689999999987655555443 4678899999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC---
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--- 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 512 (634)
|.|.-+|...+ .+++.....+..+|..||.|||++ .||.||||.+|.|+|.++++||+|||+.+.--.
T Consensus 253 GeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 253 GELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred ceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99998886543 388888999999999999999998 799999999999999999999999999875322
Q ss_pred -CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 -DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 -~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++|+.|.|||++....|+...|.|.+|||||||+.|+.||.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 234568899999999999999999999999999999999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=275.58 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.++||+|.||+||-|+. ++|+.||||++.+.. ....+.+..|+.||.+++||.||.+...|++.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999995 569999999998653 444578999999999999999999999999999999999999 56
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccCCccCCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALRPLINPD 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~~ 513 (634)
+..+.+..... ..|++..-+.++.||+.||.|||.+ +|+|+||||+|||+.+. -++||+|||+|+++.+.
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 77776655433 2488888889999999999999998 79999999999999754 35899999999998775
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|+.|.|||++....|+..-|+||.||++|--++|..||+. ++++.+.+.+. .-++.+.-
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE-------dEdIndQIQNA------aFMyPp~P 787 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE-------DEDINDQIQNA------AFMYPPNP 787 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC-------ccchhHHhhcc------ccccCCCc
Confidence 456789999999999999999999999999999999999999872 23444433211 00111110
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....++ .++++-.-++..-.+|-+.+.-+.
T Consensus 788 --W~eis~~---AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 --WSEISPE---AIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --hhhcCHH---HHHHHHHHHHHHHHHhcchHhhcc
Confidence 0111223 334444777788888888776543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=231.89 Aligned_cols=186 Identities=24% Similarity=0.393 Sum_probs=159.7
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
++||+|.||+||+|+ ..+++.||+|+++-.+ +.-.....+|+.+++.++|.|||+++++...+....+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 679999999999999 4558899999887543 33456788999999999999999999999888889999999964 7
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|..+...... .++.....+++.|+++||.|+|++ .+.||||||.|.||+.+++.|++|||+++...-.
T Consensus 87 lkkyfdslng----~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 87 LKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 8877765433 389999999999999999999998 6999999999999999999999999999865432
Q ss_pred CCccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCC
Q 038422 514 NAHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P 555 (634)
.....|..|++|.++.+.+ |++..|+||-||++.|+.....|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 2345688999999998765 78999999999999999985444
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=279.39 Aligned_cols=242 Identities=23% Similarity=0.360 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEe-----CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYR-----KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~lv~e~ 432 (634)
.++||+|.+|.||+++ .++++.+|+|++... ....++...|.++++.. +|||++.++|+|.. ++++||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 4789999999999999 566888888887654 44556788888888877 79999999999975 4689999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|.+|+..|.+.... ...+.|..+..|+++++.|+.+||.+ .++|||+|-.|||++.++.+|+.|||++..+..
T Consensus 103 C~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred cCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999998765 23499999999999999999999998 699999999999999999999999999876654
Q ss_pred ----CCCccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 513 ----DNAHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 513 ----~~~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.....+|+.|||||++.- ..|+.++|+||+|++-.||.-|.+|+-...+ ++..+. +.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mraLF~---Ip 241 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFL---IP 241 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hhhhcc---CC
Confidence 345678899999999963 3577899999999999999999999752211 111111 11
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..-.+.++.+. .-..++.+.+..|+..|-.+||++.++++
T Consensus 242 RNPPPkLkrp~---kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNPPPKLKRPK---KWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCccccchh---hHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 12233443332 33445555555999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=251.12 Aligned_cols=188 Identities=25% Similarity=0.405 Sum_probs=156.0
Q ss_pred cccCccCceeEEEEEEcC-CcEEEEEEecc--cCccChhHHHHHHHHHhcCCCCccccceeEEEeC--------CceEEE
Q 038422 361 EVLGSGTFGASYKTVISN-GQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--------EEKLLL 429 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~lv 429 (634)
.+||+|.||.||+|+..+ |+.||+|++-- ....-.....+|+++|..++|+|++.++.+|... ...|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 579999999999999654 66777776532 2233345678999999999999999999998643 247999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|++|+. +|...|..... .++..++.+++.++..||.|+|+. .|+|||+|+.|+||+.++.+||+|||+++.
T Consensus 103 f~~ceh-DLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred HHHhhh-hHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999986 88888865432 389999999999999999999998 699999999999999999999999999976
Q ss_pred cCCCC--------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 510 INPDN--------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 510 ~~~~~--------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+.... ....|..|++||.+.+ ..|+++.|||.-||||.||.||.+-++
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 54321 1234788999999886 468999999999999999999987764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=289.53 Aligned_cols=189 Identities=23% Similarity=0.302 Sum_probs=168.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||.|..+++. +++.+|.|++.+. .......|.+|-.+|..-+.+-||.++..|.+..+.|+|||||+|
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 468999999999999964 5789999999873 344556799999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|||...+.... .+++.-+..|+.+|..||.-||+. |+|||||||+|||||..|++|++|||-+-.+..+
T Consensus 160 GDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 160 GDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred chHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 99999997654 288899999999999999999998 8999999999999999999999999987666543
Q ss_pred ---CCccccccccCccccc----C-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ---NAHTLMVAYKSPEYAH----N-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~----~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....||+-|++||++. + +.|++.+|.||+||++|||+.|..||.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 3456899999999986 2 679999999999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=238.98 Aligned_cols=194 Identities=24% Similarity=0.369 Sum_probs=160.0
Q ss_pred hccccCccCceeEEEEE-EcCCcEEEEEEeccc-CccChhHHHHHHHHH-hcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQM-NNVGREDFQEHIKRL-GRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||.|-+-+ .++|+..|+|++... .....+....|+.+. +....|.+|.+||.+.+....++.||.|..
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 34569999999988877 457999999999754 333445677788764 455799999999999999999999999954
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
||..+-.+.... ...+++..+-+|+..|.+||.|||++. .++|||+||+|||++.++++|++|||++.++.++-+
T Consensus 130 -Sldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 130 -SLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 776655443322 335889999999999999999999986 699999999999999999999999999988776643
Q ss_pred c---cccccccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 516 H---TLMVAYKSPEYAHN----GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 516 ~---~~~~~y~aPE~~~~----~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
. .+.-.|||||.+.. ..|+-|+||||+|+++.||.+++.||+
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 3 35566999998863 368999999999999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=259.08 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=161.9
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChh---HHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGRE---DFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
+..+||+|+||.|..+..+ +.+.+|||++++.-....+ --+.|-++|+-- +-|.++++..+|++-+..|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 3468999999999999854 4678999999875433322 234566666655 5789999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|+|.-+++.-.. +.+..+..+|.+||-||-|||++ +|+.||||.+||++|.++++||+|||+.+.---.
T Consensus 433 nGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 433 NGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred cCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999876543 77888999999999999999998 8999999999999999999999999998753222
Q ss_pred ----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|+-|+|||.+....|+..+|.|||||+||||+.|+.||+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 23457888999999999999999999999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=275.28 Aligned_cols=194 Identities=18% Similarity=0.294 Sum_probs=147.4
Q ss_pred ccccCccCceeEEEEEE-----------------cCCcEEEEEEecccCccChhHH--------------HHHHHHHhcC
Q 038422 360 AEVLGSGTFGASYKTVI-----------------SNGQAYVVKRYKQMNNVGREDF--------------QEHIKRLGRL 408 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~~~l~~l 408 (634)
.++||+|+||+||+|.. ..++.||||+++.......++| ..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 47899999999999964 2356799999875433333333 3466777777
Q ss_pred CCCcc-----ccceeEEEe--------CCceEEEEEcCCCCChhhHHhhccCC-------------------CCCCCCHH
Q 038422 409 EHPNL-----LPLTAFYYR--------KEEKLLLYEFVENGSLAGKLHANHTK-------------------QRPGLDWQ 456 (634)
Q Consensus 409 ~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~ 456 (634)
+|.++ ++++++|.. ++..+|||||+++|+|.++++..... ....++|.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 76654 678888753 35689999999999999998753210 01236788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-----ccccccccCcccccCC
Q 038422 457 TRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-----HTLMVAYKSPEYAHNG 531 (634)
Q Consensus 457 ~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-----~~~~~~y~aPE~~~~~ 531 (634)
.+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...++.|+|||.+...
T Consensus 310 ~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 8999999999999999998 799999999999999999999999999875533211 2235789999987543
Q ss_pred C--------------------C--CcchhHHHHHHHHHHHHhCCC-Ccc
Q 038422 532 K--------------------I--SKKSDVWSLGILILELLTGKY-PEN 557 (634)
Q Consensus 532 ~--------------------~--~~k~DVwSfGvvl~elltg~~-P~~ 557 (634)
. + ..+.||||+||++|||++|.. |+.
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 2 1 135799999999999999875 553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=281.86 Aligned_cols=255 Identities=16% Similarity=0.232 Sum_probs=159.5
Q ss_pred ccccCccCceeEEEEEEcC-----CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeE------EEeCCceEE
Q 038422 360 AEVLGSGTFGASYKTVISN-----GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF------YYRKEEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~~~~~~~l 428 (634)
.+.||+|+||.||+|+..+ +..||+|++..... .+.+..| .+....+.+++.++.. +......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 4789999999999999754 68999998764321 1211111 1222223333333222 234567899
Q ss_pred EEEcCCCCChhhHHhhccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe
Q 038422 429 LYEFVENGSLAGKLHANHTK---------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 493 (634)
||||+.+++|.+++...... .........+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDLKP~NILl 288 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDVKPQNIIF 288 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcCCHHHEEE
Confidence 99999999999998653210 000122344668999999999999998 79999999999999
Q ss_pred CC-CCCeEEeccccCCccCCC-----CCccccccccCcccccCC----------------------CCCcchhHHHHHHH
Q 038422 494 DR-SFEPLLTDYALRPLINPD-----NAHTLMVAYKSPEYAHNG----------------------KISKKSDVWSLGIL 545 (634)
Q Consensus 494 ~~-~~~~kl~DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~k~DVwSfGvv 545 (634)
++ ++.+||+|||+++.+... ....+++.|+|||.+... .++.++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 86 578999999999765432 223456789999965422 24456799999999
Q ss_pred HHHHHhCCCCcccccccC-----CCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCC
Q 038422 546 ILELLTGKYPENYLLQGY-----DSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME 620 (634)
Q Consensus 546 l~elltg~~P~~~~~~~~-----~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs 620 (634)
+|||+++..|.+...... .....+..|....... ...+ +...+........ ...+++.+|++.||++|||
T Consensus 369 L~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~d~~~~---~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 369 FLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPD-LRRGFEVLDLDGG---AGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchh-hhhhhhhccccch---HHHHHHHHHccCCcccCCC
Confidence 999999877754110000 0011222332111100 0000 0000000000111 2234555999999999999
Q ss_pred HHHHHHH
Q 038422 621 LKEVIEK 627 (634)
Q Consensus 621 ~~evl~~ 627 (634)
++|+++.
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=266.61 Aligned_cols=203 Identities=19% Similarity=0.298 Sum_probs=169.0
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccCh---hHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGR---EDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||-|+||.|..+.. ++...+|.|.+++.+...+ ...+.|-.||...+.+-||+||..|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 5699999999999884 4567889998877654433 34678999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC--------
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP-------- 508 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~-------- 508 (634)
++..+|..... +.+..+..++.++..|+++.|.. ++|||||||+|||||.++++||+||||+.
T Consensus 715 DmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999976543 88888899999999999999998 89999999999999999999999999853
Q ss_pred -ccCCCC-------------------------------------CccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 038422 509 -LINPDN-------------------------------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELL 550 (634)
Q Consensus 509 -~~~~~~-------------------------------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ell 550 (634)
++...+ ...+|..|+|||++....|+.-+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 222110 113466799999999999999999999999999999
Q ss_pred hCCCCcccccccCCCCCcHHHHH
Q 038422 551 TGKYPENYLLQGYDSKASLSNWV 573 (634)
Q Consensus 551 tg~~P~~~~~~~~~~~~~l~~~~ 573 (634)
.|+.||-....+.. ...+.+|-
T Consensus 866 ~g~~pf~~~tp~~t-q~kv~nw~ 887 (1034)
T KOG0608|consen 866 VGQPPFLADTPGET-QYKVINWR 887 (1034)
T ss_pred hCCCCccCCCCCcc-eeeeeehh
Confidence 99999964433322 24455663
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=276.59 Aligned_cols=239 Identities=21% Similarity=0.300 Sum_probs=177.8
Q ss_pred hccccCccCce-eEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFG-ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+++|.|+-| .||+|.+ +|+.||||++-.. .-.-..+|++.|..- +|||||++++.-.+++..||..|.|. -
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 34679999998 6899997 6789999987542 233567899999887 69999999999888899999999996 4
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---C--CCeEEeccccCCccC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---S--FEPLLTDYALRPLIN 511 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~--~~~kl~DfGla~~~~ 511 (634)
+|.+++...... .....-...+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++.+.
T Consensus 588 sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 588 SLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 999999874111 01011134567889999999999996 7999999999999976 2 579999999998876
Q ss_pred CCC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 512 PDN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTG-KYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 512 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg-~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.+. ...||-+|+|||.+....-+..+||+|+|||+|..+|| +.||... +...+ +.+.....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~---------~~R~~-NIl~~~~~- 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS---------LERQA-NILTGNYT- 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch---------HHhhh-hhhcCccc-
Confidence 543 23567899999999988888899999999999999995 8998522 11111 11111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
++ .+ .. ....+..+++. +++..+|..||++.+|+.
T Consensus 732 --L~-~L-~~-~~d~eA~dLI~---~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 --LV-HL-EP-LPDCEAKDLIS---RMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --ee-ee-cc-CchHHHHHHHH---HhcCCCcccCCCHHHHhC
Confidence 00 01 11 11124445555 999999999999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=257.52 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=189.5
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCC-C-C----ccccceeEEEeCCceEEEEEcC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-H-P----NLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+|+|+||.|-.+... .+..||+|+++.. ...++...-|++++.++. + | -+|.+.++|.-.++.++|+|.+
T Consensus 95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 56999999999999854 4789999998765 344567778999999993 2 2 3788888898899999999998
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC------------------
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR------------------ 495 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~------------------ 495 (634)
|-|+.++|.++.- .+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 174 -G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 174 -GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred -ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 5699999976543 3589999999999999999999998 7999999999999831
Q ss_pred --CCCeEEeccccCCccCCCCCc-cccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHH
Q 038422 496 --SFEPLLTDYALRPLINPDNAH-TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNW 572 (634)
Q Consensus 496 --~~~~kl~DfGla~~~~~~~~~-~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~ 572 (634)
+..+||+|||-|....+.... ..|--|+|||++.+-.++.++||||+||||.|+.||..-|. ..++.+++ ..
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq----tHen~EHL-aM 320 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ----THENLEHL-AM 320 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc----cCCcHHHH-HH
Confidence 345899999999887665533 45667999999999999999999999999999999998765 12221222 11
Q ss_pred HHHHH-----------------HhccCCccccccccc---------------CCCCHHHHHHHHHHHhcccccCccCCCC
Q 038422 573 VNNMV-----------------KEKRTGDVFDKEMKG---------------AKYSKSEMINLLKIGLSCCEEDVLARME 620 (634)
Q Consensus 573 ~~~~~-----------------~~~~~~~~~d~~~~~---------------~~~~~~~~~~~~~l~~~C~~~~P~~RPs 620 (634)
+...+ ..+++ ++-+....+ -.....+..++++|+..++..||.+|+|
T Consensus 321 MerIlGp~P~~mi~r~~~~Kyf~~~rl-dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 321 MERILGPIPSRMIKKTRKEKYFRRGRL-DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHhhCCCcHHHhhhhhhHhhhhcccc-cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 11111 11100 000000000 0123456778899999999999999999
Q ss_pred HHHHHH
Q 038422 621 LKEVIE 626 (634)
Q Consensus 621 ~~evl~ 626 (634)
+.|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=259.75 Aligned_cols=197 Identities=25% Similarity=0.312 Sum_probs=170.6
Q ss_pred CCHHHHHHhhccccCccCceeEEEEEEcCCc-EEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCc
Q 038422 350 FDLQDMLRASAEVLGSGTFGASYKTVISNGQ-AYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE 425 (634)
Q Consensus 350 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 425 (634)
..++++.+ ...||-|+||.|-........ .+|+|.+++.. ....+....|-++|..++.|.||++|--|.+...
T Consensus 417 v~l~dl~~--iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDLKR--IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhhhh--hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34444433 235999999999998865433 37888777643 3344567889999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
.|++||-|-||.|...|+... .++......|+..+.+|++|||++ +||.|||||+|+++|.++-+|+.|||
T Consensus 495 vYmLmEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehh
Confidence 999999999999999997654 388888999999999999999998 89999999999999999999999999
Q ss_pred cCCccCCCCC---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 506 LRPLINPDNA---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 506 la~~~~~~~~---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+|+.+..... .++|+.|.|||.+.....+..+|.||+|+++|||+||++||+
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs 620 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS 620 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9998877654 457888999999999999999999999999999999999997
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=239.06 Aligned_cols=210 Identities=20% Similarity=0.287 Sum_probs=173.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+||+|+|++|..+++. +.+.+|+|++++.- ..+.+-.+.|-.+..+. +||.+|.+..+|.+....++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 468999999999999854 57789999887542 22233355666666555 79999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.-+++..++ +++..+..+..+|..||.|||+. +|+.||||..|+|+|..+++|++|||+.+.--..
T Consensus 335 ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 335 GGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred Ccceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999988876543 99999999999999999999998 8999999999999999999999999998753222
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
....+|+.|+|||.+.+..|+...|.|++||+|+||+.|+.||+..- ....+++..+++.+.+-+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg-m~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG-MDNPDMNTEDYLFQVILE 473 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec-CCCcccchhHHHHHHHhh
Confidence 34567889999999999999999999999999999999999998433 333345566666555544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=230.33 Aligned_cols=206 Identities=32% Similarity=0.485 Sum_probs=178.0
Q ss_pred cCccCceeEEEEEEcC-CcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhh
Q 038422 363 LGSGTFGASYKTVISN-GQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 440 (634)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999765 889999998764332 34689999999999999999999999999899999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccCCC----CC
Q 038422 441 KLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 441 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~----~~ 515 (634)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. +..++|+|||.+...... ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 987543 2389999999999999999999998 7999999999999999 899999999998765443 22
Q ss_pred ccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 516 HTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
......|++||..... .++.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3345679999999877 788999999999999999
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 234556669999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=222.72 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=185.2
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCC--ceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKE--EKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv~e~~~~ 435 (634)
.+.+|+|.|+.||.|. ..+.+.++||+++.. ..+.+.+|+++|..++ ||||++++++..+.. ...||+||+.+
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 3579999999999998 567888999998753 4578899999999997 999999999998765 46799999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINPDN 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~ 514 (634)
-+....-. .|+-.++..++.++++||.|+|+. ||+|||+||.|++||.. -..+++|+|+|.++.+..
T Consensus 120 ~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 120 TDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 87765542 378888999999999999999998 89999999999999965 468999999999987765
Q ss_pred Ccc---ccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHH--------HHHHhccC
Q 038422 515 AHT---LMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVN--------NMVKEKRT 582 (634)
Q Consensus 515 ~~~---~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~--------~~~~~~~~ 582 (634)
... .+-.|.-||.+.. ..|+..-|+|||||++.+|+..+.||- .+.+...+++..++ ..+..-.+
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF---hG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF---HGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc---CCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 443 3345888998875 468889999999999999999999985 23333333433321 11111111
Q ss_pred Cccccccccc----------------CC--CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKG----------------AK--YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~----------------~~--~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+|+++.+ +. ....++.++++ ..+..|-.+|||++|...
T Consensus 265 --~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlld---klLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 --DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLD---KLLRYDHQERLTAKEAMA 321 (338)
T ss_pred --CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHH---HHHhhccccccchHHHhc
Confidence 12222211 00 01245555555 888999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=251.36 Aligned_cols=189 Identities=25% Similarity=0.339 Sum_probs=162.5
Q ss_pred hccccCccCceeEEEEEEcC-CcEEEEEEecccCcc--------ChhHHHHHHHHHhcCC---CCccccceeEEEeCCce
Q 038422 359 SAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNV--------GREDFQEHIKRLGRLE---HPNLLPLTAFYYRKEEK 426 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 426 (634)
+.+.+|+|+||.|+.+.++. ...|++|.+.+.... ..-..--||+||..++ |+||++++++|++++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 45679999999999999754 568889988654211 1123567999999997 99999999999999999
Q ss_pred EEEEEcC-CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 427 LLLYEFV-ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 427 ~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
||+||-- ++-+|.+++.... .+++.++..|+.||+.|+++||+. +|||||||-+|+.+|.++.+|++|||
T Consensus 645 yl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred EEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeecc
Confidence 9999964 5678999986543 399999999999999999999998 89999999999999999999999999
Q ss_pred cCCccCCC--CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCc
Q 038422 506 LRPLINPD--NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 506 la~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~ 556 (634)
-+.+.... ....+|+.|.|||++.+.+| +..-|||++||+||-++....||
T Consensus 716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99877655 45678999999999999887 56789999999999999988886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=227.90 Aligned_cols=190 Identities=30% Similarity=0.458 Sum_probs=166.7
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 3679999999999999765 889999998765444 56789999999999999999999999999899999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++...... +++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 84 LFDYLRKKGGK----LSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHHhcccC----CCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99998754321 78999999999999999999998 7999999999999999999999999998776543
Q ss_pred -CCccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYA-HNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~-~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+...|++||.. ....++.++|||+||++++||++|+.||+
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 233445679999998 66678889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=233.82 Aligned_cols=187 Identities=22% Similarity=0.373 Sum_probs=156.5
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCC-----ceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~ 432 (634)
+.||-|+||.||.... ++|+.|+.|++... +-...+.+.+|+++|..++|.|++..+++..... +.|+|.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999885 46899999988542 2334578889999999999999999999876543 57889999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|. -+|..++... ..++-..++-+.+||++||.|||+. +|.||||||.|.|++.+...||+|||+++....
T Consensus 139 mQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 85 4777766432 2488888999999999999999998 899999999999999999999999999998766
Q ss_pred CCCcc-----ccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 DNAHT-----LMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~~~~~-----~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+.... .|..|+|||.+.+. .|+...||||.||++.|++-.+.-|.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 54432 35679999999975 68999999999999999998876664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-28 Score=253.76 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=192.9
Q ss_pred cccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
..+|+|+||.|||++ ...++..|+|.++-....+-.-.++|+-+++..+|||||.++|.|...+..++.||||.+|+|+
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ 100 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ 100 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence 579999999999999 4568899999998776666677889999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC----CCCC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN----PDNA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~----~~~~ 515 (634)
+.-+... ++++.++..++++..+|++|||+. +-+|||||-.|||+++.+.+|++|||.+..+. ....
T Consensus 101 diy~~Tg-----plselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 101 DIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred ceeeecc-----cchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 8766443 489999999999999999999998 67899999999999999999999999975543 3455
Q ss_pred ccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc-cccc
Q 038422 516 HTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD-KEMK 591 (634)
Q Consensus 516 ~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~~~ 591 (634)
..||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|.... ..... ..-+ ....++ +.++
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-------hpmr~-l~Lm-----TkS~~qpp~lk 238 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-------HPMRA-LFLM-----TKSGFQPPTLK 238 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-------chHHH-HHHh-----hccCCCCCccc
Confidence 67899999999875 467899999999999999998888884311 11111 1111 112222 2333
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+..-..+-+..+++ .|+..+|++||+++.++.
T Consensus 239 Dk~kws~~fh~fvK---~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVK---GALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHH---HHhcCCCccCCChhhhee
Confidence 32233455667777 789999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=226.53 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=179.3
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEEE
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLYE 431 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~e 431 (634)
..+|.|+- .|..+.. -.++.||+|++... .....+...+|...+..+.|+||++++.+|.... +.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 35677666 4554442 24788999887543 2233467789999999999999999999996543 5799999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
||. ++|...++.. ++-..+..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+...
T Consensus 102 ~m~-~nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 102 LMD-ANLCQVILME-------LDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hhh-hHHHHHHHHh-------cchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhcccC
Confidence 995 5888887622 66778899999999999999998 89999999999999999999999999997654
Q ss_pred CC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc----
Q 038422 512 PD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD---- 584 (634)
Q Consensus 512 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---- 584 (634)
.. .....+-.|.|||++.+..+.+.+||||.||++.||++|+.-|. ++..+.+|.+..-.-+...+
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~-------g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP-------GKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec-------CchHHHHHHHHHHHhcCCCHHHHH
Confidence 43 33445667999999999899999999999999999999997654 23455556432211111110
Q ss_pred -----------------------cc-ccccccCCC-CHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 -----------------------VF-DKEMKGAKY-SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 -----------------------~~-d~~~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+ |-.+..... +.-.....-+++.+++..+|++|-+++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 101110000 1112223334556999999999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=229.60 Aligned_cols=127 Identities=24% Similarity=0.322 Sum_probs=106.0
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-----C---CccccceeEEEeC----Cc
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-----H---PNLLPLTAFYYRK----EE 425 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~----~~ 425 (634)
..++||=|.|++||.++. ...+.||+|+.+.. ....+....||++|++++ | .+||+|++.|... .+
T Consensus 82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred EEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 347899999999999995 45678888887754 445667789999999983 3 3699999999753 47
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 493 (634)
.+||+|++ |-+|..+|....- ..++...+++|++||+.||.|||++| +|+|-||||+|||+
T Consensus 161 VCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 89999999 5688888876543 24899999999999999999999998 89999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=215.68 Aligned_cols=257 Identities=18% Similarity=0.341 Sum_probs=178.4
Q ss_pred CCCCHHHHHHhhccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeE-EEeCC
Q 038422 348 EPFDLQDMLRASAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAF-YYRKE 424 (634)
Q Consensus 348 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~ 424 (634)
+..+++|.. ...+.+|+|.||.+-.+.++. .+.+++|.+... ....++|.+|...--.| .|.||+.-|++ |+..+
T Consensus 18 ~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 18 KKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 344555542 345679999999999999765 567788877543 45668899998765555 58999987654 56677
Q ss_pred ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC--CCCCeEEe
Q 038422 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD--RSFEPLLT 502 (634)
Q Consensus 425 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~ 502 (634)
.+.+++||++.|+|..-+... .+-+....+++.|++.|+.|+|++ .+||||||.+||||- +...+|++
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred eEEEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEee
Confidence 888999999999999877543 377888899999999999999999 799999999999993 33579999
Q ss_pred ccccCCccCCCC-CccccccccCcccccC---C--CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHH
Q 038422 503 DYALRPLINPDN-AHTLMVAYKSPEYAHN---G--KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM 576 (634)
Q Consensus 503 DfGla~~~~~~~-~~~~~~~y~aPE~~~~---~--~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 576 (634)
|||+++.....- ....+..|.|||.... + ...+.+|||.||++++.++||+.||+..... .....+|....
T Consensus 166 DFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 166 DFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQWL 242 (378)
T ss_pred ecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHHh
Confidence 999986543321 1123456899987653 2 3467899999999999999999999833222 13344443322
Q ss_pred HHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 577 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
.+... .+...++ .++ +-+.++. .+-+..+|++|-...++-++.
T Consensus 243 --~rk~~-~~P~~F~--~fs-~~a~r~F---kk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 243 --KRKNP-ALPKKFN--PFS-EKALRLF---KKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --cccCc-cCchhhc--ccC-HHHHHHH---HHhcCCcccccchhHHHHHHH
Confidence 22111 1111221 122 2222333 367788888886666655543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=266.19 Aligned_cols=191 Identities=16% Similarity=0.133 Sum_probs=137.7
Q ss_pred hcCCC-CccccceeEE-------EeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038422 406 GRLEH-PNLLPLTAFY-------YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477 (634)
Q Consensus 406 ~~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 477 (634)
+.++| +||++++++| ...+..+.++||+ +++|.++|.... ..+++.+++.|+.||++||+|||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 34566 6888899987 2334567888988 569999996432 2499999999999999999999998
Q ss_pred CCCccccCCCCCCEEeCC-------------------CCCeEEeccccCCccCCC--------------------CCccc
Q 038422 478 GSIIPHGHLKSSNVLLDR-------------------SFEPLLTDYALRPLINPD--------------------NAHTL 518 (634)
Q Consensus 478 ~~~ivHrdlk~~NILl~~-------------------~~~~kl~DfGla~~~~~~--------------------~~~~~ 518 (634)
+|+||||||+|||++. ++.+|++|||+++..... ....+
T Consensus 100 --gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 100 --GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred --CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 8999999999999953 456777888877642110 01234
Q ss_pred cccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHH
Q 038422 519 MVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKS 598 (634)
Q Consensus 519 ~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 598 (634)
|..|||||++.+..++.++|||||||+||||++|..|+... ...+..+. .. ...+.. ..
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~~-----~~----~~~~~~------~~ 236 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSLR-----HR----VLPPQI------LL 236 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHHH-----Hh----hcChhh------hh
Confidence 66799999999999999999999999999999998885410 01111111 10 011111 01
Q ss_pred HHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 599 EMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 599 ~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+...++..||+.+|.+||+|.||++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1223456667999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=210.04 Aligned_cols=170 Identities=20% Similarity=0.197 Sum_probs=123.8
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|+|.+++..... .++|.++..|+.||+.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc-
Confidence 789999975432 399999999999999999999987 3 999999999999999 99987765433
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..++..|||||++.+..++.++|||||||++|||+||+.||... .................. +.......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE-------RELSAILEILLNGMPADD---PRDRSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc-------chhcHHHHHHHHHhccCC---ccccccHH
Confidence 35678999999999999999999999999999999999998521 111122222111111000 00000000
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
...+...+.+++.+||+.+|++||++.|+++.+..+.
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0111124666777999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=233.29 Aligned_cols=189 Identities=20% Similarity=0.249 Sum_probs=158.4
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCC------CCccccceeEEEeCCceEEEEEcC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE------HPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
...|+|-|++|.+|... .|+.||||++... +...+.=..|+++|++|. --|+++|+-.|....++|||+|-+
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L 516 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL 516 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence 45799999999999954 4889999999764 333344568999999994 348999999999999999999988
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINP 512 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~ 512 (634)
. -+|.+.|...+.. ..|....+..|+.|+..||..|-.. +|+|.||||.|||+++. ...||||||-|.....
T Consensus 517 s-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 517 S-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred h-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcceeeeccCcccccccc
Confidence 5 5899999866543 3488889999999999999999876 89999999999999876 5689999999887665
Q ss_pred CCC--ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 DNA--HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~~~--~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... +..+-.|.|||.+.+..|+...|+||.||.||||.||+.-|.
T Consensus 590 neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 590 NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 432 223445999999999999999999999999999999997764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-25 Score=206.75 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=181.8
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+|.+...|..|+|+++ |..+++|+++.. .....++|.+|.-.|+-+.||||..++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35788889999999996 455666766543 333457899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCccc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL 518 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 518 (634)
+..|++...- .++-.++.+++.+||+|++|||+..+ -|.--.|.+..+++|++.+++|+- +-.++.........
T Consensus 275 ynvlhe~t~v---vvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarism-ad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 275 YNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVGRAY 348 (448)
T ss_pred HHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheec-ccceeeeecccccc
Confidence 9999876432 36778899999999999999999742 355567999999999999998751 11222122222334
Q ss_pred cccccCcccccCCCCC---cchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 519 MVAYKSPEYAHNGKIS---KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 519 ~~~y~aPE~~~~~~~~---~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
.+.||+||.++..+-+ ..+|+|||.|++||+.|...||....+...+ +.+ .+ ++ ..- .+ ++.
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-mki------al-eg-lrv----~i--ppg 413 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-MKI------AL-EG-LRV----HI--PPG 413 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-hhh------hh-cc-ccc----cC--CCC
Confidence 5789999999876543 5789999999999999999999743322111 000 00 11 111 11 112
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
...-+.++++ -|...||.+||.++.|+-.|++..
T Consensus 414 is~hm~klm~---icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 ISRHMNKLMN---ICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccHHHHHHHH---HHhcCCCCcCCCcceehhhHHHhc
Confidence 2334555555 799999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=217.18 Aligned_cols=187 Identities=21% Similarity=0.374 Sum_probs=156.3
Q ss_pred ccccCccCceeEEEEEEc----CCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||+|.|++||++... ..+.||+|.+...+ ....+..|+++|..+ -+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 468999999999999854 36789999987643 345688999999998 48999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCcc---
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLI--- 510 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~--- 510 (634)
.-...++... ++..++..+++.+.+||.|+|++ +||||||||+|+|.+.. +.-.|.|||+|...
T Consensus 119 H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 119 HDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9988888753 77899999999999999999999 89999999999999865 45679999997511
Q ss_pred --------------CC-C------------------------------CCccccccccCcccccCC-CCCcchhHHHHHH
Q 038422 511 --------------NP-D------------------------------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGI 544 (634)
Q Consensus 511 --------------~~-~------------------------------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGv 544 (634)
.+ . ....||.||+|||++... .-+++.||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 00 0 012357889999998753 4688999999999
Q ss_pred HHHHHHhCCCCccccc
Q 038422 545 LILELLTGKYPENYLL 560 (634)
Q Consensus 545 vl~elltg~~P~~~~~ 560 (634)
|++-+++++.||-...
T Consensus 267 I~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAK 282 (418)
T ss_pred eeehhhccccccccCc
Confidence 9999999999986443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=251.14 Aligned_cols=185 Identities=34% Similarity=0.610 Sum_probs=129.2
Q ss_pred cCCccHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCCCCeeeEEec-CCcEEEEEecCCCCccccChhhhcCCCCcCEE
Q 038422 25 TFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCL-NGSVWGLKLEQMNLSGTIAAESLGLLSSLRAV 103 (634)
Q Consensus 25 ~~~~~~~~~l~~~k~~l~~~~~~l~~W~~~~~~C~~~~~~w~gv~C~-~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L 103 (634)
.....|+++|++||+++.+|.+.+.+|+...|||. |.||+|+ .++|+.|+|++++++|.+++ .+..+++|+.|
T Consensus 25 ~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~-----w~gv~c~~~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L 98 (968)
T PLN00113 25 MLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL-----WQGITCNNSSRVVSIDLSGKNISGKISS-AIFRLPYIQTI 98 (968)
T ss_pred CCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCc-----CcceecCCCCcEEEEEecCCCccccCCh-HHhCCCCCCEE
Confidence 33568899999999999888878899987788885 9999997 57999999999999998874 78889999999
Q ss_pred eccCCcCcccCCC--CCCCCCCcEEEccCCcCccccChh---------------------hhhCCCCCCeEEcccCcCcc
Q 038422 104 SFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDD---------------------AFEGMTSLKKLYMANNRLTG 160 (634)
Q Consensus 104 ~l~~n~l~g~~p~--~~~l~~L~~L~ls~N~~~g~ip~~---------------------~~~~~~~L~~l~l~~N~l~g 160 (634)
+|++|+++|.+|. +.++++|++|+|++|+++|.+|.. .++++++|++|+|++|.+++
T Consensus 99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~ 178 (968)
T PLN00113 99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG 178 (968)
T ss_pred ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc
Confidence 9999999888883 336777777777777776655521 14455555555555555555
Q ss_pred CCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 161 TIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 161 ~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
.+|.+++++++|++|+|++|+++|.+|.. ...+|+.|++++|+++|.+|..++++
T Consensus 179 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 235 (968)
T PLN00113 179 KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235 (968)
T ss_pred cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcC
Confidence 55555555555555555555555555543 23355555555555555555554443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=213.66 Aligned_cols=213 Identities=27% Similarity=0.392 Sum_probs=161.0
Q ss_pred HhcCCCCccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 038422 405 LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHG 484 (634)
Q Consensus 405 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHr 484 (634)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+..... .++|.....++++|++||+|||+. + ...|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~s--~-i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHNS--P-IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhcC--c-ceeee
Confidence 4678999999999999999999999999999999999987443 399999999999999999999986 1 33899
Q ss_pred CCCCCCEEeCCCCCeEEeccccCCccCCC------CCccccccccCcccccCC-------CCCcchhHHHHHHHHHHHHh
Q 038422 485 HLKSSNVLLDRSFEPLLTDYALRPLINPD------NAHTLMVAYKSPEYAHNG-------KISKKSDVWSLGILILELLT 551 (634)
Q Consensus 485 dlk~~NILl~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~-------~~~~k~DVwSfGvvl~ellt 551 (634)
.++++|+++|..+.+|++|||+....... .......-|.|||.+... ..+.++||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998776421 111122449999998763 14678999999999999999
Q ss_pred CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 552 GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 552 g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.+.||+........ ..+..++.. .....+-|.+.... +....++.++..||..+|.+||++++|-..++.+
T Consensus 154 r~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99999743222211 223333222 12222333332111 1122567777799999999999999999988876
Q ss_pred hc
Q 038422 632 KE 633 (634)
Q Consensus 632 ~~ 633 (634)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 43
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=206.48 Aligned_cols=152 Identities=18% Similarity=0.186 Sum_probs=117.6
Q ss_pred ccccCccCceeEEEEEEc--CCcEEEEEEeccc-----CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS--NGQAYVVKRYKQM-----NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|+.. +++.+|+|++... .....+.|.+|+++|++++|+|++..+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 467999999999999864 5777899986532 11234579999999999999999863322 2568999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCC-CCCCEEeCCCCCeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHL-KSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
+++++|... . . .. ...++.++++||+|||+. +|+|||| ||+|||++.++.+||+|||+++...
T Consensus 100 ~~G~~L~~~-~---~-----~~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 100 TEGVPLHLA-R---P-----HG---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cCCCCHHHh-C---c-----cc---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999632 1 1 11 146788999999999998 8999999 9999999999999999999998654
Q ss_pred CCCC------------ccccccccCcccccC
Q 038422 512 PDNA------------HTLMVAYKSPEYAHN 530 (634)
Q Consensus 512 ~~~~------------~~~~~~y~aPE~~~~ 530 (634)
.... ..++..|+|||++..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4321 123456999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-20 Score=190.31 Aligned_cols=253 Identities=26% Similarity=0.331 Sum_probs=186.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCC-ccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHP-NLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++......++++||+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 357899999999999976 78888988765433 367899999999999988 799999999777778999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPD- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~- 513 (634)
+++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999776654321 2388899999999999999999998 799999999999999988 7999999998754432
Q ss_pred ---------CCccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 514 ---------NAHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 514 ---------~~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
....++..|+|||.+.+ ..++...|+||+|++++++++|..|+..... ..........+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~-----~~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN-----SSATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc-----cccHHHHHHHHHhcC
Confidence 33456788999999987 5788999999999999999999999642110 001111222221111
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. ......... ........+.++...|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 000000000 001112344455558999999999999887653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-20 Score=190.69 Aligned_cols=251 Identities=19% Similarity=0.198 Sum_probs=184.3
Q ss_pred hccccCccCceeEEEEEEcCC--cEEEEEEecccCccChhHHHHHHHHHhcCCC----CccccceeEE-EeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISNG--QAYVVKRYKQMNNVGREDFQEHIKRLGRLEH----PNLLPLTAFY-YRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~lv~e 431 (634)
..+.||+|+||.||.+..... ..+|+|............+..|..++..+.+ +++..+++.. ..+...++||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 346899999999999996553 4788887765543333378888999888873 5788888887 46778899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-----CCeEEecccc
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-----FEPLLTDYAL 506 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-----~~~kl~DfGl 506 (634)
.+ +.+|.++..... ...++....+.|+.|++.+|++||+. +++||||||.|+++... ..+.+.|||+
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 87 779999775544 23499999999999999999999998 89999999999999865 4589999999
Q ss_pred CC--ccC-CC-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHH
Q 038422 507 RP--LIN-PD-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNW 572 (634)
Q Consensus 507 a~--~~~-~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~ 572 (634)
++ ... .. ....+|..|.++....+...+.+.|+||++.++.|+..|..||...... .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~----~~~~~- 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT----DLKSK- 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc----chHHH-
Confidence 98 321 11 1233788999999999999999999999999999999999999632211 11111
Q ss_pred HHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 573 VNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 573 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+.... .....+. . ......++..+.. .+-+.+..++|....+.+.|++..
T Consensus 249 ~~~~~----~~~~~~~-~--~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 249 FEKDP----RKLLTDR-F--GDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHh----hhhcccc-c--cCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHH
Confidence 11111 1111111 1 1223455555555 455589999999999999887653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-21 Score=213.95 Aligned_cols=148 Identities=34% Similarity=0.533 Sum_probs=87.4
Q ss_pred HHHHHHHHHHHhhccCCccHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCCCCeeeEEecC--C----cEEEEEecCCC
Q 038422 11 NVLHVLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN--G----SVWGLKLEQMN 84 (634)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~l~~~k~~l~~~~~~l~~W~~~~~~C~~~~~~w~gv~C~~--~----~v~~l~L~~~~ 84 (634)
++++++-+.. ........|.+||+.+|+++.++.. .+|+ .|+|.+..+.|.||.|.. . .|..|+|++++
T Consensus 355 NaiEI~~~~~-~~~~t~~~~~~aL~~~k~~~~~~~~--~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~ 429 (623)
T PLN03150 355 NAIEVFEIIT-AESKTLLEEVSALQTLKSSLGLPLR--FGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429 (623)
T ss_pred eeeeeeeccc-cccccCchHHHHHHHHHHhcCCccc--CCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCC
Confidence 4444443332 2333456789999999999986642 4896 368865555799999952 1 24555555555
Q ss_pred CccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCc
Q 038422 85 LSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS 164 (634)
Q Consensus 85 l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~ 164 (634)
|.|.+|. .+ +++++|+.|+|++|+|+|.+|+. ++.+++|+.|+|++|+|+|.+|.
T Consensus 430 L~g~ip~-~i-----------------------~~L~~L~~L~Ls~N~l~g~iP~~-~~~l~~L~~LdLs~N~lsg~iP~ 484 (623)
T PLN03150 430 LRGFIPN-DI-----------------------SKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGSIPE 484 (623)
T ss_pred ccccCCH-HH-----------------------hCCCCCCEEECCCCcccCcCChH-HhCCCCCCEEECCCCCCCCCCch
Confidence 5555543 34 44455555555555555555543 55555555555555555555555
Q ss_pred cccCCCCccEEeCCCCceeecCCc
Q 038422 165 SLVQLPKLMELRLEANKFQGQVPE 188 (634)
Q Consensus 165 ~~~~l~~L~~L~l~~N~~~g~ip~ 188 (634)
.+++|++|+.|+|++|+|+|.+|.
T Consensus 485 ~l~~L~~L~~L~Ls~N~l~g~iP~ 508 (623)
T PLN03150 485 SLGQLTSLRILNLNGNSLSGRVPA 508 (623)
T ss_pred HHhcCCCCCEEECcCCcccccCCh
Confidence 555555555555555555555554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=179.41 Aligned_cols=139 Identities=17% Similarity=0.217 Sum_probs=107.6
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCcc--C-------hhH-----------------HHHHHHHHhcCCCCccc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV--G-------RED-----------------FQEHIKRLGRLEHPNLL 414 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~niv 414 (634)
..||+|+||.||+|...+|+.||+|+++..... . ... ...|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999754211 1 112 23499999999888775
Q ss_pred cceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCccccCCCCCCEEe
Q 038422 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL-HNELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 415 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivHrdlk~~NILl 493 (634)
....+.. ...+|||||++++++....... ..+++.+...++.|++.+|+|+ |+. +|+||||||+|||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEE
Confidence 4333322 2348999999988776543322 1388999999999999999999 565 79999999999999
Q ss_pred CCCCCeEEeccccCCccC
Q 038422 494 DRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 494 ~~~~~~kl~DfGla~~~~ 511 (634)
++ +.++++|||++....
T Consensus 152 ~~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 HD-GKLYIIDVSQSVEHD 168 (190)
T ss_pred EC-CcEEEEEccccccCC
Confidence 84 789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=214.76 Aligned_cols=248 Identities=17% Similarity=0.243 Sum_probs=174.5
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChh----HHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGRE----DFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+++|.|++|.|+..... .....+.|..... ...... .+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3568999999988776633 3343444433210 111111 25567777888999999988888777776666699
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
||++ +|..++.... .++..++-.++.|+..|++|+|+. +|.|||+|++|++++.++.+||+|||.+....
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 9999987542 277888999999999999999998 89999999999999999999999999976543
Q ss_pred CCC--------CccccccccCcccccCCCCCcc-hhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 512 PDN--------AHTLMVAYKSPEYAHNGKISKK-SDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 512 ~~~--------~~~~~~~y~aPE~~~~~~~~~k-~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
-.. ...++-.|+|||.+.+..|++. .||||.||++..|++|+.||......... +. ...... .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~---~~----~~~~~~-~ 543 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS---FK----TNNYSD-Q 543 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc---hh----hhcccc-c
Confidence 221 2234567999999999999764 79999999999999999999754332221 10 000000 0
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..+..... ......-...-.++.++++.+|.+|-||++|++.
T Consensus 544 ~~~~~~~~---~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 RNIFEGPN---RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccChH---HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000000 0001112233456669999999999999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=167.65 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=185.3
Q ss_pred ccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCCC-CccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEH-PNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.+|.|. ..+|+.||+|.-.. ......+..|.++.+.++| ..|..+..|..++....+|||.. +.+
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 4679999999999998 67899999998543 2334567889999998876 45666777777888889999988 789
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccCCccCCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALRPLINPD- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~~- 513 (634)
|.+...-... .++.++.+.++-|++.-++|+|.+ +++||||||+|.|..-+ ..+.++|||+|+.+.+.
T Consensus 97 LEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 97 LEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred HHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9988764433 389999999999999999999998 69999999999998643 45789999999876442
Q ss_pred ----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 ----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 ----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
...++|.+|.+--...+..-+.+-|+=|+|.+|...--|..||+... ..-....++.+.+.+..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk------a~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK------AATKKQKYEKISEKKMS 242 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc------hhhHHHHHHHHHHhhcC
Confidence 23457788988777766677888999999999999999999997432 12222233344444333
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
-.++....+ -+.|+...+. .|-..--++-|+..-+.+.+.-+
T Consensus 243 ~~ie~LC~G---~P~EF~myl~---Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 TPIEVLCKG---FPAEFAMYLN---YCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCHHHHhCC---CcHHHHHHHH---HHhhcCCCCCCcHHHHHHHHHHH
Confidence 333333322 2345555555 78888888888887777665543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=172.67 Aligned_cols=140 Identities=18% Similarity=0.250 Sum_probs=110.2
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCcc---------------------C-----hhHHHHHHHHHhcCCCCccc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV---------------------G-----REDFQEHIKRLGRLEHPNLL 414 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~niv 414 (634)
..||+|+||.||+|+..+|+.||+|+++..... . ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999878999999998754211 0 11245789999999999886
Q ss_pred cceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCccccCCCCCCEEe
Q 038422 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN-ELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 415 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl 493 (634)
....+... ..++||||++++++....... ..++..+...++.|++.++.|+|+ . +|+||||||+||++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIll 151 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNILY 151 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEEE
Confidence 54444333 358999999988654432221 137788899999999999999999 6 89999999999999
Q ss_pred CCCCCeEEeccccCCccCC
Q 038422 494 DRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 494 ~~~~~~kl~DfGla~~~~~ 512 (634)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.9e-20 Score=177.51 Aligned_cols=164 Identities=14% Similarity=0.173 Sum_probs=127.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhH---------HHHHHHHHhcCCCCccccceeEEEeC-------
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRED---------FQEHIKRLGRLEHPNLLPLTAFYYRK------- 423 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~------- 423 (634)
.+++|.|+||.||.... ++..+|+|.+.......... +.+|++.+.+++|++|.....++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 57899999999999655 57789999997543322222 68999999999999999999886643
Q ss_pred -CceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 424 -EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 424 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
...++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||+++.++ ++++
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999987631 222 2456999999999998 899999999999999888 9999
Q ss_pred ccccCCccCCCCCccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 038422 503 DYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELL 550 (634)
Q Consensus 503 DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ell 550 (634)
|||..+......... .++....|+.++|+|||||++.-..
T Consensus 177 Dfg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence 999876553322211 1333445677999999999876553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-18 Score=169.06 Aligned_cols=252 Identities=14% Similarity=0.190 Sum_probs=189.0
Q ss_pred hhccccCccCceeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCC
Q 038422 358 ASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+++||+|.||..+.|+ +-+++.||||.-... ....++..|.+..+.|. -+.|..++.|-..+-+-.||+|.+ |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 346789999999999998 778999999974432 23346777888887774 578887777666677788999988 7
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-----CCeEEeccccCCcc
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-----FEPLLTDYALRPLI 510 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-----~~~kl~DfGla~~~ 510 (634)
.+|.|+..-... .++.++...||.|+..-++|+|++ .+|.|||||+|.||..- ..+.+.|||+|+.+
T Consensus 108 PSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 108 PSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred cCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 899998876554 399999999999999999999998 69999999999999643 45789999999876
Q ss_pred CCC-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 511 NPD-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 511 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
.+. ....+|.+||+--...+.+-+.+-|.=|+|-+++..+-|..||..+... --...++.+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~------tnK~kYeKIGe 253 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD------TNKEKYEKIGE 253 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc------chHHHHHHhcc
Confidence 543 2345788999999888888899999999999999999999999744221 11222233333
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+..--++..+.+ -++|+...++.+.+ .+-.+-|+.+-+...+..+.
T Consensus 254 ~Kr~T~i~~Lc~g---~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 254 TKRSTPIEVLCEG---FPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ccccCCHHHHHhc---CHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHH
Confidence 2222222222222 35677777776653 67778888887777766553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=168.82 Aligned_cols=134 Identities=16% Similarity=0.212 Sum_probs=105.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC-----CCCccccceeEEEeCC---ceE-EEE
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-----EHPNLLPLTAFYYRKE---EKL-LLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~-lv~ 430 (634)
.+.||+|+||.||. .++....+||++........+++.+|+++++.+ +||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 433333468887655444567899999999999 6799999999998863 333 789
Q ss_pred Ec--CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCCccccCCCCCCEEeCC----CCCeEEec
Q 038422 431 EF--VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM-AYLHNELPGSIIPHGHLKSSNVLLDR----SFEPLLTD 503 (634)
Q Consensus 431 e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~ivHrdlk~~NILl~~----~~~~kl~D 503 (634)
|| +.+|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 6689999999542 15554 35678888888 999998 7999999999999974 34799999
Q ss_pred cccC
Q 038422 504 YALR 507 (634)
Q Consensus 504 fGla 507 (634)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=162.71 Aligned_cols=176 Identities=17% Similarity=0.142 Sum_probs=130.5
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccC----hhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG----REDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..|++|+||+||.+.. ++..++.+.+....... ...+.+|+++|+++. |+++++++++ +..+++|||+.+
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 5799999999997665 66777777766543211 235889999999995 5789888886 457999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCC-CCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHL-KSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
.+|.+.+.. ....++.|++.+|+|+|+. +|+|||| ||+|||++.++.++|+|||++.......
T Consensus 83 ~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 83 AAMYQRPPR------------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ccHHhhhhh------------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 888654311 1135778999999999998 8999999 7999999999999999999998554332
Q ss_pred Cc-----------------cccccccCcccccCC-CCC-cchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 AH-----------------TLMVAYKSPEYAHNG-KIS-KKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ~~-----------------~~~~~y~aPE~~~~~-~~~-~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ..+..|++|+-..-. ..+ ...+.++-|.-+|.++|+..+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 012335555432211 223 46789999999999999998854
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=199.26 Aligned_cols=240 Identities=23% Similarity=0.299 Sum_probs=172.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEeccc-CccChhHHHHHHHH--HhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQM-NNVGREDFQEHIKR--LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||++.|=+|.+|+.++|. |+||++.+. .....+.|.++++- .+.++|||.+++.-+-......|||-+|+.+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 467999999999999998888 777877544 35556666655444 4456899999988877677778899999965
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC--ccCCCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP--LINPDN 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~--~~~~~~ 514 (634)
+|+|.|..+ +-+...+.+-|+.|++.||.-+|.. +|+|+|||.+|||++.-.=+.++||.--+ ++..++
T Consensus 106 nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 106 NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 899888643 3478888899999999999999998 89999999999999988888999997533 233332
Q ss_pred Cc---------cccccccCcccccCC-----------CCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHH
Q 038422 515 AH---------TLMVAYKSPEYAHNG-----------KISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWV 573 (634)
Q Consensus 515 ~~---------~~~~~y~aPE~~~~~-----------~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~ 573 (634)
.. ..-..|+|||.+... ..+++-||||.||++.|+++ |++||... ++..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------QL~aY- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------QLLAY- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------HHHhH-
Confidence 21 112459999987541 25788999999999999998 78887521 11111
Q ss_pred HHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 574 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
+.+. -.|+...-...... .+-++.+.+++.||++|-++++.++.-.
T Consensus 248 ----r~~~---~~~~e~~Le~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 ----RSGN---ADDPEQLLEKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ----hccC---ccCHHHHHHhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1110 11111100001111 2345666899999999999999998744
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-20 Score=193.73 Aligned_cols=185 Identities=25% Similarity=0.321 Sum_probs=156.2
Q ss_pred ccCccCceeEEEEE----EcCCcEEEEEEecccCccC--hhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCC
Q 038422 362 VLGSGTFGASYKTV----ISNGQAYVVKRYKQMNNVG--REDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
++|+|+||.|+.++ ...|..++.|..++..... +.....|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999755 3346778888876543222 224456777888887 9999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|...+.... .++......+...+|.+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-+..
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999988775443 277777788889999999999998 89999999999999999999999999999877666
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|||||++. .....+|.||||++++||+||..||.
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 668899999999987 56778999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-17 Score=157.78 Aligned_cols=134 Identities=19% Similarity=0.300 Sum_probs=113.0
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCcc--------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV--------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
+.||+|++|.||+|.. +|..+++|+....... ....+.+|++++..++|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 6777888876543211 124578899999999999998888888788889999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
+++++|.+++... .+ .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988532 22 7788999999999999998 799999999999999 78899999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=157.13 Aligned_cols=131 Identities=18% Similarity=0.279 Sum_probs=107.5
Q ss_pred ccCccCceeEEEEEEcCCcEEEEEEecccCcc--------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 362 VLGSGTFGASYKTVISNGQAYVVKRYKQMNNV--------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.||+|+||.||+|.. ++..+++|........ ..+.+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5678888886543211 1245778999999999988776666666777889999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
++++|.+.+.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998874321 0 7899999999999998 899999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-17 Score=163.40 Aligned_cols=230 Identities=20% Similarity=0.330 Sum_probs=141.7
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCc---cChhHHHHHHHHHhcCCC----------CccccceeEEE----
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEH----------PNLLPLTAFYY---- 421 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~---- 421 (634)
.+.||.|+|+.||.++..+ ++.+|+|+...... ...+++.+|.-....+.+ -.++--++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4679999999999999754 89999998854332 223566676655555432 11222122221
Q ss_pred -----eCC--------ceEEEEEcCCCCChhhHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCC
Q 038422 422 -----RKE--------EKLLLYEFVENGSLAGKLHANHT--KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHL 486 (634)
Q Consensus 422 -----~~~--------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl 486 (634)
... ..+++|+-+ .+||.+++..-.. .....+....++.+..|+.+-+++||+. +++|+||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlVHgdi 171 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----GLVHGDI 171 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEEEST-
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----ceEeccc
Confidence 111 235677777 5688887653111 1112245566778889999999999998 8999999
Q ss_pred CCCCEEeCCCCCeEEeccccCCccCCCCC-ccccccccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 487 KSSNVLLDRSFEPLLTDYALRPLINPDNA-HTLMVAYKSPEYAHN--------GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 487 k~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
||+|++++.++.++++||+.......... ...+..|.+||.... ..++.+.|.|++|+++|.|..+..||+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 99999999999999999986544333222 233466999997643 257889999999999999999999987
Q ss_pred cccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCC
Q 038422 558 YLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLAR 618 (634)
Q Consensus 558 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 618 (634)
........ +| .+.......+.++.++. ..++.+|.+|
T Consensus 252 ~~~~~~~~-----~~----------------~f~~C~~~Pe~v~~LI~---~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADP-----EW----------------DFSRCRDMPEPVQFLIR---GLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTS-----GG----------------GGTTSS---HHHHHHHH---HHT-SSGGGS
T ss_pred CCCccccc-----cc----------------cchhcCCcCHHHHHHHH---HHccCCcccC
Confidence 43222211 00 12121233455666666 8899999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=160.38 Aligned_cols=140 Identities=17% Similarity=0.242 Sum_probs=106.3
Q ss_pred hccccCccCceeEEEEE--EcCCcEEEEEEecccCcc------------------------ChhHHHHHHHHHhcCCCCc
Q 038422 359 SAEVLGSGTFGASYKTV--ISNGQAYVVKRYKQMNNV------------------------GREDFQEHIKRLGRLEHPN 412 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n 412 (634)
..+.||+|+||.||+|+ ..+|+.||+|.++..... ....+..|++.+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 35789999999999998 568999999998743210 0123568999999997633
Q ss_pred cccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC-ccccCCCCCCE
Q 038422 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI-IPHGHLKSSNV 491 (634)
Q Consensus 413 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrdlk~~NI 491 (634)
+.+..++.. ...++||||+++++|........ .+...+...++.|++.+++|||+. + |+||||||+||
T Consensus 112 -i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~NI 180 (237)
T smart00090 112 -VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEYNI 180 (237)
T ss_pred -CCCCeeeEe-cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChhhE
Confidence 222222222 34589999999988876542221 255566788999999999999998 7 99999999999
Q ss_pred EeCCCCCeEEeccccCCcc
Q 038422 492 LLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 492 Ll~~~~~~kl~DfGla~~~ 510 (634)
+++ ++.++++|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 789999999998654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=178.03 Aligned_cols=133 Identities=20% Similarity=0.268 Sum_probs=108.5
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEeccc-Cc------cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQM-NN------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|.+.....++.++..+. .. ...+.+.+|++++++++|++++....++.+....++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 4789999999999998765544333333221 11 1124688999999999999999888888887888999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999998874 3467899999999999998 79999999999999 5778999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=151.52 Aligned_cols=134 Identities=14% Similarity=0.166 Sum_probs=105.1
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCcc----------------------ChhHHHHHHHHHhcCCCCc--cc
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV----------------------GREDFQEHIKRLGRLEHPN--LL 414 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n--iv 414 (634)
..+.||+|+||.||++...+|+.||||++...... ....+..|+.++.++.|++ +.
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~ 98 (198)
T cd05144 19 LGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP 98 (198)
T ss_pred cCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence 35789999999999999888999999987542210 1123677889999998874 33
Q ss_pred cceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC
Q 038422 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD 494 (634)
Q Consensus 415 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~ 494 (634)
..++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+||||||+||+++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill~ 159 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILVD 159 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEEc
Confidence 3333 3456899999999998765321 23456889999999999997 899999999999999
Q ss_pred CCCCeEEeccccCCccC
Q 038422 495 RSFEPLLTDYALRPLIN 511 (634)
Q Consensus 495 ~~~~~kl~DfGla~~~~ 511 (634)
+++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=157.61 Aligned_cols=192 Identities=18% Similarity=0.256 Sum_probs=128.1
Q ss_pred CCCccccceeEEEeC---------------------------CceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHH
Q 038422 409 EHPNLLPLTAFYYRK---------------------------EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI 461 (634)
Q Consensus 409 ~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 461 (634)
+|||||+++++|.+. ...|+||.-+.. +|.+++...+ .+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 599999999998752 236899987754 8999997654 344556678
Q ss_pred HHHHHHHHHHHHhcCCCCCccccCCCCCCEEe--CCCCC--eEEeccccCCccCC---------CC-CccccccccCccc
Q 038422 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL--DRSFE--PLLTDYALRPLINP---------DN-AHTLMVAYKSPEY 527 (634)
Q Consensus 462 ~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl--~~~~~--~kl~DfGla~~~~~---------~~-~~~~~~~y~aPE~ 527 (634)
+.|+++|+.|||.+ +|.|||+|++|||+ |+|.. ..|+|||.+-..+. +. ...+...-||||+
T Consensus 347 laQlLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 89999999999998 89999999999998 44544 56899997532211 11 1123345899998
Q ss_pred ccCCC-----C-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHH
Q 038422 528 AHNGK-----I-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMI 601 (634)
Q Consensus 528 ~~~~~-----~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 601 (634)
..... . -.|+|.|+.|.+-||+++...||.. + +++.+..-- +++.... .+.. .....
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--r---Gem~L~~r~---Yqe~qLP-----alp~--~vpp~-- 485 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--R---GEMLLDTRT---YQESQLP-----ALPS--RVPPV-- 485 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc--c---chheechhh---hhhhhCC-----CCcc--cCChH--
Confidence 86431 1 2589999999999999999999852 1 112221111 1111111 1100 01112
Q ss_pred HHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 602 NLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 602 ~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
+-++...-++.||++|++..-..+.|+
T Consensus 486 -~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 486 -ARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -HHHHHHHHhcCCccccCCccHHHhHHH
Confidence 233445778899999999876665554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.8e-16 Score=173.75 Aligned_cols=185 Identities=22% Similarity=0.280 Sum_probs=144.1
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCC---CCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE---HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+...||+|+||+||+|...+|+.||+|+-+..... +|.--.+++.+|+ -+-|..+...+.-.+.-+||+||.+.
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 34679999999999999888999999987654322 1222233444444 23445555555567778999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-------CCCCeEEeccccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-------RSFEPLLTDYALRP 508 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-------~~~~~kl~DfGla~ 508 (634)
|+|.+++... ..++|.-.+.++.|+++-++.||.. +|||+||||+|.||. +...++|+|||.+-
T Consensus 779 Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 779 GTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999732 3489999999999999999999998 799999999999994 33458999999874
Q ss_pred ccC---CC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 038422 509 LIN---PD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 509 ~~~---~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P 555 (634)
-+. +. .....|-.+-.+|+..+..++..+|-|.+.-+++-|+.|++-
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 332 22 123345668889999999999999999999999999999853
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=138.64 Aligned_cols=134 Identities=19% Similarity=0.192 Sum_probs=111.7
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCC--CccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEH--PNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++.++++++..++..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999999755 7889998765433 5679999999999977 5888998888877889999999998776
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
..+ +......++.+++.+++++|.... .+++|+|++|+||++++...+++.|||.+...
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~-~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPL-LVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCc-eEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 543 455667889999999999998532 25999999999999999899999999987653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-16 Score=164.19 Aligned_cols=118 Identities=24% Similarity=0.354 Sum_probs=102.1
Q ss_pred ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 425 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
..|+.|++|...+|.++|...... ...+|...+.++.|++.|++| + +.+|||+||.||+...+...||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhh
Confidence 468999999999999999755443 347888899999999999999 3 6889999999999999999999999
Q ss_pred ccCCccCCCC----------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 038422 505 ALRPLINPDN----------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT 551 (634)
Q Consensus 505 Gla~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt 551 (634)
|+...+.... ...+|..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9976544332 2346788999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.7e-15 Score=139.83 Aligned_cols=136 Identities=18% Similarity=0.262 Sum_probs=96.6
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccC--hhH----------------------HHHHHHHHhcCCCCc--cc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG--RED----------------------FQEHIKRLGRLEHPN--LL 414 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--iv 414 (634)
+.||+|+||+||+|...+++.||+|+++...... ... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5799999999999998889999999886532111 111 134555555554433 33
Q ss_pred cceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCccccCCCCCCEEe
Q 038422 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN-ELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 415 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl 493 (634)
+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. . +|+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEEE
Confidence 33332 346899999999654322111110 11 5577899999999999999 6 79999999999999
Q ss_pred CCCCCeEEeccccCCccC
Q 038422 494 DRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 494 ~~~~~~kl~DfGla~~~~ 511 (634)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-14 Score=140.99 Aligned_cols=138 Identities=21% Similarity=0.251 Sum_probs=106.4
Q ss_pred hhccccC-ccCceeEEEEEEcCCcEEEEEEecccC-------------ccChhHHHHHHHHHhcCCCCcc--ccceeEEE
Q 038422 358 ASAEVLG-SGTFGASYKTVISNGQAYVVKRYKQMN-------------NVGREDFQEHIKRLGRLEHPNL--LPLTAFYY 421 (634)
Q Consensus 358 ~~~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~ 421 (634)
....+|| .|+.|+||..... +..+++|.+.... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3456788 8999999999874 6778888775311 1233567889999999998885 66777654
Q ss_pred eCC-c---eEEEEEcCCC-CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 422 RKE-E---KLLLYEFVEN-GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 422 ~~~-~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
.+. . .++|+||+++ .+|.+++... .++.. .+.+|+.++.+||+. +|+||||||.|||++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPD 178 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCC
Confidence 432 2 2599999997 6898887532 24443 367899999999998 89999999999999998
Q ss_pred CCeEEeccccCCcc
Q 038422 497 FEPLLTDYALRPLI 510 (634)
Q Consensus 497 ~~~kl~DfGla~~~ 510 (634)
+.++|+|||.+...
T Consensus 179 ~~v~LIDfg~~~~~ 192 (239)
T PRK01723 179 GKFWLIDFDRGELR 192 (239)
T ss_pred CCEEEEECCCcccC
Confidence 89999999988653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.8e-15 Score=163.58 Aligned_cols=152 Identities=26% Similarity=0.343 Sum_probs=110.5
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.|-.|+||.||..+++. .+.+|.| +.+.+-. .+- ++.....|.+| ||=
T Consensus 88 IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee---------------------chh
Confidence 4678999999999998654 5677773 3332111 110 23333344433 444
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC------
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP------ 512 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~------ 512 (634)
...+..... ++- +++.+++|||+. +|+|||+||+|.+|+.-+++|++|||+++....
T Consensus 139 ~tllk~~g~-----lPv--------dmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 139 ATLLKNIGP-----LPV--------DMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred hhhcccCCC-----Ccc--------hhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 444432221 221 237899999998 899999999999999999999999999764211
Q ss_pred -------------CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 -------------DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 -------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+....+|+.|+|||++....|+..+|.|++|+++||.+.|+.||.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 112356888999999999999999999999999999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-14 Score=160.19 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=170.5
Q ss_pred cccCccCceeEEEEEEcC--CcEEEEEEecccC--ccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISN--GQAYVVKRYKQMN--NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++.||..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 458999999988777533 3455555554332 222234445777767776 99999999999999999999999999
Q ss_pred CChhhHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCC
Q 038422 436 GSLAGKL-HANHTKQRPGLDWQTRLKIIKGVVKGMAYLH-NELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~ 512 (634)
|++.+.+ ..... ..+......+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus 106 ~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 106 GSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccCCcc----CCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999888 33221 2455667789999999999999 65 799999999999999999 999999999876554
Q ss_pred -CC------Cccc-cccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 513 -DN------AHTL-MVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 513 -~~------~~~~-~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
.. ...+ +..|+|||...+.. ..+..|+||.|+++.-+++|..|++..... ......|.... ....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~---~~~~~~~~~~~---~~~~ 251 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK---DGRYSSWKSNK---GRFT 251 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc---cccceeecccc---cccc
Confidence 21 2335 77899999998754 467889999999999999999998732221 12223332111 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVI 625 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 625 (634)
.. . ...... ...++..+++..+|..|.+.+++.
T Consensus 252 ~~----~--~~~~~~---~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 QL----P--WNSISD---QAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cC----c--cccCCh---hhhhcccccccCCchhcccccccc
Confidence 00 0 000112 233344478889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.3e-13 Score=142.99 Aligned_cols=141 Identities=13% Similarity=0.231 Sum_probs=99.5
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCcc--------------------------Ch--------------hHHHH
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV--------------------------GR--------------EDFQE 400 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~--------------~~~~~ 400 (634)
+.||+|++|.||+|++.+|+.||||+.+..-.. .. -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 569999999999999999999999998543100 00 03445
Q ss_pred HHHHHhcC----CCCccccceeEEE-eCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 038422 401 HIKRLGRL----EHPNLLPLTAFYY-RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK-GMAYLHN 474 (634)
Q Consensus 401 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~ 474 (634)
|++.+.++ +|.+-+.+-.+|. .....+|||||++|++|.++....... .+ +..++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~----~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG----LD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC----CC---HHHHHHHHHHHHHHHHHh
Confidence 55555554 2333333333332 234679999999999999876532211 22 3456666666 4678888
Q ss_pred cCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 475 ~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
. +++|+|+||.||++++++.+++.|||++..+.+
T Consensus 276 ~----g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D----GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C----CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 899999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.8e-12 Score=126.81 Aligned_cols=149 Identities=20% Similarity=0.333 Sum_probs=115.9
Q ss_pred HHHHhcCCCCccccceeEEEeCC-----ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 038422 402 IKRLGRLEHPNLLPLTAFYYRKE-----EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476 (634)
Q Consensus 402 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 476 (634)
+.-+-++.|.|||++..|+.+.. +..++.|||+.|++..+|++....+ ..+......+++.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34566678999999999986543 4678999999999999998765443 34777778899999999999999975
Q ss_pred CCCCccccCCCCCCEEeCCCCCeEEeccccCCccC---------CCCCccccccccCcccccCCCCCcchhHHHHHHHHH
Q 038422 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN---------PDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILIL 547 (634)
Q Consensus 477 ~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ 547 (634)
| .|+|+++..+.|++..++-+|+.-- ...... +....++..+|.|||+-.....+..+|||+||....
T Consensus 197 P--piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 P--PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred C--ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 4 4899999999999999888887422 111111 111223457899999988778888999999999999
Q ss_pred HHHhCCC
Q 038422 548 ELLTGKY 554 (634)
Q Consensus 548 elltg~~ 554 (634)
||..+..
T Consensus 274 emailEi 280 (458)
T KOG1266|consen 274 EMAILEI 280 (458)
T ss_pred HHHHhee
Confidence 9988764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-12 Score=145.10 Aligned_cols=112 Identities=31% Similarity=0.586 Sum_probs=99.5
Q ss_pred CCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEe
Q 038422 122 PLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGL 199 (634)
Q Consensus 122 ~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l 199 (634)
.++.|+|++|+++|.+|+. ++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|.. ...+|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 4788999999999999986 999999999999999999999999999999999999999999999986 4569999999
Q ss_pred ecCcccccCCccccCC----CCCcccCCCCCCCCCC-CCC
Q 038422 200 ANNELEGPIPESLSKM----DPSTFAGNKNLCGPPL-DPC 234 (634)
Q Consensus 200 ~~N~l~g~ip~~~~~~----~~~~~~gn~~lcg~p~-~~c 234 (634)
++|+|+|.+|..+..+ ....+.+|+.+|+.|. ..|
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 9999999999988653 2456889999998643 345
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.2e-14 Score=123.97 Aligned_cols=146 Identities=21% Similarity=0.385 Sum_probs=118.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+++.|.|++|.|+- +|| .++.|.+|+.|+|++|++...++++++++.|+.|+++-|++. .+|.. ||+++.|+.||
T Consensus 33 s~ITrLtLSHNKl~~-vpp-nia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprg-fgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTV-VPP-NIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRG-FGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCceee-cCC-cHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccc-cCCCchhhhhh
Confidence 468889999999984 454 699999999999999999998889999999999999999998 56765 99999999999
Q ss_pred cccCcCcc-CCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCCC---CcccCC
Q 038422 153 MANNRLTG-TIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMDP---STFAGN 223 (634)
Q Consensus 153 l~~N~l~g-~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~gn 223 (634)
|++|+++. .+|..|.-++.|+.|+|++|.|.=-.|+. ..++|+.|.+..|.|- ++|..++.+.. ....||
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999874 56888888888888889888887544544 5668888888888775 57777665542 334555
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.7e-13 Score=140.20 Aligned_cols=139 Identities=25% Similarity=0.406 Sum_probs=110.3
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCcc------------------
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSG------------------ 135 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g------------------ 135 (634)
....|+|+.|++. +||.+.+-+|+.|-.||||+|.|.-.+|.+.++.+|++|+||+|-+.-
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 4567788888776 778777889999999999999999999999999999999999987752
Q ss_pred -------ccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCc-ccccCCCEEEeecCccccc
Q 038422 136 -------NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE-IKQNEMRSLGLANNELEGP 207 (634)
Q Consensus 136 -------~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~-~~~~~l~~l~l~~N~l~g~ 207 (634)
.||+. +..|.+|..+|||.|+|. .+|..+.++.+|+.|+||+|+++----. ....+|++|+||.|+|+ .
T Consensus 206 ~TqRTl~N~Pts-ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 206 NTQRTLDNIPTS-LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred cccchhhcCCCc-hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence 35554 777888888889999988 7888899999999999999988732111 12347888999999998 6
Q ss_pred CCccccCCC
Q 038422 208 IPESLSKMD 216 (634)
Q Consensus 208 ip~~~~~~~ 216 (634)
+|+++.+++
T Consensus 283 LP~avcKL~ 291 (1255)
T KOG0444|consen 283 LPDAVCKLT 291 (1255)
T ss_pred chHHHhhhH
Confidence 787776654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.5e-11 Score=112.82 Aligned_cols=131 Identities=20% Similarity=0.252 Sum_probs=96.4
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCcccc-ceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLP-LTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
+.++.|.++.||++... +..+++|....... ....+..|+++++.+.+.++++ ++++ ..+..++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 46889999999999864 77899998754321 2345678999999887666554 4443 334568999999998775
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP-GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
+. . . ....++.+++++|+.||.... +..++|+|++|.||+++ ++.+++.||+.+..
T Consensus 80 ~~-----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 42 0 1 113456789999999999742 23469999999999999 56899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.9e-13 Score=120.56 Aligned_cols=138 Identities=23% Similarity=0.368 Sum_probs=117.4
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
.+..|++.+|++. .+|. ++..|+.|+.|+++.|.+.-.+-.|++++.|++|||++|+++-..-|..|-.|+.|+.|+|
T Consensus 57 nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 3556778887776 5664 7999999999999999998766689999999999999999986543444667999999999
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
+.|.|. .+|..+++|++|+.|.+.+|.+- ++|.. ....|+.|.+++|+|+ .+|+.+++++
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 999999 79999999999999999999987 56654 4568999999999998 6787877665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-11 Score=130.43 Aligned_cols=198 Identities=21% Similarity=0.222 Sum_probs=150.1
Q ss_pred CCHHHHHHhhccccCc--cCceeEEEEEE---cCCcEEEEEEeccc--CccChhHHHHHHHHHhcC-CCCccccceeEEE
Q 038422 350 FDLQDMLRASAEVLGS--GTFGASYKTVI---SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYY 421 (634)
Q Consensus 350 ~~~~~~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 421 (634)
+++.+........+|+ |.+|.||.+.. .++..+|+|+-+.. .......=.+|+...+++ .|+|.|+.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3344444445567899 99999999986 45778888874322 223333445666666666 4999999999999
Q ss_pred eCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCCccccCCCCCCEEeCCC-
Q 038422 422 RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK----GMAYLHNELPGSIIPHGHLKSSNVLLDRS- 496 (634)
Q Consensus 422 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~ivHrdlk~~NILl~~~- 496 (634)
.++..++-.|++. .+|..+.+..... ++......+..+... |+.++|.. .++|-|+||.||++.++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~----~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNF----LPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cCCcceeeecccc-chhHHhhhccccc----CCchhhhhHHhhhhhcccccccccCCC----cccccccchhheeccccc
Confidence 9999999999985 6888887765432 555566667777777 99999998 79999999999999999
Q ss_pred CCeEEeccccCCccCCCCC----c-----cccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 497 FEPLLTDYALRPLINPDNA----H-----TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 497 ~~~kl~DfGla~~~~~~~~----~-----~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...+++|||+...+.+..- . .+...|++||... +.++...|+|++|.+..|..++..+..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 8899999998766554321 1 2345699999874 567889999999999999999877653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-10 Score=122.95 Aligned_cols=166 Identities=25% Similarity=0.285 Sum_probs=125.3
Q ss_pred EEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCC
Q 038422 375 VISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD 454 (634)
Q Consensus 375 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~ 454 (634)
+..++..|.|...+.......+...+-++.|+.+|||||++++..+...+..|||.|-+. .|..++.+. .
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------G 102 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------H
Confidence 355688888888876655334556777889999999999999999999999999999875 567777543 3
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC----ccccccccCcccccC
Q 038422 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA----HTLMVAYKSPEYAHN 530 (634)
Q Consensus 455 ~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~----~~~~~~y~aPE~~~~ 530 (634)
.......+.||+.||.|||+.| .++|++|.-..|+++..++.||++|-+......... ...--.|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 4455567899999999999886 799999999999999999999999977543222111 111123666665432
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCC
Q 038422 531 GKISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 531 ~~~~~k~DVwSfGvvl~elltg~~P 555 (634)
.. -..|.|-|||++||++.|..+
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcccC
Confidence 22 246999999999999999433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.2e-11 Score=129.13 Aligned_cols=141 Identities=13% Similarity=0.162 Sum_probs=90.0
Q ss_pred cccCccCceeEEEEEEcC-CcEEEEEEecccCc--------------------------cC--------hh------HHH
Q 038422 361 EVLGSGTFGASYKTVISN-GQAYVVKRYKQMNN--------------------------VG--------RE------DFQ 399 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--------------------------~~--------~~------~~~ 399 (634)
+.||+|++|.||+|++++ |+.||||+.+..-. .. .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 99999999864310 00 01 234
Q ss_pred HHHHHHhcC----CCCccccceeEEEe-CCceEEEEEcCCCCChhhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHH
Q 038422 400 EHIKRLGRL----EHPNLLPLTAFYYR-KEEKLLLYEFVENGSLAGKLHANHTK-QRPGLDWQTRLKIIKGVVKGMAYLH 473 (634)
Q Consensus 400 ~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH 473 (634)
+|+..+.++ .+.+.+.+-.++.+ ....+|||||+.|+.+.++-.-.... ....+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 444444444 24444444444433 34678999999999998742211110 00012222223333333 3
Q ss_pred hcCCCCCccccCCCCCCEEeCCCC----CeEEeccccCCccCC
Q 038422 474 NELPGSIIPHGHLKSSNVLLDRSF----EPLLTDYALRPLINP 512 (634)
Q Consensus 474 ~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~~~~~ 512 (634)
.. +++|+|+||.||+++.++ .+++.|||+...+.+
T Consensus 278 ~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 799999999999999888 899999999766543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.6e-10 Score=128.19 Aligned_cols=171 Identities=22% Similarity=0.312 Sum_probs=110.8
Q ss_pred ccCCccHHHHHHHHhhcCCCCCCCCCC----CCCCCCCCCCCC-----------CCeeeEEecCCcEE------------
Q 038422 24 VTFGLSDTEILLQFKSSLNDSSSALVN----WNALRNPCTFNY-----------PNWNGVLCLNGSVW------------ 76 (634)
Q Consensus 24 ~~~~~~~~~~l~~~k~~l~~~~~~l~~----W~~~~~~C~~~~-----------~~w~gv~C~~~~v~------------ 76 (634)
.....+|.+.+++..+.|..|. .+.+ |+..+|+|..+. +.=--|.|..+.|+
T Consensus 58 ~~~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 58 ETASPEEIKSKFECLRMLAFPA-YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCCHHHHHHHHHHHHHhcCCc-hhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 3445678899999999998885 4555 998899996433 11223788655444
Q ss_pred ---------------------------------------------EEEecCCCCccccChhhhcCCCCcCEEeccCCcCc
Q 038422 77 ---------------------------------------------GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFE 111 (634)
Q Consensus 77 ---------------------------------------------~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~ 111 (634)
.|+|++++|+ .+|. .+ .++|+.|+|++|+|+
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~-~I--p~~L~~L~Ls~N~Lt 212 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPA-CI--PEQITTLILDNNELK 212 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCc-cc--ccCCcEEEecCCCCC
Confidence 3444444444 2332 12 246777788888777
Q ss_pred ccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccc
Q 038422 112 GPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ 191 (634)
Q Consensus 112 g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~ 191 (634)
..++.+. .+|+.|+|++|+|+ .||.. +. .+|+.|+|++|+++ .||..+. ++|+.|+|++|+|+ .+|....
T Consensus 213 sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~-l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~ 282 (754)
T PRK15370 213 SLPENLQ--GNIKTLYANSNQLT-SIPAT-LP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP 282 (754)
T ss_pred cCChhhc--cCCCEEECCCCccc-cCChh-hh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC
Confidence 5333333 47788888888877 46654 32 46777777777777 6676664 46777777777777 4666545
Q ss_pred cCCCEEEeecCcccccCCc
Q 038422 192 NEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 192 ~~l~~l~l~~N~l~g~ip~ 210 (634)
.+|+.|++++|+|++ +|.
T Consensus 283 ~sL~~L~Ls~N~Lt~-LP~ 300 (754)
T PRK15370 283 EELRYLSVYDNSIRT-LPA 300 (754)
T ss_pred CCCcEEECCCCcccc-Ccc
Confidence 577777777777774 443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.2e-11 Score=129.13 Aligned_cols=133 Identities=23% Similarity=0.316 Sum_probs=102.4
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
....|+|+.|+++- +....+.+|+.|+.|+||+|.+...-+ ...-+.+|++|+||+|+++ .++++.|..+..|+.|+
T Consensus 270 kme~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 270 KMEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELN 347 (873)
T ss_pred ccceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhc
Confidence 46678888888873 333568889999999999999988766 4666778999999999998 68888888888888888
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-----cccCCCEEEeecCcccccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-----KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-----~~~~l~~l~l~~N~l~g~ip 209 (634)
|++|+++----..|-.+++|+.|||++|.+++.|-+. ...+|+.|+|.+|+|- .||
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~ 408 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIP 408 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecc
Confidence 8888887444455667788888888888888877653 2347777777777775 344
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.7e-12 Score=131.72 Aligned_cols=138 Identities=25% Similarity=0.373 Sum_probs=111.5
Q ss_pred EEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~ 154 (634)
+.++.+..|+|...-.|..|..|..|+.||||+|+|.-.+-.+-+..++-+||||+|++. +||...|-+++.|-+||||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccc
Confidence 567777888886553345789999999999999999887768888889999999999998 7998889999999999999
Q ss_pred cCcCccCCCccccCCCCccEEeCCCCcee----ecCCcc-----------------------cccCCCEEEeecCccccc
Q 038422 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQ----GQVPEI-----------------------KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 155 ~N~l~g~ip~~~~~l~~L~~L~l~~N~~~----g~ip~~-----------------------~~~~l~~l~l~~N~l~g~ 207 (634)
+|+|. .+|+.+..|..|++|+|++|.+. -.+|.. ...+|..+|+|.|+|. .
T Consensus 159 ~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~ 236 (1255)
T KOG0444|consen 159 NNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-I 236 (1255)
T ss_pred cchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-c
Confidence 99998 78999999999999999999763 133431 1236778888888887 6
Q ss_pred CCccccCC
Q 038422 208 IPESLSKM 215 (634)
Q Consensus 208 ip~~~~~~ 215 (634)
+|.++.++
T Consensus 237 vPecly~l 244 (1255)
T KOG0444|consen 237 VPECLYKL 244 (1255)
T ss_pred chHHHhhh
Confidence 77776544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-10 Score=109.76 Aligned_cols=143 Identities=20% Similarity=0.237 Sum_probs=109.4
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCC--ccccceeEEEeC---CceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHP--NLLPLTAFYYRK---EEKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~e~~~ 434 (634)
+.|+.|.++.||++...+|+.+++|....... .....+..|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778899998764332 2355789999999999763 456677776553 25689999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL-------------------------------------- 476 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 476 (634)
+.++.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765431 12677788888999999999998531
Q ss_pred --------------CCCCccccCCCCCCEEeCC--CCCeEEeccccCCc
Q 038422 477 --------------PGSIIPHGHLKSSNVLLDR--SFEPLLTDYALRPL 509 (634)
Q Consensus 477 --------------~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~ 509 (634)
.+..++|+|+.+.||+++. +..+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245789999999999998 56688999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-09 Score=103.13 Aligned_cols=136 Identities=13% Similarity=0.138 Sum_probs=96.2
Q ss_pred cccCccCceeEEEEEEcC-------CcEEEEEEecccC------------c----------cChhHHH----HHHHHHhc
Q 038422 361 EVLGSGTFGASYKTVISN-------GQAYVVKRYKQMN------------N----------VGREDFQ----EHIKRLGR 407 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~~ 407 (634)
..||.|.-+.||.|...+ +..+|+|..+... . ..++.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998653 4789999874311 0 0122333 79999988
Q ss_pred CCC--CccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCcccc
Q 038422 408 LEH--PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL-HNELPGSIIPHG 484 (634)
Q Consensus 408 l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivHr 484 (634)
+.. -++.+.+++ ...++||||+.++.+....... ..++..+...+..+++.+|.+| |.. +|+|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC----CeecC
Confidence 853 355555554 5678999999775443221111 1245556677889999999999 665 79999
Q ss_pred CCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 485 HLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 485 dlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||++.||++++ +.+.++|||.+-..
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999974 67999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-10 Score=120.37 Aligned_cols=238 Identities=18% Similarity=0.190 Sum_probs=162.2
Q ss_pred cccCccCceeEEEEEEc--CCcEEEEEEecccCccChhH--HHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS--NGQAYVVKRYKQMNNVGRED--FQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..||.|.|+.||+...+ ++..+++|.+.+.......+ -..|+-+...+ .|.++++++..+...+..|+-.|||++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 46999999999987743 57788998876543332222 23455444444 588899988777777788899999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINPD- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~- 513 (634)
+++...+... ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||.+..+.-.
T Consensus 351 ~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 351 GSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cchhhhhHHH-----HhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccccccceec
Confidence 9988766322 2377888899999999999999987 79999999999999886 77889999987532221
Q ss_pred CCcccccccc--CcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 NAHTLMVAYK--SPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 ~~~~~~~~y~--aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
.......++. +++......+..+.|++|||.-+.|.+|+..-.. ....|.. +..+.. +..
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~----------~~~~~~~--i~~~~~-----p~~- 483 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE----------SGVQSLT--IRSGDT-----PNL- 483 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCc----------cccccee--eecccc-----cCC-
Confidence 2222233444 5555556678899999999999999999875422 1112210 011100 111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHh
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~ 630 (634)
.....+...+.+ .....++..||.+.+.....+.
T Consensus 484 --~~~~~~~q~~~k---v~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 --PGLKLQLQVLLK---VMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --CchHHhhhhhhh---hhcCCccccchhhhhhcccchh
Confidence 111233334444 5667899999998887765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.2e-09 Score=96.50 Aligned_cols=130 Identities=21% Similarity=0.293 Sum_probs=98.0
Q ss_pred ccCccCceeEEEEEEcCCcEEEEEEecccC--------ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 362 VLGSGTFGASYKTVISNGQAYVVKRYKQMN--------NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+++|+-+.+|.+.+.+. .+++|.-.... ...++.-.+|++++.+++--.|..-.=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999976443 35555432221 112245678999998886555544445566788889999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
++-.|.+.+... ...++..|-.-+.-||.. +|+|+||.++||++.++. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888643 245777888888999998 899999999999998765 89999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.9e-12 Score=124.87 Aligned_cols=122 Identities=27% Similarity=0.493 Sum_probs=72.7
Q ss_pred CCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCcccc-CCCCccEE
Q 038422 97 LSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV-QLPKLMEL 175 (634)
Q Consensus 97 l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~-~l~~L~~L 175 (634)
++.|+.||+..|-+...+|+++.+.+|.-|+|..|.+. .+| + |++|+.|..|+++.|++. .+|++.+ +|++|..|
T Consensus 182 m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-e-f~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vL 257 (565)
T KOG0472|consen 182 MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-E-FPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVL 257 (565)
T ss_pred HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-C-CCccHHHHHHHhcccHHH-hhHHHHhcccccceee
Confidence 44444444444444444444455555555555555544 333 2 555555555555555555 5566655 67788888
Q ss_pred eCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC--CCcccCCC
Q 038422 176 RLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD--PSTFAGNK 224 (634)
Q Consensus 176 ~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~--~~~~~gn~ 224 (634)
||.+|+++ +.|+. ...+|+.||+|+|.++ .+|.+++++. ....+|||
T Consensus 258 DLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 258 DLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred eccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCc
Confidence 88888887 56654 4567888888888888 4677777763 23445663
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.4e-11 Score=125.10 Aligned_cols=116 Identities=25% Similarity=0.278 Sum_probs=83.3
Q ss_pred hcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCc
Q 038422 94 LGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172 (634)
Q Consensus 94 l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L 172 (634)
+..+.+++.|+|..|+++..-- .+.+|++|+.|+||+|.+. .|-.+.|.-+++|++|+|++|+++.--|.+|.-|..|
T Consensus 265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~-rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L 343 (873)
T KOG4194|consen 265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ-RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL 343 (873)
T ss_pred eeeecccceeecccchhhhhhcccccccchhhhhccchhhhh-eeecchhhhcccceeEeccccccccCChhHHHHHHHh
Confidence 3345566677777777665433 4677777888888888877 4555557777888888888888886556677777788
Q ss_pred cEEeCCCCceeecCCcc---cccCCCEEEeecCcccccCCcc
Q 038422 173 MELRLEANKFQGQVPEI---KQNEMRSLGLANNELEGPIPES 211 (634)
Q Consensus 173 ~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l~g~ip~~ 211 (634)
+.|+|++|.++ .|.+. ..++|+.|||++|.|++.|-+.
T Consensus 344 e~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDa 384 (873)
T KOG4194|consen 344 EELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDA 384 (873)
T ss_pred hhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence 88888888776 23332 3468999999999999988764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.5e-11 Score=129.22 Aligned_cols=147 Identities=26% Similarity=0.442 Sum_probs=119.0
Q ss_pred EEEEEecCCCCccccChhhh-------------------------cCCCCcCEEeccCCcCcc-cCCCCCCCCCCcEEEc
Q 038422 75 VWGLKLEQMNLSGTIAAESL-------------------------GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYL 128 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l-------------------------~~l~~L~~L~l~~n~l~g-~~p~~~~l~~L~~L~l 128 (634)
+..|+|..|+|.- +|...+ ..+..|+.|.|.+|.|+. .+|-+.++..|++|+|
T Consensus 312 L~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 312 LRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 8899999988752 221100 124468889999999986 4688999999999999
Q ss_pred cCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCccc-c
Q 038422 129 SDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELE-G 206 (634)
Q Consensus 129 s~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~-g 206 (634)
++|++. ++|...+.++..|+.|+||+|+|+ .||..+.+|..|++|...+|++. ..|+. ..++|+++|++.|+|+ +
T Consensus 391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~ 467 (1081)
T KOG0618|consen 391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEV 467 (1081)
T ss_pred cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhh
Confidence 999997 799988999999999999999999 79999999999999999999998 56665 5678999999999997 4
Q ss_pred cCCccc--cCCCCCcccCCCC
Q 038422 207 PIPESL--SKMDPSTFAGNKN 225 (634)
Q Consensus 207 ~ip~~~--~~~~~~~~~gn~~ 225 (634)
.+|... .++....+.||..
T Consensus 468 ~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 468 TLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhCCCcccceeeccCCcc
Confidence 455443 3556667788864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.7e-10 Score=113.34 Aligned_cols=87 Identities=22% Similarity=0.348 Sum_probs=66.0
Q ss_pred hhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---
Q 038422 142 FEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD--- 216 (634)
Q Consensus 142 ~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~--- 216 (634)
|..+++|+.|+|++|++++.=+.+|..+..+++|+|..|++.-.--.. ....|+.|+|.+|+++---|.+|..+.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 777888888888888888877888888888888888888875211111 345899999999999988888776443
Q ss_pred CCcccCCCCCCC
Q 038422 217 PSTFAGNKNLCG 228 (634)
Q Consensus 217 ~~~~~gn~~lcg 228 (634)
.....+||..|.
T Consensus 350 ~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 350 TLNLLSNPFNCN 361 (498)
T ss_pred eeehccCcccCc
Confidence 344667887773
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-09 Score=123.78 Aligned_cols=112 Identities=29% Similarity=0.490 Sum_probs=76.7
Q ss_pred CCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeC
Q 038422 98 SSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRL 177 (634)
Q Consensus 98 ~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l 177 (634)
.+|++|+|++|+|++ +|.+ ..+|+.|++++|++++ ||.. .++|+.|+|++|+|++ +|... ++|+.|+|
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~l--p~~L~~L~Ls~N~L~~-LP~l----~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdL 409 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTL--PSELYKLWAYNNRLTS-LPAL----PSGLKELIVSGNRLTS-LPVLP---SELKELMV 409 (788)
T ss_pred cccceEecCCCccCC-CCCC--Ccccceehhhcccccc-Cccc----ccccceEEecCCcccC-CCCcc---cCCCEEEc
Confidence 368899999999986 4433 2467778888888874 6642 3568888888888884 66543 56778888
Q ss_pred CCCceeecCCcccccCCCEEEeecCcccccCCccccCCCCC---cccCCC
Q 038422 178 EANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPS---TFAGNK 224 (634)
Q Consensus 178 ~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~---~~~gn~ 224 (634)
++|+|++ ||.. ..+|+.|++++|+|+ .||..+.+++.. .+.+|+
T Consensus 410 S~N~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~ 456 (788)
T PRK15387 410 SGNRLTS-LPML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 456 (788)
T ss_pred cCCcCCC-CCcc-hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence 8888874 6653 346777888888877 677766555433 344553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=93.25 Aligned_cols=141 Identities=16% Similarity=0.281 Sum_probs=103.1
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEeccc--------CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQM--------NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.++-+|+-+.|+++.+ .|+..+||.--.. ....+....+|++.+.+++--.|..-.=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5678999999999987 4677666643221 122345678899999988655554444556677778899999
Q ss_pred CCC-CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC---CeEEeccccCC
Q 038422 433 VEN-GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF---EPLLTDYALRP 508 (634)
Q Consensus 433 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~ 508 (634)
+++ -++.+++....... ........++..|-+.+.-||.+ .|+|+||..+||++..++ .+.+.|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 47888887654321 22223367889999999999998 799999999999996554 35799999975
Q ss_pred c
Q 038422 509 L 509 (634)
Q Consensus 509 ~ 509 (634)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.7e-09 Score=121.15 Aligned_cols=123 Identities=19% Similarity=0.347 Sum_probs=93.2
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..++.|+|++|+|. .+|.. + .++|+.|+|++|+|++.+..+. .+|+.|+|++|++. .||.. +. ++|+.|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~-l--~~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~-l~--s~L~~L~ 268 (754)
T PRK15370 199 EQITTLILDNNELK-SLPEN-L--QGNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPER-LP--SALQSLD 268 (754)
T ss_pred cCCcEEEecCCCCC-cCChh-h--ccCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChh-Hh--CCCCEEE
Confidence 46889999999999 56643 3 3589999999999985332343 47899999999998 78765 43 5789999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCc
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~ 210 (634)
|++|+|+ .+|..+. ++|+.|+|++|+|++ +|.....+|+.|++++|+|++ +|.
T Consensus 269 Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 269 LFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred CcCCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCcccc-CCc
Confidence 9999998 5788775 589999999999885 565444567777777777774 443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.8e-08 Score=105.06 Aligned_cols=168 Identities=19% Similarity=0.308 Sum_probs=128.8
Q ss_pred eeEEEEE-EcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEcCCC-CChhhHH
Q 038422 369 GASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEFVEN-GSLAGKL 442 (634)
Q Consensus 369 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~~l 442 (634)
.+.||+. ..||..+++|+++............-++.++++.|+|||++..++.. +...++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 4788988 56899999999954433333334456788999999999999998873 3468899999986 6787765
Q ss_pred hhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 443 HANHTK----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 443 ~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
...... .....++..++.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+..
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 433221 123477889999999999999999998 788899999999999999999999888776655
Q ss_pred CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 038422 513 DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK 553 (634)
Q Consensus 513 ~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~ 553 (634)
+.. |.+.. -.+-|.=.||.+++-|.||.
T Consensus 446 d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DPT----------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCC----------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 431 11111 23568889999999999984
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.1e-09 Score=119.09 Aligned_cols=118 Identities=25% Similarity=0.430 Sum_probs=63.7
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
++..|+|.+|+|.. +|. .+++|++|+|++|+|+. +|.+ .++|+.|+|++|.++ .+|.. ..+|+.|+|
T Consensus 223 ~L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~Lts-LP~l--p~sL~~L~Ls~N~L~-~Lp~l----p~~L~~L~L 289 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTS-LPVL--PPGLLELSIFSNPLT-HLPAL----PSGLCKLWI 289 (788)
T ss_pred CCCEEEccCCcCCC-CCC----CCCCCcEEEecCCccCc-ccCc--ccccceeeccCCchh-hhhhc----hhhcCEEEC
Confidence 46677777777773 442 25678888888888875 3432 245556666666555 23321 133444555
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceee-------------------cCCcccccCCCEEEeecCcccccCCc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQG-------------------QVPEIKQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g-------------------~ip~~~~~~l~~l~l~~N~l~g~ip~ 210 (634)
++|+++ .+|.. +++|+.|+|++|+|++ .+|. ...+|+.|+|++|+|++ +|.
T Consensus 290 s~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~-lp~~Lq~LdLS~N~Ls~-LP~ 359 (788)
T PRK15387 290 FGNQLT-SLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPT-LPSGLQELSVSDNQLAS-LPT 359 (788)
T ss_pred cCCccc-ccccc---ccccceeECCCCccccCCCCcccccccccccCccccccc-cccccceEecCCCccCC-CCC
Confidence 555554 23432 2345555555555553 1332 11356777777777764 443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.1e-09 Score=122.33 Aligned_cols=187 Identities=22% Similarity=0.280 Sum_probs=133.9
Q ss_pred ccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
-+-+|+|+.++.+.-. .|...++|........ ..+....+-.++-..+||-+++..--+......+||++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 5778889888876632 2444444443332211 12223333344444556777765555555677899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC------
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN------ 511 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~------ 511 (634)
|...|+.... .+..-...+...+..+.+|||.. .+.|||++|.|+++..++..+++|||......
T Consensus 891 ~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 891 LPSKLHNSGC-----LSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred chhhhhcCCC-----cccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999886552 44444455677788999999996 48899999999999999999999998422110
Q ss_pred ----C-------------------------CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 ----P-------------------------DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ----~-------------------------~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
. .....+|..|.|||...+......+|.|++|++++|.++|..|++
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 011234677999999999999999999999999999999999987
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.4e-09 Score=81.84 Aligned_cols=61 Identities=34% Similarity=0.549 Sum_probs=45.7
Q ss_pred CCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCce
Q 038422 121 GPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182 (634)
Q Consensus 121 ~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~ 182 (634)
++|++|+|++|+++ .||++.|.++++|++|+|++|+++..-|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 35777777777777 56777777788888888888888765566777788888888877764
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.8e-09 Score=97.05 Aligned_cols=104 Identities=34% Similarity=0.481 Sum_probs=27.0
Q ss_pred EEEEEecCCCCccccChhhhc-CCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 75 VWGLKLEQMNLSGTIAAESLG-LLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~-~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
...|+|.++.++- | +.++ .+++|+.|+|++|.++. ++.+..++.|+.|+|++|+++ .|++.....+++|+.|+|
T Consensus 21 ~~~L~L~~n~I~~-I--e~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 21 LRELNLRGNQIST-I--ENLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-c--cchhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 3445555555542 2 1243 35556666666666553 344555556666666666665 343321234556666666
Q ss_pred ccCcCccCC-CccccCCCCccEEeCCCCcee
Q 038422 154 ANNRLTGTI-PSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 154 ~~N~l~g~i-p~~~~~l~~L~~L~l~~N~~~ 183 (634)
++|++..-- =..+..+++|+.|+|.+|.++
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666654210 123445555666666555554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.5e-10 Score=121.93 Aligned_cols=126 Identities=25% Similarity=0.390 Sum_probs=108.7
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..|.|.+|.|.-..-| .+-+..+|+.|+|++|.|...+. .+.++..|+.|+||+|.++ .||.. +.++..|++|.
T Consensus 360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~t-va~~~~L~tL~ 436 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDT-VANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHH-HHhhhhhHHHh
Confidence 567788889998876554 58899999999999999875433 4899999999999999999 78855 89999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceee-cCCcccc-cCCCEEEeecCcc
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQG-QVPEIKQ-NEMRSLGLANNEL 204 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g-~ip~~~~-~~l~~l~l~~N~l 204 (634)
..+|++. .+| .+.+++.|+.+|||.|+|+- .+|.... .+|++|||++|.-
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999 678 89999999999999999984 4565544 7999999999973
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.4e-09 Score=96.35 Aligned_cols=108 Identities=27% Similarity=0.433 Sum_probs=39.0
Q ss_pred hhcCCCCcCEEeccCCcCcccCCCCC-CCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccc-cCCC
Q 038422 93 SLGLLSSLRAVSFMNNKFEGPLPDLR-KMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSL-VQLP 170 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~l~g~~p~~~-~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~-~~l~ 170 (634)
.+.+...+++|+|.+|.++- |..++ .+.+|+.|+||+|+++ .|+ . +..+++|+.|+|++|+++ .++..+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~-~l~-~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQIT-KLE-G-LPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T-----TT--EEE--SS----S-CHHHHHH-T
T ss_pred cccccccccccccccccccc-ccchhhhhcCCCEEECCCCCCc-ccc-C-ccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 35566679999999999876 45566 5789999999999999 464 3 888999999999999999 466555 4689
Q ss_pred CccEEeCCCCceeec--CCc-ccccCCCEEEeecCccc
Q 038422 171 KLMELRLEANKFQGQ--VPE-IKQNEMRSLGLANNELE 205 (634)
Q Consensus 171 ~L~~L~l~~N~~~g~--ip~-~~~~~l~~l~l~~N~l~ 205 (634)
+|+.|+|++|++..- +-. ...++|+.|++.+|.++
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 999999999998742 211 24568999999998776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.1e-07 Score=92.10 Aligned_cols=141 Identities=17% Similarity=0.128 Sum_probs=98.3
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCc-----------cChhHHHHHHHHHhcCCCCcc--ccceeEEEe-----
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNN-----------VGREDFQEHIKRLGRLEHPNL--LPLTAFYYR----- 422 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~----- 422 (634)
+++-+-....|++..+ +|+.+.||+...... .....+.+|.+.+.++..-+| ...+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445667655 677899997643220 111247889888887743333 344555543
Q ss_pred CCceEEEEEcCCCC-ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC------
Q 038422 423 KEEKLLLYEFVENG-SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR------ 495 (634)
Q Consensus 423 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~------ 495 (634)
...-++|+|++++- +|.+++..... ...+...+..++.+++..+.-||.. +|+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCC
Confidence 22468999999986 79888753211 1245667788999999999999998 8999999999999975
Q ss_pred -CCCeEEeccccCCc
Q 038422 496 -SFEPLLTDYALRPL 509 (634)
Q Consensus 496 -~~~~kl~DfGla~~ 509 (634)
+..+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.1e-08 Score=90.86 Aligned_cols=125 Identities=18% Similarity=0.296 Sum_probs=81.1
Q ss_pred eEEEEEEcCCcEEEEEEecccC--------------c-------cC-----hhHHHHHHHHHhcCCCC--ccccceeEEE
Q 038422 370 ASYKTVISNGQAYVVKRYKQMN--------------N-------VG-----REDFQEHIKRLGRLEHP--NLLPLTAFYY 421 (634)
Q Consensus 370 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~~-----~~~~~~E~~~l~~l~H~--niv~l~g~~~ 421 (634)
.||.|...+|..+|+|..+... . .. +....+|.+.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999875321 0 00 12457899999999765 45555544
Q ss_pred eCCceEEEEEcCC--CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCccccCCCCCCEEeCCCCC
Q 038422 422 RKEEKLLLYEFVE--NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL-HNELPGSIIPHGHLKSSNVLLDRSFE 498 (634)
Q Consensus 422 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivHrdlk~~NILl~~~~~ 498 (634)
....|||||++ +..+.... ... ++......++.+++..+..+ |.. +|+|+||.+.||+++++ .
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~~------~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DVD------LSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HCG------GGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-C
T ss_pred --eCCEEEEEecCCCccchhhHH-hcc------ccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-e
Confidence 24689999998 54444332 221 11234566778888877775 555 89999999999999988 9
Q ss_pred eEEeccccCCcc
Q 038422 499 PLLTDYALRPLI 510 (634)
Q Consensus 499 ~kl~DfGla~~~ 510 (634)
+.++|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.6e-09 Score=109.04 Aligned_cols=117 Identities=25% Similarity=0.360 Sum_probs=104.9
Q ss_pred CccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCc
Q 038422 85 LSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS 164 (634)
Q Consensus 85 l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~ 164 (634)
+-+++|+ .++.+.+|.-|+|..|.+.- +|+|.+|..|..|+++.|++. .+|.+....+.+|..|||-.|++. ++|+
T Consensus 194 ~L~tlP~-~lg~l~~L~~LyL~~Nki~~-lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pd 269 (565)
T KOG0472|consen 194 LLETLPP-ELGGLESLELLYLRRNKIRF-LPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPD 269 (565)
T ss_pred hhhcCCh-hhcchhhhHHHHhhhccccc-CCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCch
Confidence 4568886 69999999999999999874 679999999999999999998 789886779999999999999999 8999
Q ss_pred cccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCccc
Q 038422 165 SLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELE 205 (634)
Q Consensus 165 ~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~ 205 (634)
.+..|.+|++||||+|.+++-.+....-.|++|-+.+|.+.
T Consensus 270 e~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 270 EICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred HHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 99999999999999999998777654448999999999884
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-09 Score=114.53 Aligned_cols=131 Identities=21% Similarity=0.344 Sum_probs=104.8
Q ss_pred ccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCcccc
Q 038422 88 TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV 167 (634)
Q Consensus 88 ~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~ 167 (634)
.|| +.+++|..|++|+|+.|+++-..+.++.|+ |+.|-+++|+++ .+|++ ++.+..|..||.+.|.+. ++|+.++
T Consensus 112 ~ip-~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~-ig~~~tl~~ld~s~nei~-slpsql~ 186 (722)
T KOG0532|consen 112 TIP-EAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEE-IGLLPTLAHLDVSKNEIQ-SLPSQLG 186 (722)
T ss_pred ecc-hhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcc-cccchhHHHhhhhhhhhh-hchHHhh
Confidence 344 468889999999999999888777788776 889999999987 67777 788888889999999888 7888888
Q ss_pred CCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCCC---cccCCC
Q 038422 168 QLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPS---TFAGNK 224 (634)
Q Consensus 168 ~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~---~~~gn~ 224 (634)
.|.+|+.|.+..|++.--.++...-.|..||+|+|+++ .||-+|.+|.-. ..+.||
T Consensus 187 ~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 187 YLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred hHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 88899988888888875444555557888999999998 788888777643 355554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.8e-08 Score=116.34 Aligned_cols=56 Identities=27% Similarity=0.349 Sum_probs=30.8
Q ss_pred CCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecC
Q 038422 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANN 202 (634)
Q Consensus 147 ~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N 202 (634)
+|+.|+|++|...+.+|.+++++++|+.|+|++|+.-+.+|.. ...+|+.|++++|
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c 835 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC 835 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence 4555666666555566666666666666666665544455542 2233444444433
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.4e-08 Score=76.23 Aligned_cols=60 Identities=30% Similarity=0.530 Sum_probs=53.1
Q ss_pred CCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcC
Q 038422 98 SSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRL 158 (634)
Q Consensus 98 ~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l 158 (634)
++|+.|+|++|+++...+ .|.++++|++|++++|.++ .|+++.|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence 478999999999997766 5788999999999999998 57777899999999999999985
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.3e-08 Score=103.86 Aligned_cols=133 Identities=23% Similarity=0.298 Sum_probs=86.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCC---cCEEeccCCcCccc----CC-CCCCC-CCCcEEEccCCcCccccCh---h
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSS---LRAVSFMNNKFEGP----LP-DLRKM-GPLKSIYLSDNGFSGNISD---D 140 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~---L~~L~l~~n~l~g~----~p-~~~~l-~~L~~L~ls~N~~~g~ip~---~ 140 (634)
.++..|+|+++.+.+..+. .+..+.+ |++|++++|.+++. +. .+..+ ++|+.|+|++|.+++.... .
T Consensus 81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 4788888888888764442 3444444 88888888887731 11 24555 7788888888888753221 2
Q ss_pred hhhCCCCCCeEEcccCcCccC----CCccccCCCCccEEeCCCCceeecCCc----c--cccCCCEEEeecCcccc
Q 038422 141 AFEGMTSLKKLYMANNRLTGT----IPSSLVQLPKLMELRLEANKFQGQVPE----I--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g~----ip~~~~~l~~L~~L~l~~N~~~g~ip~----~--~~~~l~~l~l~~N~l~g 206 (634)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.-.. . ..++|+.|++++|.+++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 355667788888888887742 344455566788888888877643222 1 23468888888887775
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.5e-07 Score=112.04 Aligned_cols=132 Identities=20% Similarity=0.326 Sum_probs=81.5
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
.++.|+|.++.+. .++ ..+..+++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.. ++++++|+.|+|
T Consensus 612 ~L~~L~L~~s~l~-~L~-~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~s-i~~L~~L~~L~L 688 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLW-DGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSS-IQYLNKLEDLDM 688 (1153)
T ss_pred CCcEEECcCcccc-ccc-cccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchh-hhccCCCCEEeC
Confidence 3555666655554 333 2355666677777766655566666666677777777666655566654 666777777777
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCcc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPES 211 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~ 211 (634)
++|..-+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.|++++|.++ .+|..
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~-~~nL~~L~L~~n~i~-~lP~~ 743 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI-STNISWLDLDETAIE-EFPSN 743 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc-cCCcCeeecCCCccc-ccccc
Confidence 7665555666655 5666777777766655555543 346677777777664 45544
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-08 Score=104.51 Aligned_cols=131 Identities=22% Similarity=0.319 Sum_probs=81.6
Q ss_pred EEEEEecCCCCcc------ccChhhhcCCCCcCEEeccCCcCcccCC-CCCCC---CCCcEEEccCCcCccc----cChh
Q 038422 75 VWGLKLEQMNLSG------TIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKM---GPLKSIYLSDNGFSGN----ISDD 140 (634)
Q Consensus 75 v~~l~L~~~~l~g------~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l---~~L~~L~ls~N~~~g~----ip~~ 140 (634)
+..+++..+.+.+ .++ ..+..+++|++|+|++|.+.+..+ .+..+ ++|++|++++|++++. +. .
T Consensus 53 l~~l~l~~~~~~~~~~~~~~~~-~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~-~ 130 (319)
T cd00116 53 LKELCLSLNETGRIPRGLQSLL-QGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA-K 130 (319)
T ss_pred ceEEeccccccCCcchHHHHHH-HHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH-H
Confidence 5566666665542 122 345667788888888888876444 22222 4488888888887732 21 2
Q ss_pred hhhCC-CCCCeEEcccCcCccC----CCccccCCCCccEEeCCCCceeec----CCcc--cccCCCEEEeecCccccc
Q 038422 141 AFEGM-TSLKKLYMANNRLTGT----IPSSLVQLPKLMELRLEANKFQGQ----VPEI--KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 141 ~~~~~-~~L~~l~l~~N~l~g~----ip~~~~~l~~L~~L~l~~N~~~g~----ip~~--~~~~l~~l~l~~N~l~g~ 207 (634)
.+..+ ++|+.|+|++|++++. ++..+..+.+|+.|+|++|++++. ++.. ...+|+.|++++|.+++.
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 24556 7788888888888743 334455667788888888887752 1211 224788888888877643
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.7e-06 Score=87.03 Aligned_cols=262 Identities=16% Similarity=0.182 Sum_probs=147.5
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEE----E--eCC-ceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFY----Y--RKE-EKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~----~--~~~-~~~lv~e 431 (634)
+..||+|+-+.+|-.-- -...+.|+..........+. +..|... .||-+-.=+.+= + +.+ ..-++|.
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45699999999996432 12234566654433222222 2233333 566443311111 0 112 2456677
Q ss_pred cCCCC-ChhhHHhhc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 432 FVENG-SLAGKLHAN-HTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 432 ~~~~g-sL~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
.+++- -..++.... +....+...|...+++++.+|.+.+-||.. +-+-+|+.++|+|+.++..+.+.|----.+
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceee
Confidence 66553 222333221 222345689999999999999999999998 778899999999999999998876321111
Q ss_pred cCCCCCc---cccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCcccccccCCCCC----cHHHHHHHH
Q 038422 510 INPDNAH---TLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTG-KYPENYLLQGYDSKA----SLSNWVNNM 576 (634)
Q Consensus 510 ~~~~~~~---~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg-~~P~~~~~~~~~~~~----~l~~~~~~~ 576 (634)
-..+..+ .+...|.+||.-. +..-+...|-|.+||++++++.| +.||.......+... .+..-....
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 1122222 2344599999654 33456789999999999999986 999875433222211 111100000
Q ss_pred HHhccCCcccccccccCCCCHHHHHHHHHHHhccccc--CccCCCCHHHHHHHHHhhhc
Q 038422 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEE--DVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 577 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~--~P~~RPs~~evl~~L~~i~~ 633 (634)
-.+....-.-.+.-.....-...+..+.. .|... .+.-||+.+.-+..|.+++.
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 00000000000000000011233444444 77765 36789999999999887754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.9e-07 Score=88.01 Aligned_cols=136 Identities=19% Similarity=0.246 Sum_probs=94.9
Q ss_pred HHHHhhccccCccCceeEEEEEEcCCcEEEEEEecccC----------------------ccChhHHHHHHHHHhcCCCC
Q 038422 354 DMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMN----------------------NVGREDFQEHIKRLGRLEHP 411 (634)
Q Consensus 354 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~ 411 (634)
....+.++.||-|.-+.||.|..+.|..+|+|.=+... ...+...++|.++|.++.-.
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 34456678999999999999999999999999542110 11234567899999998644
Q ss_pred --ccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCC
Q 038422 412 --NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSS 489 (634)
Q Consensus 412 --niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~ 489 (634)
.|.+-+++ +...+||||+++-.|...- ++-...-.++..|..-+.-+-.. +|||+|+.+-
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSef 231 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEF 231 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchh
Confidence 55555544 5678999999986665321 11122223444444444333343 7999999999
Q ss_pred CEEeCCCCCeEEeccccC
Q 038422 490 NVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 490 NILl~~~~~~kl~DfGla 507 (634)
||++++++.+.++||--+
T Consensus 232 NIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 232 NILVTEDGDIVVIDWPQA 249 (304)
T ss_pred eEEEecCCCEEEEeCccc
Confidence 999999999999999654
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.5e-08 Score=67.56 Aligned_cols=39 Identities=49% Similarity=0.961 Sum_probs=30.2
Q ss_pred ccHHHHHHHHhhcCC-CCCCCCCCCCCC--CCCCCCCCCCeeeEEec
Q 038422 28 LSDTEILLQFKSSLN-DSSSALVNWNAL--RNPCTFNYPNWNGVLCL 71 (634)
Q Consensus 28 ~~~~~~l~~~k~~l~-~~~~~l~~W~~~--~~~C~~~~~~w~gv~C~ 71 (634)
.+|+++|++||+++. +|.+.+.+|+.. .+||. |.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~-----W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCS-----WSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCC-----STTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCee-----eccEEeC
Confidence 468999999999998 577889999976 78996 9999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.9e-08 Score=104.31 Aligned_cols=130 Identities=26% Similarity=0.381 Sum_probs=105.2
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
.++-|+|+.|.++ .+|. .++.|+ |+.|.+++|+++-..++++.+..|..||.+.|.+. ++|++ ++.+.+|+.|++
T Consensus 122 ~lt~l~ls~NqlS-~lp~-~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsq-l~~l~slr~l~v 196 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPD-GLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQ-LGYLTSLRDLNV 196 (722)
T ss_pred HHHHhhhccchhh-cCCh-hhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHH-hhhHHHHHHHHH
Confidence 4567888888888 4553 567665 88899999999877778888888999999999998 68877 888999999999
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESL 212 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~ 212 (634)
..|++. .+|.+++.| .|..||+|.|+++ .||.. ....|++|.|.+|-|.. -|..+
T Consensus 197 rRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqI 253 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQI 253 (722)
T ss_pred hhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHH
Confidence 999988 688888865 4889999999998 67765 55689999999999973 34444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1e-07 Score=103.12 Aligned_cols=91 Identities=23% Similarity=0.419 Sum_probs=72.1
Q ss_pred HHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCc-------------cccccccCcccc
Q 038422 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH-------------TLMVAYKSPEYA 528 (634)
Q Consensus 462 ~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-------------~~~~~y~aPE~~ 528 (634)
+.+++.|+.|+|... .+||++|.|++|.++.++..||+.|+.+-........ ....-|.|||++
T Consensus 105 l~~v~dgl~flh~sA---k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA---KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccCc---ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 345669999999974 7999999999999999999999999876443331110 012349999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCC
Q 038422 529 HNGKISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 529 ~~~~~~~k~DVwSfGvvl~elltg~~P 555 (634)
.....+.++|+||+||++|-+..|..+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcc
Confidence 998889999999999999999854444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.34 E-value=6e-08 Score=94.28 Aligned_cols=101 Identities=25% Similarity=0.301 Sum_probs=46.9
Q ss_pred EEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEccc
Q 038422 76 WGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMAN 155 (634)
Q Consensus 76 ~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~ 155 (634)
+.+||++|.++ .+. +++..++.++.|++|+|.+.-. -.+..+++|+.||||+|.++. + ..+-..+-+.+.|.|+.
T Consensus 287 telDLS~N~I~-~iD-ESvKL~Pkir~L~lS~N~i~~v-~nLa~L~~L~~LDLS~N~Ls~-~-~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 287 TELDLSGNLIT-QID-ESVKLAPKLRRLILSQNRIRTV-QNLAELPQLQLLDLSGNLLAE-C-VGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhccccccchh-hhh-hhhhhccceeEEeccccceeee-hhhhhcccceEeecccchhHh-h-hhhHhhhcCEeeeehhh
Confidence 34455554443 222 3444455555555555554321 124445555555555555542 2 12233444555555555
Q ss_pred CcCccCCCccccCCCCccEEeCCCCcee
Q 038422 156 NRLTGTIPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 156 N~l~g~ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
|.+.. -+.+++|-+|.+||+++|++.
T Consensus 362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 362 NKIET--LSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhHhh--hhhhHhhhhheeccccccchh
Confidence 55431 123445555555555555543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.5e-06 Score=80.27 Aligned_cols=107 Identities=24% Similarity=0.297 Sum_probs=82.3
Q ss_pred ChhHHHHHHHHHhcCCCC--ccccceeEEEeCC----ceEEEEEcCCCC-ChhhHHhhccCCCCCCCCHHHHHHHHHHHH
Q 038422 394 GREDFQEHIKRLGRLEHP--NLLPLTAFYYRKE----EKLLLYEFVENG-SLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466 (634)
Q Consensus 394 ~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 466 (634)
......+|.+.+.++..- .+.+.+++..... .-++|+|++++- +|.+++..... .+......++.+++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALA 128 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHH
Confidence 345678888887777433 3445666665532 347999999984 78888865322 44566788999999
Q ss_pred HHHHHHHhcCCCCCccccCCCCCCEEeCCCC---CeEEeccccCCc
Q 038422 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSF---EPLLTDYALRPL 509 (634)
Q Consensus 467 ~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~ 509 (634)
..+.-||.. +|+|+|+++.|||++.+. .+.++||+.++.
T Consensus 129 ~~i~~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999998 899999999999999887 788999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.5e-06 Score=90.77 Aligned_cols=140 Identities=16% Similarity=0.298 Sum_probs=90.9
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccC----------------------cc----Ch--------------hHHHH
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMN----------------------NV----GR--------------EDFQE 400 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~----~~--------------~~~~~ 400 (634)
+.|+.++-|.||+|++++|+.||||+.+..- .. .. -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5688999999999999999999999874320 00 00 12344
Q ss_pred HHHHHhcCC-----CCccccceeEEEe-CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHH
Q 038422 401 HIKRLGRLE-----HPNLLPLTAFYYR-KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM-AYLH 473 (634)
Q Consensus 401 E~~~l~~l~-----H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH 473 (634)
|..-+.+++ .++ +++=.+|++ .....|+|||+.|-.+.+...-... .++-+. ++..++++. ..+-
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHH---HHHHHHHHHHHHHH
Confidence 555554442 233 233334433 4577899999999988887532221 144333 333333321 2222
Q ss_pred hcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 474 ~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
.. +++|.|..|.||+++.+++.-+.|||+...+.+
T Consensus 283 ~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22 699999999999999999999999999765544
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.5e-07 Score=89.63 Aligned_cols=92 Identities=28% Similarity=0.447 Sum_probs=56.9
Q ss_pred ChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccC
Q 038422 90 AAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ 168 (634)
Q Consensus 90 ~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~ 168 (634)
|..-+..|++|+.|+|++|++++.-+ .|..+..++.|.|..|++. .+....|.+++.|+.|+|.+|++|---|.+|..
T Consensus 266 P~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~ 344 (498)
T KOG4237|consen 266 PAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQT 344 (498)
T ss_pred hHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccc
Confidence 33445566666666666666666554 4566666666666666665 344455666666666666666666555666666
Q ss_pred CCCccEEeCCCCce
Q 038422 169 LPKLMELRLEANKF 182 (634)
Q Consensus 169 l~~L~~L~l~~N~~ 182 (634)
+.+|..|+|-.|.|
T Consensus 345 ~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 345 LFSLSTLNLLSNPF 358 (498)
T ss_pred cceeeeeehccCcc
Confidence 66666666666654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.3e-05 Score=73.73 Aligned_cols=137 Identities=16% Similarity=0.154 Sum_probs=99.1
Q ss_pred cCccCceeEEEEEEcCCcEEEEEEecc-c----C-ccChhHHHHHHHHHhcCCCCc--cccceeEEE-eCC----ceEEE
Q 038422 363 LGSGTFGASYKTVISNGQAYVVKRYKQ-M----N-NVGREDFQEHIKRLGRLEHPN--LLPLTAFYY-RKE----EKLLL 429 (634)
Q Consensus 363 lG~G~fg~Vy~~~~~~~~~vavK~~~~-~----~-~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~~~----~~~lv 429 (634)
-|+|+-+-|++-.+. |+.+-+|+-.. . . ...+..|.+|+..+.++..-+ +.+.. ++. ... .-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888889987664 44677887641 1 1 446678999999998885332 44444 332 211 35799
Q ss_pred EEcCCC-CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC--eEEecccc
Q 038422 430 YEFVEN-GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PLLTDYAL 506 (634)
Q Consensus 430 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGl 506 (634)
+|-+.+ -+|.+++..... .+.+..++..+..+|++.+.-||+. ++.|+|+-+.||+++.++. ++++||--
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 997764 588888754322 1357777889999999999999998 8999999999999986666 88999976
Q ss_pred CC
Q 038422 507 RP 508 (634)
Q Consensus 507 a~ 508 (634)
++
T Consensus 177 ~r 178 (216)
T PRK09902 177 SR 178 (216)
T ss_pred cc
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-05 Score=77.63 Aligned_cols=142 Identities=15% Similarity=0.170 Sum_probs=85.1
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc--ccceeEEEeCCceEEEEEcCCCCC-
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL--LPLTAFYYRKEEKLLLYEFVENGS- 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lv~e~~~~gs- 437 (634)
+.||+|..+.||+. .+..+++|..... .......+|.++++.+..-.+ .+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999983 2456777876542 244567899999988864433 566777777777889999999863
Q ss_pred hhhHH------------------hhccCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhcCCCCCccccCCC
Q 038422 438 LAGKL------------------HANHTKQRPGLDWQTRLK-IIK----------GVVK-GMAYLHNELPGSIIPHGHLK 487 (634)
Q Consensus 438 L~~~l------------------~~~~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~~~~~~ivHrdlk 487 (634)
+...+ ..-+.-............ +.. ++.. ...+|.....+..++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 11111 001110000111111110 100 0111 12333322223357899999
Q ss_pred CCCEEeCCCCCeEEeccccCC
Q 038422 488 SSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 488 ~~NILl~~~~~~kl~DfGla~ 508 (634)
|.||++++++ ..|.||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.9e-07 Score=96.82 Aligned_cols=177 Identities=18% Similarity=0.161 Sum_probs=127.1
Q ss_pred ccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCc-cccceeEEEeCCceEEEEEcCCCC-Chh
Q 038422 362 VLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN-LLPLTAFYYRKEEKLLLYEFVENG-SLA 439 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~~~~g-sL~ 439 (634)
-+++|+++++||.+-...+....+.+... ....-++++|.+++||| .++.++-+..++..+++++|+.+| +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46889999999987433333335544332 44556789999999999 777777777777889999999887 222
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---CCc
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---NAH 516 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---~~~ 516 (634)
.-.... ...+...+...+.+.-.++++|+|+. .-+||| ||+..+ ...|..||+....+... ...
T Consensus 324 ~~~~~s----e~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 324 LEMTVS----EIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred ccCChh----hHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCcccccccC
Confidence 111110 11244445566777788899999986 247998 777765 57899999987766544 334
Q ss_pred cccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 517 TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 517 ~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
.++..|+|||+.....+..+.|+|+.|+--.++.-|-.|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4567799999999999999999999998767777676663
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.1e-05 Score=85.38 Aligned_cols=142 Identities=16% Similarity=0.214 Sum_probs=90.8
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCcc-------------------------------------ChhHHHHHHH
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV-------------------------------------GREDFQEHIK 403 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~ 403 (634)
+.||.-+.|.||+|++++|+.||||+-+..-.. ..-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 568889999999999999999999987532100 0013555655
Q ss_pred HHhcC----CCCc---cccceeEEEe-CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 038422 404 RLGRL----EHPN---LLPLTAFYYR-KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475 (634)
Q Consensus 404 ~l~~l----~H~n---iv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 475 (634)
-..++ +|-+ =|.+=.++++ .....|+||||.|..+.|.-.-... .++-..+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHHHHHhc--
Confidence 44333 3544 1122233333 3468899999999888765332221 2555554444444333233322
Q ss_pred CCCCCccccCCCCCCEEeCC----CCCeEEeccccCCccCC
Q 038422 476 LPGSIIPHGHLKSSNVLLDR----SFEPLLTDYALRPLINP 512 (634)
Q Consensus 476 ~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGla~~~~~ 512 (634)
|++|+|-.|.||++.. +..+.+-|||+...+..
T Consensus 321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 6899999999999983 67889999999765543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.2e-07 Score=80.47 Aligned_cols=134 Identities=21% Similarity=0.220 Sum_probs=94.9
Q ss_pred EEEEEecCCCCccccC--hhhhcCCCCcCEEeccCCcCcccCCCCCC-CCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 75 VWGLKLEQMNLSGTIA--AESLGLLSSLRAVSFMNNKFEGPLPDLRK-MGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~--~~~l~~l~~L~~L~l~~n~l~g~~p~~~~-l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
...++|++..|- .++ ...+.....|...+|++|.|....+.|.. ++.++.|||++|.++ .+|.+ +..|+.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE-~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEE-LAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHH-HhhhHHhhhc
Confidence 344555555432 122 12345567788889999999988776644 458999999999999 68888 9999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCcccc
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLS 213 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~ 213 (634)
+++.|.|. ..|..+..|.+|..||..+|..- +||-. ..+..-..++.+|.+.|.-|..+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 99999999 67888888999999999888765 45532 122333344566666665554433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.3e-06 Score=91.83 Aligned_cols=133 Identities=26% Similarity=0.313 Sum_probs=97.9
Q ss_pred eeeEEecCCcEE---EEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCC-CCcEEEccCCcCccccChh
Q 038422 65 WNGVLCLNGSVW---GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMG-PLKSIYLSDNGFSGNISDD 140 (634)
Q Consensus 65 w~gv~C~~~~v~---~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~-~L~~L~ls~N~~~g~ip~~ 140 (634)
+.+..+...... .+++..+.+...+. .+..++.++.|++.+|+++-..|....+. +|+.|++++|++. .+|..
T Consensus 82 ~l~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~ 158 (394)
T COG4886 82 SLDGSENLLNLLPLPSLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158 (394)
T ss_pred cccccccccCCCCCceeeccccccccCch--hhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhh
Confidence 344444333333 46777776654443 35666888888888888888777777774 8889999999888 56533
Q ss_pred hhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCc
Q 038422 141 AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNE 203 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~ 203 (634)
++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.. ....|++|.+++|.
T Consensus 159 -~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 159 -LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred -hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 788888999999999888 67777778888888999888888 56654 44568888888885
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.9e-08 Score=103.15 Aligned_cols=108 Identities=31% Similarity=0.375 Sum_probs=70.5
Q ss_pred hhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCC
Q 038422 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPK 171 (634)
Q Consensus 92 ~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~ 171 (634)
+++..+++|+.|||++|+|+..- .+..|+.|++|||++|.+. .+|.-...+|. |+.|+|.+|.++.- -.+.+|.+
T Consensus 181 ~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lks 255 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKS 255 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhh
Confidence 34566777777777777777644 5677777777788887777 45543333444 77777777777632 24667777
Q ss_pred ccEEeCCCCceeec---CCcccccCCCEEEeecCcc
Q 038422 172 LMELRLEANKFQGQ---VPEIKQNEMRSLGLANNEL 204 (634)
Q Consensus 172 L~~L~l~~N~~~g~---ip~~~~~~l~~l~l~~N~l 204 (634)
|+.|||++|-+++- .|-+....|..|+|.+|-+
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 77777777776642 2223445666777777766
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.1e-06 Score=92.17 Aligned_cols=126 Identities=28% Similarity=0.458 Sum_probs=57.1
Q ss_pred EEEEEecCCCCccccChhhhcCCC-CcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLS-SLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~-~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
+..+++.+++++ .+++ ..+.+. +|+.|++++|++.-....+..++.|+.|++++|+++ .+|+. .+.+++|+.|++
T Consensus 118 l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~-~~~~~~L~~L~l 193 (394)
T COG4886 118 LTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKL-LSNLSNLNNLDL 193 (394)
T ss_pred eeEEecCCcccc-cCcc-ccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhh-hhhhhhhhheec
Confidence 444555554444 2222 233332 555555555555443334455555555555555555 34432 224455555555
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCc-ccccCCCEEEeecCccc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE-IKQNEMRSLGLANNELE 205 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~-~~~~~l~~l~l~~N~l~ 205 (634)
++|+++ .+|..+..+..|++|++++|+..-.+.. ....++..|.+++|++.
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee
Confidence 555555 4455444444455555555532211111 12334444445555443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.7e-07 Score=86.69 Aligned_cols=104 Identities=19% Similarity=0.295 Sum_probs=66.6
Q ss_pred CCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEe
Q 038422 97 LSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELR 176 (634)
Q Consensus 97 l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~ 176 (634)
...|+.||||+|.++-.=-+.--++.++.|++|+|++. .+ +.+..+++|+.||||+|.++ .+-.+=.+|-+.+.|.
T Consensus 283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred HhhhhhccccccchhhhhhhhhhccceeEEecccccee-ee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 34677777777776654334445567777777777776 33 22666777777777777777 4444445566677777
Q ss_pred CCCCceeecCCcc-cccCCCEEEeecCccc
Q 038422 177 LEANKFQGQVPEI-KQNEMRSLGLANNELE 205 (634)
Q Consensus 177 l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~ 205 (634)
|+.|.+.. +... ..-+|..||+++|++.
T Consensus 359 La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 359 LAQNKIET-LSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhhHhh-hhhhHhhhhheeccccccchh
Confidence 77776541 1111 2347888888888875
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.4e-06 Score=57.90 Aligned_cols=36 Identities=22% Similarity=0.508 Sum_probs=18.9
Q ss_pred CCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCc
Q 038422 122 PLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLT 159 (634)
Q Consensus 122 ~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~ 159 (634)
+|++|+|++|+++ .||++ +++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~-l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPE-LSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGH-GTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCch-HhCCCCCCEEEecCCCCC
Confidence 4555555555555 35443 555555555555555555
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00011 Score=73.24 Aligned_cols=142 Identities=15% Similarity=0.093 Sum_probs=82.9
Q ss_pred cCccCc-eeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCCChhh
Q 038422 363 LGSGTF-GASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440 (634)
Q Consensus 363 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 440 (634)
|-.|.. ..||+.... +..+++|...... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.++.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 689998764 4677888765432 345678888888774 3334567777766667899999999877764
Q ss_pred HH----------------hhccCCC--CCCCC--HHHHHHHHHH--------------------HHHHHHHHHhcC---C
Q 038422 441 KL----------------HANHTKQ--RPGLD--WQTRLKIIKG--------------------VVKGMAYLHNEL---P 477 (634)
Q Consensus 441 ~l----------------~~~~~~~--~~~l~--~~~~~~i~~~--------------------ia~gL~yLH~~~---~ 477 (634)
.. ..-+... ..++. ......-... +......|-... .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 0111100 00111 0011100000 111122221111 1
Q ss_pred CCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 478 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
+..++|+|+.|.|||++++....|.||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2358999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.2e-07 Score=98.99 Aligned_cols=125 Identities=28% Similarity=0.297 Sum_probs=91.7
Q ss_pred CcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCcc-ccCCCCccEEeC
Q 038422 99 SLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSS-LVQLPKLMELRL 177 (634)
Q Consensus 99 ~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~-~~~l~~L~~L~l 177 (634)
.|...+++.|.|.-.=-++.-++.|+.||||+|+|+. -+.+..|+.|+.|||++|+|+ .+|.- ...+ +|+.|.|
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~---v~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK---VDNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh---hHHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 4566677777776554456667889999999999984 246889999999999999999 56642 2334 4999999
Q ss_pred CCCceeecCCcccccCCCEEEeecCcccccC---C-ccccCCCCCcccCCCCCCC
Q 038422 178 EANKFQGQVPEIKQNEMRSLGLANNELEGPI---P-ESLSKMDPSTFAGNKNLCG 228 (634)
Q Consensus 178 ~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~i---p-~~~~~~~~~~~~gn~~lcg 228 (634)
++|.++.-.--....+|+.||+++|-|+|-- | ..+..+......|||-.|.
T Consensus 240 rnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 240 RNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999884433346679999999999998621 1 1234445667889986664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=4.2e-05 Score=72.68 Aligned_cols=102 Identities=19% Similarity=0.140 Sum_probs=79.6
Q ss_pred HHHHHHHhcCCC-CccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038422 399 QEHIKRLGRLEH-PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477 (634)
Q Consensus 399 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 477 (634)
..|.-++..+++ +++.+++|+| ..++|.||...+++...-.. ...-..-+|..|.+||.++++.++++++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457888888876 6999999999 34678999988766432000 0001126899999999999999999998655
Q ss_pred CCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 478 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
.. +.-.|++++|+-+++++++|+.|....
T Consensus 81 ~~-~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 81 GF-FYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred Cc-EEEeecchHHeEEeCCCcEEEEechhc
Confidence 44 888999999999999999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=85.04 Aligned_cols=150 Identities=15% Similarity=0.270 Sum_probs=92.0
Q ss_pred cccCccCceeEEEEEEcCC---cEEEEEEecccC-ccChhHHHHHHHHHhcCC-CCcc--ccceeEEEeC---CceEEEE
Q 038422 361 EVLGSGTFGASYKTVISNG---QAYVVKRYKQMN-NVGREDFQEHIKRLGRLE-HPNL--LPLTAFYYRK---EEKLLLY 430 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv~ 430 (634)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4688999999999876554 366777654322 223457899999999995 6665 6778887664 4678999
Q ss_pred EcCCCCChhh--------------------H---HhhccCCC------CCCCCH--HHHHHHH---------------HH
Q 038422 431 EFVENGSLAG--------------------K---LHANHTKQ------RPGLDW--QTRLKII---------------KG 464 (634)
Q Consensus 431 e~~~~gsL~~--------------------~---l~~~~~~~------~~~l~~--~~~~~i~---------------~~ 464 (634)
||+++..+.+ . |+...... ..+..+ .++..+. -.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998754321 1 11110000 000111 1111110 12
Q ss_pred HHHHHHHHHhcCCC-------CCccccCCCCCCEEeCCC-C-CeEEeccccCCcc
Q 038422 465 VVKGMAYLHNELPG-------SIIPHGHLKSSNVLLDRS-F-EPLLTDYALRPLI 510 (634)
Q Consensus 465 ia~gL~yLH~~~~~-------~~ivHrdlk~~NILl~~~-~-~~kl~DfGla~~~ 510 (634)
+...+++|..+.+. ..++|+|+++.||+++.+ . ..-|.||.++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 33446777665443 359999999999999853 2 3568999887653
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.8e-05 Score=55.63 Aligned_cols=37 Identities=35% Similarity=0.618 Sum_probs=23.6
Q ss_pred CCCCeEEcccCcCccCCCccccCCCCccEEeCCCCcee
Q 038422 146 TSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 146 ~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
++|++|+|++|+++ .+|..+++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35667777777776 56666677777777777777666
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 634 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-38 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-23 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 3e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 3e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-67
Identities = 92/280 (32%), Positives = 150/280 (53%), Gaps = 14/280 (5%)
Query: 350 FDLQDMLRA-----SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGRE-DFQEHIK 403
F L+++ A + +LG G FG YK +++G VKR K+ G E FQ ++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 404 RLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIK 463
+ H NLL L F E+LL+Y ++ NGS+A L + +P LDW R +I
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIAL 138
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAH-TLMVA- 521
G +G+AYLH+ II H +K++N+LLD FE ++ D+ L L++ + H T V
Sbjct: 139 GSARGLAYLHDHCDPKII-HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 522 ---YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578
+ +PEY GK S+K+DV+ G+++LEL+TG+ + D L +WV ++K
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLAR 618
EK+ + D +++G Y E+ L+++ L C + + R
Sbjct: 258 EKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMER 296
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 7e-57
Identities = 79/291 (27%), Positives = 137/291 (47%), Gaps = 19/291 (6%)
Query: 350 FDLQDMLRA-----SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR 404
L D+ A ++G G FG YK V+ +G +KR ++ G E+F+ I+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 405 LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG 464
L HP+L+ L F + E +L+Y+++ENG+L L+ + + W+ RL+I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICIG 147
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAH-TLMVA- 521
+G+ YLH +II H +KS N+LLD +F P +TD+ + + D H + +V
Sbjct: 148 AARGLHYLHT---RAII-HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 522 ---YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578
Y PEY G++++KSDV+S G+++ E+L + L +L+ W
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHN 261
Query: 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629
+ + D + K + + C R + +V+ K+E
Sbjct: 262 NGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 350 FDLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV----GREDFQEHIKRL 405
FD + + +G G FG YK + N VK+ M ++ ++ F + IK +
Sbjct: 27 FD-ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 406 GRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGV 465
+ +H NL+ L F ++ L+Y ++ NGSL +L P L W R KI +G
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS--CLDGTPPLSWHMRCKIAQGA 142
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAH-TLMVA-- 521
G+ +LH I H +KS+N+LLD +F ++D+ L R T +
Sbjct: 143 ANGINFLHEN---HHI-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 522 --YKSPEYAHNGKISKKSDVWSLGILILELLTGK------YPENYLLQGYDSKASLSNWV 573
Y +PE G+I+ KSD++S G+++LE++TG LL
Sbjct: 199 TAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD----------IK 247
Query: 574 NNMVKEKRT-GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
+ E++T D DK+M + + + + C E R ++K+V + ++ +
Sbjct: 248 EEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 30/223 (13%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN----GSVWGLKLEQMN 84
D + LLQ K L + ++ L +W + C W GVLC V L L +N
Sbjct: 6 QDKQALLQIKKDLGNPTT-LSSWLPTTDCC---NRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 85 LSGTIA-AESLGLLSSLRAVSFMN-NKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDA 141
L SL L L + N GP+P + K+ L +Y++ SG I D
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF- 120
Query: 142 FEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP-EIK--QNEMRSLG 198
+ +L L + N L+GT+P S+ LP L+ + + N+ G +P S+
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 199 LANNELEGPIPESLSKMD---------------PSTFAGNKNL 226
++ N L G IP + + ++ F +KN
Sbjct: 181 ISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 43/167 (25%), Positives = 64/167 (38%), Gaps = 29/167 (17%)
Query: 71 LNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLS 129
+ + + + L+G I L+ L V N EG + I+L+
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPT-FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI 189
N + ++ +L L + NNR+ GT+P L QL L
Sbjct: 230 KNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL----------------- 270
Query: 190 KQNEMRSLGLANNELEGPIPES--LSKMDPSTFAGNKNLCGPPLDPC 234
SL ++ N L G IP+ L + D S +A NK LCG PL C
Sbjct: 271 -----HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 57/297 (19%), Positives = 109/297 (36%), Gaps = 32/297 (10%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF- 419
EV G FG +K + + VK + + + + L ++H N+L
Sbjct: 30 EVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAE 87
Query: 420 ---YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ L+ F E GSL+ L + W I + + +G+AYLH ++
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 477 PGSI------IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA------YKS 524
PG I H +KS NVLL + + D+ L + Y +
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 525 PEYAHNG-----KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579
PE + D++++G+++ EL + + + Y + +++
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261
Query: 580 KRTGDVFDK---EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+ V K ++ + M L + C + D AR+ V E+I +++
Sbjct: 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 42/213 (19%), Positives = 75/213 (35%), Gaps = 37/213 (17%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT 88
+ L+ FK L D + L +W++ +NPC ++GV C + V + L L+
Sbjct: 12 REIHQLISFKDVLPDKN-LLPDWSSNKNPC-----TFDGVTCRDDKVTSIDLSSKPLNVG 65
Query: 89 IAA-------------------------ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPL 123
+A +SL ++ N GP+ L +G
Sbjct: 66 FSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125
Query: 124 KS---IYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ---LPKLMELRL 177
+ +S N + SL+ L ++ N ++G V +L L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 178 EANKFQGQVPEIKQNEMRSLGLANNELEGPIPE 210
NK G V + + L +++N IP
Sbjct: 186 SGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF 218
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 5/138 (3%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFE 143
LSG + ++ + L+ ++ +N+F GP+P L + L+ + L++N F+G I D
Sbjct: 234 KLSGDFSR-AISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSLAENKFTGEIPDFLSG 291
Query: 144 GMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLA 200
+L L ++ N G +P L L L +N F G++P K ++ L L+
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 201 NNELEGPIPESLSKMDPS 218
NE G +PESL+ + S
Sbjct: 352 FNEFSGELPESLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 5/132 (3%)
Query: 84 NLSGTIAAE--SLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDA 141
++SG L+ ++ NK G + + + L+ + +S N FS I
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIP--F 218
Query: 142 FEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLAN 201
++L+ L ++ N+L+G ++ +L L + +N+F G +P + ++ L LA
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAE 278
Query: 202 NELEGPIPESLS 213
N+ G IP+ LS
Sbjct: 279 NKFTGEIPDFLS 290
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD---LRKMGPLKSIYLSDNGFSGNISDD 140
SG + L +SL + +N F GP+ L+ +YL +NGF+G I
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 141 AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLG 198
+ L L+++ N L+GTIPSSL L KL +L+L N +G++P+ + +L
Sbjct: 414 -LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 199 LANNELEGPIPESLSKM 215
L N+L G IP LS
Sbjct: 473 LDFNDLTGEIPSGLSNC 489
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 47/135 (34%), Positives = 66/135 (48%), Gaps = 5/135 (3%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAF 142
LSGTI SLG LS LR + N EG +P L + L+++ L N +G I
Sbjct: 429 YLSGTIP-SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG-L 486
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLA 200
T+L + ++NNRLTG IP + +L L L+L N F G +P + + L L
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 201 NNELEGPIPESLSKM 215
N G IP ++ K
Sbjct: 547 TNLFNGTIPAAMFKQ 561
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 47/138 (34%), Positives = 67/138 (48%), Gaps = 7/138 (5%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDA 141
+ G + G S L +++ +N F G LP L KM LK + LS N FSG + +
Sbjct: 305 HFYGAVP-PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
Query: 142 FEGMTSLKKLYMANNRLTGTIPSSL--VQLPKLMELRLEANKFQGQVPEIKQN--EMRSL 197
SL L +++N +G I +L L EL L+ N F G++P N E+ SL
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
Query: 198 GLANNELEGPIPESLSKM 215
L+ N L G IP SL +
Sbjct: 424 HLSFNYLSGTIPSSLGSL 441
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 38/158 (24%), Positives = 58/158 (36%), Gaps = 23/158 (14%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGN 136
+ G + + S+ + N G +P + M L + L N SG+
Sbjct: 613 CNITSRVYGGHTS-PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRS 196
I D + L L +++N+L G IP ++ L L E+ L N G +PE+ Q
Sbjct: 672 IPD-EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ----- 725
Query: 197 LGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPC 234
P+ F N LCG PL C
Sbjct: 726 ---------------FETFPPAKFLNNPGLCGYPLPRC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-21
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 10/148 (6%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
L + G I L SL+ +S NKF G +PD L + LS N F G
Sbjct: 252 LNISSNQFVGPI---PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIP-SSLVQLPKLMELRLEANKFQGQVPEIKQN-- 192
+ F + L+ L +++N +G +P +L+++ L L L N+F G++PE N
Sbjct: 309 AVPPF-FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS 367
Query: 193 -EMRSLGLANNELEGPIPESLSKMDPST 219
+ +L L++N GPI +L + +T
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-18
Identities = 35/156 (22%), Positives = 56/156 (35%), Gaps = 25/156 (16%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNI----- 137
L+G I + +G L +L + NN F G +P L L + L+ N F+G I
Sbjct: 501 RLTGEIP-KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 138 ------SDDAFEG--------MTSLKKLYMANN--RLTGTIPSSLVQLPKLMELRLEANK 181
+ + G K+ + A N G L +L + +
Sbjct: 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619
Query: 182 FQGQVPEIKQN--EMRSLGLANNELEGPIPESLSKM 215
+ G N M L ++ N L G IP+ + M
Sbjct: 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-18
Identities = 33/133 (24%), Positives = 58/133 (43%), Gaps = 3/133 (2%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAF 142
+L+G I L ++L +S NN+ G +P + ++ L + LS+N FSGNI +
Sbjct: 477 DLTGEIP-SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE-L 534
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANN 202
SL L + N GTIP+++ + + A K + +
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 203 ELEGPIPESLSKM 215
E +G E L+++
Sbjct: 595 EFQGIRSEQLNRL 607
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
EVLG G FG + K T G+ V+K + + + F + +K + LEHPN+L
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
Y+ + + E+++ G+L G + W R+ K + GMAYLH+ +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 480 IIPHGHLKSSNVLLDRSF--------------EPLLTDYALRPLINPDNAHTLMVA---- 521
II H L S N L+ + + LR L PD V
Sbjct: 129 II-HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLL 560
+ +PE + +K DV+S GI++ E++ + L
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
EV+G G FG K + +K+ + + R+ F +++L R+ HPN++ L
Sbjct: 14 EVVGRGAFGVVCK-AKWRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
L+ E+ E GSL LH + P + +G+AYLH+ P ++
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 481 IPHGHLKSSNVLLDRSFEPL-LTDYAL-RPLINPDNAHTLMVAYKSPEYAHNGKISKKSD 538
I H LK N+LL L + D+ + + A+ +PE S+K D
Sbjct: 127 I-HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 539 VWSLGILILELLTGKYP 555
V+S GI++ E++T + P
Sbjct: 186 VFSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYK----QMNNVGREDFQEHIKRLGRLEHPNLLPL 416
E++G G FG Y+ G VK + + + E+ ++ K L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
++ L+ EF G L L + + + +GM YLH+E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEA 125
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPL--------LTDYALRPLINPDNAHTLM--VAYKSPE 526
II H LKSSN+L+ + E +TD+ L + + A+ +PE
Sbjct: 126 IVPII-HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
SK SDVWS G+L+ ELLTG+ P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 16/203 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGR--EDFQEHIKRLGRLEHPNLLPLTA 418
L G +K G VVK K + R DF E RL HPN+LP+
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 419 FYYRKEEKLL--LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ ++ GSL LH +D +K + +GMA+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMARGMAFLHTLE 131
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPE---YAHNGK 532
P +IP L S +V++D ++ + +P + A+ +PE
Sbjct: 132 P--LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP--AWVAPEALQKKPEDT 187
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+ +D+WS +L+ EL+T + P
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP 210
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 46/216 (21%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGR-------EDFQEHIKRLGRLEHPN 412
+ +G G FG +K ++ + +K ++ G ++FQ + + L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L ++ EFV G L +L + + W +L+++ + G+ Y+
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPL-----LTDYAL-RPLINPDNAHTLM-----VA 521
N+ P I+ H L+S N+ L E + D+ L + + H++
Sbjct: 139 QNQNP-PIV-HRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQ 191
Query: 522 YKSPE--YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ +PE A ++K+D +S +++ +LTG+ P
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 70/311 (22%), Positives = 120/311 (38%), Gaps = 53/311 (17%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE--HIKRLGRLEHPNLLPLTA 418
E++G G +GA YK + + VK + N R++F +I R+ +EH N+
Sbjct: 19 ELIGRGRYGAVYK-GSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 419 FYYR-----KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
R + E LL+ E+ NGSL L DW + ++ V +G+AYLH
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 474 NELPGSI-----IPHGHLKSSNVLLDRSFEPLLTDYAL---------RPLINPDNAHTLM 519
ELP I H L S NVL+ +++D+ L DNA
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 520 V---AYKSPEYA-------HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASL 569
V Y +PE K+ D+++LG++ E+ + + +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 570 SNWVNN---------MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME 620
V N +V ++ F + K + + ++ C ++D AR+
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE---DCWDQDAEARLT 305
Query: 621 LKEVIEKIERL 631
+ E++ L
Sbjct: 306 AQXAEERMAEL 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYK--QMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
E +G+G+FG ++ +G VK + +F + + RL HPN++
Sbjct: 43 EKIGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ ++ E++ GSL LH + +++ LD + RL + V KGM YLHN P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNP- 158
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMV---AYKSPEYAHNGKIS 534
I+ H +LKS N+L+D+ + + D+ L R + + + +PE + +
Sbjct: 159 PIV-HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 535 KKSDVWSLGILILELLTGKYP 555
+KSDV+S G+++ EL T + P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 361 EVLGSGTFGASYK-----TVISNGQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNL 413
+ +GSG+FG YK V A VK + F+ + L + H N+
Sbjct: 30 QRIGSGSFGTVYKGKWHGDV-----A--VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L Y + ++ ++ E SL LH + + + I + +GM YLH
Sbjct: 83 LLFMG-YSTAPQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLH 137
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM-----VAYKSPE- 526
+ SII H LKS+N+ L + D+ L +H + + +PE
Sbjct: 138 AK---SII-HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 527 --YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ S +SDV++ GI++ EL+TG+ P
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 54/305 (17%), Positives = 111/305 (36%), Gaps = 48/305 (15%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE-HIKRLGRLEHPNLLPLTAF 419
+ +G G +G + G+ VK + F+E I + + H N+L F
Sbjct: 43 KQIGKGRYGEVWM-GKWRGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENIL---GF 96
Query: 420 Y-------YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ L+ ++ ENGSL L LD ++ LK+ V G+ +L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHL 150
Query: 473 HNELPGSI----IPHGHLKSSNVLLDRSFEPLLTDY--ALRPLINPDNAHTLMVA----- 521
H E+ + I H LKS N+L+ ++ + D A++ + + +
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 522 -YKSPE------YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVN 574
Y PE ++ + +D++S G+++ E+ +++ Y +
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-GGIVEEYQLPYHDLVPSD 269
Query: 575 NMVKEKRTGDVFDK------EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628
++ R K + +M L+ C + +R+ V + +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTL 326
Query: 629 ERLKE 633
++ E
Sbjct: 327 AKMSE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/303 (19%), Positives = 119/303 (39%), Gaps = 44/303 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE-HIKRLGRLEHPNLLPL--- 416
E +G G FG ++ G+ VK + R F+E I + L H N+L
Sbjct: 48 ESIGKGRFGEVWR-GKWRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 417 -TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ L+ ++ E+GSL L+ R + + +K+ G+A+LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 476 LPGSI----IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA--------YK 523
+ G+ I H LKS N+L+ ++ + D L + + Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 524 SPE------YAHNGKISKKSDVWSLGILILELLTGKYP----ENYLLQGYD---SKASLS 570
+PE + + K++D++++G++ E+ E+Y L YD S S+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIER 630
+ ++K ++ ++ M +++ C + AR+ + + + +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEAL--RVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333
Query: 631 LKE 633
L +
Sbjct: 334 LSQ 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 48/218 (22%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQE-HIKRLGRLEHPNLLPL--- 416
E +G G +G ++ G+ VK + + + F+E + L H N+L
Sbjct: 14 ECVGKGRYGEVWR-GSWQGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIAS 70
Query: 417 -TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ + L+ + E GSL L LD + L+I+ + G+A+LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIASGLAHLHIE 124
Query: 476 LPGSI----IPHGHLKSSNVLLDRSFEPLLTDYAL--------RPLINPDNAHTLMVAYK 523
+ G+ I H LKS N+L+ ++ + + D L L +N Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 524 SPE------YAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE K+ D+W+ G+++ E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 67/294 (22%), Positives = 119/294 (40%), Gaps = 45/294 (15%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+ LG G F + +G Y +KR RE+ Q HPN+L L A+
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 420 YYRKEEK----LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
R+ LL F + G+L ++ K L L ++ G+ +G+ +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIH-A 152
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALRPLINPDNAHTLMV-----------AY 522
H LK +N+LL +P+L D + I+ + + + +Y
Sbjct: 153 KG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 523 KSPE----YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578
++PE +H I +++DVWSLG ++ ++ G+ P + + Q DS A V N +
Sbjct: 210 RAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---VQNQLS 265
Query: 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
+ ++S S + LL S D R + ++ ++E L+
Sbjct: 266 IP----------QSPRHS-SALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 24/242 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLP-L 416
+G G+F YK + + +++ R+ F+E + L L+HPN++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 417 TAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKGMAYL 472
++ + K + E + +G+L L +R + + + ++KG+ +L
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYL------KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPDNAHTLM--VAYKSPEYAH 529
H P I H LK N+ + + D L L A ++ + +PE
Sbjct: 146 HTRTPPII--HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE 203
Query: 530 NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589
+ DV++ G+ +LE+ T +YP + A + V + VK V E
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 590 MK 591
+K
Sbjct: 259 VK 260
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKR---YKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
+ +G G F Y+ + +G +K+ + M+ R D + I L +L HPN+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV--- 94
Query: 417 TAFY--YRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+Y + ++ +L + E + G L+ + ++R + +T K + + ++H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEHMH 153
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP-DNAHTLMVA---YKSPEYA 528
+ ++ H +K +NV + + L D L R + AH+ +V Y SPE
Sbjct: 154 SR---RVM-HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
H + KSD+WSLG L+ E+ + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 45/219 (20%), Positives = 77/219 (35%), Gaps = 39/219 (17%)
Query: 361 EVLGSGTFGASYK-----TVISNGQAYVVKRYK--QMNNVGREDFQEHIKRLGRLEHPNL 413
E++G G FG Y V A ++ + N + F+ + + H N+
Sbjct: 39 ELIGKGRFGQVYHGRWHGEV-----A--IRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ ++ + +L + + LD +I + +VKGM YLH
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 474 NELPGSIIPHGHLKSSNVLLDR----------SFEPLLTDYALRPLINPDNAHTL----- 518
+ I+ H LKS NV D + R L
Sbjct: 148 AK---GIL-HKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 519 -MVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYP 555
++ SP+ + SK SDV++LG + EL ++P
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+G+G++G K S+G+ V K Y M ++ + L L+HPN++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 418 -AFYYRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
R L + E+ E G LA + +++ LD + L+++ + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 130
Query: 476 -LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHN 530
G + H LK +NV LD L D+ L ++N D + Y SPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 531 GKISKKSDVWSLGILILELLTGKYP 555
++KSD+WSLG L+ EL P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 27/236 (11%)
Query: 330 EIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVK--R 386
D G + ME + + +G G+FG + +G+ YV+K
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRL-------QKIGEGSFGKAILVKSTEDGRQYVIKEIN 58
Query: 387 YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLY---EFVENGSLAGKLH 443
+M++ RE+ + + L ++HPN++ + EE LY ++ E G L +++
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIV---QYRESFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 444 ANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503
A ++ L + + ++H+ I+ H +KS N+ L + L D
Sbjct: 116 A---QKGVLFQEDQILDWFVQICLALKHVHDR---KIL-HRDIKSQNIFLTKDGTVQLGD 168
Query: 504 YAL-RPLINPDNAHTLMVA---YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ + R L + + Y SPE N + KSD+W+LG ++ EL T K+
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN------- 412
E++GSG FG +K +G+ YV+KR E + +K L +L+H N
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 413 ------LLPLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIK 463
++ + + L+ EF + G+L + ++ LD L++ +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVLALELFE 129
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV--- 520
+ KG+ Y+H++ +I + LK SN+ L + + + D+ L + D T
Sbjct: 130 QITKGVDYIHSK---KLI-NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 521 AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y SPE + K+ D+++LG+++ ELL
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 40/226 (17%), Positives = 86/226 (38%), Gaps = 43/226 (19%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRL-EHPNLLPL 416
E +GSG FG+ +K V +G Y +KR +V ++ + L +H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--- 73
Query: 417 TAFY--YRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
++ + +++ +L+ E+ GSLA + N+ ++ V +G+ Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGLRYIH 132
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA------------ 521
+ S++ H +K SN+ + R+ P N +
Sbjct: 133 SM---SLV-HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 522 -------YKSPE-----YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ + E Y H K+D+++L + ++ +
Sbjct: 189 VEEGDSRFLANEVLQENYTHL----PKADIFALALTVVCAAGAEPL 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
VLG GT+G Y +SN +K + ++ + E I L+H N + +
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN---IVQY 84
Query: 420 Y--YRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ + + ++ E V GSL+ L + + K +++G+ YLH+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIG-FYTKQILEGLKYLHDN- 141
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPL-LTDY--ALRPLINPDNAHTLM--VAYKSPEYAHNG 531
I+ H +K NVL++ L ++D+ + R T + Y +PE G
Sbjct: 142 --QIV-HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 532 KI--SKKSDVWSLGILILELLTGKYP 555
K +D+WSLG I+E+ TGK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 25/205 (12%)
Query: 362 VLGSGTFGASYK-TVISNGQAYVVK--------RYKQMNNVGREDFQEHIKRLGRLEHPN 412
LG G FG Y + +K + + + RE ++ L HPN
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE-----VEIQSHLRHPN 70
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+L L +++ L+ E+ G++ +L K + +T I + ++Y
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTA-TYITELANALSYC 125
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL--MVAYKSPEYAHN 530
H++ +I H +K N+LL + E + D+ L + Y PE
Sbjct: 126 HSK---RVI-HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 531 GKISKKSDVWSLGILILELLTGKYP 555
+K D+WSLG+L E L GK P
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 27/173 (15%), Positives = 55/173 (31%), Gaps = 25/173 (14%)
Query: 79 KLEQMNLSG------TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNG 132
LE ++LS ++S +SL+ + N + + L+ + +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
F + +L L +++ L L L++ N FQ
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 193 EMRS---LGLANNELEGPIPESLSKM----------------DPSTFAGNKNL 226
E+R+ L L+ +LE P + + + D + +L
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 24/144 (16%), Positives = 47/144 (32%), Gaps = 3/144 (2%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGN 136
L + NL L +L + + + L+ + ++ N F N
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EM 194
D F + +L L ++ +L P++ L L L + N F + +
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
Query: 195 RSLGLANNELEGPIPESLSKMDPS 218
+ L + N + + L S
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 33/173 (19%), Positives = 64/173 (36%), Gaps = 16/173 (9%)
Query: 57 PCTFNYPNWNGVLCLNG------SVWGLKLEQMNLSG----TIAAESLGLLSSLRAVSFM 106
PC PN C+ + ++LS + + S L+ +
Sbjct: 2 PCVEVVPNIT-YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 107 NNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSS 165
+ + + + L ++ L+ N ++ AF G++SL+KL L
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 166 LVQLPKLMELRLEANKFQG-QVPEIKQN--EMRSLGLANNELEGPIPESLSKM 215
+ L L EL + N Q ++PE N + L L++N+++ L +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 27/144 (18%), Positives = 58/144 (40%), Gaps = 10/144 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L + L+G ++A + LSSL+ + + + + LK + ++ N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL----MELRLEANKFQGQVPEI 189
+ F +T+L+ L +++N++ + L L ++ + L L N P
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 190 -KQNEMRSLGLANNELEGPIPESL 212
K+ + L L NN + ++
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 27/137 (19%), Positives = 43/137 (31%), Gaps = 7/137 (5%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
L + + LSSL + N F+ ++ L + LS
Sbjct: 426 LDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMR 195
+S AF ++SL+ L M++N L L L N + Q+
Sbjct: 485 -LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543
Query: 196 SLG---LANNELEGPIP 209
SL L N+
Sbjct: 544 SLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 17/106 (16%), Positives = 32/106 (30%), Gaps = 11/106 (10%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
K++ LS N + +F L+ L ++ + + L L L L N
Sbjct: 30 TKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 183 QGQVPEIKQN--EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
Q ++ L +L+ ++ K L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVET--------NLASLENFPIGHLKTL 126
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 28/197 (14%), Positives = 48/197 (24%), Gaps = 41/197 (20%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFM----NNKFEGPLPDLRKMGPLKSIYLSD 130
LE ++LS +I L +L + ++ N P K L + L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGT----------------------------- 161
N S N+ +G+ L+ +
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 162 ----IPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDP 217
I L + L + + + L L N + L +
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 218 STFAGNKNLCGPPLDPC 234
TF NK
Sbjct: 330 LTFTSNKGGNAFSEVDL 346
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 30/194 (15%), Positives = 61/194 (31%), Gaps = 26/194 (13%)
Query: 27 GLSDTEIL-LQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNL 85
GL+ E+ L N+ + + +AL C +L ++
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE-------------FRLAYLDY 269
Query: 86 SGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGM 145
+ L+++ + S ++ E + D + + L + F + +
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQ-FPTLKLKSL 327
Query: 146 TSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK--FQGQVPEIKQN--EMRSLGLAN 201
L G S V LP L L L N F+G + ++ L L+
Sbjct: 328 KRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 202 NELEGPIPESLSKM 215
N + + + +
Sbjct: 383 NGVIT-MSSNFLGL 395
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 7/121 (5%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L ++LS ++ + LSSL+ ++ +N F + + L+ + S N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSS--LVQLPKLMELRLEANKFQGQVPEIKQ 191
+ + +SL L + N T L + +L +E + + P KQ
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590
Query: 192 N 192
Sbjct: 591 G 591
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 145 MTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANN 202
S K L ++ N L S P+L L L + Q Q+ + +L L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 203 ELEGPIPESLSKMDPSTFAGNKNL 226
++ + F+G +L
Sbjct: 87 PIQSLALGA--------FSGLSSL 102
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 52/265 (19%), Positives = 101/265 (38%), Gaps = 29/265 (10%)
Query: 305 RASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLR--ASAEV 362
+ + L ++ S + + + + + + G L + ++ ++ +
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR 65
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYY 421
+G G+FG ++ G VK ++ + +E + L P ++PL
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVK---KVR-LEVFRVEE-LVACAGLSSPRIVPLYGAV- 119
Query: 422 RKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
R+ + ++ E +E GSL + KQ L L + ++G+ YLH I
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 481 IPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMVAYKS---------PEYAHN 530
+ HG +K+ NVLL L D+ + PD ++ PE
Sbjct: 172 L-HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 531 GKISKKSDVWSLGILILELLTGKYP 555
K D+WS ++L +L G +P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 45/206 (21%), Positives = 73/206 (35%), Gaps = 25/206 (12%)
Query: 361 EVLGSGTFGASYKTVIS--NGQAYVVK--RYKQMNNVGREDFQEHIKRLGRL-EHPNLLP 415
LG G++G +K V S +G+ Y VK R + ++ +HP
Sbjct: 63 SRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC-- 119
Query: 416 LTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
EE +LY E SL L ++ + +A+L
Sbjct: 120 -VRLEQAWEEGGILYLQTELCG-PSLQQHCE----AWGASLPEAQVWGYLRDTLLALAHL 173
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM--VAYKSPEYAH 529
H++ ++ H +K +N+ L L D+ L L Y +PE
Sbjct: 174 HSQ---GLV-HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LL 228
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
G +DV+SLG+ ILE+
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 36/221 (16%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYK-QMNNVGREDFQEHIKRLGRLEHPNLL---- 414
+ LG G FG ++ + Y +KR + + RE +K L +LEHP ++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 415 -----PLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
T K+ LY + +L ++ T + + L I +
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER--ERSVCLHIFLQIA 128
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLD-------------RSFEPLLTDYALRPLINPD 513
+ + +LH++ ++ H LK SN+ + + + + +
Sbjct: 129 EAVEFLHSK---GLM-HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 514 NAHTLMV---AYKSPEYAHNGKISKKSDVWSLGILILELLT 551
HT V Y SPE H S K D++SLG+++ ELL
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 52/257 (20%), Positives = 101/257 (39%), Gaps = 26/257 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLP 415
LG+G G +K +G K ++ + + I R L P +
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKL---IHLEIKPAIRNQIIRELQVLHECNSPYI-- 93
Query: 416 LTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
FY + + ++ + E ++ GSL L K+ + Q K+ V+KG+ YL
Sbjct: 94 -VGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM--VAYKSPEYAH 529
+ I+ H +K SN+L++ E L D+ + LI+ A++ + +Y SPE
Sbjct: 148 REKH--KIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ 203
Query: 530 NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589
S +SD+WS+G+ ++E+ G+YP + + +
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 590 MKGAKYSKSEMINLLKI 606
+ + + ++
Sbjct: 264 LNKFGMDSRPPMAIFEL 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 32/223 (14%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPL-T 417
VL G F Y+ + +G+ Y +KR + + + +L HPN++ +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 418 AFYYRKEE------KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
A KEE + LL + G L L + R L T LKI + + +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY--ALRPLINPDNAHTLMV--------- 520
+H + P I H LK N+LL L D+ A PD + +
Sbjct: 152 MHRQKP--PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 521 -----AYKSPE---YAHNGKISKKSDVWSLGILILELLTGKYP 555
Y++PE N I +K D+W+LG ++ L ++P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV----VKRYKQMNNVGREDFQEHIKRLGRLEHPN 412
E LG GTF + V GQ + +K + + E F E + +L H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ +E +L+ EFV+ GSL L N + ++ +L++ K + M +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFL 129
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPL--------LTDYALRPLINPDNAHTLMVAYKS 524
E I HG++ + N+LL R + L+D + + P + + +
Sbjct: 130 --EENTLI--HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 525 PEYAHNGKI-SKKSDVWSLGILILELLT-GKYP 555
PE N K + +D WS G + E+ + G P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 31/232 (13%), Positives = 57/232 (24%), Gaps = 44/232 (18%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRY---KQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
E L G + + + + +K + + + E E RL +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 417 TAFY--------------------------YRKEEKLLLYEFVENGSLA--GKLHANHTK 448
Y LLL L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYV 186
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508
R + +++ A L ++ ++ HGH N+ + +L D +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSK---GLV-HGHFTPDNLFIMPDGRLMLGDVSA-- 240
Query: 509 LINPDNAHTLMV---AYKSPEY--AHNGKISKKSDVWSLGILILELLTGKYP 555
L Y E+ A + + W LG+ I + P
Sbjct: 241 LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 43/227 (18%), Positives = 85/227 (37%), Gaps = 46/227 (20%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
VLG G FG K + + Y +K+ + + L L H ++ A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 420 YYRK----------EEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
+ + ++K L+ E+ ENG+L +H + ++ + ++
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQIL 126
Query: 467 KGMAYLHNELPGSIIPHGH--LKSSNVLLDRS---------------FEPLLTDYALRPL 509
+ ++Y+H++ II H LK N+ +D S + + L
Sbjct: 127 EALSYIHSQ---GII---HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 510 INPDNAHTLMV---AYKSPE-YAHNGKISKKSDVWSLGILILELLTG 552
+ T + Y + E G ++K D++SLGI+ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 19/202 (9%)
Query: 362 VLGSGTFGASYKTV-ISNGQAYVVKR-YKQMNNVGREDFQEHIKR----LGRLEHPNLLP 415
LG G FG Y N +K +K + +E + ++R L HPN+L
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ +++ ++ L+ EF G L +L K + ++ ++ + + Y H
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSA-TFMEELADALHYCHER 133
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL--MVAYKSPEYAHNGKI 533
+I H +K N+L+ E + D+ T+ + Y PE
Sbjct: 134 ---KVI-HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTH 189
Query: 534 SKKSDVWSLGILILELLTGKYP 555
+K D+W G+L E L G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 37/240 (15%), Positives = 82/240 (34%), Gaps = 51/240 (21%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK---RYKQMNNVGREDFQEHIKRLGRL-------- 408
VLG A + T G+++ V ++ + + +E + RL L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 409 -----------------EHPNLLPLTAFYYRKEEK---LLLYEFVENGSLAGKLHANHTK 448
+ ++ + L N G++ +H+
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD--YAL 506
L RL++ V++ +A LH+ ++ H +L+ +++LD+ LT + +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLV-HTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 507 RPLINPDNAHTLMVAYKSPEY-----------AHNGKISKKSDVWSLGILILELLTGKYP 555
R ++ + ++ PE ++ D W+LG++I + P
Sbjct: 255 RDGARVVSSVSR--GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG G +G Y+ V V VK K+ + + E+F + + ++HPNL+ L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
R+ ++ EF+ G+L L R + L + + M YL + +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-----NAHTLMVAYKSPEYAHNGKIS 534
I H +L + N L+ + + D+ L L+ D + + +PE K S
Sbjct: 339 FI-HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 535 KKSDVWSLGILILELLT-GKYP 555
KSDVW+ G+L+ E+ T G P
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSP 419
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
E +G G FG + + V VK ++ + + F + + L + HPN++ L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+K+ ++ E V+ G L + L +T L+++ GM YL ++
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR----TEGARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK-------SPEYAHNG 531
I H L + N L+ ++D+ + D + + +PE + G
Sbjct: 233 CCI-HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 532 KISKKSDVWSLGILILELLT-GKYP 555
+ S +SDVWS GIL+ E + G P
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP 315
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 30/235 (12%)
Query: 338 GKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGRE 396
GKL + F +D+ +G G +G+ K V +GQ VKR + + E
Sbjct: 7 GKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKR---IRSTVDE 61
Query: 397 DFQEHIKR-----LGRLEHPNLLPLTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTK 448
Q+ + + + P + FY +E + E + + S ++
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYI---VQFYGALFREGDCWICMELM-STSFDKFYKYVYSV 117
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-R 507
+ + KI VK + +L L II H +K SN+LLDRS L D+ +
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENL--KII-HRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 508 PLINPDNAHTLMV---AYKSPE----YAHNGKISKKSDVWSLGILILELLTGKYP 555
L++ A T Y +PE A +SDVWSLGI + EL TG++P
Sbjct: 175 QLVD-SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 18/160 (11%)
Query: 77 GLKLEQMNLSGT-IAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFS 134
GLKL + +S + L +L + +NK + L DL + L + L N
Sbjct: 171 GLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK--------FQGQV 186
I + + + +L++L++ NN+L+ +P+ L L L + L N F
Sbjct: 231 -MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG 288
Query: 187 PEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+K+ + L NN + ++ P+TF +
Sbjct: 289 FGVKRAYYNGISLFNNPV------PYWEVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 26/155 (16%), Positives = 49/155 (31%), Gaps = 21/155 (13%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGP--LKSIYLSDNG 132
L + L I ++ L L+ + N L ++ P L + + DN
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH----LVEIPPNLPSSLVELRIHDNR 134
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGT-IPSSLVQLPKLMELRLEANKFQGQVPEIKQ 191
+ F G+ ++ + M N L + KL LR+ K +P+
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP 192
Query: 192 NEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ L L +N + ++ L
Sbjct: 193 ETLNELHLDHN--------KIQAIELEDLLRYSKL 219
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 10/104 (9%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ L +N S + D F+G+ L L + NN+++ + L KL +L + N
Sbjct: 56 TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 183 QGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
P + + + L + +N + K+ F+G +N+
Sbjct: 115 VEIPPNLPSS-LVELRIHDN--------RIRKVPKGVFSGLRNM 149
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 19/98 (19%), Positives = 31/98 (31%), Gaps = 12/98 (12%)
Query: 72 NGSVWGL-KLEQMNLSG---TIAAESLGLLSSLRAVSFMNNKFE-------GPLPDLRKM 120
NGS+ L L +++L + L L L+ V N P+ K
Sbjct: 234 NGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293
Query: 121 GPLKSIYLSDNGFS-GNISDDAFEGMTSLKKLYMANNR 157
I L +N + F +T + N +
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-17
Identities = 30/146 (20%), Positives = 59/146 (40%), Gaps = 10/146 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
+L +++ + E L L+ ++ +N+ L ++L N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI---- 189
I ++ F +L L +++N L+ T + VQL L EL L NK Q E
Sbjct: 110 QK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 190 KQNEMRSLGLANNELEGPIPESLSKM 215
+ ++ L L++N+++ P +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAI 194
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-16
Identities = 36/161 (22%), Positives = 62/161 (38%), Gaps = 14/161 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGP----LKSIYLSD 130
L+++ LS + + L + N + L + + ++++ LS+
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 131 NGFSGNISDDAFEGM--TSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188
+ S S+ F G+ T+L L ++ N L S LP+L LE N Q
Sbjct: 232 SQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 189 IKQN--EMRSLGLANNELEGPIPE-SLSKMDPSTFAGNKNL 226
+R L L + + I SL K+D +F K L
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 30/150 (20%), Positives = 59/150 (39%), Gaps = 13/150 (8%)
Query: 79 KLEQMNLSG------TIAAESLGLL--SSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLS 129
L+ ++LS T+ E+ L S L ++ NK D +G L+ + L
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG--QVP 187
N ++ + G+ ++ ++Y++ N+ +S +P L L L + P
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473
Query: 188 EIKQN--EMRSLGLANNELEGPIPESLSKM 215
Q + L L+NN + + L +
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGL 503
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 30/147 (20%), Positives = 50/147 (34%), Gaps = 17/147 (11%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFE---------GPLPDLRKMGPLKS 125
L ++LS I + L L L + +N GP+ L+ + L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 126 IYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQ 185
+ L NGF I + F+ + LK + + N L S L L L+ N
Sbjct: 541 LNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV 599
Query: 186 VPEIKQNEMRSLG---LANNELEGPIP 209
++ R+L + N +
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 28/177 (15%), Positives = 53/177 (29%), Gaps = 28/177 (15%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSG- 135
L L + + + L ++ + NK+ + + L+ + L
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE-- 193
+ S F+ + +L L ++NN + L L KL L L+ N
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 194 --------MRSLGLANNELEGPIPES----------------LSKMDPSTFAGNKNL 226
+ L L +N + E L+ + S F +L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 27/151 (17%), Positives = 59/151 (39%), Gaps = 11/151 (7%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGF 133
L +++L I +L + +N L ++ L+ + LS+N
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 134 SGNISDD-AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---- 188
S++ +SLKKL +++N++ P + +L L L + + E
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 189 -IKQNEMRSLGLANNELEGPIPESLSKMDPS 218
+ +R+L L+N++L + + +
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 32/147 (21%), Positives = 61/147 (41%), Gaps = 8/147 (5%)
Query: 80 LEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFS 134
+ +NL+ + A + S L ++ N P+ +K+ LK + L N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN-- 192
+SD F T+L +L++ +N + + V+ L+ L L N +
Sbjct: 87 Q-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 193 EMRSLGLANNELEGPIPESLSKMDPST 219
++ L L+NN+++ E L S+
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 26/156 (16%), Positives = 54/156 (34%), Gaps = 19/156 (12%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L ++LS + +S L L N + L + ++ + L +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 134 SGNIS--------DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQ 185
+IS D +F+ + L+ L M +N + G + L L L L + +
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 186 VPE------IKQNEMRSLGLANNELEGPIPESLSKM 215
+ + + L L N++ ++ S +
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 20/122 (16%), Positives = 37/122 (30%), Gaps = 19/122 (15%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ + L+ N + F + L L + N ++ P +LP L L L+ N+
Sbjct: 27 ITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 183 QGQVPEIKQN--EMRSLGLANNELEGPIPESLSKM----------------DPSTFAGNK 224
+ + L L +N ++ K T +
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 225 NL 226
NL
Sbjct: 146 NL 147
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 23/122 (18%), Positives = 45/122 (36%), Gaps = 22/122 (18%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ S + + DD T++ L + +N+L ++ + +L L + N
Sbjct: 6 HEVADCSHLKLT-QVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 183 QGQVPEIKQN--EMRSLGLANNELEGPIPES----------------LSKMDPSTFAGNK 224
PE+ Q ++ L L +NEL ++ + K+ + F K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 225 NL 226
NL
Sbjct: 122 NL 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 19/91 (20%), Positives = 26/91 (28%), Gaps = 5/91 (5%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L +NL I E L L+ + N LKS+ L N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPS 164
+ +L +L M N T S
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ LG+G FG + + VK K ++ E F + L+H L+ L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
KE ++ EF+ GSL L ++ + + + +GMA++ E I
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFI--EQRNYI 306
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHNGKIS 534
H L+++N+L+ S + D+ L +I DN +T + + +PE + G +
Sbjct: 307 --HRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 535 KKSDVWSLGILILELLT-GKYP 555
KSDVWS GIL++E++T G+ P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP 385
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 9e-17
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 363 LGSGTFGASYK-TVISNGQAYVVK--------RYKQMNNVGREDFQEHIKRLGRLEHPNL 413
LG G+F Y+ I G +K + + V E +K +L+HP++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE-----VKIHCQLKHPSI 73
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
L L ++ L+ E NG + L + +P + + R + ++ GM YLH
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEAR-HFMHQIITGMLYLH 129
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--HTL--MVAYKSPEYAH 529
+ I+ H L SN+LL R+ + D+ L + + +TL Y SPE A
Sbjct: 130 SH---GIL-HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
+SDVWSLG + LL G+ P
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+ +GSG FG + + V +K ++ + EDF E + + +L HP L+ L
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ L+ EF+E+G L+ L R +T L + V +GMAYL E
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYL--EEACV 125
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------SPEYAHNGKI 533
I H L + N L+ + ++D+ + + D+ +T K SPE +
Sbjct: 126 I--HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 534 SKKSDVWSLGILILELLT-GKYP 555
S KSDVWS G+L+ E+ + GK P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+ +GSG ++ + Q Y +K ++ +N + ++ I L +L+ + +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 419 F-YYRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ Y ++ + + E N L L K++ +D R K +++ + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 146
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPE---- 526
I+ H LK +N L+ L D+ + + PD + V Y PE
Sbjct: 147 --GIV-HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 527 -------YAHNGKISKKSDVWSLGILILELLTGKYP 555
KIS KSDVWSLG ++ + GK P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+ LGSG FG GQ V VK K+ ++ ++F + + + +L HP L+
Sbjct: 14 KELGSGQFGVVKLGKW-KGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
++ ++ E++ NG L L ++ GL+ L++ V +GMA+L E
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFL--ESHQF 125
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------SPEYAHNGKI 533
I H L + N L+DR ++D+ + + D+ + V K +PE H K
Sbjct: 126 I--HRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 534 SKKSDVWSLGILILELLT-GKYP 555
S KSDVW+ GIL+ E+ + GK P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 44/213 (20%), Positives = 81/213 (38%), Gaps = 32/213 (15%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQ--MNNVGREDFQEHIKRLGRLEHPNL 413
+VLGSG FG + + V +K ++ ++ + + +++P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHV 79
Query: 414 LPL----TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
L L+ + + G L + + + + Q L + KGM
Sbjct: 80 CRLLGICL-----TSTVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------ 523
YL E + H L + NVL+ +TD+ L L+ + K
Sbjct: 131 NYL--EDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+ E + + +SDVWS G+ + EL+T G P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+ +GSG ++ + Q Y +K ++ +N + ++ I L +L+ + +
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 419 F-YYRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ Y ++ + + E N L L K++ +D R K +++ + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPE---- 526
I+ H LK +N L+ L D+ + + PD + V Y PE
Sbjct: 128 --GIV-HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 527 -------YAHNGKISKKSDVWSLGILILELLTGKYP 555
KIS KSDVWSLG ++ + GK P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+ LG+G FG GQ V +K K+ ++ ++F E K + L H L+ L
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
++ ++ E++ NG L L R Q L++ K V + M YL E
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYL--ESKQF 141
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------SPEYAHNGKI 533
+ H L + N L++ ++D+ L + D+ +T V K PE K
Sbjct: 142 L--HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 534 SKKSDVWSLGILILELLT-GKYP 555
S KSD+W+ G+L+ E+ + GK P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 36/219 (16%), Positives = 72/219 (32%), Gaps = 27/219 (12%)
Query: 361 EVLGSGTFGASYK------TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
+LG G F Y+ N Q +V+K K N + ++RL +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
+ + + +L+ E G+L ++ + + ++ + +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPL-----------LTDYALRPLINPDNAHTLMVA-- 521
II HG +K N +L F L D + T+ A
Sbjct: 191 ---CEII-HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 522 ----YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556
++ E N + + D + + + +L G Y +
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 39/237 (16%), Positives = 81/237 (34%), Gaps = 46/237 (19%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK---RYKQMNNVGREDFQEHIKRLGRL-------- 408
VLG A + T G+++ V ++ + + +E + RL L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 409 --------------EHPNLLPLTAFYYRKEEKLLLYEFV----ENGSLA--GKLHANHTK 448
+ P + + + +L F +L G++ +H+
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508
L RL++ V++ +A LH+ ++ H +L+ +++LD+ LT +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLV-HTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 509 LINPDNAHTLMVAYKSPEY----------AHNGKISKKSDVWSLGILILELLTGKYP 555
+ + PE H ++ D W+LG+ I + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
LG G FG Y + N A V VK+ + + DFQ I+ L L ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 416 LTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
Y + L+ E++ +G L L + R LD L + KGM YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG 144
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSP------E 526
+ + H L + N+L++ + D+ L + L + + + +SP E
Sbjct: 145 SR---RCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 527 YAHNGKISKKSDVWSLGILILELLT-GKYP 555
+ S++SDVWS G+++ EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/240 (23%), Positives = 93/240 (38%), Gaps = 36/240 (15%)
Query: 333 KKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN 391
K+ Y + R E DL+++ +GSGT G +K G VK+ M
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQ---MR 59
Query: 392 NVGREDFQEHIKR-----LGRLEHPNLLPLTAFY--YRKEEKL-LLYEFVENGSLAGKLH 443
G ++ + I L + P + + + + + E + + K
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYI---VQCFGTFITNTDVFIAMELMGTCAEKLKKR 116
Query: 444 ANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503
L K+ +VK + YL + +I H +K SN+LLD + L D
Sbjct: 117 MQGPIPERILG-----KMTVAIVKALYYLKEKH--GVI-HRDVKPSNILLDERGQIKLCD 168
Query: 504 YALRPLINPDNAHTLMV---AYKSPE-----YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ + + D A AY +PE ++DVWSLGI ++EL TG++P
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 56/280 (20%), Positives = 96/280 (34%), Gaps = 29/280 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEH-IKRLGRLEHPNLLPLTA 418
++LG G ++ G + +K + ++ + D Q + L +L H N++ L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 419 FYYRKEEKL--LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ L+ EF GSL L GL L +++ VV GM +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMVAYKSPEYAH--- 529
I+ H ++K N++ + LTD+ + D + Y + EY H
Sbjct: 132 --GIV-HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDM 186
Query: 530 ----------NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579
K D+WS+G+ TG P +K + +
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM 619
+G + + L GL VLA +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
+ LG G FG Y + N V VK+ + DF+ I+ L L+H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 416 LTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
Y + L+ E++ GSL L + + +D L+ + KGM YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG 131
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKS--------- 524
+ I H L + N+L++ + D+ L ++ D +K
Sbjct: 132 TK---RYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-----FKVKEPGESPIF 182
Query: 525 ---PEYAHNGKISKKSDVWSLGILILELLT 551
PE K S SDVWS G+++ EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 356 LRASAEVLGSGTFGASYKTVISNGQAYV---VKRYKQ--MNNVGREDFQEHIKRLGRLEH 410
L + LGSG FG K + VK K + +++ + +L++
Sbjct: 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 77
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
P ++ + E +L+ E E G L L +Q + + ++++ V GM
Sbjct: 78 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMK 131
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYK------ 523
YL E + H L + NVLL ++D+ L + L +N + K
Sbjct: 132 YL--EESNFV--HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
+PE + K S KSDVWS G+L+ E + G+ P
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLP 415
+V+G+G FG + S + V +K K R DF +G+ +HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + + +++ E++ENGSL L K + +++G+ GM YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR----KHDAQFTVIQLVGMLRGIASGMKYL--S 164
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI--NPDNAHT-----LMVAYKSPEYA 528
G + H L + N+L++ + ++D+ L ++ +P+ A+T + + + SPE
Sbjct: 165 DMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 529 HNGKISKKSDVWSLGILILELLT-GKYP 555
K + SDVWS GI++ E+++ G+ P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLP 415
+++GSG G V V +K K R DF +G+ +HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L R +++ E++ENGSL L + + +++GV GM YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYL--S 168
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI--NPDNAHTLMVAYK------SPEY 527
G + H L + NVL+D + ++D+ L ++ +PD A+T K +PE
Sbjct: 169 DLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG-KIPIRWTAPEA 225
Query: 528 AHNGKISKKSDVWSLGILILELLT-GKYP 555
S SDVWS G+++ E+L G+ P
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
+ LG G FG Y + N V VK+ + DF+ I+ L L+H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 416 LTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
Y + L+ E++ GSL L + + +D L+ + KGM YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG 162
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKS--------- 524
+ I H L + N+L++ + D+ L ++ D + YK
Sbjct: 163 TK---RYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-----YKVKEPGESPIF 213
Query: 525 ---PEYAHNGKISKKSDVWSLGILILELLT 551
PE K S SDVWS G+++ EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLL 414
+VLGSG FG + + + V +K + + +H+ +G L+H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L L+ +++ GSL + + R L Q L + KGM YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYL-- 131
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------SPEYA 528
E G + H +L + NVLL + + D+ + L+ PD+ L K + E
Sbjct: 132 EEHGMV--HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 529 HNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
H GK + +SDVWS G+ + EL+T G Y + L +G
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 24/210 (11%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQ---MNNVGREDFQEHIKRLGRLEHPNL 413
E LG G+FG + S V VK K +DF + + L+H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ L ++ E GSL +L + + T + V +GM YL
Sbjct: 84 IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYK------SPE 526
E I H L + N+LL + D+ L R L D+ + + K +PE
Sbjct: 138 -ESKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 527 YAHNGKISKKSDVWSLGILILELLT-GKYP 555
S SD W G+ + E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 346 DMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR 404
+++ DL+ + LG G +G K + +GQ VKR + Q+ +
Sbjct: 3 EVKADDLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKR---IRATVNSQEQKRLLM 54
Query: 405 -----LGRLEHPNLLPLTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQ 456
+ ++ P FY +E + + E + + SL K + + +
Sbjct: 55 DLDISMRTVDCPFT---VTFYGALFREGDVWICMELM-DTSLD-KFYKQVIDKGQTIPED 109
Query: 457 TRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNA 515
KI +VK + +LH++L S+I H +K SNVL++ + + D+ + L++
Sbjct: 110 ILGKIAVSIVKALEHLHSKL--SVI-HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 516 HTLM--VAYKSPE----YAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE + S KSD+WSLGI ++EL ++P
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 362 VLGSGTFGASYKTV--ISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLT 417
LG G FG+ + V + Q V +K KQ E+ + + +L++P ++ L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ E +L+ E G L L R + +++ V GM YL E
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYL--EEK 455
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYK------SPEYAHN 530
+ H +L + NVLL ++D+ L + L D+ +T A K +PE +
Sbjct: 456 NFV--HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 531 GKISKKSDVWSLGILILELLT-GKYP 555
K S +SDVWS G+ + E L+ G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 30/213 (14%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLL 414
+V+G+G FG KT + V +K K R DF +G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L + + +++ E++ENG+L L + +++G+ GM YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKS---------- 524
+ H L + N+L++ + ++D+ L ++ D Y +
Sbjct: 164 ANMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDP----EATYTTSGGKIPIRWT 217
Query: 525 -PEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
PE K + SDVWS GI++ E++T G+ P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-VKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG G +G Y+ V V VK K+ + + E+F + + ++HPNL+ L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
R+ ++ EF+ G+L L R + L + + M YL E
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYL--EKKNF 132
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------SPEYAHNGKI 533
I H L + N L+ + + D+ L L+ + +T K +PE K
Sbjct: 133 I--HRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 534 SKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
S KSDVW+ G+L+ E+ T G YP L + Y
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E LG+G FG ++ + G + K + +E ++ I+ + L HP L+ L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ E +++YEF+ G L K+ + + ++ ++ V KG+ ++H +
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 480 IIPHGHLKSSNVLLDRSFEPLL--TDYALRPLINPDNAHTLMVA---YKSPEYAHNGKIS 534
+ H LK N++ L D+ L ++P + + + +PE A +
Sbjct: 276 YV-HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 535 KKSDVWSLGILILELLTGKYP 555
+D+WS+G+L LL+G P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 59/284 (20%), Positives = 102/284 (35%), Gaps = 37/284 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEH-IKRLGRLEHPNLLPLTA 418
++LG G ++ G + +K + ++ + D Q + L +L H N++ L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 419 FYYRKEEKL--LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ L+ EF GSL L GL L +++ VV GM +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMVAYKSPEYAH--- 529
I+ H ++K N++ + LTD+ + D + Y + EY H
Sbjct: 132 --GIV-HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDM 186
Query: 530 ----------NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579
K D+WS+G+ TG P + ++ + ++
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITG 242
Query: 580 KRTGD---VFDKEMKGAKYSKSEMI-NLLKIGLSCCEEDVLARM 619
K +G V E +S + L GL VLA +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 27/152 (17%), Positives = 55/152 (36%), Gaps = 9/152 (5%)
Query: 80 LEQMNLSGTIAAESLGLLSSLRAVSFMNNKF-EGPLP-DLRKMGPLKSIYLSDNGFSGNI 137
EQ+ A+ + ++ + N P+ L+KM L + N G +
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG--QVPEIKQ-NEM 194
AF L L +A N++T + ++ L NK + + + K + M
Sbjct: 347 --PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVM 404
Query: 195 RSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
++ + NE+ ++ + T N+
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPL-DPTPFKGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 30/248 (12%), Positives = 68/248 (27%), Gaps = 64/248 (25%)
Query: 28 LSDTEILLQFKSSLN--------DSSSALVNWNALRNPCTFNYPNWNGVLCLN-GSVWGL 78
+ D L + +LN + NWN + + GV + G V GL
Sbjct: 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG--AQPGVSLNSNGRVTGL 86
Query: 79 KLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGP-----LPDLRKMGPLKSIYLSDNGF 133
LE SG + +G L+ L ++ ++ + + + +
Sbjct: 87 SLEGFGASGRVPDA-IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145
Query: 134 SGNISD-------------------------DAFEGMTSLKKLYMANNRLTGTIPSSLVQ 168
D + ++ +N +T + ++++
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMR 204
Query: 169 LPKLMELRLEANKFQGQVPEIKQN---------------------EMRSLGLANNELEGP 207
L KL + + + F + ++ + + N
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 208 IPESLSKM 215
+P L +
Sbjct: 265 LPTFLKAL 272
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 28/156 (17%), Positives = 44/156 (28%), Gaps = 20/156 (12%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEG-------PLP-DLRKMGPLKSIYLS 129
L L +S + A+ F N+ PL K + SI LS
Sbjct: 382 LSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTG-------TIPSSLVQLPKLMELRLEANKF 182
+N S + F + L + + N LT + L + L NK
Sbjct: 442 NNQISKFP-KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500
Query: 183 QGQVPEIKQNEMRSLG---LANNELEGPIPESLSKM 215
+ + + L L+ N P
Sbjct: 501 TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 26/178 (14%), Positives = 51/178 (28%), Gaps = 18/178 (10%)
Query: 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGP------ 122
+V + L +S E S L +++ M N + K
Sbjct: 429 PFKGINVSSINLSNNQISKFPK-ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487
Query: 123 --LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLE-- 178
L SI L N + D + L + ++ N + P+ + L +
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 179 ----ANKFQGQVP-EIKQNEM-RSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPP 230
N+ + P I L + +N++ + + N N+
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 24/156 (15%), Positives = 50/156 (32%), Gaps = 22/156 (14%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEG--PLPDLRKMGPLKSIYLSDNG 132
KL +NL+ I A G + +SF +NK + + D + + + +I S N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE 413
Query: 133 FSGNISD------DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQV 186
++ + ++NN+++ L + L N
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 187 PEIKQNEMRSLG---------LANNELEGPIPESLS 213
++E + L N+L + +
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 20/135 (14%), Positives = 45/135 (33%), Gaps = 16/135 (11%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151
+++ L+ LR N+ F ++ D ++ + L +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICE----AWENENSEYAQQYKTE-DLKWDNLKDLTDV 254
Query: 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ----------NEMRSLGLAN 201
+ N +P+ L LP++ + + N+ +++ + +
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 202 NEL-EGPIPESLSKM 215
N L P+ SL KM
Sbjct: 315 NNLKTFPVETSLQKM 329
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 28/196 (14%), Positives = 65/196 (33%), Gaps = 15/196 (7%)
Query: 29 SDTEILLQFKSSLNDSSSALVN-WNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSG 87
+ I L + AL W+AL + G G+ W E +++ G
Sbjct: 16 AIVPIKLSRTAEYIKDYLALKEIWDALNGK----NWSQQGFGTQPGANWNFNKE-LDMWG 70
Query: 88 TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISD---DAFE 143
SL + +S G +PD + ++ L+ + L +G N
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 144 GMTSLKKLYMANNRLTGTIPSSL--VQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGL 199
S ++ T L++ + ++ Q + + + + +G
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190
Query: 200 ANNELEGPIPESLSKM 215
+N + + +++ ++
Sbjct: 191 LSNNITF-VSKAVMRL 205
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 16/181 (8%), Positives = 52/181 (28%), Gaps = 10/181 (5%)
Query: 48 LVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMN 107
+R + +++ + + + +I +S + + ++
Sbjct: 135 DEQKQKMRMHYQKTFVDYDPREDFS-DLIKDCINSDPQQKSIK-KSSRITLKDTQIGQLS 192
Query: 108 NKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV 167
N + ++ L+ Y+ ++ F + + + T
Sbjct: 193 NNITFVSKAVMRLTKLRQFYMGNSPFVAEN------ICEAWENENSEYAQQYKTEDLKWD 246
Query: 168 QLPKLMELRLEANKFQGQVP-EIKQ-NEMRSLGLANNELEGPIPESLSKMDPSTFAGNKN 225
L L ++ + ++P +K EM+ + +A N + +
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 226 L 226
+
Sbjct: 307 I 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 16/116 (13%), Positives = 36/116 (31%), Gaps = 16/116 (13%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMN------NKFEGPLPD-LRKMGPLKSIY 127
L ++LS + S+L+ N N+ P+ + L +
Sbjct: 514 YLVGIDLSYNSFSKFPTQ-PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 128 LSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ N +++ ++ L + +N S + + L +K Q
Sbjct: 573 IGSNDIRK-VNEKIT---PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 32/216 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+ +GSG ++ + Q Y +K ++ +N + ++ I L +L+ + +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 419 F-YYRKEEKLLLY-EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ Y ++ + + E N L L K++ +D R K +++ + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPE---- 526
I+ H LK +N L+ L D+ + + PD + V Y PE
Sbjct: 175 --GIV-HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 527 -------YAHNGKISKKSDVWSLGILILELLTGKYP 555
KIS KSDVWSLG ++ + GK P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPL---- 416
E LG+G FG + + VK KQ ++ + F + +L+H L+ L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
T +E ++ E++ENGSL L L L + + +GMA++ E
Sbjct: 78 T-----QEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFI--EE 127
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT------LMVAYKSPEYAHN 530
I H L+++N+L+ + + D+ L LI DN +T + + +PE +
Sbjct: 128 RNYI--HRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINY 184
Query: 531 GKISKKSDVWSLGILILELLT-GKYP 555
G + KSDVWS GIL+ E++T G+ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 23/206 (11%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQMNNV-GREDFQEHIKRLGRLEHPNLL 414
LG G FG Y N V VK K + D ++ I+ L L H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 415 PLTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ EF+ +GSL L N + ++ + +LK + KGM YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYL 142
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSP------ 525
+ + H L + NVL++ + + D+ L + + +T+ SP
Sbjct: 143 GSR---QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 526 EYAHNGKISKKSDVWSLGILILELLT 551
E K SDVWS G+ + ELLT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
LG G FG + + +K K + E F + + + +L H L+ L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+E ++ E++ GSL L L + + + GMAY+ E +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYV--ERMNYV 302
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-----AHTLMVAYKSPEYAHNGKISK 535
H L+++N+L+ + + D+ L LI + + + +PE A G+ +
Sbjct: 303 --HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 536 KSDVWSLGILILELLT-GKYP 555
KSDVWS GIL+ EL T G+ P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP 381
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLP 415
E +G G+FG +K + + +K ++ ED Q+ I L + + P
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQCDSPY--- 81
Query: 416 LTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+T +Y Y K+ KL ++ E++ GS L LD I++ ++KG+ YL
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYL 135
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--HTL------MVAYKS 524
H+E I H +K++NVLL E L D+ + + +T M +
Sbjct: 136 HSE--KKI--HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM----A 187
Query: 525 PEYAHNGKISKKSDVWSLGILILELLTGKYP 555
PE K+D+WSLGI +EL G+ P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ +G G FG G VK K + + F + +L H NL+ L
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 421 YRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
++ L + E++ GSL L + R L LK V + M YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYL--EGNNF 138
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHNGKISKKSD 538
+ H L + NVL+ ++D+ L + + + L V + +PE K S KSD
Sbjct: 139 V--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 539 VWSLGILILELLT-GKYP 555
VWS GIL+ E+ + G+ P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 30/212 (14%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQMNNVG-REDFQEHIKRLGRLEHPNLL 414
+VLGSG FG + + V +K ++ + ++ + + +++P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 415 PL----TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
L L+ + + G L + + + + Q L + KGM
Sbjct: 81 RLLGICL-----TSTVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMN 131
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------S 524
YL E + H L + NVL+ +TD+ L L+ + K +
Sbjct: 132 YL--EDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 525 PEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
E + + +SDVWS G+ + EL+T G P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 37/215 (17%), Positives = 81/215 (37%), Gaps = 36/215 (16%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKR--YKQMNNVGREDFQEHIKRLGRL-EHPNLLPLT 417
+VLG G G + + + VKR + + RE ++ L EHPN++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE-----VQLLRESDEHPNVIRYF 84
Query: 418 AFYYRKEEKLLLYEFVE--NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+++ Y +E +L + GL+ + +++ G+A+LH+
Sbjct: 85 CTE---KDRQFQYIAIELCAATLQEYVEQKD-FAHLGLE---PITLLQQTTSGLAHLHSL 137
Query: 476 LPGSIIPHGHLKSSNVLL-----DRSFEPLLTDYALRPLINPDNAHTLMVA-------YK 523
+I+ H LK N+L+ + +++D+ L + + +
Sbjct: 138 ---NIV-HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 524 SPEY---AHNGKISKKSDVWSLGILILELLTGKYP 555
+PE + D++S G + +++
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 41/218 (18%), Positives = 76/218 (34%), Gaps = 28/218 (12%)
Query: 362 VLGSGTFGASYKTVISNGQAYVVK-------------RYKQMNNVGREDFQEHIKR---- 404
L G F + + Y +K + + + + K
Sbjct: 38 TLNQGKFN-KIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 405 LGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN---HTKQRPGLDWQTRLKI 461
+ +++ L +E ++YE++EN S+ + Q I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-- 519
IK V+ +Y+HNE +I H +K SN+L+D++ L+D+ +
Sbjct: 157 IKSVLNSFSYIHNEK--NIC-HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGT 213
Query: 520 VAYKSPE--YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ PE + K D+WSLGI + + P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 49/235 (20%), Positives = 93/235 (39%), Gaps = 45/235 (19%)
Query: 339 KLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGRED 397
KL + +P E +G G G Y ++ GQ +++ +E
Sbjct: 8 KLRSIVSVGDPKKKYTRF----EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 398 FQEHIKRLGRLEHPNLLPLTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLD 454
I + ++PN+ + Y ++L ++ E++ GSL +
Sbjct: 64 IINEILVMRENKNPNI---VNYLDSYLVGDELWVVMEYLAGGSLTDVVT----------- 109
Query: 455 WQTRLK------IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508
+T + + + ++ + +LH+ +I H +KS N+LL LTD+
Sbjct: 110 -ETCMDEGQIAAVCRECLQALEFLHSN---QVI-HRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 509 LINPDNA--HTL------MVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
I P+ + T+ M +PE K D+WSLGI+ +E++ G+ P
Sbjct: 165 QITPEQSKRSTMVGTPYWM----APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 29/209 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--------RYKQMNNVGREDFQEHIKRLGRLEHP 411
LG G F ++ + + + K + Q + E I L H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQ 101
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD-WQTRLKIIKGVVKGMA 470
+++ F+ + ++ E SL K+R L + R ++ +V G
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQ 155
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--HTL--MVAYKSPE 526
YLH +I H LK N+ L+ E + D+ L + D L Y +PE
Sbjct: 156 YLHRN---RVI-HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
S + DVWS+G ++ LL GK P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 53/244 (21%), Positives = 101/244 (41%), Gaps = 30/244 (12%)
Query: 321 SSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNG 379
V+ ++ + S + E FD+ E LG G++G+ YK + G
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVL-------EKLGEGSYGSVYKAIHKETG 54
Query: 380 QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFY--YRKEEKL-LLYEFVEN 435
Q +K Q+ ++ + I + + + P++ +Y Y K L ++ E+
Sbjct: 55 QIVAIK---QVPVESDLQEIIKEISIMQQCDSPHV---VKYYGSYFKNTDLWIVMEYCGA 108
Query: 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR 495
GS++ + + L I++ +KG+ YLH I H +K+ N+LL+
Sbjct: 109 GSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFM---RKI-HRDIKAGNILLNT 160
Query: 496 SFEPLLTDYALRPLINPDNAH-TLMVA---YKSPEYAHNGKISKKSDVWSLGILILELLT 551
L D+ + + A ++ + +PE + +D+WSLGI +E+
Sbjct: 161 EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 552 GKYP 555
GK P
Sbjct: 221 GKPP 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ +G G FG G VK K + + F + +L H NL+ L
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 421 YRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
++ L + E++ GSL L + R L LK V + M YL E
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYL--EGNNF 310
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHNGKISKKSD 538
+ H L + NVL+ ++D+ L + + + L V + +PE K S KSD
Sbjct: 311 V--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 539 VWSLGILILELLT-GKYP 555
VWS GIL+ E+ + G+ P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 29/209 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--------RYKQMNNVGREDFQEHIKRLGRLEHP 411
LG G F ++ + + + K + Q + E I L H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQ 75
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD-WQTRLKIIKGVVKGMA 470
+++ F+ + ++ E SL K+R L + R ++ +V G
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQ 129
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--HTL--MVAYKSPE 526
YLH +I H LK N+ L+ E + D+ L + D L Y +PE
Sbjct: 130 YLHRN---RVI-HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
S + DVWS+G ++ LL GK P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 7e-15
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
LG G FG + + +K K + E F + + + +L H L+ L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+E ++ E++ GSL L L + + + GMAY+ E +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYV--ERMNYV 385
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-----AHTLMVAYKSPEYAHNGKISK 535
H L+++N+L+ + + D+ L LI + + + +PE A G+ +
Sbjct: 386 --HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 536 KSDVWSLGILILELLT-GKYP 555
KSDVWS GIL+ EL T G+ P
Sbjct: 444 KSDVWSFGILLTELTTKGRVP 464
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 363 LGSGTFGASYKTV--ISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
LG G FG+ + V + Q V +K KQ E+ + + +L++P ++ L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ E +L+ E G L L +R + +++ V GM YL E
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYL--EEKN 130
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYK------SPEYAHNG 531
+ H L + NVLL ++D+ L + L D+ +T A K +PE +
Sbjct: 131 FV--HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 532 KISKKSDVWSLGILILELLT-GKYP 555
K S +SDVWS G+ + E L+ G+ P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E LGSG FG ++ V + G+ +V K + + + I + +L HP L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ K E +L+ EF+ G L ++ + + + ++ +G+ ++H S
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH---S 169
Query: 480 IIPHGHLKSSNVLLDRSFEPLL--TDYALRPLINPDNAHTLMVA---YKSPEYAHNGKIS 534
I+ H +K N++ + + D+ L +NPD + A + +PE +
Sbjct: 170 IV-HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 535 KKSDVWSLGILILELLTGKYP 555
+D+W++G+L LL+G P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 47/241 (19%), Positives = 88/241 (36%), Gaps = 32/241 (13%)
Query: 333 KKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSG--TFGASYKTV-ISNGQAYVVKRYK- 388
+ + +S + ++L V+G G G+ V+R
Sbjct: 10 ENLYFQGMSSFLPEGGCYELL-------TVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62
Query: 389 -QMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHT 447
+N Q + HPN++P A + E ++ F+ GS + +
Sbjct: 63 EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM 122
Query: 448 KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD--YA 505
G++ I++GV+K + Y+H+ G + H +K+S++L+ + L+
Sbjct: 123 D---GMNELAIAYILQGVLKALDYIHHM--GYV--HRSVKASHILISVDGKVYLSGLRSN 175
Query: 506 LRPLINPDNAHTLMVAYK---------SPEYAHNGKI--SKKSDVWSLGILILELLTGKY 554
L + + + K SPE KSD++S+GI EL G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 555 P 555
P
Sbjct: 236 P 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 50/245 (20%), Positives = 94/245 (38%), Gaps = 45/245 (18%)
Query: 331 IKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQ 389
++K +Y + D E +++ LG G FG YK G K
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIV-------GELGDGAFGKVYKAKNKETGALAAAK---V 51
Query: 390 MNNVGREDFQEHIKR---LGRLEHPNLLPLTAFY--YRKEEKL-LLYEFVENGSLAGKLH 443
+ E+ +++I L +HP + Y + KL ++ EF G++ +
Sbjct: 52 IETKSEEELEDYIVEIEILATCDHPY---IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM- 107
Query: 444 ANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503
+ GL + + +++ + +LH++ II H LK+ NVL+ + L D
Sbjct: 108 ---LELDRGLTEPQIQVVCRQMLEALNFLHSK---RII-HRDLKAGNVLMTLEGDIRLAD 160
Query: 504 YALRPLINPDNA--HTL------MVAYKSPEYAHNGKISK-----KSDVWSLGILILELL 550
+ + + M +PE + K+D+WSLGI ++E+
Sbjct: 161 FGVSAKNLKTLQKRDSFIGTPYWM----APEVVMCETMKDTPYDYKADIWSLGITLIEMA 216
Query: 551 TGKYP 555
+ P
Sbjct: 217 QIEPP 221
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 25/207 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+ LGSG +G +K R ++ E + L L+HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
F+ E+K Y E + G L ++ R + IIK V+ G+ YLH
Sbjct: 103 DFF---EDKRNYYLVMECYKGGELFDEI-----IHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV---AYKSPEYA 528
+I+ H LK N+LL+ + + + D+ L + + Y +PE
Sbjct: 155 H---NIV-HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-V 209
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
K +K DVWS+G+++ LL G P
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 1e-14
Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 33/277 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRY-KQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
E LG+G FG + + G+ +K+ ++++ RE + I+ + +L HPN++
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 419 FY------YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ LL E+ E G L L+ + GL ++ + + YL
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYL 137
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPL---LTDYALRPLINPDNAHTLMVAYKSPEYAH 529
H I H LK N++L + L + D ++ + +Y
Sbjct: 138 HENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLA 191
Query: 530 -----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584
K + D WS G L E +TG P + W + ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP-------FLPNWQPVQWHGKVREKSNEHI 244
Query: 585 VFDKEMKGAKYSKSEMI--NLLKIGLSCCEEDVLARM 619
V ++ GA S + N L L+ E L M
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 45/258 (17%)
Query: 316 PTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYK-T 374
G+ + + + + L V D +P L D +G G+ G
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSY----VKIGEGSTGIVCLAR 65
Query: 375 VISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY--YRKEEKL-LLYE 431
+G+ VK RE + + +H N+ Y Y E+L +L E
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV---VEMYKSYLVGEELWVLME 122
Query: 432 FVENGSLAGKLHANHTKQRPGLDWQTRLK------IIKGVVKGMAYLHNELPGSIIPHGH 485
F++ G+L + Q RL + + V++ +AYLH + +I H
Sbjct: 123 FLQGGALTDIVS------------QVRLNEEQIATVCEAVLQALAYLHAQ---GVI-HRD 166
Query: 486 LKSSNVLLDRSFEPLLTDYALRPLINPDNA--HTL------MVAYKSPEYAHNGKISKKS 537
+KS ++LL L+D+ I+ D +L M +PE + +
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM----APEVISRSLYATEV 222
Query: 538 DVWSLGILILELLTGKYP 555
D+WSLGI+++E++ G+ P
Sbjct: 223 DIWSLGIMVIEMVDGEPP 240
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 26/173 (15%), Positives = 48/173 (27%), Gaps = 25/173 (14%)
Query: 79 KLEQMNLSG----TIAAESLGLL--SSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNG 132
L ++LS S L +SLR + N + + L+ + +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHST 410
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
AF + L L ++ + L L L++ N F+
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 193 EMRSL---GLANNELEGPIPESLSKM----------------DPSTFAGNKNL 226
+L L+ +LE + D S + +L
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 28/134 (20%), Positives = 46/134 (34%), Gaps = 9/134 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
KL +++S L+SL + N F+ L + LS
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
IS F+ + L+ L M++N L S QL L L N+ + ++
Sbjct: 485 LEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 193 E--MRSLGLANNEL 204
+ L NN +
Sbjct: 544 PKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 24/125 (19%), Positives = 41/125 (32%), Gaps = 5/125 (4%)
Query: 95 GLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
+ SS + + N + L+ + LS I D A+ G+ L L +
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLIL 87
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNELEG-PIPE 210
N + P S L L L K ++ L +A+N + +P
Sbjct: 88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147
Query: 211 SLSKM 215
S +
Sbjct: 148 YFSNL 152
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 23/144 (15%), Positives = 52/144 (36%), Gaps = 10/144 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L + L+G + + S L+SL + + K + ++ LK + ++ N
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL----MELRLEANKFQGQVPEI 189
F +T+L + ++ N + + L L + + L + N +
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200
Query: 190 -KQNEMRSLGLANNELEGPIPESL 212
+ ++ L L N I ++
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 22/148 (14%), Positives = 51/148 (34%), Gaps = 16/148 (10%)
Query: 77 GLKLEQMNLSG-----TIAAESLGLLSSLRAVSFMNNKFEG----PLPDLRKMGPLKSIY 127
G+KL ++ L G I L L+ L + +F+ + + M L +
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 128 LSDNGFSGN----ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ + + F + ++ + +A + + + K L + + +
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK 320
Query: 184 GQVPEIKQNEMRSLGLANNELEGPIPES 211
Q P + ++SL L N+ +
Sbjct: 321 -QFPTLDLPFLKSLTLTMNKGSISFKKV 347
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 31/154 (20%), Positives = 54/154 (35%), Gaps = 19/154 (12%)
Query: 79 KLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSG 135
+ M+L+G E + +++S + + + P DL LKS+ L+ N S
Sbjct: 286 NVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGS- 341
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQL--PKLMELRLEANKFQGQVPEIKQ-N 192
+ SL L ++ N L+ + S L L L L N
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLE 399
Query: 193 EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
E++ L ++ L+ S F + L
Sbjct: 400 ELQHLDFQHSTLKRVTE-------FSAFLSLEKL 426
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L ++LS I+ L L+ ++ +N ++ L ++ S N
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLT 159
SL + NN +
Sbjct: 534 ET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 53/285 (18%), Positives = 95/285 (33%), Gaps = 31/285 (10%)
Query: 40 SLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWG---LKLEQMNLSGTIAAESLGL 96
+L+ +AL + + + + N ++ L + L + L L
Sbjct: 366 TLDLRDNALTTIHFIPSIPDIFL-SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLR 424
Query: 97 LSSLRAVSFMNNKFEGPLPDLRKMGP--LKSIYLSDNGFSG----NISDDAFEGMTSLKK 150
+ L+ + N+F D L+ ++L +N + D FEG++ L+
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPE 210
LY+ +N L P L L L L +N+ + L ++ N+L P P+
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPD 544
Query: 211 SLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEVSL 270
+ NK +C C L N+ + G P I P+ VSL
Sbjct: 545 VFVSLSVLDITHNKFIC-----ECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSL 599
Query: 271 ----------------LKIIMIVLVLGVSLGIIAAILIIFYLRKR 299
LK + ++ + IL + R
Sbjct: 600 FSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 27/146 (18%), Positives = 53/146 (36%), Gaps = 12/146 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
E++ LS T+ A S L L+ + + + R + L+ + L +
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTI--PSSLVQLPKLMELRLEANKFQGQVPEIK 190
+ DAF+G+ L +L + L+ + L L L L N+ +
Sbjct: 85 IY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143
Query: 191 QNEMRSL---GLANNELEGPIPESLS 213
++ SL ++N++ L
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELE 169
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 29/144 (20%), Positives = 55/144 (38%), Gaps = 7/144 (4%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFS-G 135
L+L TI E+ L +LR + ++K PD + + L + L G S
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 136 NISDDAFEGMTSLKKLYMANNRLTG-TIPSSLVQLPKLMELRLEANKFQGQVPE----IK 190
+ D F + +L +L ++ N++ + S +L L + +N+ ++
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 191 QNEMRSLGLANNELEGPIPESLSK 214
+ LA N L + K
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGK 196
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 39/198 (19%), Positives = 71/198 (35%), Gaps = 8/198 (4%)
Query: 13 LHVLVLISFVGVTFGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN 72
L L S V V + + D S + N + L L
Sbjct: 181 LAANSLYSRVSVDW-GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 73 GSVWGLKLEQMNLSGTIAAESLGLL--SSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLS 129
+ G N+ + L SS+R + + + LK + L+
Sbjct: 240 HHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI 189
N + I+D+AF G+ +L+ L ++ N L S+ LPK+ + L+ N +
Sbjct: 299 YNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 190 KQN--EMRSLGLANNELE 205
+ ++++L L +N L
Sbjct: 358 FKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 27/175 (15%), Positives = 53/175 (30%), Gaps = 21/175 (12%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD---LRKMGPLKSIYLSDN 131
L ++L + ++ L L + + R + L + LS N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQL--PKLMELRLEANKFQGQVPE- 188
+F + SLK + ++N++ L L L L AN +V
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 189 -------IKQNEMRSLGLANNELEGPIPE----SLSKMDPSTFAGNKNLCGPPLD 232
+ + L ++ N I ++SK + ++ G
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 22/135 (16%), Positives = 45/135 (33%), Gaps = 12/135 (8%)
Query: 97 LSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMAN 155
L++ + N + L+ + L I +AF + +L+ L + +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 156 NRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE----IKQNEMRSLGLANNELEGPIPES 211
+++ P + L L ELRL V + + L L+ N++
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL-- 140
Query: 212 LSKMDPSTFAGNKNL 226
+F +L
Sbjct: 141 -----HPSFGKLNSL 150
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 15/88 (17%), Positives = 33/88 (37%), Gaps = 11/88 (12%)
Query: 142 FEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---IKQNEMRSLG 198
+ + + ++L ++ N + SS L +L L L + + + +R L
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 199 LANNELEGPIPESLSKMDPSTFAGNKNL 226
L ++ + + P F G +L
Sbjct: 80 LGSS--------KIYFLHPDAFQGLFHL 99
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK---RYKQMNNVGREDFQEHIKRLGRLEHPNLLPL 416
VLG G+FG GQ VK + + +E ++ L +L+HPN++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 417 TAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
F+ E+K Y E G L ++ R +II+ V+ G+ Y+H
Sbjct: 92 YEFF---EDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV---AYKSPEY 527
I+ H LK N+LL+ + + + D+ L + Y +PE
Sbjct: 144 KN---KIV-HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE- 198
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
+G +K DVWS G+++ LL+G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 43/207 (20%), Positives = 79/207 (38%), Gaps = 22/207 (10%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLP 415
+G G FG ++ N V +K K ++ RE F + + + +HP+++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + ++ E G L L + LD + + + +AYL E
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYL--E 133
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK------SPEYAH 529
+ H + + NVL+ + L D+ L + + K +PE +
Sbjct: 134 SKRFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESIN 190
Query: 530 NGKISKKSDVWSLGILILELLT-GKYP 555
+ + SDVW G+ + E+L G P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 31/183 (16%), Positives = 61/183 (33%), Gaps = 29/183 (15%)
Query: 73 GSVWGL-KLEQMNLSG------TIAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLK 124
G + L L +++LS L LS L++++ N+ ++ L+
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 125 SIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG 184
+ L+ + F+ + LK L ++++ L + LP L L L+ N F
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 185 ---QVPEIKQN--EMRSLGLANNELEGPIPES----------------LSKMDPSTFAGN 223
Q Q + L L+ +L + L+ +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523
Query: 224 KNL 226
K +
Sbjct: 524 KGI 526
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 31/164 (18%), Positives = 50/164 (30%), Gaps = 14/164 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGF 133
L ++L+ I ++ L + N L LK ++ G
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI---- 189
S I +L+ LY+ +N ++ KL L + N E
Sbjct: 118 SS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176
Query: 190 KQNEMRSLGLANNELEGPIPESLSKMDPST---FAGNKNLCGPP 230
+Q SL L N++ G I F G +NL
Sbjct: 177 QQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIF 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 23/135 (17%), Positives = 39/135 (28%), Gaps = 12/135 (8%)
Query: 95 GLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
L +S + F N ++ L + L+ I +D F+ L L +
Sbjct: 30 TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVL 88
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNELEGPIPES 211
N L ++L L L N + SL L +N
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN--------H 140
Query: 212 LSKMDPSTFAGNKNL 226
+S + + L
Sbjct: 141 ISSIKLPKGFPTEKL 155
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 31/138 (22%), Positives = 59/138 (42%), Gaps = 12/138 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEG----PLPDLRKMGPLKSIYLSD 130
L+ +NLS + + L +L+ ++ N F L+ +G L+ + LS
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK 190
S I AF + + + +++NRLT + +L L + L L +N +P +
Sbjct: 486 CDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLL 543
Query: 191 QN--EMRSLGLANNELEG 206
+ R++ L N L+
Sbjct: 544 PILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 29/158 (18%), Positives = 59/158 (37%), Gaps = 13/158 (8%)
Query: 74 SVWGLKLEQMNLSGTIAAESLGL-LSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDN 131
S+W E M+ A GL S+ +++ + F + L+ + L+
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288
Query: 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-- 189
S + G+++LKKL ++ N+ S P L L ++ N + ++
Sbjct: 289 HLS-EL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 190 -KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+R L L+++++E S +L
Sbjct: 347 ENLENLRELDLSHDDIET------SDCCNLQLRNLSHL 378
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 21/175 (12%), Positives = 45/175 (25%), Gaps = 28/175 (16%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFM--NNKFEGPLPDLRKMGPLKSIYLSDNG 132
KL+ ++ ++ E + L +S N G P +S+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 133 FSGN-ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPK--LMELRLEANKFQGQVPEI 189
+ SL + P+ L + + + L+ + F
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 190 KQN--EMRSLGLANNELEGPIPESLSKM----------------DPSTFAGNKNL 226
++ L L L +P L + + + +L
Sbjct: 274 FHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
+LE + LS +I + L + V +N+ + + L+ N S
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHIS 536
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGT 161
I ++ + + + N L T
Sbjct: 537 I-ILPSLLPILSQQRTINLRQNPLDCT 562
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 48/280 (17%), Positives = 98/280 (35%), Gaps = 30/280 (10%)
Query: 291 LIIFYLRKRKTQIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPF 350
II ++ + + ++ K + V + + +
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEI 387
Query: 351 DLQDMLRASAEVLGSGTFGASYK---TVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRL 405
+ + +G G FG ++ N V +K K ++ RE F + +
Sbjct: 388 QRERIELG--RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 406 GRLEHPNLLPL----TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI 461
+ +HP+++ L T + ++ E G L L + LD + +
Sbjct: 446 RQFDHPHIVKLIGVIT-----ENPVWIIMELCTLGELRSFLQVR----KFSLDLASLILY 496
Query: 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT---- 517
+ +AYL E + H + + NVL+ + L D+ L + +
Sbjct: 497 AYQLSTALAYL--ESKRFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 518 -LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
L + + +PE + + + SDVW G+ + E+L G P
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 23/148 (15%), Positives = 55/148 (37%), Gaps = 16/148 (10%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPL----------PDLRKMGPLKSIY 127
++L + + L L L++++ N+ D ++ Y
Sbjct: 496 VELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 128 LSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP 187
+ N + + + M L L +N++ + KL +L+L+ N+ +
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPE 612
Query: 188 EIKQN--EMRSLGLANNELEGPIPESLS 213
+ ++ LG ++N+L+ IP +
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 26/186 (13%), Positives = 55/186 (29%), Gaps = 21/186 (11%)
Query: 65 WNGVLCLNGSVWGLKLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFE--------G 112
+ C G+ + LS E S + + NN
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 113 PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172
+ + L +I L N + D + L + ++ N + + P+ + +L
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQL 778
Query: 173 MELRLE------ANKFQGQVPE-IKQ-NEMRSLGLANNELEGPIPESLSKMDPSTFAGNK 224
+ N+ Q P I + L + +N++ + ++ A N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNP 838
Query: 225 NLCGPP 230
N+
Sbjct: 839 NISIDV 844
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 23/136 (16%), Positives = 46/136 (33%), Gaps = 17/136 (12%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151
+++ L+ L+ + F N+ F + + N + ++ + L +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVD----WEDANSDYAKQYENE-ELSWSNLKDLTDV 496
Query: 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-----------NEMRSLGLA 200
+ N +P L LP+L L + N+ +++ +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 201 NNELEG-PIPESLSKM 215
N LE P SL KM
Sbjct: 557 YNNLEEFPASASLQKM 572
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 23/161 (14%), Positives = 54/161 (33%), Gaps = 17/161 (10%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
KL ++ + E+ G L + N+ E +P+ ++ + S N
Sbjct: 574 KLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNK 630
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPS-----SLVQLPKLMELRLEANKFQGQVP 187
+ + + + + + N++ + + + L N+ Q
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
Query: 188 EIKQN--EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
E+ + ++ L+NN + IPE+ K + L
Sbjct: 691 ELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 21/154 (13%), Positives = 43/154 (27%), Gaps = 18/154 (11%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDL------RKMGPLKSIYLSDN 131
L L + + + +V F NK ++ K ++ LS N
Sbjct: 624 LGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 132 GFSGNISDDAFEGMTSLKKLYMANNRLT-------GTIPSSLVQLPKLMELRLEANKFQG 184
+ F + + + ++NN +T + L + L NK
Sbjct: 684 EIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
Query: 185 QVPEIKQNEMRSLG---LANNELEGPIPESLSKM 215
+ + + L ++ N P
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 25/189 (13%), Positives = 62/189 (32%), Gaps = 37/189 (19%)
Query: 36 QFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLG 95
++ S +++ +NWN + + + GV N ++ ++L+
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELD--MWGDQPGVDLDNNG----RVTGLSLA--------- 331
Query: 96 LLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154
+G +PD + ++ LK + + + + E +T
Sbjct: 332 -----------GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRS--------LGLANNELEG 206
+ L +L L + + PE+K + S +G N +
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQIGNLTNRITF 439
Query: 207 PIPESLSKM 215
I +++ ++
Sbjct: 440 -ISKAIQRL 447
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 19/153 (12%), Positives = 43/153 (28%), Gaps = 14/153 (9%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS--GNISDDAFEGMTSLK 149
+ L + A+ N ++ + + + G+ + +
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTIN---NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVT 326
Query: 150 KLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLAN-------- 201
L +A G +P ++ QL +L L + E+
Sbjct: 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 202 -NELEGPIPESLSKMDPSTFAGNKNLCGPPLDP 233
++ + L+ D A N+N P+
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 54/211 (25%), Positives = 77/211 (36%), Gaps = 35/211 (16%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV-VKRYKQMNN-VGREDFQEHIKRLGRLEHPNLL 414
LG G FG Y V VK K R +++ I L L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 415 PLTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ E+V GSL L R + L + + +GMAYL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK--------- 523
H + I H L + NVLLD + D+ L + + + Y+
Sbjct: 151 HAQ---HYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY-----YRVREDGDSPV 201
Query: 524 ---SPEYAHNGKISKKSDVWSLGILILELLT 551
+PE K SDVWS G+ + ELLT
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLP 415
EV+GSG + +K ++N ++ + I+ + + HPN
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCHHPN--- 74
Query: 416 LTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK------IIKGVV 466
+ ++Y + +++L L+ + + GS+ L G L I++ V+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV---LDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKS-- 524
+G+ YLH G I H +K+ N+LL + D+ + + T K+
Sbjct: 132 EGLEYLHKN--GQI--HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 525 -------PEYAHNGKI-SKKSDVWSLGILILELLTGKYP 555
PE + K+D+WS GI +EL TG P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 32/176 (18%)
Query: 396 EDFQEHIKR----LGRLEHPNLLPLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTK 448
F+ ++R GRL+ P+++P+ + E LY + LA L +
Sbjct: 75 PVFRTRMQREARTAGRLQEPHVVPI---HDFGEIDGQLYVDMRLINGVDLAAML-----R 126
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHG--H--LKSSNVLLDRSFEPLLTDY 504
++ L + I++ + + H G H +K N+L+ L D+
Sbjct: 127 RQGPLAPPRAVAIVRQIGSALDAAHA--------AGATHRDVKPENILVSADDFAYLVDF 178
Query: 505 AL-RPLINPDNAHTLMV----AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ + Y +PE + ++D+++L ++ E LTG P
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 25/207 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+LG G+FG K Q Y VK N ++ L +L+HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
E+ Y E G L ++ +R +IIK V G+ Y+H
Sbjct: 88 EIL---EDSSSFYIVGELYTGGELFDEI-----IKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV---AYKSPEYA 528
I H LK N+LL+ + + + D+ L + + Y +PE
Sbjct: 140 H--N--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-V 194
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
G +K DVWS G+++ LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 55/268 (20%), Positives = 103/268 (38%), Gaps = 23/268 (8%)
Query: 297 RKRKTQIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPF-DLQDM 355
R + + S D ++ S + ++I V +
Sbjct: 33 RSGHNEAKEVWSNADLTE-RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTV 91
Query: 356 LRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
+ E+LG G FG +K + G K K +E+ + I + +L+H NL+
Sbjct: 92 SKT--EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L + K + +L+ E+V+ G L ++ + L + +K + +G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI----IDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLL--TDYALRPLINPDNAHTLMVAYKSPEYA---- 528
I H LK N+L + D+ L P L V + +PE+
Sbjct: 206 ----MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEV 259
Query: 529 HNGK-ISKKSDVWSLGILILELLTGKYP 555
N +S +D+WS+G++ LL+G
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG-LS 286
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 54/254 (21%)
Query: 330 EIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYK 388
+ D LS +RD F+L E++G+GT+G YK + GQ + K
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELV-------ELVGNGTYGQVYKGRHVKTGQLAAI---K 55
Query: 389 QMNNVG--REDFQEHIKRLGRL-EHPNLLPLTAFY--YRK------EEKL-LLYEFVENG 436
M+ G E+ ++ I L + H N + +Y + K +++L L+ EF G
Sbjct: 56 VMDVTGDEEEEIKQEINMLKKYSHHRN---IATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112
Query: 437 SLAGKLHANHTKQRPGLDWQTRLK------IIKGVVKGMAYLHNELPGSIIPHGHLKSSN 490
S+ + LK I + +++G+++LH +I H +K N
Sbjct: 113 SVTDLIKNTKGN---------TLKEEWIAYICREILRGLSHLHQH---KVI-HRDIKGQN 159
Query: 491 VLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPEYAHNGKISK-----KSDVWS 541
VLL + E L D+ + L + + +PE + KSD+WS
Sbjct: 160 VLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 219
Query: 542 LGILILELLTGKYP 555
LGI +E+ G P
Sbjct: 220 LGITAIEMAEGAPP 233
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 32/213 (15%), Positives = 70/213 (32%), Gaps = 25/213 (11%)
Query: 364 GSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK 423
+ K + ++ ++ R++ +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 424 EEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
K+ LY + +L ++ + + + L I + + + +LH++ +
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDR--EHGVCLHIFIQIAEAVEFLHSK---GL 185
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---------------YKS 524
+ H LK SN+ + D+ L + + T++ Y S
Sbjct: 186 M-HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 525 PEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557
PE H S K D++SLG+++ ELL +
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLP 415
+LG G FG Y+ T + V VK K+ +E F + L+HP+++
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L +E ++ E G L L N + L T + + K MAYL E
Sbjct: 78 LIGII-EEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL--E 130
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----AHTLM-VAYKSPEYAHN 530
+ H + N+L+ L D+ L I ++ + T + + + SPE +
Sbjct: 131 SINCV--HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 531 GKISKKSDVWSLGILILELLT-GKYP 555
+ + SDVW + + E+L+ GK P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 26/106 (24%), Positives = 49/106 (46%), Gaps = 2/106 (1%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
L L ++ I+ + LS+LR ++ +P+L + L + LS N S I
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AI 222
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+F+G+ L+KL+M +++ ++ L L+E+ L N
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 73 GSVWGL-KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKS 125
G+ GL L + L TI + LS L+ + NN E +P ++ L+
Sbjct: 106 GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRR 164
Query: 126 IYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQ 185
+ L + IS+ AFEG+++L+ L +A L IP +L L KL EL L N
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222
Query: 186 VPEIKQN--EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
P Q ++ L + ++ + ++ + F ++L
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQ--------IQVIERNAFDNLQSL 257
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 34/135 (25%), Positives = 55/135 (40%), Gaps = 11/135 (8%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
G+ ++ R ++ N+ + + + + L+ + LS N I AF G+ +L L +
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLEL 119
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNELEGPIPES 211
+NRLT + V L KL EL L N + +R L L +
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL-------KR 172
Query: 212 LSKMDPSTFAGNKNL 226
LS + F G NL
Sbjct: 173 LSYISEGAFEGLSNL 187
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 30/215 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK-------------RYKQMNNVGREDFQEHIKRLG 406
LGSG +G + +K + E+ I L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 407 RLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
L+HPN++ L + K+ L+ EF E G L ++ R D I+K ++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDECDAANIMKQIL 156
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV--- 520
G+ YLH I H +K N+LL+ + + D+ L + D +
Sbjct: 157 SGICYLHKH--N--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 521 AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE K ++K DVWS G+++ LL G P
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 32/227 (14%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLP 415
EV+G G FG + VK ++ ++G F + HPN+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 416 LTAFYYRKEEKLL-LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L R E L + ++++G L + + + V KGM YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD------NAHTLM-VAYKSPE 526
+ + H L + N +LD F + D+ L R + + + + V + + E
Sbjct: 147 K---KFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 527 YAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
K + KSDVWS G+L+ EL+T G YP+ YLLQG
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV-VKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLP 415
EV+G G FG Y + + VK ++ ++G F + HPN+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 416 LTAFYYRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L R E L+ ++++G L + + + V KGM +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHT-------LMVAYKSPE 526
+ + H L + N +LD F + D+ L R + + + L V + + E
Sbjct: 211 K---KFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 527 YAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
K + KSDVWS G+L+ EL+T G YP+ YLLQG
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 29/127 (22%), Positives = 60/127 (47%), Gaps = 4/127 (3%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
L L ++ I+ + L +L+ ++ + +P+L + L+ + +S N F I
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EI 233
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMR 195
+F G++SLKKL++ N++++ ++ L L+EL L N ++ +
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293
Query: 196 SLGLANN 202
L L +N
Sbjct: 294 ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 39/169 (23%), Positives = 65/169 (38%), Gaps = 32/169 (18%)
Query: 73 GSVWGL-KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKF----EGPLPDLRKMGPL 123
G+ GL L + L I + + LS LR + NN + L
Sbjct: 117 GAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS---L 173
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ L + IS+ AFEG+ +LK L + + +P +L L L EL + N F
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP 231
Query: 184 GQVPEIKQN------EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
EI+ ++ L + N+ +S ++ + F G +L
Sbjct: 232 ----EIRPGSFHGLSSLKKLWVMNS--------QVSLIERNAFDGLASL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 34/136 (25%), Positives = 52/136 (38%), Gaps = 13/136 (9%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
G+ S+ R ++ M N + R + L+ + L N I AF G+ SL L +
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---IKQNEMRSLGLANNELEGPIPE 210
+N LT + L KL EL L N + +P + + L L +
Sbjct: 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL-------K 182
Query: 211 SLSKMDPSTFAGNKNL 226
L + F G NL
Sbjct: 183 KLEYISEGAFEGLFNL 198
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 34/248 (13%)
Query: 340 LSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYK---TVISNGQAYV-VKRYKQMNNVG- 394
L+ V+D + P + + + + V+G G FG Y + + +K ++ +
Sbjct: 8 LAEVKDVLIPHE-RVVTHSD-RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ 65
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGL 453
E F + L HPN+L L E + ++ +G L + + +
Sbjct: 66 VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNP 121
Query: 454 DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP 512
+ + V +GM YL + H L + N +LD SF + D+ L R +++
Sbjct: 122 TVKDLISFGLQVARGMEYL--AEQKFV--HRDLAARNCMLDESFTVKVADFGLARDILDR 177
Query: 513 D------NAHTLM-VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE------ 556
+ + H + V + + E + + KSDVWS G+L+ ELLT G Y
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237
Query: 557 -NYLLQGY 563
++L QG
Sbjct: 238 THFLAQGR 245
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 62/271 (22%), Positives = 102/271 (37%), Gaps = 42/271 (15%)
Query: 302 QIERASSYEDSSKLPTSFGSSKVEPEPIEIK-KKADYGKLSFVRDDMEPFDLQDMLRASA 360
+ L + K D +L F D + F
Sbjct: 7 HHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDL------- 59
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGR------EDFQEHIKRLGRLEHPNL 413
+G G+FGA Y + N + +K +M+ G+ +D + ++ L +L HPN
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 414 LPLTAFY--YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
+ Y +E L+ E+ GS + L + L + G ++G+A
Sbjct: 117 ---IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 168
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YKSPEY 527
YLH+ ++I H +K+ N+LL L D+ ++ P N+ V + +PE
Sbjct: 169 YLHSH---NMI-HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEV 221
Query: 528 AHNGKIS---KKSDVWSLGILILELLTGKYP 555
K DVWSLGI +EL K P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 46/231 (19%), Positives = 82/231 (35%), Gaps = 32/231 (13%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV---VKRYKQMNNVG-REDFQEHIKRLGRLEHPNL 413
LG G FG Y+ + + N + + VK ++ + DF + + H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKL--HANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
+ + + +L E + G L L Q L L + + + G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLL---TDYAL-RPLINPD----NAHTLM-VAY 522
L I H + + N LL + D+ + R + ++ V +
Sbjct: 156 LEEN---HFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
PE G + K+D WS G+L+ E+ + G YP ++ G
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
E LGSG F K S G Y K + +Q R +E I+R L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
+ L Y + + +L+ E V G L A K + + IK ++ G+
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGV 128
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMVA---Y 522
YLH + I H LK N++L P+ L D+ L I + +
Sbjct: 129 NYLHTK---KIA-HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE + + ++D+WS+G++ LL+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG-AS 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 26/131 (19%), Positives = 49/131 (37%), Gaps = 10/131 (7%)
Query: 79 KLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
+L + + L LS L + N+ + ++ + LK + + N
Sbjct: 222 RLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSN----Q 276
Query: 137 ISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEM 194
ISD ++ L L++ NN+L + L L L L N + + ++M
Sbjct: 277 ISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKM 335
Query: 195 RSLGLANNELE 205
S AN ++
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 29/137 (21%), Positives = 56/137 (40%), Gaps = 18/137 (13%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKK 150
L L+SL + N+ + + M L S+ + +N I+D ++ L
Sbjct: 193 SPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNN----KITDLSPLANLSQLTW 247
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEMRSLGLANNELEGPIP 209
L + N+++ +++ L KL L + +N+ + + +++ SL L NN+L
Sbjct: 248 LEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL----- 299
Query: 210 ESLSKMDPSTFAGNKNL 226
D G NL
Sbjct: 300 ---GNEDMEVIGGLTNL 313
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 23/134 (17%), Positives = 48/134 (35%), Gaps = 9/134 (6%)
Query: 79 KLEQMNLSGTIAA--ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
KL + + +L L++LR + + + L + + S+ L N +
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSD 147
Query: 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEMR 195
+S MT L L + +++ P + L L L L N+ + + + +
Sbjct: 148 LS--PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLH 202
Query: 196 SLGLANNELEGPIP 209
N++ P
Sbjct: 203 YFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 25/150 (16%), Positives = 51/150 (34%), Gaps = 23/150 (15%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKK 150
L+ + ++ + + ++ ++ E +T+L+
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGE----KVASIQGIEYLTNLEY 70
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEMRSLGLANNELEGPIP 209
L + N++T P L L KL L + NK + ++ +R L L + + P
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
Query: 210 -ESLSKM------------DPSTFAGNKNL 226
+L+KM D S + L
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNMTGL 157
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 38/172 (22%), Positives = 74/172 (43%), Gaps = 24/172 (13%)
Query: 396 EDFQEHIKR----LGRLEHPNLLPLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTK 448
E+ + +R +L H N++ + EE Y E++E +L+ +
Sbjct: 52 EETLKRFEREVHNSSQLSHQNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIE----- 103
Query: 449 QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-R 507
L T + ++ G+ + H+ I+ H +K N+L+D + + D+ + +
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDM---RIV-HRDIKPQNILIDSNKTLKIFDFGIAK 159
Query: 508 PLINPDNAHTLM----VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
L T V Y SPE A + +D++S+GI++ E+L G+ P
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 32/231 (13%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV----VKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLL 414
++LG G FG+ + + VK K + E+F + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 415 PLTAFYYRKE-----EKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVKG 468
L + +++ F++ G L L + + P + QT LK + + G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM-VAY 522
M YL N + + H L + N +L + D+ L + + + D M V +
Sbjct: 160 MEYLSNR---NFL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
+ E + + KSDVW+ G+ + E+ T G YP +YLL G+
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 33/232 (14%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYV---VKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLL 414
+LG G FG+ + + ++V VK K + + E+F + +HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 415 PLTAF------YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-LDWQTRLKIIKGVVK 467
L R +++ F+++G L L A+ + P L QT ++ + +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM-VA 521
GM YL + + I H L + N +L + D+ L R + + D + + V
Sbjct: 149 GMEYLSSR---NFI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
+ + E + + SDVW+ G+ + E++T G+ Y NYL+ G
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKR-YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
LGSG FG + S+G V+K K + V E + I+ L L+HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 419 FYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ E+ +Y E E G L ++ + + + + +++K ++ +AY H++
Sbjct: 88 VF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHSQ 143
Query: 476 LPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMVAYKSPEYAH--- 529
+ H LK N+L + P+ + D+ L L D T + Y
Sbjct: 144 H----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG--TALYMAPEV 197
Query: 530 -NGKISKKSDVWSLGILILELLTGKYP 555
++ K D+WS G+++ LLTG
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTG-CL 223
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 46/231 (19%), Positives = 82/231 (35%), Gaps = 32/231 (13%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV---VKRYKQMNNVG-REDFQEHIKRLGRLEHPNL 413
LG G FG Y+ + + N + + VK ++ + DF + + H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKL--HANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
+ + + +L E + G L L Q L L + + + G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLL---TDYAL-RPLINPD----NAHTLM-VAY 522
L I H + + N LL + D+ + R + ++ V +
Sbjct: 197 LEEN---HFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
PE G + K+D WS G+L+ E+ + G YP ++ G
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 36/176 (20%), Positives = 62/176 (35%), Gaps = 34/176 (19%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDL-RKMGPLKSIYLSDNGF 133
L + L I LS+L + NK L + + + LKS+ + DN
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPS-SLVQLPKLMELRLEANKFQGQVPEIKQN 192
IS AF G+ SL++L + LT +IP+ +L L L+ LRL I+
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN----AIRDY 194
Query: 193 ------EMRSLGLANNELEGPIPES----------------LSKMDPSTFAGNKNL 226
++ L +++ + + L+ + L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 26/136 (19%), Positives = 54/136 (39%), Gaps = 14/136 (10%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
G+ + R + N+ + + L+ + L++N S + AF + +L+ L +
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGL 87
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANNELEGPIPE 210
+NRL L L +L + NK + + ++SL + +N+
Sbjct: 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND------- 139
Query: 211 SLSKMDPSTFAGNKNL 226
L + F+G +L
Sbjct: 140 -LVYISHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 14/116 (12%)
Query: 77 GLKLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKF----EGPLPDLRKMGPLKSIYL 128
GL L ++++ + ++ L LR ++ N L +L + L+ I L
Sbjct: 223 GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR---LQEIQL 279
Query: 129 SDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ-LPKLMELRLEANKFQ 183
+ + AF G+ L+ L ++ N+LT T+ S+ + L L L++N
Sbjct: 280 VGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 21/108 (19%), Positives = 42/108 (38%), Gaps = 5/108 (4%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
L++ T+ L L+ L ++S + +P +R + L+ + LS N S
Sbjct: 205 LEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS- 261
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
I + L+++ + +L P + L L L + N+
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 38/228 (16%), Positives = 79/228 (34%), Gaps = 43/228 (18%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRY--KQMNNVGREDFQEHIKRLGRL-EHPNLLPLT 417
++LG G+ G G+ VKR + E IK L +HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME-----IKLLTESDDHPNVIRYY 75
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKL--HANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ E +L + + + +++ + G+A+LH+
Sbjct: 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEP-------------LLTDYALRPLINPDNAHTLMVA- 521
II H LK N+L+ S L++D+ L ++ +
Sbjct: 135 ---KII-HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 522 -------YKSPE-------YAHNGKISKKSDVWSLGILILELLTGKYP 555
+++PE ++++ D++S+G + +L+
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E LG G FG ++ V S+ + Y+ K K + ++ I L H N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ EE ++++EF+ + ++ L+ + + + V + + +LH+ +
Sbjct: 70 FESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 480 IIPHGHLKSSNVLL-DRSFEPL-LTDYALRPLINPDNAHTLMVAYKSPEYA----HNGK- 532
I H ++ N++ R + + ++ + P + L+ +PEY H
Sbjct: 123 IG-HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQHDV 179
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+S +D+WSLG L+ LL+G P
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINP 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
E LGSG F K G+ Y K + +++++ R +E I+R L + HPN+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
+ L + K + +L+ E V G L A K + + +K ++ G+
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFLKQILDGV 121
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMVA---Y 522
YLH++ I H LK N++L P L D+ + I N + +
Sbjct: 122 HYLHSK---RIA-HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE + + ++D+WS+G++ LL+G
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSG-AS 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
E LGSG F K S G Y K + +Q R +E I+R L ++ HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
+ L Y + + +L+ E V G L A K + + IK ++ G+
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGV 128
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMVA---Y 522
YLH + I H LK N++L P+ L D+ L I + +
Sbjct: 129 NYLHTK---KIA-HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE + + ++D+WS+G++ LL+G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG-AS 216
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 33/156 (21%), Positives = 63/156 (40%), Gaps = 17/156 (10%)
Query: 76 WGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGF 133
+ + ++ E + L ++ + V+F N+ LP L ++ + L+D
Sbjct: 24 YDVHIDMQTQDVYFGFEDITL-NNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQI 81
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---IK 190
I AF +++KLYM N + P +P L L LE N +P
Sbjct: 82 E-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
Query: 191 QNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
++ +L ++NN +L +++ TF +L
Sbjct: 140 TPKLTTLSMSNN--------NLERIEDDTFQATTSL 167
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 26/147 (17%), Positives = 52/147 (35%), Gaps = 14/147 (9%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKF----EGPLPDLRKMGPLKSIYLSD 130
++E +NL+ I + +++ + N ++ L + L
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL---LTVLVLER 126
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK 190
N S ++ F L L M+NN L + L L+L +N+ V
Sbjct: 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184
Query: 191 QNEMRSLGLANNELEG-PIPESLSKMD 216
+ ++ N L IP ++ ++D
Sbjct: 185 IPSLFHANVSYNLLSTLAIPIAVEELD 211
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 25/159 (15%), Positives = 51/159 (32%), Gaps = 27/159 (16%)
Query: 79 KLEQMNLSGT-IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF---- 133
L+ + LS + L L+ SL + N L ++ + S N
Sbjct: 166 SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST-LAIPIA---VEELDASHNSINVVR 221
Query: 134 ------------SGN--ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179
N L ++ ++ N L + V++ +L L +
Sbjct: 222 GPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 180 NKFQGQVPEIKQN--EMRSLGLANNELEGPIPESLSKMD 216
N+ + Q ++ L L++N L + + + D
Sbjct: 282 NRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 9/109 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
L +++LS I + L + NN+ + + LK + LS N
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 308
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
++ + L+ LY+ +N + T+ S L L L N +
Sbjct: 309 -HVERNQP-QFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 48/248 (19%), Positives = 81/248 (32%), Gaps = 57/248 (22%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK-----RYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
+G G++G +K + +Q+N E + ++ + +L HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRL--------------- 459
L Y ++ L+ E G L KL+
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 460 --------------------KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL--DRSF 497
I++ + + YLHN+ I H +K N L ++SF
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GIC-HRDIKPENFLFSTNKSF 207
Query: 498 EPLLTDYAL---RPLINPDNAHTLMVAYKSPEYA-------HNGKISKKSDVWSLGILIL 547
E L D+ L +N + + +P + N K D WS G+L+
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 548 ELLTGKYP 555
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 28/141 (19%), Positives = 51/141 (36%), Gaps = 12/141 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
KL ++ L I L L++L + N+ E + + + L + L N S
Sbjct: 266 KLTELKLGANQISNI--SPLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNIS 322
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEM 194
+T L++L+ NN+++ SSL L + L N+ P +
Sbjct: 323 DIS---PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRI 377
Query: 195 RSLGLANNELEGPIPESLSKM 215
LGL + + +
Sbjct: 378 TQLGLNDQAWTNAPVNYKANV 398
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 31/133 (23%), Positives = 58/133 (43%), Gaps = 9/133 (6%)
Query: 79 KLEQMNLSGTIA-AESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
L+Q++ + + L L++L + +NK + L K+ L+S+ ++N I
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNN----QI 211
Query: 138 SD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRS 196
SD +T+L +L + N+L +L L L +L L N+ P ++
Sbjct: 212 SDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTE 269
Query: 197 LGLANNELEGPIP 209
L L N++ P
Sbjct: 270 LKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 20/120 (16%), Positives = 43/120 (35%), Gaps = 10/120 (8%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKK 150
+ L+ + + + ++ I D E + +L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRL----GIKSIDGVEYLNNLTQ 72
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEMRSLGLANNELEGPIP 209
+ +NN+LT P L L KL+++ + N+ + + + L L NN++ P
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 39/164 (23%), Positives = 64/164 (39%), Gaps = 25/164 (15%)
Query: 79 KLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
KL + ++ L L++L ++ NN+ + L+ + L + LS N
Sbjct: 91 KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSN----T 145
Query: 137 ISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE-M 194
ISD A G+TSL++L N L L L L + +NK + + + +
Sbjct: 146 ISDISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD-ISVLAKLTNL 201
Query: 195 RSLGLANNELEGPIP-ESLSKM-----------DPSTFAGNKNL 226
SL NN++ P L+ + D T A NL
Sbjct: 202 ESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNL 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 52/235 (22%), Positives = 93/235 (39%), Gaps = 36/235 (15%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV---VKRYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
LG G FG + + Q + VK K+ + R+DFQ + L L+H +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 415 PLTAFYYRKEEKLLLYEFVENGSL----------AGKLHANHTKQRPGLDWQTRLKIIKG 464
L+++E++ +G L A L L L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM 519
V GM YL + H L + N L+ + + D+ + R + + D T++
Sbjct: 167 VAAGMVYLAGL---HFV-HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 520 -VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
+ + PE K + +SDVWS G+++ E+ T GK + + + + QG
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 49/243 (20%), Positives = 91/243 (37%), Gaps = 51/243 (20%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVV--KRYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
LG G FG A + +V K K R+DFQ + L L+H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 415 PLTAFYYRKEEKLLLYEFVENGSL-----------AGKLHANHTKQRPGLDWQTRLKIIK 463
+ ++++E++++G L + + + L L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAY 522
+ GM YL ++ + H L + N L+ + + D+ + R + + D Y
Sbjct: 141 QIASGMVYLASQ---HFV-HRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-------YY 189
Query: 523 K------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLL 560
+ PE K + +SDVWS G+++ E+ T GK + + +
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
Query: 561 QGY 563
QG
Sbjct: 250 QGR 252
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
E LGSG F K S G Y K + ++ + R +E I+R L ++HPN+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHA-NHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ L Y K + +L+ E V G L L + + +K ++ G+ YL
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYL 130
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMVA---YKSP 525
H+ I H LK N++L P + D+ L I+ N + + +P
Sbjct: 131 HSL---QIA-HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E + + ++D+WS+G++ LL+G
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSG-AS 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 38/181 (20%), Positives = 75/181 (41%), Gaps = 36/181 (19%)
Query: 396 EDFQEHIKR----LGRLEHPNL----------LPLTAFYYRKEEKLLLYEFVENGSLAGK 441
F +R L HP + P Y ++ E+V+ +L
Sbjct: 53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDI 106
Query: 442 LHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501
+H + + +++I + + + H II H +K +N+++ + +
Sbjct: 107 VHTEGP-----MTPKRAIEVIADACQALNFSHQN---GII-HRDVKPANIMISATNAVKV 157
Query: 502 TDYAL-RPLINPDNAHT----LM--VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKY 554
D+ + R + + N+ T ++ Y SPE A + +SDV+SLG ++ E+LTG+
Sbjct: 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
Query: 555 P 555
P
Sbjct: 218 P 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 52/213 (24%), Positives = 80/213 (37%), Gaps = 38/213 (17%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+LG G+FG K Q Y VK N ++ L +L+HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 418 AFYYRKEEKLLLY---EFVENGSL------AGKLHANHTKQRPGLDWQTRLKIIKGVVKG 468
E+ Y E G L + + +IIK V G
Sbjct: 88 EIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----------RIIKQVFSG 133
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPDNAHTLMV---AY 522
+ Y+H I H LK N+LL ++ + + D+ L + + Y
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE G +K DVWS G+++ LL+G P
Sbjct: 190 IAPEVLR-GTYDEKCDVWSAGVILYILLSG-TP 220
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 16/135 (11%)
Query: 97 LSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154
L++ + V+F N+ LP L ++ + L+D I AF +++KLYM
Sbjct: 50 LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 107
Query: 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---IKQNEMRSLGLANNELEGPIPES 211
N + P +P L L LE N +P ++ +L ++NN +
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN--------N 158
Query: 212 LSKMDPSTFAGNKNL 226
L +++ TF +L
Sbjct: 159 LERIEDDTFQATTSL 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 26/147 (17%), Positives = 52/147 (35%), Gaps = 14/147 (9%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKF----EGPLPDLRKMGPLKSIYLSD 130
++E +NL+ I + +++ + N ++ L + L
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL---LTVLVLER 132
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK 190
N S ++ F L L M+NN L + L L+L +N+ V
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 190
Query: 191 QNEMRSLGLANNELEG-PIPESLSKMD 216
+ ++ N L IP ++ ++D
Sbjct: 191 IPSLFHANVSYNLLSTLAIPIAVEELD 217
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 27/159 (16%)
Query: 79 KLEQMNLSG-TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF---- 133
L+ + LS + L L+ SL + N L L ++ + S N
Sbjct: 172 SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNL----LSTLAIPIAVEELDASHNSINVVR 227
Query: 134 ------------SGN--ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179
N L ++ ++ N L + V++ +L L +
Sbjct: 228 GPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 180 NKFQGQVPEIKQN--EMRSLGLANNELEGPIPESLSKMD 216
N+ + Q ++ L L++N L + + + D
Sbjct: 288 NRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 324
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 24/138 (17%), Positives = 46/138 (33%), Gaps = 9/138 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
L +++LS I + L + NN+ + + LK + LS N
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 314
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEM 194
++ + L+ LY+ +N + T+ S L L L N + +
Sbjct: 315 -HVERNQP-QFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNV 369
Query: 195 RSLGLANNELEGPIPESL 212
+ + + I L
Sbjct: 370 ARPAVDDADQHCKIDYQL 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 33/178 (18%), Positives = 68/178 (38%), Gaps = 8/178 (4%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFE--GPLPDLRKMGPLKSIYLSDNG 132
LE ++LS ++++ G LSSL+ ++ M N ++ G + L+++ + +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--K 190
I F G+TSL +L + L SL + + L L ++ +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 191 QNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQ 248
+ +R L L + L L + S+ G L + ++ + +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 12/136 (8%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
GL ++++++ NK DLR L+ + L + + I DAF + SL+ L +
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDL 81
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQG-QVPEIKQN--EMRSLGLANNELEGPIPE 210
++N L+ S L L L L N +Q V + N +++L + N E
Sbjct: 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET------ 135
Query: 211 SLSKMDPSTFAGNKNL 226
S++ FAG +L
Sbjct: 136 -FSEIRRIDFAGLTSL 150
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 23/109 (21%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 76 WGLKLEQMNLSGT-IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
W K+ +NLS T I + +L + NN + L + L+ +Y+S N
Sbjct: 408 WPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPR---LQELYISRNKLK 464
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ D + L + ++ N+L +L L ++ L N +
Sbjct: 465 -TLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 37/175 (21%)
Query: 79 KLEQMNLSG-------TIAAESLGLLSSLRAVSFMNNKF---EGPLPDLRKMGPLKSIYL 128
LE ++LS + G SL+ + N + L + L S+ +
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 129 SDNGFSGNISDDAFEGMTSLKKLYMANNRLT---GTIPSSL--------------VQLPK 171
S N F D+ + ++ L +++ + IP +L + LP+
Sbjct: 395 SRNTFHPM--PDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPR 452
Query: 172 LMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
L EL + NK + + + ++ N L + F +L
Sbjct: 453 LQELYISRNKLKTLPDASLFPVLLVMKISRN--------QLKSVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 17/109 (15%), Positives = 39/109 (35%), Gaps = 12/109 (11%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
++ +++ + + +K++ + N+++ S L L L L N
Sbjct: 288 IRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 183 QGQVPEIKQNE-----MRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ + + +++L L+ N L S+ K KNL
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHL-----RSMQK-TGEILLTLKNL 389
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 13/105 (12%), Positives = 36/105 (34%), Gaps = 2/105 (1%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGN 136
L++ + I L+SL + L+ + + + L + +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-F 186
Query: 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK 181
+ + + ++S++ L + + L S L ++ A +
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 59/261 (22%), Positives = 101/261 (38%), Gaps = 58/261 (22%)
Query: 321 SSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVI---- 376
+ EP P + + E F ++LG G+F TV+
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFG-------KILGEGSFS----TVVLARE 51
Query: 377 -SNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLTAFYYRKEEKL-LLY 430
+ + Y +K ++ ++ +E+ ++ R + RL+HP + L F ++ +EKL
Sbjct: 52 LATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFFVKL-YFTFQDDEKLYFGL 109
Query: 431 EFVENGSL------AGKLHANHTK----QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+ +NG L G T+ + +V + YLH + I
Sbjct: 110 SYAKNGELLKYIRKIGSFDETCTRFYTAE---------------IVSALEYLHGK---GI 151
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYAL----RPLINPDNAHTL--MVAYKSPEYAHNGKIS 534
I H LK N+LL+ +TD+ P A++ Y SPE
Sbjct: 152 I-HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 535 KKSDVWSLGILILELLTGKYP 555
K SD+W+LG +I +L+ G P
Sbjct: 211 KSSDLWALGCIIYQLVAGLPP 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 26/209 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEH-PNLLPL 416
+ LG G F + + S GQ Y K + ++ R + I L + P ++ L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 417 TAFYYRKEEKLLLYEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
Y E +L+ E+ G + +L ++ ++IK +++G+ YL
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN------DVI-RLIKQILEGVYYL 147
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV---AYKSPE 526
H +I+ H LK N+LL + + + D+ + I ++ Y +PE
Sbjct: 148 HQN---NIV-HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ I+ +D+W++GI+ LLT
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH-TS 231
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 30/157 (19%), Positives = 62/157 (39%), Gaps = 10/157 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFE--GPLPDLRKMGPLKSIYLSDNG 132
LE ++LS +++ LSSL ++ + N ++ G + L+ + + +
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--- 189
I F G+T L++L + + L P SL + + L L + + EI
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 190 KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ + L L + +L+ LS + ++
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 14/137 (10%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
GL +++++ NN+ DL++ L+++ L+ NG + I +D+F + SL+ L +
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107
Query: 154 ANNRLTGTIPSSL-VQLPKLMELRLEANKFQGQVPEIKQNEMRSLG---LANNELEGPIP 209
+ N L+ + SS L L L L N ++ + + L + N
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM------- 159
Query: 210 ESLSKMDPSTFAGNKNL 226
++ +K+ FAG L
Sbjct: 160 DTFTKIQRKDFAGLTFL 176
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 16/119 (13%), Positives = 42/119 (35%), Gaps = 17/119 (14%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFE---------GPLPDLRKMGPLKS 125
+ + L + + + SS+ + + + G L K ++
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 126 IYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ-LPKLMELRLEANKFQ 183
+ ++D + ++ L +L + N+L ++P + L L ++ L N +
Sbjct: 259 VKITDESLFQVM--KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 17/84 (20%), Positives = 32/84 (38%), Gaps = 1/84 (1%)
Query: 76 WGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSG 135
L + T SL + R V + + L ++ L + S N
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK- 290
Query: 136 NISDDAFEGMTSLKKLYMANNRLT 159
++ D F+ +TSL+K+++ N
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 14/118 (11%), Positives = 39/118 (33%), Gaps = 13/118 (11%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDL-RKMGPLKSIYLSDNGF 133
LE++ + + +SL + ++ + + L ++ + L D
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234
Query: 134 SGN-------ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG 184
++ + + + + + L + L Q+ L+EL N+ +
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 28/180 (15%), Positives = 67/180 (37%), Gaps = 28/180 (15%)
Query: 388 KQMNNVGREDFQEHIKR----LGRLEHPNLLPLTAF--YYRKEEKLLLY---EFVENGSL 438
K + + G + Q L + HP+++ + F + + + Y E+V SL
Sbjct: 112 KGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL 171
Query: 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE 498
+ L + + ++ ++YLH+ ++ + LK N++L +
Sbjct: 172 KRSK------GQK-LPVAEAIAYLLEILPALSYLHSI---GLV-YNDLKPENIMLTEE-Q 219
Query: 499 PLLTDYAL-RPLINPDNAHTLM--VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
L D + ++ L +++PE + +D++++G + L
Sbjct: 220 LKLIDLGAVSRI---NSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 36/207 (17%), Positives = 73/207 (35%), Gaps = 19/207 (9%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
L + L+G ++A + LSSL+ + + L + + + LK + ++ N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNL 135
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL----MELRLEANKFQGQVPE 188
+ F +T+L+ L +++N++ + L L ++ + L L N P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 189 I-KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVS 247
K+ + L L NN + + G L L +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVM-------KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 248 QPPKGQPPIIVQENPNQKKEVSLLKII 274
+G + ++E + L II
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDII 275
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 21/125 (16%), Positives = 41/125 (32%), Gaps = 5/125 (4%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
L S + + N L+ + LS I D A++ ++ L L +
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNEL-EGPIPE 210
N + + L L +L + ++ L +A+N + +PE
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 211 SLSKM 215
S +
Sbjct: 144 YFSNL 148
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 7/111 (6%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
L +++S LSSL + N F+ ++ L + LS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+S AF ++SL+ L MA+N+L +L L ++ L N +
Sbjct: 482 LEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 18/101 (17%), Positives = 37/101 (36%), Gaps = 1/101 (0%)
Query: 84 NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAF 142
NL L +L + + + L+ + ++ N F N D F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ +L L ++ +L P++ L L L + +N+ +
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 16/89 (17%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
LK+ + + L +L + + E L + L+ + ++ N
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLK- 507
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPS 164
++ D F+ +TSL+K+++ N + P
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 28/126 (22%), Positives = 52/126 (41%), Gaps = 8/126 (6%)
Query: 66 NGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLK 124
N + ++ L + + E L++L + +NK + DLR + +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 125 ----SIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ-LPKLMELRLEA 179
S+ LS N + I AF+ + L KL + NN + + + +Q L L RL
Sbjct: 177 LLNLSLDLSLNPMNF-IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 180 NKFQGQ 185
+F+ +
Sbjct: 235 GEFRNE 240
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 21/150 (14%), Positives = 48/150 (32%), Gaps = 19/150 (12%)
Query: 77 GLKLEQMNLSG-----TIAAESLGLLSSLRAVSFMNNKF----------EGPLPDLRKMG 121
++L ++ L + + L+ L + +F + L L +
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL- 257
Query: 122 PLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK 181
++ L+ + + D F +T++ + + + L L K
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCK 315
Query: 182 FQGQVPEIKQNEMRSLGLANNELEGPIPES 211
F Q P +K ++ L +N+ E
Sbjct: 316 FG-QFPTLKLKSLKRLTFTSNKGGNAFSEV 344
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 28/183 (15%), Positives = 57/183 (31%), Gaps = 32/183 (17%)
Query: 72 NGSVWGL-KLEQMNLSG----TI-AAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKS 125
+ +++ ++L T+ AE +L ++ N + LK+
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKT 195
Query: 126 IYLSDNGFSGNIS--DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ LS N ++ F+ + + + NN+L I +L L L N
Sbjct: 196 LDLSSN----KLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG-- 248
Query: 184 GQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIP 243
+R N + ++++K K L G + C +P
Sbjct: 249 -----FHCGTLRDFFSKNQRV-----QTVAK------QTVKKLTGQNEEECTVPTLGHYG 292
Query: 244 NNV 246
Sbjct: 293 AYC 295
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 29/156 (18%), Positives = 61/156 (39%), Gaps = 24/156 (15%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF- 133
+++++LSG I+A L + L ++ +N DL + L+++ L++N
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ 93
Query: 134 -------------SGN-ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179
+ N IS + K +Y+ANN++T ++ L L+
Sbjct: 94 ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 180 NKFQG-QVPEIKQN--EMRSLGLANNELEGPIPESL 212
N+ E+ + + L L N + + +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 17/84 (20%), Positives = 38/84 (45%), Gaps = 3/84 (3%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
K ++D+ + ++K+L ++ N L+ + L KL L L +N
Sbjct: 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 183 QGQVPEIKQ-NEMRSLGLANNELE 205
+ +++ + +R+L L NN ++
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 30/153 (19%), Positives = 49/153 (32%), Gaps = 21/153 (13%)
Query: 82 QMNLSGTIAAESLGLLSSLRAVSFMNNKF----EGPLPDLRKMGPLKSIYLSDNGFSGNI 137
N + A S +L + +N L L+ + LSDN ++
Sbjct: 40 HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL---LEQLDLSDNAQLRSV 96
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPS-SLVQLPKLMELRLEANKFQGQVPE---IKQNE 193
F G+ L L++ L + L L L L+ N Q +P+
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGN 154
Query: 194 MRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ L L N +S + F G +L
Sbjct: 155 LTHLFLHGNR--------ISSVPERAFRGLHSL 179
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 8/111 (7%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
+L ++L + L++L+ + +N + LPD R +G L ++L N
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNR 164
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
S ++ + AF G+ SL +L + NR+ P + L +LM L L AN
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 42/221 (19%), Positives = 75/221 (33%), Gaps = 46/221 (20%)
Query: 23 GVTFGLSDTEILL----QFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN------ 72
G F + L FK S+ + +++ N N
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 73 -GSVWGL---KLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYL 128
+ GL ++ +LS + + +L F + DL + + L
Sbjct: 266 NFTFKGLEASGVKTCDLSKS-------KIFALLKSVFSH------FTDLEQ------LTL 306
Query: 129 SDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188
+ N + I D+AF G+T L KL ++ N L L KL L L N + + +
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGD 364
Query: 189 ---IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ ++ L L N+L+ +P+ F +L
Sbjct: 365 QSFLGLPNLKELALDTNQLKS-VPD-------GIFDRLTSL 397
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 19/109 (17%), Positives = 36/109 (33%), Gaps = 13/109 (11%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSS-LVQLPKLMELRLEANK 181
L+ + + I ++ F G++SL L + N+ + + L L L L
Sbjct: 56 LQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCN 114
Query: 182 FQG-QVPE---IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
G + + L L +N ++ P S F +
Sbjct: 115 LDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF-------FLNMRRF 156
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 26/194 (13%), Positives = 49/194 (25%), Gaps = 24/194 (12%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKF-EGPLPD--LRKMGPLKSIYLSDN 131
L + L + + L++L ++ L + + L+ + L DN
Sbjct: 80 SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPK--LMELRLEANKFQGQVPE- 188
F M L + N++ L+ LRL + Q
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 189 ---------IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKH 239
K + +L L+ N + + + T + L
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-- 257
Query: 240 PEIPNNVSQPPKGQ 253
N P
Sbjct: 258 ---HTNFKDPDNFT 268
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 2e-10
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 1/108 (0%)
Query: 98 SSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNR 157
+ + L L L +Y+ + ++ G+ L+ L + +
Sbjct: 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 158 LTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN-EMRSLGLANNEL 204
L P + P+L L L N + + Q ++ L L+ N L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 20/106 (18%), Positives = 33/106 (31%), Gaps = 25/106 (23%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
L +E + L L LR ++ + + +
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------------------FV 71
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ DAF L +L ++ N L ++ VQ L EL L N
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 47/224 (20%), Positives = 87/224 (38%), Gaps = 48/224 (21%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK-----RYKQMNNVGREDFQEHIKR----LGRL-E 409
E+LG G + + + Y VK + ++ +E + L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 410 HPNLLPLTAFYYRKEEKLLLY---EFVENGSL------AGKLHANHTKQRPGLDWQTRLK 460
HPN++ L Y E + + ++ G L L T+ K
Sbjct: 83 HPNIIQLKDTY---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-----------K 128
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV 520
I++ +++ + LH +I+ H LK N+LLD LTD+ ++P +
Sbjct: 129 IMRALLEVICALHKL---NIV-HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 521 ---AYKSPE------YAHNGKISKKSDVWSLGILILELLTGKYP 555
+Y +PE ++ K+ D+WS G+++ LL G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-SP 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 41/219 (18%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK----RYKQMNNVGREDFQEHIKR----LGRLEHP 411
+ LGSG G + ++ R + + D +++ L +L HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSL------AGKLHANHTKQRPGLDWQTRLKIIKGV 465
++ + F+ ++ ++L E +E G L +L K +
Sbjct: 201 CIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK-----------LYFYQM 248
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL---LTDYALRPLINPDNAHTLMV-- 520
+ + YLH II H LK NVLL E +TD+ ++ + +
Sbjct: 249 LLAVQYLHEN---GII-HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 521 -AYKSPE---YAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE ++ D WSLG+++ L+G YP
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-YP 342
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 26/168 (15%), Positives = 55/168 (32%), Gaps = 14/168 (8%)
Query: 79 KLEQMNLSG----TIAAESL-GLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGF 133
+++ ++L T+ L +L ++ N + LK++ LS N
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSN-- 201
Query: 134 SGNIS--DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ-GQVPEIK 190
++ F+ + + + NN+L I +L L L N F G + +
Sbjct: 202 --KLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 191 QNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPK 238
R +A ++ ++ + T C L +
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 29/156 (18%), Positives = 60/156 (38%), Gaps = 24/156 (15%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
+++++LSG I+A L + L ++ +N DL + L+++ L++N
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ 93
Query: 135 G---------------NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179
NIS + K +Y+ANN++T ++ L L+
Sbjct: 94 ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 180 NKFQG-QVPEIKQN--EMRSLGLANNELEGPIPESL 212
N+ E+ + + L L N + + +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV 188
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 17/84 (20%), Positives = 38/84 (45%), Gaps = 3/84 (3%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
K ++D+ + ++K+L ++ N L+ + L KL L L +N
Sbjct: 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 183 QGQVPEIKQ-NEMRSLGLANNELE 205
+ +++ + +R+L L NN ++
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 12/110 (10%), Positives = 30/110 (27%), Gaps = 2/110 (1%)
Query: 97 LSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANN 156
+S ++ E + + I + + D + L
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKK 370
Query: 157 RLTGTIPSSLVQLPKLMELRLEAN-KFQGQVPEIKQNEMRSLGLANNELE 205
L + + +L +A + + Q +Q+ ++ L E
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 32/231 (13%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVV--KRYKQMNNVG-REDFQEHIKRLGRLEHPNL 413
LG G+FG K V+ + V K + ++ R +F + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN--HTKQRPGLDWQTRLKIIK---GVVKG 468
+ L + + L++ E + G L L + P L + K+I+ + G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD----NAHTLM-VAY 522
MAYL+ + H L + N ++ F + D+ + R + D L+ V +
Sbjct: 151 MAYLNAN---KFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
SPE +G + SDVWS G+++ E+ T + Y ++++G
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 24/205 (11%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+G G++G K+ + + F++ I+ + L+HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 420 YYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ E+ +Y E G L ++ + +I+K V+ +AY H
Sbjct: 75 F---EDNTDIYLVMELCTGGELFERV-----VHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 477 PGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV---AYKSPEYAHN 530
+ H LK N L PL L D+ L P V Y SP+
Sbjct: 127 ----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE- 181
Query: 531 GKISKKSDVWSLGILILELLTGKYP 555
G + D WS G+++ LL G YP
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG-YP 205
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 15/115 (13%)
Query: 116 DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS-SLVQLPKLME 174
++ L S+ LS N + IS +AF + +L+ L +++N L T+ L L
Sbjct: 59 TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116
Query: 175 LRLEANKFQGQVPE---IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
L L N V +++ L L+ N+ +S+ L
Sbjct: 117 LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ--------ISRFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 17/138 (12%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
L + LS I++E+ + +LR + +N L + + L+ + L +N
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNH 123
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIP----SSLVQLPKLMELRLEANKFQ----G 184
+ +AFE M L+KLY++ N+++ P +LPKLM L L +NK +
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 185 QVPEIKQNEMRSLGLANN 202
+ ++ L L NN
Sbjct: 182 DLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 14/108 (12%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS-SLVQLPKLMELRLEANK 181
+ LS N S ++ +T+L L +++N L I S + V +P L L L +N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99
Query: 182 FQGQVPE---IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ E + L L NN + + + F L
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHIVV-VD-------RNAFEDMAQL 138
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 37/213 (17%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E LG G F + V + G + K K+++ + + + +L+HPN++ L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRL------KIIKGVVKG 468
+E+ Y + V G L + A + I+ +++
Sbjct: 72 DSI---QEESFHYLVFDLVTGGELFEDIVA-----------REFYSEADASHCIQQILES 117
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL---LTDYALRPLINPDNAHTLMV---AY 522
+AY H+ I H +LK N+LL + L D+ L +N A Y
Sbjct: 118 IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
SPE SK D+W+ G+++ LL G YP
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG-YP 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 52/213 (24%), Positives = 79/213 (37%), Gaps = 40/213 (18%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
EVLGSG F + G+ + +K K+ + I L +++H N++ L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 420 YYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDW---QTRL------KIIKGVVK 467
Y E Y + V G L D + +I+ V+
Sbjct: 75 Y---ESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVLS 117
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLM--VAY 522
+ YLH I+ H LK N+L E + +TD+ L + T Y
Sbjct: 118 AVKYLHEN---GIV-HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY 173
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE SK D WS+G++ LL G YP
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG-YP 205
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 45/225 (20%), Positives = 88/225 (39%), Gaps = 56/225 (24%)
Query: 361 EVLGSGTFGASYKTVIS-NGQAYVVK------RYKQMNNVGREDFQEHIKRLGRLEHPNL 413
+ G GTFG G + +K R++ RE Q ++ L L HPN+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN-----RE-LQI-MQDLAVLHHPNI 81
Query: 414 LPLTAFYYRKEEK-------LLLYEFVENGSLAGKL-HANHTKQRPGLD------WQTRL 459
+ L +++Y E+ ++ E+V + +L + + P +Q
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL-- 138
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTL 518
++ + LH + H +K NVL++ + L L D+ ++P +
Sbjct: 139 ------IRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 519 MVA---YKSPE-------YAHNGKISKKSDVWSLGILILELLTGK 553
+ Y++PE Y + D+WS+G + E++ G+
Sbjct: 191 YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 25/157 (15%), Positives = 54/157 (34%), Gaps = 24/157 (15%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNK---FEGPLPDLRKMGPLKSIYLSDN 131
L + L I+ + L L + N+ +P L+ + + +N
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPK-----TLQELRVHEN 131
Query: 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTI--PSSLVQLPKLMELRLEANKFQGQVPEI 189
+ + F G+ + + + N L + + + KL +R+ +P+
Sbjct: 132 EIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 189
Query: 190 KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ L L N ++K+D ++ G NL
Sbjct: 190 LPPSLTELHLDGN--------KITKVDAASLKGLNNL 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 26/135 (19%), Positives = 51/135 (37%), Gaps = 12/135 (8%)
Query: 79 KLEQMNLSG------TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNG 132
++ + L I + + L + + L L ++L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNK 203
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
+ + + +G+ +L KL ++ N ++ SL P L EL L NK +VP +
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 193 --EMRSLGLANNELE 205
++ + L NN +
Sbjct: 262 HKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 23/104 (22%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ L +N + I D F+ + +L L + NN+++ P + L KL L L N+
Sbjct: 54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 183 QGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+ ++ + ++ L + NE ++K+ S F G +
Sbjct: 113 KELPEKMPKT-LQELRVHENE--------ITKVRKSVFNGLNQM 147
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 13/115 (11%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
L ++ LS + SL LR + NNK L ++ +YL +N S
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 276
Query: 135 GNISDDAF------EGMTSLKKLYMANNRLTGTI--PSSLVQLPKLMELRLEANK 181
I + F S + + +N + PS+ + ++L K
Sbjct: 277 -AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 24/140 (17%), Positives = 53/140 (37%), Gaps = 22/140 (15%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
L L+ ++ + A SL L++L + N + + L L+ ++L++N
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV- 253
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSS-------LVQLPKLMELRLEANKFQGQVPE 188
+ ++ +Y+ NN ++ I S+ + + L +N Q E
Sbjct: 254 KVPG-GLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV--QYWE 309
Query: 189 IKQN------EMRSLGLANN 202
I+ + ++ L N
Sbjct: 310 IQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 17/107 (15%), Positives = 33/107 (30%), Gaps = 13/107 (12%)
Query: 64 NWNGVLCL-NGSVWGL-KLEQMNLSG---TIAAESLGLLSSLRAVSFMNNKFE------- 111
++N + + NGS+ L +++L+ L ++ V NN
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 112 GPLPDLRKMGPLKSIYLSDNGFS-GNISDDAFEGMTSLKKLYMANNR 157
P K + L N I F + + + N +
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 51/291 (17%), Positives = 108/291 (37%), Gaps = 56/291 (19%)
Query: 297 RKRKTQIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDML 356
R+ + R + ++ L + + +P+ E G + D +
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96
Query: 357 RASAEVLGSGTFGASYKTV-ISNGQAYVVK----RYKQMNNVGREDFQEHIKR----LGR 407
+V+G G + V + G + VK ++++ E+ +E +R L +
Sbjct: 97 DPK-DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 408 L-EHPNLLPLTAFYYRKEEKLLLY---EFVENGSL------AGKLHANHTKQRPGLDWQT 457
+ HP+++ L Y E ++ + + G L L T+
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--------- 203
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHG--H--LKSSNVLLDRSFEPLLTDYALRPLINPD 513
I++ +++ +++LH + H LK N+LLD + + L+D+ + P
Sbjct: 204 --SIMRSLLEAVSFLHA--------NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 514 NAHTLMV---AYKSPE------YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ Y +PE + K+ D+W+ G+++ LL G P
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG-SP 303
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 55/240 (22%), Positives = 88/240 (36%), Gaps = 49/240 (20%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV---VKRYKQM-NNVGREDFQEHIKRLGRL-EHPNLLP 415
+V+G G FG K I + +KR K+ + DF ++ L +L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 416 LTAFYYRKEEKLLLYEFVENGSL-----------AGKLHANHTKQRPGLDWQTRLKIIKG 464
L + L E+ +G+L A L Q L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK- 523
V +GM YL + I H L + N+L+ ++ + D+ L + V K
Sbjct: 151 VARGMDYLSQK---QFI-HRDLAARNILVGENYVAKIADFGL--------SRGQEVYVKK 198
Query: 524 ----------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQGY 563
+ E + + SDVWS G+L+ E+++ G Y L QGY
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 29/213 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK-----RYKQMNNVGREDFQEHIKRLGRLEHPNLL 414
EV+G G F + + GQ + VK ++ + ED + L+HP+++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 415 PLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRL--KIIKGVVKGM 469
L Y +LY EF++ L ++ + G + + ++ +++ +
Sbjct: 90 ELLETY---SSDGMLYMVFEFMDGADLCFEIVK---RADAGFVYSEAVASHYMRQILEAL 143
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYAL-RPLINPDNAHTLMV---AY 522
Y H+ +II H +K VLL P+ L + + L V +
Sbjct: 144 RYCHDN---NII-HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE K DVW G+++ LL+G
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSG-CL 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 34/162 (20%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKF----EGPLPDLRKMGPLKSIYLSD 130
L + L+G ++A + LSSL+ + + P+ L+ LK + ++
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT---LKELNVAH 133
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIP----SSLVQLPKL-MELRLEANKFQGQ 185
N + F +T+L+ L +++N++ +I L Q+P L + L L N
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192
Query: 186 VPEIKQN-EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
P + ++ L L N+L+ +P F +L
Sbjct: 193 QPGAFKEIRLKELALDTNQLKS-VP-------DGIFDRLTSL 226
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 3/62 (4%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSL-VQLPKLMELRLEANK 181
L+ + LS I D A++ ++ L L + N + ++ L L +L
Sbjct: 54 LQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN 111
Query: 182 FQ 183
Sbjct: 112 LA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 19/107 (17%), Positives = 33/107 (30%), Gaps = 13/107 (12%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSL-VQLPKLMELRLEANK 181
K++ LS N ++ +F L+ L ++ + TI L L L L N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 182 FQGQVPEIKQN--EMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
Q ++ L L+ ++ K L
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETN--------LASLENFPIGHLKTL 126
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 54/275 (19%), Positives = 101/275 (36%), Gaps = 36/275 (13%)
Query: 300 KTQIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDD---MEPFDLQDML 356
+Q + + P + + P + F ++ + D
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 357 RASAEVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLL 414
+ +++VLG G G + + + +K + RE ++ R + P+++
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----VELHWRASQCPHIV 118
Query: 415 PLTAFY---YRKEEKLLL-YEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVV 466
+ Y Y + LL+ E ++ G L + T++ +I+K +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIG 171
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV--- 520
+ + YLH+ I H +K N+L L LTD+ N+ T
Sbjct: 172 EAIQYLHSI--N--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227
Query: 521 AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE K K D+WSLG+++ LL G YP
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-YP 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 31/171 (18%), Positives = 68/171 (39%), Gaps = 20/171 (11%)
Query: 64 NWNGVLCLNGSVWGL-KLEQMNLSG----TIAAESL-GLLSSLRAVSFMNNKFEGPLPD- 116
++NGV+ ++ + GL +LE ++ ++ S+ L +L + + +
Sbjct: 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNG 144
Query: 117 -LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMEL 175
+ L+ + ++ N F N D F + +L L ++ +L P++ L L L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204
Query: 176 RLEANKFQGQVPE---IKQNEMRSLGLANNELE-------GPIPESLSKMD 216
+ N F + N ++ L + N + P SL+ ++
Sbjct: 205 NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 47/209 (22%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+V+G+G+FG ++ + +K+ Q RE ++ + ++HPN++ L AF
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE-----LQIMRIVKHPNVVDLKAF 100
Query: 420 YY-----RKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG----VVKGM 469
+Y + E L L+ E+V ++ + ++ K + + + +IK +++ +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVY-RASRHYAKLKQTMP----MLLIKLYMYQLLRSL 154
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMVA---YKSP 525
AY+H I H +K N+LLD L L D+ ++ + + Y++P
Sbjct: 155 AYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAP 210
Query: 526 EYAHNGKI-SKKSDVWSLGILILELLTGK 553
E + D+WS G ++ EL+ G+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 51/246 (20%), Positives = 85/246 (34%), Gaps = 56/246 (22%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVV--KRYKQM-NNVGREDFQEHIKRLGRLEHPNL 413
E LG FG Q V K K RE+F+ RL+HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN-----------HTKQRPGLDWQTRLKII 462
+ L + + +++ + +G L L + L+ + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 463 KGVVKGMAYL--HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM 519
+ GM YL H+ ++ H L + NVL+ ++D L R + D
Sbjct: 135 AQIAAGMEYLSSHH-----VV-HKDLATRNVLVYDKLNVKISDLGLFREVYAAD------ 182
Query: 520 VAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------N 557
YK +PE GK S SD+WS G+++ E+ + G Y
Sbjct: 183 -YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 558 YLLQGY 563
+
Sbjct: 242 MIRNRQ 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 56/266 (21%), Positives = 96/266 (36%), Gaps = 55/266 (20%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTA 418
+VLG G + + Q Y VK ++ R ++ L + + H N+L L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 419 FYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRL------KIIKGVVKGM 469
F+ EE+ Y E + GS+ +H + +++ V +
Sbjct: 79 FF---EEEDRFYLVFEKMRGGSILSHIHK-----------RRHFNELEASVVVQDVASAL 124
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMVAYK--- 523
+LHN G I H LK N+L + + P+ + D+ L I + + + +
Sbjct: 125 DFLHN--KG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 524 ---SPEY----------AHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLS 570
S EY K+ D+WSLG+++ LL+G P S
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP------FVGRCGSDC 234
Query: 571 NWVNNMVKEKRTGDVFDKEMKGAKYS 596
W +F+ +G KY
Sbjct: 235 GWDRGEACPACQNMLFESIQEG-KYE 259
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 22/134 (16%), Positives = 55/134 (41%), Gaps = 15/134 (11%)
Query: 79 KLEQMNLSGT-IA-AESLGLLSSLRAVSFMNNKFE--GPLPDLRKMGPLKSIYLSDNGFS 134
L + L+ + + +++ ++ N P+ L L+ + +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNPISGLSN---LERLRIMGK--- 98
Query: 135 GNISDD---AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ 191
+++ D G+TSL L ++++ +I + + LPK+ + L N + +K
Sbjct: 99 -DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKT 157
Query: 192 N-EMRSLGLANNEL 204
E++SL + + +
Sbjct: 158 LPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 22/108 (20%), Positives = 44/108 (40%), Gaps = 9/108 (8%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGF 133
LE++ + G + +L L+SL + ++ + L + + + SI LS NG
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK 181
+I + + LK L + + + + PKL +L +
Sbjct: 149 ITDIM--PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQT 192
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 25/210 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVG--REDFQEHIKR----LGRLEHP 411
LGSG FG + V + VVK + +++ + + L R+EH
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
N++ + + + L+ E +G L + P LD I + +V + Y
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG---LDLF-AFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAH-- 529
L + I H +K N+++ F L D+ + + EY
Sbjct: 146 LRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPE 199
Query: 530 --NGK--ISKKSDVWSLGILILELLTGKYP 555
G + ++WSLG+ + L+ + P
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 19/164 (11%), Positives = 44/164 (26%), Gaps = 40/164 (24%)
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRP 451
++ RL R++ P + + + E++ GSL
Sbjct: 75 LQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLVVAEWIRGGSLQEVADT------- 124
Query: 452 GLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511
++ ++ + H G + S V + + +L
Sbjct: 125 SPSPVGAIRAMQSLAAAADAAHRA--G--VALSIDHPSRVRVSIDGDVVLAY-------- 172
Query: 512 PDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
A + + D+ +G + LL ++P
Sbjct: 173 --------PATMPDA-------NPQDDIRGIGASLYALLVNRWP 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 46/225 (20%), Positives = 87/225 (38%), Gaps = 32/225 (14%)
Query: 346 DMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR 404
+ + + + D + S +VLG G G + GQ +K +E +
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-----VDH 74
Query: 405 LGRL-EHPNLLPLTAFY----YRKEEKLLLYEFVENGSL----AGKLHANHTKQRPGLDW 455
+ P+++ + Y + K L++ E +E G L + T++
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--- 131
Query: 456 QTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINP 512
+I++ + + +LH+ I H +K N+L ++ LTD+
Sbjct: 132 ----EIMRDIGTAIQFLHSH--N--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 513 DNAHTLM--VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ T Y +PE K K D+WSLG+++ LL G +P
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-FP 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 56/232 (24%), Positives = 84/232 (36%), Gaps = 50/232 (21%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV---VKRYKQM-NNVGREDFQEHI---KRLGRLEH 410
+ LG+G FG + + A + VK K + RE + LG H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--H 86
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSL-------------AGKLHANHTKQRPGLDWQT 457
N++ L L++ E+ G L + A LD +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAH 516
L V KGMA+L ++ + I H L + N+LL + D+ L R + N N
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSN-- 200
Query: 517 TLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GKYP 555
Y +PE N + +SDVWS GI + EL + G P
Sbjct: 201 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 55/267 (20%), Positives = 110/267 (41%), Gaps = 36/267 (13%)
Query: 302 QIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAE 361
+ + ++++ GS E++ K ++ F+ L+
Sbjct: 105 TVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE---FEY---LK---- 154
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
+LG GTFG K + G+ Y +K K+ V +++ H L HP L
Sbjct: 155 LLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDE-VAHTLTENRVLQNSRHPFL 210
Query: 414 LPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L + ++ ++L + E+ G L L ++R + + R + +V + YL
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAE-IVSALDYL 264
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEYA 528
H+E +++ + LK N++LD+ +TD+ L + + T Y +PE
Sbjct: 265 HSEK--NVV-YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
+ + D W LG+++ E++ G+ P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 47/223 (21%), Positives = 82/223 (36%), Gaps = 49/223 (21%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLP 415
++LG G++G + + VK K+ + + ++K+ L RL H N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 416 LTAFY--YRKEEKLLLY---EFVENGSL-------AGKLHANHTKQRPGLDWQTRLK--- 460
L EEK +Y E+ G + Q
Sbjct: 71 L---VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP----------VCQAHGYFCQ 117
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV 520
+I G+ YLH++ I H +K N+LL ++ + ++P A
Sbjct: 118 LIDGL----EYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 521 ------AYKSPEYAHNGKI--SKKSDVWSLGILILELLTGKYP 555
A++ PE A+ K D+WS G+ + + TG YP
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 48/214 (22%), Positives = 78/214 (36%), Gaps = 43/214 (20%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG G Y+ + Y +K K+ V ++ + I L RL HPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 420 YYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDW---QTRL------KIIKGVVK 467
+ E + E V G L D + +K +++
Sbjct: 117 F---ETPTEISLVLELVTGGEL--------------FDRIVEKGYYSERDAADAVKQILE 159
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV---A 521
+AYLH I+ H LK N+L PL + D+ L ++ +
Sbjct: 160 AVAYLHEN---GIV-HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE + D+WS+GI+ LL G +
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCG-FE 248
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 43/216 (19%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E LG G F + V + G + K K+++ + + + +L+HPN++ L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 418 AFYYRKEEKLLLY---EFVENGSL------AGKL---HANHTKQRPGLDWQTRLKIIKGV 465
+E+ Y + V G L A+H I+ +
Sbjct: 95 DSI---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------------CIQQI 137
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMV-- 520
++ +AY H+ I H +LK N+LL + + L D+ L +N A
Sbjct: 138 LESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193
Query: 521 -AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y SPE SK D+W+ G+++ LL G YP
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG-YP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 43/220 (19%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK----RYKQMNNVGREDFQEHIKR----LGRLEHP 411
+ LGSG G + +K R + + D +++ L +L HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 412 NLLPLTAFYYRKEEKL-LLYEFVENGSL------AGKLHANHTKQRPGLDWQTRLKIIKG 464
++ + F+ E ++ E +E G L +L K
Sbjct: 76 CIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-----------LYFYQ 122
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL---LTDYALRPLINPDNAHTLMV- 520
++ + YLH I H LK NVLL E +TD+ ++ + +
Sbjct: 123 MLLAVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 521 --AYKSPE---YAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE ++ D WSLG+++ L+G YP
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-YP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 61/314 (19%), Positives = 99/314 (31%), Gaps = 78/314 (24%)
Query: 294 FYLRKRKTQIERASSYEDSSKLPTSFGSSKVEPEPI-EIKKKADYGKLSFVRDDMEPFDL 352
Y +K K Q+ T +++ E + L F +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRN----NLQFGK-------- 52
Query: 353 QDMLRASAEVLGSGTFGASYK---TVISNGQAYV---VKRYKQM-NNVGREDFQEHI--- 402
LG+G FG + + A + VK K + +E +
Sbjct: 53 ---------TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 403 KRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL---------AGKLHANHTKQRPGL 453
LG+ H N++ L L++ E+ G L +
Sbjct: 104 SHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 454 DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP 512
+ L V +GMA+L I H + + NVLL + D+ L R ++N
Sbjct: 162 STRDLLHFSSQVAQGMAFL--ASKNCI--HRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 513 DNAHTLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE- 556
N Y +PE + + +SDVWS GIL+ E+ + G YP
Sbjct: 218 SN-------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 557 -------NYLLQGY 563
+ GY
Sbjct: 271 LVNSKFYKLVKDGY 284
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 35/158 (22%), Positives = 63/158 (39%), Gaps = 22/158 (13%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDL----RKMGPLKSIYLSD 130
++ S E+ G L+ L + N+ + L + +M L+ + +S
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQ 383
Query: 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE-- 188
N S + SL L M++N LT TI L P++ L L +NK + +P+
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQV 440
Query: 189 IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
+K ++ L +A+N L + F +L
Sbjct: 441 VKLEALQELNVASN--------QLKSVPDGIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 33/226 (14%), Positives = 74/226 (32%), Gaps = 21/226 (9%)
Query: 4 HIGRPARNVLHVLVLISFVGVT----FGLSDTEILLQFKSSLNDSSSALVNWNALRNPCT 59
HI P H ++ +S V + + L+ + N
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 60 FNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGL---------LSSLRAVSFMNNKF 110
WN + + VW + ++S L L +L +++ F
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
Query: 111 EGPLPDL-RKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQL 169
P + + + +G + + ++ L +NN LT T+ + L
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 170 PKLMELRLEANKFQGQVPEI-----KQNEMRSLGLANNELEGPIPE 210
+L L L+ N+ + ++ +I + ++ L ++ N + +
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 2/82 (2%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ +S N S + ++ L+ L +++NR+ S +L L L NK
Sbjct: 23 TTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 183 QGQVPEIKQNEMRSLGLANNEL 204
+ ++ L L+ N
Sbjct: 82 VK-ISCHPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 24/143 (16%), Positives = 45/143 (31%), Gaps = 13/143 (9%)
Query: 88 TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGM 145
+ + LS LR + +N+ + L + L+ + LS N + +
Sbjct: 35 ELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHN----KLVKISCHPT 89
Query: 146 TSLKKLYMANNRLTGTIPSSLV--QLPKLMELRLEANKFQGQVPEIKQN---EMRSLGLA 200
+LK L ++ N +P + +L L L + + L L
Sbjct: 90 VNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 201 NNELEGPIPESLSKMDPSTFAGN 223
E PE L + +
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIV 171
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 19/108 (17%), Positives = 43/108 (39%), Gaps = 7/108 (6%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
L + Q ++S SL +++ +N + + +K + L N
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR---IKVLDLHSNKIK- 434
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+I + + +L++L +A+N+L +L L ++ L N +
Sbjct: 435 SIPKQVVK-LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 26/141 (18%), Positives = 46/141 (32%), Gaps = 15/141 (10%)
Query: 79 KLEQMNLS--------GTIAAESLGLLSSLRAVSFMNNKFE----GPLPDLRKMGPLKSI 126
L ++LS G I+A +L+ ++ N E L+ +
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 127 YLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQV 186
LS N + + + L L ++ L +P L KL L L N+
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNP 290
Query: 187 PEIKQNEMRSLGLANNELEGP 207
+ ++ +L L N
Sbjct: 291 SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 32/208 (15%), Positives = 64/208 (30%), Gaps = 25/208 (12%)
Query: 33 ILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAE 92
++ L + + + + L S+ L + + I
Sbjct: 34 ADVELYGGGRSLEYLLKRVDTEADL--GQFTDIIKSL----SLKRLTVRAARIPSRILFG 87
Query: 93 SLGLL--SSLRAVSFMNNKFEGPLPD---LRKMGPLKSIYLSDNGFSGN---ISDDAFEG 144
+L +L S L+ ++ N + G P L + L + ++ +++
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL 147
Query: 145 MTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP------EIKQNEMRSLG 198
LK L +A + P L L L N G+ +K ++ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 199 LANNELEGPIPESLSKMDPSTFAGNKNL 226
L N + E+ S + + A L
Sbjct: 208 LRNAGM-----ETPSGVCSALAAARVQL 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 58/227 (25%)
Query: 356 LRASAEVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRL-EHP 411
L + LG G+F K V + QA+ VK + N +E I L HP
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE-----ITALKLCEGHP 66
Query: 412 NLLPLTAFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRL--------- 459
N++ L + ++L + E + G L + R+
Sbjct: 67 NIVKLHEVF---HDQLHTFLVMELLNGGEL--------------FE---RIKKKKHFSET 106
Query: 460 ---KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPD 513
I++ +V ++++H+ G + H LK N+L + + E + D+ L PD
Sbjct: 107 EASYIMRKLVSAVSHMHDV--G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 514 NAHTLMVA-----YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
N L Y +PE + + D+WSLG+++ +L+G
Sbjct: 163 N-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-QV 207
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 11/114 (9%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIP--SSLVQLPKLMELRLEAN 180
+ I + + I DA + + LK L + N L P + + L + N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDN 140
Query: 181 KFQGQVPEIK----QNEMRSLGLANNELEGPIPE---SLSKMDPSTFAGNKNLC 227
+ +P NE +L L NN + + +K+D NK L
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLT 193
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 39/212 (18%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN-NVG------REDFQEHIKRLGRLEHPN 412
++G G++G K G+ +K++ + + + RE IK L +L H N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE-----IKLLKQLRHEN 85
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ L +K+ L++EFV++ ++ L GLD+Q K + ++ G+ +
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF----PNGLDYQVVQKYLFQIINGIGFC 140
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE-- 526
H+ +II H +K N+L+ +S L D+ R L P + VA Y++PE
Sbjct: 141 HSH---NII-HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 527 -----YAHNGKISKKSDVWSLGILILELLTGK 553
Y K DVW++G L+ E+ G+
Sbjct: 197 VGDVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 48/210 (22%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
+V+G+G+FG Y+ + +G+ +K+ Q RE ++ + +L+H N++ L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQIMRKLDHCNIVRLRY 114
Query: 419 FYYRKEEKL------LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG----VVKG 468
F+Y EK L+ ++V ++ ++ ++++ + L + +K + +
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYSRAKQTLP----VIYVKLYMYQLFRS 168
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMVA---YKS 524
+AY+H I H +K N+LLD L L D+ + + + Y++
Sbjct: 169 LAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 224
Query: 525 PEYAHNGKI-SKKSDVWSLGILILELLTGK 553
PE + DVWS G ++ ELL G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK---RYKQMNNVGREDFQEHIKR----LGRLEHPN 412
+ LG GTFG G VK R K + D IKR L HP+
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK----IRSLDVVGKIKREIQNLKLFRHPH 72
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L + ++ E+V G L + H + ++ ++ + ++ + Y
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGR----VEEMEARRLFQQILSAVDYC 127
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAH--- 529
H + + H LK NVLLD + D+ L +++ L + SP YA
Sbjct: 128 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEV 181
Query: 530 -NGK--ISKKSDVWSLGILILELLTGKYP 555
+G+ + D+WS G+++ LL G P
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 57/263 (21%), Positives = 98/263 (37%), Gaps = 56/263 (21%)
Query: 320 GSSKVEPEPIEIKKKADYGKLSFVRDDMEP----FDLQD--MLRASAEVLGSGTFG---- 369
++K E +K+ K F++ P L ++ LG+G+FG
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVML 59
Query: 370 ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLTAFYYRKEE 425
+K +G Y +K + V + EH L + P L+ L F ++
Sbjct: 60 VKHK---ESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 426 KL-LLYEFVENGSL------AGKLHANHTK----QRPGLDWQTRLKIIKGVVKGMAYLHN 474
L ++ E+V G + G+ H + Q +V YLH+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ---------------IVLTFEYLHS 159
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL--MVAYKSPEYAHNGK 532
+I + LK N+L+D+ +TD+ + TL +PE +
Sbjct: 160 L---DLI-YRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLCGTPEALAPEIILSKG 214
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+K D W+LG+LI E+ G P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 45/217 (20%), Positives = 77/217 (35%), Gaps = 44/217 (20%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E LG G F + V + GQ Y K+++ + + + L+HPN++ L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRL---------KIIKGV 465
E+ Y + V G L + I+ +
Sbjct: 77 DSI---SEEGHHYLIFDLVTGGEL--------------FEDIVAREYYSEADASHCIQQI 119
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYAL-RPLINPDNAHTLMV- 520
++ + + H + H +LK N+LL + + L D+ L + A
Sbjct: 120 LEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 521 --AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y SPE K D+W+ G+++ LL G YP
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-YP 211
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 25/133 (18%), Positives = 48/133 (36%), Gaps = 13/133 (9%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
L + + F+ K G L+ I +S N I D F + L ++ +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 154 AN-NRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---IKQNEMRSLGLANNELEGPIP 209
N L P + LP L L + + +P+ I + L + +N
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN------- 138
Query: 210 ESLSKMDPSTFAG 222
++ ++ ++F G
Sbjct: 139 INIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 22/110 (20%), Positives = 35/110 (31%), Gaps = 6/110 (5%)
Query: 78 LKLEQMNLSG-----TIAAESL-GLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDN 131
L+ +++ TI S GL + N + L + LSDN
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN 187
Query: 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK 181
+ +D F G + L ++ R+ L L KL K
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 52/242 (21%), Positives = 87/242 (35%), Gaps = 45/242 (18%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV----VKRYKQM-NNVGREDFQEHI---KRLGRL 408
+ LG G FG A + + V VK K D + K +G+
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 133
Query: 409 EHPNLLPLTAFYYRKEEKLLLYEFVENGSL-----------AGKLHANHTKQRPGLDWQT 457
H N++ L + ++ E+ G+L + L +
Sbjct: 134 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD--- 513
+ V +GM YL I H L + NVL+ + D+ L R + + D
Sbjct: 193 LVSCAYQVARGMEYL--ASKKCI--HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 514 -NAHTLM-VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-------NYLLQ 561
+ + V + +PE + + +SDVWS G+L+ E+ T G YP L +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
Query: 562 GY 563
G+
Sbjct: 309 GH 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 50/218 (22%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTA 418
E +G G++ + + + + VK + + + D E I+ L R +HPN++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVK----IIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 419 FYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLK---------IIKGVV 466
Y ++ +Y E ++ G L LD R K ++ +
Sbjct: 84 VY---DDGKYVYVVTELMKGGEL--------------LDKILRQKFFSEREASAVLFTIT 126
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPL-LTDYALRPLINPDNAHTLMVA- 521
K + YLH + G + H LK SN+L + E + + D+ + +N LM
Sbjct: 127 KTVEYLHAQ--G--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPC 181
Query: 522 ----YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ +PE D+WSLG+L+ +LTG Y
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG-YT 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 44/226 (19%), Positives = 84/226 (37%), Gaps = 31/226 (13%)
Query: 346 DMEPFDLQD--MLRASAEVLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQ 399
+ +P R VLG G FG K + G+ Y K+ + R+
Sbjct: 178 EAQPMGEDWFLDFR----VLGRGGFGEVFACQMK---ATGKLYACKKLNKKRLKKRKG-Y 229
Query: 400 EHI---KR-LGRLEHPNLLPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLD 454
+ K+ L ++ ++ L A+ + + L L+ + G + + H + +
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGF 286
Query: 455 WQTRLKI-IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLIN 511
+ R +V G+ +LH +II + LK NVLLD ++D L
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQR---NII-YRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 512 PDNAHTL--MVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ +PE + D ++LG+ + E++ + P
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 51/249 (20%), Positives = 89/249 (35%), Gaps = 59/249 (23%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV----VKRYKQM-NNVGREDFQEHI---KRLGRL 408
+ LG G FG A + + VK K D + K +G+
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 99
Query: 409 EHPNLLPLTAFYYRKEEKLLLYEFVENGSL-----------AGKLHANHTKQRPGLDWQT 457
H N++ L + ++ E+ G+L + + + ++
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAH 516
+ + +GM YL ++ I H L + NVL+ + + D+ L R + N D
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDY-- 212
Query: 517 TLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE----- 556
YK +PE + + +SDVWS G+L+ E+ T G YP
Sbjct: 213 -----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 557 --NYLLQGY 563
L +G+
Sbjct: 268 LFKLLKEGH 276
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 59/313 (18%), Positives = 110/313 (35%), Gaps = 74/313 (23%)
Query: 304 ERASSYEDSSKLPTSFGSSKVEPEP----IEIKKKADYGKLSFVRDDMEPFDLQDMLRAS 359
S+ + LP+ ++ P P + + L + R+++E +R
Sbjct: 2 AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIE------YVR-- 53
Query: 360 AEVLGSGTFGASYK---TVISNGQAYV---VKRYKQM-NNVGREDFQEHIKRLGRLEHPN 412
+G G FG ++ + + + VK K+ + + DFQ + ++PN
Sbjct: 54 --DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSL-------------------AGKLHANHTKQRPGL 453
++ L + LL+E++ G L + P L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 454 DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINP 512
+L I + V GMAYL + H L + N L+ + + D+ L R + +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 513 DNAHTLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE- 556
D YK PE + + +SDVW+ G+++ E+ + G Y
Sbjct: 228 D-------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 557 ------NYLLQGY 563
Y+ G
Sbjct: 281 AHEEVIYYVRDGN 293
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 9/114 (7%)
Query: 97 LSSLRAVSFMNNKFEGPLPDL-RKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMAN 155
L L + +N+ + LP L + + L + +S N + ++ A G+ L++LY+
Sbjct: 76 LPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKG 133
Query: 156 NRLTGTIPSSL-VQLPKLMELRLEANKFQGQVPE---IKQNEMRSLGLANNELE 205
N L T+P L PKL +L L N ++P + +L L N L
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 23/114 (20%), Positives = 38/114 (33%), Gaps = 9/114 (7%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
L + N L L L + L + + L L +
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT---KLQVDGTLPVLGTLDL 84
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE---IKQNEMRSLGLANNEL 204
++N+L ++P LP L L + N+ +P E++ L L NEL
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL 136
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 25/140 (17%), Positives = 57/140 (40%), Gaps = 10/140 (7%)
Query: 79 KLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
++ ++L+ T L LS+L+ + N+ + L + L+ + + +
Sbjct: 108 SIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNA----Q 162
Query: 137 ISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMR 195
+SD ++ L L +N+++ S L LP L+E+ L+ N+ P + +
Sbjct: 163 VSDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNLF 220
Query: 196 SLGLANNELEGPIPESLSKM 215
+ L N + + +
Sbjct: 221 IVTLTNQTITNQPVFYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 26/131 (19%), Positives = 56/131 (42%), Gaps = 12/131 (9%)
Query: 79 KLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
+ ++ GT E + L++L + +N+ L L+ + + + LS N
Sbjct: 42 GITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGN----P 96
Query: 137 ISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEM 194
+ + A G+ S+K L + + ++T P L L L L L+ N+ + + +
Sbjct: 97 LKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNL 153
Query: 195 RSLGLANNELE 205
+ L + N ++
Sbjct: 154 QYLSIGNAQVS 164
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 29/209 (13%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK---RYKQMNNVGREDFQEHIKR----LGRLEHPN 412
+ LG GTFG G VK R K + D I+R L HP+
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQK----IRSLDVVGKIRREIQNLKLFRHPH 77
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L + ++ E+V G L + + + LD + ++ + ++ G+ Y
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGR----LDEKESRRLFQQILSGVDYC 132
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAH--- 529
H + + H LK NVLLD + D+ L +++ L + SP YA
Sbjct: 133 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEV 186
Query: 530 -NGK--ISKKSDVWSLGILILELLTGKYP 555
+G+ + D+WS G+++ LL G P
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 39/212 (18%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMN-NVG------REDFQEHIKRLGRLEHPN 412
+G G++G +K GQ +K++ + + RE I+ L +L+HPN
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE-----IRMLKQLKHPN 63
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
L+ L + RK L++E+ ++ ++ +L + + G+ I ++ + +
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE-- 526
H + I H +K N+L+ + L D+ R L P + + VA Y+SPE
Sbjct: 119 HKH---NCI-HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 527 -----YAHNGKISKKSDVWSLGILILELLTGK 553
Y DVW++G + ELL+G
Sbjct: 175 VGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 52/246 (21%), Positives = 90/246 (36%), Gaps = 28/246 (11%)
Query: 323 KVEPEPIEIKKKADYGKLSFVRDDMEPFDLQD--MLRASAEVLGSGTFG----ASYKTVI 376
V P + L + + +P R VLG G FG +
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR----VLGKGGFGEVCACQVR--- 206
Query: 377 SNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLTAFYYRKEEKLLLYEF 432
+ G+ Y K+ ++ R+ + L ++ ++ L Y K+ L+
Sbjct: 207 ATGKMYACKKLEKKRIKKRKG-EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265
Query: 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVL 492
+ G L K H H Q + + + + G+ LH E I+ + LK N+L
Sbjct: 266 MNGGDL--KFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRE---RIV-YRDLKPENIL 318
Query: 493 LDRSFEPLLTDYAL-RPLINPDNAHTL--MVAYKSPEYAHNGKISKKSDVWSLGILILEL 549
LD ++D L + V Y +PE N + + D W+LG L+ E+
Sbjct: 319 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 550 LTGKYP 555
+ G+ P
Sbjct: 379 IAGQSP 384
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 49/208 (23%), Positives = 83/208 (39%), Gaps = 30/208 (14%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLT 417
LG G +G V +A VK ++ D E+IK+ L H N++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
Y + E + Y E+ G L ++ + G+ + ++ G+ YLH
Sbjct: 71 --YGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV------AYKSPE-Y 527
I H +K N+LLD ++D+ L + +N L+ Y +PE
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
++ DVWS GI++ +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 49/242 (20%), Positives = 84/242 (34%), Gaps = 45/242 (18%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVV--KRYKQM-NNVGREDFQEHI---KRLGRLEH 410
+ LG G FG A + V K K+ + + +G H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--H 90
Query: 411 PNLLPLTAFYYRKEEKLLL-YEFVENGSL-----------AGKLHANHTKQRPGLDWQTR 458
N++ L + L++ EF + G+L A + L +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 459 LKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD---- 513
+ V KGM +L + I H L + N+LL + D+ L R +
Sbjct: 151 ICYSFQVAKGMEFLASR---KCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 514 NAHTLM-VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE--------NYLLQ 561
+ + + +PE + + +SDVWS G+L+ E+ + G YP L +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 562 GY 563
G
Sbjct: 267 GT 268
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 46/253 (18%), Positives = 86/253 (33%), Gaps = 73/253 (28%)
Query: 361 EVLGSGTFGASYKT------------VISNGQAYV------VKRYKQMNNVGREDF---- 398
LG G F + ++ + Y +K +++N+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 399 QEHIKRLGRLEHPNLLPLTAFYYRKEEK--------LL---LYEFVENGSLAGKLHANHT 447
HI +L L+H F ++ +L L ++ G + +
Sbjct: 85 ANHILKL--LDH--------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYV 133
Query: 448 KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507
K +I K ++ G+ Y+H II H +K NVL++ P +
Sbjct: 134 K-----------QISKQLLLGLDYMHRRC--GII-HTDIKPENVLMEIVDSP--ENLIQI 177
Query: 508 PLIN------PDNAHTLMV---AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENY 558
+ + D +T + Y+SPE +D+WS LI EL+TG +
Sbjct: 178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD----F 233
Query: 559 LLQGYDSKASLSN 571
L + + + +
Sbjct: 234 LFEPDEGHSYTKD 246
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 51/214 (23%), Positives = 75/214 (35%), Gaps = 45/214 (21%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVK---RYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLT 417
+GSG FG + + VK R ++ NV RE I L HPN++
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE-----IINHRSLRHPNIVRFK 82
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK----------IIKGVVK 467
++ E+ G L ++ R ++ GV
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG-----------RFSEDEARFFFQQLLSGV-- 129
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL--TDYALRPLINPDNA-HTL--MVAY 522
+Y H+ I H LK N LLD S P L D+ + + AY
Sbjct: 130 --SYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183
Query: 523 KSPE-YAHNGKISKKSDVWSLGILILELLTGKYP 555
+PE K +DVWS G+ + +L G YP
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 51/252 (20%), Positives = 89/252 (35%), Gaps = 60/252 (23%)
Query: 361 EVLGSGTFGASYK---TVISNGQAYV---VKRYKQM-NNVGREDFQEHIKRLGRLEHPNL 413
+ LG G FG K + Y VK K+ + D L ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSL-------------------AGKLHANHTKQRPGLD 454
+ L + LL+ E+ + GSL + + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPD 513
+ + +GM YL ++ H L + N+L+ + ++D+ L R + D
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLV-HRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 514 NAHTLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE-- 556
+ Y + E + + +SDVWS G+L+ E++T G YP
Sbjct: 205 S-------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 557 -----NYLLQGY 563
N L G+
Sbjct: 258 PERLFNLLKTGH 269
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 10/126 (7%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKK 150
SL L L+++S +N + L + L+S+YL +N I+D +T L
Sbjct: 103 SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNN----KITDITVLSRLTKLDT 157
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE-MRSLGLANNELEGPIP 209
L + +N+++ I L L KL L L N + + + + L L + E
Sbjct: 158 LSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPI 214
Query: 210 ESLSKM 215
S +
Sbjct: 215 NHQSNL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 18/110 (16%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 97 LSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKKLYMAN 155
+ + ++ + I +++ +I + + ++ KL++
Sbjct: 20 FAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNS----DIKSVQGIQYLPNVTKLFLNG 74
Query: 156 NRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELE 205
N+LT L L L L L+ NK + +++SL L +N +
Sbjct: 75 NKLTDI--KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS 122
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 58/255 (22%), Positives = 92/255 (36%), Gaps = 65/255 (25%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVV--KRYKQM-NNVGREDFQEHI---KRLGRLEH 410
+VLGSG FG A+ + G + V K K+ ++ RE + +LG H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--H 108
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSL------------------AGKLHANHTKQRPG 452
N++ L L++E+ G L + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 453 LDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLIN 511
L ++ L V KGM +L S + H L + NVL+ + D+ L R +++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCV-HRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 512 PDNAHTLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE 556
N Y +PE G + KSDVWS GIL+ E+ + G YP
Sbjct: 225 DSN-------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 557 --------NYLLQGY 563
+ G+
Sbjct: 278 IPVDANFYKLIQNGF 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG------REDFQEHIKRLGRLEHPNL 413
E LG+GT+ YK + G +K K + G RE I + L+H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE-----ISLMKELKHENI 65
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK-IIKGVVKGMAYL 472
+ L + + + L++EF++N L + + P +K +++G+A+
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE-- 526
H + I H LK N+L+++ + L D+ L R P N + V Y++P+
Sbjct: 125 HE----NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180
Query: 527 -----YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
Y S D+WS G ++ E++TGK P L G
Sbjct: 181 MGSRTY------STSIDIWSCGCILAEMITGK-P---LFPG 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 39/241 (16%), Positives = 75/241 (31%), Gaps = 62/241 (25%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV-------VKRYKQMNNVGREDFQEHIKRLGRLEHPNL 413
+ LG+G+FG + RYK RE + + L+H N+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-----RE-----LDIMKVLDHVNI 62
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRL-------------- 459
+ L ++Y ++ + N
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 460 ---KIIKGVVK-------------------GMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497
K++K ++ + ++H+ I H +K N+L++
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGIC-HRDIKPQNLLVNSKD 178
Query: 498 EPL-LTDYALRPLINPDNAHTLMVA---YKSPEYAHNGKI-SKKSDVWSLGILILELLTG 552
L L D+ + P + Y++PE + D+WS+G + EL+ G
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 553 K 553
K
Sbjct: 239 K 239
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 13/123 (10%)
Query: 93 SLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152
L S L+ + NN + LPDL L+ I +N + + + + L +Y
Sbjct: 148 ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLE-ELPE--LQNLPFLTAIY 201
Query: 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEMRSLGLANNELEGPIPES 211
NN L +P + L + N + ++PE++ + ++ NN L+ +P+
Sbjct: 202 ADNNSLK-KLPDLPLS---LESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDL 255
Query: 212 LSK 214
Sbjct: 256 PPS 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 34/160 (21%), Positives = 56/160 (35%), Gaps = 16/160 (10%)
Query: 79 KLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNIS 138
L +N S L SL ++ NNK LP L L+ + S N + +
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA-EVP 353
Query: 139 DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLG 198
E +LK+L++ N L P + L N +VPE+ QN ++ L
Sbjct: 354 ----ELPQNLKQLHVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPELPQN-LKQLH 402
Query: 199 LANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDPCVLPK 238
+ N L P+ ++ + + K
Sbjct: 403 VETNPLRE-FPDIPESVEDLRMNSERVVDPYEFAHETTDK 441
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 25/133 (18%), Positives = 46/133 (34%), Gaps = 26/133 (19%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLP----DLRKMGP----------LKSIYLSDNGFSGNI 137
+ S +++E P + R+M + L++ G S ++
Sbjct: 28 VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSL 197
+ L+ L + N LT +P L L+ P + L
Sbjct: 87 PEL----PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL-----EYL 136
Query: 198 GLANNELEGPIPE 210
G++NN+LE +PE
Sbjct: 137 GVSNNQLEK-LPE 148
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 31/136 (22%), Positives = 54/136 (39%), Gaps = 15/136 (11%)
Query: 79 KLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNIS 138
L + + L SL A++ +N LP+L L + +S+N FS +S
Sbjct: 238 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTD-LPEL--PQSLTFLDVSENIFS-GLS 293
Query: 139 DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLG 198
E +L L ++N + ++ P L EL + NK ++P + + L
Sbjct: 294 ----ELPPNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLI-ELPALPPR-LERLI 343
Query: 199 LANNELEGPIPESLSK 214
+ N L +PE
Sbjct: 344 ASFNHLAE-VPELPQN 358
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 51/249 (20%), Positives = 89/249 (35%), Gaps = 59/249 (23%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYV----VKRYKQM-NNVGREDFQEHI---KRLGRL 408
+ LG G FG A + + VK K D + K +G+
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 145
Query: 409 EHPNLLPLTAFYYRKEEKLLLYEFVENGSL-----------AGKLHANHTKQRPGLDWQT 457
H N++ L + ++ E+ G+L + + + ++
Sbjct: 146 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 458 RLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAH 516
+ + +GM YL ++ I H L + NVL+ + + D+ L R + N D
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDY-- 258
Query: 517 TLMVAYK------------SPEYAHNGKISKKSDVWSLGILILELLT-GK--YPE----- 556
YK +PE + + +SDVWS G+L+ E+ T G YP
Sbjct: 259 -----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 557 --NYLLQGY 563
L +G+
Sbjct: 314 LFKLLKEGH 322
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YK 523
G+ +LH+ II H LK SN+++ + D+ L T V Y+
Sbjct: 138 CGIKHLHS---AGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLTGK 553
+PE + D+WS+G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 22/158 (13%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNG 132
KL + L+ T+ A L +L + +NK + LP ++ L + L N
Sbjct: 62 KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQ 120
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSL-VQLPKLMELRLEANKFQGQVPE--- 188
++ F+ +T L L + N L ++P + +L L ELRL N+ + +VPE
Sbjct: 121 LK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAF 177
Query: 189 IKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNL 226
K E+++L L NN+L+ +PE F + L
Sbjct: 178 DKLTELKTLKLDNNQLKR-VPE-------GAFDSLEKL 207
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 4/86 (4%)
Query: 97 LSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154
L+ L +S N+ + LP K+ LK + L +N + + AF+ +T LK L +
Sbjct: 132 LTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLD 189
Query: 155 NNRLTGTIPSSLVQLPKLMELRLEAN 180
NN+L + L KL L+L+ N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 46/241 (19%)
Query: 343 VRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV---ISNGQAYVVKRYKQMN---NVGRE 396
V+ E ++D+ +G GT+G YK + + Y +K+ + + RE
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE 68
Query: 397 DFQEHIKRLGRLEHPNLLPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLD 454
I L L+HPN++ L F + K+ LL+++ E+ L + + +
Sbjct: 69 -----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 455 WQTRLKIIKGVV----KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL----LTDYAL 506
Q ++K ++ G+ YLH + + H LK +N+L+ + D
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHA----NWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 507 -RPLINPDNAHTLMVA------YKSPE-------YAHNGKISKKSDVWSLGILILELLTG 552
R +P + Y++PE Y +K D+W++G + ELLT
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS 232
Query: 553 K 553
+
Sbjct: 233 E 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 49/208 (23%), Positives = 83/208 (39%), Gaps = 30/208 (14%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLPLT 417
LG G +G V +A VK ++ D E+IK+ L H N++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 418 AFYYRKEEKLLLY---EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
Y + E + Y E+ G L ++ + G+ + ++ G+ YLH
Sbjct: 71 --YGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV------AYKSPE-Y 527
I H +K N+LLD ++D+ L + +N L+ Y +PE
Sbjct: 124 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
++ DVWS GI++ +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 37/210 (17%), Positives = 75/210 (35%), Gaps = 23/210 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKR--------LGRLE 409
+LG G FG + +++ +K ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 410 HPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
HP ++ L ++ +E +L+ E L ++ ++ L VV +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA---QDLF-DYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTL--MVAYKSPE 526
+ H+ + H +K N+L+D L D+ L++ + Y PE
Sbjct: 153 QHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPE 208
Query: 527 YAHNGK-ISKKSDVWSLGILILELLTGKYP 555
+ + + + VWSLGIL+ +++ G P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 21/208 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK--RYKQMNNVGREDFQEHIKR----LGRLEH--P 411
+LGSG FG+ Y + +S+ +K ++++ G + L ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
++ L ++ R + +L+ E E L + +R L + V++ + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPV---QDLF-DFITERGALQEELARSFFWQVLEAVRH 164
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTL--MVAYKSPEYA 528
HN + H +K N+L+D + L L D+ L+ Y PE+
Sbjct: 165 CHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 220
Query: 529 HNGK-ISKKSDVWSLGILILELLTGKYP 555
+ + + VWSLGIL+ +++ G P
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 40/217 (18%), Positives = 66/217 (30%), Gaps = 18/217 (8%)
Query: 3 RHIGRPARNVLHVLVLISFVGVTF-GLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFN 61
H+ ++ V V +S + LS+ ++ + L S L L N T
Sbjct: 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLN-VTLQ 257
Query: 62 YP--NWNGVLCLNGSVWGLKLEQMNLSG---------TIAAESLGLLSSLRAVSFMNNKF 110
+ W + L W +E +N+ S L SL N F
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF 317
Query: 111 EGPLPDL-RKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQL 169
L + LS + + I +S L N T ++ L
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 170 PKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNEL 204
+L L L+ N + ++ M SL + L
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 33/185 (17%), Positives = 62/185 (33%), Gaps = 11/185 (5%)
Query: 95 GLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153
L +A+S N +PD+ + L+ + LS N ++ F L+ L +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ----NEMRSLGLANNEL-EGPI 208
++NRL I + L L L N F +P K+ ++ LGL+ + + +
Sbjct: 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDL 163
Query: 209 PESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNVSQPPKGQPPIIVQENPNQKKEV 268
+ + L ++ P + V + N +
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 269 SLLKI 273
L I
Sbjct: 224 QLSNI 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 47/269 (17%), Positives = 91/269 (33%), Gaps = 41/269 (15%)
Query: 302 QIERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAE 361
+ F S + K L+ M F + R
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLT-----MNDFSV---HR---- 195
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIK-------RLGRLEH 410
++G G FG G+ Y +K + ++ + + +
Sbjct: 196 IIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDC 251
Query: 411 PNLLPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
P ++ + ++ + +KL + + + NG G LH H Q ++ G+
Sbjct: 252 PFIVCM-SYAFHTPDKLSFILDLM-NG---GDLH-YHLSQHGVFSEADMRFYAAEIILGL 305
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPE- 526
++HN ++ + LK +N+LLD ++D L + H + Y +PE
Sbjct: 306 EHMHNR---FVV-YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 361
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
+D +SLG ++ +LL G P
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 343 VRDDMEPFDLQD--MLRASAEVLGSGTFGASYKTVI----SNGQAYVVKRYKQMNNVGRE 396
V D+ E + +LR +G G+FG K I + Y +K + V R
Sbjct: 5 VFDENEDVNFDHFEILR----AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERN 57
Query: 397 DFQEHIKR----LGRLEHPNLLPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQR 450
+ ++ + + LEHP L+ L +F + EE + ++ + + G L L Q+
Sbjct: 58 E-VRNVFKELQIMQGLEHPFLVNLWYSF--QDEEDMFMVVDLLLGGDLRYHL------QQ 108
Query: 451 PGL--DWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508
+ +L I + +V + YL N+ II H +K N+LLD +TD+ +
Sbjct: 109 NVHFKEETVKLFICE-LVMALDYLQNQ---RII-HRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 509 LINPDNAHTLM---VAYKSPE-YAHNGKI--SKKSDVWSLGILILELLTGKYP 555
++ + T M Y +PE ++ S D WSLG+ ELL G+ P
Sbjct: 164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 47/212 (22%), Positives = 79/212 (37%), Gaps = 40/212 (18%)
Query: 363 LGSGTFGASYKTV-----ISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
+G G F V I G+ +K Q+N + ++ + L HPN++
Sbjct: 23 IGKGNFA----KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRL------KIIKGVVKGM 469
L ++ L+ E+ G + L A+ R+ + +V +
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHG-----------RMKEKEARSKFRQIVSAV 127
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYA- 528
Y H + I H LK+ N+LLD + D+ L +P YA
Sbjct: 128 QYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAA 181
Query: 529 ---HNGK--ISKKSDVWSLGILILELLTGKYP 555
GK + DVWSLG+++ L++G P
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 50/372 (13%), Positives = 118/372 (31%), Gaps = 110/372 (29%)
Query: 341 SFVRDDMEPFDLQDMLRA---SAEV---LGSGT-FGASYK--TVISNGQAYVVKRYKQMN 391
+FV + + D+QDM ++ E+ + S + + + + Q +V+++ +
Sbjct: 28 AFVDN-FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF--VE 84
Query: 392 NVGREDFQ---EHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN--- 445
V R +++ IK P++ +T Y + ++L + + K + +
Sbjct: 85 EVLRINYKFLMSPIKT--EQRQPSM--MTRMYIEQRDRLY-----NDNQVFAKYNVSRLQ 135
Query: 446 -HTKQRPGLDWQTRLKIIKGV-VKGMA---------------YLHNELPGSI--IPHGHL 486
+ K R L L+ K V + G+ + ++ I + +
Sbjct: 136 PYLKLRQAL---LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC 192
Query: 487 KSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKS--------- 537
S +L+ + LL D++ + + S + + K
Sbjct: 193 NSPETVLEM-LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 538 DVWSLGIL--------IL-------------ELLTGKYPENYLLQGY---DSKASLSNWV 573
+V + IL T ++ + K+ L ++
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEE--DVLAR---------MELK 622
+ ++ +E+ N ++ + E D LA +L
Sbjct: 312 DCRPQDLP------REVLT--------TNPRRLSI-IAESIRDGLATWDNWKHVNCDKLT 356
Query: 623 EVIEK-IERLKE 633
+IE + L+
Sbjct: 357 TIIESSLNVLEP 368
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 46/364 (12%), Positives = 98/364 (26%), Gaps = 142/364 (39%)
Query: 256 IIVQENPNQKKEVSLLKIIMIVLVLGVSLGIIAAILIIF---------YLRKRKTQIERA 306
Q+ P + + ++ IIA + + T I +
Sbjct: 313 CRPQDLPREVLTTNPRRL-----------SIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 307 S-----------SYED------SSKLPTS------FGSSKVEPEPI--EIKKKADYGKLS 341
S ++ S+ +PT F K + + ++ K S
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY------S 415
Query: 342 FVRDDMEPF-----DLQDMLRASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG-- 394
V + + L+ E A +++++ Y + + +++
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENE-----YALHRSIV---DHYNIPKTFDSDDLIPP 467
Query: 395 RED---FQE---HIKRLGRLEHPNLLPLTAFYYRKEEKLLL-YEFVENGSLAGKLHANHT 447
D + H+K + E L + L + F+E K+ H
Sbjct: 468 YLDQYFYSHIGHHLKNIEHPERMTLFR----------MVFLDFRFLEQ-----KI--RHD 510
Query: 448 KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTDYAL 506
W GSI+ N L + ++P + D
Sbjct: 511 ----STAWNA-------------------SGSIL--------NTLQQLKFYKPYICD--- 536
Query: 507 RPLINPDNAHTLMVAYKS--PEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYD 564
N L+ A P+ N SK +D+ + ++ + + ++
Sbjct: 537 ----NDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM--------AEDEAI---FE 581
Query: 565 SKAS 568
Sbjct: 582 EAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 70/487 (14%), Positives = 147/487 (30%), Gaps = 131/487 (26%)
Query: 7 RPARNV-LHVLVLISFVGVT-FGLSDTEILLQFKSSLNDSSSALVNWNALRNP---CTFN 61
RPA+NV + GV G K+ + AL + + C +
Sbjct: 148 RPAKNVLID--------GVLGSG----------KTWV-----AL---DVCLSYKVQCKMD 181
Query: 62 YPNWNGVLCLN-GSVW--GLKLEQM-NLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDL 117
+ LN + LE + L I + + + L L
Sbjct: 182 ----FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 118 RKMGPLKS--IYLSD-------NGF---------SGNISDDAFEGMTSLKKLYMANNRLT 159
K P ++ + L + N F + F + + + ++ +T
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 160 GTIPSSLVQLPKLM-----ELRLEANKFQ----GQVPEIKQNEM----RSLGLANNELEG 206
T L K + +L E + E ++ + + ++L
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 207 PIPESLSKMDPSTFAGNKNLCGPPLDPCVLPKHPEIPNNV-----SQPPKGQPPIIVQEN 261
I SL+ ++P+ + + V P IP + K ++V +
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLS------VFPPSAHIPTILLSLIWFDVIKSDVMVVVNK- 410
Query: 262 PNQKKEVSLLKI---IMIVLVLGVSLGIIAAILIIFYLRKRKTQIERASSYEDSSKLPTS 318
K SL++ + + + L + + + L + ++ Y +P +
Sbjct: 411 -LHKY--SLVEKQPKESTISIPSIYLELKVKLENEYALHRS--IVDH---Y----NIPKT 458
Query: 319 FGSSKVEPEPIE----------IKKKADYGKLSFVRD---DMEPFDLQDMLRASAEVLGS 365
F S + P ++ +K +++ R D F L+ +R + +
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-F-LEQKIRHDSTAWNA 516
Query: 366 GTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE 425
S + + Y K Y N+ E + + + F + EE
Sbjct: 517 ---SGSILNTLQQLKFY--KPYICDNDPKYE------RLVNAILD--------FLPKIEE 557
Query: 426 KLLLYEF 432
L+ ++
Sbjct: 558 NLICSKY 564
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
VLG G +G T + G+ + +K K+ V H K L ++HP +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 414 LPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI-IKGVVKGMA 470
+ L AF + KL L+ E++ G L +L +R G+ + + + +
Sbjct: 84 VDLIYAF--QTGGKLYLILEYLSGGELFMQL------EREGIFMEDTACFYLAEISMALG 135
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPE 526
+LH + II + LK N++L+ LTD+ L + + HT + Y +PE
Sbjct: 136 HLHQK---GII-YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
++ D WSLG L+ ++LTG P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 34/209 (16%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRL-EHPNLLPL 416
LG G + ++ + I+N + VVK K + + RE IK L L PN++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-----IKILENLRGGPNIITL 96
Query: 417 TAFYYRKEEK--LLLYEFVENG---SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
+ L++E V N L L + + ++K + Y
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-----------FYMYEILKALDY 145
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMVA---YKSPEY 527
H+ I+ H +K NV++D L L D+ L +P + + VA +K PE
Sbjct: 146 CHS---MGIM-HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 528 AHNGKI-SKKSDVWSLGILILELLTGKYP 555
+ ++ D+WSLG ++ ++ K P
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 25/150 (16%), Positives = 46/150 (30%), Gaps = 12/150 (8%)
Query: 79 KLEQMNLSGT-IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
KL ++ T + L + L + L D+ L + I
Sbjct: 255 KLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQAA----GI 309
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE-MRS 196
++ L LY+ N LT + S KL L Q + + + +
Sbjct: 310 TELDLSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQ-DFSSVGKIPALNN 365
Query: 197 LGLANNELEGPIPESLSKMDPSTFAGNKNL 226
A + +P+ + T A + +L
Sbjct: 366 NFEAEGQTIT-MPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 20/131 (15%), Positives = 41/131 (31%), Gaps = 12/131 (9%)
Query: 78 LKLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGFS 134
+L G I + + L + L K L +YL++
Sbjct: 275 TQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPK---LVYLYLNNT--- 328
Query: 135 GNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEM 194
+++ T LK L N + S + ++P L + E N
Sbjct: 329 -ELTELDVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS 385
Query: 195 RSLGLANNELE 205
++ ++ + L+
Sbjct: 386 LTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 22/133 (16%), Positives = 43/133 (32%), Gaps = 12/133 (9%)
Query: 79 KLEQMNLSGT--IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN 136
L ++ + + L+ L + +N DL + L + N
Sbjct: 43 TLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSN----K 96
Query: 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRS 196
+++ +T L L N+LT + S Q P L L N ++ ++
Sbjct: 97 LTNLDVTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EIDVSHNTQLTE 152
Query: 197 LGLANNELEGPIP 209
L N+ +
Sbjct: 153 LDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 23/149 (15%), Positives = 42/149 (28%), Gaps = 21/149 (14%)
Query: 79 KLEQMNLSGT-IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
+L ++ S I + L ++ N DL + L + S N +
Sbjct: 171 QLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSN----KL 224
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSL 197
++ +T L + N LT + S L KL L ++ ++
Sbjct: 225 TEIDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYF 280
Query: 198 GLANNELEGPIPESLSKMDPSTFAGNKNL 226
K+ N L
Sbjct: 281 QAEGC----------RKIKELDVTHNTQL 299
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 116 DLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLME 174
++ L S+ ++ +I+D E +T L KL +N +T T+ L Q L
Sbjct: 37 SEEQLATLTSLDCHNS----SITDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTY 89
Query: 175 LRLEANKFQGQVPEIKQNEMRSLGLANNELE 205
L ++NK + ++ L N+L
Sbjct: 90 LACDSNKLT-NLDVTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 24/129 (18%), Positives = 44/129 (34%), Gaps = 12/129 (9%)
Query: 79 KLEQMNLSGT-IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
KL +N + + L ++ N D+ L + N I
Sbjct: 107 KLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNK---KI 161
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN-EMRS 196
+ T L L + N++T + S Q L L + N ++ QN ++
Sbjct: 162 TKLDVTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCDTNNITK--LDLNQNIQLTF 216
Query: 197 LGLANNELE 205
L ++N+L
Sbjct: 217 LDCSSNKLT 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 20/138 (14%), Positives = 42/138 (30%), Gaps = 6/138 (4%)
Query: 80 LEQMNLSGTIAAESL-GLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNIS 138
E + G+ A +LS + + + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 139 DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP-EIKQ-NEMRS 196
L + + L P +L L + ++A ++P ++Q + +
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLET 131
Query: 197 LGLANNELEGPIPESLSK 214
L LA N L +P S++
Sbjct: 132 LTLARNPLRA-LPASIAS 148
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 29/155 (18%), Positives = 57/155 (36%), Gaps = 24/155 (15%)
Query: 79 KLEQMNLSG---TIAAESLGLLSSLRAVSFM-NNKFE---------GPLPDLRKMGPLKS 125
LE + L+ S+ L+ LR +S + + + + L+S
Sbjct: 128 GLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 126 IYLSDNGFSGNISD--DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ L I + + +LK L + N+ L+ + ++ LPKL EL L
Sbjct: 188 LRLEWT----GIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 184 GQVPE-IKQ-NEMRSLGLAN-NELEGPIPESLSKM 215
P ++ L L + + L +P + ++
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRL 276
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 6/92 (6%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISD--DAFEGMTSL 148
++ L L + P PLK + L D N+ +T L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS---NLLTLPLDIHRLTQL 279
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEAN 180
+KL + +PS + QLP + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 30/209 (14%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVK---RYKQMNNVGREDFQEHIKR----LGRLEHPN 412
E LG G+FG Q +K R + + D ++R L L HP+
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQL----LKKSDMHMRVEREISYLKLLRHPH 70
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L + +++ E+ G L + + + + + ++ + Y
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYI-VEKKR----MTEDEGRRFFQQIICAIEYC 124
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAH--- 529
H I H LK N+LLD + + D+ L ++ + L + SP YA
Sbjct: 125 HRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEV 178
Query: 530 -NGK--ISKKSDVWSLGILILELLTGKYP 555
NGK + DVWS GI++ +L G+ P
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 44/221 (19%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHPN 412
E +G GT+G YK S G+ +KR + ++ RE I L L HPN
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIRE-----ISLLKELHHPN 80
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
++ L + + L++EF+E L L + + GL + +++G+A+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLD----ENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YKSPE-- 526
H I H LK N+L++ L D+ L R P ++T V Y++P+
Sbjct: 136 HQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 527 -----YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
Y S D+WS+G + E++TGK P L G
Sbjct: 192 MGSKKY------STSVDIWSIGCIFAEMITGK-P---LFPG 222
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 27/121 (22%), Positives = 52/121 (42%), Gaps = 17/121 (14%)
Query: 96 LLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAF-EGMTSLKKLYMA 154
L +SL + +N+ LP+L LK + + +N + E L+ +
Sbjct: 98 LPASLEYLDACDNRLST-LPEL--PASLKHLDVDNNQLT------MLPELPALLEYINAD 148
Query: 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSK 214
NN+LT +P L L + N+ +PE+ ++ + +L ++ N LE +P +
Sbjct: 149 NNQLT-MLPEL---PTSLEVLSVRNNQLT-FLPELPES-LEALDVSTNLLES-LPAVPVR 201
Query: 215 M 215
Sbjct: 202 N 202
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 27/159 (16%), Positives = 51/159 (32%), Gaps = 10/159 (6%)
Query: 79 KLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNIS 138
LE +N L +SL +S NN+ LP+L L+++ +S N ++
Sbjct: 141 LLEYINADNNQLTMLPELPTSLEVLSVRNNQLTF-LPEL--PESLEALDVSTNLLE-SLP 196
Query: 139 DDAFEGMTSLKK----LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEM 194
++ NR+T IP +++ L + LE N ++ E +
Sbjct: 197 AV-PVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254
Query: 195 RSLGLANNELEGPIPESLSKMDPSTFAGNKNLCGPPLDP 233
+ + + A P
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 30/142 (21%), Positives = 57/142 (40%), Gaps = 21/142 (14%)
Query: 79 KLEQMNLSGTIAAESL-----GLLSSLRAVSFMNNKFEGPLPDLRKMGP-LKSIYLSDNG 132
K E+ L G E++ L++ + LPD + P + + ++ N
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD--NLPPQITVLEITQNA 91
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
++ E SL+ L +NRL+ T+P L L ++ N+ +PE+
Sbjct: 92 LI-SLP----ELPASLEYLDACDNRLS-TLPEL---PASLKHLDVDNNQLT-MLPELPAL 141
Query: 193 EMRSLGLANNELEGPIPESLSK 214
+ + NN+L +PE +
Sbjct: 142 -LEYINADNNQLTM-LPELPTS 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 8/111 (7%)
Query: 97 LSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154
LR + NN+ L + + L S+ L N + + FEG+ SL+ L +
Sbjct: 55 YKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112
Query: 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLG---LANN 202
N++ + L L L L NK Q + + + +R++ LA N
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS-SLVQLPKLMELRLEANKF 182
I L N I AF L+++ ++NN+++ + + L L L L NK
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 183 QGQVPEI--KQNEMRSLGLANNELE 205
+ ++ L L N++
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN 117
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 46/215 (21%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
LG+G+FG + NG+ Y +K K+ V R EH L + HP +
Sbjct: 13 TLGTGSFGRVHLIRSR---HNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 414 LPLTAFYYRKEEKL-LLYEFVENGSL------AGKLHANHTK----QRPGLDWQTRLKII 462
+ + ++ +++ ++ +++E G L + + K +
Sbjct: 69 IRM-WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------------- 114
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL--MV 520
V + YLH++ II + LK N+LLD++ +TD+ PD +TL
Sbjct: 115 --VCLALEYLHSK---DII-YRDLKPENILLDKNGHIKITDFGFAK-YVPDVTYTLCGTP 167
Query: 521 AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
Y +PE +K D WS GILI E+L G P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 23/85 (27%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
L+ + + G + +I++ + LKKL +++NR++G + + P L L L NK
Sbjct: 44 LEFLSTINVGLT-SIAN--LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 183 Q--GQVPEIKQNE-MRSLGLANNEL 204
+ + +K+ E ++SL L N E+
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 29/113 (25%), Positives = 46/113 (40%), Gaps = 5/113 (4%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSG 135
L+L + A L LR ++F NNK + + + I L+ N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE- 94
Query: 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188
N+ F+G+ SLK L + +NR+T S + L + L L N+ V
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 25/107 (23%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNGF 133
+L ++N S I + S + + +N+ E + + LK++ L N
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI 117
Query: 134 SGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEAN 180
+ + +D+F G++S++ L + +N++T P + L L L L AN
Sbjct: 118 T-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 15/84 (17%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ L++N F+ + F+ + L+K+ +NN++T + + E+ L +N+ +
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 184 GQVPEI--KQNEMRSLGLANNELE 205
++ +++L L +N +
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT 118
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 47/226 (20%), Positives = 88/226 (38%), Gaps = 54/226 (23%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG------REDFQEHIKRLGRLEHPNL 413
+ LG GT+ YK +K + + G RE + L L+H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE-----VSLLKDLKHANI 62
Query: 414 LPLTAFYYRKEEKLLLYEFVEN------GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVK 467
+ L + ++ L++E+++ ++ ++ K + +++
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK-----------LFLFQLLR 111
Query: 468 GMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---YK 523
G+AY H + + H LK N+L++ E L D+ L R P + V Y+
Sbjct: 112 GLAYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167
Query: 524 SPE-------YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
P+ Y S + D+W +G + E+ TG+ P L G
Sbjct: 168 PPDILLGSTDY------STQIDMWGVGCIFYEMATGR-P---LFPG 203
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 34/140 (24%), Positives = 59/140 (42%), Gaps = 14/140 (10%)
Query: 79 KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFS 134
KL+ ++L I L L L ++ NNK + L ++ L ++ L DN
Sbjct: 113 KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDN--- 166
Query: 135 GNISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE 193
ISD G+T L+ LY++ N ++ +L L L L L + + + + N
Sbjct: 167 -QISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL 223
Query: 194 MRSLGLANNELEGPIPESLS 213
+ + N + PE +S
Sbjct: 224 VVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 24/93 (25%), Positives = 44/93 (47%), Gaps = 12/93 (12%)
Query: 92 ESLGLLSSLRAVSFMNNKFE--GPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSL 148
+ + L ++ + NK PL +L+ L ++L +N + D + + + L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLTDIKPLANLKN---LGWLFLDEN----KVKDLSSLKDLKKL 114
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANK 181
K L + +N ++ I + LV LP+L L L NK
Sbjct: 115 KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNK 145
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 15/121 (12%)
Query: 96 LLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMAN 155
L S L+ +S +N+ LP L L ++ +N + ++ + LK+L ++
Sbjct: 179 LPSGLQELSVSDNQLAS-LPTL--PSELYKLWAYNNRLT-SLP----ALPSGLKELIVSG 230
Query: 156 NRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKM 215
NRLT ++P +L EL + N+ +P + + SL + N+L +PESL +
Sbjct: 231 NRLT-SLPVL---PSELKELMVSGNRLT-SLPMLPSG-LLSLSVYRNQLTR-LPESLIHL 283
Query: 216 D 216
Sbjct: 284 S 284
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 32/137 (23%), Positives = 50/137 (36%), Gaps = 20/137 (14%)
Query: 79 KLEQMNLSGTIAAESL-GLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
+L + T L L S L + N+ LP L L+ + +SDN +
Sbjct: 105 ELSIFSNPLT----HLPALPSGLCKLWIFGNQLTS-LPVL--PPGLQELSVSDNQLA--- 154
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSL 197
+ L KL+ NN+LT ++P L EL + N+ + + L
Sbjct: 155 --SLPALPSELCKLWAYNNQLT-SLPML---PSGLQELSVSDNQLASLPTLPSE--LYKL 206
Query: 198 GLANNELEGPIPESLSK 214
NN L +P S
Sbjct: 207 WAYNNRLT-SLPALPSG 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 15/91 (16%), Positives = 35/91 (38%), Gaps = 12/91 (13%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ ++ + DN + ++ L+ L ++ N+LT ++P L +L
Sbjct: 63 ITTLVIPDNNLT-SLP----ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT-- 114
Query: 183 QGQVPEIKQNEMRSLGLANNELEGPIPESLS 213
+P + + L + N+L +P
Sbjct: 115 --HLPALPSG-LCKLWIFGNQLTS-LPVLPP 141
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 10/119 (8%)
Query: 96 LLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD--DAFEGMTSLKKLYM 153
L S L+ + N+ LP L L S+ + N ++ ++ ++S + +
Sbjct: 239 LPSELKELMVSGNRLTS-LPML--PSGLLSLSVYRN----QLTRLPESLIHLSSETTVNL 291
Query: 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESL 212
N L+ ++ E R+L LA + P E
Sbjct: 292 EGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 45/237 (18%), Positives = 81/237 (34%), Gaps = 62/237 (26%)
Query: 363 LGSGTFGASYKTV-ISNGQAYVVK----------------------RYKQMNNVGREDFQ 399
+G G++G ++ Y +K R +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 400 EHIKR----LGRLEHPNLLPLTAFY--YRKEEKLLLY---EFVENGSL-----AGKLHAN 445
E + + L +L+HPN++ L + LY E V G + L +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL---VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 446 HTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505
Q R + ++KG+ YLH + II H +K SN+L+ + D+
Sbjct: 138 ----------QAR-FYFQDLIKGIEYLHYQ---KII-HRDIKPSNLLVGEDGHIKIADFG 182
Query: 506 LRPLINPDNAHTLMV----AYKSPE---YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ +A A+ +PE K DVW++G+ + + G+ P
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 45/208 (21%), Positives = 78/208 (37%), Gaps = 48/208 (23%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTA 418
+VLG G G + + + +K + RE ++ R + P+++ +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----VELHWRASQCPHIVRIVD 78
Query: 419 FY---YRKEEKLLL-YEFVENGSL----AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
Y Y + LL+ E ++ G L + T++ +I+K + + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGEAIQ 131
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFE--PL-LTDYALRPLINPDNAHTLMVAYKSPEY 527
YLH+ I H +K N+L L LTD+ T Y
Sbjct: 132 YLHSI--N--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGEKY----- 175
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYP 555
K D+WSLG+++ LL G YP
Sbjct: 176 ------DKSCDMWSLGVIMYILLCG-YP 196
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 56/227 (24%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHPN 412
E +G GT+G YK + G+ + +K+ + + RE I L L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIRE-----ISILKELKHSN 61
Query: 413 LLPLTAFYYRKEEKLLLYEFVEN------GSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
++ L + K+ +L++E ++ G L + K Q +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQL--------L 110
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA---Y 522
G+AY H+ + H LK N+L++R E + D+ L R P +T + Y
Sbjct: 111 NGIAYCHDRR----VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 523 KSPE-------YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
++P+ Y S D+WS+G + E++ G P L G
Sbjct: 167 RAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT-P---LFPG 203
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/209 (22%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPN 412
VLG G+FG + K + Y VK K+ + +D E + P
Sbjct: 348 VLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDD-VECTMVEKRVLALPGKPPF 403
Query: 413 LLPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGMA 470
L L ++ ++L + E+V G L + Q+ G + + G+
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLF 456
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPE 526
+L ++ II + LK NV+LD + D+ + + + T Y +PE
Sbjct: 457 FLQSK---GII-YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
K D W+ G+L+ E+L G+ P
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 15/138 (10%)
Query: 64 NWNGVLCLNGSVWGL-KLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLPDLR 118
+ ++ ++ L + + LS I SL + +LR +S N + + +L
Sbjct: 33 MIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK-IENLD 89
Query: 119 KMGP-LKSIYLSDNGFSGNISD-DAFEGMTSLKKLYMANNRLTG-TIPSSLVQLPKLMEL 175
+ L+ +++S N I+ E + +L+ LYM+NN++T L L KL +L
Sbjct: 90 AVADTLEELWISYN----QIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145
Query: 176 RLEANKFQGQVPEIKQNE 193
L N E
Sbjct: 146 LLAGNPLYNDYKENNATS 163
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 56/228 (24%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHP 411
E +G GT+G +K + +KR + +++ RE I L L+H
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALRE-----ICLLKELKHK 61
Query: 412 NLLPLTAFYYRKEEKLLLYEFVEN------GSLAGKLHANHTKQRPGLDWQTRLKIIKGV 465
N++ L + ++ L++EF + S G L K + +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-----------SFLFQL 110
Query: 466 VKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA--- 521
+KG+ + H+ +++ H LK N+L++R+ E L ++ L R P ++ V
Sbjct: 111 LKGLGFCHSR---NVL-HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 522 YKSPE-------YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
Y+ P+ Y S D+WS G + EL P L G
Sbjct: 167 YRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP---LFPG 205
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
+LG GTFG K + G+ Y +K ++ + +++ H L HP L
Sbjct: 12 LLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 414 LPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGMA 470
L AF + ++L + E+ G L L R + + R + +V +
Sbjct: 68 TALKYAF--QTHDRLCFVMEYANGGELFFHL------SRERVFTEERARFYGAEIVSALE 119
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPE 526
YLH+ ++ + +K N++LD+ +TD+ L + + T Y +PE
Sbjct: 120 YLHSR---DVV-YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ + D W LG+++ E++ G+ P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 28/136 (20%), Positives = 56/136 (41%), Gaps = 19/136 (13%)
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKK 150
L++ + L +++ +++ ++ NI + T+LK+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNS----NIQSLAGMQFFTNLKE 67
Query: 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPE 210
L++++N+++ + S L L KL EL + N+ + + I + L L NNEL
Sbjct: 68 LHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELR----- 119
Query: 211 SLSKMDPSTFAGNKNL 226
D + KNL
Sbjct: 120 -----DTDSLIHLKNL 130
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 25/116 (21%), Positives = 47/116 (40%), Gaps = 13/116 (11%)
Query: 92 ESLGLLSSLRAVSFMNNKFEG--PLPDLRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSL 148
L L+ L +S N+ + +P L ++L +N + D D+ + +L
Sbjct: 79 SPLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNN----ELRDTDSLIHLKNL 130
Query: 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNEL 204
+ L + NN+L +I L L KL L L N+ + ++ + L +
Sbjct: 131 EILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKC 184
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---YK 523
G+ +LH+ II H LK SN+++ + D+ L T V Y+
Sbjct: 175 CGIKHLHS---AGII-HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 230
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLTGK 553
+PE + D+WS+G ++ E++ K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 47/218 (21%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHP 411
LG GT+G YK + +KR + + + RE + L L+H
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIRE-----VSLLKELQHR 93
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
N++ L + + L++E+ EN L + N P + + + ++ G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNF 147
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPL-----LTDYAL-RPLINPDNAHTLMVA---Y 522
H+ + H LK N+LL S + D+ L R P T + Y
Sbjct: 148 CHSR---RCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 523 KSPE-------YAHNGKISKKSDVWSLGILILELLTGK 553
+ PE Y S D+WS+ + E+L
Sbjct: 204 RPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVG--------REDFQEHIKRLGRLEHP 411
+G GTFG +K GQ +K+ M N RE IK L L+H
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALRE-----IKILQLLKHE 76
Query: 412 NLLPL-------TAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK-II 462
N++ L + Y R + + L+++F E+ LAG L K +K ++
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSE-----IKRVM 130
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-----RPLINPDNAHT 517
+ ++ G+ Y+H + I H +K++NVL+ R L D+ L + N +T
Sbjct: 131 QMLLNGLYYIHR----NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 518 LMVA---YKSPE-------YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
V Y+ PE Y D+W G ++ E+ T P ++QG
Sbjct: 187 NRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS-P---IMQG 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 45/216 (20%)
Query: 361 EVLGSGTFGASYKTVISNGQAYV----VKRYKQMNNVGREDFQ--EHIKRLGRLEHPNLL 414
+V+G G+FG K +V V+ K+ + E+ + EH+++ + N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 415 PLT-AFYYRK-----EEKLL--LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVV 466
+ F +R E L LYE ++ G + K ++
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVR-----------KFAHSIL 210
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN------PDNAHTLMV 520
+ + LH II H LK N+LL + + +I+ +
Sbjct: 211 QCLDALHKN---RII-HCDLKPENILLKQQGRSGIK------VIDFGSSCYEHQRVYTYI 260
Query: 521 A---YKSPEYAHNGKISKKSDVWSLGILILELLTGK 553
Y++PE + D+WSLG ++ ELLTG
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 42/215 (19%), Positives = 78/215 (36%), Gaps = 36/215 (16%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
V+G G FG K + + + +K + + R + + L + +
Sbjct: 81 VIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAE-TACFREERDVLVNGDSKWI 136
Query: 414 LPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI-IKGVVKGMA 470
L AF + + L L+ ++ G L + + + + +V +
Sbjct: 137 TTLHYAF--QDDNNLYLVMDYYVGGDLL-----TLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA-----YKSP 525
+H + H +K N+L+D + L D+ + D VA Y SP
Sbjct: 190 SVHQL---HYV-HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 526 E-----YAHNGKISKKSDVWSLGILILELLTGKYP 555
E G+ + D WSLG+ + E+L G+ P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 123 LKSIYLSDNGFSGNISD-DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANK 181
L+ + L + G + + LKKL ++ NR+ G + +LP L L L NK
Sbjct: 51 LEFLSLINVG----LISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 182 FQ--GQVPEIKQNE-MRSLGLANNEL 204
+ + +K+ E ++SL L N E+
Sbjct: 107 LKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 21/85 (24%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV-QLPKLMELRLEANKF 182
+ L+DN SD F + L KL + N+LT I + + EL+L NK
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 183 QGQVPE---IKQNEMRSLGLANNEL 204
+ ++ + +++++L L +N++
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQI 114
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 25/124 (20%), Positives = 49/124 (39%), Gaps = 15/124 (12%)
Query: 92 ESLGLLSSLRAVSFM---------NNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAF 142
E+L S+L+AV M + + ++ ++L+ +
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT---VLCHL 459
Query: 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ-NEMRSLGLAN 201
E + + L +++NRL +P +L L L L+ N + V + ++ L L N
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCN 517
Query: 202 NELE 205
N L+
Sbjct: 518 NRLQ 521
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 31/136 (22%), Positives = 52/136 (38%), Gaps = 21/136 (15%)
Query: 445 NHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504
+ L + + V KGM +L + H L + N+LL + D+
Sbjct: 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS----RKCIHRDLAARNILLSEKNVVKICDF 237
Query: 505 ALRPLINPDNAHT------LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GK--YP 555
L I D + L + + +PE + + +SDVWS G+L+ E+ + G YP
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 556 E--------NYLLQGY 563
L +G
Sbjct: 298 GVKIDEEFCRRLKEGT 313
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR--LGRLEHPNLLP 415
VLG G+FG + Q Y +K K+ R+ + ++R L + HP ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 416 LT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI-IKGVVKGMAYL 472
L AF + E KL L+ +F+ G L +L + + + +K + + + +L
Sbjct: 91 LHYAF--QTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHL 142
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEYA 528
H+ II + LK N+LLD LTD+ L + + A++ V Y +PE
Sbjct: 143 HSL---GII-YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 529 HNGKISKKSDVWSLGILILELLTGKYP 555
+ ++ +D WS G+L+ E+LTG P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 46/275 (16%)
Query: 304 ERASSYEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVL 363
E S ++ G + ++ + + + +E F+L L+ VL
Sbjct: 10 EEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL---LK----VL 62
Query: 364 GSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHI---KRLGRLEHPNLLP- 415
G+G +G + G+ Y +K K+ V + EH +++ LEH P
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIRQSPF 120
Query: 416 LTAFYY--RKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI-IKGVVKGMAY 471
L +Y + E KL L+ +++ G L L + + ++I + +V + +
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHL------SQRERFTEHEVQIYVGEIVLALEH 174
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDN--AHTL--MVAYKSPE 526
LH II + +K N+LLD + +LTD+ L + + + A+ + Y +P+
Sbjct: 175 LHKL---GII-YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 527 ------YAHNGKISKKSDVWSLGILILELLTGKYP 555
H+ K D WSLG+L+ ELLTG P
Sbjct: 231 IVRGGDSGHD----KAVDWWSLGVLMYELLTGASP 261
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 31/146 (21%), Positives = 47/146 (32%), Gaps = 53/146 (36%)
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL-------------------------- 493
KII+ V++G+ YLH + II H +K N+LL
Sbjct: 150 KIIQQVLQGLDYLHTKC--RII-HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 494 ---------------DRSFEPLLTDYALRPLINPDNA------HTLMV---AYKSPEYAH 529
EP + + + NA T + Y+S E
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
+ +D+WS + EL TG Y
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYL 292
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 53/248 (21%), Positives = 88/248 (35%), Gaps = 47/248 (18%)
Query: 332 KKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFG----ASYKTVISNGQAYVVKRY 387
+ +L VR + F++ L+ V+G G F K GQ Y +K
Sbjct: 45 WAEPIVVRLKEVRLQRDDFEI---LK----VIGRGAFSEVAVVKMK---QTGQVYAMKIM 94
Query: 388 KQMNNVGREDFQEHIKR----LGRLEHPNLLPLT-AFYYRKEEKL-LLYEFVENGSLAGK 441
+ + + R + + L + + L AF + E L L+ E+ G L
Sbjct: 95 NKWDMLKRGE-VSCFREERDVLVNGDRRWITQLHFAF--QDENYLYLVMEYYVGGDLLTL 151
Query: 442 LHANHTKQRPGLDW-QTRLKI-IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499
L + G + + +V + +H + H +K N+LLDR
Sbjct: 152 L------SKFGERIPAEMARFYLAEIVMAIDSVHRL---GYV-HRDIKPDNILLDRCGHI 201
Query: 500 LLTDYALRPLINPDNAHTLMVA-----YKSPE-------YAHNGKISKKSDVWSLGILIL 547
L D+ + D +VA Y SPE G + D W+LG+
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 548 ELLTGKYP 555
E+ G+ P
Sbjct: 262 EMFYGQTP 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 58/263 (22%), Positives = 95/263 (36%), Gaps = 36/263 (13%)
Query: 310 EDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQD--MLRASAEVLGSGT 367
+PT+ I+++ + LQD +LR V+G G+
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLR----VIGRGS 64
Query: 368 FG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPNLLPLTA 418
+ K + Y ++ K+ ED + ++ HP L+ L
Sbjct: 65 YAKVLLVRLKK---TDRIYAMRVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 419 FYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGMAYLHNEL 476
++ E +L + E+V G L + QR + + + + YLH
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFYSAEISLALNYLHER- 172
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEYAHNGK 532
II + LK NVLLD LTDY + L D T Y +PE
Sbjct: 173 --GII-YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
D W+LG+L+ E++ G+ P
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSP 252
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 25/120 (20%), Positives = 37/120 (30%), Gaps = 12/120 (10%)
Query: 91 AESLGLLSSLRAVSFMNN---KFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTS 147
A R + E L + +I SDN + F +
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPVIENLGATLDQ---FDAIDFSDNEIR-KLDG--FPLLRR 65
Query: 148 LKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ--GQVPEIKQNEM-RSLGLANNEL 204
LK L + NNR+ LP L EL L N G + + + L + N +
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 31/214 (14%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKR--YKQMNNVGREDFQEH---------IKRLGRLE 409
+ SG++GA V S G +KR + + I+ L
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 410 HPNLLPLT-AFYYRKEEKL----LLYEFVENGSLAGKLHAN-HTKQRPGLDWQTRLKIIK 463
HPN+L L F + +E + L+ E + L H ++ + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-----DLAQVIHDQRIVISPQHIQY-FMY 141
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA-- 521
++ G+ LH ++ H L N+LL + + + D+ L D T V
Sbjct: 142 HILLGLHVLHE---AGVV-HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 522 -YKSPEYAHNGKI-SKKSDVWSLGILILELLTGK 553
Y++PE K +K D+WS G ++ E+ K
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/104 (25%), Positives = 43/104 (41%), Gaps = 36/104 (34%)
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLD-------------RSFEPLLTDYALRPLINPD 513
KG+ Y+H II H LK N+ ++ R + +T Y
Sbjct: 139 KGLRYIHA---AGII-HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--------- 185
Query: 514 NAHTLMVA---YKSPEYAHNGKI-SKKSDVWSLGILILELLTGK 553
V Y++PE N ++ D+WS+G ++ E++TGK
Sbjct: 186 ------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNL 413
V+G G FG +K S + Y +K + + R D + P +
Sbjct: 76 VIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSPWV 131
Query: 414 LPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ L + ++ + L ++ E++ G L N + R + VV + +
Sbjct: 132 VQL-FYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY----- 527
H+ I H +K N+LLD+S L D+ +N + A +P+Y
Sbjct: 185 HSM---GFI-HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 528 ----AHNGKISKKSDVWSLGILILELLTGKYP 555
+G ++ D WS+G+ + E+L G P
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 36/104 (34%)
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLD-------------RSFEPLLTDYALRPLINPD 513
KG+ Y+H+ ++ H LK N+ ++ R + +T Y
Sbjct: 137 KGLKYIHS---AGVV-HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--------- 183
Query: 514 NAHTLMVA---YKSPEYAHNGKI-SKKSDVWSLGILILELLTGK 553
V Y++PE + ++ D+WS+G ++ E+LTGK
Sbjct: 184 ------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 41/256 (16%)
Query: 321 SSKVEPEPIEIKKK---ADYGKLSFVRDDMEPFDLQD--MLRASAEVLGSGTFG----AS 371
S EPE + A +++ D L+ V+G G+FG A
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLLAR 58
Query: 372 YKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPNLLPLT-AFYYRKEE 425
+K + Y VK ++ + +++ ++HI L ++HP L+ L +F + +
Sbjct: 59 HK---AEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVGLHFSF--QTAD 112
Query: 426 KL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI-IKGVVKGMAYLHNELPGSIIPH 483
KL + +++ G L L QR + R + + + YLH+ +I+ +
Sbjct: 113 KLYFVLDYINGGELFYHL------QRERCFLEPRARFYAAEIASALGYLHSL---NIV-Y 162
Query: 484 GHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPEYAHNGKISKKSDV 539
LK N+LLD +LTD+ L + + T Y +PE H + D
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 540 WSLGILILELLTGKYP 555
W LG ++ E+L G P
Sbjct: 223 WCLGAVLYEMLYGLPP 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 30/209 (14%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPN 412
V+G G++ K + Y +K K+ ED + ++ HP
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPF 71
Query: 413 LLPLTAFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGMA 470
L+ L ++ E +L + E+V G L + QR + + + +
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFYSAEISLALN 124
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSPE 526
YLH II + LK NVLLD LTDY + L D T Y +PE
Sbjct: 125 YLHER---GII-YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
D W+LG+L+ E++ G+ P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 54/210 (25%), Positives = 82/210 (39%), Gaps = 32/210 (15%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPN 412
VLG G+FG A K G Y VK K+ + +D E HP
Sbjct: 30 VLGKGSFGKVMLARVK---ETGDLYAVKVLKKDVILQDDD-VECTMTEKRILSLARNHPF 85
Query: 413 LLPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGM 469
L L F + ++L + EFV G L + Q+ + R + ++ +
Sbjct: 86 LTQLFCCF--QTPDRLFFVMEFVNGGDLMFHI------QKSRRFDEARARFYAAEIISAL 137
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSP 525
+LH++ II + LK NVLLD L D+ + + N T Y +P
Sbjct: 138 MFLHDK---GII-YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E D W++G+L+ E+L G P
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHI-----------KRLGRL 408
+G G +G YK +G +K + + N + +RL
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVR-VPN--GGGGGGGLPISTVREVALLRRLEAF 71
Query: 409 EHPNLLPL----TAFYYRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIK 463
EHPN++ L +E K+ L +E V+ L L PGL +T +++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD---KAPPPGLPAETIKDLMR 127
Query: 464 GVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA-- 521
++G+ +LH I+ H LK N+L+ L D+ L + + A T +V
Sbjct: 128 QFLRGLDFLHAN---CIV-HRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 522 -YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
Y++PE + D+WS+G + E+ K P L G
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-P---LFCG 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 36/106 (33%)
Query: 465 VVKGMAYLHNELPGSIIPHGHLKSSNVLLD-------------RSFEPLLTDYALRPLIN 511
+++G+ Y+H+ II H LK SN+ ++ R +T Y
Sbjct: 141 ILRGLKYIHS---ADII-HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY------- 189
Query: 512 PDNAHTLMVA---YKSPEYAHNGKI-SKKSDVWSLGILILELLTGK 553
VA Y++PE N ++ D+WS+G ++ ELLTG+
Sbjct: 190 --------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 60/231 (25%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG-----------REDFQEHIKRLGRL 408
+ LG G F YK + Q +K+ K + + RE IK L L
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALRE-----IKLLQEL 69
Query: 409 EHPNLLPLTAFYYRKEEKLLLYEFVEN------GSLAGKLHANHTKQRPGLDWQTRLKII 462
HPN++ L + K L+++F+E + L +H K +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK-----------AYM 118
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA 521
++G+ YLH I+ H LK +N+LLD + L D+ L + +P+ A+T V
Sbjct: 119 LMTLQGLEYLHQH---WIL-HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 522 ---YKSPE-------YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
Y++PE Y D+W++G ++ ELL P L G
Sbjct: 175 TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV-P---FLPG 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 32/210 (15%)
Query: 362 VLGSGTFG----ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR-----LGRLEHPN 412
VLG G+FG + K + Y VK K+ + +D E + P
Sbjct: 27 VLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDD-VECTMVEKRVLALPGKPPF 82
Query: 413 LLPLT-AFYYRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKG-VVKGM 469
L L F + ++L + E+V G L + Q+ G + + G+
Sbjct: 83 LTQLHSCF--QTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGL 134
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL--RPLINPDNAHTL--MVAYKSP 525
+L ++ II + LK NV+LD + D+ + + + T Y +P
Sbjct: 135 FFLQSK---GII-YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYP 555
E K D W+ G+L+ E+L G+ P
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV-QLPKLMELRLEANKF 182
+ + L G + +SD F G+T L L + N+L T+ + + L +L L L N+
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL 95
Query: 183 QGQVPE---IKQNEMRSLGLANNEL 204
+P ++ L L N+L
Sbjct: 96 A-SLPLGVFDHLTQLDKLYLGGNQL 119
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 44/243 (18%), Positives = 79/243 (32%), Gaps = 81/243 (33%)
Query: 361 EVLGSGTFGASYKTVI-----SNGQAYV-------VKRY-----------KQMNNVGRED 397
LG GTFG V+ + G++ V V +Y K++ +E+
Sbjct: 25 GNLGEGTFG----KVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 398 FQEHIKRLGRLEHPNLLPLTAFYYRKE-----EKLL--LYEFVENGSLAGKLHANHTKQR 450
+ + + F + E L +EF++ + H +
Sbjct: 81 -KFLCVLM--SDW--------FNFHGHMCIAFELLGKNTFEFLKENNFQP-YPLPHVR-- 126
Query: 451 PGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL-DRSFEPLLTDYALRPL 509
+ + + +LH + H LK N+L + FE L ++
Sbjct: 127 ---------HMAYQLCHALRFLHEN---QLT-HTDLKPENILFVNSEFETLYNEHKSCEE 173
Query: 510 INPDNA----------------HTLMVA---YKSPEYAHNGKISKKSDVWSLGILILELL 550
+ N HT +VA Y+ PE ++ DVWS+G ++ E
Sbjct: 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 551 TGK 553
G
Sbjct: 234 RGF 236
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 27/111 (24%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 97 LSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANN 156
L ++R ++ NK + L+++ L + L+ N ++ + F+ +T+LK+L + N
Sbjct: 62 LPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 157 RLTGTIPSSLV-QLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNEL 204
+L ++P + +L L L L N+ Q + K + L L+ N+L
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 27/95 (28%), Positives = 52/95 (54%), Gaps = 12/95 (12%)
Query: 467 KGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM---VA- 521
+G+ Y+H+ +++ H LK SN+LL+ + + + D+ L R + + VA
Sbjct: 139 RGLKYIHS---ANVL-HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 522 --YKSPEYAHNGKI-SKKSDVWSLGILILELLTGK 553
Y++PE N K +K D+WS+G ++ E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 23/85 (27%), Positives = 41/85 (48%), Gaps = 7/85 (8%)
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV-QLPKLMELRLEANKF 182
+ L N ++ F+ +T L KL ++ N++ ++P + +L KL L L NK
Sbjct: 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL 88
Query: 183 QGQVPE---IKQNEMRSLGLANNEL 204
Q +P K +++ L L N+L
Sbjct: 89 Q-SLPNGVFDKLTQLKELALDTNQL 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 634 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.92 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.74 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.7 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.66 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.66 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.66 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.66 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.65 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.65 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.65 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.64 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.64 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.64 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.63 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.63 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.63 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.63 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.63 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.63 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.62 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.62 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.62 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.61 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.61 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.6 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.59 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.58 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.58 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.57 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.57 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.57 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.56 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.56 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.56 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.56 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.55 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.54 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.53 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.53 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.53 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.52 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.52 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.52 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.52 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.52 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.52 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.51 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.51 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.51 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.51 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.51 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.51 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.5 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.49 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.49 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.49 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.49 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.49 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.48 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.46 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.46 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.46 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.46 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.46 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.45 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.45 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.45 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.44 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.44 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.44 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.43 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.43 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.42 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.41 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.41 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.41 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.41 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.4 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.38 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.38 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.36 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.34 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.34 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.31 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.27 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.26 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.21 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.07 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.97 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.92 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.82 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.61 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.6 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.24 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.21 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.21 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.98 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.99 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.95 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.61 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.24 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.98 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.53 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.48 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.26 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 94.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.39 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.31 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.18 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.76 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.77 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.51 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.29 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.63 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 83.93 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 80.27 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.14 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=446.18 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=200.8
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
..+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3578999999999999864 4789999999877666678899999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 433 VENGSLAGKLHANHTK----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
|++|+|.++++..... ...+++|.+++.|+.|||+||+|||+. +|+||||||+|||+++++.+||+
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEEC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCcEEEc
Confidence 9999999999764321 124599999999999999999999998 79999999999999999999999
Q ss_pred ccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHH
Q 038422 503 DYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNN 575 (634)
Q Consensus 503 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 575 (634)
|||+++...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.. ....+.+.
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~--------~~~~~~~~- 271 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ--------LSNTEAID- 271 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--------SCHHHHHH-
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC--------CCHHHHHH-
Confidence 999998764332 2346789999999999999999999999999999999 8999862 12222222
Q ss_pred HHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 576 MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 576 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+..+...+. +....+++ .+|+.+||+.||++||||+||++.|+.+.+
T Consensus 272 ~i~~g~~~~~-------p~~~~~~~---~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQGRELER-------PRACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHTCCCCC-------CTTCCHHH---HHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCC-------cccccHHH---HHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2222221111 11122444 455569999999999999999999998864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=443.30 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=203.5
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
..+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3578999999999999864 4788999999876666678899999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhcc--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 433 VENGSLAGKLHANH--------TKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 433 ~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
|++|+|.++|+... ......++|.+++.|+.|||.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcEEECCc
Confidence 99999999997643 12234599999999999999999999998 7999999999999999999999999
Q ss_pred ccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHH
Q 038422 505 ALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMV 577 (634)
Q Consensus 505 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~ 577 (634)
|+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.. ....+.+ ..+
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~--------~~~~~~~-~~i 243 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ--------LSNNEVI-ECI 243 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHH-HHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHH-HHH
Confidence 9998654332 2346788999999999999999999999999999999 8999862 1222222 222
Q ss_pred HhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 578 KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 578 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+..... +....++ +.+++.+||+.||++||||+||++.|+++.+
T Consensus 244 ~~~~~~~~-------p~~~~~~---~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQGRVLQR-------PRTCPQE---VYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHTCCCCC-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCC-------CccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 23222111 1112234 4455569999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=440.26 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=202.0
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 468999999999999863 46789999997543 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEE
Q 038422 433 VENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 501 (634)
|++|+|.++|...... ....++|.+++.|+.|||+||+|||+. +||||||||+|||+++++.+||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEE
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCCCCEEE
Confidence 9999999999754321 123599999999999999999999998 7999999999999999999999
Q ss_pred eccccCCccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHH
Q 038422 502 TDYALRPLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVN 574 (634)
Q Consensus 502 ~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~ 574 (634)
+|||+++..... ....+|+.|||||++.++.|+.++|||||||+||||+| |+.||.. ....+.+
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~--------~~~~~~~- 257 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--------YSNQDVV- 257 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------CCHHHHH-
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC--------CCHHHHH-
Confidence 999999865332 23457889999999999999999999999999999999 8999862 1222222
Q ss_pred HHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 575 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
..+..+..... +....++ +.+|+.+||+.||++||||+||++.|+++.
T Consensus 258 ~~i~~~~~~~~-------p~~~~~~---~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 EMIRNRQVLPC-------PDDCPAW---VYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHTTCCCCC-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCCCCCC-------cccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22333322111 1112233 455666999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=430.04 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=194.5
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|++.+ .||||+++... ....+.|.+|+++|++++|||||+++|+|. ++..+||||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCC
Confidence 5789999999999998753 58999987543 233468999999999999999999999885 467899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.++|+.... .++|.+++.|+.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 118 L~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 118 LYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp HHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred HHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999975432 499999999999999999999998 7999999999999999999999999999876432
Q ss_pred --CCccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 --NAHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....+|+.|||||++.+ +.|+.++|||||||+||||+||+.||... .-...+...+..+... +
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~--------~~~~~~~~~~~~~~~~----p 257 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI--------NNRDQIIFMVGRGYAS----P 257 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC--------CCHHHHHHHHHTTCCC----C
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcCCCC----C
Confidence 23457899999999863 46899999999999999999999998621 1122222333332211 1
Q ss_pred cccc-CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 589 EMKG-AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 589 ~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+.. .....++ +.+++.+||+.||++||||+||++.|+.+++
T Consensus 258 ~~~~~~~~~~~~---l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DLSKLYKNCPKA---MKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CSTTSCTTSCHH---HHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CcccccccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1110 1111233 4455569999999999999999999998864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=430.33 Aligned_cols=262 Identities=20% Similarity=0.266 Sum_probs=196.7
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC----ceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE----EKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ ..+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 47899999999999997 689999999865321 1223345666677899999999999998754 57999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL----PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+|.++|+.. .++|..+.+++.|+|+||+|||+++ ...+|+||||||+|||+|+++.+||+|||+++...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999753 3899999999999999999999862 12269999999999999999999999999997654
Q ss_pred CCC--------CccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCccccccc---CC---CCCcHHH
Q 038422 512 PDN--------AHTLMVAYKSPEYAHNG------KISKKSDVWSLGILILELLTGKYPENYLLQG---YD---SKASLSN 571 (634)
Q Consensus 512 ~~~--------~~~~~~~y~aPE~~~~~------~~~~k~DVwSfGvvl~elltg~~P~~~~~~~---~~---~~~~l~~ 571 (634)
... ...+|+.|||||++.+. .++.++|||||||++|||+||+.|+...... +. ......+
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 332 23578999999999754 4678999999999999999998876422110 00 0011122
Q ss_pred HHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 572 WVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+...+.+.. .++.+.......+....+.+|+.+||+.||++||||+||++.|++|.+
T Consensus 240 ~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2222222222 222222211223455667788889999999999999999999999865
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=420.48 Aligned_cols=240 Identities=18% Similarity=0.304 Sum_probs=198.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||+++++|.+++..|||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 367999999999999964 6899999999876666677899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 9998642 289999999999999999999998 8999999999999999999999999999876543 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+.... +..... +.+....
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~-i~~~~~-----~~~~~~~ 294 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKM-IRDNLP-----PRLKNLH 294 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHH-HHHSSC-----CCCSCGG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHH-HHcCCC-----CCCCccc
Confidence 45689999999999999999999999999999999999999861 122222222 222111 1111111
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++.++++ +||+.||++|||++|+++
T Consensus 295 ~~s~~~~dli~---~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLD---RLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 12245555555 999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=410.11 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=190.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|+.. ++..||+|++... .....+.|.+|+++|++++|||||+++++|.+ ++..||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 357999999999999964 5889999998643 23345679999999999999999999999875 2457999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~ 511 (634)
|++|+|.+++.... .+++..+..|+.||+.||+|||++.+ +|+||||||+|||+++ ++.+||+|||+|+...
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~--~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCC--CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999997643 39999999999999999999999721 3999999999999984 7899999999998654
Q ss_pred CCC--CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 512 PDN--AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 512 ~~~--~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
... ...||+.|||||++.+ .|+.++|||||||++|||+||+.||.. ...... +...+..+.....++..
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~-------~~~~~~-~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE-------CQNAAQ-IYRRVTSGVKPASFDKV 254 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT-------CSSHHH-HHHHHTTTCCCGGGGGC
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC-------CCcHHH-HHHHHHcCCCCCCCCcc
Confidence 432 3457899999998864 699999999999999999999999851 112222 22223222211111111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+++.++ +.+||+.||++|||++|+++
T Consensus 255 ------~~~~~~~l---i~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 ------AIPEVKEI---IEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------CCHHHHHH---HHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCHHHHHH---HHHHccCChhHCcCHHHHhc
Confidence 12344444 45999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=425.32 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=201.1
Q ss_pred hccccCccCceeEEEEEEcC------CcEEEEEEecccCc-cChhHHHHHHHHHhcCCC-CccccceeEEEeC-CceEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN------GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEH-PNLLPLTAFYYRK-EEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~-~~~~lv 429 (634)
..+.||+|+||+||+|++.. ++.||||+++.... ...++|.+|+++|++++| ||||+++|+|.+. +..+||
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 45789999999999998643 36899999976432 334679999999999965 8999999999765 568999
Q ss_pred EEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC
Q 038422 430 YEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE 498 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 498 (634)
||||++|+|.++|+..... ....++|.+++.|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGC
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCccceeeCCCCC
Confidence 9999999999999764321 123589999999999999999999998 7999999999999999999
Q ss_pred eEEeccccCCccCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHH
Q 038422 499 PLLTDYALRPLINPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSN 571 (634)
Q Consensus 499 ~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~ 571 (634)
+||+|||+|+.+..... ..+|+.|||||++.+..|+.++|||||||+||||+| |+.||... ...+
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~--------~~~~ 295 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDE 295 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--------CCSH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC--------CHHH
Confidence 99999999987654432 346788999999999999999999999999999999 89998621 1112
Q ss_pred HHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 572 WVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+...+.++..... +....+++ .+++..||+.||++||||+||++.|+++.
T Consensus 296 ~~~~~i~~g~~~~~-------p~~~~~~~---~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 296 EFCRRLKEGTRMRA-------PDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHTCCCCC-------CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCC-------CccCCHHH---HHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 23333433322111 11223444 45555999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=419.14 Aligned_cols=241 Identities=21% Similarity=0.349 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|||||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 47899999999999996 468999999997542 334568999999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.++|..... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 109 ~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 109 DLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp BHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred cHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999975432 2479999999999999999999998 89999999999999999999999999998775432
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+.+....... ... +
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~~-~~~-----~-- 245 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--------GSMKNLVLKIISGS-FPP-----V-- 245 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTC-CCC-----C--
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcCC-CCC-----C--
Confidence 23578999999999999999999999999999999999999861 23333333333221 111 1
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+++.+++. +||+.||++|||++|+++
T Consensus 246 ~~~~s~~~~~li~---~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVS---QLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 0112244555555 999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=417.80 Aligned_cols=241 Identities=21% Similarity=0.283 Sum_probs=194.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+.. +|+.||||+++.... ..+|+++|++++|||||++++++.+++..|||||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999964 589999999975322 24799999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~--- 514 (634)
.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+....
T Consensus 138 ~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 138 GQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99997653 399999999999999999999998 899999999999999887 69999999998765431
Q ss_pred ------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 515 ------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 515 ------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
...||+.|||||++.+..|+.++|||||||++|||+||+.||... . ...+... ....... . .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~-~~~~~~~---i~~~~~~--~--~ 276 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----F-RGPLCLK---IASEPPP--I--R 276 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT----C-CSCCHHH---HHHSCCG--G--G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC----C-HHHHHHH---HHcCCCC--c--h
Confidence 235889999999999999999999999999999999999999622 1 1222221 1111110 0 0
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.+ .....+++.+++. +||+.||++|||++|+++.|...
T Consensus 277 ~~--~~~~s~~~~~li~---~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 EI--PPSCAPLTAQAIQ---EGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GS--CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hc--CccCCHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHH
Confidence 11 1112344555555 99999999999999999988765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=421.80 Aligned_cols=240 Identities=18% Similarity=0.304 Sum_probs=199.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|||||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999964 5899999999876666778899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 9998642 289999999999999999999998 8999999999999999999999999999876543 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.. ....+.+.. +..... +.+....
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~-i~~~~~-----~~~~~~~ 371 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKM-IRDNLP-----PRLKNLH 371 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHH-HHHSCC-----CCCSCTT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHH-HHcCCC-----CCCcccc
Confidence 34688999999999999999999999999999999999999851 122222222 222111 1111111
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++.++++ +||+.||++|||++|+++
T Consensus 372 ~~s~~~~dli~---~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLD---RLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHH---HHcCCChhHCcCHHHHhc
Confidence 22345555555 999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=404.31 Aligned_cols=238 Identities=21% Similarity=0.324 Sum_probs=196.9
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+. .+|+.||+|++.+. +....+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 457899999999999995 46899999999753 23445789999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 116 gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 116 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999997653 399999999999999999999998 8999999999999999999999999999876432
Q ss_pred -----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 -----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 -----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.. ....+........ ..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~i~~~-~~------ 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--------GNEGLIFAKIIKL-EY------ 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHT-CC------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcC-CC------
Confidence 234689999999999999999999999999999999999999861 2222322222222 11
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVI 625 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 625 (634)
.+. ....+++.++++ +|++.||++|||++|++
T Consensus 252 ~~p--~~~s~~~~dli~---~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFP--EKFFPKARDLVE---KLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCC--TTCCHHHHHHHH---HHSCSSGGGSTTSGGGT
T ss_pred CCC--cccCHHHHHHHH---HHccCCHhHCcChHHHc
Confidence 111 112244555555 99999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=393.35 Aligned_cols=237 Identities=21% Similarity=0.364 Sum_probs=183.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|+++|++++|||||++++++.+++..|+||||| +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 46899999999999995 468999999997542 234567999999999999999999999999999999999999 6
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 97 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 97 NELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 89999997643 399999999999999999999998 8999999999999999999999999999876543
Q ss_pred -CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....||+.|||||++.+..+ +.++||||+||++|||+||+.||.. ........... .+.. .+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~--------~~~~~~~~~i~-~~~~------~~- 231 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD--------ESIPVLFKNIS-NGVY------TL- 231 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HTCC------CC-
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHH-cCCC------CC-
Confidence 23568899999999998876 5799999999999999999999861 22333332222 2211 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+....+++.++++ +|++.||++|||++|+++
T Consensus 232 -p~~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 -PKFLSPGAAGLIK---RMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCHHHHHHHH---HHccCChhHCcCHHHHHc
Confidence 1112244555554 999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=399.74 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=187.8
Q ss_pred hccccCccCceeEEEEEEc----CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
..+.||+|+||+||+|+.. .++.||+|+++... ......+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 4578999999999999852 46799999987542 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|++|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 108 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999997653 399999999999999999999998 899999999999999999999999999986533
Q ss_pred C----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 513 D----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 513 ~----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
. ....||+.|||||++.+..|+.++||||+||++|||+||+.||.. ....+........ ..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~-~~------ 243 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--------KDRKETMTMILKA-KL------ 243 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHC-CC------
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC--------cCHHHHHHHHHcC-CC------
Confidence 2 345689999999999999999999999999999999999999861 2223333332221 11
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
.+ +....+++.++++ +||+.||++||| ++|+++
T Consensus 244 ~~--p~~~s~~~~~li~---~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 GM--PQFLSPEAQSLLR---MLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CC--CTTSCHHHHHHHH---HHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CC--CCcCCHHHHHHHH---HHcccCHHHCCCCCcCCHHHHHc
Confidence 11 1112345555555 999999999998 467664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=390.54 Aligned_cols=240 Identities=22% Similarity=0.333 Sum_probs=181.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------------c
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------------E 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------------~ 425 (634)
.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.+.+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 46899999999999996 468999999987543 334567899999999999999999999997654 2
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
.|+|||||++|+|.+++...... ...++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEccCc
Confidence 68999999999999999764322 2367788899999999999999998 79999999999999999999999999
Q ss_pred cCCccCCCC----------------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcH
Q 038422 506 LRPLINPDN----------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASL 569 (634)
Q Consensus 506 la~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l 569 (634)
+|+...... ...||+.|||||++.+..|+.++|||||||++|||++ ||... ...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~~~ 233 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------MER 233 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------HHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------cHH
Confidence 998765431 1347899999999999999999999999999999996 66411 111
Q ss_pred HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 570 SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+ ........... . .+......+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~-~~~~~~~~p~~----~------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTL-TDVRNLKFPPL----F------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHHTTCCCHH----H------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHHhcCCCCCC----C------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11111111111 1 111123345666999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.51 Aligned_cols=188 Identities=19% Similarity=0.355 Sum_probs=162.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... +..||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 46899999999999996 4689999999975432 2345788999999999999999999998643 5689999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
|||+ |+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 139 E~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 139 DLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp ECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred eCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9996 78999986532 499999999999999999999998 8999999999999999999999999999865
Q ss_pred CCC--------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD--------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~--------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|+.|||||++.+. .++.++||||+||++|||+||+.||.
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 332 234688999999998875 46999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=370.07 Aligned_cols=266 Identities=27% Similarity=0.498 Sum_probs=224.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+|+..+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999987765556678999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC------
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD------ 513 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~------ 513 (634)
+++...... ...++|.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 ~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 998654322 23499999999999999999999998 8999999999999999999999999998754322
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||..... ........|.......+.....+++.+..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 275 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNNGQLEQIVDPNLAD- 275 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHTTTCCCSSSSSSCTT-
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhccccccHHHhcChhhcc-
Confidence 123467889999999988999999999999999999999999863322 22345677776666566666666666543
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+....+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 3456677788888889999999999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=374.46 Aligned_cols=184 Identities=20% Similarity=0.353 Sum_probs=161.5
Q ss_pred ccccCccCceeEEEEEEc----CCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+|+.+ +++.||+|++... .....+.+|+++|+++ +|||||++++++.+++..|+|||||+
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 468999999999999853 4678999998653 3456788999999998 69999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINPD 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~ 513 (634)
+|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 104 g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 104 HESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp CCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred cccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999983 289999999999999999999998 89999999999999877 79999999999754322
Q ss_pred --------------------------------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 --------------------------------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 --------------------------------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|+.|||||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 123578999999999875 58999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=371.43 Aligned_cols=269 Identities=33% Similarity=0.601 Sum_probs=225.9
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+..+++.||+|++..... .....+.+|++++++++||||++++++|.+.+..++||||+++|+|
T Consensus 35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 114 (326)
T 3uim_A 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114 (326)
T ss_dssp TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence 367999999999999988899999999876432 2344799999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++...... ...++|..+..++.|++.||+|||+.+.+ +|+||||||+|||+++++.+||+|||+++......
T Consensus 115 ~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (326)
T 3uim_A 115 ASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192 (326)
T ss_dssp HHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSS-CEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEE
T ss_pred HHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCchhhEEECCCCCEEeccCccccccCccccccc
Confidence 9999765432 34599999999999999999999997433 59999999999999999999999999997654332
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...+|..|+|||++.+..++.++|||||||++|||+||+.||+...........+.+|+.............+..+..
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 271 (326)
T 3uim_A 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG- 271 (326)
T ss_dssp CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT-
T ss_pred ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc-
Confidence 233678899999998888999999999999999999999999754444444567778877666666666666666543
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
....+....+.+++..||+.||++|||++||++.|++.
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 34677788899999999999999999999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=392.94 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=198.7
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+++|++++|||||+++++|.+++..|||||||++|+
T Consensus 161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 3578999999999999964 689999999987665667789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC--CCeEEeccccCCccCCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS--FEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGla~~~~~~~~ 515 (634)
|.+++..... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 241 L~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 241 LFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp HHHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred HHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999965432 399999999999999999999998 89999999999999854 7899999999988765532
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..+|+.|||||++.+..|+.++||||+||++|||++|+.||.. ....+...... .... ..-++..
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~--------~~~~~~~~~i~-~~~~-~~~~~~~-- 380 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--------ENDDETLRNVK-SCDW-NMDDSAF-- 380 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHH-TTCC-CCCSGGG--
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHH-hCCC-CCCcccc--
Confidence 3578899999999999999999999999999999999999861 12222222222 1111 1111111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.++++ +||+.||++|||++|+++
T Consensus 381 -~~~s~~~~dli~---~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 -SGISEDGKDFIR---KLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -TTSCHHHHHHHH---TTSCSSGGGSCCHHHHHH
T ss_pred -cCCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111244555554 999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=387.79 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=190.3
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHH---HHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQE---HIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..++||+|+||+||+|+.. +|+.||+|++++.. ......+.+ ++++++.++|||||+++++|.+.+..|||||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 3578999999999999964 58999999996432 222233333 4677788899999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
||+||+|.++|.... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+...
T Consensus 273 y~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp CCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999997653 399999999999999999999998 89999999999999999999999999998765
Q ss_pred CC--CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 512 PD--NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 512 ~~--~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
.. ....||+.|||||++.. ..|+.++||||+||++|||+||+.||.... ............ ....
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~-----~~~~~~i~~~i~-~~~~------ 411 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTL-TMAV------ 411 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG-----CCCHHHHHHHHH-HCCC------
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhhc-CCCC------
Confidence 44 34578999999999975 579999999999999999999999996221 122222222221 1111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
.+ +....+++.+++. .|++.||++|++ ++||.+
T Consensus 412 ~~--p~~~S~~a~dLI~---~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 EL--PDSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC--CTTSCHHHHHHHH---HHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC--CccCCHHHHHHHH---HHccCCHhHCCCCCCCCHHHHhc
Confidence 11 1112345555555 999999999998 677654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.91 Aligned_cols=248 Identities=24% Similarity=0.435 Sum_probs=201.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 478999999999999964 5889999998776666677899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 95 ~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 95 RGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999976432 399999999999999999999998 79999999999999999999999999997654321
Q ss_pred --------------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCC-CCcHHHHHHHHHHh
Q 038422 515 --------------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDS-KASLSNWVNNMVKE 579 (634)
Q Consensus 515 --------------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~-~~~l~~~~~~~~~~ 579 (634)
...+|..|+|||++.+..++.++|||||||++|||++|..|+......... ........ ..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~----~~ 242 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL----DR 242 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH----HH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc----cc
Confidence 234678899999999999999999999999999999999997633221111 11111111 11
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
... ....++ +.+++.+||+.||++|||++|+++.|+++++
T Consensus 243 ---------~~~--~~~~~~---l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 ---------YCP--PNCPPS---FFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ---------TCC--TTCCTT---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------cCC--CCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 011122 4455569999999999999999999998863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.01 Aligned_cols=240 Identities=21% Similarity=0.335 Sum_probs=196.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 36799999999999995 56899999999876666778899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
.+++... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 9999753 289999999999999999999998 89999999999999999999999999987654432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ..-............. ....+ .
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~~~~~~~~-~~~~~-----~ 240 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------ENPLRALYLIATNGTP-ELQNP-----E 240 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHHCSC-CCSCG-----G
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC-CCCCc-----c
Confidence 33578889999999999999999999999999999999999852 1112222222222111 11111 0
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++. +++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~---~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 KLSAIFR---DFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GSCHHHH---HHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHH---HHHHHHccCChhHCcCHHHHhh
Confidence 1123444 4555999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=367.04 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=199.8
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||.||+|+.. +++.||+|.++... ....+.|.+|+++|++++|||||+++++|.+++..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3578999999999999976 68999999987542 223357889999999999999999999999989999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 198 ~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 198 DFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp BHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999976543 389999999999999999999998 7999999999999999999999999998764432
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||... .. ..+...+..+....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--------~~-~~~~~~~~~~~~~~----- 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--------SN-QQTREFVEKGGRLP----- 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--------CH-HHHHHHHHTTCCCC-----
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CH-HHHHHHHHcCCCCC-----
Confidence 11234667999999998899999999999999999999 99998621 11 11222222221111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......+++. +++..||+.||++|||++||++.|+++++
T Consensus 336 --~~~~~~~~l~---~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 --CPELCPDAVF---RLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHH---HHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0111223444 45559999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.12 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=202.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+|+..+++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 4679999999999999988999999999754 345678999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-----C
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-----N 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-----~ 514 (634)
+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 94 ~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 94 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp HHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99965432 489999999999999999999998 7999999999999999999999999999765432 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+...... .+. ....+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~--------~~~~~~~~~~~-~~~--~~~~~----- 229 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDIS-TGF--RLYKP----- 229 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHH-TTC--CCCCC-----
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC--------CCHHHHHHHHh-cCc--cCCCC-----
Confidence 3344667999999998999999999999999999999 9999862 12222222221 111 11111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhcC
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~~ 634 (634)
....+++. +++..||+.||++||+++|+++.|+++.+.
T Consensus 230 ~~~~~~~~---~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVY---QIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCHHHH---HHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11123444 455599999999999999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.26 Aligned_cols=273 Identities=26% Similarity=0.470 Sum_probs=213.8
Q ss_pred CCCCCHHHHHHhh-----------ccccCccCceeEEEEEEcCCcEEEEEEecccC----ccChhHHHHHHHHHhcCCCC
Q 038422 347 MEPFDLQDMLRAS-----------AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHP 411 (634)
Q Consensus 347 ~~~~~~~~~~~~~-----------~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~ 411 (634)
...|++.++...+ .+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3455666665553 26799999999999986 68899999987532 22346789999999999999
Q ss_pred ccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCE
Q 038422 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNV 491 (634)
Q Consensus 412 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NI 491 (634)
||+++++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Ni 164 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANI 164 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHE
Confidence 999999999999999999999999999999975432 23499999999999999999999998 899999999999
Q ss_pred EeCCCCCeEEeccccCCccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCC
Q 038422 492 LLDRSFEPLLTDYALRPLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDS 565 (634)
Q Consensus 492 Ll~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~ 565 (634)
++++++.+||+|||+++..... ....++..|+|||.+.+ .++.++|||||||++|||+||+.||.... .
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~ 239 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR----E 239 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB----S
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc----c
Confidence 9999999999999998765432 12346788999998864 58999999999999999999999986321 1
Q ss_pred CCcHHHHHHHHHHhc-cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 566 KASLSNWVNNMVKEK-RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 566 ~~~l~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...+..+........ ...+.+++.+. .........+.+++..||+.||.+||+++||++.|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSBTTHHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 122333333222211 11233343332 2334555677778889999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=351.91 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=192.8
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||+||+|+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 357899999999999987 688999999875432 22357889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI--IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|.+++..... ...+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 120 SLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp BHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999975321 12389999999999999999999998 6 999999999999999999999999998765433
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||.+.+..++.++|||||||++|||+||+.||.. ....+............. +
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~--------~~~~~~~~~~~~~~~~~~-----~ 260 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN--------LNPAQVVAAVGFKCKRLE-----I 260 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT--------SCHHHHHHHHHHSCCCCC-----C
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcCCCCC-----C
Confidence 234567889999999999999999999999999999999999862 112222221111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......++. +++..||+.||++|||++||++.|+.+.+
T Consensus 261 --~~~~~~~l~---~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 261 --PRNLNPQVA---AIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp --CTTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred --CccCCHHHH---HHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111123444 45559999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=357.73 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=197.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCc----eEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE----KLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+.. ++.||+|++... ......+..|+.++++++|||||++++++.+... .++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 478999999999999875 789999998653 2234456678999999999999999999987543 6999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL------PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|+|.+++... .++|..+..++.|++.||+|||+.+ ...+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 9999999653 2899999999999999999999851 011599999999999999999999999999976
Q ss_pred cCCCC------CccccccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCcccccccCCC--------CCcHH
Q 038422 510 INPDN------AHTLMVAYKSPEYAHNG-----KISKKSDVWSLGILILELLTGKYPENYLLQGYDS--------KASLS 570 (634)
Q Consensus 510 ~~~~~------~~~~~~~y~aPE~~~~~-----~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~--------~~~l~ 570 (634)
..... ...+|..|+|||++.+. .++.++|||||||++|||+||+.||......... .....
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 54322 23568899999999863 4567899999999999999999998632211110 01122
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
++.... ........+.... ........+.+++.+||+.||++|||++||++.|++|.+
T Consensus 261 ~~~~~~-~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQEVV-VHKKKRPVLRDYW----QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHH-TTSCCCCCCCGGG----GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhh-hcccCCCCccccc----cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 222111 1111111111111 112344556777779999999999999999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.52 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=199.3
Q ss_pred hccccCccCceeEEEEEEc--------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEE
Q 038422 359 SAEVLGSGTFGASYKTVIS--------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 428 (634)
..+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|+++++++ +||||++++++|.+.+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 3578999999999999852 35679999987543 22346789999999999 89999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 429 LYEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTC
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEEECCCC
Confidence 99999999999999865421 123489999999999999999999998 899999999999999999
Q ss_pred CeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~ 570 (634)
.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~-----~~~~~~ 315 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----PVEELF 315 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH
Confidence 99999999997654322 2234578999999999999999999999999999999 99998621 112222
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
. .+..+..... .....+++ .+++..||+.||++||+++|+++.|+++.
T Consensus 316 ~----~~~~~~~~~~-------~~~~~~~l---~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 316 K----LLKEGHRMDK-------PANCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp H----HHHTTCCCCC-------CTTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHhcCCCCCC-------CCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2 1222211110 11112344 44555999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=348.34 Aligned_cols=239 Identities=21% Similarity=0.312 Sum_probs=196.0
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 57999999999999976 69999999998766666788999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----CC
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----NA 515 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 515 (634)
+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 131 ~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 131 DIVSQV------RLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 988532 389999999999999999999998 8999999999999999999999999998765433 23
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
..+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+..... ....... +.....
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~--------~~~~~~~~~~-~~~~~~~-----~~~~~~ 266 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS--------DSPVQAMKRL-RDSPPPK-----LKNSHK 266 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHH-HHSSCCC-----CTTGGG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHH-hcCCCCC-----cCcccc
Confidence 4578889999999999999999999999999999999999852 1112222222 1211111 111011
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+++.++ +.+||+.||++|||++|+++
T Consensus 267 ~~~~l~~l---i~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 267 VSPVLRDF---LERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCHHHHHH---HHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHH---HHHHccCChhhCcCHHHHhc
Confidence 12344444 45999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=349.54 Aligned_cols=256 Identities=22% Similarity=0.365 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEE-----cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~ 432 (634)
.+.||+|+||+||++++ .+++.||+|++........+.+.+|++++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 46899999999999984 35889999999876555567899999999999999999999998654 458999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 95 LPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred CCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999976543 389999999999999999999998 899999999999999999999999999987644
Q ss_pred CC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCccccccc------CC-CCCcHHHHHHHHHH
Q 038422 513 DN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG------YD-SKASLSNWVNNMVK 578 (634)
Q Consensus 513 ~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~------~~-~~~~l~~~~~~~~~ 578 (634)
.. ...++..|+|||.+.+..++.++|||||||++|||+||..|+...... .. ........+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 32 223456799999999999999999999999999999999987522110 00 00111111112222
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...... ......+++. +++..||+.||++|||++||+++|+++++
T Consensus 247 ~~~~~~-------~~~~~~~~l~---~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 247 NNGRLP-------RPDGCPDEIY---MIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp TTCCCC-------CCTTCCHHHH---HHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcCC-------CCcCcCHHHH---HHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 211110 0111224444 45559999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.90 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=201.4
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++...++..||+|+++.. ....+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 4679999999999999988889999998754 345678999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 92 NYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp HHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred HHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99976543 389999999999999999999998 89999999999999999999999999987654432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.. ....+...... .+. ....+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~~~-~~~--~~~~~----- 227 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL--------YTNSEVVLKVS-QGH--RLYRP----- 227 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHHHHHH-TTC--CCCCC-----
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc--------cChHHHHHHHH-cCC--CCCCC-----
Confidence 2234567999999998889999999999999999999 9999862 11222222211 111 11111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhcC
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~~ 634 (634)
....+++ .+++..||+.||++|||++|+++.|++++++
T Consensus 228 ~~~~~~l---~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 HLASDTI---YQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTSCHHH---HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CcChHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1112344 4455599999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.93 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=197.0
Q ss_pred hccccCccCceeEEEEEEc----CCcEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS----NGQAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|+.. .+..||+|+++.. .....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 3578999999999999974 3556999999754 2334567999999999999999999999999989999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 133 ENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp TTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999965432 399999999999999999999998 8999999999999999999999999999876543
Q ss_pred CC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 514 NA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 514 ~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
.. ..++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.... +..+....
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~--------~~~~~~~~~-~~~~~~~~- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN--------MTNRDVISS-VEEGYRLP- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------SCHHHHHHH-HHTTCCCC-
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc--------CCHHHHHHH-HHcCCCCC-
Confidence 21 223557999999998899999999999999999999 9999852 112222222 21211100
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
. .....++ +.+++..||+.||++||+++||++.|+++.+
T Consensus 275 ----~--~~~~~~~---l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 275 ----A--PMGCPHA---LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ----C--CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----C--CCCcCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 1111233 4455559999999999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.47 Aligned_cols=250 Identities=21% Similarity=0.355 Sum_probs=191.3
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhc--CCCCccccceeEEEeC----CceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGR--LEHPNLLPLTAFYYRK----EEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+. +++.||+|++... ..+.+..|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 46899999999999987 6899999998643 34556667776665 8999999999997653 3578999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH--------NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
++|+|.+++... .+++..+..++.||+.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 999999999532 3899999999999999999999 65 79999999999999999999999999
Q ss_pred cCCccCCCC--------CccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCcccccc
Q 038422 506 LRPLINPDN--------AHTLMVAYKSPEYAHNG------KISKKSDVWSLGILILELLTG----------KYPENYLLQ 561 (634)
Q Consensus 506 la~~~~~~~--------~~~~~~~y~aPE~~~~~------~~~~k~DVwSfGvvl~elltg----------~~P~~~~~~ 561 (634)
+++...... ...+|..|+|||++.+. .++.++|||||||++|||+|| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 987544322 23578899999999876 455799999999999999999 777653221
Q ss_pred cCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 562 GYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 562 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
........ ............+... .........+.+++..||+.||++|||++||++.|++|
T Consensus 239 ---~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 ---NDPSFEDM-RKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp ---SSCCHHHH-HHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcchhhh-hHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11222222 2222111111111111 11123445667777799999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.40 Aligned_cols=246 Identities=23% Similarity=0.385 Sum_probs=200.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+|...++..||||+++... ...+.|.+|+++|++++|||||++++++. .+..++|||||++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 46899999999999999889999999997643 46788999999999999999999999985 66789999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-----C
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-----N 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-----~ 514 (634)
+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 271 ~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 271 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp HHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred HHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 99975432 1388999999999999999999998 7999999999999999999999999999876432 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||++....++.++|||||||++|||+| |+.||.. ....+.... +..+.... ..
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~--------~~~~~~~~~-i~~~~~~~-------~~ 407 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG--------MSNPEVIRA-LERGYRMP-------RP 407 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHHH-HHHTCCCC-------CC
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC--------CCHHHHHHH-HHcCCCCC-------CC
Confidence 2334678999999998999999999999999999999 9999862 122222222 22221110 01
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....++ +.+++..||+.||++||||++|++.|+++..
T Consensus 408 ~~~~~~---l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 408 ENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 111234 4455569999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.22 Aligned_cols=238 Identities=20% Similarity=0.354 Sum_probs=194.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46899999999999996 578999999987542 233457889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999997653 389999999999999999999998 89999999999999999999999999997655432
Q ss_pred -CccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 -AHTLMVAYKSPEYAHNGKIS-KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~-~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...+|..|+|||++.+..++ .++|||||||++|||+||+.||.. ....+........ .. .+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~-~~------~~-- 233 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--------QNLKELRERVLRG-KY------RI-- 233 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHC-CC------CC--
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhC-CC------CC--
Confidence 34578889999999888775 799999999999999999999862 2333333222222 11 00
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.....++.+++ .+||+.||.+|||++|+++
T Consensus 234 p~~~s~~~~~li---~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 PFYMSTDCENLL---KRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CTTSCHHHHHHH---HHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCHHHHHHH---HHHCCCChhHCcCHHHHhc
Confidence 111234444444 4999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.78 Aligned_cols=246 Identities=23% Similarity=0.433 Sum_probs=188.6
Q ss_pred ccccCccCceeEEEEEEc----CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. ++..||+|+++... ....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 468999999999999865 57789999987542 3345689999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 130 ~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 130 NGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999997543 2399999999999999999999998 79999999999999999999999999998765432
Q ss_pred C-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 515 A-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 515 ~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
. ..++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+... .+..+..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~--------~~~~~~~~-~i~~~~~---- 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE--------MSNQDVIK-AVDEGYR---- 268 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT--------CCHHHHHH-HHHTTEE----
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHH-HHHcCCC----
Confidence 1 123467999999999999999999999999999998 9999852 11222221 1211110
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
......... .+.+++..||+.||++||+|+||++.|+++.
T Consensus 269 ---~~~~~~~~~---~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 ---LPPPMDCPA---ALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ---CCCCTTCBH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCccccH---HHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 000011123 3555666999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=339.85 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=198.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||++...++..||+|+++.. ....+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 4789999999999999988889999999754 345678999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-----C
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-----N 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-----~ 514 (634)
+++..... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 108 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 108 NYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp HHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred HHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99976433 399999999999999999999998 8999999999999999999999999999765432 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+.... +..+.. ...+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~--------~~~~~~~~~-~~~~~~--~~~~----- 243 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER--------FTNSETAEH-IAQGLR--LYRP----- 243 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHHHH-HHTTCC--CCCC-----
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc--------cChhHHHHH-HhcccC--CCCC-----
Confidence 2344677999999998899999999999999999999 9999862 111122211 111110 0011
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+++ .+++..||+.||++|||++|+++.|+++.+
T Consensus 244 ~~~~~~l---~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 244 HLASEKV---YTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCHHH---HHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHH---HHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1112344 445559999999999999999999998864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=364.01 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=197.7
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC-ceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-EKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|... ++.||||+++... ..+.|.+|+++|++++|||||++++++.+.+ ..++|||||++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 468999999999999875 7899999997643 5678999999999999999999999988765 78999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-CCcc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-NAHT 517 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 517 (634)
.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 275 ~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 347 (450)
T 1k9a_A 275 VDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 347 (450)
T ss_dssp HHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC------C
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCC
Confidence 999986532 2379999999999999999999998 7999999999999999999999999998754432 2234
Q ss_pred ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCC
Q 038422 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYS 596 (634)
Q Consensus 518 ~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 596 (634)
++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+.. .+..+.... .....
T Consensus 348 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~~~~----~i~~~~~~~-------~p~~~ 411 (450)
T 1k9a_A 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVP----RVEKGYKMD-------APDGC 411 (450)
T ss_dssp CCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-----CTTTHHH----HHHTTCCCC-------CCTTC
T ss_pred CCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH----HHHcCCCCC-------CCCcC
Confidence 5678999999999999999999999999999999 99998622 1122222 122221111 11112
Q ss_pred HHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 597 KSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 597 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+++. +++..||+.||++|||++|+++.|+++..
T Consensus 412 ~~~l~---~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 412 PPAVY---DVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH---HHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 24444 45559999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=368.82 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=201.4
Q ss_pred hccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+|+... +..||+|.++.. ....++|.+|+++|++++|||||+++++|.+.+..++|||||++|+
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 35789999999999999765 789999998754 3457889999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 303 L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 303 LLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp HHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred HHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999976432 2489999999999999999999998 79999999999999999999999999998764432
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+.+. +..+... .
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-----~~~~~~~~----~~~~~~~-------~ 439 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL----LEKDYRM-------E 439 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHHHH----HHTTCCC-------C
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHH----HHcCCCC-------C
Confidence 2234568999999998899999999999999999999 99998621 11222222 2221110 0
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......+++ .+++..||+.||++|||++||++.|+.+.+
T Consensus 440 ~~~~~~~~l---~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 440 RPEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCHHH---HHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 111122344 455559999999999999999999998743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.93 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=197.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. ++.+|+|+++... ....+.+.+|++++++++||||+++++++.+. +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 468999999999999984 8899999987543 23346799999999999999999999999877 678999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI--IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
|+|.+++..... ..+++.++..++.|++.||+|||+. + |+||||||+||++++++.++|+|||++.....
T Consensus 94 ~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 94 GSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred CcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999976432 2489999999999999999999997 5 99999999999999999999999988755332
Q ss_pred CCccccccccCcccccCCCCCc---chhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 NAHTLMVAYKSPEYAHNGKISK---KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~---k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||.+.+..++. ++|||||||++|||+||+.||.. ....+........+.... +
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--------~~~~~~~~~~~~~~~~~~-----~ 232 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD--------LSNMEIGMKVALEGLRPT-----I 232 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT--------SCHHHHHHHHHHSCCCCC-----C
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc--------cChHHHHHHHHhcCCCCC-----C
Confidence 3445688999999998765544 89999999999999999999862 222222222222221111 1
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhcC
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~~ 634 (634)
. ....+++.+ ++..||+.||++|||++|+++.|+++.++
T Consensus 233 ~--~~~~~~~~~---li~~~l~~~p~~Rps~~~il~~L~~l~~~ 271 (271)
T 3kmu_A 233 P--PGISPHVSK---LMKICMNEDPAKRPKFDMIVPILEKMQDK 271 (271)
T ss_dssp C--TTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred C--CCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1 112244444 45599999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=350.73 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=199.8
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 467999999999999974 34789999987543 22346789999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe
Q 038422 433 VENGSLAGKLHANHTKQ-------------------RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 493 (634)
+++|+|.+++....... ...+++.+++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLV 207 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEE
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEE
Confidence 99999999997643211 14599999999999999999999998 89999999999999
Q ss_pred CCCCCeEEeccccCCccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCC
Q 038422 494 DRSFEPLLTDYALRPLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSK 566 (634)
Q Consensus 494 ~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~ 566 (634)
++++.+||+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-------- 279 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-------- 279 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC--------
Confidence 99999999999998654322 23345778999999998899999999999999999999 9999852
Q ss_pred CcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 567 ASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+... .+..+..... ......++ .+++..||+.||++||+++||++.|+++.+
T Consensus 280 ~~~~~~~~-~~~~~~~~~~-------~~~~~~~l---~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEVIY-YVRDGNILAC-------PENCPLEL---YNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHHHH-HHHTTCCCCC-------CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHHHH-HHhCCCcCCC-------CCCCCHHH---HHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 12222222 2222221111 01112344 445559999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=342.87 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEEcC-C-------cEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISN-G-------QAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
.+.||+|+||+||+|+... + ..||+|.+........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 4689999999999998543 3 4799999977666667889999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC--------eEEec
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--------PLLTD 503 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--------~kl~D 503 (634)
|+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 93 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999976532 389999999999999999999998 7999999999999998887 99999
Q ss_pred cccCCccCCCCCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 504 YALRPLINPDNAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 504 fGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
||++..........++..|+|||.+.+ ..++.++|||||||++|||+||..|+... ................
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~~~~~~~~~ 237 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRKLQFYEDRHQL 237 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHHHHHhhccCCC
Confidence 999977655555557788999999987 67899999999999999999965553211 1111111111111111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
... ..++ +.+++..||+.||++|||++|+++.|+++.
T Consensus 238 ----~~~------~~~~---l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 238 ----PAP------KAAE---LANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp ----CCC------SSCT---THHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ----CCC------CCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111 1122 344555999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=353.69 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=197.9
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 3568999999999999953 46789999986532 3334578899999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC---CeEEecccc
Q 038422 432 FVENGSLAGKLHANHTK--QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF---EPLLTDYAL 506 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl 506 (634)
|+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 99999999999865432 223599999999999999999999998 899999999999999544 599999999
Q ss_pred CCccC------CCCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLIN------PDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~------~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.... +..
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~--------~~~~~~~~~-i~~ 301 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------KSNQEVLEF-VTS 301 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHHH-HHT
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHH-HHc
Confidence 86431 2223445778999999999999999999999999999998 9999862 122222222 222
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+..... .....++ +.+++..||+.||++||+++||++.|+.+.+
T Consensus 302 ~~~~~~-------~~~~~~~---l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 302 GGRMDP-------PKNCPGP---VYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TCCCCC-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC-------CccCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 211110 0111233 4455569999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.55 Aligned_cols=250 Identities=18% Similarity=0.306 Sum_probs=196.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.||+|.+....... .+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 468999999999999954 68899999986543322 35788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999997653 389999999999999999999998 89999999999999999999999999998764432
Q ss_pred ----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 515 ----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
...++..|+|||.+.+..++.++|||||||++|||+||+.||.. .............. .... ....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--------~~~~~~~~~~~~~~-~~~~-~~~~ 236 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG--------ETAVSIAIKHIQDS-VPNV-TTDV 236 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS--------SCHHHHHHHHHSSC-CCCH-HHHS
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHhhcc-CCCc-chhc
Confidence 23468889999999999999999999999999999999999862 12222222222211 1111 1111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCC-CHHHHHHHHHhhhc
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARM-ELKEVIEKIERLKE 633 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~~ 633 (634)
. ....+.+ .+++.+|++.||++|| +++++.+.|+++..
T Consensus 237 ~--~~~~~~l---~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 237 R--KDIPQSL---SNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp C--TTSCHHH---HHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred c--cCCCHHH---HHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1 1112344 4455599999999999 99999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.57 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=200.2
Q ss_pred hccccCccCceeEEEEEEc--------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEE
Q 038422 359 SAEVLGSGTFGASYKTVIS--------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 428 (634)
..+.||+|+||+||+|+.. ++..||+|+++... ....+.+.+|+++++++ +|||||+++++|.+.+..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 3578999999999999852 24579999987543 22346789999999999 99999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 429 LYEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||+++++
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceEEEcCCC
Confidence 99999999999999865421 123499999999999999999999998 899999999999999999
Q ss_pred CeEEeccccCCccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~ 570 (634)
.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~--------~~~~ 300 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPVE 300 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------CCHH
Confidence 9999999999865432 22345678999999999999999999999999999999 9999851 2222
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+... .+..+..... .....+++ .+++..||+.||++||+++||++.|+++.
T Consensus 301 ~~~~-~~~~~~~~~~-------~~~~~~~l---~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 ELFK-LLKEGHRMDK-------PSNCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHH-HHHTTCCCCC-------CSSCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH-HHHcCCCCCC-------CccCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222 2222211111 01122344 44555999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.25 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=201.3
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 46799999999999999889999999997643 35578999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-----C
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-----N 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-----~ 514 (634)
+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 92 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 92 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99976432 389999999999999999999998 7999999999999999999999999998765432 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||.. ....+..... ..+.. ...+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~i-~~~~~--~~~~----- 227 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDI-STGFR--LYKP----- 227 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHH-HTTCC--CCCC-----
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC--------CCHHHHHHHH-hcCCc--CCCC-----
Confidence 2345667999999998899999999999999999999 8999862 1222222222 22111 0001
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+++. +++..||+.||++||+++|+++.|+++.+
T Consensus 228 ~~~~~~l~---~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVY---QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHH---HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123444 45559999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=342.68 Aligned_cols=238 Identities=21% Similarity=0.306 Sum_probs=194.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +|+.||+|++++. .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999965 5899999999753 234556789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999997643 389999999999999999999998 8999999999999999999999999999764322
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ............. .. .+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~-~~------~~- 224 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELILME-EI------RF- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHC-CC------CC-
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC--------CCHHHHHHHHHcC-CC------CC-
Confidence 234578899999999999999999999999999999999999851 1222222222221 11 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
.....+++.++++ .||+.||++|| +++||++
T Consensus 225 -p~~~s~~~~~li~---~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 -PRTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CTTSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCHHHHHHHH---HHhhcCHHHhcCCCCCCHHHHHc
Confidence 1112344555555 99999999999 8999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.10 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=195.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+|...++..||+|+++... ...++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 46899999999999999888889999997643 456789999999999999999999999865 6789999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 267 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 267 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 99975432 2389999999999999999999998 79999999999999999999999999998764332
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+.. ..+..+.... ..
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~--------~~~~~~~-~~i~~~~~~~-------~~ 403 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------MVNREVL-DQVERGYRMP-------CP 403 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHHHH-HHHHTTCCCC-------CC
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC--------CCHHHHH-HHHHcCCCCC-------CC
Confidence 2234578999999998999999999999999999999 9999852 1112222 2222221111 01
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....++ +.+++..||+.||++|||+++|++.|+++..
T Consensus 404 ~~~~~~---l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 404 PECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 112233 4455559999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=348.94 Aligned_cols=246 Identities=21% Similarity=0.372 Sum_probs=190.2
Q ss_pred ccccCccCceeEEEEEEc-CCcE----EEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQA----YVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+.. +++. ||+|.++.. .....+.+.+|++++++++||||++++++|.++ ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEec
Confidence 468999999999999954 3443 577777543 234567899999999999999999999999865 478999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp TTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999976433 399999999999999999999998 7999999999999999999999999998765433
Q ss_pred C------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 N------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
. ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+... +..+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~~~----~~~~~~~~-- 239 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSI----LEKGERLP-- 239 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHH----HHTTCCCC--
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC-----CHHHHHHH----HHcCCCCC--
Confidence 2 1234668999999999999999999999999999999 99998621 11222222 21211100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....... .+.+++..||+.||++||+++||++.|+++.+
T Consensus 240 -----~~~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 240 -----QPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCTTBCH---HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCccCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011112 45556669999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=353.23 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=195.2
Q ss_pred ccccCccCceeEEEEEEcC------CcEEEEEEecccCcc-----------ChhHHHHHHHHHhcCCCCccccceeEEEe
Q 038422 360 AEVLGSGTFGASYKTVISN------GQAYVVKRYKQMNNV-----------GREDFQEHIKRLGRLEHPNLLPLTAFYYR 422 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 422 (634)
.+.||+|+||.||+|.... ++.||+|++...... ....+..|+..++.++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4689999999999999765 478999998654311 11234456667788899999999999987
Q ss_pred C----CceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC--CC
Q 038422 423 K----EEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD--RS 496 (634)
Q Consensus 423 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~ 496 (634)
. ...++||||+ +|+|.+++..... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++ .+
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANAK----RFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEESSCT
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEecCCC
Confidence 5 3479999999 9999999976422 399999999999999999999998 899999999999999 88
Q ss_pred CCeEEeccccCCccCCC-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCC
Q 038422 497 FEPLLTDYALRPLINPD-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDS 565 (634)
Q Consensus 497 ~~~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~ 565 (634)
+.+||+|||+++.+... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.... .
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~----~ 266 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL----K 266 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT----T
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc----c
Confidence 99999999999765332 12237889999999999999999999999999999999999997321 1
Q ss_pred CCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 566 KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
......+....... ...+++++.+.... ..+++.++++ .||+.+|.+||++++|++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~li~---~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKYVRDSKIRYRE-NIASLMDKCFPAAN-APGEIAKYME---TVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHHHHHHHHHH-CHHHHHHHHSCTTC-CCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhh-hHHHHHHHhccccc-CHHHHHHHHH---HHhcCCCCCCCCHHHHHHHHHHHH
Confidence 12222222222211 23334444432222 2345555555 999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=352.90 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=197.4
Q ss_pred ccccCccCceeEEEEEE------cCCcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeCCc-eEEEE
Q 038422 360 AEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEE-KLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~-~~lv~ 430 (634)
.+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+++++++ +|||||+++++|.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 46899999999999974 2457899999975432 2345799999999999 79999999999987654 89999
Q ss_pred EcCCCCChhhHHhhccCCC-------------------------------------------------------------
Q 038422 431 EFVENGSLAGKLHANHTKQ------------------------------------------------------------- 449 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------- 449 (634)
||+++|+|.+++.......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999997653210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC------Ccccccccc
Q 038422 450 RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN------AHTLMVAYK 523 (634)
Q Consensus 450 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~ 523 (634)
...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...+|..|+
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeE
Confidence 12289999999999999999999998 79999999999999999999999999998654332 234567899
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHH
Q 038422 524 SPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMIN 602 (634)
Q Consensus 524 aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 602 (634)
|||++.+..++.++|||||||++|||+| |+.||... ...+.+......+..... .....++
T Consensus 263 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~~~~~~~~~~-------~~~~~~~--- 324 (359)
T 3vhe_A 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDEEFCRRLKEGTRMRA-------PDYTTPE--- 324 (359)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--------CCSHHHHHHHHHTCCCCC-------CTTCCHH---
T ss_pred ChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc--------chhHHHHHHHHcCCCCCC-------CCCCCHH---
Confidence 9999999999999999999999999999 99998621 111112222222211111 1112234
Q ss_pred HHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 603 LLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 603 ~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+.+++..||+.||++|||++||++.|+++.+
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 4455559999999999999999999998854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=333.29 Aligned_cols=246 Identities=20% Similarity=0.360 Sum_probs=191.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccC-------hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVG-------REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
.+.||+|+||+||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+. .++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--TEEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--CeEEEE
Confidence 46799999999999996 468899999986543222 16789999999999999999999998544 379999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ccccCCCCCCEEeCCCCC-----eEEecc
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI--IPHGHLKSSNVLLDRSFE-----PLLTDY 504 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~-----~kl~Df 504 (634)
|+++|+|.+++..... .+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +||+||
T Consensus 102 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp CCTTCBHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ecCCCCHHHHHhcccC----CccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 9999999998875432 499999999999999999999998 6 999999999999987776 999999
Q ss_pred ccCCccCCC-CCccccccccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 505 ALRPLINPD-NAHTLMVAYKSPEYAH--NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 505 Gla~~~~~~-~~~~~~~~y~aPE~~~--~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
|+++..... ....++..|+|||.+. ...++.++|||||||++|||+||+.||... . ..-..+........
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~-~~~~~~~~~~~~~~- 246 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-----S-YGKIKFINMIREEG- 246 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC-----C-CCHHHHHHHHHHSC-
T ss_pred CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc-----c-ccHHHHHHHHhccC-
Confidence 998755443 2345678899999984 456789999999999999999999998621 1 11122222222221
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
....+.. ...+++. +++..||+.||++|||++||++.|+++
T Consensus 247 ~~~~~~~------~~~~~l~---~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRPTIPE------DCPPRLR---NVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCCT------TSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCCc------ccCHHHH---HHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111 1123444 455599999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.26 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=191.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999996 46899999999876555667899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe--CCCCCeEEeccccCCccCCCC--
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL--DRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl--~~~~~~kl~DfGla~~~~~~~-- 514 (634)
.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 174 ~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 174 FDRIIDESY----NLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp HHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999875432 389999999999999999999998 79999999999999 677889999999998765432
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...+|..|+|||++.+..++.++|||||||++|||+||+.||.. ..-.+.......... ...+...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~--------~~~~~~~~~i~~~~~--~~~~~~~--- 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG--------DNDAETLNNILACRW--DLEDEEF--- 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCC--CSCSGGG---
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhccC--CCChhhh---
Confidence 23478889999999988999999999999999999999999862 122222222222211 1111111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.+++ ..||+.||.+||+++|+++
T Consensus 313 ~~~~~~~~~li---~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFI---SKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHH---HTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHH---HHHcCCChhhCCCHHHHhc
Confidence 11124455554 4999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.74 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=203.6
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCC--ceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE--EKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+... ++.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 4689999999999999754 8999999997543 334577889999999999999999999998765 67999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe----CCCCCeEEeccccCCccC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL----DRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGla~~~~ 511 (634)
|+|.+++...... ..+++.++..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 94 GSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999765432 2389999999999999999999998 89999999999999 888889999999998765
Q ss_pred CCC---CccccccccCccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 512 PDN---AHTLMVAYKSPEYAH--------NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 512 ~~~---~~~~~~~y~aPE~~~--------~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
... ...++..|+|||++. +..++.++|||||||++|||+||+.||..... .....+.+.......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG----PRRNKEVMYKIITGK 243 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC----GGGCHHHHHHHHHHC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----cchhHHHHHHHhcCC
Confidence 443 334678899999886 57889999999999999999999999863221 122233333333221
Q ss_pred cCC---cc---------ccccccc-CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 581 RTG---DV---------FDKEMKG-AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 581 ~~~---~~---------~d~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
... .+ ++..+.. .......-..+.+++..||+.||++|||++|+++...+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 110 00 0111111 112334445566677799999999999999999988764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.39 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=184.3
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCc----cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNN----VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. ++.+|+|+++.... ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 468999999999999974 88999999875432 2346789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC--------CCCeEEeccccC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR--------SFEPLLTDYALR 507 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--------~~~~kl~DfGla 507 (634)
|+|.+++... .+++..+..++.|++.||+|||+.... +|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~-~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 91 GPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIV-PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSS-CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCC-ceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999998532 389999999999999999999998210 1889999999999986 678999999999
Q ss_pred CccCCCC--CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 508 PLINPDN--AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 508 ~~~~~~~--~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
+...... ...++..|+|||.+.+..++.++||||||+++|||+||+.||... .-.......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~-~~~~- 233 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--------DGLAVAYGVAMN-KLAL- 233 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHTS-CCCC-
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHhhhcC-CCCC-
Confidence 7654432 345678899999999989999999999999999999999998621 111111111111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.. .....+++. +++..||+.||++|||++|+++.|++|
T Consensus 234 ---~~--~~~~~~~~~---~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 ---PI--PSTCPEPFA---KLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---CC--CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---CC--CcccCHHHH---HHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 011123444 455599999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=344.78 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=194.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+++.. +|+.||+|.++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 578999999999999965 5899999999754322 357899999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC----CeEEeccccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF----EPLLTDYALRP 508 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~ 508 (634)
+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 97 ~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999996532 499999999999999999999998 899999999999998877 79999999998
Q ss_pred ccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 509 LINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 509 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+...... .... .
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~--------~~~~~~~~~i~-~~~~--~ 236 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANIT-AVSY--D 236 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHH-TTCC--C
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHH-hcCC--C
Confidence 76543 234578899999999988999999999999999999999999852 11222222221 1111 1
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+++.... ...+++.+++ ..||..||++|||++|+++
T Consensus 237 ~~~~~~~--~~s~~~~~li---~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 FDEEFFS--QTSELAKDFI---RKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCHHHHT--TSCHHHHHHH---HHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcc--CCCHHHHHHH---HHHCCCChhHCcCHHHHhc
Confidence 1111111 1123444444 4999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.90 Aligned_cols=249 Identities=16% Similarity=0.147 Sum_probs=197.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||+|.+.... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 46899999999999995 578999999987542 345688999999999 9999999999999999999999999 999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC-----eEEeccccCCccCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE-----PLLTDYALRPLINP 512 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGla~~~~~ 512 (634)
|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 91 LEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred HHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 999997642 2499999999999999999999998 8999999999999998887 99999999976533
Q ss_pred C-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 513 D-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 513 ~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
. ....+|..|+|||++.+..++.++|||||||++|||+||+.||... ....+.+..........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~-----~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL-----KADTLKERYQKIGDTKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCSSHHHHHHHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc-----ccccHHHHHHHHHhhhc
Confidence 2 2345788999999999999999999999999999999999998632 11233332222211110
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
. .. ...+ .. ... .+.+++..||+.||.+||++++|++.|+++.
T Consensus 238 ~-~~-~~~~-~~-~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 238 A-TP-IEVL-CE-NFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp H-SC-HHHH-TT-TCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred c-CC-HHHH-hc-cCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 00 0001 11 112 4455555999999999999999999999774
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.39 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=195.3
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+++.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999995 57899999998754322 23578899999999999999999999999999999999997
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 138 g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 688888865432 399999999999999999999998 799999999999999999999999999988777667
Q ss_pred ccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 HTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..++..|+|||++. ...++.++|||||||++|||+||+.||.. ......+....... .. ....
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~--------~~~~~~~~~~~~~~-~~-----~~~~ 275 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNE-SP-----ALQS 275 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSC-CC-----CCCC
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhcC-CC-----CCCC
Confidence 77899999999984 56789999999999999999999999852 22222332222221 11 1111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
. ...+++.+++ ..||+.||++|||++|+++.
T Consensus 276 ~-~~~~~l~~li---~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 G-HWSEYFRNFV---DSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp T-TSCHHHHHHH---HHHTCSSGGGSCCHHHHTTC
T ss_pred C-CCCHHHHHHH---HHHcccChhhCcCHHHHhhC
Confidence 1 1224444444 49999999999999999853
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.07 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=187.2
Q ss_pred hccccCccCceeEEEEEEcCCc----EEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCce------
Q 038422 359 SAEVLGSGTFGASYKTVISNGQ----AYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEK------ 426 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------ 426 (634)
..+.||+|+||.||+|+..... .||+|+++.. .....+.+.+|++++++++||||+++++++...+..
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 4578999999999999965432 7999998754 233456899999999999999999999999877655
Q ss_pred EEEEEcCCCCChhhHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 427 LLLYEFVENGSLAGKLHANHTKQ-RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 427 ~lv~e~~~~gsL~~~l~~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
++||||+++|+|.+++....... ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCCCCEEEeecc
Confidence 99999999999999997654322 22489999999999999999999998 89999999999999999999999999
Q ss_pred cCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 506 LRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 506 la~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ....+.. ...
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~---~~~- 253 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-----ENAEIYN---YLI- 253 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHH---HHH-
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-----ChHHHHH---HHh-
Confidence 997654332 2234567999999999999999999999999999999 89998621 1122211 111
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+..... .....++ +.+++..||+.||++|||++|+++.|+++.+
T Consensus 254 ~~~~~~~-------~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 254 GGNRLKQ-------PPECMEE---VYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TTCCCCC-------CTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC-------CCccCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111000 1111234 4455559999999999999999999998853
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=340.50 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=194.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+++.. +++.+|+|.++.. ....+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 467999999999999965 5789999988643 33456789999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC--CCCeEEeccccCCccCCCCC-
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR--SFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~~- 515 (634)
.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 89 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99996532 2489999999999999999999998 8999999999999987 78999999999987655432
Q ss_pred --ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 516 --HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
..+++.|+|||++.+..++.++|||||||++|||+||+.||.. ....+.+......... ++....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~---~~~~~~-- 227 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--------ETNQQIIENIMNAEYT---FDEEAF-- 227 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCC---CCHHHH--
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC--------CCHHHHHHHHHcCCCC---CChhhh--
Confidence 3467889999999988899999999999999999999999862 1222222222222110 011000
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++. +++..|++.||++|||++|+++
T Consensus 228 ~~~s~~~~---~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 KEISIEAM---DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHH---HHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHH---HHHHHHcCCChhHCcCHHHHhc
Confidence 01123444 4555999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=348.50 Aligned_cols=243 Identities=19% Similarity=0.281 Sum_probs=189.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..++||+|+||+||+++.. +++.||+|++++.. ....+.+..|..++.++ +|||||++++++.+.+..++||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 3578999999999999965 47899999997542 22335688999999877 8999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 136 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999997653 399999999999999999999998 8999999999999999999999999999763222
Q ss_pred ----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 ----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||..............+++...+..... .
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------C
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------C
Confidence 234578899999999999999999999999999999999999963211111111222333333322211 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
+ +.....++.+++ ..||+.||++||++
T Consensus 281 ~--p~~~s~~~~~li---~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 I--PRSLSVKAASVL---KSFLNKDPKERLGC 307 (396)
T ss_dssp C--CTTSCHHHHHHH---HHHTCSCTTTSTTC
T ss_pred C--CCcCCHHHHHHH---HHHhcCCHhHcCCC
Confidence 1 111224444444 49999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.89 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=194.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc------cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+++.. +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 4578999999999999965 588999999875432 246789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC----CeEEeccccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF----EPLLTDYALR 507 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 507 (634)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp CCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999996432 399999999999999999999998 899999999999999887 7999999999
Q ss_pred CccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 508 PLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 508 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
+..... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+........ .. .
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~~~~~-~~-~ 235 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANVSAV-NY-E 235 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHT-CC-C
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC--------CCHHHHHHHHHhc-CC-C
Confidence 776433 234578889999999988999999999999999999999999852 1112222221111 10 1
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+... ....+++. +++..||+.||++|||++|+++
T Consensus 236 ~~~~~~---~~~~~~~~---~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FEDEYF---SNTSALAK---DFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCHHHH---TTSCHHHH---HHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCcccc---ccCCHHHH---HHHHHHccCChhhCCCHHHHhc
Confidence 101111 01123444 4555999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=342.12 Aligned_cols=237 Identities=20% Similarity=0.309 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46899999999999996 56889999998643 1233467899999999999999999999999999999999999 7
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 89999987653 389999999999999999999998 7999999999999999999999999999876543
Q ss_pred -CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....+++.|+|||.+.+..+ ++++|||||||++|||+||+.||+..... .+ ...+......
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~------------~~~i~~~~~~ 226 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NL------------FKKVNSCVYV 226 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TC------------BCCCCSSCCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HH------------HHHHHcCCCC
Confidence 23457889999999988776 78999999999999999999998621100 00 0001000010
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.......++.++ +.+||+.||.+|||++|+++
T Consensus 227 ~p~~~s~~~~~l---i~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 227 MPDFLSPGAQSL---IRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCTTSCHHHHHH---HHTTSCSSGGGSCCHHHHTT
T ss_pred CcccCCHHHHHH---HHHHcCCChhHCcCHHHHHh
Confidence 111123444444 45999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=334.73 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=187.9
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+.. ..+|+|+++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 468999999999999864 359999987543 22346789999999999999999999965 5667899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 106 LYHHLHASET----KFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp HHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999965432 399999999999999999999998 7999999999999999999999999998765431
Q ss_pred --CCccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 --NAHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....++..|+|||.+. +..++.++|||||||++|||+||+.||... .. .+.+......+........
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~-~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------NN-RDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC-------CC-HHHHHHHHHHTSCCCCTTS
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc-------ch-HHHHHHHhcccccCcchhh
Confidence 1234678899999986 567889999999999999999999998621 11 1222223323222111111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhcC
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKEG 634 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~~ 634 (634)
.. . ...+++ .+++..||+.||++||+++|++++|+++.++
T Consensus 250 ~~--~-~~~~~l---~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 250 VR--S-NCPKRM---KRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp SC--T-TSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred cc--c-cCCHHH---HHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 10 1 112344 4555599999999999999999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=337.47 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+..+++.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++||||++ |+
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 4679999999999999988999999998754322 24678899999999999999999999999999999999998 58
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 105 LKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp HHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 8888865432 389999999999999999999998 8999999999999999999999999999765432
Q ss_pred CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccc--c---
Q 038422 514 NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF--D--- 587 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--d--- 587 (634)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||... .. ......+............- .
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~-~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV----TD-DDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----ST-TTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC----Ch-HHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22356788999999876 56899999999999999999999998622 11 22222222222111110000 0
Q ss_pred ----ccccc-CCCCHH-----HHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 588 ----KEMKG-AKYSKS-----EMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 588 ----~~~~~-~~~~~~-----~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..... ...... ...++.+++.+|++.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 000000 0123455666999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=335.93 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=196.9
Q ss_pred ccccCccCceeEEEEEE-----cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||.||++++ .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 46899999999999984 468899999997543 34457899999999999999999999999876 56899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred eCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999965543 389999999999999999999998 89999999999999999999999999997765
Q ss_pred CCC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccc-------cCCCCCcHHHHHHHHH
Q 038422 512 PDN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQ-------GYDSKASLSNWVNNMV 577 (634)
Q Consensus 512 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~-------~~~~~~~l~~~~~~~~ 577 (634)
... ...++..|+|||.+.+..++.++|||||||++|||+||+.|+..... .... ......+....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG-QMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG-GGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc-ccCHHHHHHHH
Confidence 432 23456679999999988999999999999999999999998642110 0011 11111111122
Q ss_pred HhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 578 KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 578 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+.... ......+++. +++..||+.||.+|||++|+++.|+++.+
T Consensus 257 ~~~~~~~-------~~~~~~~~l~---~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 257 KEGKRLP-------CPPNCPDEVY---QLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HTTCCCC-------CCTTCCHHHH---HHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred hccCCCC-------CCCCCCHHHH---HHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 2211110 0111224444 45559999999999999999999998854
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=369.00 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=193.8
Q ss_pred ccCccCceeEEEEEEc---CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVIS---NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++++|.+ +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 46679999997643 3456789999999999999999999999976 56999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC--
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 515 (634)
|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999996542 2499999999999999999999998 799999999999999999999999999987643321
Q ss_pred -----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 516 -----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 516 -----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
..+++.|+|||++.+..++.++|||||||++|||+| |+.||... ....+. ..+..+.....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-----~~~~~~----~~i~~~~~~~~---- 560 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVM----AFIEQGKRMEC---- 560 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CSHHHH----HHHHTTCCCCC----
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHH----HHHHcCCCCCC----
Confidence 223467999999998999999999999999999998 99998621 111222 22222221111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.....+++ .+++..||+.||++||+++||++.|+.+.
T Consensus 561 ---p~~~~~~l---~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 ---PPECPPEL---YALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ---CTTCCHHH---HHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCcCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122344 45555999999999999999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=366.06 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=199.6
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||.||+|+..++..||||+++... ...++|.+|+++|++++|||||++++++.+ +..++|||||++|+|
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 356899999999999999888899999997643 456789999999999999999999999865 678999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----- 513 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----- 513 (634)
.+++..... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 349 ~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 349 LDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp HHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred HHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 999975432 1389999999999999999999998 7999999999999999999999999999876432
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.+ ..+..+.... .
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~--------~~~~~~~-~~i~~~~~~~-------~ 485 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------MVNREVL-DQVERGYRMP-------C 485 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT--------CCHHHHH-HHHHTTCCCC-------C
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHH-HHHHcCCCCC-------C
Confidence 22334678999999999999999999999999999999 9999852 1112222 2222221111 0
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.....+++ .+++..||+.||++|||+++|++.|+++.
T Consensus 486 ~~~~~~~l---~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 PPECPESL---HDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11122344 45555999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.43 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=199.5
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 357899999999999986 235789999987542 2334678999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEE
Q 038422 432 FVENGSLAGKLHANHTK-------------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVL 492 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 492 (634)
|+++|+|.+++...... ....+++.++..++.||+.||+|||+. +|+||||||+||+
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dikp~NIl 182 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLAARNIL 182 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccchheEE
Confidence 99999999999865321 112489999999999999999999998 7999999999999
Q ss_pred eCCCCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCC
Q 038422 493 LDRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDS 565 (634)
Q Consensus 493 l~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~ 565 (634)
+++++.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... .
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-----~ 257 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-----P 257 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----C
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC-----C
Confidence 9999999999999987654332 2234677999999998889999999999999999999 99998621 1
Q ss_pred CCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 566 KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...+.+ .+..+.... . .....+++ .+++..||+.||++||+++|+++.|+++.+
T Consensus 258 ~~~~~~----~~~~~~~~~-----~--~~~~~~~~---~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PERLFN----LLKTGHRME-----R--PDNCSEEM---YRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGGHHH----HHHTTCCCC-----C--CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH----HhhcCCcCC-----C--CccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122222 122221111 0 01112344 445559999999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=339.91 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=200.0
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 357899999999999985 3467899999975432 3356799999999999 9999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 431 EFVENGSLAGKLHANHTK-------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
||+++|+|.+++...... ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEcCCC
Confidence 999999999999765421 122489999999999999999999998 899999999999999999
Q ss_pred CeEEeccccCCccCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~ 570 (634)
.+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||... . ..
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~----~~ 254 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----P----VD 254 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----C----SS
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc----c----ch
Confidence 999999999987654422 234567999999999999999999999999999999 99998621 1 11
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
..+......... ... .....+++. +++..||+.||.+|||++|+++.|+++.
T Consensus 255 ~~~~~~~~~~~~-~~~------~~~~~~~l~---~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 SKFYKMIKEGFR-MLS------PEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHHHHHTCC-CCC------CTTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHhccCCC-CCC------cccCCHHHH---HHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 112222222211 110 111223444 4555999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.38 Aligned_cols=247 Identities=19% Similarity=0.329 Sum_probs=186.9
Q ss_pred hccccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|+... +..||+|.++... ....+.+.+|+.++++++||||+++++++ ..+..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 97 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELC 97 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecC
Confidence 35789999999999999643 4578999887532 23356789999999999999999999997 456789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 98 TLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp TTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999975432 389999999999999999999998 8999999999999999999999999999876443
Q ss_pred C-----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 N-----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ~-----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ....+... +..+....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-----~~~~~~~~----i~~~~~~~--- 237 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDVIGR----IENGERLP--- 237 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHH----HHTTCCCC---
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-----CHHHHHHH----HHcCCCCC---
Confidence 2 2234567999999998899999999999999999997 99998621 11222221 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+ .....+++. +++..||+.||++||+++|+++.|+++.+
T Consensus 238 --~--~~~~~~~l~---~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 238 --M--PPNCPPTLY---SLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp --C--CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --C--CCCCCHHHH---HHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 011224444 45559999999999999999999998854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.50 Aligned_cols=247 Identities=17% Similarity=0.267 Sum_probs=194.4
Q ss_pred hhccccCccCceeEEEEEEc-CCcEEEEEEeccc-----CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 358 ASAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM-----NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
...+.||+|+||+||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 106 (351)
T 3c0i_A 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106 (351)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 34578999999999999964 6899999998642 12346789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC---eEEeccccCC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE---PLLTDYALRP 508 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~ 508 (634)
||++|+|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 107 ~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp CCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred CCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999888654322 22489999999999999999999998 8999999999999986654 9999999997
Q ss_pred ccCCCC----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 509 LINPDN----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 509 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
...... ...+|..|+|||++.+..++.++|||||||++|||+||+.||... -.+...... .+...
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~i~-~~~~~- 250 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---------KERLFEGII-KGKYK- 250 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---------HHHHHHHHH-HTCCC-
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---------HHHHHHHHH-cCCCC-
Confidence 765432 345788999999999999999999999999999999999998621 111111111 11110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.++... ....+++. +++.+||+.||++||++.|+++
T Consensus 251 -~~~~~~--~~~s~~~~---~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -MNPRQW--SHISESAK---DLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCHHHH--TTSCHHHH---HHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCcccc--ccCCHHHH---HHHHHHCCCChhHCcCHHHHhc
Confidence 111100 01123444 4555999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.00 Aligned_cols=247 Identities=23% Similarity=0.415 Sum_probs=186.4
Q ss_pred ccccCccCceeEEEEEEcC--C--cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN--G--QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+..+ + ..||+|.++... ....+.|.+|++++++++||||++++++|.. ++..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 4689999999999998642 2 368899886533 2345689999999999999999999999765 45789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 174 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 174 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999975432 389999999999999999999998 7999999999999999999999999999765332
Q ss_pred C--------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 514 N--------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 514 ~--------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
. ...++..|+|||++.+..++.++|||||||++|||+| |..||... ....+...+ ..+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-----~~~~~~~~~----~~~~~-- 314 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYL----LQGRR-- 314 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CSSCHHHHH----HTTCC--
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-----CHHHHHHHH----HcCCC--
Confidence 1 1234567999999999999999999999999999999 66676421 112232221 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
... .....+++ .+++..||+.||++||+++|+++.|+++..
T Consensus 315 ~~~-----p~~~~~~l---~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 LLQ-----PEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCC-----CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----CCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11122344 445559999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.44 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=197.0
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..+.||+|+||.||+|+. .++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 457899999999999996 245689999997542 33457899999999999 8999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEE
Q 038422 431 EFVENGSLAGKLHANHTK------------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVL 492 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 492 (634)
||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|||
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl 204 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVL 204 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEE
Confidence 999999999999764321 012389999999999999999999998 8999999999999
Q ss_pred eCCCCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCC
Q 038422 493 LDRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDS 565 (634)
Q Consensus 493 l~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~ 565 (634)
++.++.+||+|||++....... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ..
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~~ 280 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI----PV 280 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----CC
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC----Cc
Confidence 9999999999999997654332 2234567999999998999999999999999999998 99998621 11
Q ss_pred CCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 566 KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...+......+.... . .....+++.+ ++..||+.||.+||+++||++.|+.+.+
T Consensus 281 ----~~~~~~~~~~~~~~~-----~--~~~~~~~l~~---li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 ----DANFYKLIQNGFKMD-----Q--PFYATEEIYI---IMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp ----SHHHHHHHHTTCCCC-----C--CTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----HHHHHHHHhcCCCCC-----C--CCCCCHHHHH---HHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111222222221111 0 1112344444 4559999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.95 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=189.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCc------------
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE------------ 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------------ 425 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++|||||+++++|.+.+.
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 468999999999999976 78999999997543 3345789999999999999999999999876542
Q ss_pred ---------------------------------------------eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHH
Q 038422 426 ---------------------------------------------KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLK 460 (634)
Q Consensus 426 ---------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 460 (634)
.++||||+++|+|.+++...... ...++..++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchhhHHHHH
Confidence 78999999999999999765432 3367888999
Q ss_pred HHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----------------CCccccccccC
Q 038422 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----------------NAHTLMVAYKS 524 (634)
Q Consensus 461 i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----------------~~~~~~~~y~a 524 (634)
++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....+|..|+|
T Consensus 169 i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 999999999999998 8999999999999999999999999998766543 12347888999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHH
Q 038422 525 PEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLL 604 (634)
Q Consensus 525 PE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 604 (634)
||++.+..++.++|||||||++|||+||..|+.. ..... ........... . ......+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~-~~~~~~~~~~~----~------~~~~~~~~ 303 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRII-TDVRNLKFPLL----F------TQKYPQEH 303 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHH-HHHHTTCCCHH----H------HHHCHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHH-HHhhccCCCcc----c------ccCChhHH
Confidence 9999999999999999999999999999877531 01111 11111111110 0 11122345
Q ss_pred HHHhcccccCccCCCCHHHHHH
Q 038422 605 KIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 605 ~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+++..||+.||++||+++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 5666999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=337.02 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=189.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||+||+++.. ++.||+|++... ...+.|.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 468999999999999874 788999998643 34578999999999999999999999875 4589999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC-eEEeccccCCccCCC-CCcc
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE-PLLTDYALRPLINPD-NAHT 517 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-~kl~DfGla~~~~~~-~~~~ 517 (634)
+++..... ...+++..++.++.|+++||+|||+..+ .+|+||||||+||+++.++. +||+|||++...... ....
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQP-KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSS-SCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCC-CCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence 99975432 1247899999999999999999999321 17999999999999988876 799999998765432 2345
Q ss_pred ccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCH
Q 038422 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSK 597 (634)
Q Consensus 518 ~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 597 (634)
++..|+|||++.+..++.++|||||||++|||+||+.||... . ......... ...+..... .. ...
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~--~~~~~~~~~-~~~~~~~~~-----~~--~~~ 230 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI----G--GPAFRIMWA-VHNGTRPPL-----IK--NLP 230 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT----C--SSHHHHHHH-HHTTCCCCC-----BT--TCC
T ss_pred CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh----C--ccHHHHHHH-HhcCCCCCc-----cc--ccC
Confidence 788999999999999999999999999999999999998621 1 111111111 111111111 01 112
Q ss_pred HHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 598 SEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 598 ~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+++ .+++.+||+.||++|||++|+++.|+.+.+
T Consensus 231 ~~l---~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 231 KPI---ESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHH---HHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 344 445559999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.74 Aligned_cols=244 Identities=21% Similarity=0.284 Sum_probs=193.7
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 4578999999999999964 588999999975432 2345788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccCCccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 512 (634)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 113 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 113 GELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999986532 389999999999999999999998 89999999999999865 4599999999987654
Q ss_pred CC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 DN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.. ...+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ......... +..+.. ....+.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~--------~~~~~~~~~-i~~~~~-~~~~~~ 253 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYAQ-IKAGAY-DYPSPE 253 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHH-HHHTCC-CCCTTG
T ss_pred CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHH-HHhCCC-CCCccc
Confidence 33 34578899999999998999999999999999999999999851 112222222 222211 111111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. ...+++.+ ++..||+.||++||+++|+++.
T Consensus 254 ~~---~~~~~~~~---li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 WD---TVTPEAKS---LIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GG---GSCHHHHH---HHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc---CCCHHHHH---HHHHHcCCChhhCcCHHHHhcC
Confidence 11 11234444 5559999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.93 Aligned_cols=243 Identities=20% Similarity=0.279 Sum_probs=193.0
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||+||++.. .+|+.+|+|++.... ....+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 357899999999999985 468899999987543 22345789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC---CCCCeEEeccccCCccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD---RSFEPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~ 512 (634)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++....
T Consensus 95 g~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 95 GELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999997643 389999999999999999999998 899999999999998 467899999999977654
Q ss_pred CC----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 513 DN----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 513 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
.. ...+|+.|+|||++.+..++.++||||+||++|||++|+.||.. ....+.... +..+.. +...+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~--------~~~~~~~~~-i~~~~~-~~~~~ 235 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--------EDQHRLYQQ-IKAGAY-DFPSP 235 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHH-HHHTCC-CCCTT
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC--------ccHHHHHHH-HHhCCC-CCCcc
Confidence 32 24578899999999998999999999999999999999999851 122222222 222211 11111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ....+++.+++ ..||+.||++|||++|+++
T Consensus 236 ~~---~~~s~~~~~li---~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 EW---DTVTPEAKDLI---NKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TT---TTSCHHHHHHH---HHHSCSSTTTSCCHHHHHH
T ss_pred cc---ccCCHHHHHHH---HHHcCCChhHCCCHHHHhc
Confidence 11 11224455544 4999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=335.05 Aligned_cols=239 Identities=18% Similarity=0.291 Sum_probs=184.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--------------------------cChhHHHHHHHHHhcCCCCc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--------------------------VGREDFQEHIKRLGRLEHPN 412 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~n 412 (634)
.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 46899999999999996 4588999999865421 12357899999999999999
Q ss_pred cccceeEEEe--CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCC
Q 038422 413 LLPLTAFYYR--KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSN 490 (634)
Q Consensus 413 iv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~N 490 (634)
|+++++++.+ .+..++||||+++|+|.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+|
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~N 167 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIKPSN 167 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGG
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHH
Confidence 9999999987 5678999999999999876532 2499999999999999999999998 89999999999
Q ss_pred EEeCCCCCeEEeccccCCccCCC----CCccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCcccccccC
Q 038422 491 VLLDRSFEPLLTDYALRPLINPD----NAHTLMVAYKSPEYAHNGK---ISKKSDVWSLGILILELLTGKYPENYLLQGY 563 (634)
Q Consensus 491 ILl~~~~~~kl~DfGla~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~k~DVwSfGvvl~elltg~~P~~~~~~~~ 563 (634)
||++.++.+||+|||+++..... ....++..|+|||.+.+.. ++.++|||||||++|||+||+.||..
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~----- 242 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD----- 242 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-----
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-----
Confidence 99999999999999999766543 2345788999999998655 47889999999999999999999851
Q ss_pred CCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 564 DSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 564 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+.... ...... . + ......+++.+ ++.+||+.||++||+++|+++
T Consensus 243 ---~~~~~~~~~~-~~~~~~-~--~---~~~~~~~~l~~---li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ---ERIMCLHSKI-KSQALE-F--P---DQPDIAEDLKD---LITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---SSHHHHHHHH-HHCCCC-C--C---SSSCCCHHHHH---HHHHHTCSCTTTSCCHHHHTT
T ss_pred ---ccHHHHHHHH-hcccCC-C--C---CccccCHHHHH---HHHHHhhcChhhCCCHHHHhc
Confidence 2222222222 221110 0 0 01112244444 455999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=344.43 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=191.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||+|+||+||+++.. +++.||+|++++. .....+.+.+|.++++.+ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999965 5889999999753 233456788999999988 79999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999997653 289999999999999999999998 8999999999999999999999999999864322
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+......... . .+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~-~------~~ 243 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA--------ENEDDLFEAILNDE-V------VY 243 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCC-C------CC
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCC-C------CC
Confidence 234578899999999988899999999999999999999999862 22222222222211 1 01
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCH------HHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMEL------KEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~------~evl~ 626 (634)
.....+++.+++ ..|++.||++||++ +|+++
T Consensus 244 --p~~~~~~~~~li---~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 --PTWLHEDATGIL---KSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CTTSCHHHHHHH---HHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCHHHHHHH---HHHhhhCHHHccCCcccCCHHHHhh
Confidence 111224444444 49999999999998 67664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.87 Aligned_cols=251 Identities=16% Similarity=0.171 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||+|++... ...+.+.+|+++++++ +|+|++++++++.+....++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46799999999999995 57899999998653 2345688999999999 7999999999999999999999999 999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC-----eEEeccccCCccCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE-----PLLTDYALRPLINP 512 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGla~~~~~ 512 (634)
|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++....
T Consensus 92 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 92 LEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999976432 399999999999999999999998 8999999999999987766 99999999876543
Q ss_pred C-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 513 D-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 513 ~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
. ....+|..|+|||++.+..++.++|||||||++|||+||+.||.... ................
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-----AATNKQKYERIGEKKQ 238 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC-----SCCHHHHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh-----ccccHHHHHHHHhhcc
Confidence 2 22346788999999999999999999999999999999999986321 1111121111111110
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
... . +.+. . ...+++. +++..||+.||++||++++|++.|+++.+
T Consensus 239 ~~~-~-~~~~-~-~~~~~l~---~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 239 STP-L-RELC-A-GFPEEFY---KYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HSC-H-HHHT-T-TSCHHHH---HHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred Ccc-H-HHHH-h-hCcHHHH---HHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 000 0 0010 0 1123444 45559999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.70 Aligned_cols=244 Identities=22% Similarity=0.367 Sum_probs=195.5
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+|+.. +++.+|+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 3468999999999999965 588999999876655556689999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC--CCCeEEeccccCCccCCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR--SFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~~ 515 (634)
|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 135 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 135 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999986532 2389999999999999999999998 8999999999999974 46799999999987655432
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+.+....... . .+++...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~--------~~~~~~~~~i~~~~-~--~~~~~~~- 274 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--------EDDLETLQNVKRCD-W--EFDEDAF- 274 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHCC-C--CCCSSTT-
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCC-C--CCCcccc-
Confidence 3467889999999999999999999999999999999999862 11222222222111 1 0111110
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.++ +..||+.||++|||++|+++
T Consensus 275 -~~~s~~~~~l---i~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 -SSVSPEAKDF---IKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -TTSCHHHHHH---HHTTSCSSGGGSCCHHHHHT
T ss_pred -ccCCHHHHHH---HHHHcCCChhHCcCHHHHhh
Confidence 1122444444 45999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.45 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=193.2
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC--CCCccccceeEEEeC----CceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL--EHPNLLPLTAFYYRK----EEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~lv~e~ 432 (634)
..+.||+|+||.||+|+.. ++.||+|++... ....+..|.+++..+ +||||+++++++... ...++||||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 3578999999999999875 899999998643 234555666666554 999999999999887 678999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL----PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
+++|+|.+++... .+++..+..++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 117 HENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999999653 3899999999999999999999861 11269999999999999999999999999987
Q ss_pred ccCCCC--------CccccccccCcccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCcccccccCC
Q 038422 509 LINPDN--------AHTLMVAYKSPEYAHNGKISKK------SDVWSLGILILELLTG----------KYPENYLLQGYD 564 (634)
Q Consensus 509 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~k------~DVwSfGvvl~elltg----------~~P~~~~~~~~~ 564 (634)
...... ...+|..|+|||++.+...+.+ +|||||||++|||+|| +.||......
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~-- 268 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS-- 268 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS--
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC--
Confidence 654322 3357889999999987766655 9999999999999999 5565422111
Q ss_pred CCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 565 SKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 565 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...... .............+..... ..+....+.+++..||+.||++|||++||++.|+++.+
T Consensus 269 -~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 269 -DPSYED-MREIVCIKKLRPSFPNRWS----SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp -SCCHHH-HHHHHTTSCCCCCCCGGGG----GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCchhh-hHHHHhhhccCccccccch----hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 112222 2222222211111111111 12344556677779999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.43 Aligned_cols=238 Identities=21% Similarity=0.318 Sum_probs=195.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+++.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 468999999999999965 68999999987532 23456788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-C
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-N 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 514 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 99999997643 389999999999999999999998 8999999999999999999999999999865443 3
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+......... . .+ ..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~-~------~~--p~ 224 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--------SNTMKTYEKILNAE-L------RF--PP 224 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHCC-C------CC--CT
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCC-C------CC--CC
Confidence 34578899999999999999999999999999999999999851 12222222222211 1 11 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
...+++.++++ +|++.||++|| +++|+++
T Consensus 225 ~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 225 FFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TSCHHHHHHHH---HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCHHHHHHHH---HHhccCHHHcCCCcCCCHHHHhc
Confidence 12345555555 99999999999 8888874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.47 Aligned_cols=189 Identities=24% Similarity=0.417 Sum_probs=164.1
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 46799999999999999889999999986543 23346789999999999999999999999999999999999985 9
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 86 LKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp HHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9998875432 389999999999999999999998 8999999999999999999999999998765422
Q ss_pred CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 223467889999999764 58999999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.06 Aligned_cols=242 Identities=20% Similarity=0.279 Sum_probs=189.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc---ChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV---GREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+++.. +++.||+|+++..... ..+.+.+|..++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999975 5889999999764322 234678899999987 89999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999997643 389999999999999999999998 8999999999999999999999999999764322
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.||..............+.+...+..... .+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~ 238 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI 238 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------CC
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------CC
Confidence 234578899999999999999999999999999999999999863211111111112222222222211 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
+.....++.+++ .+||+.||++||++
T Consensus 239 --p~~~s~~~~~li---~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 --PRSLSVKAASVL---KSFLNKDPKERLGC 264 (345)
T ss_dssp --CTTSCHHHHHHH---HHHTCSSTTTSTTC
T ss_pred --CCCCCHHHHHHH---HHHhcCCHhHCCCC
Confidence 111224444444 49999999999995
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.37 Aligned_cols=247 Identities=22% Similarity=0.415 Sum_probs=192.1
Q ss_pred ccccCccCceeEEEEEEcC-----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN-----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|+... +..||+|.++... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4689999999999998653 2359999987542 233457899999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 129 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 129 ENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp TTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999976432 389999999999999999999998 7999999999999999999999999999876443
Q ss_pred CC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 514 NA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 514 ~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
.. ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+... .+..+....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~--------~~~~~~~~-~~~~~~~~~- 270 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--------LSNHEVMK-AINDGFRLP- 270 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHH-HHHTTCCCC-
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc--------CCHHHHHH-HHHCCCcCC-
Confidence 21 223567999999998999999999999999999999 9999852 11122222 222221100
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......+++ .+++..||+.||++||+++||++.|+++.+
T Consensus 271 ------~~~~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 271 ------TPMDCPSAI---YQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ------CCTTCBHHH---HHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CcccCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011112344 455559999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=342.37 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEEEc-CCcE----EEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQA----YVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+.. +++. |++|.+.... ....+.+.+|+.++++++||||++++++|. .+..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 468999999999999964 3443 7777775432 333457789999999999999999999985 56789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 97 PLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp TTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999975432 388999999999999999999998 7999999999999999999999999999876443
Q ss_pred C------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 N------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
. ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ....+.+. +..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~----~~~~~~~~-- 237 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-----RLAEVPDL----LEKGERLA-- 237 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CTTHHHHH----HHTTCBCC--
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-----CHHHHHHH----HHcCCCCC--
Confidence 2 2234568999999998999999999999999999999 99998621 11222222 22211100
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+.. ... .+.+++..||+.||++||+++|+++.|+++.+
T Consensus 238 ~~~~-----~~~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 QPQI-----CTI---DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCTT-----BCT---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCc-----CcH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0110 111 23456669999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=369.00 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=193.5
Q ss_pred cccCccCceeEEEEEEc---CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVIS---NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++|||||+++++|. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 46789999997543 233578999999999999999999999986 4568999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999997542 389999999999999999999998 79999999999999999999999999997664432
Q ss_pred ------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 515 ------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 515 ------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+ +...+..+.....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~--------~~~~~-~~~~i~~~~~~~~-- 593 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------MKGSE-VTAMLEKGERMGC-- 593 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHH-HHHHHHTTCCCCC--
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CCHHH-HHHHHHcCCCCCC--
Confidence 1234567999999999999999999999999999999 9999862 11112 2222222221111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.....+++ .+++..||+.||++||++++|++.|+++.
T Consensus 594 -----p~~~~~~l---~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 -----PAGCPREM---YDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -----CTTCCHHH---HHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122444 44555999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.95 Aligned_cols=241 Identities=23% Similarity=0.367 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 468999999999999965 688999999865432 234678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999986432 389999999999999999999998 8999999999999999999999999999754322
Q ss_pred --CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||++.+..+ +.++|||||||++|||+||+.||.... ........|. ... ....+ .
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~-----~~~--~~~~~-~ 231 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWK-----EKK--TYLNP-W 231 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC---TTSHHHHHHH-----TTC--TTSTT-G
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHHh-----ccc--ccCCc-c
Confidence 23457888999999987775 779999999999999999999986211 1111122221 111 01010 1
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ..+++ .+++.+||+.||++|||++|+++
T Consensus 232 ~~---~~~~~---~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 KK---IDSAP---LALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GG---SCHHH---HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc---CCHHH---HHHHHHHccCChhhCcCHHHHhh
Confidence 00 12334 44555999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=341.75 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=197.6
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhc--CCCCccccceeEEEeCC----ceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGR--LEHPNLLPLTAFYYRKE----EKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e~ 432 (634)
..+.||+|+||.||+|+. +++.||+|++... ..+.+.+|++++.. ++||||+++++++...+ ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 357899999999999997 5899999998643 34677888888877 79999999999998876 78999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCCccccCCCCCCEEeCCCCCeEEecc
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH--------NELPGSIIPHGHLKSSNVLLDRSFEPLLTDY 504 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 504 (634)
+++|+|.+++... .+++.++..++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 122 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 122 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTSCEEECCC
T ss_pred cCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999653 3899999999999999999999 55 7999999999999999999999999
Q ss_pred ccCCccCCC--------CCccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCccccc
Q 038422 505 ALRPLINPD--------NAHTLMVAYKSPEYAHNG------KISKKSDVWSLGILILELLTG----------KYPENYLL 560 (634)
Q Consensus 505 Gla~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~k~DVwSfGvvl~elltg----------~~P~~~~~ 560 (634)
|+++..... ....++..|+|||.+.+. .++.++|||||||++|||+|| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998765432 223567889999999765 234789999999999999999 66765221
Q ss_pred ccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 561 QGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 561 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
. .......+... +........+.... ...+....+.+++..||+.||++|||++||++.|+++.+
T Consensus 272 ~---~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 272 P---SDPSVEEMRKV-VCEQKLRPNIPNRW----QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp C---SSCCHHHHHHH-HTTSCCCCCCCGGG----GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c---CcccHHHHHHH-HHHHHhCCCCcccc----cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1 11233333322 22211111111111 122445567777779999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.47 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=199.8
Q ss_pred hccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+|.... +..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 34689999999999999765 788999998753 3345789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC--
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA-- 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 515 (634)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 96 L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 96 LLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp HHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred HHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 9999976433 3489999999999999999999998 799999999999999999999999999987654432
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
..++..|+|||.+.+..++.++||||||+++|||+| |+.||... ....+.+. ....... ..
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~-----~~~~~~~~----~~~~~~~-----~~- 233 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL----LEKDYRM-----ER- 233 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHHHH----HHTTCCC-----CC-
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH----HhccCCC-----CC-
Confidence 234567999999998999999999999999999999 99998621 11222221 1111110 00
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.....+++. +++..|++.||.+||+++|+++.|+++.+
T Consensus 234 -~~~~~~~l~---~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 234 -PEGCPEKVY---ELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCHHHH---HHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 111123444 45559999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.49 Aligned_cols=238 Identities=22% Similarity=0.323 Sum_probs=184.6
Q ss_pred ccccCccCceeEEEEEE----cCCcEEEEEEecccC----ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
.+.||+|+||.||+++. .+++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 46899999999999997 478999999997642 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 102 YLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999997643 389999999999999999999998 89999999999999999999999999987543
Q ss_pred CC----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 512 PD----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+......... .
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~-~----- 238 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG--------ENRKKTIDKILKCK-L----- 238 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTC-C-----
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCC-C-----
Confidence 22 234578899999999998999999999999999999999999862 12222222222211 1
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
.+ ......++.++++ +||+.||++|| +++|+++
T Consensus 239 -~~--p~~~~~~~~~li~---~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 -NL--PPYLTQEARDLLK---KLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CC--CTTSCHHHHHHHH---HHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CC--CCCCCHHHHHHHH---HHHhcCHhhccCCCCCCHHHHHc
Confidence 01 1112344555554 99999999999 7778765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.46 Aligned_cols=241 Identities=20% Similarity=0.270 Sum_probs=178.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 468999999999999976 47899999987542 456788999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCCccCCC--
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~-- 513 (634)
.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 136 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 136 FDRIVEKG-----YYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp HHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99986532 389999999999999999999998 7999999999999975 889999999999866443
Q ss_pred -CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 -NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||... .. .......+..... ....+..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~-~~~~~~~i~~~~~-~~~~~~~-- 275 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE-------RG-DQFMFRRILNCEY-YFISPWW-- 275 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT-------TC-HHHHHHHHHTTCC-CCCTTTT--
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC-------cc-cHHHHHHHHhCCC-ccCCchh--
Confidence 2345688999999999989999999999999999999999998521 11 1112222222111 1111111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....++. +++.+||+.||++|||++|+++
T Consensus 276 -~~~~~~~~---~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 -DEVSLNAK---DLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTSCHHHH---HHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhCCHHHH---HHHHHHccCChhhCcCHHHHhc
Confidence 11123444 4555999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.48 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=198.4
Q ss_pred ccccCccCceeEEEEEE-----cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~ 432 (634)
.+.||+|+||.||++++ .+++.||+|++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 47899999999999984 4688999999987655566789999999999999999999999874 4568899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 108 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 108 LPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred cCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999976433 389999999999999999999998 899999999999999999999999999986643
Q ss_pred CC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccC------CCCCcHHHHHHHHHHh
Q 038422 513 DN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGY------DSKASLSNWVNNMVKE 579 (634)
Q Consensus 513 ~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~------~~~~~l~~~~~~~~~~ 579 (634)
.. ...++..|+|||.+.+..++.++|||||||++|||+||+.||....... .........+......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 32 2335667999999998889999999999999999999999975221100 0000111111111111
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+.... ......+++. +++..||+.||++|||++|+++.|+++.
T Consensus 260 ~~~~~-------~~~~~~~~l~---~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 260 GQRLP-------APPACPAEVH---ELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp TCCCC-------CCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred ccCCC-------CCCcccHHHH---HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 0111223444 4555999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.97 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=198.0
Q ss_pred hccccCccCceeEEEEEEc--------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEE
Q 038422 359 SAEVLGSGTFGASYKTVIS--------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 428 (634)
..+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 3578999999999999863 46789999987542 23346789999999999 89999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 429 LYEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENN 194 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceEEEcCCC
Confidence 99999999999999865421 112489999999999999999999998 899999999999999999
Q ss_pred CeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~ 570 (634)
.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~--------~~~~ 266 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--------IPVE 266 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc--------CCHH
Confidence 99999999987654432 2334677999999988889999999999999999999 9999852 1222
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
+... .+..+..... ......++ .+++..||+.||.+||+++|+++.|+++.
T Consensus 267 ~~~~-~~~~~~~~~~-------~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ELFK-LLKEGHRMDK-------PANCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHH-HHHHTCCCCC-------CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH-HHhcCCCCCC-------CccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2222 2222211111 01112344 44555999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=341.97 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=192.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|||||+++++|.+.+..++||||+.+
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 478999999999999965 47899999986432 33456889999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 100 GDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999997532 399999999999999999999998 8999999999999999999999999999876443
Q ss_pred -CCccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 -NAHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
....+|..|+|||++.. ..++.++|||||||++|||+||+.||... ........+.... .... .
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~~~~~~-~~~~------~ 238 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR-----SSTSSKEIVHTFE-TTVV------T 238 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC-----TTSCHHHHHHHHH-HCCC------C
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC-----CCccHHHHHHHHh-hccc------C
Confidence 23457889999999974 45899999999999999999999998621 1122322222221 1110 0
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCC-HHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARME-LKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~evl~ 626 (634)
. ......++.. ++..||+.||.+||+ +++|.+
T Consensus 239 ~--p~~~s~~~~~---li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 Y--PSAWSQEMVS---LLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C--CTTSCHHHHH---HHHHHSCSSGGGSCCSHHHHHT
T ss_pred C--CCcCCHHHHH---HHHHHhcCCHhHhcccHHHHHc
Confidence 0 1111244444 445999999999998 676654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.02 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=195.1
Q ss_pred cccCccCceeEEEEEEc---CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVIS---NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 47999999999999853 57789999997643 23456789999999999999999999999 566799999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999996432 2499999999999999999999998 89999999999999999999999999987664322
Q ss_pred -----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 515 -----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+.. ..+..+....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~-~~i~~~~~~~---- 233 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVM-AFIEQGKRME---- 233 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHH-HHHHTTCCCC----
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--------CHHHHH-HHHhcCCcCC----
Confidence 2234678999999988889999999999999999999 99998621 111211 1222221111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
. .....+++.+ ++..||+.||++||+++|+++.|+++.
T Consensus 234 -~--~~~~~~~l~~---li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 234 -C--PPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp -C--CTTCCHHHHH---HHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C--CCCcCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1112244444 455999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.06 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=193.8
Q ss_pred ccccCccCceeEEEEEEcC-C---cEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCce-EEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN-G---QAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEK-LLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~e~~ 433 (634)
.+.||+|+||+||+|+..+ + ..+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4789999999999998543 2 3789999875432 3346789999999999999999999999876655 9999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999997533 2489999999999999999999998 7999999999999999999999999999754332
Q ss_pred --------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 514 --------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 514 --------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
....++..|+|||.+.+..++.++|||||||++|||+||..|+.. ......+...+ .......
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~----~~~~~~~~~~~----~~~~~~~- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR----HIDPFDLTHFL----AQGRRLP- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT----TSCGGGHHHHH----HTTCCCC-
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc----cCCHHHHHHHh----hcCCCCC-
Confidence 223456789999999999999999999999999999996666431 11112222221 1111100
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......+++. +++..||+.||.+|||++|++++|+++.+
T Consensus 249 ------~~~~~~~~l~---~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 249 ------QPEYCPDSLY---QVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ------CCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCccchHHHH---HHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111223444 45559999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.84 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||.||+|+..++..||+|.++.. ....+.+.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 4689999999999999888889999998754 345678999999999999999999999985 55689999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 96 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 96 DFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp HHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred HHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 99965421 1389999999999999999999998 89999999999999999999999999987664432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+.... +..+... .. .
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~~~~-~~~~~~~-----~~--~ 232 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--------MTNPEVIQN-LERGYRM-----VR--P 232 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHHHHHH-HHTTCCC-----CC--C
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc--------cCHHHHHHH-HhcccCC-----CC--c
Confidence 2234567999999988889999999999999999999 8999852 111222222 2121110 00 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
....+++. +++..|++.||++|||++|+++.|+++.
T Consensus 233 ~~~~~~l~---~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 233 DNCPEELY---QLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHHHH---HHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11224444 4555999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.93 Aligned_cols=238 Identities=19% Similarity=0.257 Sum_probs=195.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 468999999999999965 68999999986532 23456789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-C
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-N 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 514 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 99999997643 389999999999999999999998 8999999999999999999999999999866543 3
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... .+.. .+ ..
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~-~~~~------~~--p~ 259 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA--------DQPIQIYEKIV-SGKV------RF--PS 259 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HCCC------CC--CT
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC--------CCHHHHHHHHH-cCCC------CC--CC
Confidence 44678899999999999999999999999999999999999851 12222222222 2211 11 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
....++.++++ +||+.||++||+ ++||++
T Consensus 260 ~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 260 HFSSDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCCHHHHHHHH---HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCHHHHHHHH---HHhhcCHHhccCCccCCHHHHHh
Confidence 12344555554 999999999998 888764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.97 Aligned_cols=193 Identities=23% Similarity=0.367 Sum_probs=159.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||++ |+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 467999999999999954 58899999987543 3345688999999999999999999999999999999999998 69
Q ss_pred hhhHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 438 LAGKLHANHTK-QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 438 L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
|.+++...... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 99998765322 123489999999999999999999998 8999999999999999999999999999765432
Q ss_pred -CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 234567889999999764 68999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.13 Aligned_cols=242 Identities=15% Similarity=0.158 Sum_probs=195.4
Q ss_pred ccccCccCceeEEEEE------EcCCcEEEEEEecccCccChhHHHHHHHHHhcCC---CCccccceeEEEeCCceEEEE
Q 038422 360 AEVLGSGTFGASYKTV------ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE---HPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 430 (634)
.+.||+|+||+||+|+ ..+++.||+|+++.. ...++..|++++++++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4689999999999994 456889999998653 4567888888888887 999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-----------CCCe
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-----------SFEP 499 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-----------~~~~ 499 (634)
|||++|+|.+++..........+++..++.|+.||+.||+|||+. +|+||||||+|||++. ++.+
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccccccCCE
Confidence 999999999999865433334599999999999999999999998 7999999999999998 8999
Q ss_pred EEeccccCCccCC---C---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHH
Q 038422 500 LLTDYALRPLINP---D---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWV 573 (634)
Q Consensus 500 kl~DfGla~~~~~---~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~ 573 (634)
||+|||+++.+.. . ....+|..|+|||++.+..++.++|||||||++|||+||+.||.....+
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------- 291 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----------- 291 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----------
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----------
Confidence 9999999965431 1 2345788999999999999999999999999999999999998532110
Q ss_pred HHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCC-CCHHHHHHHHHhhh
Q 038422 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLAR-MELKEVIEKIERLK 632 (634)
Q Consensus 574 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R-Ps~~evl~~L~~i~ 632 (634)
....+..+.. ....+...++++ .|++.+|.+| |+++++.+.|+++.
T Consensus 292 ---------~~~~~~~~~~-~~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 292 ---------ECKPEGLFRR-LPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ---------EEEECSCCTT-CSSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------ceeechhccc-cCcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0001111111 123455666666 8999999999 68888888888753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.40 Aligned_cols=248 Identities=15% Similarity=0.202 Sum_probs=190.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.||+|++....... .+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 468999999999999965 68899999987543322 36789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999997643 389999999999999999999998 79999999999999999999999999987654332
Q ss_pred ----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 515 ----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
...++..|+|||.+.+..++.++||||||+++|||+||+.||.. .. ...+......... . +..
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~-~~~~~~~~~~~~~-~---~~~ 256 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG--------DQ-LSVMGAHINQAIP-R---PST 256 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS--------CH-HHHHHHHHHSCCC-C---GGG
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC--------ch-HHHHHHHhccCCC-C---ccc
Confidence 23467889999999998999999999999999999999999862 11 1122222222111 0 000
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCC-CHHHHHHHHHhhhc
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARM-ELKEVIEKIERLKE 633 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~~ 633 (634)
.. ....+++.+ ++.+||+.||++|| +++++++.|+++.+
T Consensus 257 ~~-~~~~~~l~~---li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 257 VR-PGIPVAFDA---VIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp TS-TTCCTHHHH---HHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cC-CCCCHHHHH---HHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00 111234444 45599999999999 99999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=339.62 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=187.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 468999999999999975 68899999997543 3456789999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC--eEEeccccCCccCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PLLTDYALRPLINPD--- 513 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~~~~~--- 513 (634)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 104 ~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 104 YERICNAG-----RFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 99997643 389999999999999999999998 8999999999999987765 999999998743322
Q ss_pred CCccccccccCcccccCCCCCcc-hhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKK-SDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k-~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
....+|..|+|||++.+..++.+ +|||||||++|||+||+.||.... ........+........ .+..
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~~~~~~~~-------~~~~ 243 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPRDYRKTIQRILSVKY-------SIPD 243 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCC-------CCCT
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhcCCC-------CCCC
Confidence 33457889999999988887665 899999999999999999986321 11333333333222111 0001
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....+++.+ ++.+||+.||++|||++|+++.
T Consensus 244 ~~~~s~~~~~---li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCH---LISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHH---HHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHH---HHHHHccCChhHCcCHHHHHhC
Confidence 1111244444 4459999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=342.75 Aligned_cols=254 Identities=19% Similarity=0.209 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEEc----CCcEEEEEEecccCcc-----------ChhHHHHHHHHHhcCCCCccccceeEEEe--
Q 038422 360 AEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMNNV-----------GREDFQEHIKRLGRLEHPNLLPLTAFYYR-- 422 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~~~~-- 422 (634)
.+.||+|+||.||+|+.. ++..+|+|+....... ..+.+.+|+..++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 468999999999999975 5778999988754321 23457788899999999999999999988
Q ss_pred --CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC--C
Q 038422 423 --KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF--E 498 (634)
Q Consensus 423 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~--~ 498 (634)
....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESSSTTS
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccCCCCc
Confidence 67889999999 999999987654 399999999999999999999998 899999999999998887 9
Q ss_pred eEEeccccCCccCCC-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCC
Q 038422 499 PLLTDYALRPLINPD-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKA 567 (634)
Q Consensus 499 ~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~ 567 (634)
+||+|||+++.+... ....++..|+|||++.+..++.++|||||||++|||+||+.||.... .. .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~-~ 267 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL---KD-P 267 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT---TC-H
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc---cc-c
Confidence 999999999765322 22346788999999999999999999999999999999999985211 11 1
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
............ .....+....... ...+++.+++ ..||+.||++||+++||++.|+++.
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~l~~li---~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTNLLD-ELPQSVLKWAPSG-SSCCEIAQFL---VCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHH-TTTHHHHHHSCTT-SCCHHHHHHH---HHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHhhcc-cccHHHHhhcccc-ccHHHHHHHH---HHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111111111 1111111111110 1224454544 4999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.74 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=191.1
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCc--------cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEE
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 429 (634)
..+.||+|+||.||+|+. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 357899999999999995 5688999999876432 1334678899999999999999999999999999999
Q ss_pred EEcCCCC-ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 430 YEFVENG-SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 430 ~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
|||+.+| +|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999877 9999986542 399999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCC---ccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 509 LINPDNA---HTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 509 ~~~~~~~---~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
....... ..+|..|+|||++.+..+ +.++|||||||++|||+||+.||......
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------- 236 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------- 236 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------
Confidence 7655432 346789999999988877 88999999999999999999998621110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
............+++.++ +..||+.||++|||++|+++.
T Consensus 237 -~~~~~~~~~~~~~~l~~l---i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIHPPYLVSKELMSL---VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCCCSSCCCHHHHHH---HHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccCCCcccCHHHHHH---HHHHccCChhhCcCHHHHhcC
Confidence 000111111123444444 459999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.79 Aligned_cols=237 Identities=21% Similarity=0.327 Sum_probs=191.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 468999999999999975 58899999997532 33456788899999876 99999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999997643 289999999999999999999998 8999999999999999999999999999764322
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... .... .+
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~-~~~~------~~ 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------QDEEELFHSIR-MDNP------FY 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HCCC------CC
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC--------CCHHHHHHHHH-hCCC------CC
Confidence 234578899999999999999999999999999999999999862 12222222222 1111 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHH-HHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELK-EVI 625 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 625 (634)
. ....+++.+++ .+||+.||++||++. ||.
T Consensus 238 p--~~~s~~~~~li---~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 P--RWLEKEAKDLL---VKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C--TTSCHHHHHHH---HHHSCSSGGGSBTTBSCGG
T ss_pred C--cccCHHHHHHH---HHHhcCCHhHcCCChHHHH
Confidence 1 11224444554 499999999999997 554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=331.35 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=192.1
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 347899999999999996 568999999987533 2234678899999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 116 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 116 AGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp SCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999753321 23489999999999999999999998 89999999999999999999999999987654432
Q ss_pred ----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 515 ----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
...++..|+|||.+.+..++.++|||||||++|||+||+.||... ......+.... .........
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~-~~~~~~~~~---- 259 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKI-EQCDYPPLP---- 259 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHH-HTTCSCCCC----
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc------chhHHHHHHHh-hcccCCCCc----
Confidence 234677899999999999999999999999999999999998521 12233332222 222111110
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.. ...+++.+ ++..||+.||++||+++||++.|+++++
T Consensus 260 -~~-~~~~~l~~---li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 260 -SD-HYSEELRQ---LVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -TT-TSCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cc-ccCHHHHH---HHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11 11234444 4559999999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.74 Aligned_cols=246 Identities=21% Similarity=0.367 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEEc-CCcE----EEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQA----YVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||.||+|+.. +++. |++|.+... .....+.+.+|++++++++||||++++++|..+ ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEec
Confidence 468999999999999954 4443 577776543 344567899999999999999999999999865 488999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp SSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999976533 389999999999999999999998 8999999999999999999999999999876433
Q ss_pred C------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 N------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ....+... +..+.....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~~----~~~~~~~~~- 240 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSI----LEKGERLPQ- 240 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHH----HHTTCCCCC-
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH----HHcCCCCCC-
Confidence 2 1234567999999999999999999999999999999 99998621 11222222 112111000
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......+ +.+++..||+.||.+||+++|+++.|+++.+
T Consensus 241 ------~~~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 ------PPICTID---VYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------CTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------CccCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111233 4455559999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.85 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=188.3
Q ss_pred hccccCccCceeEEEEEEc----CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCc-----eE
Q 038422 359 SAEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE-----KL 427 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~ 427 (634)
..+.||+|+||.||+|+.. .+..||+|.++... ....+.+.+|++++++++||||+++++++.+.+. .+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 4578999999999999864 34589999987542 2234678999999999999999999999987553 49
Q ss_pred EEEEcCCCCChhhHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 428 LLYEFVENGSLAGKLHANHT-KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
+||||+++|+|.+++..... .....+++.+++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEEeecCc
Confidence 99999999999999864432 1234599999999999999999999998 799999999999999999999999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ....+.+. .. .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~---~~-~ 264 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-----QNHEMYDY---LL-H 264 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHHHH---HH-T
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-----CHHHHHHH---HH-c
Confidence 87654321 2234667999999999999999999999999999999 88887521 11222221 11 1
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+..... .....++ +.+++..||+.||++||+++|+++.|+++.+
T Consensus 265 ~~~~~~-------~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 GHRLKQ-------PEDCLDE---LYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TCCCCC-------BTTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC-------CccccHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111110 0111233 4455559999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.40 Aligned_cols=257 Identities=22% Similarity=0.372 Sum_probs=199.0
Q ss_pred hccccCccCceeEEEEEE-----cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC--ceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI-----SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE--EKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e 431 (634)
..+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 357899999999999984 368899999998765555678999999999999999999999987654 6899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp CCTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999976532 389999999999999999999998 89999999999999999999999999997765
Q ss_pred CCC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccc------cCCCC-CcHHHHHHHHH
Q 038422 512 PDN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQ------GYDSK-ASLSNWVNNMV 577 (634)
Q Consensus 512 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~------~~~~~-~~l~~~~~~~~ 577 (634)
... ...++..|+|||.+.+..++.++|||||||++|||+||+.|+..... +.... ......+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 432 22345679999999988899999999999999999999998752110 00000 01111111222
Q ss_pred HhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 578 KEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 578 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+.... ......+++ .+++..||+.||++||+++||++.|+++++
T Consensus 277 ~~~~~~~-------~~~~~~~~l---~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNNGRLP-------RPDGCPDEI---YMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTTCCCC-------CCTTCCHHH---HHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCC-------CCCcccHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111100 011122344 445559999999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.67 Aligned_cols=241 Identities=20% Similarity=0.264 Sum_probs=192.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||+||+++.. +++.||+|++++. .....+.+.+|+.+++.++|||||+++++|.+.+..++|||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999975 4889999998652 223345688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999998643 289999999999999999999998 89999999999999999999999999997765432
Q ss_pred ----CccccccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 515 ----AHTLMVAYKSPEYAHNGK----ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~~----~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
...+|+.|+|||++.+.. ++.++|||||||++|||+||+.||.. ....+............
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~--- 292 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMNHKNSL--- 292 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHC---
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC--------CChhhHHHHHHhccccc---
Confidence 445789999999998655 78999999999999999999999861 22222222222111000
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccC--CCCHHHHHH
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLA--RMELKEVIE 626 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~ 626 (634)
.+.......+++.+++. +|++.+|.+ ||+++||++
T Consensus 293 --~~p~~~~~s~~~~~li~---~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 293 --TFPDDNDISKEAKNLIC---AFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp --CCCTTCCCCHHHHHHHH---HHSSCGGGCTTSSCHHHHHT
T ss_pred --cCCCcccccHHHHHHHH---HHccChhhhCCCCCHHHHhc
Confidence 01111112345555555 999999998 999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.42 Aligned_cols=244 Identities=18% Similarity=0.251 Sum_probs=192.2
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||+||+|+... ++.||+|++++.. ....+.+.+|+.++..++||||++++++|.+++..++|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 4689999999999999765 7899999987532 22334588999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999997532 2399999999999999999999998 89999999999999999999999999997654432
Q ss_pred ----CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 515 ----AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
...+|+.|+|||++. ...++.++|||||||++|||+||+.||.. ....+.............
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~~- 301 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKERFQ- 301 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHCC-
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC--------CChhHHHHhhhhcccccc-
Confidence 245788999999987 56789999999999999999999999862 122222222221110000
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccC--CCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLA--RMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~evl~ 626 (634)
+.... ....+++.++++ +|+..+|++ ||+++|+++
T Consensus 302 ~p~~~---~~~s~~~~dLi~---~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 302 FPTQV---TDVSENAKDLIR---RLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCSSC---CCSCHHHHHHHH---TTSSCGGGCTTTTTTHHHHT
T ss_pred CCccc---ccCCHHHHHHHH---HHhcccccccCCCCHHHHhC
Confidence 00000 112345555555 888888888 999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.10 Aligned_cols=264 Identities=20% Similarity=0.292 Sum_probs=204.7
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCC--ceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE--EKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+... ++.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 4689999999999999754 8999999997543 334577889999999999999999999998765 67999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe----CCCCCeEEeccccCCccC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL----DRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGla~~~~ 511 (634)
|+|.+++...... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 94 GSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp EEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999765432 2389999999999999999999998 89999999999999 788889999999998765
Q ss_pred CCC---CccccccccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 512 PDN---AHTLMVAYKSPEYAHN--------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 512 ~~~---~~~~~~~y~aPE~~~~--------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..... .....+.+.......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG----PRRNKEVMYKIITGK 243 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC----TTTCHHHHHHHHHSC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----ccchHHHHHHHhcCC
Confidence 432 3346788999999865 4678899999999999999999999863221 122233333333221
Q ss_pred cCCcc------------ccccccc-CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 581 RTGDV------------FDKEMKG-AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 581 ~~~~~------------~d~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+ +...+.. .......-..+.+++..||+.||++||+++|+++.++++.+
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11000 0011111 11223444556667779999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.49 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=191.7
Q ss_pred ccCccCceeEEEEEEc---CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 362 VLGSGTFGASYKTVIS---NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.||+|+||.||+|... .++.||+|+++..... ..+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 7999999999999643 3678999998754322 246799999999999999999999999 667889999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC-
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA- 515 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 515 (634)
+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999997642 389999999999999999999998 899999999999999999999999999876644322
Q ss_pred ------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 516 ------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 516 ------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
..++..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+ +...+..+....
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~-~~~~~~~~~~~~---- 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSE-VTAMLEKGERMG---- 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHH-HHHHHHTTCCCC----
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--------CHHH-HHHHHHcCCCCC----
Confidence 223567999999988889999999999999999999 99998621 1111 122222221111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
. .....+++. +++..||+.||++||+++||++.|+++.
T Consensus 241 -~--~~~~~~~l~---~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 -C--PAGCPREMY---DLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -C--CTTCCHHHH---HHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -C--CCCCCHHHH---HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111224444 4555999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.27 Aligned_cols=247 Identities=23% Similarity=0.397 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEEcC----CcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISN----GQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+..+ ...+|+|.+..... ...+.+.+|++++++++||||++++++|.. ++..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 4789999999999998643 23588888875432 334678999999999999999999999754 45789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 110 ~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 110 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp TTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999997533 2389999999999999999999998 8999999999999999999999999999765432
Q ss_pred --------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 514 --------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTG-KYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 514 --------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg-~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
....++..|+|||.+.+..++.++|||||||++|||+|| ..||.. .....+... .. .+.. .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~---~~-~~~~-~ 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFDITVY---LL-QGRR-L 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-----SCTTTHHHH---HH-TTCC-C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-----CCHHHHHHH---Hh-cCCC-C
Confidence 122345679999999999999999999999999999995 455431 111222221 11 1111 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
. . .....++ +.+++..||+.||++||+++|+++.|+++.+
T Consensus 252 ~-~-----~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 L-Q-----PEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp C-C-----CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-C-----CccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 1111234 4455559999999999999999999998854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.37 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=195.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 47899999999999996 5789999999876655566789999999999999999999999973 346789999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++...... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 114 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 114 RGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999764322 23499999999999999999999998 79999999999999999999999999986543211
Q ss_pred -------------CccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 515 -------------AHTLMVAYKSPEYAHNGK---ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 515 -------------~~~~~~~y~aPE~~~~~~---~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
...++..|+|||.+.+.. ++.++|||||||++|||+||+.||....... ..+...+ .
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~----~ 261 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALAV----Q 261 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHHH----H
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHHh----h
Confidence 112467899999987554 6899999999999999999999986322111 1222111 1
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.. . .........+++. +++..||+.||.+||+++||++.|+.+..
T Consensus 262 ~~-~------~~~~~~~~~~~l~---~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 NQ-L------SIPQSPRHSSALW---QLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp CC---------CCCCTTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred cc-C------CCCccccCCHHHH---HHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 10 0 0000011123444 45559999999999999999999998854
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.32 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred ccccCccCceeEEEEEEc-----CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC--CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-----NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 431 (634)
.+.||+|+||+||++.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 468999999999988653 57899999997643 23356789999999999999999999999884 56789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999643 289999999999999999999998 89999999999999999999999999998765
Q ss_pred CCC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCccccccc------CCCCCcHHHHHHHHHH
Q 038422 512 PDN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG------YDSKASLSNWVNNMVK 578 (634)
Q Consensus 512 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~------~~~~~~l~~~~~~~~~ 578 (634)
... ...++..|+|||.+.+..++.++|||||||++|||+||+.||...... ......-...+.....
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 223566799999999889999999999999999999999998632110 0000000001111111
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+.... .......+ +.+++..||+.||++|||++|+++.|+++.+
T Consensus 266 ~~~~~~-------~~~~~~~~---l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLP-------RPDKCPAE---VYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCC-------CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCC-------CCccccHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111100 01111234 4455559999999999999999999998864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=327.14 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=189.6
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 4578999999999999964 58899999987543 345678999999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccCCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~ 513 (634)
+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 106 ~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 106 ELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp BHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred cHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 999998654321 12499999999999999999999998 89999999999999 45678999999999765443
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....++..|+|||.+. ..++.++|||||||++|||+||+.||.. ....+........... .....
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~---~~~~~ 248 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG--------TSLEEVQQKATYKEPN---YAVEC 248 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCC---CCC--
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC--------CCHHHHHhhhccCCcc---ccccc
Confidence 2345678899999885 5789999999999999999999999862 2222222221111110 00000
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ..+++. +++..||+.||++|||++||++
T Consensus 249 --~~-~~~~~~---~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 --RP-LTPQAV---DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC-CCHHHH---HHHHHHTCSCTTTSCCHHHHHT
T ss_pred --Cc-CCHHHH---HHHHHHccCChhhCcCHHHHhc
Confidence 11 123444 4555999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.27 Aligned_cols=247 Identities=18% Similarity=0.262 Sum_probs=187.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEeCCce----EEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEK----LLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lv~e 431 (634)
.+.||+|+||.||+++. .+++.||+|+++...... .+.+.+|++++++++||||+++++++...... ++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 46899999999999995 568999999997643322 34788999999999999999999999776543 99999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999997643 389999999999999999999998 79999999999999999999999999997654
Q ss_pred CCC-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PDN-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
... ...++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------DSPVSVAYQHVREDPIP- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCCCC-
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHhcCCCCC-
Confidence 321 23467889999999999999999999999999999999999862 22222222222222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHH-HHHHhh
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVI-EKIERL 631 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl-~~L~~i 631 (634)
+..... ...+++. +++.+||+.||++||+..+++ +.+.++
T Consensus 239 ---~~~~~~-~~~~~l~---~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ---PSARHE-GLSADLD---AVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---HHHHST-TCCHHHH---HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---cccccC-CCCHHHH---HHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 111011 1123444 455599999999999665544 555544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=324.76 Aligned_cols=242 Identities=19% Similarity=0.280 Sum_probs=194.1
Q ss_pred hccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+|+... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 35789999999999999654 67899999987666677899999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccCCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~- 513 (634)
|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 93 LFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp HHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999987643 389999999999999999999998 89999999999999 78899999999998765443
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||.+.+ .++.++|||||||++|||+||+.||.. ..-.+... .+..+... .......
T Consensus 164 ~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~-~~~~~~~~-~~~~~~~ 232 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA--------PTDSEVML-KIREGTFT-FPEKDWL 232 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHH-HHHHCCCC-CCHHHHT
T ss_pred chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCC--------CCHHHHHH-HHHhCCCC-CCchhhh
Confidence 23456788999999865 499999999999999999999999862 11112221 22222111 1000000
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++ .+++..|++.||++||++.|+++
T Consensus 233 ---~~~~~~---~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 ---NVSPQA---ESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---TSCHHH---HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCCHHH---HHHHHHHccCChhhCcCHHHHhc
Confidence 112334 44555999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=332.69 Aligned_cols=237 Identities=21% Similarity=0.243 Sum_probs=183.1
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||++++++|.+++..++||||+
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~- 139 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-
Confidence 4568999999999999976 689999999865322 2233455555555554 9999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++..... .++|..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 140 ~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 140 GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 6799998876543 399999999999999999999998 79999999999999999999999999987664432
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+|..|+|||++.+ .++.++|||||||++|||++|..|+... . .| ..+..+.. .+.+.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-------~---~~--~~~~~~~~----~~~~~ 274 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-------E---GW--QQLRQGYL----PPEFT 274 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-------H---HH--HHHTTTCC----CHHHH
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-------c---HH--HHHhccCC----Ccccc
Confidence 3346889999998875 7999999999999999999997765310 1 11 11111111 11111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ...++ +.+++..||+.||++|||++|+++
T Consensus 275 ~--~~~~~---l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 A--GLSSE---LRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp T--TSCHH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c--CCCHH---HHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 11234 444555999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.79 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=192.7
Q ss_pred ccccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence 4689999999999998643 3469999987542 2345679999999999999999999999754 56789999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 96 YGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999976432 389999999999999999999998 89999999999999999999999999987654432
Q ss_pred -----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 515 -----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||... ........ +..+.....
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~-----~~~~~~~~----~~~~~~~~~--- 235 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-----ENKDVIGV----LEKGDRLPK--- 235 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CGGGHHHH----HHHTCCCCC---
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC-----ChHHHHHH----HhcCCCCCC---
Confidence 2334667999999998899999999999999999999 99998621 11222221 111111000
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.....+++. +++..||+.||++||+++|+++.|+++.
T Consensus 236 ----~~~~~~~l~---~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 236 ----PDLCPPVLY---TLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ----CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHH---HHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 111123444 4555999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=330.48 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=189.8
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.||+|+||+||+|+. .+++.||+|++........+.+.+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5799999999999994 46899999999876666678899999999885 799999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC---eEEeccccCCccCCC--
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE---PLLTDYALRPLINPD-- 513 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~~~~~-- 513 (634)
.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99997653 389999999999999999999998 7999999999999998776 999999998765321
Q ss_pred ---------CCccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCC---CCc---HHHHH
Q 038422 514 ---------NAHTLMVAYKSPEYAHN-----GKISKKSDVWSLGILILELLTGKYPENYLLQGYDS---KAS---LSNWV 573 (634)
Q Consensus 514 ---------~~~~~~~~y~aPE~~~~-----~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~---~~~---l~~~~ 573 (634)
....++..|+|||++.. ..++.++|||||||++|||+||+.||......... ... ....+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12236788999999875 45889999999999999999999998632111100 000 01111
Q ss_pred HHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 574 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+..+.. ...+... ....++ +.+++.+||+.||++|||++|+++
T Consensus 250 ~~~i~~~~~-~~~~~~~---~~~~~~---~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGKY-EFPDKDW---AHISCA---AKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCCC-CCCHHHH---TTSCHH---HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccCc-ccCchhc---ccCCHH---HHHHHHHHhhCChhhCCCHHHHhc
Confidence 122222211 1101100 011233 445555999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.23 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=175.5
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.||+|+||+||+++.. +++.||+|++... ....+.+|++++++++ ||||+++++++.+++..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999975 5889999998643 3567889999999997 99999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC---CeEEeccccCCccCCCC-
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF---EPLLTDYALRPLINPDN- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~~~~~~- 514 (634)
.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 94 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 94 FERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99997643 399999999999999999999998 899999999999997665 89999999997654432
Q ss_pred ---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 ---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+|..|+|||++.+..++.++|||||||++|||+||+.||........ .....+.. ..+..+... ...+...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~-~~i~~~~~~-~~~~~~~ 241 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIM-KKIKKGDFS-FEGEAWK 241 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHH-HHHTTTCCC-CCSHHHH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHH-HHHHcCCCC-CCccccc
Confidence 23457889999999999999999999999999999999999863221111 11222222 222222110 0000000
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++ .+++..||+.||++|||++|+++
T Consensus 242 ---~~s~~~---~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 ---NVSQEA---KDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ---TSCHHH---HHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ---CCCHHH---HHHHHHHCCCChhHCCCHHHHhc
Confidence 012334 44555999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.21 Aligned_cols=252 Identities=16% Similarity=0.207 Sum_probs=195.1
Q ss_pred ccccCccCceeEEEEEEcC---------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCcccc---------------
Q 038422 360 AEVLGSGTFGASYKTVISN---------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLP--------------- 415 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------------- 415 (634)
.+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 4689999999999999764 789999998753 46889999999999999998
Q ss_pred ceeEEEe-CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC
Q 038422 416 LTAFYYR-KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD 494 (634)
Q Consensus 416 l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~ 494 (634)
+++++.. ++..++||||+ +|+|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENIFVD 193 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGEEEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEEc
Confidence 6778876 67889999999 9999999986521 2399999999999999999999998 899999999999999
Q ss_pred CCC--CeEEeccccCCccCCC-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccc
Q 038422 495 RSF--EPLLTDYALRPLINPD-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQ 561 (634)
Q Consensus 495 ~~~--~~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~ 561 (634)
.++ .+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 8999999999765432 123567889999999998999999999999999999999999873211
Q ss_pred cCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 562 GYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 562 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+........ . ......+....... ..+++.++++ .||+.||++||+++||++.|+++.+
T Consensus 274 ---~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~-~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 274 ---NTEDIMKQKQKFV-D-KPGPFVGPCGHWIR-PSETLQKYLK---VVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp ---CHHHHHHHHHHHH-H-SCCCEECTTSCEEC-CCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHhcc-C-ChhhhhhhccccCC-CcHHHHHHHH---HHHhCChhhCCCHHHHHHHHHHHHH
Confidence 1112222222111 1 12222222111111 1244555554 9999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=334.08 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=198.6
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 3578999999999999864 367899999875432 234578999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 432 FVENGSLAGKLHANHT-----KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
|+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCeEEECcCcc
Confidence 9999999999975321 1123479999999999999999999998 899999999999999999999999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+.... +..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~~~~-~~~ 255 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQVLRF-VME 255 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHHHHHH-HHT
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc--------CCHHHHHHH-HHc
Confidence 87654321 2234677999999998899999999999999999999 8888752 122222222 222
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+..... .....+++. +++..||+.||.+||+++|+++.|+++.+
T Consensus 256 ~~~~~~-------~~~~~~~l~---~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLDK-------PDNCPDMLF---ELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCCC-------CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCCC-------CCCCCHHHH---HHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 211111 111223444 45559999999999999999999998743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=335.69 Aligned_cols=238 Identities=19% Similarity=0.251 Sum_probs=191.8
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEeccc---CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQM---NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+++... ++.||+|+++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 4689999999999999764 789999998753 234456788999999988 89999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999997643 289999999999999999999998 8999999999999999999999999999764322
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.. ....+........ .. .+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~-~~------~~ 240 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIMEH-NV------AY 240 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHC-CC------CC
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhC-CC------CC
Confidence 234578899999999999999999999999999999999999862 1222222222221 11 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
+.....++.+++ ..||+.||++||+ ++|+++
T Consensus 241 --p~~~s~~~~~li---~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 --PKSMSKEAVAIC---KGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CTTSCHHHHHHH---HHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCHHHHHHH---HHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111224444444 4999999999995 466653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=327.06 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=195.2
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe---------------
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--------------- 422 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------------- 422 (634)
..+.||+|+||.||+|+.. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 3478999999999999975 68999999987542 467899999999999999999999864
Q ss_pred -CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEE
Q 038422 423 -KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501 (634)
Q Consensus 423 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 501 (634)
....++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCEEE
Confidence 3457899999999999999976532 2489999999999999999999998 8999999999999999999999
Q ss_pred eccccCCccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 502 TDYALRPLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 502 ~DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+||..|+... ..+. ....
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~-~~~~ 232 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFF-TDLR 232 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHH-HHHH
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHH-HHhh
Confidence 999998766443 2345678899999999989999999999999999999999986411 1111 1111
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+... ... ..++. +++..||+.||.+||+++|+++.|+.+.+
T Consensus 233 ~~~~~---------~~~-~~~~~---~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 233 DGIIS---------DIF-DKKEK---TLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TTCCC---------TTS-CHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccccc---------ccC-CHHHH---HHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 21111 111 23344 45559999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.31 Aligned_cols=189 Identities=23% Similarity=0.373 Sum_probs=163.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+.. +++.||+|+++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 467999999999999965 5889999999754322 236788999999999999999999999999999999999975
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 66666654332 399999999999999999999998 8999999999999999999999999999765432
Q ss_pred -CCccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++.+.. ++.++|||||||++|||+||..|+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 2345678899999998765 7999999999999999999998863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.58 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=185.3
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||.||+++. .+++.||+|+++.. .......+.+|++++++++||||++++++|.+.+..++|||||+
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 357899999999999995 46889999998753 23334567889999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN-ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999997643 38999999999999999999998 6 7999999999999999999999999999764332
Q ss_pred ----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 ----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
....+|..|+|||++.+..++.++|||||||++|||+||+.||.. ....+......... . .
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~-~------~ 367 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILMEE-I------R 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCC-C------C
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHHhCC-C------C
Confidence 234578899999999999999999999999999999999999852 22222222222211 1 0
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
+ .....+++.+++ ..||+.||++|| +++|+++
T Consensus 368 ~--p~~~~~~~~~li---~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 F--PRTLGPEAKSLL---SGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C--CTTSCHHHHHHH---HHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CccCCHHHHHHH---HHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 111224444444 499999999999 9999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.19 Aligned_cols=243 Identities=18% Similarity=0.274 Sum_probs=183.4
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHH-hcCCCCccccceeEEEe----CCceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRL-GRLEHPNLLPLTAFYYR----KEEKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lv~e~~~ 434 (634)
++||+|+||+||+++.. +++.||+|+++. ...+.+|++++ +..+||||++++++|.. .+..++|||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999965 588999999863 34677888887 45589999999999876 556899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCCccC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRPLIN 511 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 511 (634)
+|+|.+++..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999976432 2499999999999999999999998 8999999999999998 7889999999998655
Q ss_pred CC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 512 PD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 512 ~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
.. ....+|..|+|||++.+..++.++|||||||++|||+||+.||........ ...... .+..+.. ....+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~----~i~~~~~-~~~~~ 289 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKT----RIRMGQY-EFPNP 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-CCSHHH----HHHHTCC-CCCTT
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-cHHHHH----HHHcCcc-cCCCc
Confidence 43 234567889999999999999999999999999999999999863211100 011111 1111111 11011
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. ....+++.+ ++..||+.||++|||++|+++.
T Consensus 290 ~~---~~~s~~~~~---li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EW---SEVSEEVKM---LIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT---TTSCHHHHH---HHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc---ccCCHHHHH---HHHHHCCCChhHCcCHHHHhcC
Confidence 11 112244444 4559999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.31 Aligned_cols=238 Identities=21% Similarity=0.386 Sum_probs=193.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999965 68999999986532 23456789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 101 GELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999986432 399999999999999999999998 89999999999999999999999999998765432
Q ss_pred --CccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+++.|+|||++.+..+ +.++|||||||++|||+||+.||.. ........... .+.. .
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~-~~~~--------~ 234 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD--------DHVPTLFKKIC-DGIF--------Y 234 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC--------SSSHHHHHHHH-TTCC--------C
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHh-cCCc--------C
Confidence 3457888999999988766 6899999999999999999999862 12222222222 1111 0
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.......++.+ ++..||+.||++|||++|+++
T Consensus 235 ~p~~~s~~~~~---Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQYLNPSVIS---LLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCTTCCHHHHH---HHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccCCHHHHH---HHHHHcCCCchhCcCHHHHHh
Confidence 11112244444 445999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=342.28 Aligned_cols=191 Identities=22% Similarity=0.317 Sum_probs=166.8
Q ss_pred ccccCcc--CceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSG--TFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+| +||.||+++.. +++.||+|+++... ....+.+.+|++++++++|||||++++++.+++..++|||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4689999 99999999975 68999999997543 2234578889999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC--
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP-- 512 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-- 512 (634)
+|+|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+.....
T Consensus 110 ~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 110 YGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TCBHHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCHHHHHhhhccc---CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999765322 399999999999999999999998 899999999999999999999999998753311
Q ss_pred ---------CCCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 ---------DNAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ---------~~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.....++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 238 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 122356778999999987 579999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=336.09 Aligned_cols=240 Identities=22% Similarity=0.349 Sum_probs=186.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCC--CccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEH--PNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++...+++.||+|++.... ....+.+.+|++++++++| |||+++++++.+++..++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 46899999999999999889999999987543 2234678999999999987 999999999999999999999 568
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 93 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 93 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 89999997643 389999999999999999999998 799999999999997 5789999999998764432
Q ss_pred -----CccccccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 515 -----AHTLMVAYKSPEYAHN-----------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~-----------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
...+|..|+|||++.+ ..++.++|||||||++|||+||+.||... ............
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~~~~~ 235 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAIID 235 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-------hhHHHHHHHHhc
Confidence 2357889999999864 67899999999999999999999998621 111111222221
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
..... .+ .....+++. +++..||+.||.+|||++|+++.
T Consensus 236 ~~~~~-----~~--~~~~~~~l~---~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 PNHEI-----EF--PDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TTSCC-----CC--CCCSCHHHH---HHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccc-----CC--cccCCHHHH---HHHHHHcCCChhHCCCHHHHHhC
Confidence 11100 11 111223444 45559999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.47 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=189.6
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeC-CceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-EEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||++.. +++.||+|.++.. ...+.+.+|++++++++||||+++++++.+. +..++||||+++|+
T Consensus 25 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 347899999999999987 4889999998753 3567899999999999999999999997654 47899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-CCc
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-NAH 516 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~ 516 (634)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 102 L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 102 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp HHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 9999976432 1278999999999999999999998 7999999999999999999999999998765433 233
Q ss_pred cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 517 TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 517 ~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
.++..|+|||.+.+..++.++||||||+++|||+| |+.||... ....+.. .+..+.. ... ...
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-----~~~~~~~----~~~~~~~-----~~~--~~~ 238 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVP----RVEKGYK-----MDA--PDG 238 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHH----HHTTTCC-----CCC--CTT
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH----HHhcCCC-----CCC--ccc
Confidence 45678999999998899999999999999999999 99998621 1112211 1111111 111 111
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+++.+ ++..||+.||++||+++|+++.|++++.
T Consensus 239 ~~~~l~~---li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 239 CPPAVYE---VMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHH---HHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 2244444 4459999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=333.97 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=194.5
Q ss_pred hccccCccCceeEEEEEEc-CCcE--EEEEEeccc-CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQA--YVVKRYKQM-NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|+.. ++.. +++|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 3578999999999999964 4554 488888753 234456899999999999 9999999999999999999999999
Q ss_pred CCCChhhHHhhccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 434 ENGSLAGKLHANHT-----------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 434 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
++|+|.+++..... .....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCeEEEc
Confidence 99999999976430 1123599999999999999999999998 89999999999999999999999
Q ss_pred ccccCCccCC---CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 503 DYALRPLINP---DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 503 DfGla~~~~~---~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
|||+++.... .....++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+... .+.
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~--------~~~~~~~~-~~~ 255 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELYE-KLP 255 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHH-HGG
T ss_pred ccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC--------CcHHHHHH-Hhh
Confidence 9999874332 122344678999999988889999999999999999999 9999852 12222221 111
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+... .. .....+++ .+++..||+.||++||+++|+++.|+++.+
T Consensus 256 ~~~~~-----~~--~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 256 QGYRL-----EK--PLNCDDEV---YDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GTCCC-----CC--CTTBCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC-----CC--CCCCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11110 00 11112344 445559999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.41 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=188.7
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHH--HhcCCCCccccceeEEEe-----CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKR--LGRLEHPNLLPLTAFYYR-----KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|+. +++.||+|++... ....+..|.++ +..++||||+++++++.. ....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 46899999999999976 6899999998643 23445555554 456899999999987653 2256899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-----CCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG-----SIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-----~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
+++|+|.+++.... .++..+..++.||+.||+|||+.++. .+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999996532 68999999999999999999986211 15999999999999999999999999999
Q ss_pred CccCCC------------CCccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCc
Q 038422 508 PLINPD------------NAHTLMVAYKSPEYAHN-------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKAS 568 (634)
Q Consensus 508 ~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~ 568 (634)
+..... ....+|..|+|||++.+ ..++.++|||||||++|||+||..|+............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 765432 12347889999999976 35677999999999999999998876422111110011
Q ss_pred H---------HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 569 L---------SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 569 l---------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+ .+..............+..... ........+.+++..||+.||++|||++||++.|+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccc---cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1 1111111111111111111111 112233456667779999999999999999999998853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=328.98 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=194.9
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc------cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+++.. +|+.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 4578999999999999965 588999999875432 235789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC----CeEEeccccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF----EPLLTDYALR 507 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 507 (634)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 96 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp CCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999997532 389999999999999999999998 899999999999999887 7999999999
Q ss_pred CccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 508 PLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 508 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
+..... ....++..|+|||.+.+..++.++|||||||++|||+||+.||.. ....+...... ... .
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~i~-~~~--~ 235 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANIT-SVS--Y 235 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHH-TTC--C
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHH-hcc--c
Confidence 766543 233467889999999999999999999999999999999999852 11222222221 111 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+++.... ...+++. +++..||+.||++|||++|+++
T Consensus 236 ~~~~~~~~--~~~~~~~---~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFS--HTSELAK---DFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHT--TCCHHHH---HHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhc--ccCHHHH---HHHHHHcCCChhhCcCHHHHhc
Confidence 11111111 1123444 4555999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.18 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=197.5
Q ss_pred ccccCccCceeEEEEEEcC-C-----cEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISN-G-----QAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 431 (634)
.+.||+|+||.||+|.... + ..||+|.++.... ...+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 5789999999999999643 2 4799999875432 3346789999999999 89999999999999999999999
Q ss_pred cCCCCChhhHHhhccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEe
Q 038422 432 FVENGSLAGKLHANHTK---------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLT 502 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 502 (634)
|+++|+|.+++...... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEEEGGGEEEBC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEECCCCeEEEC
Confidence 99999999999754210 123489999999999999999999998 89999999999999999999999
Q ss_pred ccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHH
Q 038422 503 DYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNN 575 (634)
Q Consensus 503 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~ 575 (634)
|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |..||... .. ...+..
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~~----~~~~~~ 278 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI----LV----NSKFYK 278 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----CS----SHHHHH
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc----ch----hHHHHH
Confidence 999997654322 2234567999999998899999999999999999999 99998621 11 111222
Q ss_pred HHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 576 MVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 576 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+.... ......+++ .+++..||+.||.+|||++||++.|+++.+
T Consensus 279 ~~~~~~~~~-------~~~~~~~~l---~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 279 LVKDGYQMA-------QPAFAPKNI---YSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHTCCCC-------CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCC-------CCCCCCHHH---HHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 222221100 011122344 445559999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.62 Aligned_cols=237 Identities=15% Similarity=0.174 Sum_probs=181.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHH---HHHhcCCCCccccce-------eEEEeCCc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHI---KRLGRLEHPNLLPLT-------AFYYRKEE 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~~~~~~ 425 (634)
.+.||+|+||+||+|+. .+|+.||+|++... .....+.+.+|+ +++++++|||||+++ +++.+.+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46899999999999995 56899999999743 223346789999 556666899999998 66665532
Q ss_pred -----------------eEEEEEcCCCCChhhHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCC
Q 038422 426 -----------------KLLLYEFVENGSLAGKLHANHTKQ--RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHL 486 (634)
Q Consensus 426 -----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl 486 (634)
.++||||+ +|+|.+++....... ...+++..+..|+.||+.||+|||+. +|+||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDi 232 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 232 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 78999999 689999998643211 12355688899999999999999998 8999999
Q ss_pred CCCCEEeCCCCCeEEeccccCCccCCCC-CccccccccCcccccCC-----------CCCcchhHHHHHHHHHHHHhCCC
Q 038422 487 KSSNVLLDRSFEPLLTDYALRPLINPDN-AHTLMVAYKSPEYAHNG-----------KISKKSDVWSLGILILELLTGKY 554 (634)
Q Consensus 487 k~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~k~DVwSfGvvl~elltg~~ 554 (634)
||+|||++.++.+||+|||+++...... ...+ ..|+|||++.+. .++.++|||||||++|||+||+.
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999998644322 2334 889999999887 89999999999999999999999
Q ss_pred CcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 555 PENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 555 P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
||...... . ....+. .......+++.+ ++..||+.||++||++.|+++
T Consensus 312 Pf~~~~~~-----~------------~~~~~~----~~~~~~~~~~~~---li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 312 PITKDAAL-----G------------GSEWIF----RSCKNIPQPVRA---LLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp CC-----------C------------CSGGGG----SSCCCCCHHHHH---HHHHHTCSSGGGCCCHHHHHT
T ss_pred CCcccccc-----c------------chhhhh----hhccCCCHHHHH---HHHHHcCCCchhCCCHHHHhh
Confidence 98521110 0 000111 111112344444 455999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=325.04 Aligned_cols=239 Identities=23% Similarity=0.342 Sum_probs=173.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46799999999999996 578999999986432 23346789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 96 GEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 99999997543 2489999999999999999999998 8999999999999999999999999998765432
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||.+.+..++.++|||||||++|||+||+.||.... ..... . ........
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~-------~-----~~~~~~~~ 230 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT-----VKNTL-------N-----KVVLADYE 230 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCS-----CC-----------------CCSSCCC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh-----HHHHH-------H-----HHhhcccC
Confidence 12346788999999998889999999999999999999999986211 01100 0 00000111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.......++. +++.+||+.||++||+++|+++
T Consensus 231 ~~~~~~~~~~---~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLSIEAK---DLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSCHHHH---HHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccCHHHH---HHHHHHcccCHhhCCCHHHHhc
Confidence 1111223444 4555999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.27 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=197.5
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeCC-ceEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKE-EKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~lv 429 (634)
..+.||+|+||+||+|+. .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 357899999999999984 3468999999875432 2345789999999999 7999999999997755 48999
Q ss_pred EEcCCCCChhhHHhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC
Q 038422 430 YEFVENGSLAGKLHANHTKQ-----------RPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE 498 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 498 (634)
|||+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCC
Confidence 99999999999997654210 12388999999999999999999998 7999999999999999999
Q ss_pred eEEeccccCCccCCCCC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHH
Q 038422 499 PLLTDYALRPLINPDNA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSN 571 (634)
Q Consensus 499 ~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~ 571 (634)
+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||... . ..+
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~----~~~ 258 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----K----IDE 258 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----C----CSH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc----c----hhH
Confidence 99999999986644322 234567999999999999999999999999999999 99998521 1 111
Q ss_pred HHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 572 WVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+......+..... ......++ .+++..||+.||.+|||++||++.|+++.+
T Consensus 259 ~~~~~~~~~~~~~~-------~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 259 EFCRRLKEGTRMRA-------PDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHHHHHTCCCCC-------CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCccCCC-------CCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12222222211111 11122344 445559999999999999999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=320.14 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=195.3
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc------cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||.||+++.. +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 3578999999999999976 589999999875421 246789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC----CeEEeccccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF----EPLLTDYALR 507 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 507 (634)
|+++++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 89 LVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred ecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999997543 389999999999999999999998 899999999999998877 7999999998
Q ss_pred CccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 508 PLINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 508 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
....... ...++..|+|||.+.+..++.++||||||+++|||+||+.||.. ....+..... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~-~~~~~-- 228 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------ETKQETLTNI-SAVNY-- 228 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHH-HTTCC--
T ss_pred eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC--------cchHHHHHHh-Hhccc--
Confidence 7654432 23467889999999988999999999999999999999999862 1111221111 11110
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH--HHHhhh
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE--KIERLK 632 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~--~L~~i~ 632 (634)
..+..... ...+++ .+++.+||+.||++||+++|+++ .++.++
T Consensus 229 ~~~~~~~~--~~~~~~---~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 DFDEEYFS--NTSELA---KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCCHHHHT--TCCHHH---HHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCcchhcc--cCCHHH---HHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 01111101 112334 44555999999999999999997 355543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=338.76 Aligned_cols=241 Identities=20% Similarity=0.282 Sum_probs=184.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHHHH-HhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHIKR-LGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+++.. +++.||+|++++... ...+.+..|..+ ++.++|||||++++++.+.+..|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999975 478999999976432 223456667766 57789999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC-
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP- 512 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~- 512 (634)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999997643 389999999999999999999998 899999999999999999999999999975322
Q ss_pred ---CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 ---DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ---~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.....+|..|+|||++.+..++.++|||||||++|||++|+.||.. ....+......... . .
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~-~------~ 257 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RNTAEMYDNILNKP-L------Q 257 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--------SBHHHHHHHHHHSC-C------C
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhcc-c------C
Confidence 2234578899999999999999999999999999999999999852 22222222222211 1 0
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L 628 (634)
+ ......++.++++ .||+.||++||++.+.++++
T Consensus 258 ~--~~~~~~~~~~li~---~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 L--KPNITNSARHLLE---GLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C--CSSSCHHHHHHHH---HHTCSSGGGSTTTTTTHHHH
T ss_pred C--CCCCCHHHHHHHH---HHcccCHHhCCCCCCCHHHH
Confidence 1 1112344555555 99999999999986544443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.05 Aligned_cols=239 Identities=21% Similarity=0.318 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 467999999999999865 46789999986432 23456789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999997653 289999999999999999999998 8999999999999999999999999998655433
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.. ....+..... ..... .+ .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~-~~~~~------~~--~ 227 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--------NTYQETYKRI-SRVEF------TF--P 227 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHH-HHTCC------CC--C
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC--------CcHHHHHHHH-HhCCC------CC--C
Confidence 234567889999999999999999999999999999999999861 2222222221 11111 11 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
....+++.++ +..||+.||++||+++||++.
T Consensus 228 ~~~~~~~~~l---i~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDL---ISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHH---HHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHH---HHHHhccChhhCCCHHHHhhC
Confidence 1122444444 459999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.14 Aligned_cols=239 Identities=22% Similarity=0.351 Sum_probs=186.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCC--CCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLE--HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||++...+++.||+|++.... ....+.+.+|++++++++ |||||++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 46899999999999998889999999986542 233467899999999996 5999999999999999999999 568
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 89999997643 389999999999999999999998 799999999999996 5789999999998764432
Q ss_pred -----CccccccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 515 -----AHTLMVAYKSPEYAHN-----------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~-----------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
...+|+.|+|||++.+ ..++.++|||||||++|||+||+.||... ......+.....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-------~~~~~~~~~~~~ 282 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAIID 282 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CCHHHHHHHHHC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh-------hHHHHHHHHHhC
Confidence 3457889999999865 46899999999999999999999998621 111222222221
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.... ..+ .....+++. +++..||+.||++||+++||++
T Consensus 283 ~~~~-----~~~--~~~~~~~~~---~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 283 PNHE-----IEF--PDIPEKDLQ---DVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TTSC-----CCC--CCCSCHHHH---HHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccc-----CCC--CccchHHHH---HHHHHHcccChhhCCCHHHHhh
Confidence 1110 011 111123444 4555999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=344.04 Aligned_cols=243 Identities=19% Similarity=0.210 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||+||+++.. +++.||+|++++.. ....+.+.+|.+++.+++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 468999999999999974 68999999997532 22334688999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 146 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 146 GDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999976432 389999999999999999999998 89999999999999999999999999997765432
Q ss_pred ----CccccccccCccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 515 ----AHTLMVAYKSPEYAH-------NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~-------~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
...+|..|+|||++. ...++.++|||||||++|||+||+.||.. ....+............
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA--------DSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcccCc
Confidence 235788999999987 35689999999999999999999999862 12222222222111000
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCC---CCHHHHHH
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLAR---MELKEVIE 626 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R---Ps~~evl~ 626 (634)
. -+... ....+++.++++ +|+. +|.+| |+++|+++
T Consensus 290 ~--~p~~~--~~~s~~~~dli~---~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 S--LPLVD--EGVPEEARDFIQ---RLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp C--CC------CCCHHHHHHHH---TTSS-CGGGCTTTTTHHHHHT
T ss_pred C--CCccc--cCCCHHHHHHHH---HHcC-ChhhcCCCCCHHHHhc
Confidence 0 01110 112345555555 9999 99998 68998864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.56 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=180.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEe--------CCceEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYR--------KEEKLL 428 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--------~~~~~l 428 (634)
..++||+|+||.||+++.. +++.||+|++........+.+.+|+.+++++. ||||+++++++.. ....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 3578999999999999964 68999999987665555678899999999996 9999999999953 234789
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ccccCCCCCCEEeCCCCCeEEecccc
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI--IPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
||||+. |+|.+++...... ..+++.++..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 112 v~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 999996 7999998754322 2499999999999999999999998 6 99999999999999999999999999
Q ss_pred CCccCCCC----------------CccccccccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCC
Q 038422 507 RPLINPDN----------------AHTLMVAYKSPEYA---HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKA 567 (634)
Q Consensus 507 a~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~ 567 (634)
++...... ...++..|+|||++ .+..++.++|||||||++|||+||+.||....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------- 257 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA------- 257 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh-------
Confidence 98764422 22367789999998 56678999999999999999999999986211
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
...... . ... . .. ......+ +.+++..||+.||.+||+++|+++.|+++.
T Consensus 258 -~~~~~~----~-~~~-~---~~--~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 258 -KLRIVN----G-KYS-I---PP--HDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------CC-C---CT--TCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHhhc----C-ccc-C---Cc--ccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001100 0 000 0 00 0011122 344555999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.49 Aligned_cols=251 Identities=15% Similarity=0.178 Sum_probs=194.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEE-EeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY-YRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|++++++++|++++..++++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46799999999999996 678999999986543 345789999999999999888777766 4566789999999 999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccCCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~- 513 (634)
|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 91 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999975432 399999999999999999999998 89999999999999 48889999999998765432
Q ss_pred ----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 ----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 ----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
....++..|+|||.+.+..++.++|||||||++|||+||+.||...... .....+........... .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~-~- 239 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTP-I- 239 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSC-H-
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch-hhhhhhhhhcccccCCc-h-
Confidence 2335678899999999999999999999999999999999998732211 11112222211111110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+.+ ... ..+++ .+++..||+.||++||+++||++.|+++.+
T Consensus 240 ----~~~-~~~-~~~~l---~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 240 ----EVL-CKG-YPSEF---ATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ----HHH-TTT-SCHHH---HHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----HHH-Hhh-CCHHH---HHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 001 011 12344 445559999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=335.81 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=188.6
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc-----CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM-----NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
..+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 357899999999999996 45789999998643 233456899999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038422 433 VENGSLAGKLHANHTK-----------------------------------QRPGLDWQTRLKIIKGVVKGMAYLHNELP 477 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 477 (634)
+++|+|.+++...... ....+++..+..++.||+.||+|||+.
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 9999999998521110 011245777889999999999999998
Q ss_pred CCCccccCCCCCCEEeCCCC--CeEEeccccCCccCC--------CCCccccccccCcccccC--CCCCcchhHHHHHHH
Q 038422 478 GSIIPHGHLKSSNVLLDRSF--EPLLTDYALRPLINP--------DNAHTLMVAYKSPEYAHN--GKISKKSDVWSLGIL 545 (634)
Q Consensus 478 ~~~ivHrdlk~~NILl~~~~--~~kl~DfGla~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvv 545 (634)
+|+||||||+||+++.++ .+||+|||+++.... .....++..|+|||.+.+ ..++.++|||||||+
T Consensus 188 --~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp --TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred --CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 799999999999998776 899999999875432 123456788999999875 678999999999999
Q ss_pred HHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHH
Q 038422 546 ILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVI 625 (634)
Q Consensus 546 l~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl 625 (634)
+|||+||+.||.. ....+........... ...+... ...+++.+ ++..||+.||.+||++.|++
T Consensus 266 l~el~~g~~pf~~--------~~~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~---li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 266 LHLLLMGAVPFPG--------VNDADTISQVLNKKLC--FENPNYN---VLSPLARD---LLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHSSCSSCC--------SSHHHHHHHHHHCCCC--TTSGGGG---GSCHHHHH---HHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHCCCCCCC--------CChHHHHHHHHhcccc--cCCcccc---cCCHHHHH---HHHHHcCCChhHCCCHHHHh
Confidence 9999999999862 1222222222222111 1111111 11234444 44599999999999999998
Q ss_pred H
Q 038422 626 E 626 (634)
Q Consensus 626 ~ 626 (634)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 7
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.65 Aligned_cols=189 Identities=23% Similarity=0.317 Sum_probs=166.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-----CCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-----HPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+. .+++.||+|+++.. ....+.+..|++++++++ ||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 47899999999999996 46889999998743 233456788999999986 999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC------------------
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR------------------ 495 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~------------------ 495 (634)
+++|.+++...... .+++.++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 119 -GPSLYEIITRNNYN---GFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp -CCBHHHHHHHTTTC---CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred -CCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccccccchhccccccc
Confidence 99999999765432 389999999999999999999998 8999999999999986
Q ss_pred -------CCCeEEeccccCCccCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 496 -------SFEPLLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 496 -------~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
++.+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 788999999999765443 34457889999999999999999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=323.90 Aligned_cols=240 Identities=22% Similarity=0.330 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 457999999999999964 57789999887532 3345678999999999999999999999876 3458999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC--ccccCCCCCCEEeC-CCCCeEEeccccCCc
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI--IPHGHLKSSNVLLD-RSFEPLLTDYALRPL 509 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~-~~~~~kl~DfGla~~ 509 (634)
+++|+|.+++.... .+++..+..++.||+.||+|||+. + |+||||||+||+++ +++.+||+|||++..
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999997643 389999999999999999999998 5 99999999999998 788999999999976
Q ss_pred cCCCC--CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 510 INPDN--AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 510 ~~~~~--~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
..... ...++..|+|||.+. +.++.++|||||||++|||+||+.||... ....... .....+.....++
T Consensus 182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~-~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIY-RRVTSGVKPASFD 252 (290)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHH-HHHTTTCCCGGGG
T ss_pred ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHH-HHHhccCCccccC
Confidence 54432 234678899999886 56999999999999999999999998521 2222222 2222221111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ..++ +.+++..||+.||.+|||++|+++
T Consensus 253 ~~------~~~~---l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 KV------AIPE---VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GC------CCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC------CCHH---HHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1233 445555999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.37 Aligned_cols=251 Identities=16% Similarity=0.195 Sum_probs=192.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEE-EeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY-YRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|++++++++|++++..++++ ...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 47899999999999996 568899999865432 234688999999999999888877776 5566789999999 999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccCCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~- 513 (634)
|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 91 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999975432 399999999999999999999998 89999999999999 78899999999998765432
Q ss_pred ----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 ----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 ----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
....++..|+|||.+.+..++.++|||||||++|||+||+.||...... .....+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh-hhhhhhhhhhcccccch---
Confidence 1335678899999999999999999999999999999999999632211 11111222111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.. .+ .... .+++ .+++..||+.||++||+++||++.|+++.+
T Consensus 239 --~~-~~-~~~~-~~~l---~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 239 --IE-VL-CKGY-PSEF---ATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp --HH-HH-TTTS-CHHH---HHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred --hh-hh-hccC-CHHH---HHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 00 0111 2344 445559999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.45 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=191.9
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||.||+++.. +|+.||+|.++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 3578999999999999965 689999999987655556789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~~ 514 (634)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999987643 389999999999999999999998 79999999999999 788999999999987654332
Q ss_pred C--ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 A--HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 ~--~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
. ..++..|+|||.+.+..++.++|||||||++|||+||+.||.. ....+.... +..+.. .. +....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~-i~~~~~-~~-~~~~~- 231 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE--------ETESKLFEK-IKEGYY-EF-ESPFW- 231 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHH-HHHCCC-CC-CTTTT-
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHH-HHcCCC-CC-Ccccc-
Confidence 2 2367889999999999999999999999999999999999852 111222222 222211 00 11110
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.+ ++..|++.||++||+++|+++
T Consensus 232 -~~~~~~~~~---li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 232 -DDISESAKD---FICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -TTSCHHHHH---HHHHHHCSSTTTSCCHHHHHT
T ss_pred -ccCCHHHHH---HHHHHcCCChhHCcCHHHHhc
Confidence 111244444 455999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.56 Aligned_cols=190 Identities=25% Similarity=0.390 Sum_probs=163.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-----ccChhHHHHHHHHHhcCC---CCccccceeEEEeCC-----c
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-----NVGREDFQEHIKRLGRLE---HPNLLPLTAFYYRKE-----E 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~-----~ 425 (634)
.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++ ||||++++++|.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46899999999999995 568999999986432 222356778888877764 999999999998765 4
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
.++||||+. |+|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred EEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 789999997 699999976543 2399999999999999999999998 79999999999999999999999999
Q ss_pred cCCccCCCCC---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 506 LRPLINPDNA---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 506 la~~~~~~~~---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+++....... ..+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9987654332 346788999999999999999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=321.27 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=192.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 467999999999999964 58899999986543 223467889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC---eEEeccccCCccCCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE---PLLTDYALRPLINPD 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~~~~~ 513 (634)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999887653 389999999999999999999998 8999999999999986655 999999998765543
Q ss_pred C---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 N---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
. ...++..|+|||.+.+..++.++||||||+++|||++|+.||.. ......... +..+.. ....+..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~--------~~~~~~~~~-~~~~~~-~~~~~~~ 231 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYAQ-IKAGAY-DYPSPEW 231 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHH-HHHTCC-CCCTTTT
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC--------CchhHHHHH-HHhccc-cCCchhh
Confidence 3 24577889999999999999999999999999999999999852 112222222 222111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.+ ++..|++.||++|||++|+++
T Consensus 232 ---~~~~~~~~~---li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 232 ---DTVTPEAKS---LIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---TTSCHHHHH---HHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCHHHHH---HHHHHcccChhhCCCHHHHhc
Confidence 111244444 455999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.67 Aligned_cols=241 Identities=18% Similarity=0.269 Sum_probs=192.5
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+..+.++ +||||+++++++.+++..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 3478999999999999975 68999999987542 23346788999999999 99999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-------------------
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR------------------- 495 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~------------------- 495 (634)
+|+|.+++...... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 95 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 95 GGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp TCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC--------------------
T ss_pred CCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999765321 12489999999999999999999998 8999999999999984
Q ss_pred CCCeEEeccccCCccCCCCCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHH
Q 038422 496 SFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVN 574 (634)
Q Consensus 496 ~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~ 574 (634)
...+||+|||.+..........++..|+|||.+.+. .++.++|||||||++|||++|..|+.. ... +
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~--~-- 237 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN--------GDQ--W-- 237 (289)
T ss_dssp CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS--------SHH--H--
T ss_pred ceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc--------hhH--H--
Confidence 447999999999887776667788999999999866 567899999999999999999977531 111 1
Q ss_pred HHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 575 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+..+.... +. ....+++.+ ++..||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~-----~~--~~~~~~~~~---li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 HEIRQGRLPR-----IP--QVLSQEFTE---LLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHTTCCCC-----CS--SCCCHHHHH---HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCC-----CC--cccCHHHHH---HHHHHhCCCcccCCCHHHHhh
Confidence 1112221111 11 112244444 445999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.75 Aligned_cols=243 Identities=26% Similarity=0.314 Sum_probs=190.7
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+||+|+||.||+|+. .+++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999995 457899999998766666788999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCCccCCC----C
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~----~ 514 (634)
+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..... .
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 99976432 23478999999999999999999998 8999999999999987 899999999998765432 2
Q ss_pred CccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 AHTLMVAYKSPEYAHNGK--ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~--~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...++..|+|||++.+.. ++.++|||||||++|||+||+.||.... ........... .. . .+.+.
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~-~~-~----~~~~~- 248 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG------EPQAAMFKVGM-FK-V----HPEIP- 248 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS------SHHHHHHHHHH-HC-C----CCCCC-
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC------chhHHHHhhcc-cc-c----ccccc-
Confidence 345678899999987643 7899999999999999999999986211 11111111111 11 0 11111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.+ ++..||+.||++||+++|+++
T Consensus 249 -~~~~~~~~~---li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 -ESMSAEAKA---FILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -TTSCHHHHH---HHHHTTCSSTTTSCCHHHHHT
T ss_pred -ccCCHHHHH---HHHHHccCChhhCCCHHHHhc
Confidence 111244444 455999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.82 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=193.8
Q ss_pred ccccCccCceeEEEEEE------cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||.||+|+. .++..||+|.+.... .....++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 46899999999999984 346789999986432 33446789999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC---CCCCeEEeccccC
Q 038422 433 VENGSLAGKLHANHTK--QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD---RSFEPLLTDYALR 507 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla 507 (634)
+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++ ++..+||+|||++
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 9999999999865422 123489999999999999999999998 799999999999998 4456999999998
Q ss_pred CccCC------CCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 508 PLINP------DNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 508 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
+.... .....++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+... .+..+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~--------~~~~~~~~-~~~~~ 261 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------KSNQEVLE-FVTSG 261 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHH-HHHTT
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------cCHHHHHH-HHhcC
Confidence 64322 122345678999999998899999999999999999999 9999852 11122222 22221
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..... .....+++ .+++..||+.||.+||+++||++.|+.+.+
T Consensus 262 ~~~~~-------~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 GRMDP-------PKNCPGPV---YRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCCC-------CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC-------CCCCCHHH---HHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11110 01112344 445559999999999999999999997753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.61 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=195.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.++||+|+||.||+++.. +|+.||+|++... .....+.+.+|+++|++++|||||++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 367999999999999975 6899999998653 233456788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 269 g~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 269 GDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999975432 2499999999999999999999998 89999999999999999999999999998765442
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.... ....... +...+..... .+.
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~----~~~~~~~-i~~~i~~~~~------~~p- 409 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK----KKIKREE-VERLVKEVPE------EYS- 409 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS----SCCCHHH-HHHHHHHCCC------CCC-
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc----cchhHHH-HHHHhhcccc------cCC-
Confidence 3457889999999999899999999999999999999999986211 1111222 2222222111 110
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
.....++.++++ .||+.||++|| +++||++
T Consensus 410 -~~~s~~~~dLI~---~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 -ERFSPQARSLCS---QLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -TTSCHHHHHHHH---HHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -ccCCHHHHHHHH---HhccCCHHHcCCCCCCCHHHHHh
Confidence 111244555554 99999999999 7788874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.16 Aligned_cols=189 Identities=23% Similarity=0.372 Sum_probs=162.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999975 489999998865432 22457889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9998876432 389999999999999999999998 89999999999999999999999999997665322
Q ss_pred --CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 --AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 2356788999999876 568999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.06 Aligned_cols=187 Identities=25% Similarity=0.387 Sum_probs=153.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCC-CCccccceeEEEeCC--ceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKE--EKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv~e~~ 433 (634)
.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.+++++. ||||+++++++...+ ..++|||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46799999999999995 46899999998643 2233456789999999997 999999999998654 689999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
+ |+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7 6899988652 389999999999999999999998 8999999999999999999999999999764321
Q ss_pred -------------------------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -------------------------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -------------------------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 12356788999999986 678999999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.68 Aligned_cols=242 Identities=20% Similarity=0.310 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 467999999999999975 4889999999876666778999999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC----CCC
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN----PDN 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~----~~~ 514 (634)
.+++..... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.... ...
T Consensus 104 ~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 104 DAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999876432 389999999999999999999998 79999999999999999999999999864321 123
Q ss_pred CccccccccCcccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 AHTLMVAYKSPEYA-----HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 ~~~~~~~y~aPE~~-----~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...++..|+|||++ ....++.++|||||||++|||+||+.||.. ....+......... ......+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~-~~~~~~~~ 246 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE--------LNPMRVLLKIAKSD-PPTLLTPS 246 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSC-CCCCSSGG
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc--------CCHHHHHHHHhccC-CcccCCcc
Confidence 34567889999998 366789999999999999999999999862 12222222222221 11111110
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....++ .+++..||+.||++|||++|+++
T Consensus 247 -----~~~~~l---~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 247 -----KWSVEF---RDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----GSCHHH---HHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccCHHH---HHHHHHHcccChhhCCCHHHHhc
Confidence 112334 44555999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.68 Aligned_cols=186 Identities=18% Similarity=0.300 Sum_probs=156.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++.++|||||++++++...+ ..++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 468999999999999854 5889999999754 2333567889999999999999999999997653 469999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
|||.+ +|.+.+.. .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 99976 46666632 289999999999999999999998 8999999999999999999999999999876
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||++.+..|+.++|||||||++|||++|+.||.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 543 23456888999999999999999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.40 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=191.6
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 434 (634)
.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 467999999999999965 68899999987543 2335678999999999999999999998865 467899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP-GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
+|+|.+++...... ...+++..+..++.|++.||+|||+... ..+|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~ 169 (279)
T 2w5a_A 91 GGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169 (279)
T ss_dssp TEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---
T ss_pred CCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc
Confidence 99999999764432 2348999999999999999999999820 012999999999999999999999999998766543
Q ss_pred CC----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 NA----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ~~----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.. ..++..|+|||.+.+..++.++||||||+++|||+||+.||... ...+.. ..+..+..... .
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~-~~i~~~~~~~~-~-- 237 (279)
T 2w5a_A 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELA-GKIREGKFRRI-P-- 237 (279)
T ss_dssp CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHH-HHHHHTCCCCC-C--
T ss_pred cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--------CHHHHH-HHHhhcccccC-C--
Confidence 21 24567899999999889999999999999999999999998621 112222 22222222111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
....+++.+ ++.+||+.||++||+++||++.+.
T Consensus 238 ----~~~~~~l~~---li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 238 ----YRYSDELNE---IITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ----TTSCHHHHH---HHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----cccCHHHHH---HHHHHcCCCcccCCCHHHHHhChh
Confidence 111244444 445999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=332.96 Aligned_cols=250 Identities=17% Similarity=0.271 Sum_probs=185.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++.+.+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 467999999999999975 6889999998654322 22345679999999999999999999999999999999997 59
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 86 LKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9999876432 389999999999999999999998 89999999999999999999999999987654322
Q ss_pred -CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC---Ccccccc
Q 038422 515 -AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT---GDVFDKE 589 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~d~~ 589 (634)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||... ........+......... .......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-----TVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2345788999999876 56899999999999999999999998621 111222222222211100 0110000
Q ss_pred ---------------cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 ---------------MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ---------------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
........++ +.+++..|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSD---GADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHH---HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHH---HHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000011233 445555999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.32 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=186.8
Q ss_pred ccccCccCceeEEEEEEc--CCc--EEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS--NGQ--AYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|+.. +++ .||+|+++... ....+.+.+|++++++++||||+++++++.+.. .++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 468999999999999853 233 68999886542 233467899999999999999999999987654 8899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 102 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999976532 389999999999999999999998 899999999999999999999999999877644
Q ss_pred CCC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 513 DNA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 513 ~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
... ..++..|+|||.+.+..++.++||||||+++|||+| |+.||.. ....+.+...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGERLP 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCCCCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc--------CCHHHHHHHHHccCCCCC
Confidence 321 234567999999988889999999999999999999 9999862 122222222222211100
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
......++ +.+++..||+.||++||+++|+++.|+++..
T Consensus 246 -------~~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 -------RPEDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------CCcCcCHH---HHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01111234 4455559999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.33 Aligned_cols=238 Identities=21% Similarity=0.298 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 468999999999999975 47889999986542 23456789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 126 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 126 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999887543 389999999999999999999998 8999999999999999999999999998765432
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+........ .. .+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~~~~~-~~------~~- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKN-EY------SI- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHT-CC------CC-
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC--------CCHHHHHHHHhcC-CC------CC-
Confidence 223467889999999988999999999999999999999999862 2222222222111 11 01
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+++.+ ++..||+.||++||+++|+++
T Consensus 261 -~~~~~~~~~~---li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 -PKHINPVAAS---LIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CTTSCHHHHH---HHHHHTCSSGGGSCCGGGGGG
T ss_pred -CccCCHHHHH---HHHHHccCChhHCcCHHHHhc
Confidence 0111234444 455999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.95 Aligned_cols=239 Identities=21% Similarity=0.293 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 468999999999999975 47889999986542 23346788999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999887543 389999999999999999999998 8999999999999999999999999998765432
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....++..|+|||.+.+..++.++||||||+++|||+||+.||.. ....+...... .... .+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~-~~~~------~~- 234 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIK-KNEY------SI- 234 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHH-TTCC------CC-
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHh-hccC------CC-
Confidence 223467889999999988899999999999999999999999862 12222222111 1111 01
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.....+++. +++..||+.||++||+++|+++.
T Consensus 235 -~~~~~~~~~---~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 -PKHINPVAA---SLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CTTSCHHHH---HHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -ccccCHHHH---HHHHHHcccChhhCcCHHHHhhC
Confidence 011123444 45559999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.10 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 46799999999999985 468899999987543 3445789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 107 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 107 ALDLLEP------GPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp HHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 9999853 2389999999999999999999998 8999999999999999999999999998765432
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ........ .+...... .+. .
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~-~~~~~~~~-----~~~-~ 241 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--------LHPMKVLF-LIPKNNPP-----TLE-G 241 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHH-HHHHSCCC-----CCC-S
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC--------cCHHHHHH-HhhcCCCC-----CCc-c
Confidence 234567889999999999999999999999999999999999852 11112111 12222111 111 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. .+++. +++..||+.||++|||++|+++.
T Consensus 242 ~~-~~~l~---~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 NY-SKPLK---EFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SC-CHHHH---HHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cc-CHHHH---HHHHHHcCCChhhCcCHHHHhhC
Confidence 11 23444 45559999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=316.59 Aligned_cols=239 Identities=20% Similarity=0.362 Sum_probs=187.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 468999999999999975 68999999986432 23456889999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999997653 389999999999999999999998 79999999999999999999999999987765432
Q ss_pred --CccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...++..|+|||.+.+..+ +.++||||||+++|||+||+.||.. ........ .+..+.. . +
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~-~~~~~~~-~-----~- 230 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--------EHVPTLFK-KIRGGVF-Y-----I- 230 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHH-HHHHCCC-C-----C-
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC--------CcHHHHHH-HhhcCcc-c-----C-
Confidence 3346788999999987765 6899999999999999999999862 12222222 2222111 0 0
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
......++. +++..|++.||++|||++|+++.
T Consensus 231 -~~~~~~~l~---~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 -PEYLNRSVA---TLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CTTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -chhcCHHHH---HHHHHHccCChhhCCCHHHHHhC
Confidence 011123444 45559999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=319.91 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 468999999999999965 57789999986432 23456799999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 99999997653 389999999999999999999998 8999999999999999999999999998655432
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....++..|+|||.+.+..++.++||||||+++|||+||+.||.. ....+...... .... .+ .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~~~-~~~~------~~--~ 232 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS--------PSHTETHRRIV-NVDL------KF--P 232 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHH-TTCC------CC--C
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC--------CCHhHHHHHHh-cccc------CC--C
Confidence 234567889999999999999999999999999999999999862 11122221111 1110 11 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.++ +..|++.||.+||+++|+++
T Consensus 233 ~~~~~~~~~l---i~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLSDGSKDL---ISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSCHHHHHH---HHHHSCSSGGGSCCHHHHHT
T ss_pred CcCCHHHHHH---HHHHhhcCHhhCCCHHHHhh
Confidence 1122444444 45999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.15 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=193.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||+||+++.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 3578999999999999965 6889999998643 234567899999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC---CCCCeEEeccccCCccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD---RSFEPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~ 512 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 106 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999987653 389999999999999999999998 899999999999995 456799999999987654
Q ss_pred CC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 DN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.. ...+|+.|+|||++.+ .++.++||||+||++|||+||+.||.. ....+..... ..+..... .+.
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i-~~~~~~~~-~~~ 245 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--------KNEYDILKRV-ETGKYAFD-LPQ 245 (486)
T ss_dssp C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHH-HHTCCCSC-SGG
T ss_pred CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHH-HhCCCCCC-Ccc
Confidence 32 3457889999999875 699999999999999999999999852 1222222222 22211100 111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.. ...+++.++ +..||+.||++|||+.|+++.
T Consensus 246 ~~---~~s~~~~~l---i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WR---TISDDAKDL---IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG---GSCHHHHHH---HHHHTCSSTTTSCCHHHHHHC
T ss_pred cC---CCCHHHHHH---HHHHcCCChhhCcCHHHHhcC
Confidence 11 112444444 459999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.00 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=181.8
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC--------ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--------NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 429 (634)
..+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++|||||++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 3468999999999999964 57899999986532 112235889999999999999999999975 5568999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEecccc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYAL 506 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl 506 (634)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.+ ..+||+|||+
T Consensus 218 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 99999999999886432 499999999999999999999998 79999999999999654 4599999999
Q ss_pred CCccCCCC---CccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 507 RPLINPDN---AHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 507 a~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
++...... ...+|..|+|||++.+ ..++.++|||||||++|||+||+.||... .....+.+.+ ..+
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~i----~~~ 360 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH----RTQVSLKDQI----TSG 360 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC----SSSCCHHHHH----HTT
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC----cchHHHHHHH----hcC
Confidence 98765432 3456889999999863 57889999999999999999999998621 1112232221 121
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... ...+.. ....++ +.+++.+||+.||++||+++|+++
T Consensus 361 ~~~-~~~~~~---~~~~~~---~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYN-FIPEVW---AEVSEK---ALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCC-CCHHHH---TTSCHH---HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCchhh---cccCHH---HHHHHHHHccCChhHCcCHHHHhC
Confidence 111 101100 011233 445555999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=345.98 Aligned_cols=240 Identities=18% Similarity=0.274 Sum_probs=192.4
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
++||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 57999999999999975 58999999996532 234567889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 271 ~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 271 DIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp BHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999998764321 23599999999999999999999998 89999999999999999999999999998765432
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||... ................ .. .+
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~----~~~~~~~~~~~~i~~~-~~------~~-- 412 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR----GEKVENKELKQRVLEQ-AV------TY-- 412 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT----TCCCCHHHHHHHHHHC-CC------CC--
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC----ccchhHHHHHHHHhhc-cc------CC--
Confidence 236788999999999999999999999999999999999998622 1112222332222221 11 01
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMEL 621 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~ 621 (634)
......++.++++ .||+.||++||++
T Consensus 413 p~~~s~~~~~li~---~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 413 PDKFSPASKDFCE---ALLQKDPEKRLGF 438 (543)
T ss_dssp CTTSCHHHHHHHH---HHSCSSGGGSCCC
T ss_pred CcccCHHHHHHHH---HhccCCHhHCCCC
Confidence 1112344555555 9999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.12 Aligned_cols=242 Identities=19% Similarity=0.307 Sum_probs=188.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||.||+++.. +++.||+|+++.... .+.+|++++.++ +||||+++++++.+++..++||||+++|
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 3578999999999999965 588999999976432 345788888887 7999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC----CCeEEeccccCCccCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS----FEPLLTDYALRPLINP 512 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~~~~ 512 (634)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+.++ ..+||+|||+++....
T Consensus 102 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 102 ELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp BHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999997543 389999999999999999999998 89999999999998543 3599999999986543
Q ss_pred CC----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 513 DN----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 513 ~~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
.. ...+|..|+|||++.+..++.++|||||||++|||++|+.||... ......+... .+..+... . ..
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~~~-~i~~~~~~-~-~~ 244 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG-----PDDTPEEILA-RIGSGKFS-L-SG 244 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS-----TTSCHHHHHH-HHHHCCCC-C-CS
T ss_pred CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC-----CcCCHHHHHH-HHccCCcc-c-Cc
Confidence 32 334678899999998878999999999999999999999998621 1122223222 22222211 0 00
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. .....+++.++++ .||+.||++||++.|+++
T Consensus 245 ~~--~~~~s~~~~~li~---~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GY--WNSVSDTAKDLVS---KMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TT--TTTSCHHHHHHHH---HHTCSSTTTSCCHHHHTT
T ss_pred cc--cccCCHHHHHHHH---HHCCCChhHCcCHHHHhc
Confidence 00 0112344555555 999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.35 Aligned_cols=188 Identities=20% Similarity=0.337 Sum_probs=156.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+++..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 46899999999999985 4688999999875432 224567899999999999999999999999999999999998 5
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe-----CCCCCeEEeccccCCccC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL-----DRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl-----~~~~~~kl~DfGla~~~~ 511 (634)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999997643 389999999999999999999998 79999999999999 455669999999987654
Q ss_pred CC----CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD----NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 32 223457889999999875 48999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.01 Aligned_cols=242 Identities=23% Similarity=0.363 Sum_probs=191.2
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc-cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 3468999999999999975 688999999875432 33468899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999988643 2389999999999999999999998 8999999999999999999999999998754321
Q ss_pred ---CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
....++..|+|||.+.+..+ +.++|||||||++|||+||+.||.... .....+..|. .... ... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-----~~~~--~~~-~ 230 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS---DSCQEYSDWK-----EKKT--YLN-P 230 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC---TTSHHHHHHH-----TTCT--TST-T
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc---hHHHHHHHhh-----hccc--ccC-c
Confidence 23456788999999987765 779999999999999999999986211 1111122221 1110 000 0
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ...+++. +++..||+.||++|||++|+++
T Consensus 231 ~~---~~~~~~~---~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WK---KIDSAPL---ALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GG---GSCHHHH---HHHHHHSCSSTTTSCCHHHHTT
T ss_pred hh---hcCHHHH---HHHHHHCCCCchhCCCHHHHhc
Confidence 10 1123444 4555999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.33 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=191.6
Q ss_pred hccccCccCceeEEEEEE----cCCcEEEEEEecccC----ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 359 SAEVLGSGTFGASYKTVI----SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
..+.||+|+||.||+++. .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 357899999999999997 468999999987532 23456678899999999 699999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 138 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999997643 389999999999999999999998 799999999999999999999999999876
Q ss_pred cCCC-----CCccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 510 INPD-----NAHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 510 ~~~~-----~~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
.... ....+|..|+|||++.+ ..++.++|||||||++|||+||+.||... ........+........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD----GEKNSQAEISRRILKSE-- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT----TSCCCHHHHHHHHHHCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC----CccchHHHHHHHHhccC--
Confidence 5332 22356888999999985 34789999999999999999999998622 11123333333222211
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIEK 627 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~~ 627 (634)
+.+ .......+. +++.+||+.||++|| +++|+++.
T Consensus 283 -----~~~--~~~~~~~~~---~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -----PPY--PQEMSALAK---DLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----CCC--CTTSCHHHH---HHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCC--CcccCHHHH---HHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 011 011123344 455599999999999 99999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.79 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=188.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+..+ .+|+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 4689999999999998754 48899886532 2334578899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999996533 2489999999999999999999998 899999999999998 679999999997654211
Q ss_pred -----CCccccccccCcccccC---------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 514 -----NAHTLMVAYKSPEYAHN---------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 514 -----~~~~~~~~y~aPE~~~~---------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
....++..|+|||.+.. ..++.++|||||||++|||+||+.||.. ........ ....
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--------~~~~~~~~-~~~~ 257 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT--------QPAEAIIW-QMGT 257 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS--------CCHHHHHH-HHHT
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHH-Hhcc
Confidence 12346788999999874 4578999999999999999999999862 12222222 2222
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+......... ..++ +.+++..||+.||++|||++||+++|+++.+
T Consensus 258 ~~~~~~~~~~------~~~~---l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 258 GMKPNLSQIG------MGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TCCCCCCCSS------CCTT---HHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCCCcCC------CCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2111111111 1123 4455559999999999999999999998865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=326.10 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=190.5
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++.+++ ||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999965 58999999987532 334678999999999994 699999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCCccCCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRPLINPD 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~ 513 (634)
+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999864322 3499999999999999999999998 8999999999999998 789999999999876543
Q ss_pred C---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 N---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
. ...++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... .... ....+..
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~-~~~~-~~~~~~~ 257 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG--------EDNQETYLNIS-QVNV-DYSEETF 257 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HTCC-CCCTTTT
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCchHHHHHHH-hccc-ccCchhh
Confidence 2 33578899999999999999999999999999999999999852 11111111111 1111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++. +++..||+.||++|||++|+++
T Consensus 258 ---~~~~~~~~---~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 258 ---SSVSQLAT---DFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---TTSCHHHH---HHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cccCHHHH---HHHHHHcCCChhhCcCHHHHhC
Confidence 11123444 4555999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.10 Aligned_cols=242 Identities=23% Similarity=0.349 Sum_probs=188.6
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|++++++++|||||+++++|.+.+..++|||||++
T Consensus 41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 4578999999999999965 68899999987543 33457899999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccCCccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 512 (634)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 121 g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999887653 389999999999999999999998 89999999999999764 5599999999876644
Q ss_pred C---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 D---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. ....+|+.|+|||++. ..++.++|||||||++|||++|+.||.. ....+...... .+.. ....+.
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~-~~~~-~~~~~~ 260 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG--------QTDQEILRKVE-KGKY-TFDSPE 260 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HTCC-CCCSGG
T ss_pred CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHH-hCCC-CCCchh
Confidence 3 2345788999999886 5799999999999999999999999862 12222222222 2211 111111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ...+++.+++ ..||+.||.+|||++|+++
T Consensus 261 ~~---~~s~~~~~li---~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 WK---NVSEGAKDLI---KQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GT---TSCHHHHHHH---HHHTCSSTTTSCCHHHHHT
T ss_pred cc---cCCHHHHHHH---HHHCCCChhhCccHHHHhc
Confidence 11 1224444444 4999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.82 Aligned_cols=242 Identities=21% Similarity=0.334 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--------ChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--------GREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 378999999999999975 6999999998754321 134678999999999 799999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 179 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999997543 389999999999999999999998 899999999999999999999999999876
Q ss_pred cCCCC---CccccccccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 510 INPDN---AHTLMVAYKSPEYAHN------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 510 ~~~~~---~~~~~~~y~aPE~~~~------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
..... ...+|..|+|||++.+ ..++.++|||||||++|||+||+.||.. ......... +..+
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~--------~~~~~~~~~-i~~~ 320 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH--------RRQILMLRM-IMEG 320 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHH-HHHT
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC--------CCHHHHHHH-HHhC
Confidence 65432 3457888999999863 3588999999999999999999999852 111111111 2221
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ....+... ....+ +.+++..||+.||++||+++|+++
T Consensus 321 ~~-~~~~~~~~---~~~~~---~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QY-QFSSPEWD---DRSST---VKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CC-CCCHHHHS---SSCHH---HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-CCCCcccc---cCCHH---HHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11011110 11233 444555999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.04 Aligned_cols=240 Identities=19% Similarity=0.316 Sum_probs=189.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|+.. +|+.||+|.+... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 468999999999999975 4899999998753 3457899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++..... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 112 ~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 112 SDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp HHHHHHHTC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 999874332 389999999999999999999998 8999999999999999999999999998765432 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...++..|+|||.+.+..++.++|||||||++|||+||+.||.. ......... ...........+ .
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~-~~~~~~~~~~~~-----~ 249 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD--------IHPMRAIFM-IPTNPPPTFRKP-----E 249 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHH-HHHSCCCCCSSG-----G
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC--------CChHHHHHH-HhcCCCcccCCc-----c
Confidence 33567889999999998999999999999999999999999862 111111111 111111111001 1
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++ .+++..||+.||.+||+++|+++
T Consensus 250 ~~~~~l---~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNF---TDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHH---HHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHH---HHHHHHHccCChhhCcCHHHHHh
Confidence 112344 44555999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=342.11 Aligned_cols=250 Identities=16% Similarity=0.212 Sum_probs=192.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCC-ccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHP-NLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+++++.++|+ +|..+..++...+..++||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 46799999999999995 568999999876543 234688999999999875 5555666667778889999999 999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~~ 514 (634)
|.+++..... .+++.+++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 89 L~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 89 LEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999975432 399999999999999999999998 89999999999999 688999999999997654332
Q ss_pred -----------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 515 -----------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 515 -----------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
...++..|+|||++.+..++.++|||||||++|||+||+.||.... .....+.+...... ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~-----~~~~~~~~~~i~~~-~~~ 234 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYEKISEK-KVA 234 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC-----CSSHHHHHHHHHHH-HHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-----chhHHHHHHHHhhc-ccc
Confidence 3456788999999999999999999999999999999999986321 11222221111111 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
..++.... .+ .++ +.+++..||+.+|++||++++|++.|+++.
T Consensus 235 ~~~~~l~~--~~-p~~---l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 235 TSIEALCR--GY-PTE---FASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp SCHHHHHT--TS-CHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHHHhc--CC-cHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111111 11 233 445555999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=342.87 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=193.8
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||||+.
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999965 68999999986532 3456789999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe---CCCCCeEEeccccCCccC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~ 511 (634)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 110 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 110 GGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp SCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999987543 399999999999999999999998 89999999999999 567899999999987765
Q ss_pred CCCC---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 512 PDNA---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 512 ~~~~---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
.... ..+|+.|+|||++.+ .++.++||||+||++|||+||+.||.. ....+.+.. +..+... .-.+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~-i~~~~~~-~~~~ 249 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG--------ANEYDILKK-VEKGKYT-FELP 249 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHH-HHHCCCC-CCSG
T ss_pred cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC--------CCHHHHHHH-HHcCCCC-CCCc
Confidence 5432 346888999999865 799999999999999999999999862 122222222 2222111 0011
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... ...+++.++++ .||+.||++|||++|+++
T Consensus 250 ~~~---~~s~~~~~li~---~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 QWK---KVSESAKDLIR---KMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGG---GSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred ccc---cCCHHHHHHHH---HHCCCChhHCcCHHHHhh
Confidence 111 11244555554 999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.89 Aligned_cols=190 Identities=25% Similarity=0.353 Sum_probs=161.5
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCcc-----ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV-----GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
..+.||+|+||.||+|+.. +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 3478999999999999964 5899999998743221 235788999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++ +|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 985 8888886543 2488999999999999999999998 799999999999999999999999999987643
Q ss_pred C----CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 D----NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~----~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
. ....+|..|+|||.+.+. .++.++|||||||++|||++|..||.
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 2 233567889999999764 58999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.46 Aligned_cols=190 Identities=25% Similarity=0.373 Sum_probs=166.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 467999999999999975 68899999987542 3334678999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC--CCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP--DNA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--~~~ 515 (634)
|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 999997653 2899999999999999999999842 699999999999999999999999999864422 223
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 456888999999999999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=338.65 Aligned_cols=244 Identities=16% Similarity=0.147 Sum_probs=172.7
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---cChhHHHHHH---HHHhcCCCCccccce-------eEEEeCC-
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---VGREDFQEHI---KRLGRLEHPNLLPLT-------AFYYRKE- 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~~~~~- 424 (634)
.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+ ++++. +||||++++ +++...+
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 468999999999999964 689999999986542 2345677884 45555 799977754 5554433
Q ss_pred ----------------ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCCcc
Q 038422 425 ----------------EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTR------LKIIKGVVKGMAYLHNELPGSIIP 482 (634)
Q Consensus 425 ----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~iv 482 (634)
..++|||||+ |+|.+++...... +.+..+ ..++.||+.||+|||+. +|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~iv 216 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQLIRLAANLQSK----GLV 216 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHHHHHHHHHHHC----CCc
Confidence 3799999999 8999999865322 455555 77889999999999998 899
Q ss_pred ccCCCCCCEEeCCCCCeEEeccccCCccCCCC-CccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCcccc
Q 038422 483 HGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-AHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPENYL 559 (634)
Q Consensus 483 Hrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~~~~ 559 (634)
||||||+|||++.++.+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999998765544 4456688999999987 67999999999999999999999998733
Q ss_pred cccCCCCCcHHHHHHHHHHhccCCccc--ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 560 LQGYDSKASLSNWVNNMVKEKRTGDVF--DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 560 ~~~~~~~~~l~~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...... .| ......... ...+.......+++.+++ .+||+.||++|||++|+++
T Consensus 297 ~~~~~~-----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li---~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 297 TPGIKG-----SW-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLI---GRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CTTCTT-----CC-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHH---HHHTCSSTTTCCCHHHHTT
T ss_pred Cccccc-----ch-----hhhhhhhccccccchhhccCCCHHHHHHH---HHHcCCChhhCCCHHHHhc
Confidence 211100 00 000000000 001111111234455544 4999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=331.18 Aligned_cols=187 Identities=22% Similarity=0.376 Sum_probs=157.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 46799999999999996 468999999986432 223457889999999999999999999997653 459999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 999 88999998652 389999999999999999999998 8999999999999999999999999999876
Q ss_pred CCC-CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||++.+ ..++.++||||+||++|||+||+.||.
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 543 33457888999999887 679999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=355.22 Aligned_cols=247 Identities=19% Similarity=0.316 Sum_probs=194.5
Q ss_pred hccccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||.||+|+... +..||+|.++... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 45789999999999998643 4578999886532 233467999999999999999999999984 56789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 473 ~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 473 TLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp TTCBHHHHHHHTTT----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999975432 389999999999999999999998 8999999999999999999999999999876543
Q ss_pred CC-----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 NA-----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ~~-----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
.. ..++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+...... .+.....
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~--------~~~~~~~~~i~-~~~~~~~-- 613 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG--------VKNNDVIGRIE-NGERLPM-- 613 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHH-HTCCCCC--
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHH-cCCCCCC--
Confidence 22 234568999999998899999999999999999997 9999862 12222222222 2111111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.....+++ .+++..||+.||++||+++||++.|+++.+
T Consensus 614 -----~~~~~~~l---~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 614 -----PPNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -----CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CccccHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01112344 455559999999999999999999998854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.99 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=188.3
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC--------CceEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK--------EEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~l 428 (634)
.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++... +..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 46899999999999997 568999999986543 23346788999999999999999999999874 46899
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||+++ +|.+.+..... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 102 v~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEECCSE-EHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCC-CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 9999975 78887765432 399999999999999999999998 89999999999999999999999999987
Q ss_pred ccCCC--------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 509 LINPD--------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 509 ~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
..... ....+|..|+|||++.+ ..++.++|||||||++|||+||+.||... ........+......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQLCGS 247 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCC
Confidence 65421 22345788999999876 45799999999999999999999998621 111111222111111
Q ss_pred ccCCccc---cc-cc-------ccCCCC-HHHH------HHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 KRTGDVF---DK-EM-------KGAKYS-KSEM------INLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 ~~~~~~~---d~-~~-------~~~~~~-~~~~------~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ..+.+ +. .. ...... .+.+ ..+.+++.+|++.||++|||++|+++
T Consensus 248 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 I-TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp C-CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 00100 00 00 000000 1111 23556667999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=336.69 Aligned_cols=192 Identities=23% Similarity=0.396 Sum_probs=152.4
Q ss_pred hccccCccCceeEEEEEEc---CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVIS---NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~ 433 (634)
..++||+|+||+||+|+.. +++.||+|++... ...+.+.+|++++++++|||||++++++.. ....++||||+
T Consensus 25 ~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp SSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred cCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 3568999999999999965 4788999998753 334578899999999999999999999965 56789999999
Q ss_pred CCCChhhHHhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe----CCCCCeEEeccc
Q 038422 434 ENGSLAGKLHANHT----KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL----DRSFEPLLTDYA 505 (634)
Q Consensus 434 ~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfG 505 (634)
. |+|.+++..... .....+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 103 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 103 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp S-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred C-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 7 588888764321 1122499999999999999999999998 79999999999999 778899999999
Q ss_pred cCCccCCC-------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 506 LRPLINPD-------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 506 la~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+++..... ....+|..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99876432 223567889999999874 58999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=326.09 Aligned_cols=189 Identities=25% Similarity=0.413 Sum_probs=161.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+++.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 468999999999999975 4889999998654322 2456789999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9888765432 389999999999999999999998 8999999999999999999999999999765432
Q ss_pred -CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 233567889999999875 78999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.10 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=175.0
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||.||+|+. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 46899999999999985 468899999886532 3345678899999999999999999999999999999999999999
Q ss_pred hhhHHhhccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 438 LAGKLHANHT---KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 438 L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
|.+++..... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 9999874211 1123489999999999999999999998 7999999999999999999999999998654332
Q ss_pred --------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC--
Q 038422 514 --------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT-- 582 (634)
Q Consensus 514 --------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~-- 582 (634)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||... .. ... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~-~~~---~~~~~~~~~~~~ 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY----PP-MKV---LMLTLQNDPPSL 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS----CG-GGH---HHHHHTSSCCCT
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC----ch-hhH---HHHHhccCCCcc
Confidence 12346778999999875 56899999999999999999999998621 11 111 1111111100
Q ss_pred C-cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 G-DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~-~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ...++.... ...+++. +++.+||+.||++||+++|+++
T Consensus 248 ~~~~~~~~~~~--~~~~~~~---~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLK--KYGKSFR---KMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCC--CCCHHHH---HHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhh--hhhHHHH---HHHHHHccCChhhCcCHHHHhh
Confidence 0 011111111 1123444 4555999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.74 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc-------------cChhHHHHHHHHHhcCCCCccccceeEEEeCCc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN-------------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 425 (634)
.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++|||||+++++|.+++.
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 478999999999999965 578999999875421 235678999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC---CeEEe
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF---EPLLT 502 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~ 502 (634)
.++|||||++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999997653 399999999999999999999998 899999999999998775 69999
Q ss_pred ccccCCccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 503 DYALRPLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 503 DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
|||+++..... ....+|+.|+|||++. ..++.++||||+||++|||++|+.||.. ....+.+... ..
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i-~~ 261 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG--------QNDQDIIKKV-EK 261 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHH-HH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHH-Hc
Confidence 99999876543 2345788999999986 5699999999999999999999999862 2222222222 22
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+..... .+.. ....+++.++ +..|++.||.+|||++|+++
T Consensus 262 ~~~~~~-~~~~---~~~s~~~~~l---i~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKYYFD-FNDW---KNISDEAKEL---IKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCCC-HHHH---TTSCHHHHHH---HHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCC-cccc---CCCCHHHHHH---HHHHcCCChhHCCCHHHHhc
Confidence 211100 0001 1112344444 45999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.35 Aligned_cols=183 Identities=24% Similarity=0.386 Sum_probs=161.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEe--CCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYR--KEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+++.||+|+++. ...+.+.+|++++++++ ||||+++++++.+ ....++||||+.+
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 47899999999999985 5688999999864 34678999999999997 9999999999988 5678999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPDN 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~ 514 (634)
++|.+++.. +++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 118 ~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 118 TDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999998742 88999999999999999999998 899999999999999776 89999999998654432
Q ss_pred ---CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 515 ---AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 515 ---~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 3456778999999987 678999999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.48 Aligned_cols=190 Identities=22% Similarity=0.282 Sum_probs=164.7
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcC------CCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRL------EHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||+||+|+.. +++.||+|+++.. ....+.+.+|+++++.+ .|+||+++++++...+..++|||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 3578999999999999865 4889999998753 23345677888888776 57799999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC--eEEeccccCCc
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE--PLLTDYALRPL 509 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~ 509 (634)
|+. |+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 180 ~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 180 LLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp CCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred ccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 996 699999876543 2389999999999999999999998 7999999999999999887 99999999976
Q ss_pred cCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 510 INPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 510 ~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 5443 34467888999999999999999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.75 Aligned_cols=184 Identities=20% Similarity=0.351 Sum_probs=146.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC-----CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-----EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e 431 (634)
.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++|++++|||||++++++... ...|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 468999999999999854 68999999986532 23346788999999999999999999999544 46899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+ +|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 138 ~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 138 IA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred cc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 98 579999886432 399999999999999999999998 89999999999999999999999999998754
Q ss_pred CC-------------------------------CCccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCC
Q 038422 512 PD-------------------------------NAHTLMVAYKSPEYA-HNGKISKKSDVWSLGILILELLTGK 553 (634)
Q Consensus 512 ~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~k~DVwSfGvvl~elltg~ 553 (634)
.. ....+|..|+|||++ ....++.++|||||||++|||+||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 22 122457789999986 4567999999999999999999943
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.07 Aligned_cols=189 Identities=24% Similarity=0.340 Sum_probs=157.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccC-----------hhHHHHHHHHHhcCCCCccccceeEEEeCC----
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG-----------REDFQEHIKRLGRLEHPNLLPLTAFYYRKE---- 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 424 (634)
.+.||+|+||.||+|...+++.||+|++....... .+.+.+|++++++++||||+++++++...+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 46899999999999998889999999986432211 267899999999999999999999996533
Q ss_pred -ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEec
Q 038422 425 -EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503 (634)
Q Consensus 425 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 503 (634)
..++||||+. |+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEEEcCCCCEEEEe
Confidence 4799999998 68988887443 2499999999999999999999998 799999999999999999999999
Q ss_pred cccCCccCCCC---CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 504 YALRPLINPDN---AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 504 fGla~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 99997544332 2346778999999877 678999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=318.43 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=177.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+++. .+++.||+|+++..... ..+.+.++...++.++||||+++++++.+++..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 46799999999999996 56899999998754221 12334555566888999999999999999999999999997 5
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++...... ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 91 SLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred chHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 888887653221 234999999999999999999999863 69999999999999999999999999997664432
Q ss_pred -CccccccccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 -AHTLMVAYKSPEYA----HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 -~~~~~~~y~aPE~~----~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...++..|+|||.+ .+..++.++|||||||++|||+||+.||... ..-...+......... ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~-~~---- 234 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-------GTPFQQLKQVVEEPSP-QL---- 234 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-------SCHHHHHHHHHHSCCC-CC----
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-------CchHHHHHHHhccCCC-Cc----
Confidence 23567889999996 4567899999999999999999999998521 1111122222222111 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..... .+++ .+++..||+.||++|||++|+++
T Consensus 235 -~~~~~-~~~~---~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 -PADKF-SAEF---VDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CTTTS-CHHH---HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -ccccC-CHHH---HHHHHHHhhcChhhCcCHHHHHh
Confidence 11111 2334 45555999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=353.08 Aligned_cols=238 Identities=20% Similarity=0.260 Sum_probs=192.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||+|+||.||+|+.. +++.||+|+++.. .....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 468999999999999965 5788999998753 233456788999999988 79999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999998653 299999999999999999999998 8999999999999999999999999999854322
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|+.|+|||++.+..|+.++|||||||++|||+||+.||.. ....+....... ... .+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~-~~~------~~ 561 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIME-HNV------AY 561 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHS-SCC------CC
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC--------CCHHHHHHHHHh-CCC------CC
Confidence 234578899999999999999999999999999999999999862 222222222221 111 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCH-----HHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMEL-----KEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~-----~evl~ 626 (634)
.....+++.++++ .||+.||++||++ +||++
T Consensus 562 --p~~~s~~~~~li~---~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 --PKSMSKEAVAICK---GLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --CTTSCHHHHHHHH---HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CccCCHHHHHHHH---HHccCCHHHCCCCCCCcHHHHhc
Confidence 1112344555555 9999999999997 66653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.51 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=191.5
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccC-----------------hhHHHHHHHHHhcCCCCccccceeEEEe
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVG-----------------REDFQEHIKRLGRLEHPNLLPLTAFYYR 422 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l~g~~~~ 422 (634)
.+.||+|+||.||+|+. +++.||+|.+....... .+.+.+|++++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 46899999999999999 89999999986432211 1789999999999999999999999999
Q ss_pred CCceEEEEEcCCCCChhhH------HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCccccCCCCCCEEeCC
Q 038422 423 KEEKLLLYEFVENGSLAGK------LHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN-ELPGSIIPHGHLKSSNVLLDR 495 (634)
Q Consensus 423 ~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl~~ 495 (634)
.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNILMDK 187 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEEECT
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEEEcC
Confidence 9999999999999999998 43321 2459999999999999999999998 6 7999999999999999
Q ss_pred CCCeEEeccccCCccCCC--CCccccccccCcccccCC-CCCc-chhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHH
Q 038422 496 SFEPLLTDYALRPLINPD--NAHTLMVAYKSPEYAHNG-KISK-KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSN 571 (634)
Q Consensus 496 ~~~~kl~DfGla~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~ 571 (634)
++.+||+|||++...... ....++..|+|||.+.+. .++. ++|||||||++|||+||+.||... ....+
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~ 260 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK-------ISLVE 260 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS-------SCSHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHH
Confidence 999999999998765432 334567889999999877 6666 999999999999999999998621 11112
Q ss_pred HHHHHHHhccCCcccc-----ccccc------CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 572 WVNNMVKEKRTGDVFD-----KEMKG------AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 572 ~~~~~~~~~~~~~~~d-----~~~~~------~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.... +..+...-..+ ..... ......++ .+++..||+.||.+||+++|+++
T Consensus 261 ~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED---IDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHH---HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHH-HhccCcCCccchhhhhccccccccccchhhcCHHH---HHHHHHHccCChhhCCCHHHHhc
Confidence 2111 11111100000 00000 01122344 44555999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.07 Aligned_cols=189 Identities=22% Similarity=0.383 Sum_probs=156.1
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCc------eEEEEEc
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE------KLLLYEF 432 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lv~e~ 432 (634)
..++||+|+||+||+|+...+..+|+|++...... ..+|+++++.++||||++++++|...+. .++||||
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 35789999999999999877777999988654322 2379999999999999999999976543 7899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~ 511 (634)
++++.+......... ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 120 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 120 VPETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp CSEEHHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cCccHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 987544333322211 23499999999999999999999998 899999999999999 78999999999998654
Q ss_pred CC---CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD---NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~---~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 33 234567889999998765 58999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.75 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=185.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEe------CCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYR------KEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~lv~e 431 (634)
.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+++++++ +||||+++++++.. .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 47899999999999996 46889999998754 34557899999999999 89999999999987 457899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 108 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp CCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred cCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999976432 2489999999999999999999998 79999999999999999999999999987654
Q ss_pred CC----CCccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 512 PD----NAHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 512 ~~----~~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
.. ....++..|+|||.+. +..++.++|||||||++|||+||+.||.. .......... .....
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~-~~~~~ 251 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--------MHPMRALFLI-PRNPA 251 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHH-HHSCC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC--------CcHHHHHHHh-hcCcc
Confidence 32 2335678899999987 56789999999999999999999999852 1111111111 11111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... .... ..+++.+++ ..||+.||.+||+++|+++
T Consensus 252 ~~~-----~~~~-~~~~l~~li---~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRL-----KSKK-WSKKFQSFI---ESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCC-----SCSC-SCHHHHHHH---HHHCCSSGGGSCCHHHHHT
T ss_pred ccC-----Cccc-cCHHHHHHH---HHHhccChhhCCCHHHHhh
Confidence 111 1111 124444444 4999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.03 Aligned_cols=186 Identities=17% Similarity=0.290 Sum_probs=155.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 467999999999999854 58899999987532 223457889999999999999999999997654 679999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+. |+|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 9997 578888742 289999999999999999999998 8999999999999999999999999999866
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 543 23456788999999999999999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.22 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=181.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~e~ 432 (634)
.+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++|||||+++++|...+ ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 478999999999999975 58999999986542 22347999999999999999999986532 26799999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~ 511 (634)
+++ ++.+.+..... ....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 985 67666643211 123499999999999999999999998 89999999999999965 568999999998654
Q ss_pred CC---CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHH-------HHh-
Q 038422 512 PD---NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM-------VKE- 579 (634)
Q Consensus 512 ~~---~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~-------~~~- 579 (634)
.. ....+|..|+|||++.+. .++.++|||||||++|||++|+.||... .....+.+.+... +..
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~----~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD----SGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHhh
Confidence 33 234567889999998765 7899999999999999999999998621 1111122222110 000
Q ss_pred -ccCCcccccccccC-------CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 -KRTGDVFDKEMKGA-------KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 -~~~~~~~d~~~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+...+.+... ..... ++.+++.+||+.||++||++.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCH---HHHHHHHHhccCChhHCCCHHHHhC
Confidence 00001100111000 01123 3455555999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.10 Aligned_cols=188 Identities=22% Similarity=0.358 Sum_probs=159.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC-----CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-----EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e 431 (634)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++... ...|+|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 578999999999999964 57899999997532 23346789999999999999999999999776 56899999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 111 IAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred cCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 996 69999986532 399999999999999999999998 89999999999999999999999999998654
Q ss_pred CC--------------------------CCccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD--------------------------NAHTLMVAYKSPEYA-HNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....+|..|+|||++ ....++.++|||||||++|||+||..|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32 234567889999986 45679999999999999999998766653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.87 Aligned_cols=258 Identities=19% Similarity=0.230 Sum_probs=192.5
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC--------CCccccceeEEE----eCCc
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE--------HPNLLPLTAFYY----RKEE 425 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~----~~~~ 425 (634)
..+.||+|+||+||+|+. .+++.||+|+++.. ....+.+.+|++++++++ |+||+++++++. +...
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 356899999999999985 45889999998743 334567889999999885 788999999997 4457
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC--------
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-------- 497 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-------- 497 (634)
.++||||+ +|+|.+++..... ..+++..++.|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhhhhh
Confidence 89999999 6677777765432 24999999999999999999999863 699999999999999775
Q ss_pred -----------------------------------------CeEEeccccCCccCCC-CCccccccccCcccccCCCCCc
Q 038422 498 -----------------------------------------EPLLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISK 535 (634)
Q Consensus 498 -----------------------------------------~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ 535 (634)
.+||+|||+++..... ....+|..|+|||++.+..++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCc
Confidence 7999999999765443 3345788999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh-ccC-----------Ccccccc--------------
Q 038422 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE-KRT-----------GDVFDKE-------------- 589 (634)
Q Consensus 536 k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~-----------~~~~d~~-------------- 589 (634)
++|||||||++|||+||+.||...... ....-.+.+...... +.. .+.+...
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGE--EYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCS--SSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCccc--ccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 999999999999999999998632111 000011111111110 000 0000000
Q ss_pred ----cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 ----MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
........+....+.+++.+||+.||++|||++|+++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001123455567778888999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.32 Aligned_cols=188 Identities=21% Similarity=0.347 Sum_probs=156.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC--------------
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE-------------- 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------------- 424 (634)
.+.||+|+||+||+|+. .+|+.||+|++..... ...+|+++++.++|||||+++++|...+
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 46899999999999985 5689999999865432 2347999999999999999999995532
Q ss_pred ------------------------ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 038422 425 ------------------------EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480 (634)
Q Consensus 425 ------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ 480 (634)
..++||||++ |+|.+.+...... ...+++..+..++.||+.||+|||+. +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----g 161 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIHSL----G 161 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTT----T
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----c
Confidence 3789999998 5888877643221 23499999999999999999999998 8
Q ss_pred ccccCCCCCCEEeC-CCCCeEEeccccCCccCCCC---CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 038422 481 IPHGHLKSSNVLLD-RSFEPLLTDYALRPLINPDN---AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 481 ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P 555 (634)
|+||||||+|||++ .++.+||+|||+++...... ...++..|+|||.+.+. .++.++|||||||++|||++|+.|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 241 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence 99999999999997 68899999999998654432 34567789999998765 489999999999999999999999
Q ss_pred cc
Q 038422 556 EN 557 (634)
Q Consensus 556 ~~ 557 (634)
|.
T Consensus 242 f~ 243 (383)
T 3eb0_A 242 FS 243 (383)
T ss_dssp SC
T ss_pred CC
Confidence 86
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=314.68 Aligned_cols=242 Identities=21% Similarity=0.304 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCc---------cChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN---------VGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 428 (634)
.+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|+++++++. ||||+++++++.+.+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 467999999999999975 588999999875431 12356789999999996 9999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 102 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999997643 389999999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCC---CccccccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 509 LINPDN---AHTLMVAYKSPEYAH------NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~------~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
...... ...++..|+|||++. ...++.++||||||+++|||+||+.||.. ........... .
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~-~ 243 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--------RKQMLMLRMIM-S 243 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-H
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC--------ccHHHHHHHHh-c
Confidence 654432 234678899999885 45688999999999999999999999852 11122222222 2
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.. ....+.... ..+++ .+++..||+.||++||+++|+++
T Consensus 244 ~~~-~~~~~~~~~---~~~~l---~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNY-QFGSPEWDD---YSDTV---KDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCC-CCCTTTGGG---SCHHH---HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCc-ccCcccccc---cCHHH---HHHHHHHccCCcccCCCHHHHHh
Confidence 111 111111111 12334 45555999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.15 Aligned_cols=187 Identities=21% Similarity=0.353 Sum_probs=146.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 46899999999999985 568899999986532 23346788999999999999999999999754 4579999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 114 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp ECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 999 6899988854 2399999999999999999999998 8999999999999999999999999999865
Q ss_pred CCC-CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 443 33457888999999887 678999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.95 Aligned_cols=187 Identities=21% Similarity=0.372 Sum_probs=155.2
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEE--------------eCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYY--------------RKE 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--------------~~~ 424 (634)
.+.||+|+||.||+|+... ++.||+|++........+.+.+|++++++++||||+++++++. +..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 4679999999999999764 8999999987665555678999999999999999999999874 335
Q ss_pred ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEec
Q 038422 425 EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTD 503 (634)
Q Consensus 425 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~D 503 (634)
..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 6799999998 699999853 2389999999999999999999998 899999999999997 567999999
Q ss_pred cccCCccCCC-------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 504 YALRPLINPD-------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 504 fGla~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 9999876432 12234677999998865 678999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.22 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=193.8
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 3578999999999999975 68899999986542 34567899999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC---CCeEEeccccCCccCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS---FEPLLTDYALRPLINP 512 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 512 (634)
++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.+ ..+||+|||++.....
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999887643 389999999999999999999998 89999999999999754 4699999999876654
Q ss_pred CC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 DN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.. ...++..|+|||.+.+ .++.++||||||+++|||+||+.||.. ....+.... +..+...... +.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~-~~~~~~~~~~-~~ 245 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--------KNEYDILKR-VETGKYAFDL-PQ 245 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHH-HHHCCCCCCS-GG
T ss_pred CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC--------CCHHHHHHH-HHcCCCCCCc-hh
Confidence 32 2345778999998865 589999999999999999999999852 122222222 2222111100 11
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH--HHHhh
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE--KIERL 631 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~--~L~~i 631 (634)
. ....+++. +++..|++.||++|||++|+++ .+++.
T Consensus 246 ~---~~~~~~~~---~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 246 W---RTISDDAK---DLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp G---TTSCHHHH---HHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred h---hhcCHHHH---HHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1 11123444 4555999999999999999997 34443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.41 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=185.1
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCc--------cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNN--------VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 429 (634)
..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++..+ ..++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEEE
Confidence 3578999999999999964 578999999865321 1234588999999999999999999998665 48999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC---eEEecccc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE---PLLTDYAL 506 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl 506 (634)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 93 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 99999999999886432 489999999999999999999998 8999999999999987654 99999999
Q ss_pred CCccCCCC---CccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhc
Q 038422 507 RPLINPDN---AHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEK 580 (634)
Q Consensus 507 a~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 580 (634)
++...... ...++..|+|||++. ...++.++|||||||++|||+||+.||... .....+.+.+ ..+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~----~~~ 235 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH----RTQVSLKDQI----TSG 235 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST----TCSSCHHHHH----HHT
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc----chHHHHHHHH----HhC
Confidence 98765432 224678899999974 467899999999999999999999998622 1112333222 121
Q ss_pred cCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 581 RTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 581 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... . .+.... ...++ +.+++.+||+.||++||+++|+++
T Consensus 236 ~~~-~-~~~~~~--~~~~~---~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN-F-IPEVWA--EVSEK---ALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC-C-CHHHHT--TSCHH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc-c-Cchhhh--hcCHH---HHHHHHHHcccCHhhCCCHHHHhh
Confidence 111 0 111100 11233 445555999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=320.63 Aligned_cols=189 Identities=20% Similarity=0.304 Sum_probs=164.6
Q ss_pred ccccCccCceeEEEEEE--cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCc------cccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI--SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN------LLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~lv~e 431 (634)
.+.||+|+||.||++.. .+++.||+|+++.. ....+.+.+|+++++.++|++ ++++++++.+.+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46799999999999986 36889999998753 233567889999998887654 9999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC----------------
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---------------- 495 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---------------- 495 (634)
|+ +++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 98 LL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp CC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99 8999999976542 2489999999999999999999998 8999999999999987
Q ss_pred ---CCCeEEeccccCCccCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 496 ---SFEPLLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 496 ---~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
++.+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999999765443 33457889999999999899999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=316.33 Aligned_cols=190 Identities=23% Similarity=0.388 Sum_probs=162.4
Q ss_pred ccccCccCceeEEEEEE--cCCcEEEEEEecccC--ccChhHHHHHHHHHhcC---CCCccccceeEEE-----eCCceE
Q 038422 360 AEVLGSGTFGASYKTVI--SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRL---EHPNLLPLTAFYY-----RKEEKL 427 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~~~~~ 427 (634)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+++++.+ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 46899999999999997 467899999986432 22334677888777666 8999999999997 445789
Q ss_pred EEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
+||||+. |+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 9999998 699999976533 2389999999999999999999998 8999999999999999999999999999
Q ss_pred CccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 508 PLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 508 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 765432 23456788999999999999999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=314.28 Aligned_cols=240 Identities=20% Similarity=0.325 Sum_probs=186.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC----ccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~ 432 (634)
.+.||+|+||.||++.. .+++.+|+|+++... ....+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 46799999999999996 458899999987532 2335689999999999999999999999854 4578999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+++| |.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 90 CVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred ccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9876 7777765432 2499999999999999999999998 899999999999999999999999999876543
Q ss_pred C------CCccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 513 D------NAHTLMVAYKSPEYAHNGK--ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 513 ~------~~~~~~~~y~aPE~~~~~~--~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
. ....++..|+|||++.+.. ++.++|||||||++|||+||+.||.. ....+.... +..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~-i~~~~~-- 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--------DNIYKLFEN-IGKGSY-- 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHH-HHHCCC--
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC--------chHHHHHHH-HhcCCC--
Confidence 2 1234678899999987644 37899999999999999999999862 222222222 222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEK 627 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~ 627 (634)
.+. ....+++.+ ++.+||+.||++||+++|+++.
T Consensus 231 ----~~~--~~~~~~l~~---li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----AIP--GDCGPPLSD---LLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCC--SSSCHHHHH---HHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCC--CccCHHHHH---HHHHHccCChhhCCCHHHHhcC
Confidence 111 111244444 4559999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.37 Aligned_cols=244 Identities=19% Similarity=0.266 Sum_probs=164.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~ 434 (634)
.++||+|+||+||+|+.. +++.||+|++... .....+....++.++||||+++++++.. +...++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 357999999999999975 6899999998642 2222333344677799999999999976 345899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCCccC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRPLIN 511 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 511 (634)
+|+|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 110 gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999976432 2499999999999999999999998 8999999999999976 4559999999997654
Q ss_pred CC--CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 512 PD--NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 512 ~~--~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
.. ....++..|+|||++.+..++.++|||||||++|||+||+.||..... ................ ....+.
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~ 256 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-----QAISPGMKRRIRLGQY-GFPNPE 256 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------CCCTTT
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc-----hhhhhhHHHhhhcccc-ccCchh
Confidence 33 234567889999999888899999999999999999999999863211 1111100111100000 000000
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ....+++.+ ++..||+.||++|||++|+++
T Consensus 257 ~---~~~~~~~~~---li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 257 W---SEVSEDAKQ---LIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp S---TTCCHHHHH---HHHHHSCSSGGGSCCHHHHHH
T ss_pred h---ccCCHHHHH---HHHHHCCCChhHCcCHHHHhc
Confidence 0 112244444 455999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=324.64 Aligned_cols=186 Identities=19% Similarity=0.361 Sum_probs=158.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCce------EEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEK------LLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------~lv~ 430 (634)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 467999999999999964 58999999987542 22346788999999999999999999999876654 9999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+. |+|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 9997 688877631 289999999999999999999998 8999999999999999999999999999865
Q ss_pred CCC-CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 543 23456888999999987 678999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.50 Aligned_cols=187 Identities=21% Similarity=0.376 Sum_probs=161.2
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC-----CceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-----EEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e~ 432 (634)
.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 468999999999999964 67889999987533 22336788999999999999999999999765 368999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+. |+|.+++... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 112 ~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 112 ME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 97 5999988643 389999999999999999999998 899999999999999999999999999976543
Q ss_pred C-------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 D-------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~-------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
. ....+|..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 2 22356888999998764 458999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.57 Aligned_cols=240 Identities=20% Similarity=0.318 Sum_probs=181.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe-------------CCc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-------------KEE 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------------~~~ 425 (634)
.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|++++++++||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 46899999999999996 46899999998643 2334678999999999999999999999875 346
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSENL----NQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSCG----GGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEecCCCCCHHHhhhcccc----ccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 7899999999999999975432 378899999999999999999998 79999999999999999999999999
Q ss_pred cCCccCCC------------------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCC
Q 038422 506 LRPLINPD------------------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSK 566 (634)
Q Consensus 506 la~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~ 566 (634)
+++..... ....++..|+|||.+.+. .++.++|||||||++|||+| |+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------- 231 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------- 231 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-------
Confidence 98765421 123356789999999764 78999999999999999998 44210
Q ss_pred CcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 567 ASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+.... +... ...+.+.+.. ...+.+ .+++..||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~-~~~~--~~~~~~~~~~--~~~~~~---~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNILKK-LRSV--SIEFPPDFDD--NKMKVE---KKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHH-HHST--TCCCCTTCCT--TTSHHH---HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHh-cccc--ccccCccccc--cchHHH---HHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111 1111 1111111111 112334 45555999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.03 Aligned_cols=191 Identities=21% Similarity=0.322 Sum_probs=149.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCc-------eEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE-------KLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-------~~lv~e 431 (634)
.+.||+|+||.||+|+.. +++.||+|++... ......+.+|++.++.++||||++++++|...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 467999999999999974 5899999988654 3344567788889999999999999999976443 789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCCccccCCCCCCEEeCC-CCCeEEeccccCC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH--NELPGSIIPHGHLKSSNVLLDR-SFEPLLTDYALRP 508 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~ 508 (634)
|+++ +|.+.+..... ....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+++
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 9986 56555543222 1234899999999999999999999 66 7999999999999997 8999999999998
Q ss_pred ccCCCC---CccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 509 LINPDN---AHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 509 ~~~~~~---~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
...... ...++..|+|||++.+.. ++.++|||||||++|||+||+.||.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 765443 335678899999987654 8999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.61 Aligned_cols=191 Identities=20% Similarity=0.270 Sum_probs=162.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCC-CC-----ccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HP-----NLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|+.. +++.||+|+++.. ....+.+..|+++++.++ |+ +|+++++++...+..++||||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 468999999999999965 5789999998743 223456778888888875 55 499999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC--CCCCeEEeccccCCcc
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD--RSFEPLLTDYALRPLI 510 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~ 510 (634)
+. |+|.+++..... ..+++..+..++.|++.||+|||.+. .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 138 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATPE--LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp CC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTSTT--TCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred CC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccCC--CCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 96 599999976542 23899999999999999999999531 2799999999999994 5788999999999876
Q ss_pred CCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 212 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 212 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 543 34567888999999999999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=315.56 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=185.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCC--CCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLE--HPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+++..+++.||+|++.... ....+.+.+|++++++++ ||||+++++++.+.+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 46899999999999998889999999986542 233467899999999997 5999999999999999999999 568
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++......
T Consensus 112 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 112 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 89999997643 389999999999999999999998 7999999999999965 789999999998764432
Q ss_pred -----CccccccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 515 -----AHTLMVAYKSPEYAHN-----------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 515 -----~~~~~~~y~aPE~~~~-----------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||... ..-...+.....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~~~~~~~~ 254 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAIID 254 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH-------HHHHHHHHHHHh
Confidence 2346788999999875 47889999999999999999999998521 111122222221
Q ss_pred hccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 579 EKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 579 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.... ..+ .....+++.+ ++..||+.||++||+++|+++
T Consensus 255 ~~~~-----~~~--~~~~~~~l~~---li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 255 PNHE-----IEF--PDIPEKDLQD---VLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TTSC-----CCC--CCCSCHHHHH---HHHHHTCSSTTTSCCHHHHHT
T ss_pred cccc-----cCC--cccchHHHHH---HHHHHccCCcccCcCHHHHhc
Confidence 1111 011 1111244444 445999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.59 Aligned_cols=187 Identities=21% Similarity=0.336 Sum_probs=160.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeC-----CceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-----EEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e~ 432 (634)
.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 468999999999999965 58899999986432 22345788999999999999999999998764 578999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 97 6999988652 389999999999999999999998 899999999999999999999999999876543
Q ss_pred CC--------------CccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 513 DN--------------AHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 513 ~~--------------~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence 21 1245788999998764 678999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.79 Aligned_cols=232 Identities=20% Similarity=0.312 Sum_probs=187.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc------ChhHHHHHHHHHhcCC--CCccccceeEEEeCCceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV------GREDFQEHIKRLGRLE--HPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~ 430 (634)
.+.||+|+||.||+|+. .+++.||+|+++..... ..+.+.+|++++++++ ||||+++++++.+.+..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 47899999999999985 56889999998754322 2356778999999996 599999999999999999999
Q ss_pred EcCCC-CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEeccccCC
Q 038422 431 EFVEN-GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTDYALRP 508 (634)
Q Consensus 431 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~ 508 (634)
||+.+ ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 128 e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99986 89999997643 389999999999999999999998 899999999999999 78899999999987
Q ss_pred ccCCCC--CccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 509 LINPDN--AHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 509 ~~~~~~--~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
...... ...++..|+|||++.+..+ +.++|||||||++|||+||+.||... .+ .... .. .
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----------~~----~~~~-~~--~ 261 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EE----IIRG-QV--F 261 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------HH----HHHC-CC--C
T ss_pred ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----------hh----hhcc-cc--c
Confidence 765432 3356788999999987766 68899999999999999999998521 01 1111 00 0
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+. . ...+++. +++.+||+.||++||+++||++
T Consensus 262 ~~-----~-~~~~~~~---~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 FR-----Q-RVSSECQ---HLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CS-----S-CCCHHHH---HHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-----c-cCCHHHH---HHHHHHccCChhhCcCHHHHhc
Confidence 11 1 1123444 4555999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=330.96 Aligned_cols=244 Identities=20% Similarity=0.262 Sum_probs=179.9
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++|||||. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 3679999999998777778999999998653 245678999999876 89999999999999999999999995 699
Q ss_pred hhHHhhccCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-------------CCCeEEec
Q 038422 439 AGKLHANHTKQR--PGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-------------SFEPLLTD 503 (634)
Q Consensus 439 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-------------~~~~kl~D 503 (634)
.+++........ ...++..+..++.||+.||+|||+. +|+||||||+|||++. +..+||+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999976543211 1123445678999999999999998 8999999999999965 35899999
Q ss_pred cccCCccCCCC--------CccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCC
Q 038422 504 YALRPLINPDN--------AHTLMVAYKSPEYAHN-------GKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKA 567 (634)
Q Consensus 504 fGla~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~ 567 (634)
||+++...... ...+|..|+|||++.+ ..++.++|||||||++|||+| |+.||.... .
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~ 245 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY------S 245 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT------T
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch------h
Confidence 99998765432 2357788999999975 578999999999999999999 999985210 1
Q ss_pred cHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 568 SLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 568 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.... ......... .. ...........+.+++..||+.||++||++.||++
T Consensus 246 ~~~~----i~~~~~~~~----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESN----IIRGIFSLD----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH----HHHTCCCCC----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHH----HhcCCCCcc----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 111110000 00 01112233345666777999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.46 Aligned_cols=186 Identities=19% Similarity=0.357 Sum_probs=158.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCc------eEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE------KLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~lv~ 430 (634)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 467999999999999964 68999999987532 2234578899999999999999999999987654 49999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+. |+|.+++.. .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9997 688877632 289999999999999999999998 8999999999999999999999999999765
Q ss_pred CCC-CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 443 23456788999999887 678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=317.33 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=169.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHH-HHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIK-RLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|... +++.||+|+++... ......+..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 367999999999999974 68999999997542 222345556665 77888999999999999999999999999985
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
+|.+++..........+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 8888876432222335899999999999999999999962 59999999999999999999999999997764432
Q ss_pred -CccccccccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 -AHTLMVAYKSPEYA----HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 -~~~~~~~y~aPE~~----~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...++..|+|||++ .+..++.++|||||||++|||+||+.||..... ..+.+ .. ......+.
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~----~~--~~~~~~~~ 249 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS-------VFDQL----TQ--VVKGDPPQ 249 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CC--CCCSCCCC
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-------HHHHH----HH--HhcCCCCC
Confidence 22567889999998 456789999999999999999999999862110 00000 00 00000011
Q ss_pred ccc--CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKG--AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.. .....+++ .+++..||+.||++||+++||++
T Consensus 250 ~~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 LSNSEEREFSPSF---INFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSSCCCCHHH---HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcccccCCHHH---HHHHHHHhhCChhhCcCHHHHHh
Confidence 110 01122344 44555999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.45 Aligned_cols=233 Identities=19% Similarity=0.295 Sum_probs=181.9
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCcc------ChhHHHHHHHHHhcC----CCCccccceeEEEeCCceE
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV------GREDFQEHIKRLGRL----EHPNLLPLTAFYYRKEEKL 427 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g~~~~~~~~~ 427 (634)
..+.||+|+||.||+|+. .+++.||+|++...... ....+.+|++++.++ +||||+++++++.+.+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 357899999999999985 46889999998754321 233466789998888 8999999999999999999
Q ss_pred EEEEc-CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEeccc
Q 038422 428 LLYEF-VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTDYA 505 (634)
Q Consensus 428 lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfG 505 (634)
+|||| +.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999 78999999997643 389999999999999999999998 799999999999999 88999999999
Q ss_pred cCCccCCCC--CccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 506 LRPLINPDN--AHTLMVAYKSPEYAHNGKIS-KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 506 la~~~~~~~--~~~~~~~y~aPE~~~~~~~~-~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
+++...... ...++..|+|||++.+..+. .++|||||||++|||+||+.||... .+ .. ....
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----------~~----~~-~~~~ 250 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----------QE----IL-EAEL 250 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------HH----HH-HTCC
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----------HH----Hh-hhcc
Confidence 987665432 33467889999999877664 5899999999999999999998521 01 01 1100
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+ ......++. +++.+||+.||++||+++|+++
T Consensus 251 ------~~--~~~~~~~~~---~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 ------HF--PAHVSPDCC---ALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------CC--CTTSCHHHH---HHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CC--cccCCHHHH---HHHHHHccCChhhCcCHHHHhc
Confidence 01 111123444 4555999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.62 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-----------CCccccceeEEEeCC---
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-----------HPNLLPLTAFYYRKE--- 424 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~~--- 424 (634)
.+.||+|+||+||+|+. .+++.||+|++... ....+.+.+|++++++++ ||||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 47899999999999996 56889999998743 334567889999998886 899999999998654
Q ss_pred -ceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC------CCC
Q 038422 425 -EKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD------RSF 497 (634)
Q Consensus 425 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~------~~~ 497 (634)
..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+ +|+||||||+|||++ ..+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCCcCcc
Confidence 688999999 8999999976432 23899999999999999999999963 699999999999994 445
Q ss_pred CeEEeccccCCccCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHH
Q 038422 498 EPLLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM 576 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~ 576 (634)
.+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||+||+.||........ ..-.+.+...
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 253 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY--TKDDDHIAQI 253 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------CHHHHHHHH
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc--CChHHHHHHH
Confidence 7999999999766543 334578899999999999999999999999999999999999863211100 0011111111
Q ss_pred HHh-ccCCc-----------ccc-----------------ccc-ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 577 VKE-KRTGD-----------VFD-----------------KEM-KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 577 ~~~-~~~~~-----------~~d-----------------~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... +.... .++ ..+ ............+.+++..||+.||++|||++||++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 110 00000 000 000 011123444566777888999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.53 Aligned_cols=238 Identities=18% Similarity=0.208 Sum_probs=177.0
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.++||+|+||+||.....+++.||||++.... .+.+.+|+++++++ +|||||++++++.+.+..++|||||. |+|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 46899999999765556689999999986532 23467899999999 79999999999999999999999996 699
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-----CCCCeEEeccccCCccCCC
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-----RSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-----~~~~~kl~DfGla~~~~~~ 513 (634)
.+++...... +.+.++..++.||+.||+|||+. +|+||||||+|||++ ....+||+|||+++.....
T Consensus 105 ~~~l~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 105 QEYVEQKDFA----HLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp HHHHHSSSCC----CCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred HHHHHhcCCC----ccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9999765432 44556678999999999999998 799999999999994 3346889999999766432
Q ss_pred -------CCccccccccCccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 514 -------NAHTLMVAYKSPEYAH---NGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 514 -------~~~~~~~~y~aPE~~~---~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
....+|..|+|||++. ...++.++|||||||++|||+| |+.||... . . ....... ....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~-----~-~---~~~~~~~-~~~~ 246 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS-----L-Q---RQANILL-GACS 246 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST-----T-T---HHHHHHT-TCCC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh-----h-H---HHHHHHh-ccCC
Confidence 2234788999999997 4567889999999999999999 89997511 0 1 1111111 1111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+ ....-..+.+++.+||+.||++|||++||++
T Consensus 247 ~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LDCLHP-------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTSCT-------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCc-------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111110 1112223445666999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.65 Aligned_cols=189 Identities=17% Similarity=0.288 Sum_probs=162.9
Q ss_pred ccccCccCceeEEEEEEc-CC-cEEEEEEecccCccChhHHHHHHHHHhcCCCCc------cccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NG-QAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN------LLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~lv~e 431 (634)
.+.||+|+||+||+|+.. ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 468999999999999964 34 68999998643 234567889999999997766 8999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe------------------
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL------------------ 493 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl------------------ 493 (634)
|+ ++++.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 103 LL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp CC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred cc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeccccccccccccccccc
Confidence 99 6778888765432 2489999999999999999999998 89999999999999
Q ss_pred -CCCCCeEEeccccCCccCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 494 -DRSFEPLLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 494 -~~~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+.++.+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999765443 34467889999999999999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=308.40 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=170.0
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCcc--ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNV--GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.++..+++.++||||+++++++.+.+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 467999999999999975 6899999999754322 1234455556788899999999999999999999999999 44
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
.+..+..... ..+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 5544443322 23899999999999999999999831 69999999999999999999999999987654332
Q ss_pred -CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 515 -AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
...++..|+|||.+. ...++.++|||||||++|||+||+.||... ..-.+......... ..
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~-~~----- 248 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-------KTDFEVLTKVLQEE-PP----- 248 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHHSC-CC-----
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-------CccHHHHHHHhccC-CC-----
Confidence 234678899999984 457889999999999999999999998621 11122222222221 11
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+........++.+ ++..||+.||.+||+++|+++
T Consensus 249 ~~~~~~~~~~~l~~---li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGHMGFSGDFQS---FVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSSSCCCHHHHH---HHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccCCCCHHHHH---HHHHHccCChhHCcCHHHHhh
Confidence 11111112244444 445999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.22 Aligned_cols=233 Identities=16% Similarity=0.209 Sum_probs=185.7
Q ss_pred ccccCccCceeEEEEEEc--CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCc-----eEEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS--NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEE-----KLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lv~e 431 (634)
.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|++++++++|||||++++++...+. .|+|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 467999999999999975 58999999886432 2334578899999999999999999999988765 699999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++++|.+++.. .++|.+++.|+.||+.||+|||+. +|+||||||+|||++.+ .+||+|||+++...
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 9999999987643 399999999999999999999998 89999999999999986 89999999998877
Q ss_pred CCCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 512 PDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 512 ~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
......+|..|+|||++.+. ++.++|||||||++|||++|..|+...... . .... .+.
T Consensus 233 ~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----~-------------~~~~-~~~-- 290 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----G-------------LPED-DPV-- 290 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----S-------------CCTT-CHH--
T ss_pred cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----c-------------cccc-ccc--
Confidence 76667789999999998765 489999999999999999999887521100 0 0000 000
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCC-CHHHHHHHHHhh
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARM-ELKEVIEKIERL 631 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i 631 (634)
......+.+++.+||+.||++|| +++++.+.|..+
T Consensus 291 -----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 291 -----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 01112345566699999999999 577777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.33 Aligned_cols=226 Identities=11% Similarity=0.104 Sum_probs=173.2
Q ss_pred ccccCccCceeEEEEEEcC-CcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||.||+|+... ++.||+|++....... .+.+.+|++++++++||||+++++++.+++..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 4689999999999999754 8999999997653332 36789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
++|.+++... ....++..|+.|++.||+|||+. +|+||||||+|||+++++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999998431 35557889999999999999998 89999999999999999999998543
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCC
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 595 (634)
|++ .++.++|||||||++|||+||+.||........- ..... ........+.... ..
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~-~~ 231 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-APAER--------DTAGQPIEPADID-RD 231 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-EECCB--------CTTSCBCCHHHHC-TT
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-HHHHH--------HhccCCCChhhcc-cC
Confidence 444 3689999999999999999999998632111000 00000 0000000000000 11
Q ss_pred CHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 596 ~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
..+++. +++.+||+.||++| |++|+++.|+++..
T Consensus 232 ~~~~l~---~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 232 IPFQIS---AVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCHHHH---HHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCHHHH---HHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 123444 45559999999999 99999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.11 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=191.4
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEe------CCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR------KEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lv~ 430 (634)
..+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|++++++++||||+++++++.. ++..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 347899999999999996 45889999998753 23345678999999999999999999998755 56789999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC---eEEeccccC
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE---PLLTDYALR 507 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla 507 (634)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 99999999999976432 23488999999999999999999998 8999999999999997654 899999999
Q ss_pred CccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc---
Q 038422 508 PLINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR--- 581 (634)
Q Consensus 508 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~--- 581 (634)
+...... ...++..|+|||++.+..++.++|||||||++|||+||+.||... .....|.........
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~-------~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN-------WQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS-------CHHHHSSTTCC------C
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc-------cchhhhhhhhhcccchhh
Confidence 8765432 335678899999999999999999999999999999999998521 111122110000000
Q ss_pred -CCccc------ccccccC-CCCHHHHHHHHHHHhcccccCccCCCCHHH-----HHHHHHhhh
Q 038422 582 -TGDVF------DKEMKGA-KYSKSEMINLLKIGLSCCEEDVLARMELKE-----VIEKIERLK 632 (634)
Q Consensus 582 -~~~~~------d~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~e-----vl~~L~~i~ 632 (634)
..+.. ...+... .........+.+++..|++.||++|||++| ..+.++.+.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000 0010000 011122334555666999999999999988 445555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.60 Aligned_cols=237 Identities=17% Similarity=0.144 Sum_probs=171.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc---cChhHHHHHHHHHhcCCC-Cccccce-----------------
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN---VGREDFQEHIKRLGRLEH-PNLLPLT----------------- 417 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~----------------- 417 (634)
.++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+++.++| +|.....
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46899999999999994 5689999999874332 235789999999999987 3221111
Q ss_pred ----eEEEe-----CCceEEEEEcCCCCChhhHHhhcc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCC
Q 038422 418 ----AFYYR-----KEEKLLLYEFVENGSLAGKLHANH--TKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHL 486 (634)
Q Consensus 418 ----g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl 486 (634)
.++.. ....+++|+++ +++|.+++.... ......+++..++.++.||+.||+|||+. +|+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iiHrDi 237 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 237 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCc
Confidence 11111 12356677765 689999885221 11123488999999999999999999998 8999999
Q ss_pred CCCCEEeCCCCCeEEeccccCCccCCC-CCccccccccCcccc----------cCCCCCcchhHHHHHHHHHHHHhCCCC
Q 038422 487 KSSNVLLDRSFEPLLTDYALRPLINPD-NAHTLMVAYKSPEYA----------HNGKISKKSDVWSLGILILELLTGKYP 555 (634)
Q Consensus 487 k~~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~k~DVwSfGvvl~elltg~~P 555 (634)
||+|||++.++.+||+|||+++..... ....+ ..|+|||++ .+..++.++|||||||++|||+||+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998765443 22345 889999999 555688999999999999999999999
Q ss_pred cccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 556 ENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 556 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
|...... +..+..+.......+++.++ +..||+.||++||++.|+++
T Consensus 317 f~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l---i~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAAL---------------------GGSEWIFRSCKNIPQPVRAL---LEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGG---------------------SCSGGGGSSCCCCCHHHHHH---HHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchh---------------------hhHHHHHhhcccCCHHHHHH---HHHHccCChhhCcCHHHHHh
Confidence 8622110 01111111111123444444 45999999999999887754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.37 Aligned_cols=220 Identities=18% Similarity=0.275 Sum_probs=169.8
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHH-hcCCCCccccceeEEEe----CCceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRL-GRLEHPNLLPLTAFYYR----KEEKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lv~e~~~ 434 (634)
++||+|+||.||+++. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999996 4688999999864 35678889887 66699999999999987 667899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCCccC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRPLIN 511 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 511 (634)
+|+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999986432 2499999999999999999999998 8999999999999998 7889999999986432
Q ss_pred CCCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 512 PDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 512 ~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
+..++.++|||||||++|||+||+.||...... .. .......+......
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~--------~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AI--------SPGMKTRIRMGQYE 220 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CCSCCSSCTTCCS
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-----hh--------hHHHHHHHhhcccc
Confidence 245788999999999999999999998521100 00 00000000000000
Q ss_pred cC----CCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GA----KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ....+++ .+++..||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~---~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 FPNPEWSEVSEEV---KMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHTTSCHHH---HHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhcccCCHHH---HHHHHHHcccChhhCCCHHHHhc
Confidence 00 0112344 44555999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=303.04 Aligned_cols=187 Identities=16% Similarity=0.175 Sum_probs=156.1
Q ss_pred hhccccCccCceeEEEEEEcCCcEEEEEEecccC--------ccChhHHHHHHHHHhcCC---------CCccccceeEE
Q 038422 358 ASAEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--------NVGREDFQEHIKRLGRLE---------HPNLLPLTAFY 420 (634)
Q Consensus 358 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~g~~ 420 (634)
...+.||+|+||+||+|+. +|+.||+|+++... ....+.+.+|++++++++ |||||++.+++
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 4567899999999999997 78999999997542 223378899999998886 66666666654
Q ss_pred E-----------------e-------------CCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHH
Q 038422 421 Y-----------------R-------------KEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470 (634)
Q Consensus 421 ~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 470 (634)
. + .+..++||||+++|++.+.+.. ..+++.+++.|+.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 3 2 6789999999999987777643 23899999999999999999
Q ss_pred HHH-hcCCCCCccccCCCCCCEEeCCCC--------------------CeEEeccccCCccCCCCCccccccccCccccc
Q 038422 471 YLH-NELPGSIIPHGHLKSSNVLLDRSF--------------------EPLLTDYALRPLINPDNAHTLMVAYKSPEYAH 529 (634)
Q Consensus 471 yLH-~~~~~~~ivHrdlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~ 529 (634)
||| +. +|+||||||+|||++.++ .+||+|||+++..... ...+|..|+|||++.
T Consensus 176 ~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGC
T ss_pred HHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhc
Confidence 999 77 799999999999999887 8999999999876543 446788999999998
Q ss_pred CCCCCcchhHHHHHHH-HHHHHhCCCCcc
Q 038422 530 NGKISKKSDVWSLGIL-ILELLTGKYPEN 557 (634)
Q Consensus 530 ~~~~~~k~DVwSfGvv-l~elltg~~P~~ 557 (634)
+.. +.++||||++++ .+++++|..||.
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCc
Confidence 665 899999998777 778888999975
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=281.45 Aligned_cols=182 Identities=17% Similarity=0.075 Sum_probs=128.8
Q ss_pred ccCccCceeEEEEE-EcCCcEEEEEEecccC----------ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 362 VLGSGTFGASYKTV-ISNGQAYVVKRYKQMN----------NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
..+.|++|.++.++ ...|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777655 4568999999986532 12235799999999999 799999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||++||+|.++|.... +++.. +|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||+++.
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCee
Confidence 99999999999997543 26654 4899999999999998 899999999999999999999999999987
Q ss_pred cCCCCC----ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 510 INPDNA----HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 510 ~~~~~~----~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
...... ..+|+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 389 ~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 654432 346788999999865 5678899999999988877665443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=245.04 Aligned_cols=185 Identities=30% Similarity=0.557 Sum_probs=168.5
Q ss_pred CCccHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCCCCeeeEEecC----CcEEEEEecCCCCcc--ccChhhhcCCCC
Q 038422 26 FGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN----GSVWGLKLEQMNLSG--TIAAESLGLLSS 99 (634)
Q Consensus 26 ~~~~~~~~l~~~k~~l~~~~~~l~~W~~~~~~C~~~~~~w~gv~C~~----~~v~~l~L~~~~l~g--~~~~~~l~~l~~ 99 (634)
+..+|++||++||+++.+|. .+.+|+.++|||.. .|.||+|+. ++|+.|+|+++++.| .+|. .++.+++
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~---~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~ 77 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNR---TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTT---CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTT
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcC---CCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCC
Confidence 45678999999999998886 78999887888852 499999974 799999999999999 8885 7999999
Q ss_pred cCEEeccC-CcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeC
Q 038422 100 LRAVSFMN-NKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRL 177 (634)
Q Consensus 100 L~~L~l~~-n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l 177 (634)
|++|+|++ |++.|.+| .+.++++|++|+|++|+++|.+|.. ++++++|++|+|++|+++|.+|..++++++|++|+|
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH-HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence 99999995 99999998 6999999999999999999999876 999999999999999999999999999999999999
Q ss_pred CCCceeecCCccc--cc-CCCEEEeecCcccccCCccccCCC
Q 038422 178 EANKFQGQVPEIK--QN-EMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 178 ~~N~~~g~ip~~~--~~-~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
++|+++|.+|... .. +|+.|++++|+++|.+|..+..+.
T Consensus 157 ~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred cCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 9999999999763 33 899999999999999999987765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=253.34 Aligned_cols=177 Identities=14% Similarity=0.168 Sum_probs=143.8
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCcc--------ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV--------GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
.++||+|+||+||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 5778888876543211 13458999999999999999988788888888999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++.. +..++.|++.||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999864 457999999999999998 7999999999999999 99999999998876
Q ss_pred CCC-----------CccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 512 PDN-----------AHTLMVAYKSPEYAHN--GKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 512 ~~~-----------~~~~~~~y~aPE~~~~--~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
... ...+|..|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532 2346788999999986 56788899999999999988888775
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=260.21 Aligned_cols=183 Identities=23% Similarity=0.350 Sum_probs=132.7
Q ss_pred CCccHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCCCCeeeEEecCCcEEEEEecCCCCccc---cCh-----------
Q 038422 26 FGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT---IAA----------- 91 (634)
Q Consensus 26 ~~~~~~~~l~~~k~~l~~~~~~l~~W~~~~~~C~~~~~~w~gv~C~~~~v~~l~L~~~~l~g~---~~~----------- 91 (634)
+..+|++||++||+++.||. .+++|+.++|||. |.||+|+.++|+.|+|+++++.|. +++
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~-----w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCT-----FDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGG-----STTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcC-----CcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 34678999999999999988 8999987788885 999999999999999999999998 653
Q ss_pred -----------hhhcCCCCcCEEeccCCcCcccCC---CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCc
Q 038422 92 -----------ESLGLLSSLRAVSFMNNKFEGPLP---DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNR 157 (634)
Q Consensus 92 -----------~~l~~l~~L~~L~l~~n~l~g~~p---~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~ 157 (634)
+.++.+++|++|+|++|.|+|.+| .++++++|++|+|++|.++|.+|...+.++++|++|+|++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 245566677777777777777665 366667777777777777766665533566666666666666
Q ss_pred CccCCCcc---ccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCC
Q 038422 158 LTGTIPSS---LVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 158 l~g~ip~~---~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
++|.+|.. +.++++|++|+|++|+++|.+|.....+|++|++++|+++|.+|. ++++
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l 222 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDC 222 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTC
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccC
Confidence 66666655 566666666666666666665554555666677777766666665 4443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=249.48 Aligned_cols=180 Identities=24% Similarity=0.410 Sum_probs=156.2
Q ss_pred ccHHHHHHHHhhcCCCCCCCCCCCCCCC-----CCCCCCCCCe------------eeEEec-CCcEEEEEecCCCCcccc
Q 038422 28 LSDTEILLQFKSSLNDSSSALVNWNALR-----NPCTFNYPNW------------NGVLCL-NGSVWGLKLEQMNLSGTI 89 (634)
Q Consensus 28 ~~~~~~l~~~k~~l~~~~~~l~~W~~~~-----~~C~~~~~~w------------~gv~C~-~~~v~~l~L~~~~l~g~~ 89 (634)
.+|++||++||+++.+| +|+.+. +||. |+| .||+|+ +++|+.|+|++++|+|.+
T Consensus 268 ~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~---C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK-----NWRYYSGTINNTIHS---LNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp HHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCC---CSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred hHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCc---cccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 46889999999999876 797554 5621 259 999998 699999999999999999
Q ss_pred ChhhhcCCCCcCEEec-cCCcCccc-------------------------------------------------------
Q 038422 90 AAESLGLLSSLRAVSF-MNNKFEGP------------------------------------------------------- 113 (634)
Q Consensus 90 ~~~~l~~l~~L~~L~l-~~n~l~g~------------------------------------------------------- 113 (634)
|+ .+++|++|+.|+| ++|.|+|.
T Consensus 340 p~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 340 PD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp CG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred ch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 95 8999999999999 88877665
Q ss_pred ---------------------CC-CCCCCCCCcEEEccCCcCcc-----------------ccChhhhh--CCCCCCeEE
Q 038422 114 ---------------------LP-DLRKMGPLKSIYLSDNGFSG-----------------NISDDAFE--GMTSLKKLY 152 (634)
Q Consensus 114 ---------------------~p-~~~~l~~L~~L~ls~N~~~g-----------------~ip~~~~~--~~~~L~~l~ 152 (634)
|| .++++++|++|+|++|+|+| .||+. ++ ++++|++|+
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEE
T ss_pred cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEE
Confidence 66 58889999999999999999 48876 66 999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCc-eee-cCCccc--c-------cCCCEEEeecCcccccCCc--cccCCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANK-FQG-QVPEIK--Q-------NEMRSLGLANNELEGPIPE--SLSKMDPS 218 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~-~~g-~ip~~~--~-------~~l~~l~l~~N~l~g~ip~--~~~~~~~~ 218 (634)
|++|+++|.+|..++++++|+.|+|++|+ |+| .+|... . .+|+.|++++|+++ .||. .+++++..
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 99999999999999999999999999998 999 888742 2 38999999999999 9998 77766543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-24 Score=240.25 Aligned_cols=182 Identities=24% Similarity=0.408 Sum_probs=158.1
Q ss_pred ccHHHHHHHHhhcCCCCC-C-------CCCCCCCCCCCCCCCCCCe---eeEEec-CCcEEEEEecCCCCccccChhhhc
Q 038422 28 LSDTEILLQFKSSLNDSS-S-------ALVNWNALRNPCTFNYPNW---NGVLCL-NGSVWGLKLEQMNLSGTIAAESLG 95 (634)
Q Consensus 28 ~~~~~~l~~~k~~l~~~~-~-------~l~~W~~~~~~C~~~~~~w---~gv~C~-~~~v~~l~L~~~~l~g~~~~~~l~ 95 (634)
..|++||.++++++.++. . ...+|+.+.|+|. | .||+|+ .++|+.|+|++++++|.+|+ .++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~-----w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~ 102 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM-----WGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIG 102 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGG-----TTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGG
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCccc-----ccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHh
Confidence 358899999999987542 1 2347988888885 9 999997 58999999999999999995 899
Q ss_pred CCCCcCEEeccCC-------------------------------------------------------------------
Q 038422 96 LLSSLRAVSFMNN------------------------------------------------------------------- 108 (634)
Q Consensus 96 ~l~~L~~L~l~~n------------------------------------------------------------------- 108 (634)
+|++|++|+|++|
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 9999999999988
Q ss_pred -----------cCcccCC-CCCCCCCCcEEEccCCcCccc-----------------cChhhhh--CCCCCCeEEcccCc
Q 038422 109 -----------KFEGPLP-DLRKMGPLKSIYLSDNGFSGN-----------------ISDDAFE--GMTSLKKLYMANNR 157 (634)
Q Consensus 109 -----------~l~g~~p-~~~~l~~L~~L~ls~N~~~g~-----------------ip~~~~~--~~~~L~~l~l~~N~ 157 (634)
+|+| || .++++++|++|+|++|+|+|. ||.. ++ ++++|++|+|++|+
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCc
Confidence 4456 66 589999999999999999996 8876 88 99999999999999
Q ss_pred CccCCCccccCCCCccEEeCCCCc-eee-cCCccc--------ccCCCEEEeecCcccccCCc--cccCCCCC
Q 038422 158 LTGTIPSSLVQLPKLMELRLEANK-FQG-QVPEIK--------QNEMRSLGLANNELEGPIPE--SLSKMDPS 218 (634)
Q Consensus 158 l~g~ip~~~~~l~~L~~L~l~~N~-~~g-~ip~~~--------~~~l~~l~l~~N~l~g~ip~--~~~~~~~~ 218 (634)
++|.+|..++++++|++|+|++|+ |+| .+|... ..+|+.|++++|+++ .||. .+++++..
T Consensus 261 l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L 332 (636)
T 4eco_A 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL 332 (636)
T ss_dssp TCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred CCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence 999999999999999999999998 999 899742 278999999999999 8998 77766543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=240.50 Aligned_cols=164 Identities=33% Similarity=0.539 Sum_probs=143.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC------------------------------------
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD------------------------------------ 116 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~------------------------------------ 116 (634)
..+..|+|++|.++|.+|. .++.+++|+.|+|++|.++|.+|.
T Consensus 514 ~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (768)
T 3rgz_A 514 ENLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592 (768)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred CCCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence 3567788888888888874 688888888888888888887772
Q ss_pred -----------------------------------CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccC
Q 038422 117 -----------------------------------LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGT 161 (634)
Q Consensus 117 -----------------------------------~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ 161 (634)
+.++++|+.|||++|+++|.||.. ++++++|+.|+|++|+|+|.
T Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~ 671 (768)
T 3rgz_A 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE-IGSMPYLFILNLGHNDISGS 671 (768)
T ss_dssp EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG-GGGCTTCCEEECCSSCCCSC
T ss_pred ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHH-HhccccCCEEeCcCCccCCC
Confidence 223567899999999999999876 99999999999999999999
Q ss_pred CCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCcc--ccCCCCCcccCCCCCCCCCCCCCCCC
Q 038422 162 IPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPES--LSKMDPSTFAGNKNLCGPPLDPCVLP 237 (634)
Q Consensus 162 ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~--~~~~~~~~~~gn~~lcg~p~~~c~~~ 237 (634)
||.+++++++|+.|||++|+|+|.||.. ..++|+.|++++|+|+|.||.. +..++...|.||+++||+|..+|...
T Consensus 672 ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 9999999999999999999999999986 4568999999999999999975 67888889999999999998888754
Q ss_pred C
Q 038422 238 K 238 (634)
Q Consensus 238 ~ 238 (634)
.
T Consensus 752 ~ 752 (768)
T 3rgz_A 752 N 752 (768)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.3e-23 Score=208.47 Aligned_cols=140 Identities=18% Similarity=0.228 Sum_probs=114.7
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCc------------------cChhHHHHHHHHHhcCCCCccccceeEEE
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNN------------------VGREDFQEHIKRLGRLEHPNLLPLTAFYY 421 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 421 (634)
.+.||+|+||.||+|...+|+.||+|.++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999997799999999864321 12456899999999999 5 77777654
Q ss_pred eCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEE
Q 038422 422 RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLL 501 (634)
Q Consensus 422 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 501 (634)
.+..++||||+++|+|.+ +. . .....++.|++.||+|||+. +|+||||||+|||++ ++.+||
T Consensus 172 -~~~~~lvmE~~~g~~L~~-l~---------~--~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 172 -WEGNAVLMELIDAKELYR-VR---------V--ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp -EETTEEEEECCCCEEGGG-CC---------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-TTEEEE
T ss_pred -ccceEEEEEecCCCcHHH-cc---------h--hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-CCcEEE
Confidence 456799999999999988 42 1 12346999999999999998 899999999999999 999999
Q ss_pred eccccCCccCCCCCccccccccCccccc
Q 038422 502 TDYALRPLINPDNAHTLMVAYKSPEYAH 529 (634)
Q Consensus 502 ~DfGla~~~~~~~~~~~~~~y~aPE~~~ 529 (634)
+|||+++.. ..|+|||++.
T Consensus 234 ~DFG~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVEV---------GEEGWREILE 252 (282)
T ss_dssp CCCTTCEET---------TSTTHHHHHH
T ss_pred EECCCCeEC---------CCCCHHHHHH
Confidence 999998643 3478899874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-22 Score=205.32 Aligned_cols=188 Identities=19% Similarity=0.267 Sum_probs=158.4
Q ss_pred cCCccHHHHHHHHhhcCC-CCCCCCCCCC----CCCCCCCCCCCCeeeEEec----------CCcEEEEEecCCCCcccc
Q 038422 25 TFGLSDTEILLQFKSSLN-DSSSALVNWN----ALRNPCTFNYPNWNGVLCL----------NGSVWGLKLEQMNLSGTI 89 (634)
Q Consensus 25 ~~~~~~~~~l~~~k~~l~-~~~~~l~~W~----~~~~~C~~~~~~w~gv~C~----------~~~v~~l~L~~~~l~g~~ 89 (634)
....+|++||++||.++. ++.+.+.+|. ...++|. |.|+.|. ..+|+.|+|+++++. .+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~-----~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~l 96 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET-----RTGRALKATADLLEDATQPGRVALELRSVPLP-QF 96 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC-----SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc-----cCCcchhhhHHHHhcccccceeEEEccCCCch-hc
Confidence 345678999999999984 7766678893 3456664 9999994 378999999999998 78
Q ss_pred ChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccC
Q 038422 90 AAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ 168 (634)
Q Consensus 90 ~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~ 168 (634)
|+ .++.+++|++|+|++|.++ .+| .++++++|++|+|++|+++ .||.. ++++++|++|+|++|++.|.+|..++.
T Consensus 97 p~-~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~ 172 (328)
T 4fcg_A 97 PD-QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLAS 172 (328)
T ss_dssp CS-CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEE
T ss_pred Ch-hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhh
Confidence 75 6888999999999999999 677 5999999999999999999 88876 999999999999999999999998875
Q ss_pred ---------CCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCCC---cccCCC
Q 038422 169 ---------LPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDPS---TFAGNK 224 (634)
Q Consensus 169 ---------l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~~---~~~gn~ 224 (634)
+++|++|+|++|+|+ .+|.. ...+|+.|++++|++++ +|..+.+++.. .+.+|.
T Consensus 173 ~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp EC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred ccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence 999999999999999 88875 44689999999999996 67667655533 445543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.80 E-value=7e-20 Score=188.61 Aligned_cols=160 Identities=29% Similarity=0.493 Sum_probs=107.5
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCC-CCcEEEccCCcCccccChh----------
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMG-PLKSIYLSDNGFSGNISDD---------- 140 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~-~L~~L~ls~N~~~g~ip~~---------- 140 (634)
.++..|+|++|.+.|.+|. .++.+++|++|+|++|.++|.+| .+.+++ .|++|+|++|+++|.+|..
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence 3567777777777777764 57777777777777777777776 466666 6777777777776665543
Q ss_pred ------------hhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccc
Q 038422 141 ------------AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 141 ------------~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g 206 (634)
.++.+++|+.|+|++|++++.+|. +..+++|++|+|++|+|+|.+|.. ...+|+.|++++|+++|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 244455555555555555544443 555566666666666666666654 23477888888888888
Q ss_pred cCCcc--ccCCCCCcccCCCCCCCCCCCCC
Q 038422 207 PIPES--LSKMDPSTFAGNKNLCGPPLDPC 234 (634)
Q Consensus 207 ~ip~~--~~~~~~~~~~gn~~lcg~p~~~c 234 (634)
.+|.. +.++....+.+|+.+||.|.++|
T Consensus 283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 283 EIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 88764 34555667889999999887777
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-19 Score=175.23 Aligned_cols=133 Identities=17% Similarity=0.177 Sum_probs=102.5
Q ss_pred ccccCccCceeEEEEEE-cCCcE--EEEEEecccCccC------------------------hhHHHHHHHHHhcCCCCc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQA--YVVKRYKQMNNVG------------------------REDFQEHIKRLGRLEHPN 412 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~H~n 412 (634)
.+.||+|+||.||+|.. .+|+. ||+|+++...... ...+.+|++++.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999999997 78888 9999875431110 136789999999998886
Q ss_pred c--ccceeEEEeCCceEEEEEcCCC-C----ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCcccc
Q 038422 413 L--LPLTAFYYRKEEKLLLYEFVEN-G----SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH-NELPGSIIPHG 484 (634)
Q Consensus 413 i--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~ivHr 484 (634)
+ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~----givHr 195 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA----ELVHA 195 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS----CEECS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC----CEEeC
Confidence 5 333332 367899999942 4 56655432 223456789999999999999 76 89999
Q ss_pred CCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 485 HLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 485 dlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.5e-18 Score=164.15 Aligned_cols=145 Identities=23% Similarity=0.302 Sum_probs=122.1
Q ss_pred CeeeEEecCC-----------cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLNG-----------SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~~-----------~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..+.|++. .+..|+|++|++++..+...+..+++|++|+|++|.+++..| .+.++++|++|+|++|
T Consensus 12 ~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 12 EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5888888532 356889999999887665568889999999999999998877 6889999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
++++ +|+..|+++++|++|+|++|++++..|..+.++++|++|+|++|+|++..|.. ...+|+.|++++|.+++..+
T Consensus 92 ~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9986 55566889999999999999999888889999999999999999999887765 34589999999999987766
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.1e-18 Score=164.96 Aligned_cols=152 Identities=18% Similarity=0.254 Sum_probs=113.9
Q ss_pred CCCCCCCCCCCCCCCeeeEEecCC-----------cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-C
Q 038422 50 NWNALRNPCTFNYPNWNGVLCLNG-----------SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-L 117 (634)
Q Consensus 50 ~W~~~~~~C~~~~~~w~gv~C~~~-----------~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~ 117 (634)
.|..+.+.|+ |.+|.|+.. .+..|+|++|++++..+ ..+..+++|+.|+|++|.|++..+. +
T Consensus 11 ~~~~~~~~Cs-----~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~~ 84 (229)
T 3e6j_A 11 AACPSQCSCS-----GTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGVF 84 (229)
T ss_dssp CCCCTTCEEE-----TTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccCCCCCEEe-----CCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhhc
Confidence 4555667785 999999632 46678888888887555 4677888888888888888665554 5
Q ss_pred CCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCC
Q 038422 118 RKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMR 195 (634)
Q Consensus 118 ~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~ 195 (634)
..+++|++|+|++|++++ +|+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+.. ...+|+
T Consensus 85 ~~l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 162 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162 (229)
T ss_dssp TTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ccCCCcCEEECCCCcCCc-cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCC
Confidence 778888888888888884 55555778888888888888888 77888888888888888888888655443 345788
Q ss_pred EEEeecCcccccCC
Q 038422 196 SLGLANNELEGPIP 209 (634)
Q Consensus 196 ~l~l~~N~l~g~ip 209 (634)
.|++++|.+++..+
T Consensus 163 ~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 163 HAYLFGNPWDCECR 176 (229)
T ss_dssp EEECTTSCBCTTBG
T ss_pred EEEeeCCCccCCcc
Confidence 88888888877655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-17 Score=165.47 Aligned_cols=152 Identities=23% Similarity=0.352 Sum_probs=123.2
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..|+|++|++.+..+ ..+..+++|++|+|++|.+++..|. +.++++|++|+|++|++++ +|+..|+.+++|++|+
T Consensus 36 ~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccc-cChhHhcccCCCCEEE
Confidence 46788999999887655 4788999999999999999998774 7889999999999999985 5666688999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---CCcccCCCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNKNLC 227 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~~lc 227 (634)
|++|++++..|..+.++++|++|+|++|+|++..|.. ...+|+.|+|++|++++..|..+.+++ ...+.+|+.-|
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 9999999766666789999999999999999766643 346899999999999987776666554 34456665433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-17 Score=159.17 Aligned_cols=144 Identities=22% Similarity=0.328 Sum_probs=120.9
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N 131 (634)
.|.+|.|+. .+++.|+|++|++.+ +++..+..+++|++|+|++|++++..+. +.++++|++|+|++|
T Consensus 8 ~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 8 SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 599999963 247899999999985 4555688999999999999999977664 688999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
++++ +|+..++++++|++|+|++|++++..|..+.++++|++|+|++|++++..+.. ...+|+.|++++|.+++..|
T Consensus 87 ~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 87 QLQS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCc-cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 9995 66666889999999999999999776677899999999999999999766653 34689999999988877666
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=158.46 Aligned_cols=129 Identities=20% Similarity=0.280 Sum_probs=108.1
Q ss_pred EEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC--CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcc
Q 038422 77 GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154 (634)
Q Consensus 77 ~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~--~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~ 154 (634)
.+++++++| +.+|. .+. .+|+.|+|++|++++..+. +.++++|++|+|++|++++.+|. .|+++++|++|+|+
T Consensus 12 ~l~~s~~~l-~~ip~-~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 12 TVDCTGRGL-KEIPR-DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN-AFEGASHIQELQLG 86 (192)
T ss_dssp EEECTTSCC-SSCCS-CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT-TTTTCTTCCEEECC
T ss_pred EEEcCCCCc-CcCcc-CCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHh-HcCCcccCCEEECC
Confidence 455566666 45664 332 3899999999999988874 88999999999999999976654 48999999999999
Q ss_pred cCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCc
Q 038422 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 155 ~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~ 210 (634)
+|++++..|..+.++++|++|+|++|+|++.+|.. ...+|+.|+|++|.++|..+-
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 99999988888999999999999999999988875 346899999999999988773
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.2e-17 Score=156.76 Aligned_cols=141 Identities=23% Similarity=0.312 Sum_probs=87.0
Q ss_pred CeeeEEecCC-----------cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLNG-----------SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~~-----------~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..|.|... .++.|+|++|++.+. ++..+..+++|+.|+|++|.+++..| .+.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 12 SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVI-PPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEE-CTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCc-CHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 5888888532 355666666666643 33356666666666666666666655 4666666666666666
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccc
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g 206 (634)
+++ .+|+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+.. ...+|+.|+|++|.+..
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 666 355555566666666666666666665666666666666666666666555443 23456666666666653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.2e-17 Score=167.63 Aligned_cols=147 Identities=23% Similarity=0.316 Sum_probs=116.2
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CC---------CCCCCcEEEccCCcCccccChhhh
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LR---------KMGPLKSIYLSDNGFSGNISDDAF 142 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~---------~l~~L~~L~ls~N~~~g~ip~~~~ 142 (634)
.++..|+|++|.+. .+|. .++.+++|++|+|++|++.|.+|. +. ++++|++|+|++|+++ .+|.. +
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~-l 202 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS-I 202 (328)
T ss_dssp TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG-G
T ss_pred CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHh-h
Confidence 46888999999998 7774 688999999999999888888884 43 3888888888888888 77765 7
Q ss_pred hCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCCC--
Q 038422 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDPS-- 218 (634)
Q Consensus 143 ~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~~-- 218 (634)
+++++|++|+|++|++++ +|..++++++|++|+|++|++.+.+|.. ...+|+.|++++|++.+.+|..+.+++..
T Consensus 203 ~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 281 (328)
T 4fcg_A 203 ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281 (328)
T ss_dssp GGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCE
T ss_pred cCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCE
Confidence 888888888888888884 6777888888888888888888888875 34578888888888888888777665543
Q ss_pred -cccCCC
Q 038422 219 -TFAGNK 224 (634)
Q Consensus 219 -~~~gn~ 224 (634)
.+.+|+
T Consensus 282 L~L~~n~ 288 (328)
T 4fcg_A 282 LDLRGCV 288 (328)
T ss_dssp EECTTCT
T ss_pred EeCCCCC
Confidence 345543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-16 Score=149.27 Aligned_cols=164 Identities=19% Similarity=0.270 Sum_probs=129.8
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..+.|+. ..+..|+|++|++.+..+...++.+++|++|+|++|++++.+| .+.++++|++|+|++|
T Consensus 9 ~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 589999963 2678999999999876654458999999999999999999988 6999999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCc
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~ 210 (634)
++++..| ..|.++++|++|+|++|++++.+|..+..+++|++|+|++|.|++..+-. ....++...+..+......|.
T Consensus 89 ~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 89 KIKEISN-KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECS-SSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cCCccCH-HHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 9997554 45899999999999999999999999999999999999999999988743 111122223445555666666
Q ss_pred cccCCCCCcccCCCCCCC
Q 038422 211 SLSKMDPSTFAGNKNLCG 228 (634)
Q Consensus 211 ~~~~~~~~~~~gn~~lcg 228 (634)
.+.+.....+..+...|.
T Consensus 168 ~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 168 KVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTTSBGGGSCTTTCCCC
T ss_pred HHcCCChhhCcHhhcCcC
Confidence 666655555544444453
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8.4e-16 Score=154.70 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=127.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
..+..|+|++|.+.+. +.++.+++|++|+|++|.+++..|. +.++++|++|+|++|++++ +|+..++++++|++|
T Consensus 63 ~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 138 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI---SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYL 138 (272)
T ss_dssp TTCCEEECTTSCCCCC---GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCcEEECCCCCCCCc---hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCc-cCHHHhccCCCCCEE
Confidence 5688999999999873 3689999999999999999988775 7899999999999999996 555668999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---CCcccCCCCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNKNL 226 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~~l 226 (634)
+|++|++++..|..++++++|+.|+|++|++++..|.. ...+|+.|++++|++++..|..+.+++ ...+.+|+..
T Consensus 139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 99999999877777899999999999999999776654 456999999999999998887666554 3456677654
Q ss_pred C
Q 038422 227 C 227 (634)
Q Consensus 227 c 227 (634)
|
T Consensus 219 ~ 219 (272)
T 3rfs_A 219 C 219 (272)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=186.84 Aligned_cols=136 Identities=23% Similarity=0.353 Sum_probs=119.5
Q ss_pred hhcCCCCcCEEeccCCcCcccCCC--CCCCCCCcEEEccCCcCccc----cChhhhhCCCCCCeEEcccCcCccCCCccc
Q 038422 93 SLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGN----ISDDAFEGMTSLKKLYMANNRLTGTIPSSL 166 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~l~g~~p~--~~~l~~L~~L~ls~N~~~g~----ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~ 166 (634)
.++.+++|+.|+|++|++++..+. +..+++|+.|+|++|.+++. +++..|.++++|+.|+|++|++++..|..+
T Consensus 421 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 500 (844)
T 3j0a_A 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500 (844)
T ss_dssp HHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSS
T ss_pred hhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHc
Confidence 355789999999999999987653 66789999999999999732 223458899999999999999999889999
Q ss_pred cCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCCCcccCCCCCCC
Q 038422 167 VQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCG 228 (634)
Q Consensus 167 ~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~gn~~lcg 228 (634)
.++++|+.|+|++|+|++..|.....+|+.|++++|+|+|.+|..+.++....+.||+..|.
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred cchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence 99999999999999999877776668999999999999999999999888888999998884
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-16 Score=176.79 Aligned_cols=140 Identities=21% Similarity=0.289 Sum_probs=124.7
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++.|+|++|+|++ +++..+..+++|++|+|++|++++..| .|.++++|++|+|++|++++ +|+++|.++++|++|+
T Consensus 53 ~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 53 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLV 130 (635)
T ss_dssp TCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE-ECGGGGTTCTTCCEEE
T ss_pred CCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC-CCHHHhcCCCCCCEEE
Confidence 57899999999995 555689999999999999999999887 48999999999999999995 7777899999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceee-cCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQG-QVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g-~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
|++|++++..|..|+++++|++|+|++|++++ .+|.. ...+|+.|++++|++++..|..+..+
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 196 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 196 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccch
Confidence 99999998767789999999999999999986 46765 34699999999999999888877544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.7e-16 Score=149.85 Aligned_cols=151 Identities=21% Similarity=0.325 Sum_probs=126.6
Q ss_pred EecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC--CCCCCCCcEEEccCCcCccccChhhhhCCC
Q 038422 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGMT 146 (634)
Q Consensus 69 ~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~--~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~ 146 (634)
.|.. ..++++++++.. +|. .+ ...++.|+|++|+|++.+|. +.++++|++|+|++|++++ +++..|.+++
T Consensus 10 ~C~~---~~l~~s~n~l~~-iP~-~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~-i~~~~~~~l~ 81 (220)
T 2v70_A 10 RCEG---TTVDCSNQKLNK-IPE-HI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGAS 81 (220)
T ss_dssp EEET---TEEECCSSCCSS-CCS-CC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCE-ECTTTTTTCT
T ss_pred EECC---CEeEeCCCCccc-Ccc-CC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCE-ECHHHhCCCC
Confidence 6753 378999999874 664 33 34678999999999998763 8899999999999999996 5555699999
Q ss_pred CCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCC---Cccc
Q 038422 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDP---STFA 221 (634)
Q Consensus 147 ~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~ 221 (634)
+|++|+|++|++++..|..+.++++|++|+|++|+|++..|.. ...+|+.|+|++|++++..|..|..++. ..+.
T Consensus 82 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 161 (220)
T 2v70_A 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161 (220)
T ss_dssp TCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEec
Confidence 9999999999999888888999999999999999999988875 3469999999999999999988876654 3466
Q ss_pred CCCCCC
Q 038422 222 GNKNLC 227 (634)
Q Consensus 222 gn~~lc 227 (634)
+|+.-|
T Consensus 162 ~N~l~c 167 (220)
T 2v70_A 162 ANPFNC 167 (220)
T ss_dssp SCCEEC
T ss_pred CcCCcC
Confidence 776444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=152.87 Aligned_cols=138 Identities=23% Similarity=0.323 Sum_probs=122.5
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|++.+ +++..+..+++|++|+|++|.+++..+. +.++++|++|+|++|++++ +|+..+..+++|++|
T Consensus 52 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDL 129 (208)
T ss_dssp TTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCccCc-cChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhHhccCCcCCEE
Confidence 468999999999984 5555688999999999999999987775 7899999999999999996 566668999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
+|++|++++..+..+.++++|+.|+|++|.+++..| +|+.|+++.|+++|.||..++.++.
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-----TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-----CHHHHHHHHHhCCceeeccCccccC
Confidence 999999997666678999999999999999998766 5889999999999999999887765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=6e-16 Score=155.58 Aligned_cols=140 Identities=23% Similarity=0.370 Sum_probs=96.3
Q ss_pred EEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
+..|+|+++++.+ +++..+..+++|++|+|++|.++...+. +.++++|++|+|++|++++ +|+..+.++++|++|+|
T Consensus 39 l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 39 TKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116 (270)
T ss_dssp CSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEEC
T ss_pred CCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEEC
Confidence 5567777777664 3334677777777888877777765554 4677777788887777774 55555677777778888
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
++|++++..|..+.++++|++|+|++|++++..+.. ...+|+.|++++|++++..|..+.+++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 181 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLT 181 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCC
Confidence 777777766666777777777787777777544442 345777777777777765555554443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.2e-16 Score=169.65 Aligned_cols=151 Identities=21% Similarity=0.272 Sum_probs=131.6
Q ss_pred Ceee--EEecC----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEcc
Q 038422 64 NWNG--VLCLN----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLS 129 (634)
Q Consensus 64 ~w~g--v~C~~----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls 129 (634)
.|.+ |.|++ .+++.|+|++|++.+..| ..++.+++|++|+|++|.+.+.+| .+.++++|++|+|+
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 3665 88863 358899999999997655 579999999999999999998875 48999999999999
Q ss_pred CCcCccccChhhhhCCCCCCeEEcccCcCccCCCcc--ccCCCCccEEeCCCCceeecCCcc---cccCCCEEEeecCcc
Q 038422 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSS--LVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANNEL 204 (634)
Q Consensus 130 ~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~--~~~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l 204 (634)
+|++++.+|. .|+++++|++|+|++|++++.+|.. ++++++|++|+|++|++++..|.. ...+|+.|++++|++
T Consensus 88 ~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 88 YNQFLQLETG-AFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp TCTTCEECTT-TTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CCccCccChh-hccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 9999976665 4999999999999999999977666 999999999999999999988864 456999999999999
Q ss_pred cccCCccccCCC
Q 038422 205 EGPIPESLSKMD 216 (634)
Q Consensus 205 ~g~ip~~~~~~~ 216 (634)
++..|..+.++.
T Consensus 167 ~~~~~~~l~~l~ 178 (455)
T 3v47_A 167 KSICEEDLLNFQ 178 (455)
T ss_dssp SCCCTTTSGGGT
T ss_pred cccChhhhhccc
Confidence 999998877653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-16 Score=164.29 Aligned_cols=163 Identities=21% Similarity=0.210 Sum_probs=134.9
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhc-CCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLG-LLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSD 130 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~-~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~ 130 (634)
.|.-|.|.+ ..+..|+|++|++++..+ ..+. .+++|+.|+|++|+|++..| .+.++++|++|+|++
T Consensus 19 ~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~-~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 19 ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRA-EWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECT-TSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccCh-hhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 578889953 236789999999997554 4566 89999999999999999887 599999999999999
Q ss_pred CcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCccc-----ccCCCEEEeecCccc
Q 038422 131 NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK-----QNEMRSLGLANNELE 205 (634)
Q Consensus 131 N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~-----~~~l~~l~l~~N~l~ 205 (634)
|++++ +|+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+|++-.+..+ ..+|+.|+|++|+|+
T Consensus 98 N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99995 666679999999999999999998889999999999999999999997444332 569999999999999
Q ss_pred ccCCccccCCCC-----CcccCCCCCCC
Q 038422 206 GPIPESLSKMDP-----STFAGNKNLCG 228 (634)
Q Consensus 206 g~ip~~~~~~~~-----~~~~gn~~lcg 228 (634)
+-.+..+..++. ..+.+|+..|.
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCC
Confidence 655556665543 45677776553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.6e-17 Score=185.43 Aligned_cols=181 Identities=16% Similarity=0.173 Sum_probs=114.9
Q ss_pred CccHHHHHHHHhhcCC-CCCCCCCCCCCCCCCCCCCCCCeeeEEecCCcEEEEEecCCCCccc-----------------
Q 038422 27 GLSDTEILLQFKSSLN-DSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGT----------------- 88 (634)
Q Consensus 27 ~~~~~~~l~~~k~~l~-~~~~~l~~W~~~~~~C~~~~~~w~gv~C~~~~v~~l~L~~~~l~g~----------------- 88 (634)
...++++|+++..++. .....-..|.....++. .|.+++++.+++..|+|.++++.+.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~ 205 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG----TATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDE 205 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccc----cCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccC
Confidence 3567789999988764 22222345654433433 4999888877777776655443321
Q ss_pred ---------cChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCc
Q 038422 89 ---------IAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLT 159 (634)
Q Consensus 89 ---------~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~ 159 (634)
++++.+..++.|+.|+|++|.+....+.+.++++|++|+|++|.|+ .||.. |++|++|++|+|++|+|+
T Consensus 206 ~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 206 DDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAE-IKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGG-GGGGTTCCEEECTTSCCS
T ss_pred ccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChh-hhCCCCCCEEeCcCCcCC
Confidence 2345677889999999999999844347889999999999999999 89876 899999999999999999
Q ss_pred cCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 160 GTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 160 g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
.||.+|++|++|++|+|++|.|+ .||.. ...+|+.|+|++|.|+|.+|..+..+
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK 339 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence 88999999999999999999997 78875 34689999999999999999887543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-15 Score=148.77 Aligned_cols=154 Identities=20% Similarity=0.301 Sum_probs=125.5
Q ss_pred eeeEEecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhh
Q 038422 65 WNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFE 143 (634)
Q Consensus 65 w~gv~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~ 143 (634)
|..-.|+ ...++.+++++. .+|. +..++|++|+|++|++++..| .+.++++|++|+|++|+++ .+|+..|.
T Consensus 14 ~~~~~Cs---~~~v~c~~~~l~-~ip~---~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~ 85 (229)
T 3e6j_A 14 PSQCSCS---GTTVDCRSKRHA-SVPA---GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD 85 (229)
T ss_dssp CTTCEEE---TTEEECTTSCCS-SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred CCCCEEe---CCEeEccCCCcC-ccCC---CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcc
Confidence 4555774 335888888776 5664 234899999999999999887 5899999999999999997 57777789
Q ss_pred CCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---CC
Q 038422 144 GMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD---PS 218 (634)
Q Consensus 144 ~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~ 218 (634)
.+++|++|+|++|+|++..|..+..+++|++|+|++|+|+ .+|.. ...+|+.|+|++|+|++..+..+..++ ..
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 9999999999999999776777899999999999999999 77765 456999999999999976666666554 34
Q ss_pred cccCCCCCC
Q 038422 219 TFAGNKNLC 227 (634)
Q Consensus 219 ~~~gn~~lc 227 (634)
.+.+|+..|
T Consensus 165 ~l~~N~~~c 173 (229)
T 3e6j_A 165 YLFGNPWDC 173 (229)
T ss_dssp ECTTSCBCT
T ss_pred EeeCCCccC
Confidence 566776544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.6e-16 Score=160.57 Aligned_cols=150 Identities=21% Similarity=0.309 Sum_probs=105.7
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCccc---CCC--CCCCCCCcEEEccCCcCcc--ccChhhhhCC
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGP---LPD--LRKMGPLKSIYLSDNGFSG--NISDDAFEGM 145 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~---~p~--~~~l~~L~~L~ls~N~~~g--~ip~~~~~~~ 145 (634)
.++..|+|++|.+.+..+ ..++.+++|++|+|++|.+.|. .+. +..+++|++|+|++|+++. .++...++++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSC-EQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCT-TSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhH-HHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 356777777777755443 4677777777777777777653 222 3567777777888777762 2222235677
Q ss_pred CCCCeEEcccCcCccCCCccccCC---CCccEEeCCCCceeecCCcccccCCCEEEeecCcccc-cCCccccCCCCCccc
Q 038422 146 TSLKKLYMANNRLTGTIPSSLVQL---PKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG-PIPESLSKMDPSTFA 221 (634)
Q Consensus 146 ~~L~~l~l~~N~l~g~ip~~~~~l---~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g-~ip~~~~~~~~~~~~ 221 (634)
++|++|+|++|++++.+|..++.+ ++|++|+|++|+|+ .+|.....+|+.|+|++|++++ +++..+.++....+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~ 302 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRAPQPDELPEVDNLTLD 302 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSCCCTTSCCCCSCEECS
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCCchhhhCCCccEEECc
Confidence 888888888888888778777776 58888888888888 6777655788888888888887 566666666666666
Q ss_pred CCC
Q 038422 222 GNK 224 (634)
Q Consensus 222 gn~ 224 (634)
+|+
T Consensus 303 ~N~ 305 (310)
T 4glp_A 303 GNP 305 (310)
T ss_dssp STT
T ss_pred CCC
Confidence 664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-15 Score=153.60 Aligned_cols=143 Identities=20% Similarity=0.262 Sum_probs=105.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCc-CcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNK-FEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~-l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
.++..|+|++|.+.+..+ ..+..+++|++|+|++|. +.+..| .+..+++|++|+|++|++++.. +..+.++++|++
T Consensus 56 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~ 133 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDA-AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG-PGLFRGLAALQY 133 (285)
T ss_dssp TTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCC-TTTTTTCTTCCE
T ss_pred CCCCEEECCCCccceeCH-hhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEEC-HhHhhCCcCCCE
Confidence 457788888888876544 467788888888888886 555545 4777888888888888887644 345778888888
Q ss_pred EEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCC
Q 038422 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 151 l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
|+|++|++++..+..++++++|++|+|++|++++..+.. ...+|+.|++++|.+++..|..+.+++.
T Consensus 134 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 202 (285)
T 1ozn_A 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202 (285)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred EECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCccc
Confidence 888888888665666778888888888888887655543 3457888888888888777777665543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=170.90 Aligned_cols=174 Identities=13% Similarity=0.151 Sum_probs=133.9
Q ss_pred CCCCCCCCCCCCCCCCCCeeeEEecC------------------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCC
Q 038422 47 ALVNWNALRNPCTFNYPNWNGVLCLN------------------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNN 108 (634)
Q Consensus 47 ~l~~W~~~~~~C~~~~~~w~gv~C~~------------------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n 108 (634)
.+.+|..+.+||.... .|.++.|+. ..+..+++.++.+. .+|+..+..+++|++|+|++|
T Consensus 8 ~l~~~~~~~~C~~~~~-~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNL-QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ---CCCSEECCCCC---CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTS
T ss_pred cccCCCCCCcCcccCc-CceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCC
Confidence 4678987777775322 376666631 23456778777765 567677889999999999999
Q ss_pred cCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCC
Q 038422 109 KFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP 187 (634)
Q Consensus 109 ~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip 187 (634)
.+++.+| .+.++++|++|+|++|.+++ +|+..|+++++|++|+|++|++++..|..|+++++|++|+|++|+|++.+|
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 164 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh
Confidence 9999887 79999999999999999997 555568999999999999999996544557999999999999999999888
Q ss_pred cc--cccCCCEEEeecCcccccCCccccCCCCCcccCC
Q 038422 188 EI--KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGN 223 (634)
Q Consensus 188 ~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~gn 223 (634)
.. ...+|+.|++++|.+++.-+..+.++....+.+|
T Consensus 165 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 165 DTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred hhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 64 4469999999999999865555555554444444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.3e-15 Score=150.13 Aligned_cols=154 Identities=22% Similarity=0.280 Sum_probs=128.5
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+. .+++..+..+++|++|+|++|.+++..+. +.++++|++|+|++|++++ +|+..|+++++|++|
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L 138 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL 138 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe-eCHHHhCcCcCCCEE
Confidence 46889999999998 56666678999999999999999987764 7899999999999999996 556668999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---CCcccCCCCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNKNL 226 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~~l 226 (634)
+|++|++++..+..+..+++|+.|+|++|++++..+.. ...+|+.|++++|++++..+..+..++ ...+.+|+.-
T Consensus 139 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 99999999766667899999999999999999866654 346999999999999976665565444 4456777655
Q ss_pred CC
Q 038422 227 CG 228 (634)
Q Consensus 227 cg 228 (634)
|.
T Consensus 219 c~ 220 (270)
T 2o6q_A 219 CT 220 (270)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=4.9e-16 Score=172.40 Aligned_cols=150 Identities=21% Similarity=0.268 Sum_probs=131.7
Q ss_pred CeeeEEecC-------------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEcc
Q 038422 64 NWNGVLCLN-------------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLS 129 (634)
Q Consensus 64 ~w~gv~C~~-------------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls 129 (634)
.|.|+ |+. .+++.|+|++|++.+..| ..++.+++|++|+|++|.+++..| .+.++++|++|+|+
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 38888 852 268899999999997765 579999999999999999999887 59999999999999
Q ss_pred CCcCccccChhhhhCCCCCCeEEcccCcCcc-CCCccccCCCCccEEeCCCCceeecCCcc---cccCCCEEEeecCccc
Q 038422 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTG-TIPSSLVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANNELE 205 (634)
Q Consensus 130 ~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g-~ip~~~~~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l~ 205 (634)
+|++++ +|+..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++.+.+|.. ..++|+.|++++|+++
T Consensus 83 ~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 83 DNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 999996 556669999999999999999997 57889999999999999999977788753 3468999999999999
Q ss_pred ccCCccccCCC
Q 038422 206 GPIPESLSKMD 216 (634)
Q Consensus 206 g~ip~~~~~~~ 216 (634)
+.+|..+.++.
T Consensus 162 ~~~~~~l~~l~ 172 (549)
T 2z81_A 162 NYQSQSLKSIR 172 (549)
T ss_dssp EECTTTTTTCS
T ss_pred ccChhhhhccc
Confidence 99998887665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-15 Score=149.73 Aligned_cols=135 Identities=20% Similarity=0.306 Sum_probs=119.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+.+..+ ..+..+++|++|+|++|.+++..|. +..+++|++|+|++|++++ +|+..|..+++|++|
T Consensus 59 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSA-GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL 136 (251)
T ss_dssp TTCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred ccCCEEECCCCcCCccCH-hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCC-cChhHhccCCcccEE
Confidence 468999999999998554 5789999999999999999988774 7899999999999999995 666668999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+|++|++++..|..++++++|++|+|++|+|++..|.. ...+|+.|++++|.+++...
T Consensus 137 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 99999999776778999999999999999999777754 34699999999999998743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.4e-15 Score=145.28 Aligned_cols=151 Identities=25% Similarity=0.310 Sum_probs=124.0
Q ss_pred EecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCC
Q 038422 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTS 147 (634)
Q Consensus 69 ~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~ 147 (634)
.|.. ..+++++++|. .+|. .+ .++|+.|+|++|.+++..| .+..+++|++|+|++|++++..| +.|.++++
T Consensus 10 ~C~~---~~v~c~~~~l~-~iP~-~l--~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~ 81 (220)
T 2v9t_B 10 TCSN---NIVDCRGKGLT-EIPT-NL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP-DAFQGLRS 81 (220)
T ss_dssp EEET---TEEECTTSCCS-SCCS-SC--CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECT-TTTTTCSS
T ss_pred EECC---CEEEcCCCCcC-cCCC-cc--CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCH-HHhhCCcC
Confidence 7753 35788888887 4553 23 3689999999999999887 68999999999999999997555 45999999
Q ss_pred CCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---CCcccC
Q 038422 148 LKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAG 222 (634)
Q Consensus 148 L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~g 222 (634)
|++|+|++|+|++..+..+..+++|++|+|++|++++..|.. ...+|+.|+|++|+|++..|..+..++ ...+.+
T Consensus 82 L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (220)
T 2v9t_B 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161 (220)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCC
Confidence 999999999999544455789999999999999999988875 346999999999999988887776554 345677
Q ss_pred CCCCC
Q 038422 223 NKNLC 227 (634)
Q Consensus 223 n~~lc 227 (634)
|+..|
T Consensus 162 N~~~c 166 (220)
T 2v9t_B 162 NPFIC 166 (220)
T ss_dssp SCEEC
T ss_pred CCcCC
Confidence 76555
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.9e-15 Score=150.78 Aligned_cols=135 Identities=19% Similarity=0.294 Sum_probs=119.5
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|++.+.. +..++.+++|++|+|++|.+++..|. +.++++|++|+|++|++++ +|+..++.+++|++|
T Consensus 85 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLP-NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTEL 162 (272)
T ss_dssp TTCCEEECTTSCCCCCC-TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCccCccC-hhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEE
Confidence 57899999999999654 45689999999999999999988875 7899999999999999995 556668999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+|++|++++..|..++++++|+.|+|++|++++.+|.. ...+|+.|++++|.++|..|
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99999999877777899999999999999999877764 45699999999999988877
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.4e-16 Score=172.96 Aligned_cols=156 Identities=24% Similarity=0.362 Sum_probs=121.9
Q ss_pred CCCCCCCCCCCCCCCCCeeeE-EecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEE
Q 038422 48 LVNWNALRNPCTFNYPNWNGV-LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSI 126 (634)
Q Consensus 48 l~~W~~~~~~C~~~~~~w~gv-~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L 126 (634)
+.+|..+.++|......|.|+ .|..++++.|+|++|+|++ +|. .+ +++|++|+|++|+|+ .+| ..+++|++|
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~-~l--~~~L~~L~Ls~N~l~-~ip--~~l~~L~~L 105 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NL--PPQITVLEITQNALI-SLP--ELPASLEYL 105 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCS-CC--CTTCSEEECCSSCCS-CCC--CCCTTCCEE
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCH-hH--cCCCCEEECcCCCCc-ccc--cccCCCCEE
Confidence 557876677884211139999 7887789999999999998 775 34 478999999999998 577 667899999
Q ss_pred EccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccc
Q 038422 127 YLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206 (634)
Q Consensus 127 ~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g 206 (634)
+|++|+|++ ||. +.+ +|++|+|++|+|++ ||. .+++|+.|+|++|+|++ +|. ..++|+.|+|++|+|++
T Consensus 106 ~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 106 DACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp ECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC
T ss_pred EccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC
Confidence 999999997 776 554 89999999999997 777 67889999999999987 776 56688999999999887
Q ss_pred cCCcccc-CCCCCcccCC
Q 038422 207 PIPESLS-KMDPSTFAGN 223 (634)
Q Consensus 207 ~ip~~~~-~~~~~~~~gn 223 (634)
||. +. ++......+|
T Consensus 175 -lp~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 175 -LPE-LPESLEALDVSTN 190 (571)
T ss_dssp -CCC-CCTTCCEEECCSS
T ss_pred -cch-hhCCCCEEECcCC
Confidence 776 43 3333344444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-15 Score=151.02 Aligned_cols=138 Identities=22% Similarity=0.179 Sum_probs=100.5
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
.+..|+|++|.+.+..+ ..+..+++|++|+|++|.+++..+ ...+++|++|+|++|+++ .+|.. +..+++|++|+|
T Consensus 32 ~l~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~-~~~l~~L~~L~l 107 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLL-GQTLPALTVLDV 107 (290)
T ss_dssp TCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCS-SCCCC-TTTCTTCCEEEC
T ss_pred CCCEEEcCCCcCCccCH-HHhhcCCCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCC-cCchh-hccCCCCCEEEC
Confidence 57788888888876554 468888888888888888887544 377778888888888887 56654 677788888888
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
++|++++..|..|.++++|++|+|++|+|++..|.. ...+|+.|+|++|+|++-.+..+.++
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l 171 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCc
Confidence 888888666677778888888888888887655543 34578888888888874444334433
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.8e-16 Score=176.44 Aligned_cols=147 Identities=25% Similarity=0.393 Sum_probs=130.1
Q ss_pred CcEEEEEecCCCCccc-----------------cChhhhc--CCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCc
Q 038422 73 GSVWGLKLEQMNLSGT-----------------IAAESLG--LLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNG 132 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~-----------------~~~~~l~--~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~ 132 (634)
.++..|+|++|.++|. +|. .++ ++++|++|+|++|++.|.+| .++++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 5789999999999996 875 788 99999999999999999999 59999999999999999
Q ss_pred -Ccc-ccChhhhhCC------CCCCeEEcccCcCccCCCc--cccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeec
Q 038422 133 -FSG-NISDDAFEGM------TSLKKLYMANNRLTGTIPS--SLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLAN 201 (634)
Q Consensus 133 -~~g-~ip~~~~~~~------~~L~~l~l~~N~l~g~ip~--~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~ 201 (634)
++| .+|.. ++++ ++|++|+|++|+++ .+|. .++++++|++|+|++|+++|.+|.+ ...+|+.|++++
T Consensus 285 ~l~~~~lp~~-~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDD-WQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHH-HHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCS
T ss_pred CCccccchHH-HHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCC
Confidence 999 89876 7776 99999999999999 8999 9999999999999999999999943 345899999999
Q ss_pred CcccccCCccccCCCC----CcccCC
Q 038422 202 NELEGPIPESLSKMDP----STFAGN 223 (634)
Q Consensus 202 N~l~g~ip~~~~~~~~----~~~~gn 223 (634)
|+++ .+|..+.+++. ..+.+|
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred Cccc-cccHhhhhhcccCcEEEccCC
Confidence 9999 88988765544 344555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=158.85 Aligned_cols=160 Identities=23% Similarity=0.292 Sum_probs=129.4
Q ss_pred CCCCCCCCCCCCCCCeeeEEec--C-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-
Q 038422 50 NWNALRNPCTFNYPNWNGVLCL--N-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP- 115 (634)
Q Consensus 50 ~W~~~~~~C~~~~~~w~gv~C~--~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p- 115 (634)
.|.....+|. |.|+ |+ . .+++.|+|++|++.+ +++..+..+++|++|+|++|.+++..|
T Consensus 22 ~~~~~~~~C~-----~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 94 (353)
T 2z80_A 22 SSNQASLSCD-----RNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEED 94 (353)
T ss_dssp -----CCEEC-----TTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred CCCccCCCCC-----CCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHh
Confidence 3444455664 8887 64 1 258899999999986 454579999999999999999999887
Q ss_pred CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCc--cccCCCCccEEeCCCCc-eeecCCcc--c
Q 038422 116 DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS--SLVQLPKLMELRLEANK-FQGQVPEI--K 190 (634)
Q Consensus 116 ~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~--~~~~l~~L~~L~l~~N~-~~g~ip~~--~ 190 (634)
.+.++++|++|+|++|++++ +|+..++++++|++|+|++|++++ +|. .+.++++|++|+|++|+ +++..|.. .
T Consensus 95 ~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 172 (353)
T 2z80_A 95 SFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172 (353)
T ss_dssp TTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred hcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccC
Confidence 49999999999999999994 777779999999999999999994 665 78999999999999995 55554543 3
Q ss_pred ccCCCEEEeecCcccccCCccccCCCCC
Q 038422 191 QNEMRSLGLANNELEGPIPESLSKMDPS 218 (634)
Q Consensus 191 ~~~l~~l~l~~N~l~g~ip~~~~~~~~~ 218 (634)
..+|+.|++++|++++.+|..+.+++..
T Consensus 173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L 200 (353)
T 2z80_A 173 LTFLEELEIDASDLQSYEPKSLKSIQNV 200 (353)
T ss_dssp CCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred CCCCCEEECCCCCcCccCHHHHhccccC
Confidence 4689999999999999989888766543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=142.55 Aligned_cols=131 Identities=23% Similarity=0.390 Sum_probs=108.0
Q ss_pred CeeeEEecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhh
Q 038422 64 NWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAF 142 (634)
Q Consensus 64 ~w~gv~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~ 142 (634)
.|.+|.|+..+ +. .+|. ...++|+.|+|++|++++..+. +.++++|++|+|++|++++ +|+..+
T Consensus 8 ~~~~l~~~~~~----------l~-~~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~ 72 (177)
T 2o6r_A 8 SGTEIRCNSKG----------LT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVF 72 (177)
T ss_dssp ETTEEECCSSC----------CS-SCCT---TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTT
T ss_pred CCCEEEecCCC----------Cc-cCCC---CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE-eChhHc
Confidence 58888885433 33 2442 2347899999999999987764 6899999999999999995 666668
Q ss_pred hCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 143 EGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 143 ~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+++++|++|+|++|++++..|..+.++++|++|+|++|+|++..+.. ...+|+.|++++|.++|..|
T Consensus 73 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 73 DKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99999999999999999877777899999999999999999655543 34689999999999999877
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=155.43 Aligned_cols=139 Identities=17% Similarity=0.197 Sum_probs=89.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
.++..|+|++|.+.+ +|. .+..+++|++|+|++|.+++..+ .+.++++|++|+|++|.+++.+|. .+.++++|++
T Consensus 78 ~~L~~L~Ls~n~i~~-l~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~ 154 (306)
T 2z66_A 78 TSLKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG-IFNGLSSLEV 154 (306)
T ss_dssp SCCCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTT-TTTTCTTCCE
T ss_pred cccCEEECCCCcccc-Chh-hcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchh-hcccCcCCCE
Confidence 456677777777663 432 46667777777777777766554 466677777777777777654443 3666677777
Q ss_pred EEcccCcCcc-CCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccC
Q 038422 151 LYMANNRLTG-TIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSK 214 (634)
Q Consensus 151 l~l~~N~l~g-~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 214 (634)
|+|++|++++ .+|..+..+++|++|+|++|++++..|.. ...+|+.|++++|++++..+..+..
T Consensus 155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 7777777765 45666677777777777777776665554 2346667777777666655544443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-16 Score=165.82 Aligned_cols=134 Identities=10% Similarity=0.109 Sum_probs=93.8
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCc--------------cChhHH--------HHHHHHHhcCCCCccccc
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNN--------------VGREDF--------QEHIKRLGRLEHPNLLPL 416 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~H~niv~l 416 (634)
....||+|+||.||+|...+|+.||||+++.... ...... .+|...|.++.+.++...
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 3567999999999999998999999998753210 011122 234555555543333211
Q ss_pred eeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC
Q 038422 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS 496 (634)
Q Consensus 417 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 496 (634)
.-+.. ...+|||||+.+++|.++.. . .....++.|++.+|.|||+. +||||||||.|||++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeCC
Confidence 11111 23479999999988865432 1 12356889999999999998 89999999999999877
Q ss_pred C----------CeEEeccccCCc
Q 038422 497 F----------EPLLTDYALRPL 509 (634)
Q Consensus 497 ~----------~~kl~DfGla~~ 509 (634)
+ .+.|+||+-+-.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 6 378999987643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=170.84 Aligned_cols=138 Identities=17% Similarity=0.169 Sum_probs=71.3
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
++..|+|++|.+.+ +| ..+..+++|+.|+|++|.+.+.+| .+.++++|++|+|++|.+++.+|.. ++++++|++|
T Consensus 377 ~L~~L~L~~n~l~~-~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L 453 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MS-ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI-FLGLTSLNTL 453 (606)
T ss_dssp CCCEEECCSCSEEE-EC-CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTT-TTTCTTCCEE
T ss_pred cccEeECCCCcccc-ch-hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhh-hcCCCCCCEE
Confidence 45566666666554 33 245555555555555555555544 3455555555555555555444332 4555555555
Q ss_pred EcccCcCccC-CCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccC
Q 038422 152 YMANNRLTGT-IPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSK 214 (634)
Q Consensus 152 ~l~~N~l~g~-ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 214 (634)
+|++|++++. +|..++++++|+.|+|++|++++.+|.. ...+|+.|++++|++++.+|..+.+
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 519 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTT
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccC
Confidence 5555555542 4555555555555555555555544442 2234555555555555554544443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8.1e-15 Score=148.42 Aligned_cols=143 Identities=18% Similarity=0.192 Sum_probs=122.6
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..|+|+++++.+. ++..+..+++|++|+|++|.+++..| .+.++++|++|+|++|.+-+.+++..+..+++|++|+
T Consensus 33 ~l~~L~l~~n~i~~~-~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 33 ASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TCSEEECTTSCCCEE-CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CceEEEeeCCcCCcc-CHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 578999999999875 44579999999999999999999877 6899999999999999833456566699999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
|++|++++..|..+.++++|++|+|++|++++..+.. ...+|+.|++++|++++..+..+.+++.
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 178 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccc
Confidence 9999999888999999999999999999999766654 4569999999999999766666665543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-15 Score=140.19 Aligned_cols=130 Identities=22% Similarity=0.238 Sum_probs=113.6
Q ss_pred CcEEEEEecCCCCc-cccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLS-GTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~-g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|++. |.+|. .+..+++|+.|+|++|.+++. +.+..+++|++|+|++|++++.+|. .+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDM-LAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCH-HHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHH-HHhhCCCCCEE
Confidence 46889999999998 88875 578999999999999999987 8899999999999999999987765 47889999999
Q ss_pred EcccCcCccC-CCccccCCCCccEEeCCCCceeecCC---cc--cccCCCEEEeecCccc
Q 038422 152 YMANNRLTGT-IPSSLVQLPKLMELRLEANKFQGQVP---EI--KQNEMRSLGLANNELE 205 (634)
Q Consensus 152 ~l~~N~l~g~-ip~~~~~l~~L~~L~l~~N~~~g~ip---~~--~~~~l~~l~l~~N~l~ 205 (634)
+|++|++++. .+..+..+++|++|+|++|.+++..+ .. ..++|+.|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 9999999963 23789999999999999999997666 22 4569999999999886
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=153.75 Aligned_cols=148 Identities=22% Similarity=0.277 Sum_probs=86.5
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCccc--CC-CCCCCCCCcEEEcc
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGP--LP-DLRKMGPLKSIYLS 129 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~--~p-~~~~l~~L~~L~ls 129 (634)
.|.+|.|+. ..++.|+|++|++. .+|+..+..+++|++|+|++|.++.. +| .+..+++|++|+|+
T Consensus 8 ~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 599999963 25789999999988 56666678888899999988888743 22 33344555555555
Q ss_pred CCcCccccChh------------------------hhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceee-
Q 038422 130 DNGFSGNISDD------------------------AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG- 184 (634)
Q Consensus 130 ~N~~~g~ip~~------------------------~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g- 184 (634)
+|.+++ +|.. .+..+++|++|+|++|++++..|..+.++++|++|+|++|.+++
T Consensus 87 ~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 555542 3332 34445555555555555555445555555555555555555544
Q ss_pred cCCcc--cccCCCEEEeecCcccccCCcccc
Q 038422 185 QVPEI--KQNEMRSLGLANNELEGPIPESLS 213 (634)
Q Consensus 185 ~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~ 213 (634)
.+|.. ...+|+.|++++|++++..|..+.
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 196 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhc
Confidence 23332 223555555555555554444443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=4e-15 Score=149.91 Aligned_cols=139 Identities=21% Similarity=0.249 Sum_probs=120.0
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..|+|++|++.+..+ ..+..+++|++|+|++|.+++..+ .+.++++|++|+|++|++++. ++..+.++++|++|+
T Consensus 29 ~l~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL-ALGAFSGLSSLQKLV 106 (276)
T ss_dssp TCCEEECTTCCCCEECT-TTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE-CTTTTTTCTTCCEEE
T ss_pred CccEEECCCCcccccCH-hHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc-ChhhhcCCccccEEE
Confidence 57899999999987554 578999999999999999998877 589999999999999999965 445589999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceee-cCCcc--cccCCCEEEeecCcccccCCccccC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQG-QVPEI--KQNEMRSLGLANNELEGPIPESLSK 214 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g-~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 214 (634)
|++|++++..+..++++++|++|+|++|++++ .+|.. ...+|+.|++++|++++..+..+..
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 171 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence 99999998777789999999999999999987 46765 3469999999999999877766543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=137.59 Aligned_cols=126 Identities=21% Similarity=0.239 Sum_probs=99.7
Q ss_pred CcEEEEEecCCCCc-cccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLS-GTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~-g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|+++++. |.+|. .+..+++|+.|+|++|.+++. +.+.++++|++|+|++|.+++.+|. .++.+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEV-LAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHH-HHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHH-HhhhCCCCCEE
Confidence 45778888888888 77774 678888888888888888877 7788888888888888888876654 47778888888
Q ss_pred EcccCcCccC-CCccccCCCCccEEeCCCCceeecCC---cc--cccCCCEEEeec
Q 038422 152 YMANNRLTGT-IPSSLVQLPKLMELRLEANKFQGQVP---EI--KQNEMRSLGLAN 201 (634)
Q Consensus 152 ~l~~N~l~g~-ip~~~~~l~~L~~L~l~~N~~~g~ip---~~--~~~~l~~l~l~~ 201 (634)
+|++|++++. .|..++.+++|++|++++|++++..+ .. ..++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888888862 45778888888888888888887665 22 346788887753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=154.24 Aligned_cols=138 Identities=20% Similarity=0.190 Sum_probs=85.5
Q ss_pred CcEEEEEecCCCCccccChhhhcCC-----CCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCcccc--Chh-hhh
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLL-----SSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNI--SDD-AFE 143 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l-----~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~i--p~~-~~~ 143 (634)
.++..|+|++|.+.+. | ..++.+ ++|++|+|++|.+++..| .+.++++|++|+|++|++.|.+ |+. .++
T Consensus 121 ~~L~~L~Ls~N~l~~~-~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-D-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS-S-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch-h-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 3566777777777765 4 345554 677777777777776664 4667777777777777766652 222 126
Q ss_pred CCCCCCeEEcccCcCcc--CCCcc-ccCCCCccEEeCCCCceeecCCcc---cccCCCEEEeecCcccccCCcccc
Q 038422 144 GMTSLKKLYMANNRLTG--TIPSS-LVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANNELEGPIPESLS 213 (634)
Q Consensus 144 ~~~~L~~l~l~~N~l~g--~ip~~-~~~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l~g~ip~~~~ 213 (634)
.+++|++|+|++|++++ .+|.. +.++++|++|+|++|++++.+|.. ...+|+.|++++|+|+ .||..+.
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 66777777777777762 23322 345667777777777777665422 2356777777777776 6665543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=6.6e-15 Score=160.43 Aligned_cols=151 Identities=19% Similarity=0.244 Sum_probs=131.0
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..|.|.. ..+..|+|++|++.+..+ ..+..+++|++|+|++|.+++..| .+.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 478899953 257799999999997655 579999999999999999999887 6999999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+++ .+|+..|.++++|++|+|++|++++..|..+.++++|+.|+|++|++++..|.. ...+|+.|++++|++++..+
T Consensus 91 ~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp CCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred cCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 999 477777899999999999999999999999999999999999999999887765 34689999999999987665
Q ss_pred ccccCCC
Q 038422 210 ESLSKMD 216 (634)
Q Consensus 210 ~~~~~~~ 216 (634)
..+.+++
T Consensus 170 ~~l~~l~ 176 (477)
T 2id5_A 170 EALSHLH 176 (477)
T ss_dssp HHHTTCT
T ss_pred hHhcccC
Confidence 5565544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=7.5e-15 Score=155.70 Aligned_cols=172 Identities=13% Similarity=0.188 Sum_probs=128.8
Q ss_pred CCCCCCCCCCCCCCCCCeeeEEecC------------------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCc
Q 038422 48 LVNWNALRNPCTFNYPNWNGVLCLN------------------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNK 109 (634)
Q Consensus 48 l~~W~~~~~~C~~~~~~w~gv~C~~------------------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~ 109 (634)
+++|....+||.... .|.++.|+. ..+..+++.++.+. .+|+..+..+++|++|+|++|.
T Consensus 3 ~~~~~~~~~C~~~~~-~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~ 80 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNL-QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ 80 (390)
T ss_dssp ----CCEECBCC-------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSC
T ss_pred cCCCCCccceehhhh-hhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCc
Confidence 578987777775211 244444420 24567888887765 5676678899999999999999
Q ss_pred CcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCcc-ccCCCCccEEeCCCCceeecCC
Q 038422 110 FEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSS-LVQLPKLMELRLEANKFQGQVP 187 (634)
Q Consensus 110 l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~-~~~l~~L~~L~l~~N~~~g~ip 187 (634)
+++..| .+..+++|++|+|++|.+++ +|+..++++++|++|+|++|+++ .+|.. +.++++|++|+|++|++++..|
T Consensus 81 i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 158 (390)
T 3o6n_A 81 IEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIED 158 (390)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred ccccChhhccCCCCcCEEECCCCCCCc-CCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccCh
Confidence 999887 79999999999999999996 45556899999999999999999 56655 6899999999999999998777
Q ss_pred cc--cccCCCEEEeecCcccccCCccccCCCCCcccCC
Q 038422 188 EI--KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGN 223 (634)
Q Consensus 188 ~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~gn 223 (634)
.. ...+|+.|++++|++++.-...+.++......+|
T Consensus 159 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 159 DTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp TTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred hhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 64 4469999999999998754444555544444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=7.9e-15 Score=164.75 Aligned_cols=141 Identities=18% Similarity=0.205 Sum_probs=124.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.+++.|+|++|.+.+..+ ..+..+++|++|+|++|.+++..| .+.++++|++|+|++|.+++..|. .|+++++|++|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L 109 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG-SFSGLTSLENL 109 (606)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTT-SSTTCTTCCEE
T ss_pred CCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChh-hcCCcccCCEE
Confidence 468899999999987655 579999999999999999999888 589999999999999999976554 59999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceee-cCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQG-QVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g-~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
+|++|++++..|..++++++|++|+|++|++++ .+|.. ...+|+.|++++|++++..|..++.+
T Consensus 110 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 176 (606)
T 3vq2_A 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176 (606)
T ss_dssp ECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHH
T ss_pred EccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhh
Confidence 999999998777899999999999999999986 77875 45699999999999999888776543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=9.4e-15 Score=158.08 Aligned_cols=135 Identities=19% Similarity=0.272 Sum_probs=104.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
..+..|+|++|++.+.+| ..++.+++|++|+|++|.+++..| .+.++++|++|+|++|.+++. ++..++++++|++|
T Consensus 275 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L 352 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLK-SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI-DSRMFENLDKLEVL 352 (455)
T ss_dssp SCCCEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE-CGGGGTTCTTCCEE
T ss_pred cCceEEEecCccccccch-hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCc-ChhHhcCcccCCEE
Confidence 357778888888877665 467788888888888888888777 577888888888888888754 34457888888888
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+|++|++++..|..+.++++|++|+|++|++++..+.. ..++|+.|++++|.++|.+|
T Consensus 353 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 353 DLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 88888888777888888888888888888888644443 34578888888888888877
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-14 Score=146.77 Aligned_cols=150 Identities=23% Similarity=0.318 Sum_probs=115.8
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|++++.-+ .+.+++|+.|+|++|.++.....+..+++|++|+|++|++++ +|+..|.++++|++|+
T Consensus 55 ~~L~~L~L~~n~l~~~~~---~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELY 130 (290)
T ss_dssp TTCCEEECTTSCCCEEEC---CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCcccC---CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcc-cCHHHHcCCCCCCEEE
Confidence 568889999998886432 378889999999999988544467888999999999999985 5556688899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC---CCcccCCCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNKNLC 227 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~~lc 227 (634)
|++|++++..|..+..+++|+.|+|++|+|++..+.. ...+|+.|+|++|+|+ .||..+.... ...+.||+..|
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 9999999766667788899999999999998544443 3468999999999998 6777665443 33456676554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.56 E-value=2e-15 Score=174.52 Aligned_cols=147 Identities=24% Similarity=0.322 Sum_probs=127.5
Q ss_pred CcEEEEEecCCCCcc-----------------ccChhhhc--CCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCc
Q 038422 73 GSVWGLKLEQMNLSG-----------------TIAAESLG--LLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNG 132 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g-----------------~~~~~~l~--~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~ 132 (634)
.++..|+|++|+|+| .+|. .++ ++++|++|+|++|++.|.+| .++++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 578999999999999 4775 677 99999999999999999999 59999999999999998
Q ss_pred -Ccc-ccChhhhhCCC-------CCCeEEcccCcCccCCCc--cccCCCCccEEeCCCCceeecCCcc-cccCCCEEEee
Q 038422 133 -FSG-NISDDAFEGMT-------SLKKLYMANNRLTGTIPS--SLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLA 200 (634)
Q Consensus 133 -~~g-~ip~~~~~~~~-------~L~~l~l~~N~l~g~ip~--~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~ 200 (634)
|+| .+|.. +++++ +|+.|+|++|+|+ .||. .++++++|+.|+|++|+|+ .||.+ ...+|+.|+|+
T Consensus 527 ~lsg~~iP~~-i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKAD-WTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHH-HHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CcccccchHH-HHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 999 89875 66655 9999999999999 8999 9999999999999999999 89944 34689999999
Q ss_pred cCcccccCCccccCCCC----CcccCCC
Q 038422 201 NNELEGPIPESLSKMDP----STFAGNK 224 (634)
Q Consensus 201 ~N~l~g~ip~~~~~~~~----~~~~gn~ 224 (634)
+|+++ .+|..+.+++. ..+.+|.
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCC
Confidence 99999 89988765544 3455553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=156.53 Aligned_cols=150 Identities=21% Similarity=0.342 Sum_probs=108.3
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..|.|.+ ..+..|+|++|++.+..+ ..+..+++|+.|+|++|.+++..| .+.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 478899953 257899999999997655 578999999999999999998876 5888999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCC-------------------------CceeecC
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA-------------------------NKFQGQV 186 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~-------------------------N~~~g~i 186 (634)
++++ +|+..|+.+++|++|+|++|++++..+..+.++++|+.|+|++ |++++ +
T Consensus 134 ~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 211 (452)
T 3zyi_A 134 WLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-M 211 (452)
T ss_dssp CCSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-C
T ss_pred cCCc-cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-c
Confidence 9984 6666688888889999888888854444555555555555554 44442 2
Q ss_pred Ccc-cccCCCEEEeecCcccccCCccccCCC
Q 038422 187 PEI-KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 187 p~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|.. ...+|+.|+|++|++++..|..|.+++
T Consensus 212 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 242 (452)
T 3zyi_A 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242 (452)
T ss_dssp CCCTTCTTCCEEECTTSCCSEECGGGGTTCT
T ss_pred ccccccccccEEECcCCcCcccCcccccCcc
Confidence 322 234566666666666666666655444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.5e-15 Score=140.61 Aligned_cols=128 Identities=15% Similarity=0.271 Sum_probs=86.6
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
++..|+|+++++. .++ .+..+++|++|+|++|.++. ++.+..+++|++|+|++|++++..|.. ++.+++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPN-LSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCC-CTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChh-hcCCCCCCEEEe
Confidence 4667777777776 444 36677777777777775433 345667777777777777777655544 677777777777
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEG 206 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g 206 (634)
++|++++..|..++++++|++|+|++|++.+.+|.. ..++|+.|++++|++++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC
Confidence 777777766777777777777777777744555543 34567777777777765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=145.17 Aligned_cols=138 Identities=19% Similarity=0.230 Sum_probs=107.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+.+.. +..+..+++|++|+|++|.+++..| .+.++++|++|++++|++++. ++..++.+++|++|
T Consensus 52 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L 129 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIE-DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKEL 129 (276)
T ss_dssp TTCSEEECTTCCCCEEC-TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCS-TTCCCTTCTTCCEE
T ss_pred cCCcEEECCCCcCCccC-HHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCcccc-CchhcccCCCCCEE
Confidence 46888999999888544 4578889999999999999988876 588899999999999999864 44348889999999
Q ss_pred EcccCcCcc-CCCccccCCCCccEEeCCCCceeecCCccc--ccCCC----EEEeecCcccccCCccc
Q 038422 152 YMANNRLTG-TIPSSLVQLPKLMELRLEANKFQGQVPEIK--QNEMR----SLGLANNELEGPIPESL 212 (634)
Q Consensus 152 ~l~~N~l~g-~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~--~~~l~----~l~l~~N~l~g~ip~~~ 212 (634)
+|++|++++ .+|..++++++|++|+|++|++++..+... ..+|+ .|++++|.+++..+..+
T Consensus 130 ~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~ 197 (276)
T 2z62_A 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197 (276)
T ss_dssp ECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS
T ss_pred ECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc
Confidence 999999987 478889999999999999999887665432 22344 66677777665444433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=168.57 Aligned_cols=149 Identities=19% Similarity=0.185 Sum_probs=128.5
Q ss_pred CeeeEEecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEccCCcCccccChhh
Q 038422 64 NWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSDNGFSGNISDDA 141 (634)
Q Consensus 64 ~w~gv~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~N~~~g~ip~~~ 141 (634)
+|..|.+-..+++.|+|++|.+++..+ ..+..+++|++|+|++|.+.+.++ .+.++++|++|+|++|.+++..|. .
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-~ 92 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-A 92 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-S
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-H
Confidence 577777756789999999999987665 579999999999999998888874 589999999999999999976654 5
Q ss_pred hhCCCCCCeEEcccCcCccCCCcc--ccCCCCccEEeCCCCceeecCCc-c--cccCCCEEEeecCcccccCCccccC
Q 038422 142 FEGMTSLKKLYMANNRLTGTIPSS--LVQLPKLMELRLEANKFQGQVPE-I--KQNEMRSLGLANNELEGPIPESLSK 214 (634)
Q Consensus 142 ~~~~~~L~~l~l~~N~l~g~ip~~--~~~l~~L~~L~l~~N~~~g~ip~-~--~~~~l~~l~l~~N~l~g~ip~~~~~ 214 (634)
|+++++|++|+|++|++++.+|.. ++++++|++|+|++|++++..|. . ..++|+.|++++|.+++..|..+..
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 999999999999999999988776 89999999999999999987663 2 4568999999999999988887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.54 E-value=8.9e-16 Score=175.48 Aligned_cols=139 Identities=22% Similarity=0.314 Sum_probs=119.9
Q ss_pred CCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 72 NGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 72 ~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
...+..|+|++|.+. .+|. .++.+++|++|+|++|.|+ .+| .+++|++|++|+|++|.|+ .||.. |++|++|++
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~ 297 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAE-LGSCFQLKY 297 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSS-GGGGTTCSE
T ss_pred CCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChh-hcCCCCCCE
Confidence 356889999999998 7775 6779999999999999999 676 6999999999999999999 88876 899999999
Q ss_pred EEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccc---cCCCEEEeecCcccccCCccccCCC
Q 038422 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQ---NEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 151 l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~---~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|+|++|.|+ .||..|++|++|+.|+|++|+|+|.+|.... ..+..|+|++|.++|.+|..+..+.
T Consensus 298 L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 298 FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp EECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred EECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 999999997 8999999999999999999999999997632 1234578999999999999887665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=7.6e-15 Score=160.28 Aligned_cols=132 Identities=22% Similarity=0.165 Sum_probs=70.4
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-----------------CCCCCCCcEEEccCCcCccc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-----------------LRKMGPLKSIYLSDNGFSGN 136 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-----------------~~~l~~L~~L~ls~N~~~g~ 136 (634)
.+..|+|++|.+++..| ++.+++|++|+|++|.|++..+. ...+++|+.|+|++|.+++.
T Consensus 59 ~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~ 135 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML 135 (487)
T ss_dssp TCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSG
T ss_pred CCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCC
Confidence 45555555555554432 44455555555555544443210 01234445555555555543
Q ss_pred cChhhhhCCCCCCeEEcccCcCccCCCcccc-CCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCC
Q 038422 137 ISDDAFEGMTSLKKLYMANNRLTGTIPSSLV-QLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 137 ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~-~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip 209 (634)
.|. .++++++|++|+|++|++++.+|..+. ++++|+.|+|++|.|++..+....++|+.|+|++|.|+|..|
T Consensus 136 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 208 (487)
T 3oja_A 136 RDL-DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGP 208 (487)
T ss_dssp GGB-CGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECG
T ss_pred Cch-hhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCH
Confidence 332 255666666666666666666565554 566666666666666655444445566666666666665333
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=7.3e-15 Score=160.38 Aligned_cols=148 Identities=22% Similarity=0.174 Sum_probs=118.1
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..|+|++|.+++..+ ..+++|+.|+|++|.+++.+| .++++++|++|+|++|.++|.+|....+++++|++|+
T Consensus 100 ~L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 100 SIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TCCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 34455566666655432 246889999999999999887 6899999999999999999988776445899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCC---CCcccCCCCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNKNLCG 228 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~~lcg 228 (634)
|++|+|++. | .+..+++|+.|+|++|+|++.+|.+ ...+|+.|++++|.|++ +|..+..++ ...+.+|+..|+
T Consensus 176 Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 999999976 3 3446999999999999999977765 45699999999999996 787776544 445677765554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=160.30 Aligned_cols=138 Identities=16% Similarity=0.272 Sum_probs=104.0
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCcc--ccChhhhhCCCCCCe
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSG--NISDDAFEGMTSLKK 150 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g--~ip~~~~~~~~~L~~ 150 (634)
.+..|+++++++.+.. ....+++|++|+|++|.+++.+| .+.++++|++|+|++|++++ .+|. .++.+++|++
T Consensus 303 ~L~~L~l~~n~l~~~~---~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~-~~~~l~~L~~ 378 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML---CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE-MTTQMKSLQQ 378 (520)
T ss_dssp CCSEEEEESSCCCCCC---CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHH-HHTTCTTCCE
T ss_pred ceeEEEcCCCcccccc---chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchH-HHhhCCCCCE
Confidence 4778888888776432 12577888888888888888666 57888888888888888886 4543 3788888888
Q ss_pred EEcccCcCccCCCcc-ccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC
Q 038422 151 LYMANNRLTGTIPSS-LVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 151 l~l~~N~l~g~ip~~-~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|+|++|++++.+|.. +..+++|+.|+|++|++++.+|.....+|+.|++++|+++ .||..+..++
T Consensus 379 L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~ 444 (520)
T 2z7x_B 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLE 444 (520)
T ss_dssp EECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred EECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCC
Confidence 888888888767764 6777888888888888888777765577888888888887 7777665444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.1e-14 Score=159.94 Aligned_cols=133 Identities=22% Similarity=0.336 Sum_probs=72.1
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCccc--CC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGP--LP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~--~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
++..|+|++|.+.+.+| ..++.+++|+.|+|++|.+++. +| .+.++++|++|+|++|++++.+|...+..+++|++
T Consensus 354 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 354 SFTFLNFTQNVFTDSVF-QGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCEEECCSSCCCTTTT-TTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CceEEECCCCccccchh-hhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 45555555555555444 2455555556666655555552 22 35555555666666665555555544555555566
Q ss_pred EEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCcc
Q 038422 151 LYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPES 211 (634)
Q Consensus 151 l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~ 211 (634)
|+|++|++++.+|..+. ++|+.|+|++|+++ .||.. ...+|+.|++++|+|+ .+|..
T Consensus 433 L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~ 491 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG 491 (562)
T ss_dssp EECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTT
T ss_pred EECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHH
Confidence 66666655555555443 45555666666555 44432 2335566666666665 34443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-14 Score=161.56 Aligned_cols=144 Identities=18% Similarity=0.199 Sum_probs=110.8
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC--CCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD--LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~--~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
.++..|+|++|.+.+..+ ..+..+++|+.|+|++|.+++.+|. +.++++|++|+|++|.+++.+|. .++.+++|++
T Consensus 376 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~ 453 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKT-EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ-LFDGLPALQH 453 (606)
T ss_dssp TTCCEEECCSCSCEEECT-TTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT-TTTTCTTCCE
T ss_pred CCCCEEECCCCcCCcCCH-HHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH-HHhCCCCCCE
Confidence 467888888888887655 4688888888888888888887652 77888888888888888876554 4788888888
Q ss_pred EEcccCcCccC---CCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCCC
Q 038422 151 LYMANNRLTGT---IPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDPS 218 (634)
Q Consensus 151 l~l~~N~l~g~---ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~~ 218 (634)
|+|++|++++. .+..+..+++|++|+|++|++++.+|.. ..++|+.|++++|++++.+|..+.++...
T Consensus 454 L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 88888888762 3356788888888888888888877764 34578888888888888888777666543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.2e-14 Score=161.05 Aligned_cols=144 Identities=17% Similarity=0.182 Sum_probs=126.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
..++.|+|++|++++..| ..++.+++|++|+|++|.+++..| .|.++++|++|+|++|++++..|. .|+++++|++|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L 110 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET-ALSGPKALKHL 110 (606)
T ss_dssp TTCCEEECTTCCCSEECT-TTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT-TTSSCTTCCEE
T ss_pred CcCcEEEccCCccCcCCh-hHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh-hhcccccccEe
Confidence 358899999999997655 589999999999999999999888 599999999999999999976654 59999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceee-cCCcc-cccCCCEEEeecCcccccCCccccCCCCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQG-QVPEI-KQNEMRSLGLANNELEGPIPESLSKMDPS 218 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g-~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~~ 218 (634)
+|++|++++..|..++++++|++|+|++|++++ .+|.. ...+|+.|++++|.+++..|..++.+...
T Consensus 111 ~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 179 (606)
T 3t6q_A 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179 (606)
T ss_dssp ECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTC
T ss_pred eccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhccc
Confidence 999999998768889999999999999999998 55654 45799999999999999888877766543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.2e-14 Score=134.92 Aligned_cols=129 Identities=14% Similarity=0.199 Sum_probs=107.6
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+. .+ +.+..+++|++|+|++|.+++..| .+..+++|++|+|++|++++.+|.. ++.+++|++|
T Consensus 66 ~~L~~L~l~~n~~~--~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~-l~~l~~L~~L 141 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK-INTLPKVNSI 141 (197)
T ss_dssp TTCSEEEEESCCCS--CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHH-HTTCSSCCEE
T ss_pred CCCCEEEccCCCCC--cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHH-HhhCCCCCEE
Confidence 46889999999554 23 368999999999999999999554 7999999999999999999877654 9999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccc
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g 206 (634)
+|++|++.+.+| .+.++++|+.|+|++|++++..+-...++|+.|++++|++.+
T Consensus 142 ~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 142 DLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp ECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred EccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 999999555777 799999999999999999974333356799999999999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.5e-15 Score=153.26 Aligned_cols=128 Identities=20% Similarity=0.266 Sum_probs=81.2
Q ss_pred EEEEEecCCCC-ccccChhhhc-------CCCCcCEEeccCCcCcccCCC-C--CCCCCCcEEEccCCcCccccChhhhh
Q 038422 75 VWGLKLEQMNL-SGTIAAESLG-------LLSSLRAVSFMNNKFEGPLPD-L--RKMGPLKSIYLSDNGFSGNISDDAFE 143 (634)
Q Consensus 75 v~~l~L~~~~l-~g~~~~~~l~-------~l~~L~~L~l~~n~l~g~~p~-~--~~l~~L~~L~ls~N~~~g~ip~~~~~ 143 (634)
+..|+|++|.+ .+.++. .+. .+++|++|+|++|.++|.+|. + ..+++|++|+|++|++++. |.. ++
T Consensus 65 L~~L~L~~n~l~~~~~~~-~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~-~~ 141 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPS-RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAW-LA 141 (312)
T ss_dssp HHHCCCCEEEEEEEECBH-HHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSH-HH
T ss_pred HhhcccccccccCCCcCH-HHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHH-HH
Confidence 55566666666 344443 333 567777777777777776663 3 6677777777777777764 433 55
Q ss_pred CC-----CCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCC--c----ccccCCCEEEeecCccc
Q 038422 144 GM-----TSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP--E----IKQNEMRSLGLANNELE 205 (634)
Q Consensus 144 ~~-----~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip--~----~~~~~l~~l~l~~N~l~ 205 (634)
.+ ++|++|+|++|++++..|..++++++|++|+|++|+++|.++ . ....+|+.|++++|+++
T Consensus 142 ~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp HHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred HHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 55 677777777777776666677777777777777777666532 1 12346667777777666
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.1e-14 Score=157.90 Aligned_cols=111 Identities=18% Similarity=0.241 Sum_probs=99.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
..+..|+|++|.+.+..+ ..++.+++|++|+|++|.+++.+|. ++++++|++|+|++|.++ .+|+..|+++++|++|
T Consensus 75 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 152 (597)
T ss_dssp CCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred CCCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEE
Confidence 468899999999997655 5799999999999999999998885 799999999999999999 5777768999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeec
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQ 185 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ 185 (634)
+|++|.+++..|..++++++|++|+|++|+|++.
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 9999999998888999999999999999998863
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.5e-14 Score=161.15 Aligned_cols=155 Identities=17% Similarity=0.195 Sum_probs=130.7
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..+++..++..+..+...+..+++|+.++++.|.+.+..| .+..++.|+.|+|++|++.+.++++.|..+++|++|+
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 345666666666666666667889999999999999999888 4788999999999999876665556699999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCC----CCCcccCCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKM----DPSTFAGNKNL 226 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~----~~~~~~gn~~l 226 (634)
|++|++++..|..|.++++|++|+|++|+|++..|.. ..++|+.|++++|+|++.+|..+..+ ......+|+.-
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999999999999999887765 34699999999999999999988655 33457888877
Q ss_pred CC
Q 038422 227 CG 228 (634)
Q Consensus 227 cg 228 (634)
|.
T Consensus 581 C~ 582 (635)
T 4g8a_A 581 CT 582 (635)
T ss_dssp CS
T ss_pred cc
Confidence 64
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-13 Score=143.18 Aligned_cols=150 Identities=19% Similarity=0.323 Sum_probs=102.9
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..+.|.+ ..+..|+|++|++.+..+ ..++.+++|++|+|++|.+++..| .+.++++|++|+|++|
T Consensus 32 ~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKD-GDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeCh-hhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 699999952 257789999999987544 578999999999999999999877 5888888888888888
Q ss_pred cCccccCh---------------------hhhhCCCCCCeEEcccCcCc--cCCCccccCCCCccEEeCCCCceeecCCc
Q 038422 132 GFSGNISD---------------------DAFEGMTSLKKLYMANNRLT--GTIPSSLVQLPKLMELRLEANKFQGQVPE 188 (634)
Q Consensus 132 ~~~g~ip~---------------------~~~~~~~~L~~l~l~~N~l~--g~ip~~~~~l~~L~~L~l~~N~~~g~ip~ 188 (634)
+++ .+|. ..+.++++|+.|+|++|+++ |..|..+.++++|++|++++|+++. +|.
T Consensus 111 ~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~ 188 (330)
T 1xku_A 111 QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ 188 (330)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCS
T ss_pred cCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCc
Confidence 877 4543 33555555555555555553 2445555556666666666665553 444
Q ss_pred ccccCCCEEEeecCcccccCCccccCCC
Q 038422 189 IKQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 189 ~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
....+|+.|++++|++++..|..+.+++
T Consensus 189 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 216 (330)
T 1xku_A 189 GLPPSLTELHLDGNKITKVDAASLKGLN 216 (330)
T ss_dssp SCCTTCSEEECTTSCCCEECTGGGTTCT
T ss_pred cccccCCEEECCCCcCCccCHHHhcCCC
Confidence 4335666666666666666565555443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.7e-14 Score=139.62 Aligned_cols=135 Identities=17% Similarity=0.173 Sum_probs=114.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCc-CcccCC-CCCCCCCCcEEEccC-CcCccccChhhhhCCCCCC
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNK-FEGPLP-DLRKMGPLKSIYLSD-NGFSGNISDDAFEGMTSLK 149 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~-l~g~~p-~~~~l~~L~~L~ls~-N~~~g~ip~~~~~~~~~L~ 149 (634)
..+..|+|++|++.+. ++..+..+++|++|+|++|. +++..+ .+.++++|++|+|++ |++++ +|+..|.++++|+
T Consensus 31 ~~l~~L~l~~n~l~~i-~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~-i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTI-PSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY-IDPDALKELPLLK 108 (239)
T ss_dssp TTCCEEEEESCCCSEE-CTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE-ECTTSEECCTTCC
T ss_pred CcccEEEEeCCcceEE-CHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE-cCHHHhCCCCCCC
Confidence 4688999999999864 44578999999999999997 777666 588999999999998 99994 6666789999999
Q ss_pred eEEcccCcCccCCCccccCCCCcc---EEeCCCC-ceeecCCcc--cccCCC-EEEeecCcccccCCccc
Q 038422 150 KLYMANNRLTGTIPSSLVQLPKLM---ELRLEAN-KFQGQVPEI--KQNEMR-SLGLANNELEGPIPESL 212 (634)
Q Consensus 150 ~l~l~~N~l~g~ip~~~~~l~~L~---~L~l~~N-~~~g~ip~~--~~~~l~-~l~l~~N~l~g~ip~~~ 212 (634)
+|+|++|++++ +|. +..+++|+ +|+|++| ++++..+.. ...+|+ .|++++|+++ .||...
T Consensus 109 ~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~ 175 (239)
T 2xwt_C 109 FLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA 175 (239)
T ss_dssp EEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTT
T ss_pred EEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhh
Confidence 99999999997 887 88888888 9999999 888766653 346899 9999999998 777643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.1e-14 Score=151.19 Aligned_cols=140 Identities=24% Similarity=0.324 Sum_probs=95.7
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|++.+ +++..+..+++|++|+|++|.+++..+ .+.++++|++|+|++|+..+.+++..|.++++|++|
T Consensus 112 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 190 (440)
T 3zyj_A 112 ANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190 (440)
T ss_dssp SSCCEEECCSSCCSS-CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred ccCCEEECCCCcCCe-eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence 468899999999884 555678889999999999999887666 477777777777777666566766667777777777
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
+|++|+++ .+| .+..+++|+.|+|++|++++..|.. ...+|+.|++++|++++..|..|.++
T Consensus 191 ~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 191 NLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp ECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred cCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 77777666 445 3566666666666666666655543 22355566666665555555544433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.3e-14 Score=151.61 Aligned_cols=139 Identities=24% Similarity=0.292 Sum_probs=90.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+.+ +++..+..+++|++|+|++|.+++..+ .+.++++|+.|+|++|+..+.+|+..|.++++|++|
T Consensus 123 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 201 (452)
T 3zyi_A 123 ASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201 (452)
T ss_dssp TTCCEEECCSSCCSB-CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred ccCCEEECCCCcCCc-cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence 468899999999884 455578889999999999999987655 466677777777777555556666556666666666
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSK 214 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 214 (634)
+|++|++++ +| .+..+++|+.|+|++|+|++..|.. ...+|+.|++++|++++..|..|.+
T Consensus 202 ~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 264 (452)
T 3zyi_A 202 NLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264 (452)
T ss_dssp ECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcC
Confidence 666666663 33 3555566666666666666555543 2235555555555555555544443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.3e-14 Score=133.26 Aligned_cols=126 Identities=22% Similarity=0.263 Sum_probs=103.1
Q ss_pred EEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccC
Q 038422 77 GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANN 156 (634)
Q Consensus 77 ~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N 156 (634)
.++++++++. .+|. .+ .++|+.|+|++|+++...+.+.++++|++|+|++|++++ +++..|.++++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~-~~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPK-GI--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCS-CC--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCC-CC--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCE-eCHhHccCCCCCCEEECCCC
Confidence 3555666665 4553 22 368999999999998443478999999999999999996 55666999999999999999
Q ss_pred cCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCccccc
Q 038422 157 RLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 157 ~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ 207 (634)
++++..|..|.++++|++|+|++|+|++..+.. ...+|+.|++++|.+.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999888888999999999999999999655543 346899999999999754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-14 Score=162.38 Aligned_cols=138 Identities=23% Similarity=0.287 Sum_probs=97.2
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.+++.|+|++|++.+. ++..++.+++|++|+|++|.+++..|. +.++++|++|+|++|+++ .+|+..|+++++|++|
T Consensus 25 ~~l~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 102 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRL-PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTEL 102 (680)
T ss_dssp TTCSEEECCSSCCCCC-CGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEE
T ss_pred CCCcEEECCCCCCCCc-CHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEE
Confidence 3577888888887764 444677777788888877777777664 667777777777777777 3565557777777777
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccc
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESL 212 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~ 212 (634)
+|++|++++..|..++++++|++|+|++|++++.+|.. ...+|+.|++++|.+++..|..+
T Consensus 103 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 165 (680)
T 1ziw_A 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165 (680)
T ss_dssp ECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHH
T ss_pred ECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHh
Confidence 77777777655667777777777777777777766654 34567777777777776655543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.9e-14 Score=156.89 Aligned_cols=141 Identities=18% Similarity=0.170 Sum_probs=64.7
Q ss_pred CcEEEEEecCCCCccccC-hhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIA-AESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~-~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+++... +..+..+++|++|+|++|.+++..+.+..+++|+.|+|++|.+++..|...+.++++|++|
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 345566666666554320 1234445555555555555544444444444444444444444443332334444444444
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCcee-ecCCcc--cccCCCEEEeecCcccccCCcccc
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQ-GQVPEI--KQNEMRSLGLANNELEGPIPESLS 213 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~-g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~ 213 (634)
+|++|++++.+|..+.++++|++|+|++|+++ +.+|.. ...+|+.|++++|++++.+|..+.
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 491 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh
Confidence 44444444444444444444444444444444 334432 123444444444444444444433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=156.29 Aligned_cols=146 Identities=20% Similarity=0.309 Sum_probs=116.5
Q ss_pred cEEEEEecCCCCccccChhhh-----cCCCCcCEEeccCCcCcccCC---------------------------CCCCCC
Q 038422 74 SVWGLKLEQMNLSGTIAAESL-----GLLSSLRAVSFMNNKFEGPLP---------------------------DLRKMG 121 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l-----~~l~~L~~L~l~~n~l~g~~p---------------------------~~~~l~ 121 (634)
++..|+|+++.+.|.+|. .+ +.+++|+.+++++|.+ .+| ....++
T Consensus 248 ~L~~L~l~~n~l~~~~p~-~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~ 324 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDF-RDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324 (520)
T ss_dssp SCSEEEEEEEEEESCCCC-CCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred cccEEEeecccccCcccc-chhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCC
Confidence 677888888888888875 44 6666666666666665 233 126788
Q ss_pred CCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCcc--CCCccccCCCCccEEeCCCCceeecCCcc---cccCCCE
Q 038422 122 PLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTG--TIPSSLVQLPKLMELRLEANKFQGQVPEI---KQNEMRS 196 (634)
Q Consensus 122 ~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g--~ip~~~~~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~ 196 (634)
+|++|+|++|.+++.+|.. ++.+++|++|+|++|++++ .+|..++++++|++|+|++|++++.+|.. ...+|+.
T Consensus 325 ~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVFEN-CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCEEECCSSCCCTTTTTT-CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred cccEEEeECCccChhhhhh-hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 9999999999999888765 8999999999999999997 77888999999999999999999878864 3468999
Q ss_pred EEeecCcccccCCcccc-CCCCCcccCC
Q 038422 197 LGLANNELEGPIPESLS-KMDPSTFAGN 223 (634)
Q Consensus 197 l~l~~N~l~g~ip~~~~-~~~~~~~~gn 223 (634)
|++++|++++.+|..+. ++......+|
T Consensus 404 L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N 431 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLPPRIKVLDLHSN 431 (520)
T ss_dssp EECCSSCCCGGGGGSCCTTCCEEECCSS
T ss_pred EECcCCCCCcchhhhhcccCCEEECCCC
Confidence 99999999999988773 5655555555
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.9e-14 Score=139.44 Aligned_cols=138 Identities=17% Similarity=0.189 Sum_probs=108.6
Q ss_pred CcEEEEEecCCC-CccccChhhhcCCCCcCEEeccC-CcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCC
Q 038422 73 GSVWGLKLEQMN-LSGTIAAESLGLLSSLRAVSFMN-NKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLK 149 (634)
Q Consensus 73 ~~v~~l~L~~~~-l~g~~~~~~l~~l~~L~~L~l~~-n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~ 149 (634)
.++..|+|++|. +. .+++..+..+++|++|+|++ |.+++..+ .+.++++|++|+|++|.+++ +|. ++.+++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~--~~~l~~L~ 130 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD--LTKVYSTD 130 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC--CTTCCBCC
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc--cccccccc
Confidence 468889999887 55 55656788899999999998 88887766 47888899999999999986 764 78888888
Q ss_pred ---eEEcccC-cCccCCCccccCCCCcc-EEeCCCCceeecCCcc--cccCCCEEEeecCc-ccccCCccccCC
Q 038422 150 ---KLYMANN-RLTGTIPSSLVQLPKLM-ELRLEANKFQGQVPEI--KQNEMRSLGLANNE-LEGPIPESLSKM 215 (634)
Q Consensus 150 ---~l~l~~N-~l~g~ip~~~~~l~~L~-~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~-l~g~ip~~~~~~ 215 (634)
+|+|++| ++++..+..+.++++|+ .|+|++|+++ .+|.. ...+|+.|++++|+ +++..|..+..+
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l 203 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTC
T ss_pred cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcc
Confidence 9999999 88866666788888999 9999999888 66653 33578889999994 885555555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.1e-14 Score=155.57 Aligned_cols=121 Identities=21% Similarity=0.320 Sum_probs=96.9
Q ss_pred cCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCcc--ccChhhhhCCCCCCeEEcccCcCccCCCcc-ccCCC
Q 038422 95 GLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSG--NISDDAFEGMTSLKKLYMANNRLTGTIPSS-LVQLP 170 (634)
Q Consensus 95 ~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g--~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~-~~~l~ 170 (634)
..+++|++|+|++|.+++.+| .+.++++|++|+|++|++++ .+| ..++++++|++|+|++|++++.+|.. +..++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~ 428 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA-LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHH-HTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccch-hhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence 567888888888888888776 57888889999999998886 232 34788888999999999988877764 77888
Q ss_pred CccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCC
Q 038422 171 KLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 171 ~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
+|++|+|++|+++|.+|.....+|+.|++++|+++ .||..+..++.
T Consensus 429 ~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~ 474 (562)
T 3a79_B 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQA 474 (562)
T ss_dssp TCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCC
T ss_pred cCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCC
Confidence 89999999998888888765578899999999888 78876655543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-13 Score=131.36 Aligned_cols=121 Identities=22% Similarity=0.278 Sum_probs=105.9
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..|.|++ ..+..|+|++|+++ .+| ..+..+++|+.|+|++|.+++..| .|.++++|++|+|++|
T Consensus 11 ~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 11 LDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 478888853 25789999999998 677 589999999999999999999887 5999999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCC
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP 187 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip 187 (634)
++++ +++..|.++++|++|+|++|++++..+..+..+++|+.|+|++|.++..-.
T Consensus 89 ~l~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9996 555669999999999999999997656679999999999999999986543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.7e-14 Score=156.38 Aligned_cols=153 Identities=18% Similarity=0.221 Sum_probs=132.2
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
.++..|+|++|.+.+..+ .+..+++|+.|+|++|.+.+.+| .+.++++|++|+|++|.+++.+|. .+.++++|++
T Consensus 373 ~~L~~L~l~~n~l~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~ 449 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMSS--NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG-IFNGLSSLEV 449 (570)
T ss_dssp SCCCEEECCSCSEEEEEE--EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTT-TTTTCTTCCE
T ss_pred CccCEEECCCCccccccc--cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchh-hhhcCCcCcE
Confidence 568899999999987543 38999999999999999999877 589999999999999999987765 4899999999
Q ss_pred EEcccCcCc-cCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCC---CcccCCC
Q 038422 151 LYMANNRLT-GTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDP---STFAGNK 224 (634)
Q Consensus 151 l~l~~N~l~-g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~gn~ 224 (634)
|+|++|+++ +.+|..+..+++|++|+|++|++++.+|.. ..++|+.|++++|++++..|..+.+++. ..+.+|+
T Consensus 450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 529 (570)
T 2z63_A 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529 (570)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence 999999998 689999999999999999999999988875 3469999999999999988877765554 4567777
Q ss_pred CCCC
Q 038422 225 NLCG 228 (634)
Q Consensus 225 ~lcg 228 (634)
..|.
T Consensus 530 ~~~~ 533 (570)
T 2z63_A 530 WDCS 533 (570)
T ss_dssp BCCC
T ss_pred ccCC
Confidence 6554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.5e-13 Score=148.20 Aligned_cols=143 Identities=19% Similarity=0.294 Sum_probs=123.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|++.+. ++..+..+++|++|+|++|++++..+ .+..+++|++|+|++|.+++ +|+..|.++++|++|
T Consensus 88 ~~L~~L~Ls~n~i~~i-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L 165 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTI-EIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRL 165 (440)
T ss_dssp SSCCEEECCSSCCCEE-CGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE-ECTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcc-ChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc-cCHHHhhhCcccCEe
Confidence 3688999999999864 44689999999999999999998777 58999999999999999994 667679999999999
Q ss_pred EcccCcCccCCCc-cccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCCCC
Q 038422 152 YMANNRLTGTIPS-SLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMDPS 218 (634)
Q Consensus 152 ~l~~N~l~g~ip~-~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~~ 218 (634)
+|++|+..+.+|. .+.++++|++|+|++|+++ .+|.. ...+|+.|+|++|++++..|..|.+++..
T Consensus 166 ~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 233 (440)
T 3zyj_A 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233 (440)
T ss_dssp ECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccC
Confidence 9999766666665 7899999999999999998 56765 55699999999999999889888766543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.48 E-value=3.8e-14 Score=128.69 Aligned_cols=119 Identities=22% Similarity=0.307 Sum_probs=101.5
Q ss_pred CCCCcCEEeccCCcCc-ccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCcc
Q 038422 96 LLSSLRAVSFMNNKFE-GPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLM 173 (634)
Q Consensus 96 ~l~~L~~L~l~~n~l~-g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~ 173 (634)
..++|+.|++++|.++ |.+|. +..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI---ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC---TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc---hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence 3578999999999999 78874 68999999999999999975 3489999999999999999998999888999999
Q ss_pred EEeCCCCceeec-CCcc--cccCCCEEEeecCcccccCC---ccccCCCC
Q 038422 174 ELRLEANKFQGQ-VPEI--KQNEMRSLGLANNELEGPIP---ESLSKMDP 217 (634)
Q Consensus 174 ~L~l~~N~~~g~-ip~~--~~~~l~~l~l~~N~l~g~ip---~~~~~~~~ 217 (634)
+|+|++|++++. .|.. ..++|+.|++++|.+++..+ ..+..++.
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~ 141 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQ 141 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTT
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCC
Confidence 999999999983 3333 45689999999999998766 45555443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-14 Score=147.06 Aligned_cols=140 Identities=16% Similarity=0.183 Sum_probs=104.5
Q ss_pred cEEEEEecCCCCccccChhhh--cCCCCcCEEeccCCcCcccCCC-----CCCCCCCcEEEccCCcCccccChhhhhCCC
Q 038422 74 SVWGLKLEQMNLSGTIAAESL--GLLSSLRAVSFMNNKFEGPLPD-----LRKMGPLKSIYLSDNGFSGNISDDAFEGMT 146 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l--~~l~~L~~L~l~~n~l~g~~p~-----~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~ 146 (634)
++..|+|++|++.|.+|. .+ +.+++|++|+|++|.+++..|. +..+++|++|+|++|++++.. +..++.++
T Consensus 92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~-~~~~~~l~ 169 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFS-CEQVRAFP 169 (310)
T ss_dssp CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCC-TTSCCCCT
T ss_pred ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhh-HHHhccCC
Confidence 477888999988888875 44 7888889999999988887663 456888888888888887644 44588888
Q ss_pred CCCeEEcccCcCccC--CC--ccccCCCCccEEeCCCCceeec--CCc-c--cccCCCEEEeecCcccccCCccccCC
Q 038422 147 SLKKLYMANNRLTGT--IP--SSLVQLPKLMELRLEANKFQGQ--VPE-I--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 147 ~L~~l~l~~N~l~g~--ip--~~~~~l~~L~~L~l~~N~~~g~--ip~-~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
+|++|+|++|+++|. +| ..++++++|++|+|++|+++.. ++. . ...+|+.|+|++|++++.+|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 888888888888763 32 3346788888888888888632 211 1 33688888888888888877666544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=153.56 Aligned_cols=109 Identities=17% Similarity=0.164 Sum_probs=67.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC----CCCCCCCCcEEEccCCcCccccC-hhhhhCCCC
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP----DLRKMGPLKSIYLSDNGFSGNIS-DDAFEGMTS 147 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p----~~~~l~~L~~L~ls~N~~~g~ip-~~~~~~~~~ 147 (634)
+++..|+|++|.+. .+|...+..+++|+.|+|++|.+++.+| .++.+++|++|+|++|++++..+ ...++.+++
T Consensus 310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~ 388 (549)
T 2z81_A 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388 (549)
T ss_dssp TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTT
T ss_pred ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCC
Confidence 45667777777664 5554333466777777777777776553 25666677777777777764211 133566666
Q ss_pred CCeEEcccCcCccCCCccccCCCCccEEeCCCCcee
Q 038422 148 LKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 148 L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
|++|+|++|+|+ .+|..++.+++|++|+|++|+++
T Consensus 389 L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~ 423 (549)
T 2z81_A 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423 (549)
T ss_dssp CCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCEEECCCCCCc-cCChhhcccccccEEECCCCCcc
Confidence 777777777666 46666666666666666665554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=128.10 Aligned_cols=114 Identities=23% Similarity=0.382 Sum_probs=100.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
..+..|+|++|++.+ +++..++.+++|++|+|++|.+++..+. +.++++|++|+|++|++++ +|+..++.+++|++|
T Consensus 28 ~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L 105 (177)
T 2o6r_A 28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKEL 105 (177)
T ss_dssp TTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccc-cCHHHhhCCcccCEE
Confidence 468999999999985 5555789999999999999999987775 7899999999999999996 556668999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCc
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~ 188 (634)
+|++|++++..+..+.++++|++|+|++|.|++..|.
T Consensus 106 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 106 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 9999999965555578899999999999999998874
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=1e-13 Score=129.76 Aligned_cols=127 Identities=20% Similarity=0.288 Sum_probs=108.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCC-CcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLS-SLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~-~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
..+..|+|++|++.. ++ .+..+. +|++|+|++|.+++. +.+..+++|++|+|++|++++ +|+..++.+++|++|
T Consensus 19 ~~L~~L~l~~n~l~~-i~--~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IE--NLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL 93 (176)
T ss_dssp TSCEEEECTTSCCCS-CC--CGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred CCceEEEeeCCCCch-hH--HhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEE
Confidence 468899999999984 54 355554 999999999999986 889999999999999999995 676667999999999
Q ss_pred EcccCcCccCCCc--cccCCCCccEEeCCCCceeecCCcc------cccCCCEEEeecCcccc
Q 038422 152 YMANNRLTGTIPS--SLVQLPKLMELRLEANKFQGQVPEI------KQNEMRSLGLANNELEG 206 (634)
Q Consensus 152 ~l~~N~l~g~ip~--~~~~l~~L~~L~l~~N~~~g~ip~~------~~~~l~~l~l~~N~l~g 206 (634)
+|++|+++ .+|. .+..+++|+.|+|++|.++ .+|.. ..++|+.|++++|.+.-
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99999996 6787 8999999999999999998 45652 45689999999998763
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=153.46 Aligned_cols=106 Identities=21% Similarity=0.284 Sum_probs=70.1
Q ss_pred CcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCC
Q 038422 99 SLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLE 178 (634)
Q Consensus 99 ~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~ 178 (634)
.|+.|+|++|.|++ +|.++++++|+.|+|++|+++ .||.. ++++++|+.|+|++|+|++ +| .++++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCCGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcCccccccCcEeecCccccc-ccchh-hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 36667777777766 455666677777777777776 56654 6667777777777777765 55 66667777777777
Q ss_pred CCceeecC-Ccc--cccCCCEEEeecCcccccCC
Q 038422 179 ANKFQGQV-PEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 179 ~N~~~g~i-p~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+|+|++.+ |.. ..++|+.|+|++|.|++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 77776665 543 34467777777777766554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.4e-13 Score=150.22 Aligned_cols=117 Identities=25% Similarity=0.370 Sum_probs=73.0
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
++..|+|++|+|. .+| ..+++|+.|+|++|+|++ +|.+.+ +|++|+|++|++++ ||. .+++|++|+|
T Consensus 81 ~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~L 147 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE----LPALLEYINA 147 (571)
T ss_dssp TCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC----CCTTCCEEEC
T ss_pred CCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC----cCccccEEeC
Confidence 4667777777776 455 345677777777777776 554443 66677777776665 554 4566666666
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~ 210 (634)
++|+|++ +|. .+++|++|+|++|+|++ +|. ...+|+.|+|++|+|+ .||.
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LPESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCS-SCCC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hhCCCCEEECcCCCCC-chhh
Confidence 6666665 555 35566666666666665 555 3356666666666666 4554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-13 Score=137.80 Aligned_cols=133 Identities=29% Similarity=0.415 Sum_probs=103.8
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|++.+..+ +..+++|+.|+|++|.+++ +|.+..+++|++|+|++|++++ ++ .+..+++|++|+
T Consensus 68 ~~L~~L~L~~n~l~~~~~---l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~-~~--~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP---LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-IN--GLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-CG--GGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCCCcc---cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCC-Ch--hhcCCCCCCEEE
Confidence 468888888888886432 7888888888988888877 5668888888899998888886 43 378888889999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|++|++++. ..++.+++|+.|+|++|++++..|-....+|+.|++++|++++ +|. +..++
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~-l~~l~ 200 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRA-LAGLK 200 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGG-GTTCT
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chh-hccCC
Confidence 998888864 6788888889999998888876663355688889999888875 443 44443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.3e-13 Score=148.20 Aligned_cols=143 Identities=17% Similarity=0.178 Sum_probs=124.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|.+.+..| ..+..+++|++|+|++|.+++..+. +.++++|++|+|++|.+++.+|. .|..+++|+.|
T Consensus 56 ~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L 133 (477)
T 2id5_A 56 PHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY-MFQDLYNLKSL 133 (477)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTT-TTTTCTTCCEE
T ss_pred CCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChh-HccccccCCEE
Confidence 468999999999998666 5799999999999999999987764 78999999999999999976654 59999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
+|++|++++..|..+.++++|+.|+|++|++++..+.. ...+|+.|++++|.+++..+..+.+++.
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~ 201 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTT
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcc
Confidence 99999999988999999999999999999999755543 4569999999999999887777765543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-13 Score=156.48 Aligned_cols=142 Identities=22% Similarity=0.263 Sum_probs=126.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.+++.|+|++|.+.+..| ..++.+++|++|+|++|.+++..+ .+.++++|++|+|++|++++ +|+..|+++++|++|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 126 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITL 126 (680)
T ss_dssp TTCSEEECCSSCCCCCCT-THHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCSCTTTTCTTCCEE
T ss_pred CcCcEEECCCCccCccCH-HHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc-cChhHccccCCCCEE
Confidence 568999999999998666 579999999999999999998766 49999999999999999985 555569999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc----cccCCCEEEeecCcccccCCccccCCC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI----KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~----~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
+|++|++++..|..++++++|++|+|++|++++..|.. ...+|+.|++++|++++..|..+..+.
T Consensus 127 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~ 195 (680)
T 1ziw_A 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195 (680)
T ss_dssp ECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSS
T ss_pred ECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhh
Confidence 99999999999999999999999999999999887753 236899999999999999888766543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=6.4e-14 Score=144.14 Aligned_cols=130 Identities=22% Similarity=0.180 Sum_probs=69.8
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-----------------CCCCCCCcEEEccCCcCcc
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-----------------LRKMGPLKSIYLSDNGFSG 135 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-----------------~~~l~~L~~L~ls~N~~~g 135 (634)
.++..|+|++|.+.+..+ +..+++|++|+|++|.+++..+. ...+++|++|+|++|++++
T Consensus 58 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp TTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 356666676666665442 56666666666666666653210 0123344555555555553
Q ss_pred ccChhhhhCCCCCCeEEcccCcCccCCCcccc-CCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccc
Q 038422 136 NISDDAFEGMTSLKKLYMANNRLTGTIPSSLV-QLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206 (634)
Q Consensus 136 ~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~-~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g 206 (634)
. ++..++.+++|++|+|++|++++..|..+. .+++|++|+|++|++++..+.....+|+.|++++|++++
T Consensus 135 ~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~ 205 (317)
T 3o53_A 135 L-RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF 205 (317)
T ss_dssp G-GGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE
T ss_pred c-cchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc
Confidence 2 222355555566666666665555444442 455566666666655544322344566666666666664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=5.9e-13 Score=137.63 Aligned_cols=138 Identities=21% Similarity=0.282 Sum_probs=106.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcc--cCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCC
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEG--PLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLK 149 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g--~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~ 149 (634)
..+..|+|++|.+.+. ++..+..+++|+.|+|++|.+.. ..| .+.++++|++|++++|+++. +|.. + .++|+
T Consensus 121 ~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~-~--~~~L~ 195 (330)
T 1xku_A 121 KTLQELRVHENEITKV-RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG-L--PPSLT 195 (330)
T ss_dssp TTCCEEECCSSCCCBB-CHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS-C--CTTCS
T ss_pred ccccEEECCCCccccc-CHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcc-c--cccCC
Confidence 3678899999988854 44578889999999999998863 444 47788888888888888874 6654 2 27888
Q ss_pred eEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCCC
Q 038422 150 KLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 150 ~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
+|+|++|++++..|..+.++++|+.|+|++|++++..|.. ...+|+.|++++|+++ .+|..+..++
T Consensus 196 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 263 (330)
T 1xku_A 196 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263 (330)
T ss_dssp EEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred EEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence 8888888888877888888888888888888888776643 3457888888888887 7777665544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.3e-13 Score=142.07 Aligned_cols=131 Identities=17% Similarity=0.190 Sum_probs=117.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|+++.+.+.. +..++.+++|++|+|++|.+++.+|. +.++++|++|+|++|+++ .+|+..|+++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEID-TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEEC-TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccC-hhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 46889999999998654 45799999999999999999998885 899999999999999999 6888778999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccc
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g 206 (634)
+|++|++++..|..+.++++|++|+|++|++++. +.....+|+.|++++|.+++
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-CGGGCTTCSEEECCSSCCSE
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCcc-ccccccccceeecccccccc
Confidence 9999999988888899999999999999999864 54556789999999998876
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=127.52 Aligned_cols=121 Identities=22% Similarity=0.286 Sum_probs=102.2
Q ss_pred cCCCCcCEEeccCCcCc-ccCCC-CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCc
Q 038422 95 GLLSSLRAVSFMNNKFE-GPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172 (634)
Q Consensus 95 ~~l~~L~~L~l~~n~l~-g~~p~-~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L 172 (634)
...++|+.|+|++|.++ |.+|. +..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 97 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV---SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC---SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh---hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC
Confidence 34578999999999998 88885 58999999999999999975 348999999999999999999899988889999
Q ss_pred cEEeCCCCceeecC--Ccc-cccCCCEEEeecCcccccCC---ccccCCCCC
Q 038422 173 MELRLEANKFQGQV--PEI-KQNEMRSLGLANNELEGPIP---ESLSKMDPS 218 (634)
Q Consensus 173 ~~L~l~~N~~~g~i--p~~-~~~~l~~l~l~~N~l~g~ip---~~~~~~~~~ 218 (634)
++|+|++|++++.. +.. ...+|+.|++++|.+++..+ ..+..++..
T Consensus 98 ~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L 149 (168)
T 2ell_A 98 THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQL 149 (168)
T ss_dssp CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSC
T ss_pred CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccC
Confidence 99999999999742 233 45699999999999997655 355555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=2.4e-13 Score=150.78 Aligned_cols=123 Identities=22% Similarity=0.317 Sum_probs=99.6
Q ss_pred hhhcCCCCcCEEe-ccCCcC-------------cccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCc
Q 038422 92 ESLGLLSSLRAVS-FMNNKF-------------EGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNR 157 (634)
Q Consensus 92 ~~l~~l~~L~~L~-l~~n~l-------------~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~ 157 (634)
..++.|++|+.|+ ++.|.+ ++..+ ..|+.|+|++|++++ ||. ++.+++|+.|+|++|+
T Consensus 403 ~~l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSC
T ss_pred HHHHHHHhcccCcchhhcccchhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC--ccccccCcEeecCccc
Confidence 3567788888888 555533 32221 258999999999997 774 8999999999999999
Q ss_pred CccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccC-CccccCCCCC---cccCCC
Q 038422 158 LTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPI-PESLSKMDPS---TFAGNK 224 (634)
Q Consensus 158 l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~i-p~~~~~~~~~---~~~gn~ 224 (634)
|+ .+|..++++++|+.|+|++|+|++ +|.+ ...+|+.|+|++|+|++.+ |..+.+++.. .+.+|+
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~ 544 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence 99 899999999999999999999998 7754 4569999999999999987 9888776644 455663
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=5.1e-13 Score=124.23 Aligned_cols=107 Identities=15% Similarity=0.297 Sum_probs=86.8
Q ss_pred EEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEccc
Q 038422 77 GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMAN 155 (634)
Q Consensus 77 ~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~ 155 (634)
.+++++++|.. +|. .+ .++|++|+|++|+|++..| .+.++++|++|+|++|++++ +|+..|.++++|++|+|++
T Consensus 13 ~l~~s~n~l~~-ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 13 TVDCSGKSLAS-VPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp EEECTTSCCSS-CCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcCc-cCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCc-cChhhccCCCCCCEEECCC
Confidence 45666777764 553 23 4789999999999999877 48889999999999999994 6667688999999999999
Q ss_pred CcCccCCCccccCCCCccEEeCCCCceeecCCc
Q 038422 156 NRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188 (634)
Q Consensus 156 N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~ 188 (634)
|+|++..|..+.++++|++|+|++|.|+...+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 999976666788999999999999988876653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=7.8e-13 Score=138.62 Aligned_cols=134 Identities=22% Similarity=0.251 Sum_probs=113.3
Q ss_pred EecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CC-CCCCCcEEEccCCcCccccChhhhhCCC
Q 038422 69 LCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LR-KMGPLKSIYLSDNGFSGNISDDAFEGMT 146 (634)
Q Consensus 69 ~C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~-~l~~L~~L~ls~N~~~g~ip~~~~~~~~ 146 (634)
.|.. ..+++++++|.. +|. .+ ...|+.|+|++|+|++..+. +. ++++|++|+|++|++++ +++..|.+++
T Consensus 17 ~C~~---~~l~c~~~~l~~-iP~-~~--~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~-i~~~~~~~l~ 88 (361)
T 2xot_A 17 LCAS---NILSCSKQQLPN-VPQ-SL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVP 88 (361)
T ss_dssp EEET---TEEECCSSCCSS-CCS-SC--CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCE-ECTTTTTTCT
T ss_pred EECC---CEEEeCCCCcCc-cCc-cC--CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCc-cChhhccCCC
Confidence 7753 368899999885 663 22 35689999999999998885 55 89999999999999996 5556699999
Q ss_pred CCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCcc
Q 038422 147 SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPES 211 (634)
Q Consensus 147 ~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~ 211 (634)
+|++|+|++|+|++..|..|.++++|++|+|++|++++..|.. ...+|+.|+|++|+|++ +|..
T Consensus 89 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~ 154 (361)
T 2xot_A 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVE 154 (361)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGG
T ss_pred CCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHH
Confidence 9999999999999877788999999999999999999887765 34699999999999996 5543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.9e-13 Score=146.50 Aligned_cols=140 Identities=15% Similarity=0.111 Sum_probs=97.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..|+|++|+..|.++ ++.+++|+.|+|++|++++ +| +..+++|+.|++++|++++. + ++.+++|++|+
T Consensus 148 ~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~-l~~l~~L~~L~l~~N~l~~~-~---l~~l~~L~~L~ 218 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD-VSQNKLLNRLNCDTNNITKL-D---LNQNIQLTFLD 218 (457)
T ss_dssp TTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC-CTTCTTCCEEECCSSCCSCC-C---CTTCTTCSEEE
T ss_pred CcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec-cccCCCCCEEECcCCcCCee-c---cccCCCCCEEE
Confidence 457788888887777763 6778888888888888888 45 77788888888888888863 2 67788888888
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCccc---------ccCCCEEEeecCcccccCCcc-ccCCCCCcccC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK---------QNEMRSLGLANNELEGPIPES-LSKMDPSTFAG 222 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~---------~~~l~~l~l~~N~l~g~ip~~-~~~~~~~~~~g 222 (634)
|++|++++ +| ++.+++|+.|+|++|+|+|..+... .++|+.|++++|.+.|.+|.. +.++......+
T Consensus 219 Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~ 295 (457)
T 3bz5_A 219 CSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTH 295 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTT
T ss_pred CcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCC
Confidence 88888887 66 7778888888888888877543221 125566666677767776632 23344444444
Q ss_pred CC
Q 038422 223 NK 224 (634)
Q Consensus 223 n~ 224 (634)
|.
T Consensus 296 n~ 297 (457)
T 3bz5_A 296 NT 297 (457)
T ss_dssp CT
T ss_pred Cc
Confidence 43
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.42 E-value=5.3e-13 Score=136.69 Aligned_cols=127 Identities=17% Similarity=0.360 Sum_probs=87.6
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|.+.+. ++ +..+++|++|+|++|.+++ +|.+..+++|++|+|++|++++ +|+ +..+++|++|+
T Consensus 63 ~~L~~L~L~~n~i~~~-~~--~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITDL-AP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD-VTP--LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCCC-GG--GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCC-CGG--GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCCC-hh--HccCCCCCEEEccCCcCCC-chhhcCCCCCCEEECCCCCCCC-chh--hcCCCCCCEEE
Confidence 4577777777777653 22 7777777777777777776 3567777777777777777775 432 67777777777
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPI 208 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~i 208 (634)
|++|++++. |. ++++++|+.|+|++|++++..+-....+|+.|++++|++++..
T Consensus 136 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 136 LDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp CCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCccCcC-cc-ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcCh
Confidence 777777753 33 7777777777777777775433224457777777777776543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=3e-13 Score=139.15 Aligned_cols=147 Identities=21% Similarity=0.165 Sum_probs=112.8
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..|+|++|.+.+..+ ..+++|+.|+|++|.+++..| .+..+++|++|+|++|.+++..|...+..+++|++|+
T Consensus 100 ~L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 100 SIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TCCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 34455555665554432 246789999999999999877 6888999999999999999876665446899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCC---CCcccCCCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNKNLC 227 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~~lc 227 (634)
|++|++++. | ....+++|++|+|++|++++..|.+ ...+|+.|++++|+++ .+|..+..++ ...+.+|+..|
T Consensus 176 L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 999999965 4 3445899999999999999866654 4569999999999999 5787765544 33456665433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.42 E-value=7.4e-13 Score=147.75 Aligned_cols=133 Identities=29% Similarity=0.402 Sum_probs=108.8
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..|+|++|.+.+..+ +..+++|+.|+|++|.|++ +|.+..+++|+.|+|++|++++ ++ . +..|++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP---LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISD-IN-G-LVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCCCGG---GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCCC-CG-G-GGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCCChh---hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCCC-Cc-c-ccCCCccCEEE
Confidence 468899999999987533 8889999999999999987 5688899999999999999986 43 3 88899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|++|++++. ..+..|++|+.|+|++|+|++.+|-....+|+.|+|++|+|++. | .+..++
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~ 197 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R-ALAGLK 197 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-G-GGTTCT
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-h-HHccCC
Confidence 999999864 67888999999999999998877744567899999999998873 4 344443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=7.1e-13 Score=123.72 Aligned_cols=107 Identities=18% Similarity=0.309 Sum_probs=89.4
Q ss_pred EEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcc
Q 038422 76 WGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154 (634)
Q Consensus 76 ~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~ 154 (634)
..+++++++|. .+|. .+ .++|+.|+|++|+|++.+| .+.++++|++|+|++|+|++ ||+..|.++++|++|+|+
T Consensus 15 ~~l~~~~n~l~-~iP~-~~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA-GI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SEEECCSSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred cEEEeCCCCCC-ccCC-Cc--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECC
Confidence 46788888884 6764 33 3889999999999999887 58899999999999999996 677768899999999999
Q ss_pred cCcCccCCCccccCCCCccEEeCCCCceeecCC
Q 038422 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP 187 (634)
Q Consensus 155 ~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip 187 (634)
+|+|++..|..+.++++|++|+|++|.|+...+
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999996555568999999999999999886554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.4e-13 Score=137.52 Aligned_cols=154 Identities=20% Similarity=0.306 Sum_probs=115.1
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..+.|.. ..+..|+|++|++.+..+ ..+..+++|++|+|++|.+++..| .+.++++|++|+|++|
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRK-DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCH-hHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 588888852 257789999998885544 578889999999999999998877 5888999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceee--cCCccc-ccCCCEEEeecCcccccC
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG--QVPEIK-QNEMRSLGLANNELEGPI 208 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g--~ip~~~-~~~l~~l~l~~N~l~g~i 208 (634)
+++ .+|.. +. ++|++|+|++|++++..+..+.++++|+.|+|++|.++. ..|... ..+|+.|++++|++++ +
T Consensus 113 ~l~-~l~~~-~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~-l 187 (332)
T 2ft3_A 113 HLV-EIPPN-LP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-I 187 (332)
T ss_dssp CCC-SCCSS-CC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS-C
T ss_pred cCC-ccCcc-cc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc-c
Confidence 988 67765 32 788899999998886555668888889999999888863 444432 2278888888888876 5
Q ss_pred Cccc-cCCCCCcccCC
Q 038422 209 PESL-SKMDPSTFAGN 223 (634)
Q Consensus 209 p~~~-~~~~~~~~~gn 223 (634)
|..+ .++......+|
T Consensus 188 ~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 188 PKDLPETLNELHLDHN 203 (332)
T ss_dssp CSSSCSSCSCCBCCSS
T ss_pred CccccCCCCEEECCCC
Confidence 5543 23444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.41 E-value=9.5e-13 Score=131.56 Aligned_cols=123 Identities=20% Similarity=0.397 Sum_probs=66.2
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
++..|+|+++++.. ++ .+..+++|+.|+|++|.+++..| +.++++|++|+|++|++++ +|. +.. ++|+.|+|
T Consensus 42 ~L~~L~l~~n~i~~-l~--~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~--~~~-~~L~~L~L 113 (263)
T 1xeu_A 42 GVQNFNGDNSNIQS-LA--GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNG--IPS-ACLSRLFL 113 (263)
T ss_dssp TCSEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTT--CCC-SSCCEEEC
T ss_pred cCcEEECcCCCccc-ch--HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCc--ccc-CcccEEEc
Confidence 35555555555542 33 35555666666666666655444 5555666666666666654 332 222 55666666
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCccccc
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ 207 (634)
++|++++ +| .+.++++|+.|+|++|++++. |.. ...+|+.|++++|++++.
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence 6666554 22 355556666666666665543 322 334566666666665544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.41 E-value=7.4e-13 Score=137.05 Aligned_cols=139 Identities=22% Similarity=0.357 Sum_probs=119.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|.+.+..| ..++.+++|++|+|++|.++...+.+. ++|++|+|++|++++ +|+..|.++++|+.|+
T Consensus 78 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~ 153 (332)
T 2ft3_A 78 QHLYALVLVNNKISKIHE-KAFSPLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIE 153 (332)
T ss_dssp TTCCEEECCSSCCCEECG-GGSTTCTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCC-CCSGGGSSCSSCCEEE
T ss_pred CCCcEEECCCCccCccCH-hHhhCcCCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCc-cCHhHhCCCccCCEEE
Confidence 468899999999997655 579999999999999999995444454 899999999999995 6677799999999999
Q ss_pred cccCcCc--cCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCC
Q 038422 153 MANNRLT--GTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 153 l~~N~l~--g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
|++|.++ |..|..+..+ +|++|++++|++++ +|.....+|+.|++++|++++..|..+.+++.
T Consensus 154 l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~ 218 (332)
T 2ft3_A 154 MGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHLDHNKIQAIELEDLLRYSK 218 (332)
T ss_dssp CCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTT
T ss_pred CCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEECCCCcCCccCHHHhcCCCC
Confidence 9999996 4778888888 99999999999986 77766689999999999999888777765543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=8.3e-13 Score=135.24 Aligned_cols=141 Identities=22% Similarity=0.365 Sum_probs=117.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|.+.+. + .+..+++|+.|+|++|.+++. |.+..+++|++|+|++|.+++ +++ ++.+++|++|+
T Consensus 85 ~~L~~L~L~~n~l~~~-~--~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~L~ 157 (308)
T 1h6u_A 85 TKITELELSGNPLKNV-S--AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITN-ISP--LAGLTNLQYLS 157 (308)
T ss_dssp CSCCEEECCSCCCSCC-G--GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCC-CGG--GGGCTTCCEEE
T ss_pred CCCCEEEccCCcCCCc-h--hhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc-Ccc--ccCCCCccEEE
Confidence 5789999999999873 3 689999999999999999884 559999999999999999996 443 88999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC---CCcccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGNK 224 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn~ 224 (634)
|++|++++ +|. +.++++|+.|+|++|++++..|-....+|+.|++++|++++..| +..++ ...+.+|+
T Consensus 158 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~ 228 (308)
T 1h6u_A 158 IGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQT 228 (308)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEE
T ss_pred ccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCe
Confidence 99999996 454 99999999999999999976554456799999999999997654 44443 33445553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=122.07 Aligned_cols=107 Identities=20% Similarity=0.252 Sum_probs=91.9
Q ss_pred cCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCC
Q 038422 100 LRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179 (634)
Q Consensus 100 L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~ 179 (634)
.+.|++++|.|+..+..+. +.|++|+|++|++++..| ..|+++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEP-GVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCT-TTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccCh-hhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4789999999988544553 889999999999997544 5599999999999999999976667789999999999999
Q ss_pred CceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 180 NKFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 180 N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
|+|++..|.. ...+|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999876654 45699999999999997765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.6e-12 Score=131.97 Aligned_cols=133 Identities=22% Similarity=0.405 Sum_probs=113.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+++++++... + .+..+++|+.|+|++|.+++..| +.++++|++|+|++|.+++ +| . ++.+++|++|+
T Consensus 46 ~~L~~L~l~~~~i~~~-~--~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~-l~~l~~L~~L~ 118 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-S-LKDLKKLKSLS 118 (291)
T ss_dssp HTCCEEECTTSCCCCC-T--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-G-GTTCTTCCEEE
T ss_pred CcccEEEccCCCcccC-h--hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-h-hccCCCCCEEE
Confidence 3588999999988753 3 48899999999999999999776 9999999999999999996 44 3 89999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
|++|++++ + +.+..+++|+.|+|++|++++. +.. ...+|+.|++++|++++..| +..++.
T Consensus 119 L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~ 179 (291)
T 1h6t_A 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTK 179 (291)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred CCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCc
Confidence 99999997 3 5789999999999999999975 543 55799999999999998655 554443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.7e-12 Score=129.75 Aligned_cols=124 Identities=21% Similarity=0.295 Sum_probs=107.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|.+++..+ +..+++|+.|+|++|.+++ +|.+.. ++|++|+|++|++++ ++ . ++.+++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~~~~---l~~l~~L~~L~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~-~~-~-l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP---LKDLTKLEELSVNRNRLKN-LNGIPS-ACLSRLFLDNNELRD-TD-S-LIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCCCGG---GTTCSSCCEEECCSSCCSC-CTTCCC-SSCCEEECCSSCCSB-SG-G-GTTCTTCCEEE
T ss_pred CCCCEEECCCCccCCChh---hccCCCCCEEECCCCccCC-cCcccc-CcccEEEccCCccCC-Ch-h-hcCcccccEEE
Confidence 578999999999997432 8999999999999999998 455555 999999999999997 43 3 89999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCccccc
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ 207 (634)
|++|++++ +| .++.+++|+.|+|++|++++. +.. ...+|+.|++++|.+++.
T Consensus 135 Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 99999997 45 799999999999999999987 433 556999999999999876
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.8e-13 Score=141.50 Aligned_cols=135 Identities=19% Similarity=0.239 Sum_probs=113.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-CCCCCCCcEEEccCCcCccccCh-hhhhCCCCCCe
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISD-DAFEGMTSLKK 150 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~ip~-~~~~~~~~L~~ 150 (634)
.++..|+|++|++.+..+ ..++.+++|++|+|++|.+++..+. +.++++|++|+|++|+++ .+|. ..+.++++|++
T Consensus 76 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCEEECCCCccCccCH-hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 468899999999987554 5789999999999999999976665 889999999999999998 4666 55889999999
Q ss_pred EEcccCc-CccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCc
Q 038422 151 LYMANNR-LTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 151 l~l~~N~-l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~ 210 (634)
|+|++|+ +++..|..++++++|++|+|++|++++.+|.. ...+|+.|++++|+++ .+|.
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~ 215 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHH
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchh
Confidence 9999994 66656778999999999999999999988875 3458899999999985 4554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=139.49 Aligned_cols=135 Identities=21% Similarity=0.311 Sum_probs=75.5
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
++..|+|++|.+.+ +| .++.+++|++|++++|++++ +|.. ..+|++|+|++|++++ +| + ++++++|++|++
T Consensus 132 ~L~~L~L~~n~l~~-lp--~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~-~~~l~~L~~L~l 202 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-E-LQNLPFLTAIYA 202 (454)
T ss_dssp TCCEEECCSSCCSS-CC--CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-C-CTTCTTCCEEEC
T ss_pred CCCEEECcCCCCCC-Cc--ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-c-ccCCCCCCEEEC
Confidence 45555555555554 44 25556666666666666655 3322 1355555555555554 44 2 556666666666
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCCCCcccCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMDPSTFAGN 223 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~gn 223 (634)
++|++++ +|... ++|++|++++|+++ .+|.. ...+|+.|++++|++++ +|..+.++....+.+|
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N 267 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDN 267 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSS
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCc-ccccccccCEEECCCC
Confidence 6666654 44322 35555555555555 45543 33578888888888875 5655555554445554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=142.39 Aligned_cols=132 Identities=20% Similarity=0.290 Sum_probs=110.7
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|.+.+..+ +..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++.. + ++.+++|+.|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~-~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDIS-P--ISNLKNLTYLT 315 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCG-G--GGGCTTCSEEE
T ss_pred CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCch-h--hcCCCCCCEEE
Confidence 468899999999987643 7889999999999999998666 888999999999999999743 3 78899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|++|++++..| +..+++|+.|++++|++++. +.. ...+|+.|++++|+++|.+| +..++
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~ 375 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLT 375 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGG--GTTCT
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccch--hhcCC
Confidence 99999998765 78899999999999999875 443 55789999999999998887 44444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-15 Score=143.90 Aligned_cols=133 Identities=23% Similarity=0.315 Sum_probs=113.1
Q ss_pred CcEEEEEecCCCCccccCh-----hhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCC
Q 038422 73 GSVWGLKLEQMNLSGTIAA-----ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTS 147 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~-----~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~ 147 (634)
..++.++|..++++|.+|. ..++.+++|++|+|++|.+++ +|.+.++++|++|+|++|.++ .+|.. +..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~-~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENL-DAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSH-HHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccch-hhcCCc
Confidence 3566677777888888763 368899999999999999999 778999999999999999999 68764 778899
Q ss_pred CCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCC--cc-cccCCCEEEeecCcccccCCc
Q 038422 148 LKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP--EI-KQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 148 L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip--~~-~~~~l~~l~l~~N~l~g~ip~ 210 (634)
|++|+|++|++++ +| .+.++++|++|+|++|++++..+ .. ...+|+.|++++|.+++.+|.
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999999999997 56 68899999999999999986332 22 456899999999999998775
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.4e-12 Score=138.06 Aligned_cols=123 Identities=16% Similarity=0.122 Sum_probs=89.7
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..|+|++|.+.+ ++ ++.+++|++|+|++|.+++. +++++++|++|++++|++.|.++ ++.+++|++|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ 176 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLD 176 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEE
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCcccccc---cccCCcCCEEE
Confidence 467889999998887 43 78888899999999988884 37777778888888877666663 66777777777
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip 209 (634)
|++|++++ +| ++.+++|+.|++++|++++. +-....+|+.|++++|+++| +|
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC
Confidence 77777776 55 66677777777777777653 33344567777777777776 55
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=145.08 Aligned_cols=127 Identities=23% Similarity=0.347 Sum_probs=112.4
Q ss_pred CCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 72 NGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 72 ~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
-.++..|+|++|.|.+ ++ .+..+++|+.|+|++|.+++ +|.+..+++|+.|+|++|++++. + .++.|++|+.|
T Consensus 86 l~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~-~l~~l~~L~~L 158 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--T-VLSRLTKLDTL 158 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC--G-GGGSCTTCSEE
T ss_pred CCCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc--h-hhcccCCCCEE
Confidence 3578899999999987 33 68999999999999999998 57899999999999999999974 3 48999999999
Q ss_pred EcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccC
Q 038422 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPI 208 (634)
Q Consensus 152 ~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~i 208 (634)
+|++|+|++..| +..+++|+.|+|++|+|++ +|.. ...+|+.|+|++|.+++..
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEECCSEEEECCC
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCC-ChHHccCCCCCEEEccCCcCcCCc
Confidence 999999998766 9999999999999999997 4554 5679999999999999753
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.3e-12 Score=119.18 Aligned_cols=106 Identities=18% Similarity=0.279 Sum_probs=88.6
Q ss_pred CEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCC
Q 038422 101 RAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEAN 180 (634)
Q Consensus 101 ~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N 180 (634)
+.+++++|.++..++.+. +.|++|+|++|++++..| ..|+++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEP-GVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCH-HHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 689999999965433454 899999999999997554 55999999999999999999755556789999999999999
Q ss_pred ceeecCCcc--cccCCCEEEeecCcccccCC
Q 038422 181 KFQGQVPEI--KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 181 ~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip 209 (634)
+|++..+.. ...+|+.|+|++|.++...+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999766653 35699999999999986543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.6e-13 Score=149.71 Aligned_cols=137 Identities=20% Similarity=0.332 Sum_probs=94.1
Q ss_pred CCCCCCCCCCCCCCCCCCeeeEE--------ecCCcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCC
Q 038422 47 ALVNWNALRNPCTFNYPNWNGVL--------CLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLR 118 (634)
Q Consensus 47 ~l~~W~~~~~~C~~~~~~w~gv~--------C~~~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~ 118 (634)
.+..|....+||. |.|.. |....+..|++++++|+ .+|. .+. ++|+.|+|++|+|++ +|.
T Consensus 11 ~w~~W~~~~~~~~-----~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~~-lp~-- 78 (622)
T 3g06_A 11 VWSAWRRAAPAEE-----SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLTS-LPA-- 78 (622)
T ss_dssp HHHHHHHTCCGGG-----HHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCSC-CCC--
T ss_pred HHHHHHhcCCcch-----hccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCCC-CCC--
Confidence 3556766666774 86643 23445788999999888 7764 333 788888888888884 554
Q ss_pred CCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEE
Q 038422 119 KMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLG 198 (634)
Q Consensus 119 ~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~ 198 (634)
.+++|++|+|++|+++ .||. .+++|++|+|++|++++ +|. .+++|+.|+|++|++++ +|.. ..+|+.|+
T Consensus 79 ~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~-l~~L~~L~ 147 (622)
T 3g06_A 79 LPPELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL-PPGLQELS 147 (622)
T ss_dssp CCTTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC-CTTCCEEE
T ss_pred cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC-CCCCCEEE
Confidence 5678888888888887 4664 56778888888888775 555 45667777777777664 4442 25666666
Q ss_pred eecCcccc
Q 038422 199 LANNELEG 206 (634)
Q Consensus 199 l~~N~l~g 206 (634)
+++|++++
T Consensus 148 Ls~N~l~~ 155 (622)
T 3g06_A 148 VSDNQLAS 155 (622)
T ss_dssp CCSSCCSC
T ss_pred CcCCcCCC
Confidence 66666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-12 Score=139.55 Aligned_cols=140 Identities=24% Similarity=0.319 Sum_probs=118.6
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++|.+.+. +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|.+++. |+ +..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI---GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNI-SP--LAGLTALTNLE 293 (466)
T ss_dssp TTCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC-GG--GTTCTTCSEEE
T ss_pred CCCCEEECCCCCcccc---hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcc-cc--ccCCCccCeEE
Confidence 4688999999999863 368899999999999999998776 89999999999999999974 33 88999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCC---CcccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDP---STFAGN 223 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~---~~~~gn 223 (634)
|++|++++..| ++.+++|+.|+|++|++++..|-....+|+.|++++|.+++. ..+.+++. ....+|
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHN 363 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSS
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCC
Confidence 99999997544 889999999999999999988855678999999999999985 34554443 334455
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.34 E-value=6.6e-14 Score=145.01 Aligned_cols=147 Identities=16% Similarity=0.226 Sum_probs=113.4
Q ss_pred CeeeEEecCCcEEEEEecCCCCccccChhhhcCC--CCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccc-cChh
Q 038422 64 NWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLL--SSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGN-ISDD 140 (634)
Q Consensus 64 ~w~gv~C~~~~v~~l~L~~~~l~g~~~~~~l~~l--~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~-ip~~ 140 (634)
.|.++.|+...+..++|+++++.. ..+..+ ++|+.|++++|.+.+.+|.+.++++|++|+|++|.+++. +|.
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~- 112 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG- 112 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHH-
T ss_pred HHHHHhcCchhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHH-
Confidence 488888876667788888887763 345566 788888888888888888888888888888888888876 544
Q ss_pred hhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCC-ceeec-CCcc--cccCCCEEEeecC-ccccc-CCccccC
Q 038422 141 AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEAN-KFQGQ-VPEI--KQNEMRSLGLANN-ELEGP-IPESLSK 214 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N-~~~g~-ip~~--~~~~l~~l~l~~N-~l~g~-ip~~~~~ 214 (634)
.+..+++|++|+|++|++++.+|..++++++|++|+|++| .+++. +|.. ...+|+.|++++| .+++. +|..+..
T Consensus 113 ~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~ 192 (336)
T 2ast_B 113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAH 192 (336)
T ss_dssp HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHH
T ss_pred HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHh
Confidence 4788888888888888888888888888888888888888 67763 5553 3468888888888 88764 5554443
Q ss_pred C
Q 038422 215 M 215 (634)
Q Consensus 215 ~ 215 (634)
+
T Consensus 193 l 193 (336)
T 2ast_B 193 V 193 (336)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.5e-12 Score=132.62 Aligned_cols=134 Identities=22% Similarity=0.329 Sum_probs=81.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..|+|++|.+.+.. .+..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++ +++ +..+++|++|+
T Consensus 177 ~~L~~L~l~~n~l~~~~---~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~ 249 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDIS---PLASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITD-LSP--LANLSQLTWLE 249 (347)
T ss_dssp TTCSEEECTTSCCCCCG---GGGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEE
T ss_pred CCCCEEEccCCcccccc---cccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCC-Ccc--hhcCCCCCEEE
Confidence 45777888887776532 25666666666666666665544 5666666666666666664 322 56666666666
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|++|++++ + +.+..+++|++|+|++|++++. |.. ...+|+.|++++|++++..|..+.+++
T Consensus 250 l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 311 (347)
T 4fmz_A 250 IGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311 (347)
T ss_dssp CCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCT
T ss_pred CCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccc
Confidence 66666664 2 3456666666666666666653 332 334666666666666666655554443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.8e-12 Score=132.46 Aligned_cols=107 Identities=23% Similarity=0.292 Sum_probs=83.7
Q ss_pred CeeeEEecCCcEEEEEecCC-CCccccChhhhcCCCCcCEEeccC-CcCcccCC-CCCCCCCCcEEEccCCcCccccChh
Q 038422 64 NWNGVLCLNGSVWGLKLEQM-NLSGTIAAESLGLLSSLRAVSFMN-NKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDD 140 (634)
Q Consensus 64 ~w~gv~C~~~~v~~l~L~~~-~l~g~~~~~~l~~l~~L~~L~l~~-n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~ 140 (634)
.|..|.|+ ++ +|.+ +|. +..+++|+.|+|++ |.|++.+| .|.++++|++|+|++|+|+|.. +.
T Consensus 9 ~~~~v~~~----------~~n~l~~-ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~ 74 (347)
T 2ifg_A 9 GSSGLRCT----------RDGALDS-LHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA-PD 74 (347)
T ss_dssp SSSCEECC----------SSCCCTT-TTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC-TT
T ss_pred cCCEEEcC----------CCCCCCc-cCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeC-HH
Confidence 47777774 33 4553 664 88899999999996 99998876 5889999999999999999754 45
Q ss_pred hhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeec
Q 038422 141 AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQ 185 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ 185 (634)
.|++|++|++|+|++|+|++..|..+..++ |+.|+|++|.|...
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 589999999999999999964444455454 99999999988754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.32 E-value=2e-12 Score=134.47 Aligned_cols=142 Identities=26% Similarity=0.350 Sum_probs=118.0
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..++++++.+.+..+ +..+++|+.|+|++|.+++..+ +..+++|++|+|++|.+++ ++ .+..+++|++|+
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~--~~~~l~~L~~L~ 271 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-IN--AVKDLTKLKMLN 271 (347)
T ss_dssp TTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG--GGTTCTTCCEEE
T ss_pred CccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-Ch--hHhcCCCcCEEE
Confidence 467889999999886543 7889999999999999998766 8999999999999999986 43 389999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCC-ccccCCCCCcccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIP-ESLSKMDPSTFAGN 223 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip-~~~~~~~~~~~~gn 223 (634)
|++|++++. +.+..+++|+.|+|++|++++..|.. ...+|+.|++++|.+++..| ..+.++....+.+|
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhh
Confidence 999999974 46889999999999999999888774 45799999999999998877 22334444455555
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.31 E-value=9.2e-12 Score=134.50 Aligned_cols=101 Identities=30% Similarity=0.455 Sum_probs=57.4
Q ss_pred CCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeC
Q 038422 98 SSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRL 177 (634)
Q Consensus 98 ~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l 177 (634)
++|++|+|++|++++ +|+++++++|++|++++|++++ +|.. ..+|++|+|++|++++ +| .++++++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 355566666666555 4556666666666666666654 4432 2356666666666664 45 4566666666666
Q ss_pred CCCceeecCCcccccCCCEEEeecCcccccCC
Q 038422 178 EANKFQGQVPEIKQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 178 ~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip 209 (634)
++|++++ +|... .+|+.|++++|+++ .+|
T Consensus 203 ~~N~l~~-l~~~~-~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 203 DNNSLKK-LPDLP-LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CSSCCSS-CCCCC-TTCCEEECCSSCCS-SCC
T ss_pred CCCcCCc-CCCCc-CcccEEECcCCcCC-ccc
Confidence 6666654 33322 35666666666665 555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.1e-12 Score=120.76 Aligned_cols=113 Identities=21% Similarity=0.206 Sum_probs=94.6
Q ss_pred hhcCCCCcCEEeccCCcCcccCCCCCCCC-CCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCC
Q 038422 93 SLGLLSSLRAVSFMNNKFEGPLPDLRKMG-PLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPK 171 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~l~g~~p~~~~l~-~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~ 171 (634)
.+..+.+|+.|+|++|+++. +|.+..+. +|++|+|++|++++. + .++.+++|++|+|++|++++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--c-ccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 35678899999999999995 58777776 999999999999974 3 4899999999999999999643444599999
Q ss_pred ccEEeCCCCceeecCCc--c--cccCCCEEEeecCcccccCCcc
Q 038422 172 LMELRLEANKFQGQVPE--I--KQNEMRSLGLANNELEGPIPES 211 (634)
Q Consensus 172 L~~L~l~~N~~~g~ip~--~--~~~~l~~l~l~~N~l~g~ip~~ 211 (634)
|++|+|++|+++ .+|. . ...+|+.|++++|.++ .+|..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHY 131 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhH
Confidence 999999999995 5665 2 4468999999999998 56653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=8.8e-12 Score=129.72 Aligned_cols=104 Identities=17% Similarity=0.282 Sum_probs=90.4
Q ss_pred EEeccCC-cCcccCCCCCCCCCCcEEEccC-CcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCC
Q 038422 102 AVSFMNN-KFEGPLPDLRKMGPLKSIYLSD-NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179 (634)
Q Consensus 102 ~L~l~~n-~l~g~~p~~~~l~~L~~L~ls~-N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~ 179 (634)
.+++++| +|++ ||.+..+++|+.|+|++ |+|++ +|+..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~l~~~~~L~~L~l~~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQH-LELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTTSCSCSCCSEEECCSCSSCCE-ECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCCCCCCCCeeEEEccCCCCCCC-cChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 5688888 8987 45599999999999996 99996 5666699999999999999999999999999999999999999
Q ss_pred CceeecCCccc-ccCCCEEEeecCccccc
Q 038422 180 NKFQGQVPEIK-QNEMRSLGLANNELEGP 207 (634)
Q Consensus 180 N~~~g~ip~~~-~~~l~~l~l~~N~l~g~ 207 (634)
|+|++..|..+ ..+|+.|+|++|.|...
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 99997655543 33599999999999854
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.27 E-value=8.2e-13 Score=139.73 Aligned_cols=153 Identities=22% Similarity=0.307 Sum_probs=121.6
Q ss_pred CCcEEEEEecCCCCccccC---hhhhcCC---------CCcCEEeccCCcCc-ccCC----CCCCCCCCcEEEccCCcCc
Q 038422 72 NGSVWGLKLEQMNLSGTIA---AESLGLL---------SSLRAVSFMNNKFE-GPLP----DLRKMGPLKSIYLSDNGFS 134 (634)
Q Consensus 72 ~~~v~~l~L~~~~l~g~~~---~~~l~~l---------~~L~~L~l~~n~l~-g~~p----~~~~l~~L~~L~ls~N~~~ 134 (634)
..++..|+|++|++.+..+ +..+..+ ++|++|+|++|.++ +.+| .+..+++|++|+|++|+++
T Consensus 121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 4689999999999975422 2345556 89999999999998 5566 4667889999999999998
Q ss_pred cc----cChhhhhCCCCCCeEEcccCcCc----cCCCccccCCCCccEEeCCCCceeec----CCcc----cccCCCEEE
Q 038422 135 GN----ISDDAFEGMTSLKKLYMANNRLT----GTIPSSLVQLPKLMELRLEANKFQGQ----VPEI----KQNEMRSLG 198 (634)
Q Consensus 135 g~----ip~~~~~~~~~L~~l~l~~N~l~----g~ip~~~~~l~~L~~L~l~~N~~~g~----ip~~----~~~~l~~l~ 198 (634)
.. +.+..+..+++|++|+|++|+++ +.+|..+..+++|+.|+|++|++++. +|.. ..++|+.|+
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 32 22324788999999999999997 78899999999999999999999876 5553 257899999
Q ss_pred eecCcccc----cCCccc----cCCCCCcccCCC
Q 038422 199 LANNELEG----PIPESL----SKMDPSTFAGNK 224 (634)
Q Consensus 199 l~~N~l~g----~ip~~~----~~~~~~~~~gn~ 224 (634)
|++|.+++ .+|..+ .++....+.+|+
T Consensus 281 L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred CcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 99999998 588776 344444556663
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.26 E-value=6.6e-13 Score=137.47 Aligned_cols=127 Identities=17% Similarity=0.182 Sum_probs=70.6
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCccc-CC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCe
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGP-LP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKK 150 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~-~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~ 150 (634)
..+..++|+++.+.+..+. +..+++|++|+|++|.+++. +| .+.++++|++|+|++|.+++.+|.. ++.+++|++
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~-l~~~~~L~~ 146 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT-LAKNSNLVR 146 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHH-HTTCTTCSE
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHH-HhcCCCCCE
Confidence 3455666666666655442 44566666666666666554 44 3455566666666666665555433 555666666
Q ss_pred EEcccC-cCccC-CCccccCCCCccEEeCCCC-ceeec-CCcc--ccc-CCCEEEeecC
Q 038422 151 LYMANN-RLTGT-IPSSLVQLPKLMELRLEAN-KFQGQ-VPEI--KQN-EMRSLGLANN 202 (634)
Q Consensus 151 l~l~~N-~l~g~-ip~~~~~l~~L~~L~l~~N-~~~g~-ip~~--~~~-~l~~l~l~~N 202 (634)
|+|++| .+++. +|..+.++++|++|+|++| ++++. +|.. ..+ +|+.|++++|
T Consensus 147 L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 147 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp EECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred EECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 666666 45542 4555555666666666666 55543 3332 233 5555555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.22 E-value=7.1e-13 Score=140.20 Aligned_cols=140 Identities=20% Similarity=0.328 Sum_probs=115.0
Q ss_pred CCcEEEEEecCCCCcc----ccChhhhcCCCCcCEEeccCCcCcccCC-----CCCCC---------CCCcEEEccCCcC
Q 038422 72 NGSVWGLKLEQMNLSG----TIAAESLGLLSSLRAVSFMNNKFEGPLP-----DLRKM---------GPLKSIYLSDNGF 133 (634)
Q Consensus 72 ~~~v~~l~L~~~~l~g----~~~~~~l~~l~~L~~L~l~~n~l~g~~p-----~~~~l---------~~L~~L~ls~N~~ 133 (634)
..++..|+|++|.+.+ .++ ..+..+++|++|+|++|.+++..+ .+..+ ++|++|+|++|++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~-~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l 171 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLI-DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHH-HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred CCcccEEECCCCcCCHHHHHHHH-HHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCC
Confidence 3679999999999998 455 478899999999999999976543 13344 8999999999999
Q ss_pred c-cccCh--hhhhCCCCCCeEEcccCcCc--c---CCCccccCCCCccEEeCCCCcee----ecCCcc--cccCCCEEEe
Q 038422 134 S-GNISD--DAFEGMTSLKKLYMANNRLT--G---TIPSSLVQLPKLMELRLEANKFQ----GQVPEI--KQNEMRSLGL 199 (634)
Q Consensus 134 ~-g~ip~--~~~~~~~~L~~l~l~~N~l~--g---~ip~~~~~l~~L~~L~l~~N~~~----g~ip~~--~~~~l~~l~l 199 (634)
+ +.+|. ..+..+++|+.|+|++|+++ | .+|..+..+++|+.|+|++|.++ +.+|.. ..++|+.|+|
T Consensus 172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L 251 (386)
T 2ca6_A 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251 (386)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence 8 45542 34778999999999999998 4 45668999999999999999997 677764 4468999999
Q ss_pred ecCccccc----CCccc
Q 038422 200 ANNELEGP----IPESL 212 (634)
Q Consensus 200 ~~N~l~g~----ip~~~ 212 (634)
++|.+++. +|..+
T Consensus 252 ~~n~i~~~~~~~l~~~l 268 (386)
T 2ca6_A 252 NDCLLSARGAAAVVDAF 268 (386)
T ss_dssp TTCCCCHHHHHHHHHHH
T ss_pred CCCCCchhhHHHHHHHH
Confidence 99999876 66654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.8e-11 Score=119.66 Aligned_cols=136 Identities=16% Similarity=0.079 Sum_probs=105.2
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
..++.|+++.||+.... ++.+++|............+.+|+++++.+. |..+.++++++.+.+..++||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677888899998754 6889999986532233456899999999884 677888999998888999999999999987
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL------------------------------------------- 476 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 476 (634)
+.+. +......++.+++++|..||+..
T Consensus 99 ~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 6531 11123468899999999999811
Q ss_pred ------------CCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 477 ------------PGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 477 ------------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
.+..++|+|+++.||+++++....|.||+.+
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 1135899999999999987666779999865
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=127.72 Aligned_cols=141 Identities=15% Similarity=0.157 Sum_probs=100.9
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcE-EEcc
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKS-IYLS 129 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~-L~ls 129 (634)
.|..|.|++ ..++.|+|++|+++ .||+..+..|++|++|+|++|.+.+.+| .|.++++|.. ++++
T Consensus 10 ~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 588899953 24678889998887 5676678889999999999999888777 3678887764 6677
Q ss_pred CCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCc-c---cccCCCEEEeecCccc
Q 038422 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE-I---KQNEMRSLGLANNELE 205 (634)
Q Consensus 130 ~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~-~---~~~~l~~l~l~~N~l~ 205 (634)
+|++++ ||++.|..+++|++|++++|++++..+..+....++..|++++|.--..+|. . ....++.|++++|+|+
T Consensus 89 ~N~l~~-l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCE-ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccc-cCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 788884 6666688889999999999988866555566666667777755332223333 1 1235667777777776
Q ss_pred c
Q 038422 206 G 206 (634)
Q Consensus 206 g 206 (634)
.
T Consensus 168 ~ 168 (350)
T 4ay9_X 168 E 168 (350)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=135.38 Aligned_cols=65 Identities=34% Similarity=0.548 Sum_probs=46.5
Q ss_pred CCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCC
Q 038422 146 TSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDP 217 (634)
Q Consensus 146 ~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~ 217 (634)
++|+.|+|++|++++ +| ..+++|+.|+|++|+|+ .||. ...+|+.|+|++|+|+ .||..+.+++.
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~-~lp~~l~~l~~ 285 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT-RLPESLIHLSS 285 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc-ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence 567777777777775 66 34567788888888877 4665 5567888888888888 77777665543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.15 E-value=7.2e-12 Score=131.27 Aligned_cols=136 Identities=20% Similarity=0.227 Sum_probs=65.7
Q ss_pred EEEEEecCCCCccccCh---hhhcCCC-CcCEEeccCCcCcccCC-CCCCC-----CCCcEEEccCCcCccccChh---h
Q 038422 75 VWGLKLEQMNLSGTIAA---ESLGLLS-SLRAVSFMNNKFEGPLP-DLRKM-----GPLKSIYLSDNGFSGNISDD---A 141 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~---~~l~~l~-~L~~L~l~~n~l~g~~p-~~~~l-----~~L~~L~ls~N~~~g~ip~~---~ 141 (634)
++.|+|++|.+++..+. ..+..++ +|++|+|++|.+++..+ .+..+ ++|++|+|++|.+++..+.. .
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 55566666555543220 2344555 56666666665555443 22221 55666666666655433221 1
Q ss_pred hhCC-CCCCeEEcccCcCccCCCcccc----C-CCCccEEeCCCCceeecCCc----c--cc-cCCCEEEeecCcccccC
Q 038422 142 FEGM-TSLKKLYMANNRLTGTIPSSLV----Q-LPKLMELRLEANKFQGQVPE----I--KQ-NEMRSLGLANNELEGPI 208 (634)
Q Consensus 142 ~~~~-~~L~~l~l~~N~l~g~ip~~~~----~-l~~L~~L~l~~N~~~g~ip~----~--~~-~~l~~l~l~~N~l~g~i 208 (634)
+..+ ++|++|+|++|++++..+..++ . .++|++|+|++|++++.-+. . .. .+|+.|+|++|++++..
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 2223 5566666666665544433322 2 24566666666655532221 1 11 25666666666665544
Q ss_pred Cc
Q 038422 209 PE 210 (634)
Q Consensus 209 p~ 210 (634)
+.
T Consensus 184 ~~ 185 (362)
T 3goz_A 184 CA 185 (362)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.14 E-value=7.2e-11 Score=123.06 Aligned_cols=147 Identities=17% Similarity=0.224 Sum_probs=95.3
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCE-EeccCCcCcccCCC-CCCCCCCcEEEccCCcCcccc-------------
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRA-VSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNI------------- 137 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~-L~l~~n~l~g~~p~-~~~l~~L~~L~ls~N~~~g~i------------- 137 (634)
.+++.|+|++|.+.+.+++..+.++++|.. +.+.+|++++..|+ +..+++|++|++++|++++..
T Consensus 54 ~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l 133 (350)
T 4ay9_X 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 133 (350)
T ss_dssp TTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEE
T ss_pred CCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhh
Confidence 468889999998888888777778887664 55667888887774 677888888888888877422
Q ss_pred -----------ChhhhhCCC-CCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc---cccCCCEEEeecC
Q 038422 138 -----------SDDAFEGMT-SLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANN 202 (634)
Q Consensus 138 -----------p~~~~~~~~-~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N 202 (634)
|+..|..+. .|+.|+|++|+++ .||.......+|+.|++++|+.-+.||.. ...+|+.|++++|
T Consensus 134 ~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N 212 (350)
T 4ay9_X 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212 (350)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTS
T ss_pred hhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCC
Confidence 222233332 4566777777776 45555555666777777655544556642 2347777777777
Q ss_pred cccccCCccccCCCCCcc
Q 038422 203 ELEGPIPESLSKMDPSTF 220 (634)
Q Consensus 203 ~l~g~ip~~~~~~~~~~~ 220 (634)
+|+.--+..+.++.....
T Consensus 213 ~l~~lp~~~~~~L~~L~~ 230 (350)
T 4ay9_X 213 RIHSLPSYGLENLKKLRA 230 (350)
T ss_dssp CCCCCCSSSCTTCCEEEC
T ss_pred CcCccChhhhccchHhhh
Confidence 777433333455544433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.8e-11 Score=128.25 Aligned_cols=131 Identities=21% Similarity=0.225 Sum_probs=67.0
Q ss_pred cEEEEEecCCCCccccChhhhcCC-----CCcCEEeccCCcCcccCCC-----CCCC-CCCcEEEccCCcCccccChhhh
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLL-----SSLRAVSFMNNKFEGPLPD-----LRKM-GPLKSIYLSDNGFSGNISDDAF 142 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l-----~~L~~L~l~~n~l~g~~p~-----~~~l-~~L~~L~ls~N~~~g~ip~~~~ 142 (634)
++..|+|++|.+.+..+ ..++.+ ++|++|+|++|.+++..+. +..+ ++|++|+|++|++++.. ...+
T Consensus 52 ~L~~L~Ls~N~l~~~~~-~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~-~~~l 129 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNS-DELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS-SSEF 129 (362)
T ss_dssp TCCEEECCSSCGGGSCH-HHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC-HHHH
T ss_pred ceeEEECcCCCCCHHHH-HHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH-HHHH
Confidence 45666666666555433 233332 5666666666666555442 3333 55666666666665432 2222
Q ss_pred ----hC-CCCCCeEEcccCcCccC----CCccccCCC-CccEEeCCCCceeecCCcc------cc-cCCCEEEeecCccc
Q 038422 143 ----EG-MTSLKKLYMANNRLTGT----IPSSLVQLP-KLMELRLEANKFQGQVPEI------KQ-NEMRSLGLANNELE 205 (634)
Q Consensus 143 ----~~-~~~L~~l~l~~N~l~g~----ip~~~~~l~-~L~~L~l~~N~~~g~ip~~------~~-~~l~~l~l~~N~l~ 205 (634)
.. .++|++|+|++|++++. ++..+..++ +|++|+|++|++++..+.. .. .+|+.|+|++|.++
T Consensus 130 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 130 KQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209 (362)
T ss_dssp HHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCC
Confidence 22 24666666666666542 223333443 5666666666665544421 11 35666666666665
Q ss_pred c
Q 038422 206 G 206 (634)
Q Consensus 206 g 206 (634)
+
T Consensus 210 ~ 210 (362)
T 3goz_A 210 L 210 (362)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-12 Score=124.61 Aligned_cols=125 Identities=26% Similarity=0.325 Sum_probs=103.0
Q ss_pred hcCCCCcCEEeccCCcCcccCCC-------CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccc
Q 038422 94 LGLLSSLRAVSFMNNKFEGPLPD-------LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSL 166 (634)
Q Consensus 94 l~~l~~L~~L~l~~n~l~g~~p~-------~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~ 166 (634)
+.....++.++++.|.|+|.+|. +.++++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchh
Confidence 55677899999999999999884 6788999999999999997 77 4899999999999999999 789988
Q ss_pred cCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCC-ccccCCC---CCcccCC
Q 038422 167 VQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIP-ESLSKMD---PSTFAGN 223 (634)
Q Consensus 167 ~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip-~~~~~~~---~~~~~gn 223 (634)
..+++|++|+|++|++++ +|.. ...+|+.|++++|++++.-+ ..+.+++ ...+.+|
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N 150 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred hcCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence 888999999999999997 5543 44689999999999985322 3444443 3344555
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=2.4e-10 Score=113.37 Aligned_cols=130 Identities=15% Similarity=0.105 Sum_probs=96.9
Q ss_pred cC-ccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCc--cccceeEEEeCCceEEEEEcCCCCChh
Q 038422 363 LG-SGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN--LLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 363 lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
++ .|..+.||+....+|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 44 55668999998777888999987543 3356789999998886545 456888888777889999999998874
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL------------------------------------------- 476 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 476 (634)
... .+ ...++.++++.|..||+..
T Consensus 104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 210 11 2356777888888888642
Q ss_pred -----------CCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 477 -----------PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 477 -----------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
.+..++|+|++|.||+++++..++|.||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01238999999999999887667799999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=9.9e-10 Score=114.77 Aligned_cols=141 Identities=18% Similarity=0.258 Sum_probs=104.1
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEec--ccC-ccChhHHHHHHHHHhcCC--CCccccceeEEEeC---CceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYK--QMN-NVGREDFQEHIKRLGRLE--HPNLLPLTAFYYRK---EEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~e~ 432 (634)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468999999999988754 577788765 321 123457889999999887 45578888888766 458999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP----------------------------------- 477 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----------------------------------- 477 (634)
+++..+.+.. ...++..++..++.++++.|+.||+...
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998775421 1127788889999999999999997310
Q ss_pred -------------------CCCccccCCCCCCEEeCCCCC--eEEeccccCCc
Q 038422 478 -------------------GSIIPHGHLKSSNVLLDRSFE--PLLTDYALRPL 509 (634)
Q Consensus 478 -------------------~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~ 509 (634)
+..++|+|+++.||+++.+.. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 236899999999999997753 68999998764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.97 E-value=6e-11 Score=128.22 Aligned_cols=135 Identities=25% Similarity=0.305 Sum_probs=96.5
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCccc----CC-CCCCCCCCcEEEccCCcCccccChhhhhCCC--
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGP----LP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMT-- 146 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~----~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~-- 146 (634)
+++.|+|++++++.......+..+++|+.|+|++|.+++. +| .+..+++|++|+|++|.+++..+......+.
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 5678888888877554333466778888888888888753 33 3667788888888888887654444344555
Q ss_pred --CCCeEEcccCcCcc----CCCccccCCCCccEEeCCCCceeecCCcc-------cccCCCEEEeecCcccccC
Q 038422 147 --SLKKLYMANNRLTG----TIPSSLVQLPKLMELRLEANKFQGQVPEI-------KQNEMRSLGLANNELEGPI 208 (634)
Q Consensus 147 --~L~~l~l~~N~l~g----~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-------~~~~l~~l~l~~N~l~g~i 208 (634)
+|++|+|++|+++. .+|..+.++++|++|+|++|.+++..+.. ...+|+.|++++|++++..
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 68888888888883 56788888888888888888887654432 1236888888888887643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-11 Score=122.91 Aligned_cols=143 Identities=20% Similarity=0.184 Sum_probs=94.2
Q ss_pred CeeeEEecCC--cEEEEEecC---CCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcE--EEccCCc--
Q 038422 64 NWNGVLCLNG--SVWGLKLEQ---MNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKS--IYLSDNG-- 132 (634)
Q Consensus 64 ~w~gv~C~~~--~v~~l~L~~---~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~--L~ls~N~-- 132 (634)
+|.|+.|+.. +|..+...+ ..+.|.+.++.+..|+. .|+..+|..++.++ .+...+.|.. ++++.|+
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 5999999733 676665555 35567777665555443 34445565555554 3555555655 6777773
Q ss_pred -CccccChhhhhCCCCCCeEEcccCcCcc--CCCccccCCCCccEEeCCCCceeec--CCcccccCCCEEEeecCccccc
Q 038422 133 -FSGNISDDAFEGMTSLKKLYMANNRLTG--TIPSSLVQLPKLMELRLEANKFQGQ--VPEIKQNEMRSLGLANNELEGP 207 (634)
Q Consensus 133 -~~g~ip~~~~~~~~~L~~l~l~~N~l~g--~ip~~~~~l~~L~~L~l~~N~~~g~--ip~~~~~~l~~l~l~~N~l~g~ 207 (634)
+.+.++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. +......+|+.|+|++|.+++.
T Consensus 157 ~~~~~l~i-~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~ 235 (267)
T 3rw6_A 157 CMAATLRI-IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDT 235 (267)
T ss_dssp HHHHHHHH-HHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGG
T ss_pred HHHHHHHH-HHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccc
Confidence 3332221 23567888888888888887 6677777888888888888888864 2222222788888888888887
Q ss_pred CC
Q 038422 208 IP 209 (634)
Q Consensus 208 ip 209 (634)
+|
T Consensus 236 ~~ 237 (267)
T 3rw6_A 236 FR 237 (267)
T ss_dssp CS
T ss_pred cC
Confidence 77
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-10 Score=125.22 Aligned_cols=150 Identities=21% Similarity=0.197 Sum_probs=109.6
Q ss_pred CcEEEEEecCCCCcccc----ChhhhcCCCCcCEEeccCCcCccc----CC-CCCCCCCCcEEEccCCcCccccChhhhh
Q 038422 73 GSVWGLKLEQMNLSGTI----AAESLGLLSSLRAVSFMNNKFEGP----LP-DLRKMGPLKSIYLSDNGFSGNISDDAFE 143 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~----~~~~l~~l~~L~~L~l~~n~l~g~----~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~ 143 (634)
.++..|+|++|.+.+.. .+.....+++|++|+|++|.+++. ++ .+.++++|++|+|++|.+++..+.. +.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-l~ 305 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL-LC 305 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH-HH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH-HH
Confidence 57889999999887642 222233588999999999998874 44 4667888999999999987643322 32
Q ss_pred -----CCCCCCeEEcccCcCccC----CCccccCCCCccEEeCCCCceeecCCccc-------ccCCCEEEeecCcccc-
Q 038422 144 -----GMTSLKKLYMANNRLTGT----IPSSLVQLPKLMELRLEANKFQGQVPEIK-------QNEMRSLGLANNELEG- 206 (634)
Q Consensus 144 -----~~~~L~~l~l~~N~l~g~----ip~~~~~l~~L~~L~l~~N~~~g~ip~~~-------~~~l~~l~l~~N~l~g- 206 (634)
..++|++|+|++|.+++. +|..+.++++|++|+|++|++++..+... ..+|+.|++++|.+++
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~ 385 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChh
Confidence 236899999999998876 67777888999999999998887654321 3589999999999986
Q ss_pred ---cCCccccCC---CCCcccCC
Q 038422 207 ---PIPESLSKM---DPSTFAGN 223 (634)
Q Consensus 207 ---~ip~~~~~~---~~~~~~gn 223 (634)
.+|..+..+ ....+.+|
T Consensus 386 ~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 386 SCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSS
T ss_pred hHHHHHHHHHhCCCccEEECCCC
Confidence 778765433 33445555
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.3e-09 Score=111.18 Aligned_cols=181 Identities=19% Similarity=0.229 Sum_probs=118.9
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCc--cccceeEEEeCC---ceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPN--LLPLTAFYYRKE---EKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~e~~~ 434 (634)
+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999853 45788875432 23467889999998874 333 233444332222 3479999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL-------------------------------------- 476 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 476 (634)
|.++.+.... .++..++..++.++++.++.||+..
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9888654321 2677778888888888888888611
Q ss_pred ----------------CCCCccccCCCCCCEEeCC--CCCeEEeccccCCccCCCCCccccc----------------cc
Q 038422 477 ----------------PGSIIPHGHLKSSNVLLDR--SFEPLLTDYALRPLINPDNAHTLMV----------------AY 522 (634)
Q Consensus 477 ----------------~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~----------------~y 522 (634)
.+..++|+|+++.||++++ +..+.|.||+.+............. .|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1135799999999999998 5567899999876533211000000 12
Q ss_pred --cC-cccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 523 --KS-PEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 523 --~a-PE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
.. |+... +.....+.|+++.++|++.+|..++
T Consensus 253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 22211 1122368999999999999999775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=4.5e-10 Score=117.81 Aligned_cols=139 Identities=19% Similarity=0.201 Sum_probs=87.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-C----C-CCCCCCcEEEccCCcCccc----cChhhh
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-D----L-RKMGPLKSIYLSDNGFSGN----ISDDAF 142 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~----~-~~l~~L~~L~ls~N~~~g~----ip~~~~ 142 (634)
..+..|+|++|+++..........+.+|+.|+|++|.++..-. . + ...++|++|+|++|.++.. ++ ..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~-~~L 179 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLM-EGL 179 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHH-HHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHH-HHH
Confidence 4677788887777654322223345677788888887765322 1 1 3456788888888887642 22 234
Q ss_pred hCCCCCCeEEcccCcCcc----CCCccccCCCCccEEeCCCCceeecC----Ccc--cccCCCEEEeecCcccccCCccc
Q 038422 143 EGMTSLKKLYMANNRLTG----TIPSSLVQLPKLMELRLEANKFQGQV----PEI--KQNEMRSLGLANNELEGPIPESL 212 (634)
Q Consensus 143 ~~~~~L~~l~l~~N~l~g----~ip~~~~~l~~L~~L~l~~N~~~g~i----p~~--~~~~l~~l~l~~N~l~g~ip~~~ 212 (634)
..+++|++|+|++|+++. .++..+...++|+.|+|++|+++..- +.. ...+|+.|+|++|.++..-...+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 667778888888888764 23455666777888888888776432 221 23568888888887765444333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=1.6e-09 Score=113.57 Aligned_cols=133 Identities=16% Similarity=0.191 Sum_probs=98.2
Q ss_pred CcEEEEEecCCCCccccCh---hhhc-CCCCcCEEeccCCcCcccC-CCC-CCCCCCcEEEccCCcCccccChhhh----
Q 038422 73 GSVWGLKLEQMNLSGTIAA---ESLG-LLSSLRAVSFMNNKFEGPL-PDL-RKMGPLKSIYLSDNGFSGNISDDAF---- 142 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~---~~l~-~l~~L~~L~l~~n~l~g~~-p~~-~~l~~L~~L~ls~N~~~g~ip~~~~---- 142 (634)
..+..|+|++|+++..-.. ..+. ..++|+.|+|++|.++..- ..+ ..+.+|+.|+|++|+++..-. ..+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~-~~L~~~L 150 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEAC-KDLRDLL 150 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHH-HHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHH-HHHHHHH
Confidence 4688999999998864321 1122 2379999999999997532 222 345689999999999975422 223
Q ss_pred -hCCCCCCeEEcccCcCcc----CCCccccCCCCccEEeCCCCceeecC----Ccc--cccCCCEEEeecCcccc
Q 038422 143 -EGMTSLKKLYMANNRLTG----TIPSSLVQLPKLMELRLEANKFQGQV----PEI--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 143 -~~~~~L~~l~l~~N~l~g----~ip~~~~~l~~L~~L~l~~N~~~g~i----p~~--~~~~l~~l~l~~N~l~g 206 (634)
...++|+.|+|++|.++. .++..+..+++|++|+|++|+|+..- +.. ...+|+.|+|++|.++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 356899999999999975 35566678899999999999997532 222 23589999999999975
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.60 E-value=6.3e-09 Score=116.06 Aligned_cols=133 Identities=11% Similarity=0.059 Sum_probs=80.1
Q ss_pred cEEEEEecCCCCccccChhhhcC-CCCcCEEecc----CCcCcccC-----C-CCCCCCCCcEEEccCC--cCccccChh
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGL-LSSLRAVSFM----NNKFEGPL-----P-DLRKMGPLKSIYLSDN--GFSGNISDD 140 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~-l~~L~~L~l~----~n~l~g~~-----p-~~~~l~~L~~L~ls~N--~~~g~ip~~ 140 (634)
++..|+|..+++++..+. .++. +++|+.|+|+ .|.+++.+ + -+.++++|+.|+|+++ .+++..+..
T Consensus 379 ~L~~L~l~~~~l~~~~~~-~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TCSEEEEEESCCCHHHHH-HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred cCeEEEeecCCccHHHHH-HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 455556655666554432 3333 6666677664 55555532 1 1345667777777632 356555444
Q ss_pred hhhCCCCCCeEEcccCcCcc-CCCccccCCCCccEEeCCCCceeec-CCcc--cccCCCEEEeecCccccc
Q 038422 141 AFEGMTSLKKLYMANNRLTG-TIPSSLVQLPKLMELRLEANKFQGQ-VPEI--KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g-~ip~~~~~l~~L~~L~l~~N~~~g~-ip~~--~~~~l~~l~l~~N~l~g~ 207 (634)
....+++|++|+|++|++++ .+|..+..+++|+.|+|++|.|++. ++.. ..++|+.|++++|++++.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 33447777777777777775 3455556777777777777777654 3332 345777777777777654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1e-08 Score=101.46 Aligned_cols=100 Identities=23% Similarity=0.291 Sum_probs=69.5
Q ss_pred ccccChhhhcCCCCcCE--EeccCCc---CcccCCC-CCCCCCCcEEEccCCcCcc--ccChhhhhCCCCCCeEEcccCc
Q 038422 86 SGTIAAESLGLLSSLRA--VSFMNNK---FEGPLPD-LRKMGPLKSIYLSDNGFSG--NISDDAFEGMTSLKKLYMANNR 157 (634)
Q Consensus 86 ~g~~~~~~l~~l~~L~~--L~l~~n~---l~g~~p~-~~~l~~L~~L~ls~N~~~g--~ip~~~~~~~~~L~~l~l~~N~ 157 (634)
++.+..+.+...+.|.. ++++.|. +.+.++. ..++++|+.|+|++|++++ .+|. .+..+++|+.|+|++|+
T Consensus 129 ~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~-~~~~l~~L~~L~Ls~N~ 207 (267)
T 3rw6_A 129 QQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSS-IVQKAPNLKILNLSGNE 207 (267)
T ss_dssp TTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTT-HHHHSTTCCEEECTTSC
T ss_pred ccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchh-HHhhCCCCCEEECCCCc
Confidence 33343333555555655 6677773 2332221 2467889999999999987 5554 37789999999999999
Q ss_pred CccCCCccccCCC--CccEEeCCCCceeecCCc
Q 038422 158 LTGTIPSSLVQLP--KLMELRLEANKFQGQVPE 188 (634)
Q Consensus 158 l~g~ip~~~~~l~--~L~~L~l~~N~~~g~ip~ 188 (634)
|++. ..+..+. +|++|+|++|.+++.+|.
T Consensus 208 i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 208 LKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp CCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred cCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 9875 4455555 899999999999988874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.36 E-value=1.4e-06 Score=89.60 Aligned_cols=83 Identities=19% Similarity=0.206 Sum_probs=50.9
Q ss_pred CCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCcc-EEeCCCCceeecCCc-c--cccCCC
Q 038422 120 MGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLM-ELRLEANKFQGQVPE-I--KQNEMR 195 (634)
Q Consensus 120 l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~-~L~l~~N~~~g~ip~-~--~~~~l~ 195 (634)
+++|+.|+|++|+++ .||+.+|.+|++|+.|+|.+| ++..-+..|.+|++|+ .++|.+ +++ .|+. . ...+|+
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCC
Confidence 556777777776666 566666777777777777766 5532234566677776 777765 444 2332 2 234677
Q ss_pred EEEeecCcccc
Q 038422 196 SLGLANNELEG 206 (634)
Q Consensus 196 ~l~l~~N~l~g 206 (634)
.+++++|+++.
T Consensus 301 ~l~l~~n~i~~ 311 (329)
T 3sb4_A 301 YVLATGDKITT 311 (329)
T ss_dssp EEEECSSCCCE
T ss_pred EEEeCCCccCc
Confidence 77776666653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3e-06 Score=86.12 Aligned_cols=136 Identities=17% Similarity=0.128 Sum_probs=91.3
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCC---ccccceeEEE-eCCceEEEEEcCCCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHP---NLLPLTAFYY-RKEEKLLLYEFVENG 436 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~~g 436 (634)
+.++.|....||+. +..+++|+-.. ......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 56678887432 22346789999999998753 2455666664 345678999999998
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL---------------------------------------- 476 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 476 (634)
.+.+.... .++..++..++.++++.|..||+..
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 87653211 1344445555555555555555421
Q ss_pred ----------------CCCCccccCCCCCCEEeCC---CCC-eEEeccccCCc
Q 038422 477 ----------------PGSIIPHGHLKSSNVLLDR---SFE-PLLTDYALRPL 509 (634)
Q Consensus 477 ----------------~~~~ivHrdlk~~NILl~~---~~~-~kl~DfGla~~ 509 (634)
.+..++|+|+++.||+++. ++. ..|.||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 344 57999987654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.24 E-value=2.4e-07 Score=86.92 Aligned_cols=112 Identities=17% Similarity=0.243 Sum_probs=83.5
Q ss_pred hhcCCCCcCEEeccCC-cCccc----C-CCCCCCCCCcEEEccCCcCccc----cChhhhhCCCCCCeEEcccCcCccC-
Q 038422 93 SLGLLSSLRAVSFMNN-KFEGP----L-PDLRKMGPLKSIYLSDNGFSGN----ISDDAFEGMTSLKKLYMANNRLTGT- 161 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n-~l~g~----~-p~~~~l~~L~~L~ls~N~~~g~----ip~~~~~~~~~L~~l~l~~N~l~g~- 161 (634)
.+...++|++|+|++| .+... + ..+...+.|++|+|++|++... | .+.+...++|++|+|++|+++..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l-~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFAL-AEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHH-HHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHH-HHHHHhCCCcCEEECcCCcCCHHH
Confidence 4667888999999998 87642 1 1356678899999999998742 2 12356678899999999998853
Q ss_pred ---CCccccCCCCccEEeC--CCCceeecCC----cc--cccCCCEEEeecCccc
Q 038422 162 ---IPSSLVQLPKLMELRL--EANKFQGQVP----EI--KQNEMRSLGLANNELE 205 (634)
Q Consensus 162 ---ip~~~~~l~~L~~L~l--~~N~~~g~ip----~~--~~~~l~~l~l~~N~l~ 205 (634)
+...+...++|++|+| ++|.++..-- .. ...+|+.|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566777889999999 8898875422 11 2358999999999885
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.5e-07 Score=104.77 Aligned_cols=107 Identities=11% Similarity=0.120 Sum_probs=48.1
Q ss_pred CCCcCEEeccCCcCcccCC-CCC-CCCCCcEEEcc--C----CcCcc-----ccChhhhhCCCCCCeEEcccCcCccCCC
Q 038422 97 LSSLRAVSFMNNKFEGPLP-DLR-KMGPLKSIYLS--D----NGFSG-----NISDDAFEGMTSLKKLYMANNRLTGTIP 163 (634)
Q Consensus 97 l~~L~~L~l~~n~l~g~~p-~~~-~l~~L~~L~ls--~----N~~~g-----~ip~~~~~~~~~L~~l~l~~N~l~g~ip 163 (634)
+++|++|+++.|++++..+ .+. ++++|+.|+|+ + |++++ .++ ..+.++++|+.|+|++ .+++..+
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~-~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFG-AIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHH-HHHHHCTTCCEEECCS-SCCHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHH-HHHhhCCCccEEeecC-cccHHHH
Confidence 4555555555555554322 222 34555555555 2 33331 011 1134455555555544 4444333
Q ss_pred ccccC-CCCccEEeCCCCceeecCCcc---cccCCCEEEeecCccc
Q 038422 164 SSLVQ-LPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANNELE 205 (634)
Q Consensus 164 ~~~~~-l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l~ 205 (634)
..++. +++|+.|+|++|.+++..+.. ..++|+.|++++|.++
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 33433 455555555555554432221 1335555555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.7e-07 Score=100.80 Aligned_cols=104 Identities=11% Similarity=0.123 Sum_probs=75.0
Q ss_pred cEEEEEecCCC-CccccChhhhcCCCCcCEEeccCCcCccc----CCC-CCCCCCCcEEEccCCcCc----cccChhhhh
Q 038422 74 SVWGLKLEQMN-LSGTIAAESLGLLSSLRAVSFMNNKFEGP----LPD-LRKMGPLKSIYLSDNGFS----GNISDDAFE 143 (634)
Q Consensus 74 ~v~~l~L~~~~-l~g~~~~~~l~~l~~L~~L~l~~n~l~g~----~p~-~~~l~~L~~L~ls~N~~~----g~ip~~~~~ 143 (634)
++..|+|+++. ++..-.......+++|++|+|++|.+++. ++. +.++++|++|+|++|.++ +.++ ..+.
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~-~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLE-TIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHH-HHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHH-HHHh
Confidence 38889998876 22111112334788999999999988765 332 356788999999999987 3343 2367
Q ss_pred CCCCCCeEEcccCcCccCCCccccCCCCccEEeCCC
Q 038422 144 GMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179 (634)
Q Consensus 144 ~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~ 179 (634)
++++|+.|+|++|.+++ +|..+.++++|+.|+++.
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 78999999999998886 677777888888888875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=5e-06 Score=82.60 Aligned_cols=135 Identities=19% Similarity=0.212 Sum_probs=93.3
Q ss_pred ccCccCce-eEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 362 VLGSGTFG-ASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 362 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68987754 4567888875432 3457888999988774 22356788999999999999999999887
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE------------------------------------------- 475 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 475 (634)
.+...... .....++.+++..|.-||..
T Consensus 108 ~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 76543211 12234555666666666642
Q ss_pred --------C---CCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 476 --------L---PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 476 --------~---~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
. .+..++|+|+.+.||+++++..+-|.||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0 12237899999999999988777799998763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.8e-07 Score=101.58 Aligned_cols=118 Identities=17% Similarity=0.184 Sum_probs=72.9
Q ss_pred cCCCCcCEEeccCCcCcccCC-CCC-CCCCCcEEEccCC-cCccccChhhhhCCCCCCeEEcccCcCccCCCcccc----
Q 038422 95 GLLSSLRAVSFMNNKFEGPLP-DLR-KMGPLKSIYLSDN-GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLV---- 167 (634)
Q Consensus 95 ~~l~~L~~L~l~~n~l~g~~p-~~~-~l~~L~~L~ls~N-~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~---- 167 (634)
..+++|++|+|++|.+++..+ .+. ++++|++|+|++| .++....+..+.++++|++|+|++|.+++..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 356778888888877776544 333 5677888888777 454332233345677888888888877765444433
Q ss_pred CCCCccEEeCCCCceeecCCc-----c--cccCCCEEEeecC-cccccCCccccCC
Q 038422 168 QLPKLMELRLEANKFQGQVPE-----I--KQNEMRSLGLANN-ELEGPIPESLSKM 215 (634)
Q Consensus 168 ~l~~L~~L~l~~N~~~g~ip~-----~--~~~~l~~l~l~~N-~l~g~ip~~~~~~ 215 (634)
.+++|+.|+|++|. +.++. . ..++|+.|++++| .+++ +|..+.++
T Consensus 182 ~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~ 234 (594)
T 2p1m_B 182 TYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRA 234 (594)
T ss_dssp TCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHC
T ss_pred cCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcC
Confidence 55678888887776 22322 1 2357788888777 3443 55544433
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=3.1e-06 Score=87.92 Aligned_cols=79 Identities=8% Similarity=0.017 Sum_probs=54.7
Q ss_pred ccc-CccCceeEEEEEEc-------CCcEEEEEEecccC---ccChhHHHHHHHHHhcCCC---CccccceeEEEeC---
Q 038422 361 EVL-GSGTFGASYKTVIS-------NGQAYVVKRYKQMN---NVGREDFQEHIKRLGRLEH---PNLLPLTAFYYRK--- 423 (634)
Q Consensus 361 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~--- 423 (634)
+.| +.|....+|+.... ++..+++|...... ......+.+|+++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988764 26678888765432 1123567888888887742 2466777777554
Q ss_pred CceEEEEEcCCCCChh
Q 038422 424 EEKLLLYEFVENGSLA 439 (634)
Q Consensus 424 ~~~~lv~e~~~~gsL~ 439 (634)
+..++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.98 E-value=1.6e-05 Score=81.45 Aligned_cols=100 Identities=13% Similarity=0.090 Sum_probs=83.0
Q ss_pred CCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCC-eEEcccCcCccCCCccccCCCCccE
Q 038422 97 LSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLK-KLYMANNRLTGTIPSSLVQLPKLME 174 (634)
Q Consensus 97 l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~-~l~l~~N~l~g~ip~~~~~l~~L~~ 174 (634)
+++|+.|+|++|+++...+ .|.+|++|+.|+|++| +. .|++.+|.+|++|+ .|+|.+ +++..-+..|.+|++|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 7899999999999886544 5999999999999998 66 69999999999999 999998 777444688999999999
Q ss_pred EeCCCCceeecCCccc--ccCCCEEEe
Q 038422 175 LRLEANKFQGQVPEIK--QNEMRSLGL 199 (634)
Q Consensus 175 L~l~~N~~~g~ip~~~--~~~l~~l~l 199 (634)
|+|+.|+++.--+..+ ..+|+.++.
T Consensus 302 l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 302 VLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEeCCCccCccchhhhcCCcchhhhcc
Confidence 9999999985444332 347877753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.94 E-value=1.3e-06 Score=81.80 Aligned_cols=111 Identities=22% Similarity=0.293 Sum_probs=84.7
Q ss_pred CCcEEEEEecCC-CCccccC---hhhhcCCCCcCEEeccCCcCccc----CC-CCCCCCCCcEEEccCCcCccc----cC
Q 038422 72 NGSVWGLKLEQM-NLSGTIA---AESLGLLSSLRAVSFMNNKFEGP----LP-DLRKMGPLKSIYLSDNGFSGN----IS 138 (634)
Q Consensus 72 ~~~v~~l~L~~~-~l~g~~~---~~~l~~l~~L~~L~l~~n~l~g~----~p-~~~~l~~L~~L~ls~N~~~g~----ip 138 (634)
...+..|+|++| ++...-. ...+...++|++|+|++|.+... +. .+...+.|++|+|++|.++.. |.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 457899999998 8864311 23566788999999999999642 21 245667899999999999853 22
Q ss_pred hhhhhCCCCCCeEEc--ccCcCccC----CCccccCCCCccEEeCCCCcee
Q 038422 139 DDAFEGMTSLKKLYM--ANNRLTGT----IPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 139 ~~~~~~~~~L~~l~l--~~N~l~g~----ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
+.+...++|++|+| ++|.++.. +-..+...++|++|+|++|.+.
T Consensus 115 -~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 -EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp -HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred -HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 34677889999999 88999854 3445566789999999999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00011 Score=75.40 Aligned_cols=143 Identities=15% Similarity=0.221 Sum_probs=80.2
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcC-----CCCccccce-e--EEEeCCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-----EHPNLLPLT-A--FYYRKEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g--~~~~~~~~~lv~e~ 432 (634)
+.|+.|..+.||+....+| .+++|+... ..+.+..|.++++.+ ..|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999887655 488888764 223444555555444 234444311 1 12346678999999
Q ss_pred CCCCChh--------------hHHhhccCCC--C-------CCCCHHHHH------------------------------
Q 038422 433 VENGSLA--------------GKLHANHTKQ--R-------PGLDWQTRL------------------------------ 459 (634)
Q Consensus 433 ~~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~~------------------------------ 459 (634)
++|..+. ..++...... . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122211100 0 012343211
Q ss_pred -HHHHHHHHHHHHHHh--------c-CCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 460 -KIIKGVVKGMAYLHN--------E-LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 460 -~i~~~ia~gL~yLH~--------~-~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
.+...+..++++|+. . ..+..++|+|+++.||+++.+..+.|.||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446677763 1 013369999999999999888889999998653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=8.9e-05 Score=78.05 Aligned_cols=74 Identities=14% Similarity=0.154 Sum_probs=49.5
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC-------ccChhHHHHHHHHHhcCCC--Cccc-cceeEEEeCCceEEE
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-------NVGREDFQEHIKRLGRLEH--PNLL-PLTAFYYRKEEKLLL 429 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~lv 429 (634)
+.||.|.++.||++... +++.+++|...... ....+.+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 46789999764321 1234567788888887742 3444 44433 45667899
Q ss_pred EEcCCCC
Q 038422 430 YEFVENG 436 (634)
Q Consensus 430 ~e~~~~g 436 (634)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=2.8e-05 Score=80.66 Aligned_cols=131 Identities=14% Similarity=0.177 Sum_probs=87.7
Q ss_pred CcEEEEEecCCCCc---------cccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhh
Q 038422 73 GSVWGLKLEQMNLS---------GTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFE 143 (634)
Q Consensus 73 ~~v~~l~L~~~~l~---------g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~ 143 (634)
.++..|.+...... +.+. ..+..+++|+.|+|++|.-. .+|.+. +++|+.|+|..++++..... .+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~-~ll~~~P~L~~L~L~g~~~l-~l~~~~-~~~L~~L~L~~~~l~~~~l~-~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLS-PVLDAMPLLNNLKIKGTNNL-SIGKKP-RPNLKSLEIISGGLPDSVVE-DIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCH-HHHHTCTTCCEEEEECCBTC-BCCSCB-CTTCSEEEEECSBCCHHHHH-HHH
T ss_pred chhhheeecCcchhhcccccccccCHH-HHHhcCCCCcEEEEeCCCCc-eecccc-CCCCcEEEEecCCCChHHHH-HHH
Confidence 46777877654331 2232 35677899999999987311 344443 78999999999887654322 243
Q ss_pred --CCCCCCeEEccc--CcCccC-----CCccc--cCCCCccEEeCCCCceeecCCcc-----cccCCCEEEeecCccccc
Q 038422 144 --GMTSLKKLYMAN--NRLTGT-----IPSSL--VQLPKLMELRLEANKFQGQVPEI-----KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 144 --~~~~L~~l~l~~--N~l~g~-----ip~~~--~~l~~L~~L~l~~N~~~g~ip~~-----~~~~l~~l~l~~N~l~g~ 207 (634)
.+++|+.|+|+. |...|. +-..+ ..+++|++|+|++|.++...+.. ..++|+.|+|++|.+++.
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 789999999864 332222 11122 35789999999999988654432 345899999999999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00017 Score=72.21 Aligned_cols=74 Identities=15% Similarity=0.200 Sum_probs=54.8
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCC---ccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHP---NLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.+|.|..+.||+....+|+.+++|+...........|..|++.|+.+.-. -+.+++++ +..++||||+..+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 458999999999999999999999987654444456789999998877422 23344443 23578999998765
Q ss_pred h
Q 038422 438 L 438 (634)
Q Consensus 438 L 438 (634)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=8.6e-06 Score=84.55 Aligned_cols=130 Identities=15% Similarity=0.248 Sum_probs=89.5
Q ss_pred CcEEEEEecCCC-CccccChhhhcCCCCcCEEeccCCcCcccCC-CC--CCCCCCcEEEccC--CcCccccCh----hhh
Q 038422 73 GSVWGLKLEQMN-LSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DL--RKMGPLKSIYLSD--NGFSGNISD----DAF 142 (634)
Q Consensus 73 ~~v~~l~L~~~~-l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~--~~l~~L~~L~ls~--N~~~g~ip~----~~~ 142 (634)
.++..|+|.++. + .+++ + .+++|+.|+|..|.++...- .+ ..+++|++|+|+. |...|.... ..+
T Consensus 172 P~L~~L~L~g~~~l--~l~~--~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK--K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS--C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCc--eecc--c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 578899998762 2 2332 3 37899999999887754321 23 3788999999863 332222100 112
Q ss_pred --hCCCCCCeEEcccCcCccCCCcccc---CCCCccEEeCCCCceeec----CCcc--cccCCCEEEeecCccccc
Q 038422 143 --EGMTSLKKLYMANNRLTGTIPSSLV---QLPKLMELRLEANKFQGQ----VPEI--KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 143 --~~~~~L~~l~l~~N~l~g~ip~~~~---~l~~L~~L~l~~N~~~g~----ip~~--~~~~l~~l~l~~N~l~g~ 207 (634)
..+++|++|+|.+|.+++..+..+. .+++|++|+|+.|.+++. ++.. ..++|+.|++++|.++..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 3578999999999999865544443 478999999999999874 3322 346899999999988754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0003 Score=71.22 Aligned_cols=140 Identities=20% Similarity=0.168 Sum_probs=90.6
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCC---CCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE---HPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4588999999999876 4677888876532 3567889998888873 3567788888887888999999999876
Q ss_pred hh--------h---HHhhccC-CC----------------CCCCCHHHHH---HHH--HH--------------HHHH-H
Q 038422 438 LA--------G---KLHANHT-KQ----------------RPGLDWQTRL---KII--KG--------------VVKG-M 469 (634)
Q Consensus 438 L~--------~---~l~~~~~-~~----------------~~~l~~~~~~---~i~--~~--------------ia~g-L 469 (634)
+. + .|+.... .. .-.-+|.+.. ++. .+ +... .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 52 1 2232211 00 0012465321 111 11 1111 1
Q ss_pred HHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccc
Q 038422 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505 (634)
Q Consensus 470 ~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 505 (634)
..|.....++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2343222344799999999999999887 8888873
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00051 Score=72.27 Aligned_cols=126 Identities=15% Similarity=0.160 Sum_probs=86.5
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCc----cccChhhhhCCCCC
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFS----GNISDDAFEGMTSL 148 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~----g~ip~~~~~~~~~L 148 (634)
.+..|+|+.+ +. .|....+.+ .+|+.+.|. |+++..-+ .|.+|++|+.++|.+|.+. ..|+..+|.+|++|
T Consensus 227 ~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 227 QLKTIEIPEN-VS-TIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TCCCEECCTT-CC-EECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCEEecCCC-cc-Ccccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 4566666653 32 444445555 788888884 44443323 5888999999999888775 24777788999999
Q ss_pred CeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccc
Q 038422 149 KKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 149 ~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g 206 (634)
+.++|. |+++-.-...|.+|++|+.++|.+| ++ .|+.. ...+|+.+++.+|.+.-
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTTPPQ 359 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSSCCCEEEECCSSCCB
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCCCcc
Confidence 999998 4466333467888899999999655 44 34432 22389999999887653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0008 Score=71.30 Aligned_cols=74 Identities=12% Similarity=0.087 Sum_probs=48.3
Q ss_pred CCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCCcc-----ccccccCcccccCC---CCCcchhHHHHHHHHHHHH
Q 038422 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHT-----LMVAYKSPEYAHNG---KISKKSDVWSLGILILELL 550 (634)
Q Consensus 479 ~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-----~~~~y~aPE~~~~~---~~~~k~DVwSfGvvl~ell 550 (634)
..++|+|+++.|||++++. ++|.||+.+.......... ....|.+|+..... .-....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3689999999999998876 9999999876533211100 11246676655321 1122355668888888888
Q ss_pred hCC
Q 038422 551 TGK 553 (634)
Q Consensus 551 tg~ 553 (634)
+++
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0015 Score=68.71 Aligned_cols=123 Identities=19% Similarity=0.271 Sum_probs=90.3
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+..+.|..+ +. .|+...+.++++|+.++|..| ++..-. .|.+ .+|+.+.|. |+++ .|+..+|.+|++|+.++
T Consensus 204 ~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~-~I~~~aF~~c~~L~~l~ 277 (401)
T 4fdw_A 204 GIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVT-NIASRAFYYCPELAEVT 277 (401)
T ss_dssp CCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCC-EECTTTTTTCTTCCEEE
T ss_pred ccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCcc-EEChhHhhCCCCCCEEE
Confidence 4667777643 43 566667889999999999875 332222 3555 789999994 5565 68888899999999999
Q ss_pred cccCcCcc----CC-CccccCCCCccEEeCCCCceeecCCcc---cccCCCEEEeecCccc
Q 038422 153 MANNRLTG----TI-PSSLVQLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANNELE 205 (634)
Q Consensus 153 l~~N~l~g----~i-p~~~~~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l~ 205 (634)
|.+|.+.. .| +..|.+|++|+.++|.+ +++ .|+.. ...+|+.+++..| ++
T Consensus 278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp EESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT-CC
T ss_pred eCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc-cc
Confidence 99998761 23 46789999999999984 455 45543 2368999999655 44
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0048 Score=62.67 Aligned_cols=144 Identities=16% Similarity=0.186 Sum_probs=81.7
Q ss_pred ccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCC--ccccceeE-----EEeCCceEEEEEcCC
Q 038422 362 VLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHP--NLLPLTAF-----YYRKEEKLLLYEFVE 434 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~~~ 434 (634)
.++ |....||+....+|+.+++|..... ....+.+..|..++..+... .+.+++.. ....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 7777999887777778999987632 12456777888887766321 23444432 223456688999998
Q ss_pred CCChh-----h---------HHhhccC----CCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhcC-
Q 038422 435 NGSLA-----G---------KLHANHT----KQRPGLDWQTR----LKI---------------IKGVVKGMAYLHNEL- 476 (634)
Q Consensus 435 ~gsL~-----~---------~l~~~~~----~~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~~- 476 (634)
|..+. . .++.... .....+++... ..+ ...+...++.+....
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 0 1121111 01112333221 001 111112233333221
Q ss_pred --CCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 477 --PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 477 --~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
.+..++|+|+++.||+++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 889999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0033 Score=63.68 Aligned_cols=144 Identities=13% Similarity=0.147 Sum_probs=79.7
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCc--ccccee------EEEeCCceEEEEEc
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPN--LLPLTA------FYYRKEEKLLLYEF 432 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lv~e~ 432 (634)
+.|+.|....+|+....+| .+++|..... ...+.+..|++++..+.... +.+++. +....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788889999887665 5778877642 23345667777776663211 222321 11234567899999
Q ss_pred CCCCChhh--------------HHhhccCC-CCC---C---CCHHHHHH------------HHHHHHHHHHHHHhcC---
Q 038422 433 VENGSLAG--------------KLHANHTK-QRP---G---LDWQTRLK------------IIKGVVKGMAYLHNEL--- 476 (634)
Q Consensus 433 ~~~gsL~~--------------~l~~~~~~-~~~---~---l~~~~~~~------------i~~~ia~gL~yLH~~~--- 476 (634)
++|..+.. .++..... ... . ..|..... +...+...+++++...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 12221110 000 0 12433111 0112445566665432
Q ss_pred CCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 477 ~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
.+..++|+|+.+.|||++++....|.||+.+
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 2346899999999999998766689999865
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0012 Score=57.54 Aligned_cols=35 Identities=34% Similarity=0.438 Sum_probs=15.4
Q ss_pred CCeEEcccCcCccCCCccccCCCCccEEeCCCCce
Q 038422 148 LKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182 (634)
Q Consensus 148 L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~ 182 (634)
|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444422222334444455555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0014 Score=56.96 Aligned_cols=56 Identities=13% Similarity=0.249 Sum_probs=42.6
Q ss_pred CEEeccCCcCc-ccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCc
Q 038422 101 RAVSFMNNKFE-GPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLT 159 (634)
Q Consensus 101 ~~L~l~~n~l~-g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~ 159 (634)
..++.++++|+ ..+| .+. .+|++|+|++|+|+ .||++.|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 36788888887 3445 332 36888888888888 578877888888888888888765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0015 Score=69.39 Aligned_cols=72 Identities=13% Similarity=0.123 Sum_probs=48.1
Q ss_pred cccCccCceeEEEEEEcC--------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-ccceeEEEeCCceEEEEE
Q 038422 361 EVLGSGTFGASYKTVISN--------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-LPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 431 (634)
+.|+.|....+|+....+ +..+++|+.... ...+.+..|..+++.+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 457788888999998753 468888887431 122566689988887753344 45666542 2 38999
Q ss_pred cCCCCCh
Q 038422 432 FVENGSL 438 (634)
Q Consensus 432 ~~~~gsL 438 (634)
|+++.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0085 Score=61.00 Aligned_cols=143 Identities=15% Similarity=0.075 Sum_probs=71.0
Q ss_pred ccCccCcee-EEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCC--CccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 362 VLGSGTFGA-SYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEH--PNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 362 ~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.|+.|.... +|+....++..+++|...... .+++..|+++++.+.. -.+.+++.+. .+.-++|||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcch
Confidence 355554443 667665446677777543321 1344556666665532 2344566553 2333789999987666
Q ss_pred hhHHhhcc------------------C---CCCCCCCHHHHH-------H-H------------HHHHHHHHHHHHh--c
Q 038422 439 AGKLHANH------------------T---KQRPGLDWQTRL-------K-I------------IKGVVKGMAYLHN--E 475 (634)
Q Consensus 439 ~~~l~~~~------------------~---~~~~~l~~~~~~-------~-i------------~~~ia~gL~yLH~--~ 475 (634)
.+++.... . ...+.++..... . + ...+...++.+.. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54432211 0 001112211100 0 0 0111122233321 1
Q ss_pred CCCCCccccCCCCCCEEeCCC----CCeEEeccccCCc
Q 038422 476 LPGSIIPHGHLKSSNVLLDRS----FEPLLTDYALRPL 509 (634)
Q Consensus 476 ~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~ 509 (634)
..+..++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123468999999999999875 6789999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0053 Score=61.61 Aligned_cols=70 Identities=1% Similarity=-0.018 Sum_probs=42.1
Q ss_pred cccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-ccceeEEEeCCceEEEEEcC-CCCCh
Q 038422 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-LPLTAFYYRKEEKLLLYEFV-ENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~gsL 438 (634)
+.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 46888999999998 55778876543211 1123467777766643233 344443 444567899999 55444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0074 Score=62.68 Aligned_cols=142 Identities=14% Similarity=0.198 Sum_probs=81.3
Q ss_pred ccCccCceeEEEEEEcC--------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-ccceeEEEeCCceEEEEEc
Q 038422 362 VLGSGTFGASYKTVISN--------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-LPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~ 432 (634)
.|..|-...+|+....+ ++.+++|+.... .....++.+|.++++.+.--.+ .++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45667777889988642 467888875332 2345677789998887742223 456665532 399999
Q ss_pred CCCCChhh--------------H---HhhccCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHHH-
Q 038422 433 VENGSLAG--------------K---LHANHTKQRPGL--DWQTRLKIIKGVVK-------------------GMAYLH- 473 (634)
Q Consensus 433 ~~~gsL~~--------------~---l~~~~~~~~~~l--~~~~~~~i~~~ia~-------------------gL~yLH- 473 (634)
++|..|.. . |+.......... -|.++.++..++.. .++.|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99855431 1 111111111112 24555555544322 233333
Q ss_pred ---hcCCCCCccccCCCCCCEEeCCC----CCeEEeccccCC
Q 038422 474 ---NELPGSIIPHGHLKSSNVLLDRS----FEPLLTDYALRP 508 (634)
Q Consensus 474 ---~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~ 508 (634)
....+..++|+|+.+.||+++.+ ..+.+.||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22233468999999999999876 688999997653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00059 Score=62.51 Aligned_cols=81 Identities=11% Similarity=0.113 Sum_probs=41.3
Q ss_pred CcCEEeccCCcCcc-cCCCCCCCCCCcEEEccCCc-CccccChhhhhCC----CCCCeEEcccCc-CccCCCccccCCCC
Q 038422 99 SLRAVSFMNNKFEG-PLPDLRKMGPLKSIYLSDNG-FSGNISDDAFEGM----TSLKKLYMANNR-LTGTIPSSLVQLPK 171 (634)
Q Consensus 99 ~L~~L~l~~n~l~g-~~p~~~~l~~L~~L~ls~N~-~~g~ip~~~~~~~----~~L~~l~l~~N~-l~g~ip~~~~~l~~ 171 (634)
+|++|||+++.++. .+..+.++++|+.|+|+++. ++..-- ..++.+ ++|++|+|+++. +|..==..+.++++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL-~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCL-ERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHH-HHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHH-HHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 45555555555432 12334556666666666653 443211 124443 356777776653 54321123556666
Q ss_pred ccEEeCCCC
Q 038422 172 LMELRLEAN 180 (634)
Q Consensus 172 L~~L~l~~N 180 (634)
|+.|+|++.
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 776666654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.005 Score=63.83 Aligned_cols=73 Identities=8% Similarity=0.079 Sum_probs=42.2
Q ss_pred cccCccCceeEEEEEEcC---------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-ccceeEEEeCCceEEEE
Q 038422 361 EVLGSGTFGASYKTVISN---------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-LPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 430 (634)
+.++.|....+|+....+ +..+++|+....... ..+...|.++++.+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 357778888999988654 267888876542211 1124577777777643333 3555543 2 37899
Q ss_pred EcCCCCCh
Q 038422 431 EFVENGSL 438 (634)
Q Consensus 431 e~~~~gsL 438 (634)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.21 E-value=0.002 Score=60.10 Aligned_cols=111 Identities=16% Similarity=0.204 Sum_probs=69.2
Q ss_pred hcCCCCcCEEeccCC-cCccc----CC-CCCCCCCCcEEEccCCcCccc----cChhhhhCCCCCCeEEcccCcCccC--
Q 038422 94 LGLLSSLRAVSFMNN-KFEGP----LP-DLRKMGPLKSIYLSDNGFSGN----ISDDAFEGMTSLKKLYMANNRLTGT-- 161 (634)
Q Consensus 94 l~~l~~L~~L~l~~n-~l~g~----~p-~~~~l~~L~~L~ls~N~~~g~----ip~~~~~~~~~L~~l~l~~N~l~g~-- 161 (634)
+.+-+.|++|+|++| .+... +- .+..-+.|+.|+|++|++... | .+++..-+.|+.|+|++|+++..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~al-A~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGL-IELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTH-HHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHH-HHHHhcCCccCeEecCCCcCCHHHH
Confidence 445678889999875 65421 11 245567889999999988732 2 22355567899999999988742
Q ss_pred --CCccccCCCCccEEeCCCC---ceeec----CCcc--cccCCCEEEeecCccc
Q 038422 162 --IPSSLVQLPKLMELRLEAN---KFQGQ----VPEI--KQNEMRSLGLANNELE 205 (634)
Q Consensus 162 --ip~~~~~l~~L~~L~l~~N---~~~g~----ip~~--~~~~l~~l~l~~N~l~ 205 (634)
|-..+..-+.|+.|+|++| .+... |-+. ..++|+.|+++.|...
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2223444467888888765 22221 1111 2347888888776543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.044 Score=58.41 Aligned_cols=73 Identities=15% Similarity=0.194 Sum_probs=46.1
Q ss_pred cccCccCceeEEEEEEcC-CcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-ccceeEEEeCCceEEEEEcCCCCCh
Q 038422 361 EVLGSGTFGASYKTVISN-GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-LPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
+.|+.|-...+|+....+ +..+++|+....... .-+..+|..+++.+...++ .++++++ .+ .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457788888999998765 477888876432211 1122578888888865555 4566665 22 359999987444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.98 E-value=0.093 Score=49.28 Aligned_cols=104 Identities=13% Similarity=0.018 Sum_probs=66.8
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 515 (634)
-+|.+.|..... ++++.+++.++.|.+.+|.-+-....+ ..+=+-|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc-------
Confidence 378899876543 599999999999999998776221101 1222346889999999887764 1110
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCc
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPE 556 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~ 556 (634)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1122467888764 34567889999999999999855553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.039 Score=57.50 Aligned_cols=109 Identities=13% Similarity=0.255 Sum_probs=71.8
Q ss_pred hhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCC
Q 038422 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPK 171 (634)
Q Consensus 92 ~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~ 171 (634)
..+...+.|+.+.+..+..+=.--.+.++..|+.+.+. +.+. .|+..+|.+|++|+.++|..| ++---..+|.+|++
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~ 335 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ 335 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred ceeeecccccEEecccccceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence 35666778888888655432111247778888888886 4444 577777888888888888754 44222356778888
Q ss_pred ccEEeCCCCceeecCCcc---cccCCCEEEeecCccc
Q 038422 172 LMELRLEANKFQGQVPEI---KQNEMRSLGLANNELE 205 (634)
Q Consensus 172 L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N~l~ 205 (634)
|+.+.|..| ++ .|... ...+|+.+++.+|...
T Consensus 336 L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 336 LERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp CCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence 888888654 43 45543 2357888888777543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.51 E-value=0.0057 Score=56.99 Aligned_cols=112 Identities=11% Similarity=0.111 Sum_probs=76.3
Q ss_pred CCcEEEEEecCC-CCcccc---ChhhhcCCCCcCEEeccCCcCcc--cCC---CCCCCCCCcEEEccCCcCccccC---h
Q 038422 72 NGSVWGLKLEQM-NLSGTI---AAESLGLLSSLRAVSFMNNKFEG--PLP---DLRKMGPLKSIYLSDNGFSGNIS---D 139 (634)
Q Consensus 72 ~~~v~~l~L~~~-~l~g~~---~~~~l~~l~~L~~L~l~~n~l~g--~~p---~~~~l~~L~~L~ls~N~~~g~ip---~ 139 (634)
+..++.|+|+++ ++...- -.+.|..-++|+.|+|++|.+.. ... .+..-+.|+.|+|++|+++..-- .
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 567889999885 664321 12356667899999999999974 222 24455789999999999985311 1
Q ss_pred hhhhCCCCCCeEEcccCc---CccC----CCccccCCCCccEEeCCCCcee
Q 038422 140 DAFEGMTSLKKLYMANNR---LTGT----IPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 140 ~~~~~~~~L~~l~l~~N~---l~g~----ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
+++..-+.|+.|+|++|. +... |-..+..=++|..|+|+.|...
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 235556779999999763 3321 2334445578999999988653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.48 E-value=0.098 Score=53.30 Aligned_cols=31 Identities=19% Similarity=0.308 Sum_probs=26.7
Q ss_pred CCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 479 ~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999976543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.26 E-value=0.0073 Score=55.20 Aligned_cols=85 Identities=11% Similarity=0.143 Sum_probs=62.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCc-Cccc-CCCCCCC----CCCcEEEccCCc-CccccChhhhhCC
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNK-FEGP-LPDLRKM----GPLKSIYLSDNG-FSGNISDDAFEGM 145 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~-l~g~-~p~~~~l----~~L~~L~ls~N~-~~g~ip~~~~~~~ 145 (634)
-.+..|||+++.++-.-- ..+..+++|+.|+|+++. ++.. +-.+..+ ++|++|+|+++. ++..-- ..+..+
T Consensus 61 ~~L~~LDLs~~~Itd~GL-~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl-~~L~~~ 138 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGF-DHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI-IALHHF 138 (176)
T ss_dssp CCEEEEEEESCCCCGGGG-GGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH-HHGGGC
T ss_pred ceEeEEeCcCCCccHHHH-HHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH-HHHhcC
Confidence 369999999998765432 357889999999999985 5542 2334543 479999999974 764321 237789
Q ss_pred CCCCeEEcccCc-Cc
Q 038422 146 TSLKKLYMANNR-LT 159 (634)
Q Consensus 146 ~~L~~l~l~~N~-l~ 159 (634)
++|+.|+|++.. +|
T Consensus 139 ~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 139 RNLKYLFLSDLPGVK 153 (176)
T ss_dssp TTCCEEEEESCTTCC
T ss_pred CCCCEEECCCCCCCC
Confidence 999999999974 44
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.12 Score=53.69 Aligned_cols=79 Identities=16% Similarity=0.311 Sum_probs=48.1
Q ss_pred CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCC-ccccCCCCccEEeCCCCceeecCCcc---ccc
Q 038422 117 LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIP-SSLVQLPKLMELRLEANKFQGQVPEI---KQN 192 (634)
Q Consensus 117 ~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip-~~~~~l~~L~~L~l~~N~~~g~ip~~---~~~ 192 (634)
|.++..|+.+.+.++.. .|...+|.++++|+.+.+. +.++ .|+ ..|.+|.+|+.++|..| ++ .|.+. ...
T Consensus 261 F~~c~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~ 334 (394)
T 4gt6_A 261 FDSCAYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCE 334 (394)
T ss_dssp TTTCSSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCT
T ss_pred eeecccccEEecccccc--eecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCC
Confidence 56677777777766554 3556667777777777775 3444 233 45667777777777654 32 33332 234
Q ss_pred CCCEEEeec
Q 038422 193 EMRSLGLAN 201 (634)
Q Consensus 193 ~l~~l~l~~ 201 (634)
+|+.+.+..
T Consensus 335 ~L~~i~ip~ 343 (394)
T 4gt6_A 335 QLERIAIPS 343 (394)
T ss_dssp TCCEEEECT
T ss_pred CCCEEEECc
Confidence 677776643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.1 Score=53.91 Aligned_cols=105 Identities=13% Similarity=0.195 Sum_probs=72.7
Q ss_pred ChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccC
Q 038422 90 AAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQ 168 (634)
Q Consensus 90 ~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~ 168 (634)
....+.....|+.+.+..+ ++..-. .+.++.+|+.+.+..+ +. .|+..+|.+|++|+.+.+.+|.++--=...|.+
T Consensus 232 ~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 232 GDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD 308 (379)
T ss_dssp CTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred ccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcC
Confidence 3345667788999888765 332212 4778888999998755 44 577777899999999999888887333467888
Q ss_pred CCCccEEeCCCCceeecCCcc---cccCCCEEEe
Q 038422 169 LPKLMELRLEANKFQGQVPEI---KQNEMRSLGL 199 (634)
Q Consensus 169 l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l 199 (634)
|.+|+.+.|.+| ++ .|... ...+|+.+.+
T Consensus 309 c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 309 CVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp CTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred CCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 999999998654 33 34432 2346776654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.31 E-value=0.037 Score=37.22 Aligned_cols=27 Identities=19% Similarity=0.496 Sum_probs=13.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 038422 275 MIVLVLGVSLGIIAAILIIFYLRKRKT 301 (634)
Q Consensus 275 vi~~v~~v~l~il~~~~~~~~~r~~~~ 301 (634)
++++++|+++++++++.+++|.|||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 444455555555555555555555543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.21 E-value=0.04 Score=37.13 Aligned_cols=22 Identities=18% Similarity=0.519 Sum_probs=10.7
Q ss_pred HHHHHHHHHHHHHHHhhhhhhh
Q 038422 281 GVSLGIIAAILIIFYLRKRKTQ 302 (634)
Q Consensus 281 ~v~l~il~~~~~~~~~r~~~~~ 302 (634)
|+++++++++.+++++|||+++
T Consensus 19 Gv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 19 GLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHhhhhhhh
Confidence 3444444444555555555444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.074 Score=55.37 Aligned_cols=102 Identities=18% Similarity=0.230 Sum_probs=75.7
Q ss_pred hhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCC-Ccccc
Q 038422 91 AESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTI-PSSLV 167 (634)
Q Consensus 91 ~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~i-p~~~~ 167 (634)
...+.....|+.+.+..+. ++ .+..+.+|+.+.+.+| +. .|+..+|.+|++|+.++|..+ ++ .| ..+|.
T Consensus 269 ~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~ 340 (394)
T 4fs7_A 269 GSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFR 340 (394)
T ss_dssp SCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTT
T ss_pred ccccccccccceeccCcee----eccccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhcc
Confidence 3456667788888776553 44 4778899999999766 54 588888999999999999754 55 44 46788
Q ss_pred CCCCccEEeCCCCceeecCCcc---cccCCCEEEeecC
Q 038422 168 QLPKLMELRLEANKFQGQVPEI---KQNEMRSLGLANN 202 (634)
Q Consensus 168 ~l~~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N 202 (634)
+|++|+.+++..| ++ .|+.. ...+|+.+++..|
T Consensus 341 ~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 341 GCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGG
T ss_pred CCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCC
Confidence 9999999999876 44 45542 3358999988755
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.76 E-value=0.22 Score=51.23 Aligned_cols=106 Identities=12% Similarity=0.117 Sum_probs=74.9
Q ss_pred hhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCc
Q 038422 93 SLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L 172 (634)
.+.....|+.+.+..+--.=.--.+.++..|+.+.+..+ ++ .|...+|.++.+|+.+.+..+ ++-.-...|.+|++|
T Consensus 212 ~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccceeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceecccccccccccc
Confidence 455667888888765522111125788899999999876 44 577778999999999999755 442223567889999
Q ss_pred cEEeCCCCceeecCCcc---cccCCCEEEeecC
Q 038422 173 MELRLEANKFQGQVPEI---KQNEMRSLGLANN 202 (634)
Q Consensus 173 ~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N 202 (634)
+.+.+.+|.++ .|++. ...+|+.++|..+
T Consensus 289 ~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 289 TKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp CEEEECCTTCC-EECTTTTTTCTTCCEEECCTT
T ss_pred ccccccccccc-eehhhhhcCCCCCCEEEcCcc
Confidence 99999888776 45542 3358999987543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.00 E-value=0.058 Score=36.45 Aligned_cols=21 Identities=24% Similarity=0.447 Sum_probs=9.7
Q ss_pred HHHHHHHHHHHHHHHhhhhhh
Q 038422 281 GVSLGIIAAILIIFYLRKRKT 301 (634)
Q Consensus 281 ~v~l~il~~~~~~~~~r~~~~ 301 (634)
|+++++++++.+++++|||+.
T Consensus 20 Gv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 20 ALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHHHHHHHHhhhhHh
Confidence 344434444444555555443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.77 E-value=0.41 Score=50.23 Aligned_cols=142 Identities=15% Similarity=0.179 Sum_probs=81.3
Q ss_pred cccCccCceeEEEEEEcC--------CcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-ccceeEEEeCCceEEEEE
Q 038422 361 EVLGSGTFGASYKTVISN--------GQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-LPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 431 (634)
+.+..|-...+|+....+ +..+++++...... ..-+..+|.++++.+.-.++ .++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 346667777899988753 57788887644321 11234578888777743233 3455533 2 378999
Q ss_pred cCCCCChhh-----------------HHhhccC-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 038422 432 FVENGSLAG-----------------KLHANHT-----K---QRPGLDWQTRLKIIKGV-------------------VK 467 (634)
Q Consensus 432 ~~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------a~ 467 (634)
|+++..|.. .|+.... . ...+--|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865421 1111111 0 11112355444443322 22
Q ss_pred HHHHHHhc--------------------CCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 468 GMAYLHNE--------------------LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 468 gL~yLH~~--------------------~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
.+.+|.+. ..+..++|+|+.+.||+ +++..+.+.||..+.
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 33444321 12345789999999999 778889999997653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.51 E-value=0.33 Score=50.34 Aligned_cols=103 Identities=14% Similarity=0.179 Sum_probs=75.4
Q ss_pred hhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCC-CccccCCC
Q 038422 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTI-PSSLVQLP 170 (634)
Q Consensus 92 ~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~i-p~~~~~l~ 170 (634)
..+.....|+.+.+..+...=.--.+..+..|+.+.+..+. |+...|..+.+|+.+.+..| ++ .| ...|.+|+
T Consensus 247 ~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~ 320 (394)
T 4fs7_A 247 SVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCT 320 (394)
T ss_dssp STTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCT
T ss_pred ccccccccceeEEcCCCcceeeccccccccccceeccCcee----eccccccccccccccccccc-cc-eechhhhcCCC
Confidence 45667888999999877654333368888999999887764 55667889999999999765 55 34 45688999
Q ss_pred CccEEeCCCCceeecCCcc---cccCCCEEEeecC
Q 038422 171 KLMELRLEANKFQGQVPEI---KQNEMRSLGLANN 202 (634)
Q Consensus 171 ~L~~L~l~~N~~~g~ip~~---~~~~l~~l~l~~N 202 (634)
+|+.++|.++ ++ .|+.. ...+|+.+++..|
T Consensus 321 ~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 321 SLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred CCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence 9999999754 44 45542 2358999887655
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.29 E-value=1 Score=42.06 Aligned_cols=122 Identities=11% Similarity=0.134 Sum_probs=82.2
Q ss_pred CCCCccccceeEEEeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCC
Q 038422 408 LEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLK 487 (634)
Q Consensus 408 l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk 487 (634)
-.||+.+.. .+-.+.+...+.|+.-+ +...+-.-. .++...+++++.+|+.-.++++.. +|--|.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~r------~tf~L~ 106 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRTR------YTFVLA 106 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGSS------EECCCS
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcCc------eEEEEe
Confidence 368888865 45556666656565443 233332211 278889999999999888766643 477899
Q ss_pred CCCEEeCCCCCeEEeccccCCccCCCCCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCccccccc
Q 038422 488 SSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562 (634)
Q Consensus 488 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~ 562 (634)
|+||+++.++.+++.-.|+...+ +|. ..+...=.-.+=+++..+++++..|+....+
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G 163 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEG 163 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHS
T ss_pred cceEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcC
Confidence 99999999999999988875432 222 1222222445778889999999998755443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.63 E-value=1.4 Score=45.87 Aligned_cols=29 Identities=21% Similarity=0.424 Sum_probs=23.7
Q ss_pred CccccCCCCCCEEe------CCCCCeEEeccccCC
Q 038422 480 IIPHGHLKSSNVLL------DRSFEPLLTDYALRP 508 (634)
Q Consensus 480 ~ivHrdlk~~NILl------~~~~~~kl~DfGla~ 508 (634)
.++|+|+.+.|||+ +++..+.+.||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456778999997653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=83.93 E-value=1.8 Score=28.23 Aligned_cols=11 Identities=18% Similarity=0.612 Sum_probs=5.0
Q ss_pred HHHHHHHHHHH
Q 038422 274 IMIVLVLGVSL 284 (634)
Q Consensus 274 ~vi~~v~~v~l 284 (634)
+++.+++++++
T Consensus 12 aIAGiVvG~v~ 22 (38)
T 2k1k_A 12 EIVAVIFGLLL 22 (38)
T ss_dssp HHHHHHHHHHH
T ss_pred ceeeeehHHHH
Confidence 34444444443
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=80.27 E-value=0.94 Score=28.74 Aligned_cols=25 Identities=28% Similarity=0.538 Sum_probs=11.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhh
Q 038422 275 MIVLVLGVSLGIIAAILIIFYLRKR 299 (634)
Q Consensus 275 vi~~v~~v~l~il~~~~~~~~~r~~ 299 (634)
+++.++|+++++++.+.+.++.|||
T Consensus 10 IaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 10 IIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred eHHHHHHHHHHHHHHHHhheEEeec
Confidence 4444555444444444444555554
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.14 E-value=0.27 Score=52.30 Aligned_cols=59 Identities=8% Similarity=0.031 Sum_probs=17.1
Q ss_pred cccCccCceeEEEEEEcC-CcEEEE------EEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEe
Q 038422 361 EVLGSGTFGASYKTVISN-GQAYVV------KRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR 422 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 422 (634)
+.|| ||.||+|.+.. ...||+ |..+... ......|.+|..+++.++|||+++.++|...
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4566 99999999754 357777 6655422 2233568889999999999999999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 634 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 7e-44
Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 32/282 (11%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ +GSG+FG YK A + + F+ + L + H N+L +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+ ++ ++ E SL LH TK + + I + +GM YLH +
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAK----S 124
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPEYAH---NG 531
I H LKS+N+ L + D+ L + + + + + +PE
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 532 KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591
S +SDV++ GI++ EL+TG+ P +++ + V V K
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
K ++ C ++ R +++ IE L
Sbjct: 241 AMK----------RLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-42
Identities = 53/297 (17%), Positives = 108/297 (36%), Gaps = 32/297 (10%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
E +G G FG ++ G+ VK + + I + L H N+L A
Sbjct: 9 ESIGKGRFGEVWR-GKWRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 421 YRKEEKL----LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ L+ ++ E+GSL L+ R + + +K+ G+A+LH E+
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 477 PGSI----IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--------VAYKS 524
G+ I H LKS N+L+ ++ + D L + + Y +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 525 PEY------AHNGKISKKSDVWSLGILILELLTGKYPENYL--LQGYDSKASLSNWVNNM 576
PE + + K++D++++G++ E+ Q S+
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+++ + S + + KI C + AR+ + + + +L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 9e-42
Identities = 57/278 (20%), Positives = 109/278 (39%), Gaps = 32/278 (11%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ +GSG FG + N +K ++ + EDF E + + +L HP L+ L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+ L++EF+E+G L+ L +T L + V +GMAYL
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEEA----C 121
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAHNGKISK 535
+ H L + N L+ + ++D+ + + D + V + SPE + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595
KSDVWS G+L+ E+ + S + + ++ + +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVEDISTGFRLYK-------------- 223
Query: 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+ ++ +I C +E R ++ ++ + E
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKR-YKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
LG+G G +K + +G K + ++ R ++ L P ++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+Y E + E ++ GSL K+ + Q K+ V+KG+ YL +
Sbjct: 72 AFYSDGEISICMEHMDGGSLD-----QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 125
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPEYAHNGKISKK 536
I H +K SN+L++ E L D+ + + A++ + +Y SPE S +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 537 SDVWSLGILILELLTGKYP 555
SD+WS+G+ ++E+ G+YP
Sbjct: 184 SDIWSMGLSLVEMAVGRYP 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-40
Identities = 61/274 (22%), Positives = 108/274 (39%), Gaps = 32/274 (11%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
E LG+G FG + + VK KQ ++ + F + +L+H L+ L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
+E ++ E++ENGSL L T L L + + +GMA++
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEERN---- 129
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAHNGKISK 535
H L+++N+L+ + + D+ L LI + + + +PE + G +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595
KSDVWS GIL+ E++T + + N+ + R M
Sbjct: 190 KSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYR--------MVRPDN 234
Query: 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629
E+ L++ C +E R + +E
Sbjct: 235 CPEELYQLMR---LCWKERPEDRPTFDYLRSVLE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 62/276 (22%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ +G G FG G VK K N+ + F + +L H NL+ L
Sbjct: 13 QTIGKGEFGDVML-GDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 421 YRKEEKL-LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
++ L ++ E++ GSL L ++ R L LK V + M YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---- 122
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-VAYKSPEYAHNGKISKKSD 538
H L + NVL+ ++D+ L + + V + +PE K S KSD
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 539 VWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKS 598
VWS GIL+ E+ + DV + KG K
Sbjct: 183 VWSFGILLWEIYSFGRVPYP--------------------RIPLKDVVPRVEKGYKMDAP 222
Query: 599 EMI--NLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
+ + ++ +C D R ++ E++E +K
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+G+G++G K S+G+ V K Y M ++ + L L+HPN++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 418 AFYYRKEEKLL--LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ L + E+ E G LA + TK+R LD + L+++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 476 LPGSI-IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV----AYKSPEYAHN 530
G + H LK +NV LD L D+ L ++N D + Y SPE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 531 GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590
++KSD+WSLG L+ EL P + K +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREGKFRRIP--------- 235
Query: 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
+YS E+ ++ R ++E++E
Sbjct: 236 --YRYSD-ELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 2e-37
Identities = 57/279 (20%), Positives = 107/279 (38%), Gaps = 38/279 (13%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
+ LG+G FG +K K+ ++ ++F E K + L H L+ L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
++ ++ E++ NG L L + R Q L++ K V + M YL ++
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLESK----Q 120
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAHNGKISK 535
H L + N L++ ++D+ L + D + + V + PE K S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 536 KSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594
KSD+W+ G+L+ E+ + GK P + + + +G +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP---------------------YERFTNSETAEHIAQGLR 219
Query: 595 YSKSEMIN--LLKIGLSCCEEDVLARMELKEVIEKIERL 631
+ + + + I SC E R K ++ I +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 5e-37
Identities = 55/279 (19%), Positives = 100/279 (35%), Gaps = 32/279 (11%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
LG G +G Y+ VK K + + E+F + + ++HPNL+ L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
R+ ++ EF+ G+L L R + L + + M YL
Sbjct: 82 CTREPPFYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYMATQISSAMEYLEK----K 134
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL-----MVAYKSPEYAHNGKIS 534
H L + N L+ + + D+ L L+ D + + +PE K S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 535 KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594
KSDVW+ G+L+ E+ T LS + K+ R +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS-------PYPGIDLSQVYELLEKDYR-----------ME 236
Query: 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+ + ++ +C + + R E+ + E + +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-37
Identities = 56/278 (20%), Positives = 100/278 (35%), Gaps = 36/278 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFY 420
LG G FG + + +K K + E F + + + +L H L+ L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSI 480
E ++ E++ GSL L + L + + + GMAY+
Sbjct: 82 SE-EPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER----MN 133
Query: 481 IPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAHNGKISK 535
H L+++N+L+ + + D+ L LI + + + +PE A G+ +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595
KSDVWS GIL+ EL T +V D+ +G +
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYP--------------------GMVNREVLDQVERGYRM 233
Query: 596 SKSEMI--NLLKIGLSCCEEDVLARMELKEVIEKIERL 631
+L + C ++ R + + +E
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-37
Identities = 56/287 (19%), Positives = 104/287 (36%), Gaps = 40/287 (13%)
Query: 361 EVLGSGTFGASYKTVISN----GQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLP 415
EV+G G FG Y + + VK ++ ++G F + HPN+L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 416 LTAFYYRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L R E L+ ++++G L + + + V KGM +L +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--------VAYKSPE 526
+ H L + N +LD F + D+ L + ++ V + + E
Sbjct: 149 K----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586
K + KSDVWS G+L+ EL+T P + + +++ +R
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRR----- 252
Query: 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+ +Y + ++ L C R E++ +I +
Sbjct: 253 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 61/294 (20%), Positives = 104/294 (35%), Gaps = 39/294 (13%)
Query: 343 VRDDMEPFDLQDMLRASAEVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEH 401
V D+ P D +++ LG G FG YK K + ED+
Sbjct: 4 VTRDLNPEDFWEIIG----ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 402 IKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKI 461
I L +HPN++ L +Y + +L EF G+ + A + L +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA----VDAVMLELERPLTESQIQVV 115
Query: 462 IKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMV 520
K + + YLH+ II H LK+ N+L + L D+ + +
Sbjct: 116 CKQTLDALNYLHDN---KII-HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 521 ---AYKSPEYA-----HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNW 572
+ +PE + K+DVWSLGI ++E+ + P + L
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKI 227
Query: 573 VNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
+ + K + LK C E++V AR ++++
Sbjct: 228 AKSEPPTLAQPSRWSSNFK----------DFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 52/286 (18%), Positives = 112/286 (39%), Gaps = 39/286 (13%)
Query: 361 EVLGSGTFGASYKTVISNGQ-----AYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNLL 414
+V+G+G FG YK ++ +K K R DF +G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L + + +++ E++ENG+L ++ + +++G+ GM YL N
Sbjct: 73 RLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-------VAYKSPEY 527
H L + N+L++ + ++D+ L ++ D T + + +PE
Sbjct: 129 M----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 528 AHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587
K + SDVWS GI++ E++T + S + + R
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGER-------PYWELSNHEVMKAINDGFRL----- 232
Query: 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+ ++ + C +++ R + +++ +++L
Sbjct: 233 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-36
Identities = 53/276 (19%), Positives = 109/276 (39%), Gaps = 35/276 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYK--QMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+G G+F YK + + ++ R+ F+E + L L+HPN++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 418 AFYY----RKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ K+ +L+ E + +G+L + K+ + + + ++KG+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLK-----TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 474 NELPGSIIPHGHLKSSNVLL-DRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPEYAHN 530
I H LK N+ + + + D L L A ++ + +PE
Sbjct: 130 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY-E 186
Query: 531 GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590
K + DV++ G+ +LE+ T +YP + A + V + VK V E+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
Query: 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
K +++ C ++ R +K+++
Sbjct: 243 K----------EIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 3e-36
Identities = 51/305 (16%), Positives = 101/305 (33%), Gaps = 54/305 (17%)
Query: 361 EVLGSGTFGASYK------TVISNGQAYVVKRYK-QMNNVGREDFQEHIKRLGRLEHPNL 413
+G G FG ++ VK K + + + DFQ + ++PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN-------------------HTKQRPGLD 454
+ L + LL+E++ G L L + + P L
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514
+L I + V GMAYL H L + N L+ + + D+ L I +
Sbjct: 139 CAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 515 AHTLM------VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKAS 568
+ + + PE + + +SDVW+ G+++ E+ + Y G +
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY---GMAHEEV 251
Query: 569 LSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628
+ + + ++ + L + C + R + +
Sbjct: 252 IYYVRDGNILA---------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 629 ERLKE 633
+R+ E
Sbjct: 297 QRMCE 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 136 bits (344), Expect = 4e-36
Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 31/240 (12%)
Query: 322 SKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYK-TVISNGQ 380
+ P+P+EIK ++ +D+ E LG+G FG ++ T + G
Sbjct: 10 KQYYPQPVEIKHD----------HVLDHYDIH-------EELGTGAFGVVHRVTERATGN 52
Query: 381 AYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440
+ K + +E ++ I+ + L HP L+ L + E +++YEF+ G L
Sbjct: 53 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112
Query: 441 KLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL--DRSFE 498
K+ + + ++ ++ V KG+ ++H H LK N++ RS E
Sbjct: 113 KVA----DEHNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNE 164
Query: 499 PLLTDYALRPLINPDNAH---TLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
L D+ L ++P + T + +PE A + +D+WS+G+L LL+G P
Sbjct: 165 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 53/271 (19%), Positives = 103/271 (38%), Gaps = 32/271 (11%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E +G G G Y ++ GQ +++ +E I + ++PN++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
Y +E ++ E++ GSL +D + + ++ + +LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---- 135
Query: 480 IIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHNGKISK 535
+ H +KS N+LL LTD+ I P+ + + + +PE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 536 KSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKY 595
K D+WSLGI+ +E++ G+ P + +L N E + + +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPEKLSAIFR---- 247
Query: 596 SKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
+ L C + DV R KE+++
Sbjct: 248 ------DFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 4e-36
Identities = 53/287 (18%), Positives = 112/287 (39%), Gaps = 40/287 (13%)
Query: 361 EVLGSGTFGASYKTVI----SNGQAYVVKR-YKQMNNVGREDFQEHIKRLGRLEHPNLLP 415
+V+G+G FG + +K R DF +G+ +HPN++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + +++ EF+ENGSL L N + + +++G+ GM YL +
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADM 147
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA---------YKSPE 526
H L + N+L++ + ++D+ L + D + + + +PE
Sbjct: 148 ----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586
K + SDVWS GI++ E+++ + + +N + ++ R
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGER-------PYWDMTNQDVINAIEQDYRL---- 252
Query: 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
L ++ L C ++D R + +++ ++++
Sbjct: 253 -------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 5e-36
Identities = 58/273 (21%), Positives = 108/273 (39%), Gaps = 34/273 (12%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQ---MNNVGREDFQEHIKRLGRLEHPNLLPL 416
+G G+FGA Y + N + +K+ +N +D + ++ L +L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
Y R+ L+ E+ + + L + G ++G+AYLH+
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSH- 134
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEYA---HNGKI 533
+ H +K+ N+LL L D+ ++ P N+ + +PE G+
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 534 SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593
K DVWSLGI +EL K P L ++ ++L + N ++G +
Sbjct: 192 DGKVDVWSLGITCIELAERKPP----LFNMNAMSALYHIAQNESPALQSGHWSE------ 241
Query: 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
N + SC ++ R + +++
Sbjct: 242 -----YFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 48/298 (16%)
Query: 361 EVLGSGTFGASYKTVI------SNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLE-HPN 412
+ LG+G FG + VK K ++ RE +K L L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 413 LLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTK-------------QRPGLDWQTRL 459
++ L L++ E+ G L L LD + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM 519
V KGMA+L ++ + I H L + N+LL + D+ L I D+ + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 520 ------VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWV 573
V + +PE N + +SDVWS GI + EL + + +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-------PYPGMPVDSKF 257
Query: 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
M+KE M +++ +EM +++K +C + D L R K++++ IE+
Sbjct: 258 YKMIKE-------GFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 129 bits (326), Expect = 1e-33
Identities = 65/311 (20%), Positives = 128/311 (41%), Gaps = 47/311 (15%)
Query: 322 SKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTV-ISNGQ 380
K P+P+E+K+ + Y +D+ E LGSG FG ++ V + G+
Sbjct: 13 KKYVPQPVEVKQGSVYDY----------YDIL-------EELGSGAFGVVHRCVEKATGR 55
Query: 381 AYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAG 440
+V K + + + I + +L HP L+ L + K E +L+ EF+ G L
Sbjct: 56 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115
Query: 441 KLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL 500
++ + + + ++ +G+ ++H SI+ H +K N++ +
Sbjct: 116 RIA----AEDYKMSEAEVINYMRQACEGLKHMHEH---SIV-HLDIKPENIMCETKKASS 167
Query: 501 --LTDYALRPLINPDNAHTLMVA---YKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ D+ L +NPD + A + +PE + +D+W++G+L LL+G P
Sbjct: 168 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
Query: 556 ENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDV 615
G D +L N D E + S E + +K + +++
Sbjct: 228 ----FAGEDDLETLQNVKR--------CDWEFDEDAFSSVSP-EAKDFIK---NLLQKEP 271
Query: 616 LARMELKEVIE 626
R+ + + +E
Sbjct: 272 RKRLTVHDALE 282
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-33
Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 15/201 (7%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPL 416
LG G FG Y + +K + + ++ L HPN+L L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+++ L+ E+ G++ +L + D Q I + ++Y H++
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSK- 125
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPEYAHNGKIS 534
+I H +K N+LL + E + D+ TL + Y PE
Sbjct: 126 --RVI-HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 535 KKSDVWSLGILILELLTGKYP 555
+K D+WSLG+L E L GK P
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP 203
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 73/353 (20%), Positives = 122/353 (34%), Gaps = 63/353 (17%)
Query: 309 YEDSSKLPTSFGSSKVEPEPIEIKKKADYGKLSFVRDDMEPFDLQDMLRASAEVLGSGTF 368
YE ++ GSS E ++ ++ K F R++ + +VLGSG F
Sbjct: 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPREN---LEFG-------KVLGSGAF 50
Query: 369 GASYKTV------ISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLE-HPNLLPLTAFY 420
G VK K+ + RE +K + +L H N++ L
Sbjct: 51 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110
Query: 421 YRKEEKLLLYEFVENGSLAGKLHANHTK------------------QRPGLDWQTRLKII 462
L++E+ G L L + K L ++ L
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170
Query: 463 KGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--- 519
V KGM +L + S + H L + NVL+ + D+ L I D+ + +
Sbjct: 171 YQVAKGMEFLEFK---SCV-HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 226
Query: 520 ---VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNM 576
V + +PE G + KSDVWS GIL+ E+ + G A+ + N
Sbjct: 227 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDANFYKLIQN- 282
Query: 577 VKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629
+M Y+ E+ +++ SC D R + +
Sbjct: 283 ----------GFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-33
Identities = 55/275 (20%), Positives = 99/275 (36%), Gaps = 35/275 (12%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTA 418
+ LG G +G +A VK V E+ ++ I L H N++
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ L E+ G + + G+ + ++ G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 122
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPEYAHNGK 532
I H +K N+LLD ++D+ L + +N L+ + Y +PE +
Sbjct: 123 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 533 I-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591
++ DVWS GI++ +L G+ P + Q DS S+W +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTYLNPWKKI------ 232
Query: 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
S + LL E+ AR+ + ++ +
Sbjct: 233 -----DSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 57/311 (18%), Positives = 108/311 (34%), Gaps = 48/311 (15%)
Query: 342 FVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVISNG---QAYVVKRYKQMNNV-GRED 397
+ D Q +V+G G FG K I +KR K+ + D
Sbjct: 4 YPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 398 FQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANH---------- 446
F ++ L +L HPN++ L + L E+ +G+L L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 447 -TKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYA 505
L Q L V +GM YL + H L + N+L+ ++ + D+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFG 172
Query: 506 LRPLINPDNAHTLMV---AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQG 562
L T+ + + E + + SDVWS G+L+ E+++ +
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-- 230
Query: 563 YDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELK 622
+ + + + R ++ E+ +L++ C E R
Sbjct: 231 -----TCAELYEKLPQGYR--------LEKPLNCDDEVYDLMR---QCWREKPYERPSFA 274
Query: 623 EVIEKIERLKE 633
+++ + R+ E
Sbjct: 275 QILVSLNRMLE 285
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-33
Identities = 55/282 (19%), Positives = 97/282 (34%), Gaps = 44/282 (15%)
Query: 362 VLGSGTFGASYKTVISN---GQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLLPL 416
LGSG FG K + VK K + +++ + +L++P ++ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
E +L+ E E G L + +Q + + ++++ V GM YL
Sbjct: 74 IGICEA-ESWMLVMEMAELGPLN-----KYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-------VAYKSPEYAH 529
H L + NVLL ++D+ L + D + V + +PE +
Sbjct: 128 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 530 NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589
K S KSDVWS G+L+ E + + + +V
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--------------------PYRGMKGSEVTAML 223
Query: 590 MKGAKYSKSEMI--NLLKIGLSCCEEDVLARMELKEVIEKIE 629
KG + + + C DV R V ++
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 9e-33
Identities = 60/305 (19%), Positives = 111/305 (36%), Gaps = 53/305 (17%)
Query: 339 KLSFVRDDMEPFDLQDMLRASAEVLGSGTFGASYKTVI---SNGQAYVVKRYKQ-MNNVG 394
KL RD++ D++ LG G FG+ + V +K KQ
Sbjct: 2 KLFLKRDNLLIADIE---------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD 52
Query: 395 REDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLD 454
E+ + + +L++P ++ L + E +L+ E G L L +R +
Sbjct: 53 TEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLV----GKREEIP 107
Query: 455 WQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514
+++ V GM YL + H L + NVLL ++D+ L + D+
Sbjct: 108 VSNVAELLHQVSMGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 515 AHTLM-------VAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSK 566
++ + + +PE + K S +SDVWS G+ + E L+ G+ P
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----------- 212
Query: 567 ASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMI--NLLKIGLSCCEEDVLARMELKEV 624
K+ + +V +G + L + C R + V
Sbjct: 213 ----------YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262
Query: 625 IEKIE 629
+++
Sbjct: 263 EQRMR 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 53/285 (18%), Positives = 105/285 (36%), Gaps = 39/285 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAY----VVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLL 414
+VLGSG FG YK I G+ +K ++ + ++ + + +++P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L L+ + + G L + + + Q L + KGM YL +
Sbjct: 75 RLL-GICLTSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPEYA 528
+ H L + NVL+ +TD+ L L+ + + + + E
Sbjct: 130 R----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 529 HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588
+ + +SDVWS G+ + EL+T S + + K +R
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSK-------PYDGIPASEISSILEKGER------- 231
Query: 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
I++ I + C D +R + +E+I + ++
Sbjct: 232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 53/286 (18%), Positives = 90/286 (31%), Gaps = 40/286 (13%)
Query: 361 EVLGSGTFG----ASYKTVISNGQAYVVKRYKQ---MNNVGREDFQEHIKRLGRLEHPNL 413
E LG G+FG + + VK K +DF + + L+H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ L K++ E GSL K + T + V +GM YL
Sbjct: 74 IRLYGVVLTPPMKMV-TELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-------VAYKSPE 526
++ H L + N+LL + D+ L + ++ H +M A+ +PE
Sbjct: 129 SK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586
S SD W G+ + E+ T G + L + R D
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632
+ + + C R + + + +
Sbjct: 242 QD--------------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 51/291 (17%), Positives = 101/291 (34%), Gaps = 40/291 (13%)
Query: 361 EVLGSGTFGASYKTV------ISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNL 413
LG G+FG Y+ V +K + ++ R +F + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHT-----KQRPGLDWQTRLKIIKGVVKG 468
+ L + + L++ E + G L L + +++ + G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAY 522
MAYL+ + H L + N ++ F + D+ + I + + V +
Sbjct: 146 MAYLNA----NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 523 KSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582
SPE +G + SDVWS G+++ E+ T QG ++ L + + +K
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEGGLLDKP- 257
Query: 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
D + ++ C + + R E+I I+ E
Sbjct: 258 -DNCPDMLF-------------ELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 3e-31
Identities = 60/285 (21%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
E LG G FG ++ V S+ + Y+ K K + + ++ I L H N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ EE ++++EF+ + +++ L+ + + + V + + +LH+
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHS----H 121
Query: 480 IIPHGHLKSSNVLLDRSFEPL--LTDYAL-RPLINPDNAHTLMVA--YKSPEYAHNGKIS 534
I H ++ N++ + ++ R L DN L A Y +PE + +S
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 535 KKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594
+D+WSLG L+ LL+G P ++ + N +N + E +
Sbjct: 182 TATDMWSLGTLVYVLLSGINP----FLAETNQQIIENIMN--------AEYTFDEEAFKE 229
Query: 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVI------EKIERLKE 633
S E ++ + ++ +RM E + +KIER+
Sbjct: 230 ISI-EAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVST 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 46/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLP 415
++LG G+F ++ + Y +K + ++ +E+ ++ R + RL+HP +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + E+ + +NG L + ++ D +V + YLH +
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELL-----KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM------VAYKSPEYAH 529
I H LK N+LL+ +TD+ +++P++ Y SPE
Sbjct: 128 ----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 530 NGKISKKSDVWSLGILILELLTGKYP 555
K SD+W+LG +I +L+ G P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 46/285 (16%), Positives = 96/285 (33%), Gaps = 41/285 (14%)
Query: 361 EVLGSGTFGASYKTVISN----GQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLP 415
+G G FG ++ + + A +K K + RE F + + + +HP+++
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
L + ++ E G L + ++ LD + + + +AYL ++
Sbjct: 73 LIG-VITENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM-----VAYKSPEYAHN 530
H + + NVL+ + L D+ L + + + + +PE +
Sbjct: 128 ----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 531 GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590
+ + SDVW G+ + E+L + DV +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQ--------------------GVKNNDVIGRIE 223
Query: 591 KGAKYSKSEMI--NLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
G + L + C D R E+ ++ + E
Sbjct: 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (286), Expect = 6e-29
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 29/215 (13%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYK---------QMNNVGREDFQEHIKRLGRL-E 409
E+LG G + + Y VK + RE + + L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 410 HPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGM 469
HPN++ L Y L+++ ++ G L L ++ L + KI++ +++ +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVI 123
Query: 470 AYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV--------- 520
LH I H LK N+LLD LTD+ ++P +
Sbjct: 124 CALHK----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 521 AYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
+ ++ K+ D+WS G+++ LL G P
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 9e-29
Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 17/203 (8%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGRED-FQEHIKRLGRLEHPNLLPLTA 418
+VLG+G F + +K + G+E + I L +++HPN++ L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
Y L+ + V G L ++ ++ + ++I V+ + YLH+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAVKYLHDL--- 126
Query: 479 SIIPHGHLKSSNVLL---DRSFEPLLTDYALRPLINPDNAHTLMV---AYKSPEYAHNGK 532
I H LK N+L D + +++D+ L + +P + + Y +PE
Sbjct: 127 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
SK D WS+G++ LL G P
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 55/299 (18%), Positives = 101/299 (33%), Gaps = 47/299 (15%)
Query: 361 EVLGSGTFGASYKTV------ISNGQAYVVKRYKQ-MNNVGREDFQEHIKRLGRLEHPNL 413
+ LG G FG + + + VK K+ + +K L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 414 LPLTAFYYRKEEK--LLLYEFVENGSLAGKLHANHTKQRPG-----------LDWQTRLK 460
+ K +++ EF + G+L+ L + + P L + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 461 IIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM- 519
V KGM +L + H L + N+LL + D+ L I D +
Sbjct: 139 YSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 520 -----VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVN 574
+ + +PE + + +SDVWS G+L+ E+ + +
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------PYPGVKIDEEFC 247
Query: 575 NMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633
+KE M+ Y+ EM + L C + R E++E + L +
Sbjct: 248 RRLKE-------GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 7e-28
Identities = 51/298 (17%), Positives = 95/298 (31%), Gaps = 49/298 (16%)
Query: 361 EVLGSGTFGASYK--------TVISNGQAYVVKRYK-QMNNVGREDFQEHIKRLGRL-EH 410
+ LG G FG + VK K D ++ + + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPG-----------LDWQTRL 459
N++ L + ++ E+ G+L L A L + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 460 KIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM 519
V +GM YL ++ H L + NVL+ + D+ L I+ + +
Sbjct: 139 SCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 520 ------VAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWV 573
V + +PE + + +SDVWS G+L+ E+ T +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--------GVPVEEL 246
Query: 574 NNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
++KE D + C R K+++E ++R+
Sbjct: 247 FKLLKEGHRMDKPSNCTNELY----------MMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (275), Expect = 1e-27
Identities = 48/290 (16%), Positives = 106/290 (36%), Gaps = 41/290 (14%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQ---MNNVGREDFQEHIKRLGRLEHPNLLPL 416
E+LG G + + + VK + + F+ + L HP ++ +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 417 TAFYYRKEEKL----LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ ++ E+V+ +L +H + + +++I + + +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFS 127
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLM------VAYKSP 525
H + I H +K +N+++ + + D+ + R + + N+ T Y SP
Sbjct: 128 HQ----NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585
E A + +SDV+SLG ++ E+LTG+ P G + V D
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVR--------EDP 231
Query: 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME-LKEVIEKIERLKEG 634
+ S ++ ++ ++ R + E+ + R+ G
Sbjct: 232 IPPSARHEGLSA-DLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (277), Expect = 4e-27
Identities = 37/205 (18%), Positives = 78/205 (38%), Gaps = 19/205 (9%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGRED------FQEHIKRLGRLEHPNL 413
++G G FG Y G+ Y +K + ++ + + + + P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ ++ ++ ++ + + + G L L Q ++ G+ ++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLM--VAYKSPEYAHNG 531
N + + LK +N+LLD ++D L + H + Y +PE G
Sbjct: 125 NR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 532 K-ISKKSDVWSLGILILELLTGKYP 555
+D +SLG ++ +LL G P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 47/272 (17%), Positives = 96/272 (35%), Gaps = 21/272 (7%)
Query: 361 EVLGSGTFGASYK--TVISNGQAYVVKRYKQMNNVGREDFQ-----EHIKRLGRLEHPNL 413
+G G +G +K + + G+ +KR + ++ L EHPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGK-LHANHTKQRPGLDWQTRLKIIKGVVKGMAYL 472
+ L + + PG+ +T ++ +++G+ +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 473 HNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV---AYKSPEYAH 529
H+ ++ H LK N+L+ S + L D+ L + + A T +V Y++PE
Sbjct: 133 HSH---RVV-HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 530 NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589
+ D+WS+G + E+ K +G L ++ + D
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 590 MKGAKYSKSEMINLLKIGLSCCEE--DVLARM 619
+ + + K E D+L +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 23/209 (11%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYK------QMNNVGREDFQEHIKRLGRLEHPNL 413
E LGSG F K S G Y K K V RED + + L ++HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 414 LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+ L Y K + +L+ E V G L + ++ L + + +K ++ G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPL----LTDYALRPLINPDNAHTLMV---AYKSPE 526
+ I H LK N++L P + D+ L I+ N + + +PE
Sbjct: 131 SL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 527 YAHNGKISKKSDVWSLGILILELLTGKYP 555
+ + ++D+WS+G++ LL+G P
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-26
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 18/204 (8%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEHPNLLP 415
++LG G+FG + Q + +K K+ + +D + + EHP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 416 LTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNE 475
+ + KE + E++ G L H + D ++ G+ +LH++
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLM-----YHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 476 LPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMV---AYKSPEYAHNG 531
I + LK N+LLD+ + D+ + + + D Y +PE
Sbjct: 123 G----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 532 KISKKSDVWSLGILILELLTGKYP 555
K + D WS G+L+ E+L G+ P
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 8e-26
Identities = 45/200 (22%), Positives = 83/200 (41%), Gaps = 14/200 (7%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQ---MNNVGREDFQEHIKRLGRLEHPNLLPL 416
LG+G+FG + NG+ Y +K K+ + E + L + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ ++ ++ +++E G + ++ V + YLH++
Sbjct: 70 WGTFQDAQQIFMIMDYIE-----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK- 123
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHNGKISK 535
II + LK N+LLD++ +TD+ + + + Y +PE +K
Sbjct: 124 --DII-YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 536 KSDVWSLGILILELLTGKYP 555
D WS GILI E+L G P
Sbjct: 181 SIDWWSFGILIYEMLAGYTP 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 57/278 (20%), Positives = 107/278 (38%), Gaps = 36/278 (12%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTA 418
+VLG G G + + + +K + RE ++ R + P+++ +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-----VELHWRASQCPHIVRIVD 72
Query: 419 FY---YRKEEKLLL-YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
Y Y + LL+ E ++ G L ++ + + +I+K + + + YLH+
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS 129
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPL---LTDYALRPLINPDNAHTLM---VAYKSPEYA 528
I H +K N+L LTD+ N+ T Y +PE
Sbjct: 130 ----INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 529 HNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588
K K D+WSLG+++ LL G P + S L+ M R G
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP-------FYSNHGLAIS-PGMKTRIRMGQYEFP 237
Query: 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626
+ ++ S+ E+ L++ + + + RM + E +
Sbjct: 238 NPEWSEVSE-EVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 16/203 (7%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E +G GT+G YK G+ +K R I L L HPN++ L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ + + L++EF+ G+ + +++G+A+ H+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLK----KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMV---AYKSPE-YAHNGK 532
+ H LK N+L++ L D+ L R P +T V Y++PE
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
S D+WSLG + E++T +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYK-----QMNNVGREDFQEHIKRLGRLEHPNLL 414
+ LG G F YK + Q +K+ K + + IK L L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 415 PLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
L + K L+++F+E L L + ++G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDY-ALRPLINPDNAHTLMVA---YKSPEYAHN 530
I H LK +N+LLD + L D+ + +P+ A+T V Y++PE
Sbjct: 119 H----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 531 GK-ISKKSDVWSLGILILELLTGKYP 555
+ D+W++G ++ ELL
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-24
Identities = 42/205 (20%), Positives = 83/205 (40%), Gaps = 16/205 (7%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVG-REDFQEHIKRLGRLEHPNLLPLTA 418
+G G +G N +K+ + + IK L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ + ++ L G K + L + +++G+ Y+H+
Sbjct: 74 IIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA--- 128
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTL-------MVAYKSPEYAHNG 531
+ H LK SN+LL+ + + + D+ L + +PD+ HT Y++PE N
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 532 -KISKKSDVWSLGILILELLTGKYP 555
+K D+WS+G ++ E+L+ +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-24
Identities = 41/208 (19%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGRED------FQEHIKRLGRL--EHP 411
+LGSG FG+ Y + +S+ +K ++ + + L ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
++ L ++ R + +L+ E E + +R L + V++ + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQD----LFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINPDNAHTLM--VAYKSPEYA 528
HN + H +K N+L+D + E L D+ L+ Y PE+
Sbjct: 126 CHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 529 HNGK-ISKKSDVWSLGILILELLTGKYP 555
+ + + VWSLGIL+ +++ G P
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (250), Expect = 3e-24
Identities = 44/202 (21%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTA 418
E +G GT+G YK + G+ + +K R ++ + I L L+H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 419 FYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPG 478
+ K+ +L++E ++ L GL+ T + ++ G+AY H+
Sbjct: 68 VIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---- 118
Query: 479 SIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA-----YKSPEYAHNGKI 533
+ H LK N+L++R E + D+ L + K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 534 SKKSDVWSLGILILELLTGKYP 555
S D+WS+G + E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPL 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-24
Identities = 45/207 (21%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+V+G+G+FG Y+ + +G+ +K+ Q + ++ + +L+H N++ L F
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 420 YYRKEEK------LLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLH 473
+Y EK L+ ++V ++ ++++ + L + + + +AY+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 474 NELPGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMV---AYKSPEYAH 529
+ I H +K N+LLD L L D+ + + + Y++PE
Sbjct: 140 SF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 530 NG-KISKKSDVWSLGILILELLTGKYP 555
+ DVWS G ++ ELL G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 10/200 (5%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+ +GSG +GA V G +K+ + + + + ++ L + H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ E +F G K L ++ ++KG+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAA-- 140
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHNG-KISK 535
I H LK N+ ++ E + D+ L R + + + Y++PE N + ++
Sbjct: 141 --GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 536 KSDVWSLGILILELLTGKYP 555
D+WS+G ++ E++TGK
Sbjct: 199 TVDIWSVGCIMAEMITGKTL 218
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 31/212 (14%), Positives = 70/212 (33%), Gaps = 27/212 (12%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+G G+FG ++ T + N Q +K + ++ ++ + L +P +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ ++ +L + SL L +T K ++ + +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHE----K 120
Query: 480 IIPHGHLKSSNVLLDRSFEPL-----LTDYALRPLINPDNAHTLM-----------VAYK 523
+ + +K N L+ R + D+ + + Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 524 SPEYAHNGKISKKSDVWSLGILILELLTGKYP 555
S + S++ D+ +LG + + L G P
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.6 bits (242), Expect = 4e-23
Identities = 41/286 (14%), Positives = 81/286 (28%), Gaps = 37/286 (12%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF 419
+GSG+FG Y T I+ G+ +K K ++ +P +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 420 YYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGS 479
+ + ++ + SL +T L + ++ + Y+H+
Sbjct: 71 CGAEGDYNVMVMELLGPSL----EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS----K 122
Query: 480 IIPHGHLKSSNVL---LDRSFEPLLTDYALRPLINPDNAHTLM-----------VAYKSP 525
H +K N L + + D+ L H + Y S
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 526 EYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585
+ S++ D+ SLG +++ G P L + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--------ATKRQKYERISEKKMS 234
Query: 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631
E+ Y E L C + + + + L
Sbjct: 235 TPIEVLCKGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 41/200 (20%), Positives = 74/200 (37%), Gaps = 14/200 (7%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQ---MNNVGREDFQEHIKRLGRLEHPNLLPL 416
+ LG+G+FG +G Y +K + + E + L + P L+ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ ++ E+V G + L + +V YLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL- 160
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAHNGKISK 535
+I + LK N+L+D+ +TD+ + + +PE + +K
Sbjct: 161 --DLI-YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 536 KSDVWSLGILILELLTGKYP 555
D W+LG+LI E+ G P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 2e-22
Identities = 41/203 (20%), Positives = 79/203 (38%), Gaps = 17/203 (8%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGRED---FQEHIKRLGRLEHPNLLPL 416
++LG GTFG + G+ Y +K ++ + +++ + L HP L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 417 TAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ + + E+ G L H + + +V + YLH+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELF-----FHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVA----YKSPEYAHNGK 532
+ + +K N++LD+ +TD+ L D A Y +PE +
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
+ D W LG+++ E++ G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 3e-22
Identities = 42/203 (20%), Positives = 75/203 (36%), Gaps = 17/203 (8%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVK--RYKQMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
E +G GT+G +K + +K R + I L L+H N++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ ++ L++EF + LD + + ++KG+ + H+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKK-----YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-- 120
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVA----YKSPEYAHNGK 532
+ H LK N+L++R+ E L ++ L R P ++ V
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 533 ISKKSDVWSLGILILELLTGKYP 555
S D+WS G + EL P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP 201
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 92.2 bits (228), Expect = 5e-21
Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 24/204 (11%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRL-EHPNLLPLTA 418
LG G + ++ + I+N + VVK + V ++ + IK L L PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 419 FYYRKEEKL--LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL 476
+ L++E V N L + ++K + Y H+
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS-- 147
Query: 477 PGSIIPHGHLKSSNVLLDRSFEPL-LTDYALRPLINPDNAHTLMV---AYKSPEYAHNGK 532
I H +K NV++D L L D+ L +P + + V +K PE + +
Sbjct: 148 --MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 533 -ISKKSDVWSLGILILELLTGKYP 555
D+WSLG ++ ++ K P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 9e-20
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 361 EVLGSGTFGASYK----TVISNGQAYVVKRYKQMNNVGREDFQEHIKR----LGRLEH-P 411
+VLG+G +G + + G+ Y +K K+ V + EH + L + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 412 NLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAY 471
L+ L + + + L+ +++ G L L QR + +V + +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEH 144
Query: 472 LHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYKSPEY---- 527
LH II + +K N+LLD + +LTD+ L D + EY
Sbjct: 145 LHKL---GII-YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 528 ---AHNGKISKKSDVWSLGILILELLTGKYP 555
+ K D WSLG+L+ ELLTG P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 3e-19
Identities = 42/200 (21%), Positives = 82/200 (41%), Gaps = 10/200 (5%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+GSG +G+ G VK+ + + + + ++ L ++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ + L G N K + L +I +++G+ Y+H+
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSA-- 140
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN-PDNAHTLMVAYKSPEYAHNGK-ISK 535
I H LK SN+ ++ E + D+ L + + Y++PE N ++
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 536 KSDVWSLGILILELLTGKYP 555
D+WS+G ++ ELLTG+
Sbjct: 199 TVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 48/256 (18%), Positives = 87/256 (33%), Gaps = 27/256 (10%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL------ 413
LG G F + + N +K + + V E ++ IK L R+ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 414 -----LPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKG 468
L L + K + V L + G+ +I K ++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 469 MAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRPLINPDNAHTLMV------A 521
+ Y+H I H +K NVL++ L + L N
Sbjct: 138 LDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 522 YKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581
Y+SPE +D+WS LI EL+TG + + + + + + +
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQIIEL 250
Query: 582 TGDVFDKEMKGAKYSK 597
G++ ++ KY++
Sbjct: 251 LGELPSYLLRNGKYTR 266
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 1e-18
Identities = 48/283 (16%), Positives = 94/283 (33%), Gaps = 25/283 (8%)
Query: 361 EVLGSGTFGASYK-TVISNGQAYVVKRYK--QMNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+G GTFG +K GQ +K+ IK L L+H N++ L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 418 AFYYRKEEKLLLYE---FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHN 474
K + ++ L + ++++ ++ G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 475 ELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMVAYK---SPEYAHNG 531
I H +K++NVL+ R L D+ L + + Y
Sbjct: 136 NK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 532 KI------SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585
+ D+W G ++ E+ T +QG + L+ + T +V
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALISQ--LCGSITPEV 245
Query: 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKI 628
+ Y K E++ K + + + ++I+K+
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.0 bits (196), Expect = 8e-17
Identities = 32/201 (15%), Positives = 71/201 (35%), Gaps = 12/201 (5%)
Query: 361 EVLGSGTFGASYKTV-ISNGQAYVVKRYKQ--MNNVGREDFQEHIKRLGRLEHPNLLPLT 417
+ +GSG G + +K+ + N + + + + H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 418 AFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP 477
+ ++ + L + D + ++ ++ G+ +LH+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLCGIKHLHSAGI 140
Query: 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNAHTLMV---AYKSPEYAHNGKIS 534
H LK SN+++ + D+ L T V Y++PE
Sbjct: 141 I----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 535 KKSDVWSLGILILELLTGKYP 555
+ D+WS+G ++ E++ K
Sbjct: 197 ENVDIWSVGCIMGEMVRHKIL 217
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 4e-14
Identities = 26/83 (31%), Positives = 35/83 (42%), Gaps = 20/83 (24%)
Query: 152 YMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPES 211
+ NNR+ GT+P L QL L L + N G++P+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-------------------- 289
Query: 212 LSKMDPSTFAGNKNLCGPPLDPC 234
L + D S +A NK LCG PL C
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 3e-13
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 12/167 (7%)
Query: 29 SDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGS----VWGLKLEQMN 84
D + LLQ K L + + L +W + C W GVLC + V L L +N
Sbjct: 6 QDKQALLQIKKDLGN-PTTLSSWLPTTDCCN---RTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 85 LSGTIA-AESLGLLSSLR--AVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDA 141
L SL L L + +NN P + K+ L +Y++ SG I D
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF- 120
Query: 142 FEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPE 188
+ +L L + N L+GT+P S+ LP L+ + + N+ G +P+
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 14/82 (17%), Positives = 30/82 (36%), Gaps = 1/82 (1%)
Query: 50 NWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNK 109
+ + G + L+ ++ GL L + GT+ + L L L +++ N
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNN 279
Query: 110 FEGPLPDLRKMGPLKSIYLSDN 131
G +P + ++N
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 16/59 (27%), Positives = 23/59 (38%), Gaps = 3/59 (5%)
Query: 106 MNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIP 163
NN+ G LP L ++ L S+ +S N G I + ANN+ P
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.6 bits (159), Expect = 6e-13
Identities = 33/199 (16%), Positives = 63/199 (31%), Gaps = 24/199 (12%)
Query: 361 EVLGSGTFGASYKTVISNGQAYVVKRYK----------QMNNVGREDFQEHIKRLGRLEH 410
+++G G A + VVK +K + + G F R R E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 411 PNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMA 470
L L K Y + N L + A + + +++ +++ +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVR---VENPDEVLDMILEEVA 117
Query: 471 YLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL-RPLINPDNAHTLMVAYKSPEYAH 529
++ I HG L NVL+ + D+ + L ++
Sbjct: 118 KFYHR----GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 530 NGKISKKSDVWSLGILILE 548
+ + D+ S IL+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.6 bits (143), Expect = 5e-10
Identities = 36/198 (18%), Positives = 64/198 (32%), Gaps = 29/198 (14%)
Query: 26 FGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNL 85
L++ E L+ + ++D + + N N G L ++ L L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQI 253
Query: 86 SGTIAAESLGLLSSLRAVSFMNNKFEGPLP---------------------DLRKMGPLK 124
S L L+ L + N+ P + + L
Sbjct: 254 SNLA---PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 125 SIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQG 184
+ L N S +T L++L+ ANN+++ SSL L + L N+
Sbjct: 311 YLTLYFNNISDISP---VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 185 QVPEIKQNEMRSLGLANN 202
P + LGL +
Sbjct: 366 LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 34/181 (18%), Positives = 63/181 (34%), Gaps = 29/181 (16%)
Query: 55 RNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPL 114
R + N + VL ++ L +S +L++L +S N+ +
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKDI- 234
Query: 115 PDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIP----------- 163
L + L + L++N S G+T L +L + N+++ P
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 164 ---------SSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSK 214
S + L L L L N P +++ L ANN++ SL+
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 215 M 215
+
Sbjct: 350 L 350
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.0 bits (123), Expect = 9e-08
Identities = 21/93 (22%), Positives = 41/93 (44%), Gaps = 2/93 (2%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKF 182
+ L +N + I D F+ + +L L + NN+++ P + L KL L L N+
Sbjct: 33 TALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 183 QGQVPEIKQNEMRSLGLANNELEGPIPESLSKM 215
+ +PE ++ L + NE+ + +
Sbjct: 92 KE-LPEKMPKTLQELRVHENEITKVRKSVFNGL 123
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 3/85 (3%)
Query: 146 TSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN--EMRSLGLANNE 203
L + NN++T L L L L NK P ++ L L+ N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 204 LEGPIPESLSKMDPSTFAGNKNLCG 228
L+ +PE + K +
Sbjct: 91 LKE-LPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 34/203 (16%), Positives = 62/203 (30%), Gaps = 17/203 (8%)
Query: 34 LLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGL-KLEQMNLSGT-IAA 91
L ++ + ++ N NG+ G+ KL + ++ T I
Sbjct: 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164
Query: 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151
GL SL + NK K + + + + L++L
Sbjct: 165 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224
Query: 152 YMANNRLTGTIPSSLVQLPKLMELRLEANK--------FQGQVPEIKQNEMRSLGLANNE 203
++ NN+L +P L + + L N F K+ + L +N
Sbjct: 225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN- 282
Query: 204 LEGPIPESLSKMDPSTFAGNKNL 226
P ++ PSTF
Sbjct: 283 -----PVQYWEIQPSTFRCVYVR 300
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 18/96 (18%), Positives = 41/96 (42%), Gaps = 3/96 (3%)
Query: 83 MNLSG-TIAAESLGLLSS--LRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISD 139
++L+G + + G L S + A + + PL + ++ + LS++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64
Query: 140 DAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMEL 175
+ L+ L + RL+ I ++L + L+ L
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 3e-06
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 8/85 (9%)
Query: 133 FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQN 192
S N + SL++L ++NN+L +P+ P+L L N +VPE+ QN
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQN 325
Query: 193 EMRSLGLANNELEG--PIPESLSKM 215
++ L + N L IPES+ +
Sbjct: 326 -LKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 13/67 (19%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 123 LKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTG----TIPSSLVQLPKLMELRLE 178
++S+ + S + + + + + + LT I S+L P L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 179 ANKFQGQ 185
+N+
Sbjct: 64 SNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 13/85 (15%), Positives = 33/85 (38%), Gaps = 11/85 (12%)
Query: 142 FEGMTSLKKLYMANNRLTGT----IPSSLVQLPKLMELRLEANKFQGQVPE-----IKQN 192
+ + L+ L++A+ ++ + + ++L+ L EL L N ++Q
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 193 E--MRSLGLANNELEGPIPESLSKM 215
+ L L + + + L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 12/90 (13%)
Query: 123 LKSIYLSDNGFSGNISD---DAFEGMTSLKKLYMANNRLTGTIPSSLVQ-----LPKLME 174
L+ ++L+D S + SL++L ++NN L LV+ L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 175 LRLEANKFQGQVPEIKQNEMRSLGLANNEL 204
L L + ++ + +++L L
Sbjct: 431 LVLYDIYWSEEMEDR----LQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 13/68 (19%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 114 LPDLRKMGPLKSIYLSDNGFSGNISDD---AFEGMTSLKKLYMANNRLTGTIPSSLVQLP 170
LP L++ + + L D G + D A +L +L + +N L ++Q
Sbjct: 23 LPLLQQ---CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 79
Query: 171 KLMELRLE 178
+ +++
Sbjct: 80 QTPSCKIQ 87
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 18/103 (17%), Positives = 36/103 (34%), Gaps = 7/103 (6%)
Query: 79 KLEQMNLSG---TIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSG 135
+ ++LS +L L L + +N E + + + L+ + L +N
Sbjct: 21 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQ 79
Query: 136 NISDDAFEGMTSLKKLYMANNRLTG--TIPSSLVQ-LPKLMEL 175
+ + L L + N L I L + LP + +
Sbjct: 80 SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 1e-04
Identities = 23/115 (20%), Positives = 45/115 (39%), Gaps = 7/115 (6%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
L L +L+ L L + + +N+ P L L+ + + +
Sbjct: 3 LHLAHKDLTVL---CHLEQLLLVTHLDLSHNRLRALPPAL---AALRCLEVLQASDNALE 56
Query: 138 SDDAFEGMTSLKKLYMANNRLTGT-IPSSLVQLPKLMELRLEANKFQGQVPEIKQ 191
+ D + L++L + NNRL + LV P+L+ L L+ N + ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 1e-04
Identities = 18/93 (19%), Positives = 35/93 (37%), Gaps = 5/93 (5%)
Query: 124 KSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQ 183
+ ++L+ + E + + L +++NRL P +L L L L+ N +
Sbjct: 1 RVLHLAHKDLT---VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE 56
Query: 184 GQVPEIKQNEMRSLGLANNELEG-PIPESLSKM 215
++ L L NN L+ + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 89
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 30/154 (19%), Positives = 49/154 (31%), Gaps = 1/154 (0%)
Query: 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNI 137
L L L + G L L + N+ G P+ + I
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93
Query: 138 SDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNE-MRS 196
S+ F G+ LK L + +N+++ +P S L L L L +N F E +R
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRK 153
Query: 197 LGLANNELEGPIPESLSKMDPSTFAGNKNLCGPP 230
L P + + ++ C
Sbjct: 154 KSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 2e-05
Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 3/61 (4%)
Query: 130 DNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI 189
DN + +D F G + L ++ R+ L L KL K ++P +
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
Query: 190 K 190
+
Sbjct: 242 E 242
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 16/79 (20%), Positives = 23/79 (29%), Gaps = 1/79 (1%)
Query: 105 FMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPS 164
N+ + P L P N + G+ +L L + N L TIP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 165 SLVQLPKLMELRLEANKFQ 183
L L N +
Sbjct: 190 GFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 4/65 (6%)
Query: 113 PLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172
P+ ++ K+ + + + D L+++ N L ++L+ +L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRL 57
Query: 173 MELRL 177
+L L
Sbjct: 58 TQLNL 62
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 41/232 (17%), Positives = 77/232 (33%), Gaps = 32/232 (13%)
Query: 27 GLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLNGSVWGLKLEQMNLS 86
+ IL + L +A AL + + +L ++L
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 87 GT----IAAESLGLLSSLRAVSFMNNKFEGPLPD-LRKMGPLKSIYLSDNGFSGNISDDA 141
+ L++L+ + +N + D R +G L ++L N S + + A
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERA 172
Query: 142 FEGMTSLKKLYMANNRLTGTIPSSLVQLP------------------------KLMELRL 177
F G+ SL +L + NR+ P + L L LRL
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 178 EANKFQGQVPEIKQ-NEMRSLGLANNELEGPIPESLSKMDPSTFAGNKNLCG 228
N + ++ +++E+ +P+ L+ D A N +L G
Sbjct: 233 NDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAAN-DLQG 283
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 12/64 (18%), Positives = 25/64 (39%), Gaps = 5/64 (7%)
Query: 115 PDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLME 174
L + L ++ DN S + +L ++++ NN+++ P L L
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP---LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 175 LRLE 178
+ L
Sbjct: 222 VTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 13/75 (17%), Positives = 29/75 (38%), Gaps = 10/75 (13%)
Query: 123 LKSIYLSDNGFSGN----ISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLE 178
L+++ L N + + E M L L + NR + + ++ ++ R
Sbjct: 275 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRG- 332
Query: 179 ANKFQGQVPEIKQNE 193
+G++ E+ E
Sbjct: 333 ----RGELDELDDME 343
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 634 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.67 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.55 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.55 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.46 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.46 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.35 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.32 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.3 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.27 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.24 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.23 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.22 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.13 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.12 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.08 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.04 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.02 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.93 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.46 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.36 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.15 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.14 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.05 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.98 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.93 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.93 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.29 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.04 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.68 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.56 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.46 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=411.04 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++|||||++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 4679999999999999988999999998753 456688999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .++|..++.|+.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+++......
T Consensus 89 ~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 89 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHhhcccc----CCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99875432 489999999999999999999998 79999999999999999999999999998765432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+|..|+|||++.+..++.++|||||||++|||+|+..|+.. .....+.+... ..+.. ...+.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~-------~~~~~~~~~~i-~~~~~--~~~p~----- 225 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDI-STGFR--LYKPR----- 225 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC-------SCCHHHHHHHH-HHTCC--CCCCT-----
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC-------CCCHHHHHHHH-HhcCC--CCCcc-----
Confidence 23457889999999999999999999999999999996544321 12222222222 22211 11111
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
...+++ .+++..||+.||++||||+||++.|++|+|
T Consensus 226 ~~~~~l---~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHV---YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHH---HHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 112344 455559999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=409.07 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=193.8
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+.. ..||||+++... ....+.|.+|+++|++++|||||+++|++. .+..++|||||++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 467999999999999864 359999987543 334578999999999999999999999875 467899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++..... .++|.+++.|+.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 90 L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 90 LYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp HHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999975432 399999999999999999999998 7999999999999999999999999999876432
Q ss_pred --CCccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 --NAHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||... .-...+...+..+........
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~--------~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC--------CCHHHHHHHHHHTSCCCCGGG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcCCCCCcchh
Confidence 22357889999999864 35899999999999999999999998621 111222223333222111111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
. .....+++. +++.+||+.||++||||+||++.|+.+++
T Consensus 234 -~--~~~~~~~l~---~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 234 -V--RSNCPKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -S--CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -c--cccchHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 111124444 45559999999999999999999998864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=413.01 Aligned_cols=246 Identities=23% Similarity=0.439 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEEcC-C---cEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN-G---QAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||+|+||+||+|+... + ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 4689999999999999743 3 25888887643 33345689999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++..... .++|.+++.|+.|||+||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 111 ~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 111 NGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999998875432 499999999999999999999998 79999999999999999999999999998765432
Q ss_pred C---------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 515 A---------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 515 ~---------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
. ..+|+.|||||++.+..++.++|||||||++|||+| |+.||.. ....+.+.. +..+....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~--------~~~~~~~~~-i~~~~~~~ 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD--------MTNQDVINA-IEQDYRLP 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHH-HHTTCCCC
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC--------CCHHHHHHH-HHcCCCCC
Confidence 1 234678999999999999999999999999999998 8999852 122222222 22221111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
......+++ .+++.+||+.||++||||+||++.|+++.
T Consensus 254 -------~~~~~~~~l---~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 254 -------PPMDCPSAL---HQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -------CCTTCCHHH---HHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCccchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111122444 44555999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=404.35 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||+++|++. ++..++|||||++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 4679999999999999988899999999754 445678999999999999999999999875 46679999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... ..++|.+++.|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 96 ~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 96 DFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp HHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred HHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 98765432 2399999999999999999999998 79999999999999999999999999998765432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+++.|+|||++.+..++.++|||||||++|||+||..|+.. .....+.. ..+..+.... . +.
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-------~~~~~~~~-~~i~~~~~~~-----~--p~ 233 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-------GMTNPEVI-QNLERGYRMV-----R--PD 233 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHH-HHHHTTCCCC-----C--CT
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC-------CCCHHHHH-HHHHhcCCCC-----C--cc
Confidence 23467789999999999999999999999999999997666431 11222222 2222221111 0 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
...+++ .+++.+||+.||++||||+||++.|+.+
T Consensus 234 ~~~~~l---~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 234 NCPEEL---YQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cChHHH---HHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 122344 4555599999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-50 Score=405.41 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=202.1
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+.. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+++..++|||||++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 468999999999999975 4889999998754 44577899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCCC---
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDNA--- 515 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 515 (634)
.+++..... ..++|..++.|+.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 101 ~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 101 LDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp HHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred HHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 999976433 2499999999999999999999998 799999999999999999999999999988755432
Q ss_pred --ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 516 --HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 516 --~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
..+++.|+|||++.+..|+.++|||||||++|||+||..|+.. .....+ +...+..+...+ . .
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-------~~~~~~-~~~~i~~~~~~~-----~--~ 238 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQ-VYELLEKDYRME-----R--P 238 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-------TCCHHH-HHHHHHTTCCCC-----C--C
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-------cchHHH-HHHHHhcCCCCC-----C--C
Confidence 2356789999999999999999999999999999998777531 122222 222222221111 1 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+++ .+++..||+.||++||||+||++.|+.+.+
T Consensus 239 ~~~~~~l---~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ccchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122444 455559999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=396.58 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=202.2
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
.+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 4689999999999999988889999999864 445788999999999999999999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-----
Q 038422 440 GKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN----- 514 (634)
Q Consensus 440 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 514 (634)
+++..... .+++..+.+++.|||+||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 88 ~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 88 NYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred Hhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99876543 389999999999999999999998 89999999999999999999999999998654432
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...+|..|+|||.+.+..++.|+|||||||++|||+| |+.||.. ....+ +...+..+.. ...+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~--------~~~~~-~~~~i~~~~~--~~~p----- 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER--------FTNSE-TAEHIAQGLR--LYRP----- 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------SCHHH-HHHHHHTTCC--CCCC-----
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC--------CCHHH-HHHHHHhCCC--CCCc-----
Confidence 2346778999999999999999999999999999998 8999862 22222 2223333211 1111
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
....+++. +++.+||+.||++|||++||++.|.+|
T Consensus 224 ~~~~~~l~---~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVY---TIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHH---HHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHH---HHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11224444 455599999999999999999999765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=398.56 Aligned_cols=240 Identities=21% Similarity=0.354 Sum_probs=198.1
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+. .+|+.||+|+++.......+.+.+|++++++++|||||++++++.+++..|+|||||++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 36799999999999995 56899999999876666778899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 9987642 389999999999999999999998 8999999999999999999999999999876443 2
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ..-.+.+......... ..-.+ .
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~~~~~~~~-~~~~~-----~ 240 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------ENPLRALYLIATNGTP-ELQNP-----E 240 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHHCSC-CCSSG-----G
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC--------CCHHHHHHHHHhCCCC-CCCCc-----c
Confidence 34578899999999999999999999999999999999999851 1222223333322211 11000 1
Q ss_pred CCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++.++++ +||+.||++|||++|+++
T Consensus 241 ~~s~~~~~li~---~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHH---HHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 11244555554 999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=393.41 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=197.4
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+.. +++.||+|++... +....+.+.+|++++++++|||||++++++.+++..++|||||+
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4578999999999999975 5889999998643 23456789999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999997643 399999999999999999999998 89999999999999999999999999998765443
Q ss_pred --CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 515 --AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
...+|+.|||||++.+..++.++|||||||++|||+||+.||.. ....+..... ..... .+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i-~~~~~------~~-- 223 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--------NTYQETYKRI-SRVEF------TF-- 223 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHH-HTTCC------CC--
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC--------CCHHHHHHHH-HcCCC------CC--
Confidence 34578999999999999999999999999999999999999861 2222222222 22111 11
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+....+++.+++. +||+.||++|||++|+++
T Consensus 224 p~~~s~~~~~li~---~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHH---HHccCCHhHCcCHHHHHc
Confidence 1112345555555 999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=400.36 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=194.8
Q ss_pred ccCccCceeEEEEEEc---CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 362 VLGSGTFGASYKTVIS---NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++|||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999864 35579999997543 3345789999999999999999999999864 56899999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC---
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN--- 514 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 514 (634)
|.+++..... .+++.+++.|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999864432 499999999999999999999998 79999999999999999999999999998765432
Q ss_pred ----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 ----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+. ...+..+...+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--------~~~~~-~~~i~~~~~~~~---- 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEV-MAFIEQGKRMEC---- 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHH-HHHHHTTCCCCC----
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC--------CHHHH-HHHHHcCCCCCC----
Confidence 2346788999999999999999999999999999998 89998621 11122 222333322111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
+....+++. +|+..||+.||++||||.+|++.|+.+
T Consensus 234 ---p~~~~~~l~---~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 ---PPECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---CTTCCHHHH---HHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcCCHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111224444 455599999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=398.27 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=193.0
Q ss_pred cccCccCceeEEEEEEcC---CcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 361 EVLGSGTFGASYKTVISN---GQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
+.||+|+||+||+|.+.+ ++.||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998653 4689999986532 2234679999999999999999999999864 567899999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC-
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN- 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 514 (634)
|+|.+++.... .++|.+++.|+.|||.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999987543 399999999999999999999998 79999999999999999999999999998765432
Q ss_pred ------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 515 ------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 515 ------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+ +...+..+...+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~--------~~~~~-~~~~i~~~~~~~~-- 231 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------MKGSE-VTAMLEKGERMGC-- 231 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHH-HHHHHHTTCCCCC--
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC--------CCHHH-HHHHHHcCCCCCC--
Confidence 2346788999999999999999999999999999998 8999862 11122 2222333221111
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
+....+++. +|+.+||+.||++||||+||+++|+..
T Consensus 232 -----p~~~~~~~~---~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 -----PAGCPREMY---DLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -----CTTCCHHHH---HHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CcccCHHHH---HHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 111224444 455599999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=397.78 Aligned_cols=247 Identities=21% Similarity=0.406 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEEcCC-----cEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISNG-----QAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.++||+|+||+||+|++... ..||||+++... ....++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 46899999999999997643 379999986532 333457999999999999999999999999999999999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|++.+++..... .++|.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999998876543 399999999999999999999998 7999999999999999999999999999876443
Q ss_pred C-------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 N-------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~-------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
. ...+|+.|||||++.+..++.++|||||||++|||+||..|+.. .....+.. ..+..+.....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~-------~~~~~~~~-~~i~~~~~~~~- 234 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVM-KAINDGFRLPT- 234 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHH-HHHHTTCCCCC-
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc-------cCCHHHHH-HHHhccCCCCC-
Confidence 2 12357789999999999999999999999999999997666531 11222222 22222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.....++ +.+|+.+||+.||++||||+||++.|+++.
T Consensus 235 ------~~~~~~~---l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 235 ------PMDCPSA---IYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ------CTTCBHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------chhhHHH---HHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1111233 445566999999999999999999998874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=390.43 Aligned_cols=241 Identities=22% Similarity=0.341 Sum_probs=189.7
Q ss_pred cccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEe----CCceEEEEEcC
Q 038422 361 EVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR----KEEKLLLYEFV 433 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~ 433 (634)
+.||+|+||+||+|+.. +++.||+|++.... ....+.|.+|+++|++++|||||+++++|.+ +...++|||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 57999999999999965 57899999986542 3345679999999999999999999999875 34578999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC-CCCCeEEeccccCCccCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD-RSFEPLLTDYALRPLINP 512 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~ 512 (634)
++|+|.+++.... .+++.++..++.||+.||+|||++.+ +|+||||||+|||++ +++.+||+|||+++....
T Consensus 95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~--~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTP--PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSS--CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCC--CEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999997653 38999999999999999999999721 399999999999996 578999999999987554
Q ss_pred CC--CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 513 DN--AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 513 ~~--~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
.. ...+|+.|||||++.+ .++.++|||||||++|||+||+.||... ..... +...+..+.....+++.
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~-~~~~i~~~~~~~~~~~~- 237 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQ-IYRRVTSGVKPASFDKV- 237 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHH-HHHHHTTTCCCGGGGGC-
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHH-HHHHHHcCCCCcccCcc-
Confidence 43 3457899999998865 6999999999999999999999998511 12222 22222222211111111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..+++.++ +.+||+.||++|||++|+++
T Consensus 238 -----~~~~~~~l---i~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 -----AIPEVKEI---IEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----CCHHHHHH---HHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCHHHHHH---HHHHccCCHhHCcCHHHHhC
Confidence 12344444 45999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=397.60 Aligned_cols=242 Identities=23% Similarity=0.360 Sum_probs=195.9
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||+||+|+.. +++.||+|+++.......+.+.+|+++|++++|||||++++++.+++..++|||||++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 467999999999999964 6889999999876666678899999999999999999999999999999999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----C
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD----N 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 514 (634)
.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 97 ~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 97 DAVMLELER----PLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999875432 399999999999999999999998 8999999999999999999999999998754322 3
Q ss_pred CccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 515 AHTLMVAYKSPEYAH-----NGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~-----~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
...+|+.|+|||++. ...|+.++|||||||++|||+||+.||... . ...+ +...... .......+
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~----~-~~~~---~~~i~~~-~~~~~~~~- 238 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL----N-PMRV---LLKIAKS-EPPTLAQP- 238 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS----C-GGGH---HHHHHHS-CCCCCSSG-
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC----C-HHHH---HHHHHcC-CCCCCCcc-
Confidence 456788999999984 456899999999999999999999998621 1 1111 1122221 11111111
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.++++ +||+.||++|||++|+++
T Consensus 239 ----~~~s~~~~~li~---~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 ----SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTT
T ss_pred ----ccCCHHHHHHHH---HHccCChhHCcCHHHHhc
Confidence 111244555554 999999999999999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=394.02 Aligned_cols=241 Identities=22% Similarity=0.334 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|+++|++++|||||++++++.+++..++|||||++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 46899999999999996 468999999987543 2334678999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 90 L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 90 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999986432 399999999999999999999998 8999999999999999999999999999865322
Q ss_pred --CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|+.|||||++.+..+ +.++|||||||++|||+||+.||.... .....+ .. ........ ...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~-~~-~~~~~~~~---~~~ 229 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEY-SD-WKEKKTYL---NPW 229 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS------TTSHHH-HH-HHTTCTTS---TTG
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC------hHHHHH-HH-HhcCCCCC---Ccc
Confidence 23457899999999988776 578999999999999999999986211 111111 11 11111100 001
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
. ...+++.+ ++.+||+.||++|||++|+++
T Consensus 230 ~---~~s~~~~~---li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 K---KIDSAPLA---LLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp G---GSCHHHHH---HHHHHSCSSTTTSCCHHHHTT
T ss_pred c---cCCHHHHH---HHHHHcCCChhHCcCHHHHhc
Confidence 0 11234444 445999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=394.70 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=185.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEe--CCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--KEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+|+. .+|+.||+|.++... ....+.+.+|++++++++|||||++++++.+ .+..|+|||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 46899999999999996 468999999987543 2334678999999999999999999999975 456899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELP-GSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
+|+|.+++...... ...+++.+++.++.||+.||+|||+... ..+|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 99999998754322 2349999999999999999999998631 124999999999999999999999999999876543
Q ss_pred C----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 514 N----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 514 ~----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. ...+|+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+.. ..+..+....+ .
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~--------~~~~~~~-~~i~~~~~~~~-~-- 235 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--------FSQKELA-GKIREGKFRRI-P-- 235 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHH-HHHHHTCCCCC-C--
T ss_pred CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC--------CCHHHHH-HHHHcCCCCCC-C--
Confidence 2 34578899999999999999999999999999999999999862 1222222 22233222111 1
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... .+++.++++ +||+.||++|||++|+++
T Consensus 236 ---~~~-s~~l~~li~---~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 ---YRY-SDELNEIIT---RMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---TTS-CHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred ---ccc-CHHHHHHHH---HHcCCChhHCcCHHHHHh
Confidence 112 244555554 999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=392.07 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=195.7
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCCh
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGSL 438 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 438 (634)
..+.||+|+||+||+|+..+++.||||+++.. ....+.|.+|+.++++++|||||+++|+|. .+..++|||||++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 45789999999999999988889999998754 456688999999999999999999999984 5678999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC----
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN---- 514 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 514 (634)
..++...... .++|.+++.|+.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+++......
T Consensus 99 ~~~~~~~~~~---~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 99 LDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp HHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhhhhhcccc---cchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9988764332 399999999999999999999998 79999999999999999999999999998764432
Q ss_pred -CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 515 -AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 515 -~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
...+|..|+|||++..+.++.++|||||||++|||+||..|+.. .....+.+.. +..+..... .
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~-------~~~~~~~~~~-i~~~~~~~~-~------ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------GMVNREVLDQ-VERGYRMPC-P------ 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHH-HHTTCCCCC-C------
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC-------CCCHHHHHHH-HHhcCCCCC-C------
Confidence 23467889999999999999999999999999999997766531 1222222222 222211111 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
....+++ .+++.+||+.||++||+|+||+++|+...
T Consensus 237 ~~~~~~l---~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 PECPESL---HDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cccCHHH---HHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1122444 45555999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=396.58 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=196.5
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCcc---ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV---GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 346799999999999995 46889999998754322 23568899999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
+|+|..++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 99 ~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (309)
T d1u5ra_ 99 GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (309)
T ss_dssp EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence 999976665432 399999999999999999999998 89999999999999999999999999999887777
Q ss_pred CccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 515 AHTLMVAYKSPEYAHN---GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~---~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
...+|+.|||||++.+ ..|+.++|||||||++|||+||+.||.. ..-.+.+....... .....
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~--------~~~~~~~~~i~~~~-~~~~~----- 235 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNE-SPALQ----- 235 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSC-CCCCS-----
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCC-CCCCC-----
Confidence 7889999999999864 4689999999999999999999999851 12222222222221 11111
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.. ...+++.++++ +||+.||++|||++|+++
T Consensus 236 ~~-~~s~~~~~li~---~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 SG-HWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CT-TSCHHHHHHHH---HHTCSSGGGSCCHHHHTT
T ss_pred CC-CCCHHHHHHHH---HHCcCChhHCcCHHHHHh
Confidence 11 12345555555 999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=401.64 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=194.8
Q ss_pred hccccCccCceeEEEEEEcC-C-----cEEEEEEeccc-CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVISN-G-----QAYVVKRYKQM-NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..++||+|+||+||+|+... + ..||+|.+... .......+.+|+++|.++ +|||||+++++|.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 45789999999999999643 2 36899988653 344556899999999998 8999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEE
Q 038422 431 EFVENGSLAGKLHANHTK------------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVL 492 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 492 (634)
|||++|+|.++|...... ....++|.+++.|+.||+.||+|||++ +|+||||||+|||
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp~Nil 196 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVL 196 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCchhccc
Confidence 999999999999764321 123489999999999999999999998 7999999999999
Q ss_pred eCCCCCeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCC
Q 038422 493 LDRSFEPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDS 565 (634)
Q Consensus 493 l~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~ 565 (634)
++.++.+||+|||+|+...... ...+|+.|||||++.+..++.++|||||||++|||+| |+.||... ..
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~----~~ 272 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI----PV 272 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----CC
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC----CH
Confidence 9999999999999998765433 2335788999999999999999999999999999998 89998621 11
Q ss_pred CCcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHH
Q 038422 566 KASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIE 629 (634)
Q Consensus 566 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~ 629 (634)
...+ ...+..+...+ .+....+++.+ |+..||+.||++||||+||++.|.
T Consensus 273 ~~~~----~~~~~~~~~~~-------~p~~~~~~l~~---li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANF----YKLIQNGFKMD-------QPFYATEEIYI---IMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHH----HHHHHTTCCCC-------CCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH----HHHHhcCCCCC-------CCCcCCHHHHH---HHHHHcCCChhHCcCHHHHHHHHh
Confidence 1122 22232221111 11122344444 555999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=388.13 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=191.3
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEe-CCceEEEEEcCCCCCh
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR-KEEKLLLYEFVENGSL 438 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL 438 (634)
.+.||+|+||.||+|++ .|+.||||+++.. ...+.|.+|++++++++|||||+++|+|.+ ++..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 47799999999999998 5788999999753 455789999999999999999999999965 4568999999999999
Q ss_pred hhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-CCcc
Q 038422 439 AGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-NAHT 517 (634)
Q Consensus 439 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 517 (634)
.+++...... .++|..+++|+.|||.||+|||+. +|+||||||+|||++.++.+|++|||+++..... ....
T Consensus 89 ~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~ 161 (262)
T d1byga_ 89 VDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 161 (262)
T ss_dssp HHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred HHHHHhcCCC---CCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCCcccc
Confidence 9999754321 389999999999999999999998 7999999999999999999999999999876543 2345
Q ss_pred ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCCCC
Q 038422 518 LMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAKYS 596 (634)
Q Consensus 518 ~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 596 (634)
++..|+|||++.+..+++++|||||||++|||+| |+.|+.. .....+.+++ ..+...+. . ...
T Consensus 162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-----~~~~~~~~~i----~~~~~~~~-----~--~~~ 225 (262)
T d1byga_ 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-----IPLKDVVPRV----EKGYKMDA-----P--DGC 225 (262)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-----SCGGGHHHHH----TTTCCCCC-----C--TTC
T ss_pred ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-----CCHHHHHHHH----HcCCCCCC-----C--ccC
Confidence 6778999999999999999999999999999999 6777652 1223344333 22211111 1 112
Q ss_pred HHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 597 KSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 597 ~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+++.++ +.+||+.||++||||+||+++|++++.
T Consensus 226 ~~~~~~l---i~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 226 PPAVYEV---MKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CHHHHHH---HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHH---HHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2445554 459999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=401.42 Aligned_cols=190 Identities=25% Similarity=0.375 Sum_probs=168.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.+++..++|||||++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 46799999999999996 468999999987543 3335678999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--CC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--NA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 515 (634)
|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 999997653 3999999999999999999999742 6999999999999999999999999999865332 34
Q ss_pred ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 516 HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 516 ~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..+|..|+|||++.+..|+.++||||+||++|||+||+.||.
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 568899999999999999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=392.51 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=196.3
Q ss_pred ccccCccCceeEEEEEEcCC----cEEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeC-CceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISNG----QAYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-EEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~~ 433 (634)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|+++|++++|||||+++|+|.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 36899998753 333457899999999999999999999998764 5789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..+++++.|+|.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999875433 388999999999999999999998 7999999999999999999999999999876433
Q ss_pred C--------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 514 N--------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 514 ~--------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
. ...+|..|+|||++.+..++.++||||||+++|||+||+.|+.... ....+..+ . ..+....
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~~~~~~~~---i-~~g~~~~- 254 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY---L-LQGRRLL- 254 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH---H-HTTCCCC-
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----CHHHHHHH---H-HcCCCCC-
Confidence 2 2346788999999999999999999999999999999888865211 11122222 2 2222111
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
. +....+++. +++.+||+.||++||+|+||++.|+++.+
T Consensus 255 -~-----p~~~~~~l~---~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 255 -Q-----PEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -C-----CTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C-----cccCcHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 112234444 55559999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=392.18 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=199.8
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccCcc-ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMNNV-GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|+.. +++.||||+++..... ..++|.+|++++++++||||++++++|.+.+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 467999999999999964 3578999998754322 356799999999999999999999999999999999999
Q ss_pred CCCCChhhHHhhccC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEe
Q 038422 433 VENGSLAGKLHANHT-------------------KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLL 493 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 493 (634)
+++|+|.+++..... .....++|.+++.|+.|+|.||+|||+. +|+||||||+|||+
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlKp~NILl 173 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLV 173 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEE
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEcccceEE
Confidence 999999999975321 1123489999999999999999999998 79999999999999
Q ss_pred CCCCCeEEeccccCCccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CcccccccCCCC
Q 038422 494 DRSFEPLLTDYALRPLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKY-PENYLLQGYDSK 566 (634)
Q Consensus 494 ~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~-P~~~~~~~~~~~ 566 (634)
|.++.+||+|||+++..... ....+++.|+|||.+.+..|+.++|||||||++|||+||.. ||..
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-------- 245 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-------- 245 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC--------
Confidence 99999999999998765332 22345678999999999999999999999999999999864 5541
Q ss_pred CcHHHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 567 ASLSNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 567 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+... .+.++...+. +....++ +.+|+.+||+.||++||||+||+++|++|.|
T Consensus 246 ~~~~e~~~-~v~~~~~~~~-------p~~~~~~---~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 MAHEEVIY-YVRDGNILAC-------PENCPLE---LYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SCHHHHHH-HHHTTCCCCC-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHH-HHHcCCCCCC-------CccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22222222 2333322211 1111233 4556669999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=392.98 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=195.4
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccCccChhHH--HHHHHHHhcCCCCccccceeEEEeCC----ceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDF--QEHIKRLGRLEHPNLLPLTAFYYRKE----EKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e~~ 433 (634)
.+.||+|+||+||+|++ +|+.||||+++.. ..+++ ..|+..+.+++|||||+++|+|.+.+ ..++|||||
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 46799999999999986 6889999998643 23333 34555567889999999999998754 578999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL----PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
++|+|.++++.. .++|.++++++.|+|.||+|||+.. ...+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 84 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999753 3899999999999999999999731 112799999999999999999999999999876
Q ss_pred cCCC--------CCccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCcccccccCCC------CCcH
Q 038422 510 INPD--------NAHTLMVAYKSPEYAHNG------KISKKSDVWSLGILILELLTGKYPENYLLQGYDS------KASL 569 (634)
Q Consensus 510 ~~~~--------~~~~~~~~y~aPE~~~~~------~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~------~~~l 569 (634)
.... ....+|+.|+|||++.+. .++.|+|||||||++|||+||..|+......... ....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 5432 223578899999998754 2678999999999999999999886532111100 0111
Q ss_pred HHHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 570 SNWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 570 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
.+........+.. ++.+.......+....+.+++.+||+.||++||||.||++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2223333322222 22221111123455667788889999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-47 Score=387.02 Aligned_cols=243 Identities=20% Similarity=0.319 Sum_probs=180.8
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||||++|
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3578999999999999964 58899999987543 233457889999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC---CCCCeEEeccccCCccCCC
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD---RSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~ 513 (634)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 93 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 93 ELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp BHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred cHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999997532 399999999999999999999998 899999999999994 5789999999999876543
Q ss_pred C---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 N---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
. ...+|+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+...... .... . ++...
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~-~~~~-~-~~~~~ 232 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD--------ENDAKLFEQIL-KAEY-E-FDSPY 232 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHH-TTCC-C-CCTTT
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHHh-ccCC-C-CCCcc
Confidence 2 34578999999999999999999999999999999999999861 12222222222 1111 0 11111
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+++.+++ .+||+.||++|||++|+++
T Consensus 233 --~~~~s~~~~~li---~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 --WDDISDSAKDFI---RHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --TTTSCHHHHHHH---HHHSCSSGGGSCCHHHHHH
T ss_pred --ccCCCHHHHHHH---HHHccCCHhHCcCHHHHhc
Confidence 011124455554 4999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=385.13 Aligned_cols=239 Identities=21% Similarity=0.313 Sum_probs=194.2
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+. .+++.||||+++.. +....+.+.+|+++|++++|||||++++++.+++..|+|||||+
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 357899999999999996 46899999998643 23445789999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999987654 399999999999999999999998 8999999999999999999999999999876432
Q ss_pred -----CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccc
Q 038422 514 -----NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDK 588 (634)
Q Consensus 514 -----~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 588 (634)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... ....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~-~~~~------ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--------GNEYLIFQKII-KLEY------ 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-TTCC------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC--------cCHHHHHHHHH-cCCC------
Confidence 234578999999999999999999999999999999999999861 12222222222 2111
Q ss_pred ccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 EMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.+. ....+++.+++ .+||+.||++|||++|+++
T Consensus 228 ~~p--~~~s~~~~~li---~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFP--EKFFPKARDLV---EKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCC--TTCCHHHHHHH---HTTSCSSGGGSTTSGGGTC
T ss_pred CCC--ccCCHHHHHHH---HHHccCCHhHCcCHHHHcC
Confidence 111 11224454454 4999999999999998743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-46 Score=390.91 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=198.3
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 357899999999999996 4689999999987665666789999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC--CCCCeEEeccccCCccCCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD--RSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~~~~~~ 515 (634)
|.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 110 L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 110 LFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp HHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999864332 399999999999999999999998 899999999999996 457899999999987765433
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..+|+.|||||++.+..++.++|||||||++|||+||+.||.. ....+.+......... ++.....
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~---~~~~~~~ 250 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG--------ENDDETLRNVKSCDWN---MDDSAFS 250 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCC---SCCGGGG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC---CCccccc
Confidence 4568899999999999999999999999999999999999851 2222333332222111 1111100
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
...+++.+++ .+||+.||++|||++|+++
T Consensus 251 --~~s~~~~~li---~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 251 --GISEDGKDFI---RKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --GCCHHHHHHH---HHHCCSSGGGSCCHHHHHH
T ss_pred --CCCHHHHHHH---HHHccCChhHCcCHHHHhc
Confidence 1124445554 4999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=382.72 Aligned_cols=247 Identities=19% Similarity=0.322 Sum_probs=188.4
Q ss_pred hccccCccCceeEEEEEEcC----CcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 359 SAEVLGSGTFGASYKTVISN----GQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
..+.||+|+||+||+|+... +..||+|.++... ...++.|.+|+++|++++|||||+++|+|. .+..++||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 35789999999999998643 3468888886543 333567999999999999999999999985 56789999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 90 TLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp TTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999998865432 389999999999999999999998 7999999999999999999999999999876433
Q ss_pred C-----CccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 514 N-----AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 514 ~-----~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
. ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ....+... +..+..... .
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~-----~~~~~~~~----i~~~~~~~~-~ 231 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDVIGR----IENGERLPM-P 231 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHH----HHTTCCCCC-C
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC-----CHHHHHHH----HHcCCCCCC-C
Confidence 2 2345788999999999999999999999999999998 88888622 11223222 222221111 1
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
....+++.+ ++..||+.||++|||++||++.|+++.+
T Consensus 232 ------~~~~~~~~~---li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 232 ------PNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ------TTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCHHHHH---HHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112244544 4559999999999999999999998854
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=378.63 Aligned_cols=243 Identities=25% Similarity=0.380 Sum_probs=195.1
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccC------ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN------NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+++..++|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999996 468999999986432 2245789999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC----CeEEeccccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF----EPLLTDYALR 507 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 507 (634)
||++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+|++|||++
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999997653 399999999999999999999998 799999999999998776 4999999999
Q ss_pred CccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 508 PLINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 508 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
+...... ...+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+...... .... .
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~-~~~~-~ 234 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANVS-AVNY-E 234 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-TTCC-C
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC--------CCHHHHHHHHH-hcCC-C
Confidence 8765432 34567889999999999999999999999999999999999862 12222222221 1111 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+... ....+++.++ +.+||+.||++|||++|+++
T Consensus 235 -~~~~~~--~~~s~~~~~l---i~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDEYF--SNTSALAKDF---IRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHHHH--TTSCHHHHHH---HHTTSCSSGGGSCCHHHHHH
T ss_pred -CCchhc--CCCCHHHHHH---HHHHccCChhHCcCHHHHhc
Confidence 011110 0112344444 45999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=380.96 Aligned_cols=245 Identities=21% Similarity=0.293 Sum_probs=187.9
Q ss_pred ccccCccCceeEEEEEEcC--C--cEEEEEEecccC---ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVISN--G--QAYVVKRYKQMN---NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.+.||+|+||+||+|++.. + ..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 4679999999999998643 2 378999886542 2234689999999999999999999999965 567899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|++|++.+++..... .+++..++.++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 92 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999998876543 399999999999999999999998 799999999999999999999999999987654
Q ss_pred CCC-------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 513 DNA-------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 513 ~~~-------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.. ....+.+......+...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~--------~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGERLP 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCCCCC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC--------cCHHHHHHHHHhCCCCCC
Confidence 322 235678999999999999999999999999999998 8999851 223333333333321111
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
. ......++ .+++..||+.||++||||+||++.|++.
T Consensus 236 ~-------~~~~~~~l---~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 R-------PEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C-------CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------cccccHHH---HHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11112344 4555599999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=387.23 Aligned_cols=245 Identities=21% Similarity=0.380 Sum_probs=192.5
Q ss_pred ccccCccCceeEEEEEEc-CCc----EEEEEEeccc-CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQ----AYVVKRYKQM-NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 433 (634)
.++||+|+||+||+|+.. +|+ .||+|+++.. +....++|.+|++++++++|||||+++|+|.+ +..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEec
Confidence 478999999999999864 344 5888888643 34456789999999999999999999999976 4678889999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|+|.+++..... .+++..++.|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 93 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp TTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred cCCccccccccccc----CCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999998876543 399999999999999999999998 7999999999999999999999999999876443
Q ss_pred CC------ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHHHHHHHHHhccCCccc
Q 038422 514 NA------HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVF 586 (634)
Q Consensus 514 ~~------~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 586 (634)
.. ..+|..|+|||++.++.++.++|||||||++|||+| |+.||+.. ....+.. .+..+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-----~~~~~~~----~i~~~~~~~-- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISS----ILEKGERLP-- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CGGGHHH----HHHHTCCCC--
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-----CHHHHHH----HHHcCCCCC--
Confidence 22 235788999999999999999999999999999999 78887521 1122322 222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 587 DKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 587 d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+....++ +.+++.+||+.||++||||+||++.|+.+.
T Consensus 234 -----~p~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 234 -----QPPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -----CCTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCcccCHH---HHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11111233 445555999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.6e-46 Score=388.81 Aligned_cols=244 Identities=22% Similarity=0.389 Sum_probs=197.8
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||+||+|+. .+|+.||+|+++.......+.+.+|+++|++++|||||++++++.+++..|+|||||++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 347899999999999996 4699999999987655556788999999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC--CCCCeEEeccccCCccCCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD--RSFEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~~~~~~ 515 (634)
|.+++.... ..+++.++..|+.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+|+.......
T Consensus 113 L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 113 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 998875432 2499999999999999999999998 899999999999998 578999999999988765533
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..+|+.|+|||++.+..++.++||||+||++|||+||+.||.. ....+........ .. . +....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~-~~-~-~~~~~-- 251 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--------EDDLETLQNVKRC-DW-E-FDEDA-- 251 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHC-CC-C-CCSST--
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhC-CC-C-CCccc--
Confidence 3567889999999999999999999999999999999999861 1222222222221 11 0 11111
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
.....+++.+++ .+||+.||.+|||++|+++
T Consensus 252 ~~~~s~~~~~li---~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 FSSVSPEAKDFI---KNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTSCHHHHHHH---HTTSCSSGGGSCCHHHHHT
T ss_pred ccCCCHHHHHHH---HHHccCChhHCcCHHHHhc
Confidence 011224455554 4999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=384.71 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=195.3
Q ss_pred ccccCccCceeEEEEEEcC-Cc--EEEEEEeccc-CccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVISN-GQ--AYVVKRYKQM-NNVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 4789999999999999754 44 4778887543 344567899999999998 79999999999999999999999999
Q ss_pred CCChhhHHhhcc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEec
Q 038422 435 NGSLAGKLHANH-----------TKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTD 503 (634)
Q Consensus 435 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 503 (634)
+|+|.++++... ......++|.++..++.|||.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCceEEcc
Confidence 999999997542 11234599999999999999999999998 799999999999999999999999
Q ss_pred cccCCccCCCC---CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CcccccccCCCCCcHHHHHHHHHHh
Q 038422 504 YALRPLINPDN---AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKY-PENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 504 fGla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~-P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
||+++...... ...+|..|+|||.+.+..++.++|||||||++|||+||.. ||.. ....+.. ..+.+
T Consensus 171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--------~~~~~~~-~~i~~ 241 (309)
T d1fvra_ 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELY-EKLPQ 241 (309)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHH-HHGGG
T ss_pred ccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--------CCHHHHH-HHHHh
Confidence 99987654332 3346788999999999999999999999999999999765 5531 2222222 22222
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+... .. .....+++.+++ .+||+.||++||||+||++.|+++.+
T Consensus 242 ~~~~-----~~--~~~~~~~~~~li---~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 GYRL-----EK--PLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TCCC-----CC--CTTBCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC-----CC--CccCCHHHHHHH---HHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2111 11 111224555555 49999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.3e-46 Score=374.09 Aligned_cols=250 Identities=18% Similarity=0.259 Sum_probs=196.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccC---hhHHHHHHHHHhcCCCCccccceeEEEeCCc----eEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVG---REDFQEHIKRLGRLEHPNLLPLTAFYYRKEE----KLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lv~e 431 (634)
.+.||+|+||+||+|+. .+|+.||+|+++...... .+.|.+|++++++++|||||++++++...+. .|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 46899999999999996 568999999997543322 3578999999999999999999999987543 789999
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.++..+++|||.++...
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999887654 399999999999999999999998 89999999999999999999999999876543
Q ss_pred CC-------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCc
Q 038422 512 PD-------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGD 584 (634)
Q Consensus 512 ~~-------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 584 (634)
.. ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ..-.+............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------DSPVSVAYQHVREDPIP- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCCCC-
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC--------cCHHHHHHHHHhcCCCC-
Confidence 22 233578899999999999999999999999999999999999862 22233333333332211
Q ss_pred ccccccccCCCCHHHHHHHHHHHhcccccCccCCC-CHHHHHHHHHhhhcC
Q 038422 585 VFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARM-ELKEVIEKIERLKEG 634 (634)
Q Consensus 585 ~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~evl~~L~~i~~~ 634 (634)
+..... ...+++.++++ +|++.||++|| |++|+++.|.++++|
T Consensus 234 ---~~~~~~-~~s~~l~~li~---~~L~~dp~~R~~sa~~l~~~l~r~~ng 277 (277)
T d1o6ya_ 234 ---PSARHE-GLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 277 (277)
T ss_dssp ---GGGTSS-SCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHHHC-
T ss_pred ---Cchhcc-CCCHHHHHHHH---HHccCCHhHCHhHHHHHHHHHHHHhCc
Confidence 111111 12345555555 99999999999 899999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=382.47 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=187.7
Q ss_pred ccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCC-ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKE-EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~lv~ 430 (634)
.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++.++ +|+|||.+++++...+ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 478999999999999864 24689999987533 23345677888887776 6899999999987654 689999
Q ss_pred EcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCe
Q 038422 431 EFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEP 499 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 499 (634)
|||++|+|.+++...... ....++|.+++.++.||++||+|||++ +|+||||||+|||+++++.+
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NILl~~~~~~ 173 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVV 173 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCccceeECCCCcE
Confidence 999999999999754321 123489999999999999999999998 79999999999999999999
Q ss_pred EEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCcccccccCCCCCcHHHH
Q 038422 500 LLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK-YPENYLLQGYDSKASLSNW 572 (634)
Q Consensus 500 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~-~P~~~~~~~~~~~~~l~~~ 572 (634)
||+|||+|+...... ...+|+.|+|||++.+..++.++|||||||++|||+||. .||.. ....+.
T Consensus 174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~--------~~~~~~ 245 (299)
T d1ywna1 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--------VKIDEE 245 (299)
T ss_dssp EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCCSHH
T ss_pred EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC--------CCHHHH
Confidence 999999998654332 235788999999999999999999999999999999975 46541 111122
Q ss_pred HHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 573 VNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 573 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+...+..+...+. .....++ +.+++.+||+.||++||||+||++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~-------~~~~~~~---l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 FCRRLKEGTRMRA-------PDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHTCCCCC-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCC-------CccCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3333333322211 1112233 4455669999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=378.87 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=194.2
Q ss_pred ccccCccCceeEEEEEEcC--------CcEEEEEEecccCc-cChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEE
Q 038422 360 AEVLGSGTFGASYKTVISN--------GQAYVVKRYKQMNN-VGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 429 (634)
.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 4789999999999998532 34799999875432 3346788899999888 899999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCC
Q 038422 430 YEFVENGSLAGKLHANHTK-----------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFE 498 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 498 (634)
||||++|+|.+++...... ....+++.+++.++.|||.||+|||+. +|+||||||+|||++.++.
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCC
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccceeecCCCC
Confidence 9999999999999765421 123589999999999999999999998 7999999999999999999
Q ss_pred eEEeccccCCccCCC------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCcccccccCCCCCcHHH
Q 038422 499 PLLTDYALRPLINPD------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLT-GKYPENYLLQGYDSKASLSN 571 (634)
Q Consensus 499 ~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~ellt-g~~P~~~~~~~~~~~~~l~~ 571 (634)
+||+|||+++..... ....+++.|+|||.+.++.|++++|||||||++|||+| |+.||.. ... +
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~--------~~~-~ 244 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPV-E 244 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCH-H
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC--------CCH-H
Confidence 999999999866433 22346788999999999999999999999999999999 6777651 111 2
Q ss_pred HHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 572 WVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 572 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
.+...+..+..... +....++ +.+++.+||+.||++|||++||++.|++|.
T Consensus 245 ~~~~~i~~~~~~~~-------p~~~~~~---l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFKLLKEGHRMDK-------PSNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHTTCCCCC-------CSSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCC-------CccchHH---HHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 22233333322111 1111234 445556999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=377.86 Aligned_cols=238 Identities=21% Similarity=0.303 Sum_probs=195.6
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+|+.||+|++++. .....+.+.+|+++|++++|||||++++++.+++..|+|||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 46899999999999996 56899999999753 233457789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC--
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-- 513 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 513 (634)
|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 90 g~L~~~~~~~~~-----~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 90 GELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CchhhhhhcccC-----CcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999876543 89999999999999999999998 8999999999999999999999999999865433
Q ss_pred --CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccc
Q 038422 514 --NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMK 591 (634)
Q Consensus 514 --~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 591 (634)
....||+.|+|||++.+..|+.++||||+||++|||+||+.||.. ....+...... .+.. .+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~--------~~~~~~~~~i~-~~~~------~~- 224 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELIL-MEEI------RF- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HCCC------CC-
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC--------cCHHHHHHHHh-cCCC------CC-
Confidence 234678999999999999999999999999999999999999862 22222222222 2111 11
Q ss_pred cCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 592 GAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 592 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
+....+++.++++ .||+.||++||+ ++|+++
T Consensus 225 -p~~~s~~~~dli~---~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 -PRTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CTTSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CccCCHHHHHHHH---hhccCCchhhcccccccHHHHHc
Confidence 1112244555555 999999999995 778765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=377.89 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=200.8
Q ss_pred hccccCccCceeEEEEEEc------CCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS------NGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 431 (634)
..+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++|||||+++|+|..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 3578999999999999863 35789999997543 2233568999999999999999999999999999999999
Q ss_pred cCCCCChhhHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEecccc
Q 038422 432 FVENGSLAGKLHANHT-----KQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYAL 506 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 506 (634)
||++|+|.+++..... .....+++..+.+|+.|+|+||.|||+. +|+||||||+|||+|+++++||+|||+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999874321 1223479999999999999999999998 799999999999999999999999999
Q ss_pred CCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCcccccccCCCCCcHHHHHHHHHHh
Q 038422 507 RPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGK-YPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 507 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~-~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
++...... ...+++.|+|||.+.+..++.++|||||||++|||+||. .|+. .....++..... .
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~--------~~~~~~~~~~i~-~ 250 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------GLSNEQVLRFVM-E 250 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT--------TSCHHHHHHHHH-T
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC--------CCCHHHHHHHHH-h
Confidence 98664432 234678899999999999999999999999999999985 5553 133344433332 2
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhhc
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLKE 633 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~~ 633 (634)
+...+. .....++ +.+++.+||+.+|++||||+||++.|++..+
T Consensus 251 ~~~~~~-------p~~~~~~---l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGLLDK-------PDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCCCCC-------CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCC-------cccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222111 1111234 4455559999999999999999999998654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=379.35 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=198.4
Q ss_pred hccccCccCceeEEEEEE------cCCcEEEEEEecccC-ccChhHHHHHHHHHhcC-CCCccccceeEEEeCCceEEEE
Q 038422 359 SAEVLGSGTFGASYKTVI------SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRL-EHPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 430 (634)
..++||+|+||.||+|++ .+++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+++..++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 357899999999999985 345789999997543 23445789999999999 6999999999999999999999
Q ss_pred EcCCCCChhhHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC
Q 038422 431 EFVENGSLAGKLHANHTK-------------QRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF 497 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 497 (634)
|||++|+|.++++..... ....+++..++.++.|||.||+|||++ +|+||||||+||+++.++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccccccccccccC
Confidence 999999999999764321 123599999999999999999999998 799999999999999999
Q ss_pred CeEEeccccCCccCCCC------CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC-cccccccCCCCCcHH
Q 038422 498 EPLLTDYALRPLINPDN------AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYP-ENYLLQGYDSKASLS 570 (634)
Q Consensus 498 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P-~~~~~~~~~~~~~l~ 570 (634)
.+|++|||+++...... ...+|+.|+|||++.+..++.++|||||||++|||+|+..| +.. ......+
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~----~~~~~~~- 257 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG----MPVDSKF- 257 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT----CCSSHHH-
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC----CCHHHHH-
Confidence 99999999998765432 23467889999999999999999999999999999995544 431 1111112
Q ss_pred HHHHHHHHhccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 571 NWVNNMVKEKRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 571 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
...+..+.... ......++ +.+|+.+||+.||++||||+||+++|+++.
T Consensus 258 ---~~~i~~~~~~~-------~~~~~~~~---l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 258 ---YKMIKEGFRML-------SPEHAPAE---MYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---HHHHHHTCCCC-------CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHhcCCCCC-------CcccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 22232221111 11112234 445555999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-45 Score=375.78 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=196.4
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+.++++++|||||++++++.+++..|+|||||+
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 357899999999999996 46899999998643 23456789999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 88 GGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp SCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred Ccccccccccccc-----ccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 9999998876543 88999999999999999999998 8999999999999999999999999999876544
Q ss_pred CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccC
Q 038422 514 NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGA 593 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 593 (634)
....+|+.|||||++.+..|+.++||||+||++|||+||+.||.. ....+........ .. .+ .
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~i~~~-~~------~~--p 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--------SNTMKTYEKILNA-EL------RF--P 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHC-CC------CC--C
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC--------cCHHHHHHHHHcC-CC------CC--C
Confidence 345688999999999999999999999999999999999999861 2222222222221 11 01 1
Q ss_pred CCCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 594 KYSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 594 ~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
....+++.++++ +|++.||.+|| |++|+++
T Consensus 222 ~~~s~~~~~li~---~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHH---HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHH---HHhhhCHHhccccchhhHHHHHc
Confidence 112244555555 99999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-44 Score=363.72 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccC---------hhHHHHHHHHHhcCC-CCccccceeEEEeCCceEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVG---------REDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 428 (634)
.+.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|++++++++ |||||++++++.+++..||
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 57899999999999996 568999999987543221 235889999999997 9999999999999999999
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
|||||++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999997643 399999999999999999999998 79999999999999999999999999998
Q ss_pred ccCCC---CCccccccccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHh
Q 038422 509 LINPD---NAHTLMVAYKSPEYAHN------GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKE 579 (634)
Q Consensus 509 ~~~~~---~~~~~~~~y~aPE~~~~------~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 579 (634)
..... ....+|..|+|||.+.+ ..++.++||||+||++|||+||+.||.. ....+ +...+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~--------~~~~~-~~~~i~~ 229 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--------RKQML-MLRMIMS 229 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHH-HHHHHHH
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC--------CCHHH-HHHHHHh
Confidence 76543 23456889999998863 3578899999999999999999999861 12122 2222222
Q ss_pred ccCCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 580 KRTGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 580 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+... ...+... . ..+++.++ +.+||+.||++|||++||++
T Consensus 230 ~~~~-~~~~~~~--~-~s~~~~~l---i~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQ-FGSPEWD--D-YSDTVKDL---VSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCC-CCTTTGG--G-SCHHHHHH---HHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC-CCCcccc--c-CCHHHHHH---HHHHccCChhHCcCHHHHHc
Confidence 2211 1111111 1 12445444 45999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=373.06 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=185.8
Q ss_pred cccCccCceeEEEEEE-cCCcEEEEEEecccCcc-----ChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 361 EVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV-----GREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999996 46899999998654321 23578999999999999999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN 514 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 514 (634)
++++..+.... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88776554322 2388999999999999999999998 89999999999999999999999999997765432
Q ss_pred ----CccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc--
Q 038422 515 ----AHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD-- 587 (634)
Q Consensus 515 ----~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-- 587 (634)
...+|..|+|||++... .|+.++|||||||++|||+||+.||... ........+.............+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-----~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-----SDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC-----CHHHHHHHHHHhcCCCChhhccchh
Confidence 34578889999998754 5799999999999999999999998521 11111111111111110000000
Q ss_pred -----ccccc-CCCCHHH-----HHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 588 -----KEMKG-AKYSKSE-----MINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 588 -----~~~~~-~~~~~~~-----~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
..... ....... -.++.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 0000010 123455556999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-44 Score=375.69 Aligned_cols=238 Identities=19% Similarity=0.257 Sum_probs=196.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc---CccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM---NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVEN 435 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 435 (634)
.+.||+|+||+||+|+. .+|+.||+|++... .....+.+.+|+++|++++|||||++++++.+....++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 46899999999999996 46899999998643 234456789999999999999999999999999999999999999
Q ss_pred CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-C
Q 038422 436 GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD-N 514 (634)
Q Consensus 436 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 514 (634)
|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999997653 399999999999999999999998 7999999999999999999999999999876543 3
Q ss_pred CccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccccccCC
Q 038422 515 AHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKGAK 594 (634)
Q Consensus 515 ~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 594 (634)
...+|+.|||||++.+..++.++|||||||++|||+||+.||.. ........... .+.. .. ..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~i~-~~~~------~~--p~ 259 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA--------DQPIQIYEKIV-SGKV------RF--PS 259 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHH-HCCC------CC--CT
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC--------cCHHHHHHHHh-cCCC------CC--Cc
Confidence 45688999999999999999999999999999999999999851 22222222222 2211 00 11
Q ss_pred CCHHHHHHHHHHHhcccccCccCCC-----CHHHHHH
Q 038422 595 YSKSEMINLLKIGLSCCEEDVLARM-----ELKEVIE 626 (634)
Q Consensus 595 ~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~evl~ 626 (634)
...+++.++++ +||+.||++|+ +++|+++
T Consensus 260 ~~s~~~~~li~---~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 HFSSDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCCHHHHHHHH---HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCHHHHHHHH---HHhhhCHHhccccccccHHHHHc
Confidence 12345555555 99999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=371.03 Aligned_cols=243 Identities=22% Similarity=0.353 Sum_probs=194.1
Q ss_pred hccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 359 SAEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
..+.||+|+||+||+|+.. +++.||+|.++.. ......+.+|+++|++++|||||++++++.+++..|+|||||++|+
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 3478999999999999964 6889999999754 2334568899999999999999999999999999999999999999
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC--CCeEEeccccCCccCCCCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS--FEPLLTDYALRPLINPDNA 515 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGla~~~~~~~~ 515 (634)
|.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 88 L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 88 IFERINTSAF----ELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp HHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 9999965432 399999999999999999999998 89999999999999854 5799999999987655432
Q ss_pred ---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccccc
Q 038422 516 ---HTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEMKG 592 (634)
Q Consensus 516 ---~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 592 (634)
..+++.|+|||.+.+..++.++||||+||++|||+||+.||.. ....+........... ++....
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~---~~~~~~- 227 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--------ETNQQIIENIMNAEYT---FDEEAF- 227 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCC---CCHHHH-
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC---CChhhc-
Confidence 3457789999999999999999999999999999999999862 1222222222221110 111110
Q ss_pred CCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 593 AKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 593 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
....+++.+++ ..|++.||++|||++|+++
T Consensus 228 -~~~s~~~~~li---~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 -KEISIEAMDFV---DRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -TTSCHHHHHHH---HTTSCSSGGGSCCHHHHHH
T ss_pred -cCCCHHHHHHH---HHHccCChhHCcCHHHHhc
Confidence 01123444454 4999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=371.48 Aligned_cols=237 Identities=21% Similarity=0.332 Sum_probs=191.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEeccc---CccChhHHHHHHHHHh-cCCCCccccceeEEEeCCceEEEEEcCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQM---NNVGREDFQEHIKRLG-RLEHPNLLPLTAFYYRKEEKLLLYEFVE 434 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~e~~~ 434 (634)
.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..|+|||||+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 578999999999999964 6899999999743 2334556777777765 6899999999999999999999999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC-
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 513 (634)
+|+|.+++..... +++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 87 GGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp TCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999976543 89999999999999999999998 7999999999999999999999999999865432
Q ss_pred ---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCccccccc
Q 038422 514 ---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKEM 590 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 590 (634)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+ +...+..+.. .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~--------~~~~~-~~~~i~~~~~------~~ 222 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------QDEEE-LFHSIRMDNP------FY 222 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHH-HHHHHHHCCC------CC
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC--------CCHHH-HHHHHHcCCC------CC
Confidence 234578899999999999999999999999999999999999861 12222 2222222211 11
Q ss_pred ccCCCCHHHHHHHHHHHhcccccCccCCCCHH-HHH
Q 038422 591 KGAKYSKSEMINLLKIGLSCCEEDVLARMELK-EVI 625 (634)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-evl 625 (634)
+....+++.++++ +||+.||++||+++ |++
T Consensus 223 --p~~~s~~~~dli~---~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 --PRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp --CTTSCHHHHHHHH---HHSCSSGGGSBTTBSCGG
T ss_pred --CccCCHHHHHHHH---HhcccCCCCCcCHHHHHH
Confidence 1112344555555 99999999999995 675
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=375.22 Aligned_cols=243 Identities=19% Similarity=0.287 Sum_probs=185.8
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhc-CCCCccccceeEEEe----CCceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGR-LEHPNLLPLTAFYYR----KEEKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~lv~e~~ 433 (634)
.++||+|+||+||+|+. .+++.||||+++. .+.+.+|++++.+ .+|||||+++++|.+ +...|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 35699999999999996 5689999999864 3567889998765 589999999999876 35689999999
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC---CCCeEEeccccCCcc
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR---SFEPLLTDYALRPLI 510 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~ 510 (634)
++|+|.+++..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++..
T Consensus 92 ~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 92 DGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp CSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccceeeec
Confidence 99999999975432 2499999999999999999999998 8999999999999986 457999999999866
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFD 587 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 587 (634)
... ....+|+.|+|||++.+..|+.++|||||||++|||+||+.||.... .......+......... +.-.
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~-----~~~~~~~~~~~i~~~~~-~~~~ 238 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----GLAISPGMKTRIRMGQY-EFPN 238 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT-----CC--------CCCSCSS-SCCT
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC-----HHHHHHHHHHHHhcCCC-CCCC
Confidence 543 33457899999999999999999999999999999999999996221 11111111111000000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 588 KEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+... ...+ ++.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~---~~s~---~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PEWS---EVSE---EVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp THHH---HSCH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccc---cCCH---HHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 0112 3445556999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-44 Score=376.62 Aligned_cols=241 Identities=20% Similarity=0.280 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC---ccChhHHHH---HHHHHhcCCCCccccceeEEEeCCceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN---NVGREDFQE---HIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 432 (634)
.++||+|+||+||+|+.. +|+.||+|++.... ......+.+ |+++++.++|||||++++++.+.+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 478999999999999964 68999999986432 222333444 46778888999999999999999999999999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINP 512 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 512 (634)
|++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999997653 389999999999999999999998 899999999999999999999999999987654
Q ss_pred C--CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcccccc
Q 038422 513 D--NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDVFDKE 589 (634)
Q Consensus 513 ~--~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 589 (634)
. ....+|+.|+|||++.. ..|+.++|||||||++|||+||+.||... ........ ...... .. ..
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~-~~~~~~---~~---~~ 227 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-----KTKDKHEI-DRMTLT---MA---VE 227 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS-----CSSCHHHH-HHHSSS---CC---CC
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC-----CHHHHHHH-HHhccc---CC---CC
Confidence 3 34568899999999975 46899999999999999999999998621 11222211 111100 00 01
Q ss_pred cccCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 590 MKGAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 590 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
+ .....+++.+++. +||+.||++||| ++|+++
T Consensus 228 ~--~~~~s~~~~~li~---~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 L--PDSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C--CSSSCHHHHHHHH---HHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C--CCCCCHHHHHHHH---HHcccCHHHhCCCcccCHHHHHc
Confidence 1 1112244555555 999999999999 577764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=361.41 Aligned_cols=190 Identities=24% Similarity=0.386 Sum_probs=161.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+++|++++|||||++++++.+++..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 46899999999999996 568999999996543 23457899999999999999999999999999999999999975
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC---
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD--- 513 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 513 (634)
++.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 45555543322 2499999999999999999999998 7999999999999999999999999999766443
Q ss_pred -CCccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -NAHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -~~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|+.|+|||.+.... ++.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 2345788899999887665 4789999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=363.64 Aligned_cols=232 Identities=21% Similarity=0.332 Sum_probs=186.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCcc------ChhHHHHHHHHHhcCC--CCccccceeEEEeCCceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNV------GREDFQEHIKRLGRLE--HPNLLPLTAFYYRKEEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~ 430 (634)
.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+|+.++++++ |||||++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 47899999999999996 46899999998753211 2234678999999986 899999999999999999999
Q ss_pred EcCCC-CChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCC-CCeEEeccccCC
Q 038422 431 EFVEN-GSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRS-FEPLLTDYALRP 508 (634)
Q Consensus 431 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~ 508 (634)
||+.+ +++.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 89 e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccccce
Confidence 99976 67888876543 399999999999999999999998 89999999999999854 789999999998
Q ss_pred ccCCC--CCccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCCcc
Q 038422 509 LINPD--NAHTLMVAYKSPEYAHNGKI-SKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTGDV 585 (634)
Q Consensus 509 ~~~~~--~~~~~~~~y~aPE~~~~~~~-~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 585 (634)
..... ....+|..|+|||++.+..+ +.++|||||||++|||+||+.||... . ... .+.. .
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~-------~i~-~~~~--~ 222 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------E-------EII-RGQV--F 222 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------H-------HHH-HCCC--C
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------h-------HHh-hccc--C
Confidence 65543 33467899999999987766 56789999999999999999998521 0 011 1110 1
Q ss_pred cccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 586 FDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 586 ~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
+.+ .-.+++.++++ +||+.||++|||++|+++
T Consensus 223 ~~~------~~s~~~~~li~---~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 FRQ------RVSSECQHLIR---WCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CSS------CCCHHHHHHHH---HHTCSSGGGSCCHHHHHT
T ss_pred CCC------CCCHHHHHHHH---HHccCCHhHCcCHHHHhc
Confidence 111 12245555555 999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-43 Score=356.52 Aligned_cols=189 Identities=23% Similarity=0.382 Sum_probs=163.6
Q ss_pred ccccCccCceeEEEEEEcCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVISNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..++++||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 46799999999999999999999999996543 3345789999999999999999999999999999999999998876
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC----
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD---- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 513 (634)
+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+......
T Consensus 87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 66655432 2499999999999999999999998 7999999999999999999999999998765443
Q ss_pred CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+++.|+|||.+.+. .++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 223466789999998765 56899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=353.28 Aligned_cols=190 Identities=22% Similarity=0.356 Sum_probs=158.8
Q ss_pred ccccCccCceeEEEEEE-cC-CcEEEEEEecccC--ccChhHHHHHHHHHhcC---CCCccccceeEEEeC-----CceE
Q 038422 360 AEVLGSGTFGASYKTVI-SN-GQAYVVKRYKQMN--NVGREDFQEHIKRLGRL---EHPNLLPLTAFYYRK-----EEKL 427 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~~~~ 427 (634)
.+.||+|+||+||+|+. .+ ++.||+|+++... ......+.+|+++|+.+ +|||||+++++|... ...+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 46799999999999996 34 5679999986432 23344667788777665 899999999998642 3578
Q ss_pred EEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 428 LLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 428 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
++|||+.+|++........ ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 92 ~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 9999999877655443322 2489999999999999999999998 7999999999999999999999999998
Q ss_pred CccCCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 508 PLINPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 508 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
+..... ....+|+.|+|||++.+..|+.++||||+||++|||+||+.||.
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 765433 34567889999999999999999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=353.89 Aligned_cols=188 Identities=23% Similarity=0.350 Sum_probs=155.3
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEEEc
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLYEF 432 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~e~ 432 (634)
.++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|||||+++++|.... ..++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 468999999999999964 689999999976432 2347999999999999999999996532 46899999
Q ss_pred CCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccC
Q 038422 433 VENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLIN 511 (634)
Q Consensus 433 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~ 511 (634)
|++|.+......... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 101 ~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 101 VPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp CSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred cCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 987644433322221 23499999999999999999999998 899999999999999775 89999999998765
Q ss_pred CC---CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD---NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~---~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....++..|+|||.+.+ ..++.++||||+||++|||+||+.||.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 43 23456788999998875 468999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=347.03 Aligned_cols=249 Identities=16% Similarity=0.180 Sum_probs=185.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCccccceeE-EEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLLPLTAF-YYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+. .+|+.||||++.... ..+++..|++++++++|+|+|..++. +.+.+..++||||+ +|+
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 46899999999999996 568999999887542 33468899999999988876665544 56677888999999 567
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeC---CCCCeEEeccccCCccCCC-
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLD---RSFEPLLTDYALRPLINPD- 513 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~- 513 (634)
+.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+.....
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 89 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred hhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 7766654332 399999999999999999999998 899999999999975 4567999999999876432
Q ss_pred ----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccCC
Q 038422 514 ----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRTG 583 (634)
Q Consensus 514 ----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 583 (634)
....+|+.|||||.+.+..++.++|||||||++|||+||+.||........ ...+..+........
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTP--- 236 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSC---
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH-HHHHHHhhcccCCCC---
Confidence 223578899999999999999999999999999999999999863221110 011111111111000
Q ss_pred cccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhh
Q 038422 584 DVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERL 631 (634)
Q Consensus 584 ~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i 631 (634)
.+.+. . ...+++.+++ ..||+.+|++||+++++.+.|+.+
T Consensus 237 ---~~~~~-~-~~p~~~~~li---~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 ---IEVLC-K-GYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HHHHT-T-TSCHHHHHHH---HHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---hhHhc-c-CCCHHHHHHH---HHHccCChhHCcCHHHHHHHHHHH
Confidence 01110 1 1124444554 499999999999999999988875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=345.47 Aligned_cols=189 Identities=22% Similarity=0.319 Sum_probs=158.2
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEeccc--CccChhHHHHHHHHHhcCCCCccccceeEEEe--------CCceEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQM--NNVGREDFQEHIKRLGRLEHPNLLPLTAFYYR--------KEEKLL 428 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~l 428 (634)
.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 46799999999999996 57899999998643 23345688999999999999999999999865 345789
Q ss_pred EEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 429 LYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 429 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
||||+.++.+..+... ...++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 95 v~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 95 VFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecceee
Confidence 9999988766544332 22489999999999999999999998 89999999999999999999999999997
Q ss_pred ccCCC--------CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 509 LINPD--------NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 509 ~~~~~--------~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
..... ....+|..|+|||.+.+. .+++++|||||||++|||+||+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 55422 224578899999998765 68999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=350.37 Aligned_cols=188 Identities=21% Similarity=0.358 Sum_probs=157.3
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC-ccChhHHHHHHHHHhcCCCCccccceeEEEeCC----ceEEEEEcC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN-NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE----EKLLLYEFV 433 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e~~ 433 (634)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.... ..+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 46899999999999985 579999999997543 223457889999999999999999999997653 235556677
Q ss_pred CCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCC
Q 038422 434 ENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPD 513 (634)
Q Consensus 434 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 513 (634)
.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 799999999643 389999999999999999999998 8999999999999999999999999998765432
Q ss_pred -------CCccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 -------NAHTLMVAYKSPEYAHN-GKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 -------~~~~~~~~y~aPE~~~~-~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....++..|+|||++.. ..++.++||||+||++|||+||+.||.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 22346788999999854 467899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.5e-41 Score=339.31 Aligned_cols=250 Identities=15% Similarity=0.181 Sum_probs=193.5
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccCccChhHHHHHHHHHhcCCC-CccccceeEEEeCCceEEEEEcCCCCC
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEH-PNLLPLTAFYYRKEEKLLLYEFVENGS 437 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gs 437 (634)
.+.||+|+||+||+|+.. +|+.||+|++.... ..+.+.+|+++++.++| +|++.+++++..+...++||||+ +|+
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 468999999999999954 68899999886532 34567889999999976 89999999999999999999999 689
Q ss_pred hhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCC-----CCCeEEeccccCCccCC
Q 038422 438 LAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDR-----SFEPLLTDYALRPLINP 512 (634)
Q Consensus 438 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGla~~~~~ 512 (634)
|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 87 l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 87 LEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9998865433 389999999999999999999998 8999999999999974 56799999999986543
Q ss_pred C-----------CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc
Q 038422 513 D-----------NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR 581 (634)
Q Consensus 513 ~-----------~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 581 (634)
. ....||+.|||||.+.+..++.++|||||||++|||+||+.||.... ................
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~-----~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-----AATNKQKYERIGEKKQ 233 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC-----SCCHHHHHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc-----chhHHHHHHHHHhccC
Confidence 2 12357899999999999999999999999999999999999996221 1222222111111110
Q ss_pred CCcccccccccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHHHHHhhh
Q 038422 582 TGDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIEKIERLK 632 (634)
Q Consensus 582 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~~L~~i~ 632 (634)
... . +.+. .. .++++.++++ .|++.+|++||+++.+.+.|+++.
T Consensus 234 ~~~-~-~~l~-~~-~p~~l~~ii~---~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 234 STP-L-RELC-AG-FPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSC-H-HHHT-TT-SCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCC-h-HHhc-CC-CCHHHHHHHH---HHhcCCcccCcCHHHHHHHHHHHH
Confidence 000 0 0111 11 1244555554 899999999999999999888764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=348.55 Aligned_cols=187 Identities=22% Similarity=0.376 Sum_probs=155.4
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeCC------ceEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRKE------EKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~ 430 (634)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ ..++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 46799999999999996 469999999997532 223457889999999999999999999997654 469999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
||+ +.+|..+.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++..
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccceecc
Confidence 999 55777766432 399999999999999999999998 8999999999999999999999999999876
Q ss_pred CCC-CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD-NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~-~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 554 345678889999998764 56899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=337.80 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=190.9
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeCCceEEEEEcCCCC
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRKEEKLLLYEFVENG 436 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 436 (634)
.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+.+..++|+||+.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 36899999999999996 5688999999875432 23468899999999999999999999999999999999999999
Q ss_pred ChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccCCCC--
Q 038422 437 SLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLINPDN-- 514 (634)
Q Consensus 437 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 514 (634)
++..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 87 ~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 87 LKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc-----ccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 8888775432 389999999999999999999998 89999999999999999999999999998765432
Q ss_pred --CccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhcc-C-Cccccc-
Q 038422 515 --AHTLMVAYKSPEYAHNGK-ISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKR-T-GDVFDK- 588 (634)
Q Consensus 515 --~~~~~~~y~aPE~~~~~~-~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~-~-~~~~d~- 588 (634)
...++..|+|||.+.... ++.++|||||||++|||+||+.||.. .....++......... . ......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-------GNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-------CSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC-------CCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 233557799999987665 68999999999999999999999741 1233333332221100 0 000000
Q ss_pred ----------ccc-------cCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 589 ----------EMK-------GAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 589 ----------~~~-------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
... ......+++ .+++.+|++.||++|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~---~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATG---RDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHH---HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHH---HHHHHHHccCChhHCcCHHHHhc
Confidence 000 000112334 44555999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=344.49 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=189.8
Q ss_pred hccccCccCceeEEEEEEc----CCcEEEEEEecccC----ccChhHHHHHHHHHhcCCC-CccccceeEEEeCCceEEE
Q 038422 359 SAEVLGSGTFGASYKTVIS----NGQAYVVKRYKQMN----NVGREDFQEHIKRLGRLEH-PNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv 429 (634)
..+.||+|+||+||+|+.. +|+.||+|.++... ....+.+.+|++++++++| |||+++++++.+....++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 4578999999999999852 47899999986432 2345678899999999976 8999999999999999999
Q ss_pred EEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCc
Q 038422 430 YEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPL 509 (634)
Q Consensus 430 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 509 (634)
|||+.+|+|.+++..... +....+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999976643 77889999999999999999998 799999999999999999999999999976
Q ss_pred cCCC-----CCccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHHhccC
Q 038422 510 INPD-----NAHTLMVAYKSPEYAHNG--KISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVKEKRT 582 (634)
Q Consensus 510 ~~~~-----~~~~~~~~y~aPE~~~~~--~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 582 (634)
.... ....++..|+|||.+.+. .++.++|||||||+||||+||+.||... . .......+.........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~----~-~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD----G-EKNSQAEISRRILKSEP 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT----T-SCCCHHHHHHHHHHCCC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC----C-HHHHHHHHHHhcccCCC
Confidence 5432 233467789999999764 4688999999999999999999998632 1 12222222222111111
Q ss_pred CcccccccccCCCCHHHHHHHHHHHhcccccCccCCCC-----HHHHHH
Q 038422 583 GDVFDKEMKGAKYSKSEMINLLKIGLSCCEEDVLARME-----LKEVIE 626 (634)
Q Consensus 583 ~~~~d~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~evl~ 626 (634)
.+ .....+++.++++ +||+.||++||| ++|+++
T Consensus 254 ------~~--~~~~s~~~~~li~---~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ------PY--PQEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CC--CTTSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CC--cccCCHHHHHHHH---HHcccCHHHcCCCCcccHHHHHc
Confidence 11 1112345555555 999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-40 Score=338.28 Aligned_cols=184 Identities=24% Similarity=0.375 Sum_probs=159.6
Q ss_pred hccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeC--CceEEEEEcCC
Q 038422 359 SAEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRK--EEKLLLYEFVE 434 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e~~~ 434 (634)
..+.||+|+||+||+|+. .+|+.||+|+++. ...+.+.+|+++|++++ ||||+++++++... ...++|||||.
T Consensus 39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 357899999999999996 5689999999864 34678899999999995 99999999999854 46899999999
Q ss_pred CCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC-CeEEeccccCCccCCC
Q 038422 435 NGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF-EPLLTDYALRPLINPD 513 (634)
Q Consensus 435 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~ 513 (634)
+|+|..+.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 116 ~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 116 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred CCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999976532 389999999999999999999998 899999999999998654 6899999999876543
Q ss_pred ---CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 514 ---NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 514 ---~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
....+|..|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 334567889999998765 47999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=338.89 Aligned_cols=186 Identities=18% Similarity=0.285 Sum_probs=151.8
Q ss_pred ccccCccCceeEEEEEEc-CCcEEEEEEecccC--ccChhHHHHHHHHHhcCCCCccccceeEEEeC------CceEEEE
Q 038422 360 AEVLGSGTFGASYKTVIS-NGQAYVVKRYKQMN--NVGREDFQEHIKRLGRLEHPNLLPLTAFYYRK------EEKLLLY 430 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv~ 430 (634)
.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||+++++|... ...|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 368999999999999965 69999999997543 22345688999999999999999999999643 5789999
Q ss_pred EcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCcc
Q 038422 431 EFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLI 510 (634)
Q Consensus 431 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 510 (634)
|||.++ +.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++..|++|||+++..
T Consensus 102 Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 102 ELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp ECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhhcc
Confidence 999765 444442 1389999999999999999999998 8999999999999999999999999998765
Q ss_pred CCC---CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 511 NPD---NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 511 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
... ....+|..|+|||++.+..+++++||||+||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 443 23456788999999999999999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=338.35 Aligned_cols=188 Identities=21% Similarity=0.349 Sum_probs=157.5
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCc--cChhHHHHHHHHHhcCCCCccccceeEEEeC-----CceEEEEE
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNN--VGREDFQEHIKRLGRLEHPNLLPLTAFYYRK-----EEKLLLYE 431 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e 431 (634)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... ...++++|
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 46899999999999995 5699999999975432 2345788999999999999999999998643 34567778
Q ss_pred cCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeEEeccccCCccC
Q 038422 432 FVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPLLTDYALRPLIN 511 (634)
Q Consensus 432 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 511 (634)
|+.+|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhcccC
Confidence 88999999998532 399999999999999999999998 89999999999999999999999999987654
Q ss_pred CC-CCccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCcc
Q 038422 512 PD-NAHTLMVAYKSPEYAHNG-KISKKSDVWSLGILILELLTGKYPEN 557 (634)
Q Consensus 512 ~~-~~~~~~~~y~aPE~~~~~-~~~~k~DVwSfGvvl~elltg~~P~~ 557 (634)
.. ....++..|+|||.+.+. .++.++|||||||++|||+||+.||.
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 33 344567889999987765 46899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-35 Score=308.07 Aligned_cols=259 Identities=20% Similarity=0.231 Sum_probs=183.7
Q ss_pred ccccCccCceeEEEEEE-cCCcEEEEEEecccCccChhHHHHHHHHHhcCC-----------CCccccceeEEEeC--Cc
Q 038422 360 AEVLGSGTFGASYKTVI-SNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-----------HPNLLPLTAFYYRK--EE 425 (634)
Q Consensus 360 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~--~~ 425 (634)
.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+|||++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 57899999999999996 569999999997542 33467788999888875 57899999988653 45
Q ss_pred eEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCC------Ce
Q 038422 426 KLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSF------EP 499 (634)
Q Consensus 426 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~------~~ 499 (634)
.+++++++..+........... ...+++..+..++.||+.||+|||+.. +|+||||||+|||++.++ .+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eeeeeeeccccccccccccccc--ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccccee
Confidence 6677777766554444333222 234899999999999999999999842 799999999999998654 38
Q ss_pred EEeccccCCccCCC-CCccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCcccccccCCCCCcHHHHHHHHHH
Q 038422 500 LLTDYALRPLINPD-NAHTLMVAYKSPEYAHNGKISKKSDVWSLGILILELLTGKYPENYLLQGYDSKASLSNWVNNMVK 578 (634)
Q Consensus 500 kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~DVwSfGvvl~elltg~~P~~~~~~~~~~~~~l~~~~~~~~~ 578 (634)
|++|||.+...... ....++..|+|||++....++.++||||+||+++||+||+.||........ ....+.......
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~--~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY--TKDDDHIAQIIE 249 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------CHHHHHHHHHH
T ss_pred eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc--cchhHHHHHHHH
Confidence 99999998755433 345678899999999999999999999999999999999999863221110 111111111100
Q ss_pred -hccC-----------Cccccc-----cc-------------ccCCCCHHHHHHHHHHHhcccccCccCCCCHHHHHH
Q 038422 579 -EKRT-----------GDVFDK-----EM-------------KGAKYSKSEMINLLKIGLSCCEEDVLARMELKEVIE 626 (634)
Q Consensus 579 -~~~~-----------~~~~d~-----~~-------------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~evl~ 626 (634)
-+.. ...++. .+ ............+.++..+|++.||.+|||++|+++
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 000000 00 011123445567788888999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=3e-31 Score=271.37 Aligned_cols=205 Identities=33% Similarity=0.569 Sum_probs=158.4
Q ss_pred CCccHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCCCCCCeeeEEecC----CcEEEEEecCCCCccc--cChhhhcCCCC
Q 038422 26 FGLSDTEILLQFKSSLNDSSSALVNWNALRNPCTFNYPNWNGVLCLN----GSVWGLKLEQMNLSGT--IAAESLGLLSS 99 (634)
Q Consensus 26 ~~~~~~~~l~~~k~~l~~~~~~l~~W~~~~~~C~~~~~~w~gv~C~~----~~v~~l~L~~~~l~g~--~~~~~l~~l~~ 99 (634)
+.++|++||++||+++.+|. .+.+|..++|||.. .|.||+|++ +||+.|+|++++++|. +| +.+++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~---~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp-~~l~~L~~ 77 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNR---TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP-SSLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTT---CSTTEEECCSSSCCCEEEEEEECCCCSSCEECC-GGGGGCTT
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCC---cCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCC-hHHhcCcc
Confidence 35789999999999999885 79999988999942 499999973 3799999999999994 66 48999999
Q ss_pred cCEEeccC-CcCcccCC-CCCCCCCCcEEEccCCcCccccCh-----------------------hhhhCCCCCCeEEcc
Q 038422 100 LRAVSFMN-NKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISD-----------------------DAFEGMTSLKKLYMA 154 (634)
Q Consensus 100 L~~L~l~~-n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~-----------------------~~~~~~~~L~~l~l~ 154 (634)
|++|+|++ |+|+|.+| +++++++|++|+|++|+|.|..|. ..++++++|+.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 99999996 89999998 699999999999999988875432 125555556666665
Q ss_pred cCcCccCCCccc--------------------------------------------------------------------
Q 038422 155 NNRLTGTIPSSL-------------------------------------------------------------------- 166 (634)
Q Consensus 155 ~N~l~g~ip~~~-------------------------------------------------------------------- 166 (634)
+|.++|.+|..+
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~ 237 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 555555554432
Q ss_pred ---cCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCcc--ccCCCCCcccCCCCCCCCCCCCCC
Q 038422 167 ---VQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPES--LSKMDPSTFAGNKNLCGPPLDPCV 235 (634)
Q Consensus 167 ---~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~--~~~~~~~~~~gn~~lcg~p~~~c~ 235 (634)
+.+++|+.|+|++|+|+|.+|+. ..++|++|+|++|+|+|.||.. +.++....+.||+.+||.|+++|.
T Consensus 238 ~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 23455667777777777777764 3357888888888888888863 456666778899989998888873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.8e-23 Score=194.16 Aligned_cols=161 Identities=16% Similarity=0.168 Sum_probs=118.4
Q ss_pred hccccCccCceeEEEEEEcCCcEEEEEEecccCcc------------------ChhHHHHHHHHHhcCCCCccccceeEE
Q 038422 359 SAEVLGSGTFGASYKTVISNGQAYVVKRYKQMNNV------------------GREDFQEHIKRLGRLEHPNLLPLTAFY 420 (634)
Q Consensus 359 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~g~~ 420 (634)
..+.||+|+||+||+|+..+|+.||||+++..... ....+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46789999999999999989999999987532100 012345688889999999999877653
Q ss_pred EeCCceEEEEEcCCCCChhhHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCccccCCCCCCEEeCCCCCeE
Q 038422 421 YRKEEKLLLYEFVENGSLAGKLHANHTKQRPGLDWQTRLKIIKGVVKGMAYLHNELPGSIIPHGHLKSSNVLLDRSFEPL 500 (634)
Q Consensus 421 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~k 500 (634)
..+++|||++++.+.+ ++......++.|++.+++|||+. +|+||||||+|||++++ .++
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEE
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEE
Confidence 3479999998865432 33344567999999999999998 89999999999999965 589
Q ss_pred EeccccCCccCCCCCccccccccC------cccccCCCCCcchhHHHHHHH
Q 038422 501 LTDYALRPLINPDNAHTLMVAYKS------PEYAHNGKISKKSDVWSLGIL 545 (634)
Q Consensus 501 l~DfGla~~~~~~~~~~~~~~y~a------PE~~~~~~~~~k~DVwSfGvv 545 (634)
++|||+|.......... |.. .|.+ ...|+.++|+||..--
T Consensus 143 liDFG~a~~~~~~~~~~----~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE----ILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTHHH----HHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCcHH----HHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99999987654332111 111 1112 3567889999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=1.7e-17 Score=155.67 Aligned_cols=107 Identities=21% Similarity=0.323 Sum_probs=50.9
Q ss_pred CcCEEeccCCcCcccCC--CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEe
Q 038422 99 SLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELR 176 (634)
Q Consensus 99 ~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~ 176 (634)
++++|+|++|.|++.++ .|.++++|+.|+|++|++.+. +++.+..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~-~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI-EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB-CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccc-cccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 44555555555544333 234455555555555555532 223344555555555555555544344445555555555
Q ss_pred CCCCceeecCCcc--cccCCCEEEeecCcccc
Q 038422 177 LEANKFQGQVPEI--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 177 l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g 206 (634)
|++|+|++..|.. ...+|++|+|++|.+.+
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cCCccccccCHHHhcCCccccccccccccccc
Confidence 5555555443432 12345555555555443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.67 E-value=2.2e-17 Score=167.41 Aligned_cols=137 Identities=28% Similarity=0.413 Sum_probs=114.9
Q ss_pred CcEEEEEecC-CCCccccChhhhcCCCCcCEEeccCCcCcccCC-------------------------CCCCCCCCcEE
Q 038422 73 GSVWGLKLEQ-MNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-------------------------DLRKMGPLKSI 126 (634)
Q Consensus 73 ~~v~~l~L~~-~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-------------------------~~~~l~~L~~L 126 (634)
..+..|+|++ |+++|.+|+ .+++|++|++|+|++|+|.|.+| .+.+++.|+++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~-~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp TTCSEEEEEEETTEESCCCG-GGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred cccccccccccccccccccc-ccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 3577899987 899999985 79999999999999999888655 14566778888
Q ss_pred EccCCcCccccChh------------------------------------------------------------------
Q 038422 127 YLSDNGFSGNISDD------------------------------------------------------------------ 140 (634)
Q Consensus 127 ~ls~N~~~g~ip~~------------------------------------------------------------------ 140 (634)
++++|.++|.+|..
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88888888777632
Q ss_pred ----hhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCc-cccc-CCc
Q 038422 141 ----AFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNE-LEGP-IPE 210 (634)
Q Consensus 141 ----~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~-l~g~-ip~ 210 (634)
.++.+++|++|+|++|+|+|.+|.+|+++++|++|+|++|+|+|.||+. ...+|+.+++++|+ +.|. +|.
T Consensus 235 ~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~ 311 (313)
T d1ogqa_ 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp CBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSC
T ss_pred ccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCC
Confidence 1455678899999999999999999999999999999999999999986 45789999999997 6774 664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.5e-14 Score=142.57 Aligned_cols=149 Identities=22% Similarity=0.218 Sum_probs=94.1
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
.++.|+|++|.+++ +++..+.++++|++|+|++|+|+. +|.+..+++|++|+|++|++++. +. .+.++++|++|++
T Consensus 32 ~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~~~-~~-~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQSL-PL-LGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCSSC-CC-CTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCC-cCHHHhhccccccccccccccccc-ccccccccccccccccccccccc-cc-ccccccccccccc
Confidence 47788899888875 455678888888888888888874 56667788888888888888753 33 2566666666666
Q ss_pred ccCcCccCCCcc------------------------ccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCccccc
Q 038422 154 ANNRLTGTIPSS------------------------LVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 154 ~~N~l~g~ip~~------------------------~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ 207 (634)
++|.+.+..+.. +..+++|+.|++++|++++..|.. ...+|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 666555433333 444555555666666655544443 2345666666666666 5
Q ss_pred CCccccCCCC---CcccCCCCCC
Q 038422 208 IPESLSKMDP---STFAGNKNLC 227 (634)
Q Consensus 208 ip~~~~~~~~---~~~~gn~~lc 227 (634)
||..+..+.. ....||+.-|
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCC
T ss_pred cChhHCCCCCCCEEEecCCCCCC
Confidence 6655443332 2345555444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.55 E-value=9.9e-15 Score=136.49 Aligned_cols=164 Identities=20% Similarity=0.295 Sum_probs=139.2
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|..|.|++ ..++.|+|++|.+++.++...+..+++|+.|+|++|.+.+.++ .+..+++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 588899962 2578999999999998887788999999999999999999888 5888999999999999
Q ss_pred cCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCc
Q 038422 132 GFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPE 210 (634)
Q Consensus 132 ~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~ 210 (634)
++++ ||+++|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.. ....++.+.+..|.+....|.
T Consensus 89 ~l~~-l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCE-ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccc-cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 9994 77778999999999999999999888888999999999999999998766543 233456667788999988898
Q ss_pred cccCCCCCcccCCCCCCC
Q 038422 211 SLSKMDPSTFAGNKNLCG 228 (634)
Q Consensus 211 ~~~~~~~~~~~gn~~lcg 228 (634)
.+.++.......|...|.
T Consensus 168 ~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 168 KVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTTSBGGGSCTTTCCCC
T ss_pred hhcCCEeeecCHhhCcCC
Confidence 887777666666655564
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.4e-13 Score=135.44 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=105.1
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
....++.++++|+ .+|+ .+. ++|+.|+|++|++++..+ .|.++++|++|+|++|+++ .||. ++.+++|++|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~ 83 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVLGTLD 83 (266)
T ss_dssp TCCEEECTTSCCS-SCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTCCEEE
T ss_pred CCeEEEccCCCCC-eeCc-CcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--ccccccccccc
Confidence 3445677788888 4664 332 579999999999998766 5899999999999999998 5654 68899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESLSKM 215 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~~~~ 215 (634)
|++|++++ +|..+.++++|+.|++++|.+.+..+.. ...+++.|++++|.+++..|..+..+
T Consensus 84 Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l 147 (266)
T d1p9ag_ 84 LSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147 (266)
T ss_dssp CCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred cccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceecccccccc
Confidence 99999995 5788999999999999999988655543 33467777777777775544444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.8e-13 Score=135.96 Aligned_cols=152 Identities=21% Similarity=0.320 Sum_probs=121.2
Q ss_pred EEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
+..+....++....+++..+.++++|++|+|++|.+.+..+ .+..+.+|+.+++++|++++ ||++.|..+++|+.|+|
T Consensus 82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~-i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEEC
T ss_pred ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc-cChhHhccccchhhccc
Confidence 33444443333445556678889999999999999987665 57778899999999999984 66777889999999999
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCccc--ccCCCEEEeecCcccccCCccccCCCCC---cccCCCCCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIK--QNEMRSLGLANNELEGPIPESLSKMDPS---TFAGNKNLC 227 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~--~~~l~~l~l~~N~l~g~ip~~~~~~~~~---~~~gn~~lc 227 (634)
++|+|++..|..+.++++|+.|++++|++++..|..+ ..+|+.|++++|.+++..|..|.++... .+.||+.-|
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 9999998778889999999999999999998888764 3589999999999998888777665543 456776544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=4.3e-13 Score=133.23 Aligned_cols=150 Identities=18% Similarity=0.263 Sum_probs=105.2
Q ss_pred eeeEEecCC-----------cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCC-----------------
Q 038422 65 WNGVLCLNG-----------SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPD----------------- 116 (634)
Q Consensus 65 w~gv~C~~~-----------~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~----------------- 116 (634)
|.-|.|++. .+..|+|++|+++ .+|+..+..+++|++|++++|.+.+..+.
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 556888631 3578999999998 57767899999999999999998775441
Q ss_pred ---------CCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCC
Q 038422 117 ---------LRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVP 187 (634)
Q Consensus 117 ---------~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip 187 (634)
+.++++|++|+|++|.+.+ ++...+..+.+|+.+++++|++++..+..+..+++|+.|+|++|+|++-.|
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ccccccchhhcccccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 3445667777777777764 334446667777777777777775545566677777777777777776555
Q ss_pred cc--cccCCCEEEeecCcccccCCccccCCC
Q 038422 188 EI--KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 188 ~~--~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
.. ...+|+.+++++|++++..|..|.+++
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~ 201 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred hhhccccccchhhhhhccccccChhHhhhhh
Confidence 44 234677777777777776676666554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.9e-13 Score=117.70 Aligned_cols=100 Identities=25% Similarity=0.419 Sum_probs=44.0
Q ss_pred EEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCc
Q 038422 78 LKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNR 157 (634)
Q Consensus 78 l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~ 157 (634)
|+|++|+++ .++ .+..+++|++|+|++|.++...+.++.+++|++|++++|.+++ +| . ++.+++|+.|++++|+
T Consensus 3 L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 3 LHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-G-VANLPRLQELLLCNNR 76 (124)
T ss_dssp EECTTSCCS-SCC--CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-G-GTTCSSCCEEECCSSC
T ss_pred EEcCCCCCC-CCc--ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-c-cccccccCeEECCCCc
Confidence 444444444 222 2444444445555544444322234444444455555444442 22 1 4444444444444444
Q ss_pred CccCC-CccccCCCCccEEeCCCCcee
Q 038422 158 LTGTI-PSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 158 l~g~i-p~~~~~l~~L~~L~l~~N~~~ 183 (634)
++..- +..++++++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 44211 123444444444444444444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.35 E-value=9.3e-13 Score=113.32 Aligned_cols=101 Identities=22% Similarity=0.331 Sum_probs=87.7
Q ss_pred CEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCC
Q 038422 101 RAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEAN 180 (634)
Q Consensus 101 ~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N 180 (634)
+.|+|++|+++ .+|.+..++.|++|+|++|.++ .+|+. ++.+++|+.|++++|++++ +| .++++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcccccCCCCCEEECCCCccC-cchhh-hhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999998 5578999999999999999998 68875 8999999999999999995 55 5999999999999999
Q ss_pred ceeecCC--cc-cccCCCEEEeecCcccc
Q 038422 181 KFQGQVP--EI-KQNEMRSLGLANNELEG 206 (634)
Q Consensus 181 ~~~g~ip--~~-~~~~l~~l~l~~N~l~g 206 (634)
+++.... .. ...+|+.|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9985332 22 44689999999999974
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.32 E-value=4.5e-12 Score=126.94 Aligned_cols=144 Identities=28% Similarity=0.423 Sum_probs=96.5
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDN 131 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N 131 (634)
.|.+|.|++ ..++.|+|++|+++ .+|+..+.++++|++|++++|.+....| .|.+++.|++|++++|
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred cCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 699999963 34678999999987 4665678999999999999999998877 4889999999999999
Q ss_pred cCccccCh-----------------------------------------------hhhhCCCCCCeEEcccCcCccCCCc
Q 038422 132 GFSGNISD-----------------------------------------------DAFEGMTSLKKLYMANNRLTGTIPS 164 (634)
Q Consensus 132 ~~~g~ip~-----------------------------------------------~~~~~~~~L~~l~l~~N~l~g~ip~ 164 (634)
+++. ||. ..+..+++|+++++++|+++ .+|.
T Consensus 90 ~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~ 167 (305)
T d1xkua_ 90 QLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167 (305)
T ss_dssp CCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCS
T ss_pred ccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCc
Confidence 8873 331 12445556666666666655 3444
Q ss_pred cccCCCCccEEeCCCCceeecCCcc--cccCCCEEEeecCcccccCCccc
Q 038422 165 SLVQLPKLMELRLEANKFQGQVPEI--KQNEMRSLGLANNELEGPIPESL 212 (634)
Q Consensus 165 ~~~~l~~L~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~g~ip~~~ 212 (634)
.+ +++|+.|++++|..++.+|.. ....++.|++++|.+++..|..+
T Consensus 168 ~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~ 215 (305)
T d1xkua_ 168 GL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215 (305)
T ss_dssp SC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTG
T ss_pred cc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccc
Confidence 33 345555555555555555443 12345555555555554444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.30 E-value=5.2e-12 Score=119.35 Aligned_cols=133 Identities=30% Similarity=0.427 Sum_probs=94.7
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.+++.|+|++|.+++ ++ .++.+++|+.|++++|.+++ +|.+..+++|+.|++++|.+.. ++ .+..+++|+.++
T Consensus 68 ~~L~~L~L~~n~i~~-l~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~-~~--~l~~l~~l~~l~ 140 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK--PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-IN--GLVHLPQLESLY 140 (210)
T ss_dssp TTCCEEECCSSCCCC-CG--GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-CG--GGGGCTTCCEEE
T ss_pred CCCCEEeCCCccccC-cc--ccccCccccccccccccccc-cccccccccccccccccccccc-cc--cccccccccccc
Confidence 357778888887776 33 36778888888888888775 4567778888888888888763 33 267788888888
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
+++|.+++ +..+..+++|+.+++++|++++..|-...++|+.|++++|+++ .|| .+.+++
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~ 200 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLK 200 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCT
T ss_pred cccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCC
Confidence 88888774 3456777888888888888875333235567888888888887 355 354444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=4e-12 Score=114.75 Aligned_cols=104 Identities=21% Similarity=0.302 Sum_probs=54.2
Q ss_pred EEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~ 154 (634)
+..|+|++|+++. ++ .....+++|+.|+|++|.++. ++.+..+++|++|+|++|+++. +|+..+..+++|+.|+|+
T Consensus 20 lr~L~L~~n~I~~-i~-~~~~~l~~L~~L~Ls~N~i~~-l~~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 20 DRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIRK-LDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILT 95 (162)
T ss_dssp CEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCCE-ECCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECC
T ss_pred CcEEECCCCCCCc-cC-ccccccccCCEEECCCCCCCc-cCCcccCcchhhhhcccccccC-CCccccccccccccceec
Confidence 4455555555543 22 233445555555555555553 3445555555555555555553 444434455555555555
Q ss_pred cCcCccCCC--ccccCCCCccEEeCCCCcee
Q 038422 155 NNRLTGTIP--SSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 155 ~N~l~g~ip--~~~~~l~~L~~L~l~~N~~~ 183 (634)
+|+++. ++ ..+..+++|++|++++|.++
T Consensus 96 ~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 96 NNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp SCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccccc-cccccccccccccchhhcCCCccc
Confidence 555552 22 23455555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.24 E-value=2e-11 Score=114.23 Aligned_cols=121 Identities=23% Similarity=0.448 Sum_probs=54.7
Q ss_pred EEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcc
Q 038422 75 VWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMA 154 (634)
Q Consensus 75 v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~ 154 (634)
++.|+|+++++.- +. .+..+++|++|+|++|++++..| +.++++|++|++++|.+.. +++ ++++++|+.|+++
T Consensus 42 l~~L~l~~~~i~~-l~--~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~-~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 42 VTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD-ITP--LANLTNLTGLTLF 114 (199)
T ss_dssp CCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCSEEECC
T ss_pred CCEEECCCCCCCC-cc--ccccCCCcCcCccccccccCccc-ccCCccccccccccccccc-ccc--ccccccccccccc
Confidence 4445555544431 21 24445555555555555544322 4455555555555555442 221 4445555555555
Q ss_pred cCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCccc
Q 038422 155 NNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELE 205 (634)
Q Consensus 155 ~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~ 205 (634)
+|.+... ..+..+++|+.|++++|+++. +|.. ...+|+.|++++|+++
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhcc-ccccccccccccccccccccc
Confidence 5544431 224444555555555554442 2222 2334455555555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.23 E-value=2.5e-11 Score=113.47 Aligned_cols=133 Identities=20% Similarity=0.357 Sum_probs=110.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..|+|++|.+++.. .++.+++|++|++++|.+.. +|.+.+++.|+.|++++|.+... + .+..+++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~~~---~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~~~-~--~~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTDIT---PLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDI-D--PLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCCCG---GGTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCC-G--GGTTCTTCSEEE
T ss_pred CCcCcCccccccccCcc---cccCCccccccccccccccc-ccccccccccccccccccccccc-c--ccchhhhhHHhh
Confidence 57899999999998743 38899999999999998865 45689999999999999999863 2 278999999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
+++|+++. + +.+..+++|+.|++++|++++..|-...++|+.|++++|+++. || .+.+++
T Consensus 135 l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~ 194 (199)
T d2omxa2 135 LSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-VLAKLT 194 (199)
T ss_dssp CCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCT
T ss_pred hhhhhhcc-c-ccccccccccccccccccccCCccccCCCCCCEEECCCCCCCC-Cc-cccCCC
Confidence 99999984 4 4688999999999999999974333356799999999999985 44 344443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=5.9e-12 Score=113.65 Aligned_cols=110 Identities=20% Similarity=0.203 Sum_probs=90.6
Q ss_pred hhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCc
Q 038422 93 SLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L 172 (634)
.+.+...|+.|+|++|+++....-+..+++|++|||++|+++ .++ . +..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-C-CCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-C-cccCcchhhhhcccccccCCCcccccccccc
Confidence 466778999999999999876333477899999999999999 564 3 8899999999999999996444456789999
Q ss_pred cEEeCCCCceeecCCc---c-cccCCCEEEeecCcccc
Q 038422 173 MELRLEANKFQGQVPE---I-KQNEMRSLGLANNELEG 206 (634)
Q Consensus 173 ~~L~l~~N~~~g~ip~---~-~~~~l~~l~l~~N~l~g 206 (634)
+.|+|++|+++. +++ . ..++|+.|++++|.++.
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCcccc
Confidence 999999999974 332 2 44689999999999863
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=2.5e-11 Score=114.49 Aligned_cols=139 Identities=21% Similarity=0.362 Sum_probs=112.9
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEc
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYM 153 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l 153 (634)
.++.|+++++.+.. ++ .+..+++|++|+|++|.+++ ++.+.++++|++|++++|++++ +| . +..+++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~-l~~~~~l~~L~~L~l~~n~i~~-l~-~-l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVKD-LS-S-LKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC-GG-G-GTTCTTCCEEEC
T ss_pred CccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccC-ccccccCccccccccccccccc-cc-c-cccccccccccc
Confidence 57788999988875 33 47889999999999999998 4568899999999999999995 65 3 889999999999
Q ss_pred ccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCC---CCcccCC
Q 038422 154 ANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMD---PSTFAGN 223 (634)
Q Consensus 154 ~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~---~~~~~gn 223 (634)
++|.++. + ..+..+++|+.+++++|.+++..+.....+|+.+++++|++++ +++ +.+++ .....+|
T Consensus 120 ~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKN 188 (210)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred ccccccc-c-ccccccccccccccccccccccccccccccccccccccccccc-ccc-ccCCCCCCEEECCCC
Confidence 9999873 3 4688999999999999999875555567899999999999986 442 44443 3344454
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=8.3e-11 Score=117.50 Aligned_cols=109 Identities=22% Similarity=0.330 Sum_probs=57.3
Q ss_pred hhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCc
Q 038422 93 SLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKL 172 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L 172 (634)
.+..+++|+.+++++|.++. +|. .-+++|+.|++++|..++.++. .+.+++.+++|++++|++++..|..+.++++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~~-l~~-~~~~~L~~L~l~~n~~~~~~~~-~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNITT-IPQ-GLPPSLTELHLDGNKITKVDAA-SLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCCS-CCS-SCCTTCSEEECTTSCCCEECTG-GGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccCccccccCCccc-cCc-ccCCccCEEECCCCcCCCCChh-Hhhccccccccccccccccccccccccccccc
Confidence 34455555556665555543 221 1234555555555555554433 25555555555555555555555555555555
Q ss_pred cEEeCCCCceeecCCcc--cccCCCEEEeecCccc
Q 038422 173 MELRLEANKFQGQVPEI--KQNEMRSLGLANNELE 205 (634)
Q Consensus 173 ~~L~l~~N~~~g~ip~~--~~~~l~~l~l~~N~l~ 205 (634)
++|+|++|+|+ .||.. ..++|+.|+|++|+|+
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred eeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 55555555555 34432 2345555555555555
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=9.9e-11 Score=104.68 Aligned_cols=89 Identities=26% Similarity=0.332 Sum_probs=67.3
Q ss_pred hhcCCCCcCEEeccCCc-CcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCC
Q 038422 93 SLGLLSSLRAVSFMNNK-FEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLP 170 (634)
Q Consensus 93 ~l~~l~~L~~L~l~~n~-l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~ 170 (634)
.+..+++|++|++++|+ ++...+ .|.++++|+.|+|++|+++ .|++++|..+++|++|+|++|+|+ .+|..+....
T Consensus 26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~ 103 (156)
T d2ifga3 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL 103 (156)
T ss_dssp TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSC
T ss_pred cccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-CcccccccccccccceeccCCCCc-ccChhhhccc
Confidence 46677888888887664 665444 5788888888888888888 466677888888888888888888 5666655555
Q ss_pred CccEEeCCCCcee
Q 038422 171 KLMELRLEANKFQ 183 (634)
Q Consensus 171 ~L~~L~l~~N~~~ 183 (634)
+|+.|+|++|.|.
T Consensus 104 ~l~~L~L~~Np~~ 116 (156)
T d2ifga3 104 SLQELVLSGNPLH 116 (156)
T ss_dssp CCCEEECCSSCCC
T ss_pred cccccccCCCccc
Confidence 7888888888764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=9.3e-11 Score=104.87 Aligned_cols=103 Identities=17% Similarity=0.284 Sum_probs=84.6
Q ss_pred CEEeccCCcCcccCCCCCCCCCCcEEEccCCc-CccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCC
Q 038422 101 RAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNG-FSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEA 179 (634)
Q Consensus 101 ~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~-~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~ 179 (634)
+.++++++++...+..+..+++|+.|+|++|+ ++ .|+++.|.++++|+.|+|++|+++..-|..|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555556655555567788999999998775 66 68888899999999999999999977788899999999999999
Q ss_pred CceeecCCcc--cccCCCEEEeecCccc
Q 038422 180 NKFQGQVPEI--KQNEMRSLGLANNELE 205 (634)
Q Consensus 180 N~~~g~ip~~--~~~~l~~l~l~~N~l~ 205 (634)
|+|+ .+|.. ...+|+.|+|++|.|.
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCc-ccChhhhccccccccccCCCccc
Confidence 9999 55543 3348999999999985
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.08 E-value=1.1e-10 Score=120.24 Aligned_cols=132 Identities=20% Similarity=0.299 Sum_probs=103.6
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..+++.++.+++.. .++.+++|+.|++++|.+++.. .+..+..++.++++.|++++ + .. +..+++++.|+
T Consensus 241 ~~L~~L~l~~n~l~~~~---~~~~~~~L~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~-~-~~-~~~~~~l~~L~ 313 (384)
T d2omza2 241 TNLTDLDLANNQISNLA---PLSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLED-I-SP-ISNLKNLTYLT 313 (384)
T ss_dssp TTCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSC-C-GG-GGGCTTCSEEE
T ss_pred cccchhccccCccCCCC---cccccccCCEeeccCcccCCCC-cccccccccccccccccccc-c-cc-cchhcccCeEE
Confidence 35778999999998754 3788999999999999998754 47778888899999998886 3 23 77788889999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccccCCccccCCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEGPIPESLSKMD 216 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ip~~~~~~~ 216 (634)
|++|++++. + .+..+++|+.|+|++|++++ +|.. ..++|+.|++++|++++-+| +.+++
T Consensus 314 ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~ 373 (384)
T d2omza2 314 LYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLT 373 (384)
T ss_dssp CCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCT
T ss_pred CCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCC
Confidence 999998864 3 37888889999999998875 5543 45688999999999887655 44444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.04 E-value=4.1e-10 Score=107.30 Aligned_cols=127 Identities=18% Similarity=0.363 Sum_probs=87.1
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccC--------------
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNIS-------------- 138 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip-------------- 138 (634)
.++..|+|++|.+.+.. .+..+++|++|++++|.++ .++.+..++.|+.+++++|.+.+..+
T Consensus 63 ~~L~~L~ls~n~i~~~~---~l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLA---PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCG---GGTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeeccc---ccccccccccccccccccc-ccccccccccccccccccccccccchhccccchhhhhchh
Confidence 46778888888777543 2677778888888877766 35567777777777777777665321
Q ss_pred -----hhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeCCCCceeecCCcc-cccCCCEEEeecCcccc
Q 038422 139 -----DDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEI-KQNEMRSLGLANNELEG 206 (634)
Q Consensus 139 -----~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g 206 (634)
...+.++++|+.|++++|.+++. ..++++++|+.|+|++|++++ +|.. ..++|+.|++++|++++
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB
T ss_pred hhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC
Confidence 01255667777888877777643 237777888888888888775 4443 45678888888888774
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=4.6e-10 Score=115.37 Aligned_cols=140 Identities=25% Similarity=0.322 Sum_probs=114.7
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..+..++++++.+.. + +.+..+++|+.|++++|.+++.. .+..+++|++|++++|.+++. ++ +.+++.++.++
T Consensus 219 ~~L~~L~l~~n~l~~-~--~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~-~~--~~~~~~l~~l~ 291 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I--GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNI-SP--LAGLTALTNLE 291 (384)
T ss_dssp TTCCEEECCSSCCCC-C--GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCC-GG--GTTCTTCSEEE
T ss_pred CCCCEEECCCCCCCC-c--chhhcccccchhccccCccCCCC-cccccccCCEeeccCcccCCC-Cc--ccccccccccc
Confidence 457889999998885 3 36889999999999999999854 488899999999999999964 32 78899999999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccccCCccccCCCCC---cccCC
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEGPIPESLSKMDPS---TFAGN 223 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~---~~~gn 223 (634)
++.|++++ +..+..+++|+.|+|++|++++..|-...++|+.|++++|++++ +| .+.+++.. ...+|
T Consensus 292 ~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 292 LNENQLED--ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHN 361 (384)
T ss_dssp CCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSS
T ss_pred cccccccc--ccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCC
Confidence 99999996 34688899999999999999986544466799999999999985 44 46655443 44555
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.02 E-value=2.1e-12 Score=120.80 Aligned_cols=113 Identities=21% Similarity=0.315 Sum_probs=92.8
Q ss_pred hhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCC
Q 038422 92 ESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPK 171 (634)
Q Consensus 92 ~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~ 171 (634)
.++..|++|++|+|++|+++. ++.+.++++|+.|+|++|+++ .||.- +..+++|+.|++++|+++. + +.+.++++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~-~i~~~-~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENL-DAVADTLEELWISYNQIAS-L-SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEEC-SCSSH-HHHHHHCCEEECSEEECCC-H-HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cccccCCccccChhhcccccc-ccccc-ccccccccccccccccccc-c-cccccccc
Confidence 468899999999999999984 677899999999999999998 57643 5556789999999999995 4 35888999
Q ss_pred ccEEeCCCCceeec--CCcc-cccCCCEEEeecCcccccCC
Q 038422 172 LMELRLEANKFQGQ--VPEI-KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 172 L~~L~l~~N~~~g~--ip~~-~~~~l~~l~l~~N~l~g~ip 209 (634)
|+.|+|++|+++.. +... ..++|+.|++++|.++...+
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 99999999999743 2222 45689999999999876544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.93 E-value=2.5e-09 Score=101.72 Aligned_cols=127 Identities=21% Similarity=0.362 Sum_probs=95.9
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
..++.|++.++++.. ++ .+..+++|+.|+|++|.+++..| +..+++|++|++++|.++ .++ .+..+++|++++
T Consensus 41 ~~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~ 113 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-IE--GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVS--AIAGLQSIKTLD 113 (227)
T ss_dssp HTCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCG--GGTTCTTCCEEE
T ss_pred CCcCEEECCCCCCCc-ch--hHhcCCCCcEeecCCceeecccc-cccccccccccccccccc-ccc--cccccccccccc
Confidence 368899999999884 54 48899999999999999988654 899999999999999998 464 388999999999
Q ss_pred cccCcCccCCC--------------------ccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcccc
Q 038422 153 MANNRLTGTIP--------------------SSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNELEG 206 (634)
Q Consensus 153 l~~N~l~g~ip--------------------~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l~g 206 (634)
+++|..++..+ ..+.++++|+.|++++|.+++..+-....+|+.|++++|++++
T Consensus 114 l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 114 LTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp CTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred cccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC
Confidence 99998775322 1234456667777777766643332344577777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.75 E-value=4.7e-11 Score=111.40 Aligned_cols=108 Identities=29% Similarity=0.414 Sum_probs=89.8
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCC-CCCCCCcEEEccCCcCccccChhhhhCCCCCCeE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDL-RKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~-~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l 151 (634)
.++..|+|++|+++ .++ .+..+++|+.|+|++|.++. +|.+ ..++.|++|++++|+++. ++ . +..+++|+.|
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l~-~-~~~l~~L~~L 120 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-G-IEKLVNLRVL 120 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-HH-H-HHHHHHSSEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhccccccc-ccccccccccccccccccccccc-cc-c-cccccccccc
Confidence 46889999999988 454 48899999999999999874 4543 445679999999999995 53 3 7889999999
Q ss_pred EcccCcCccCCC--ccccCCCCccEEeCCCCceeecCCc
Q 038422 152 YMANNRLTGTIP--SSLVQLPKLMELRLEANKFQGQVPE 188 (634)
Q Consensus 152 ~l~~N~l~g~ip--~~~~~l~~L~~L~l~~N~~~g~ip~ 188 (634)
+|++|+++. ++ ..+.++++|+.|+|++|.++...+.
T Consensus 121 ~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 121 YMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccccchhcc-ccccccccCCCccceeecCCCccccCccc
Confidence 999999984 44 4689999999999999999876654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=1.1e-08 Score=98.06 Aligned_cols=87 Identities=21% Similarity=0.301 Sum_probs=59.6
Q ss_pred CCcCEEeccCCcCcccCC-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEccc-CcCccCCCccccCCCCccEE
Q 038422 98 SSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMAN-NRLTGTIPSSLVQLPKLMEL 175 (634)
Q Consensus 98 ~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~-N~l~g~ip~~~~~l~~L~~L 175 (634)
+++++|+|++|.++...+ .|.++++|++|+|++|.+...+++..|.++++++++++.. |+++...|..+.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 466777777777765444 3667777777777777777666666667777777777653 56666666667777777777
Q ss_pred eCCCCceee
Q 038422 176 RLEANKFQG 184 (634)
Q Consensus 176 ~l~~N~~~g 184 (634)
++++|+++.
T Consensus 109 ~l~~~~l~~ 117 (242)
T d1xwdc1 109 LISNTGIKH 117 (242)
T ss_dssp EEESCCCCS
T ss_pred ccchhhhcc
Confidence 777777664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.71 E-value=2.1e-08 Score=95.92 Aligned_cols=144 Identities=16% Similarity=0.183 Sum_probs=109.7
Q ss_pred CeeeEEecC-----------CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC--CCCCCCCCcEEEccC
Q 038422 64 NWNGVLCLN-----------GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP--DLRKMGPLKSIYLSD 130 (634)
Q Consensus 64 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p--~~~~l~~L~~L~ls~ 130 (634)
.+..|.|.+ ..++.|+|++|.+. .+++..+.++++|++|+|++|.+...+| .+.+++.++.|++..
T Consensus 9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 477888942 25789999999997 5776678999999999999999988776 478899999999865
Q ss_pred -CcCccccChhhhhCCCCCCeEEcccCcCccCCC-ccccCCCCccEEeCCCCceeecCCccc---ccCCCEEEeecCccc
Q 038422 131 -NGFSGNISDDAFEGMTSLKKLYMANNRLTGTIP-SSLVQLPKLMELRLEANKFQGQVPEIK---QNEMRSLGLANNELE 205 (634)
Q Consensus 131 -N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip-~~~~~l~~L~~L~l~~N~~~g~ip~~~---~~~l~~l~l~~N~l~ 205 (634)
|++.. +++..|.++++|+.|++++|+++..-+ ..+..+..|..+..++++++.--+..+ ...+..|++++|+++
T Consensus 88 ~n~l~~-~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCCE-ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccc-cccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 66764 556668999999999999999985322 234556777777777777764333322 237888999999998
Q ss_pred ccCCc
Q 038422 206 GPIPE 210 (634)
Q Consensus 206 g~ip~ 210 (634)
. ++.
T Consensus 167 ~-i~~ 170 (242)
T d1xwdc1 167 E-IHN 170 (242)
T ss_dssp E-ECT
T ss_pred c-ccc
Confidence 4 443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.46 E-value=2.3e-07 Score=93.09 Aligned_cols=115 Identities=24% Similarity=0.363 Sum_probs=84.4
Q ss_pred CcEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEE
Q 038422 73 GSVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLY 152 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~ 152 (634)
.++..|+|++++|+ .+|. .+++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .|+. + .++|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~--~~~L~~L~l~~n~l~-~l~~--l--p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL--PQSLKSLLVDNNNLK-ALSD--L--PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC--CTTCCEEECCSSCCS-CCCS--C--CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccc--hhhhhhhhhhhcccc-hhhh--h--cccccccc
Confidence 45778999999987 5763 3578999999999998 56643 468999999999988 4542 2 24699999
Q ss_pred cccCcCccCCCccccCCCCccEEeCCCCceeecCCcccccCCCEEEeecCcc
Q 038422 153 MANNRLTGTIPSSLVQLPKLMELRLEANKFQGQVPEIKQNEMRSLGLANNEL 204 (634)
Q Consensus 153 l~~N~l~g~ip~~~~~l~~L~~L~l~~N~~~g~ip~~~~~~l~~l~l~~N~l 204 (634)
|++|+++ .+|. ++.+++|+.|++++|.+++..+. ...+..+.+.++..
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQL 152 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCC
T ss_pred ccccccc-cccc-hhhhccceeeccccccccccccc--cccccchhhccccc
Confidence 9999998 5775 68899999999999988754432 23455555554444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.44 E-value=3e-07 Score=92.27 Aligned_cols=97 Identities=25% Similarity=0.379 Sum_probs=79.1
Q ss_pred CCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCccccCCCCccEEeC
Q 038422 98 SSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSSLVQLPKLMELRL 177 (634)
Q Consensus 98 ~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~~~~l~~L~~L~l 177 (634)
.+|+.|+|++|.++. +|++ +++|++|+|++|+++ .||.. +.+|+.|++++|+++ .++.-. ++|++|+|
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDLP---PLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSCC---TTCCEEEC
T ss_pred cCCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhhc---cccccccc
Confidence 478999999999985 6753 578999999999999 78753 468999999999998 455321 46999999
Q ss_pred CCCceeecCCcc-cccCCCEEEeecCccccc
Q 038422 178 EANKFQGQVPEI-KQNEMRSLGLANNELEGP 207 (634)
Q Consensus 178 ~~N~~~g~ip~~-~~~~l~~l~l~~N~l~g~ 207 (634)
++|.++ .+|.. ...+|+.|++++|.+++.
T Consensus 106 ~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 106 SNNQLE-KLPELQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp CSSCCS-SCCCCTTCTTCCEEECCSSCCSCC
T ss_pred cccccc-cccchhhhccceeecccccccccc
Confidence 999998 56654 567999999999998754
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=5.4e-08 Score=95.60 Aligned_cols=143 Identities=17% Similarity=0.243 Sum_probs=86.0
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCC-CCCCCCCCcEEEccC-CcCccccChhhhhCCCCCCeE
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLP-DLRKMGPLKSIYLSD-NGFSGNISDDAFEGMTSLKKL 151 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p-~~~~l~~L~~L~ls~-N~~~g~ip~~~~~~~~~L~~l 151 (634)
++..|+|+++.+.+......+..+++|++|+|+++.+++..+ .+..+++|++|+|++ +.++..--.....++++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 577888888777665444456778888888888888876554 577788888888888 456532112224567888888
Q ss_pred EcccC-cCccC-CCccccC-CCCccEEeCCCC--ceeec-CCcc--cccCCCEEEeecC-cccccCCccccCCC
Q 038422 152 YMANN-RLTGT-IPSSLVQ-LPKLMELRLEAN--KFQGQ-VPEI--KQNEMRSLGLANN-ELEGPIPESLSKMD 216 (634)
Q Consensus 152 ~l~~N-~l~g~-ip~~~~~-l~~L~~L~l~~N--~~~g~-ip~~--~~~~l~~l~l~~N-~l~g~ip~~~~~~~ 216 (634)
+|+++ .++.. ++..+.. +++|+.|++++. +++.. +... ..++|+.|++++| .+++.....+.+++
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 88874 44421 2222222 356777777643 23221 2211 2346777777654 45655555554443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=4e-07 Score=89.15 Aligned_cols=124 Identities=18% Similarity=0.214 Sum_probs=84.3
Q ss_pred EEEecCCCCccccChhhhcCCCCcCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccC
Q 038422 77 GLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANN 156 (634)
Q Consensus 77 ~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N 156 (634)
.|||+++++.+......+. ..+..+.++.+.....+.......+|++|||+++.+++......+..+++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh--ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5788887776443221111 13456666666655555555666788888888888876544555788888889988888
Q ss_pred cCccCCCccccCCCCccEEeCCCC-ceeec-CCcc--cccCCCEEEeecC
Q 038422 157 RLTGTIPSSLVQLPKLMELRLEAN-KFQGQ-VPEI--KQNEMRSLGLANN 202 (634)
Q Consensus 157 ~l~g~ip~~~~~l~~L~~L~l~~N-~~~g~-ip~~--~~~~l~~l~l~~N 202 (634)
.+++..+..++++++|++|+|+++ .++.. +... ..++|+.|+++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 888888888888888888888884 55521 2221 3467888888874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.14 E-value=4e-06 Score=80.50 Aligned_cols=131 Identities=15% Similarity=0.084 Sum_probs=88.8
Q ss_pred CceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCC-CCccccceeEEEeCCceEEEEEcCCCCChhhHHhhc
Q 038422 367 TFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLE-HPNLLPLTAFYYRKEEKLLLYEFVENGSLAGKLHAN 445 (634)
Q Consensus 367 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~ 445 (634)
+.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998764 55667788876554444556788888877663 323566778888888899999999998776543211
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------------
Q 038422 446 HTKQRPGLDWQTRLKIIKGVVKGMAYLHNEL------------------------------------------------- 476 (634)
Q Consensus 446 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------- 476 (634)
-. ...++.++++.++.||+..
T Consensus 105 -------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 105 -------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp -------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred -------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 11 2234555566666666421
Q ss_pred ------CCCCccccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 477 ------PGSIIPHGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 477 ------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
.+..++|+|+.|.||+++++...-|.||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12237899999999999987777799998753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.05 E-value=4.8e-07 Score=94.08 Aligned_cols=109 Identities=27% Similarity=0.307 Sum_probs=61.6
Q ss_pred cEEEEEecCCCCccccChhhhcCCCCcCEEeccCCcCcc----cCC-CCCCCCCCcEEEccCCcCccccChhhhh-----
Q 038422 74 SVWGLKLEQMNLSGTIAAESLGLLSSLRAVSFMNNKFEG----PLP-DLRKMGPLKSIYLSDNGFSGNISDDAFE----- 143 (634)
Q Consensus 74 ~v~~l~L~~~~l~g~~~~~~l~~l~~L~~L~l~~n~l~g----~~p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~----- 143 (634)
.+..|||+.+++++.--...+..+++|+.|+|++|+++- .+. .+..+++|+.|||++|.++.. ....+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~-~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV-GVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHH-HHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChH-HHHHHHHHHhc
Confidence 366777777777664322344556667777777776652 122 245666677777777766421 001111
Q ss_pred CCCCCCeEEcccCcCccC----CCccccCCCCccEEeCCCCcee
Q 038422 144 GMTSLKKLYMANNRLTGT----IPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 144 ~~~~L~~l~l~~N~l~g~----ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
...+|+.|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 124566777777666542 3445556666666666666654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=2.7e-07 Score=82.30 Aligned_cols=104 Identities=22% Similarity=0.227 Sum_probs=61.8
Q ss_pred cCEEeccCCcCcccCCCCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccC--CCccccCCCCccEEeC
Q 038422 100 LRAVSFMNNKFEGPLPDLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGT--IPSSLVQLPKLMELRL 177 (634)
Q Consensus 100 L~~L~l~~n~l~g~~p~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~--ip~~~~~l~~L~~L~l 177 (634)
.+.|+++++.. .+.+..+..+..+++.+|..+ .+ +..+..+++|++|+|++|+++.- ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~---~~~l~~~~~~~~l~~~~~~~~-~l-~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRS---DPDLVAQNIDVVLNRRSSMAA-TL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSS---CTTTTTTTCCCCTTSHHHHHH-HH-HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCC---CchhhhccchhhcchhhhHhh-hh-HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 44556654432 234444555555555555443 33 33355677788888888877742 2344566777888888
Q ss_pred CCCceeecCCcc---cccCCCEEEeecCcccccCC
Q 038422 178 EANKFQGQVPEI---KQNEMRSLGLANNELEGPIP 209 (634)
Q Consensus 178 ~~N~~~g~ip~~---~~~~l~~l~l~~N~l~g~ip 209 (634)
++|+++. +++. ...+|+.|++++|.++....
T Consensus 99 s~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 99 SGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred ccCcccc-chhhhhhhccccceeecCCCCcCcCcc
Confidence 8887773 3332 33467777788887776544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.93 E-value=1.3e-06 Score=87.85 Aligned_cols=135 Identities=19% Similarity=0.252 Sum_probs=83.8
Q ss_pred CCcEEEEEecCCCCc--c------ccC----hhhhcCCCCcCEEeccCCcCccc----CC-CCCCCCCCcEEEccCCcCc
Q 038422 72 NGSVWGLKLEQMNLS--G------TIA----AESLGLLSSLRAVSFMNNKFEGP----LP-DLRKMGPLKSIYLSDNGFS 134 (634)
Q Consensus 72 ~~~v~~l~L~~~~l~--g------~~~----~~~l~~l~~L~~L~l~~n~l~g~----~p-~~~~l~~L~~L~ls~N~~~ 134 (634)
..++..|+|+++.+. | .+. .........|+.|++++|.++-. +. .+..+..|+.|+|++|+++
T Consensus 120 ~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 199 (344)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred cccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccc
Confidence 356788888887752 1 110 01123456788888888776532 11 2445667888888888876
Q ss_pred cc----cChhhhhCCCCCCeEEcccCcCccC----CCccccCCCCccEEeCCCCceeecCCc--------ccccCCCEEE
Q 038422 135 GN----ISDDAFEGMTSLKKLYMANNRLTGT----IPSSLVQLPKLMELRLEANKFQGQVPE--------IKQNEMRSLG 198 (634)
Q Consensus 135 g~----ip~~~~~~~~~L~~l~l~~N~l~g~----ip~~~~~l~~L~~L~l~~N~~~g~ip~--------~~~~~l~~l~ 198 (634)
.. +....+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|.+++.-.. ....+|+.|+
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ 279 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 279 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEE
Confidence 32 1122356677888888888887632 345566778888888888887653111 1224688888
Q ss_pred eecCcccc
Q 038422 199 LANNELEG 206 (634)
Q Consensus 199 l~~N~l~g 206 (634)
+++|+++.
T Consensus 280 ls~N~i~~ 287 (344)
T d2ca6a1 280 LQYNEIEL 287 (344)
T ss_dssp CCSSCCBH
T ss_pred CCCCcCCh
Confidence 88888764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=1e-06 Score=78.34 Aligned_cols=80 Identities=23% Similarity=0.262 Sum_probs=39.6
Q ss_pred CCCCcCEEeccCCcCcccC--C-CCCCCCCCcEEEccCCcCccccChhhhhCCCCCCeEEcccCcCccCCCcc-------
Q 038422 96 LLSSLRAVSFMNNKFEGPL--P-DLRKMGPLKSIYLSDNGFSGNISDDAFEGMTSLKKLYMANNRLTGTIPSS------- 165 (634)
Q Consensus 96 ~l~~L~~L~l~~n~l~g~~--p-~~~~l~~L~~L~ls~N~~~g~ip~~~~~~~~~L~~l~l~~N~l~g~ip~~------- 165 (634)
.+++|++|+|++|+++..- + .+..+++|+.|+|++|.++ .+++-.+....+|+.|+|++|.++......
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 4556666666666665421 1 1344555666666666655 233322233345555666666555443321
Q ss_pred ccCCCCccEEe
Q 038422 166 LVQLPKLMELR 176 (634)
Q Consensus 166 ~~~l~~L~~L~ 176 (634)
+..+++|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 33455555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.89 E-value=7.3e-07 Score=92.63 Aligned_cols=134 Identities=19% Similarity=0.214 Sum_probs=76.7
Q ss_pred CcEEEEEecCCCCccccC---hhhhcCCCCcCEEeccCCcCcccCC-C-----CCCCCCCcEEEccCCcCccccCh---h
Q 038422 73 GSVWGLKLEQMNLSGTIA---AESLGLLSSLRAVSFMNNKFEGPLP-D-----LRKMGPLKSIYLSDNGFSGNISD---D 140 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~---~~~l~~l~~L~~L~l~~n~l~g~~p-~-----~~~l~~L~~L~ls~N~~~g~ip~---~ 140 (634)
..+..++|+++++..... ...+...+.++.+++++|.++..-. . ......|+.+++++|.++..-.. .
T Consensus 255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~ 334 (460)
T d1z7xw1 255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 334 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccc
Confidence 457778888887764321 1234556777777777777754211 0 12334677777777776643211 1
Q ss_pred hhhCCCCCCeEEcccCcCccC----CCcccc-CCCCccEEeCCCCceeec----CCcc--cccCCCEEEeecCcccc
Q 038422 141 AFEGMTSLKKLYMANNRLTGT----IPSSLV-QLPKLMELRLEANKFQGQ----VPEI--KQNEMRSLGLANNELEG 206 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g~----ip~~~~-~l~~L~~L~l~~N~~~g~----ip~~--~~~~l~~l~l~~N~l~g 206 (634)
.+..+++|++|+|++|+++.. ++..+. ..+.|++|+|++|+|+.. +++. ...+|++|++++|+++.
T Consensus 335 ~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 234456677777777776542 333333 345677777777777632 2221 23467777777777764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=4.3e-05 Score=72.58 Aligned_cols=74 Identities=16% Similarity=0.108 Sum_probs=52.4
Q ss_pred cCccCc-eeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCC--CccccceeEEEeCCceEEEEEcCCCCChh
Q 038422 363 LGSGTF-GASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEH--PNLLPLTAFYYRKEEKLLLYEFVENGSLA 439 (634)
Q Consensus 363 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 439 (634)
+..|.. +.||+....++..+++|..... ...++..|++.++.+.. -.+.+++++..+++..++||||+++-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 5799998888888888876543 23356778877776643 23556788888888899999999886553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.67 E-value=5.6e-06 Score=83.00 Aligned_cols=135 Identities=20% Similarity=0.264 Sum_probs=99.0
Q ss_pred CcEEEEEecCCCCccccC---hhhhcCCCCcCEEeccCCcCccc--------CCC------CCCCCCCcEEEccCCcCcc
Q 038422 73 GSVWGLKLEQMNLSGTIA---AESLGLLSSLRAVSFMNNKFEGP--------LPD------LRKMGPLKSIYLSDNGFSG 135 (634)
Q Consensus 73 ~~v~~l~L~~~~l~g~~~---~~~l~~l~~L~~L~l~~n~l~g~--------~p~------~~~l~~L~~L~ls~N~~~g 135 (634)
.++..|+|++|.+...-. ...+...++|+.|+|++|.|+-. +.. ......|+.|++++|.++-
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 568899999998876421 13466789999999999988531 111 2456789999999999863
Q ss_pred ccC---hhhhhCCCCCCeEEcccCcCccC-----CCccccCCCCccEEeCCCCceeec----CCcc--cccCCCEEEeec
Q 038422 136 NIS---DDAFEGMTSLKKLYMANNRLTGT-----IPSSLVQLPKLMELRLEANKFQGQ----VPEI--KQNEMRSLGLAN 201 (634)
Q Consensus 136 ~ip---~~~~~~~~~L~~l~l~~N~l~g~-----ip~~~~~l~~L~~L~l~~N~~~g~----ip~~--~~~~l~~l~l~~ 201 (634)
.-- ...+..++.|+.|+|++|+++.. +...+..+++|+.|+|++|.|+.. +... ...+|+.|++++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 211 12366788999999999998742 345577889999999999998643 2221 345899999999
Q ss_pred Cccccc
Q 038422 202 NELEGP 207 (634)
Q Consensus 202 N~l~g~ 207 (634)
|.+++.
T Consensus 253 n~i~~~ 258 (344)
T d2ca6a1 253 CLLSAR 258 (344)
T ss_dssp CCCCHH
T ss_pred CccCch
Confidence 999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.29 E-value=0.00058 Score=69.11 Aligned_cols=76 Identities=12% Similarity=0.092 Sum_probs=48.0
Q ss_pred cccCccCceeEEEEEEcC-CcEEEEEEeccc-------CccChhHHHHHHHHHhcCC-C--CccccceeEEEeCCceEEE
Q 038422 361 EVLGSGTFGASYKTVISN-GQAYVVKRYKQM-------NNVGREDFQEHIKRLGRLE-H--PNLLPLTAFYYRKEEKLLL 429 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lv 429 (634)
+.||.|....||+....+ ++.+++|.-... -....+....|.+.|+.+. + ..+.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468999999999998654 678888865321 1122344566777776552 2 23444544 356677899
Q ss_pred EEcCCCCCh
Q 038422 430 YEFVENGSL 438 (634)
Q Consensus 430 ~e~~~~gsL 438 (634)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.04 E-value=0.00011 Score=64.97 Aligned_cols=109 Identities=14% Similarity=0.172 Sum_probs=65.7
Q ss_pred CCCCcCEEeccCC-cCccc-CC----CCCCCCCCcEEEccCCcCccccC---hhhhhCCCCCCeEEcccCcCccC----C
Q 038422 96 LLSSLRAVSFMNN-KFEGP-LP----DLRKMGPLKSIYLSDNGFSGNIS---DDAFEGMTSLKKLYMANNRLTGT----I 162 (634)
Q Consensus 96 ~l~~L~~L~l~~n-~l~g~-~p----~~~~l~~L~~L~ls~N~~~g~ip---~~~~~~~~~L~~l~l~~N~l~g~----i 162 (634)
+.++|++|+|+++ .++.. +. .+...+.|+.|+|++|.+...-. .+.+...++|+.|+|++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4567888888763 44331 11 35666778888888887763210 12355567788888888887742 1
Q ss_pred CccccCCCCccEEeCCCCceeec-------CCcc--cccCCCEEEeecCcc
Q 038422 163 PSSLVQLPKLMELRLEANKFQGQ-------VPEI--KQNEMRSLGLANNEL 204 (634)
Q Consensus 163 p~~~~~l~~L~~L~l~~N~~~g~-------ip~~--~~~~l~~l~l~~N~l 204 (634)
=..+...++|++|+|++|.++.- +... ..++|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 22455667788888887765421 1111 234778888776654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0019 Score=63.31 Aligned_cols=136 Identities=15% Similarity=0.221 Sum_probs=77.6
Q ss_pred eEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCCcc-----ccc--eeEEEeCCceEEEEEcCCCCChh---
Q 038422 370 ASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNL-----LPL--TAFYYRKEEKLLLYEFVENGSLA--- 439 (634)
Q Consensus 370 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~l--~g~~~~~~~~~lv~e~~~~gsL~--- 439 (634)
.||+...++|+.+++|..+.. ....+++..|.+.+..|....+ +.. -..+...+..+.++++++|..+.
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred eeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 799999999999999987643 3356778888888777642211 111 11223456678999999863321
Q ss_pred -----------hHHhhc----cCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc---CCCCCcc
Q 038422 440 -----------GKLHAN----HTKQRPGLDWQT-------------------RLKIIKGVVKGMAYLHNE---LPGSIIP 482 (634)
Q Consensus 440 -----------~~l~~~----~~~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~~---~~~~~iv 482 (634)
..++.. ....+..+++.. +..+...+.+.++.+... ..+.+++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 111111 111111222221 111222222333333322 2244689
Q ss_pred ccCCCCCCEEeCCCCCeEEeccccCC
Q 038422 483 HGHLKSSNVLLDRSFEPLLTDYALRP 508 (634)
Q Consensus 483 Hrdlk~~NILl~~~~~~kl~DfGla~ 508 (634)
|+|+.+.|||++++ ..+.||+-+.
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCC
T ss_pred cCCCCcccEEEeCC--ceEEechhcc
Confidence 99999999999754 4588998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.68 E-value=0.00038 Score=61.36 Aligned_cols=110 Identities=10% Similarity=0.078 Sum_probs=77.4
Q ss_pred CcEEEEEecCC-CCccccC---hhhhcCCCCcCEEeccCCcCccc--CC---CCCCCCCCcEEEccCCcCccccC---hh
Q 038422 73 GSVWGLKLEQM-NLSGTIA---AESLGLLSSLRAVSFMNNKFEGP--LP---DLRKMGPLKSIYLSDNGFSGNIS---DD 140 (634)
Q Consensus 73 ~~v~~l~L~~~-~l~g~~~---~~~l~~l~~L~~L~l~~n~l~g~--~p---~~~~l~~L~~L~ls~N~~~g~ip---~~ 140 (634)
.++..|+|+++ .++...- ...+...++|++|+|++|.+... .. .+...+.|+.|+|++|.++..-- ..
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 56889999874 4543211 12466778899999999998642 22 24566889999999999985311 12
Q ss_pred hhhCCCCCCeEEcccCcCccC-------CCccccCCCCccEEeCCCCce
Q 038422 141 AFEGMTSLKKLYMANNRLTGT-------IPSSLVQLPKLMELRLEANKF 182 (634)
Q Consensus 141 ~~~~~~~L~~l~l~~N~l~g~-------ip~~~~~l~~L~~L~l~~N~~ 182 (634)
++...++|++|+|++|.+... +-..+...++|+.|+++.+..
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 366778999999999976521 333455568999999987754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.63 E-value=0.0018 Score=56.70 Aligned_cols=110 Identities=16% Similarity=0.271 Sum_probs=67.9
Q ss_pred cCCCCcCEEeccC-CcCcccC--C---CCCCCCCCcEEEccCCcCccccC---hhhhhCCCCCCeEEcccCcCccC----
Q 038422 95 GLLSSLRAVSFMN-NKFEGPL--P---DLRKMGPLKSIYLSDNGFSGNIS---DDAFEGMTSLKKLYMANNRLTGT---- 161 (634)
Q Consensus 95 ~~l~~L~~L~l~~-n~l~g~~--p---~~~~l~~L~~L~ls~N~~~g~ip---~~~~~~~~~L~~l~l~~N~l~g~---- 161 (634)
.+.++|++|+|++ |.++... + .+...+.|+.|+|++|.++..-- .+.+...++|+.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4557888888886 4454221 1 35567788888888888764311 12356678888888888887643
Q ss_pred CCccccCCCCccEEeC--CCCceeec----CCcc--cccCCCEEEeecCcc
Q 038422 162 IPSSLVQLPKLMELRL--EANKFQGQ----VPEI--KQNEMRSLGLANNEL 204 (634)
Q Consensus 162 ip~~~~~l~~L~~L~l--~~N~~~g~----ip~~--~~~~l~~l~l~~N~l 204 (634)
+-..+...++|+.++| +.|.+... +... ..++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2245666777876555 45555421 1111 335788888876654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.56 E-value=0.012 Score=59.16 Aligned_cols=72 Identities=13% Similarity=0.111 Sum_probs=46.7
Q ss_pred cccCccCceeEEEEEEcCC--------cEEEEEEecccCccChhHHHHHHHHHhcCCCCccc-cceeEEEeCCceEEEEE
Q 038422 361 EVLGSGTFGASYKTVISNG--------QAYVVKRYKQMNNVGREDFQEHIKRLGRLEHPNLL-PLTAFYYRKEEKLLLYE 431 (634)
Q Consensus 361 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e 431 (634)
+.|+.|-.-.+|+....++ +.|++++... .....+..+|..+++.+.-.+++ ++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 3577777779999886543 4566655542 22344567888888877433444 6777663 268999
Q ss_pred cCCCCCh
Q 038422 432 FVENGSL 438 (634)
Q Consensus 432 ~~~~gsL 438 (634)
|+++-.+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.13 E-value=0.0018 Score=56.65 Aligned_cols=111 Identities=21% Similarity=0.242 Sum_probs=76.9
Q ss_pred CcEEEEEecCC-CCccccC---hhhhcCCCCcCEEeccCCcCcccCC-----CCCCCCCCcEEEccCCcCccccCh---h
Q 038422 73 GSVWGLKLEQM-NLSGTIA---AESLGLLSSLRAVSFMNNKFEGPLP-----DLRKMGPLKSIYLSDNGFSGNISD---D 140 (634)
Q Consensus 73 ~~v~~l~L~~~-~l~g~~~---~~~l~~l~~L~~L~l~~n~l~g~~p-----~~~~l~~L~~L~ls~N~~~g~ip~---~ 140 (634)
..+..|+|+++ +++...- ...+...++|+.|+|++|.++..-- .+...+.|+.|++++|.++..--. +
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 46788888873 4543211 1245678899999999998865321 245678899999999998754211 2
Q ss_pred hhhCCCCCCeEEc--ccCcCcc----CCCccccCCCCccEEeCCCCcee
Q 038422 141 AFEGMTSLKKLYM--ANNRLTG----TIPSSLVQLPKLMELRLEANKFQ 183 (634)
Q Consensus 141 ~~~~~~~L~~l~l--~~N~l~g----~ip~~~~~l~~L~~L~l~~N~~~ 183 (634)
.+...++|+.++| ++|.+.. .|-..+...++|+.|+++.|...
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 3667888987655 5677753 34455667899999999887654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.46 E-value=0.27 Score=46.75 Aligned_cols=143 Identities=15% Similarity=0.103 Sum_probs=72.5
Q ss_pred ccCccCceeEEEEEEcCCcEEEEEEecccCccChhHHHHHHHHHhcCCCC-----ccccce---eEEEeCCceEEEEEcC
Q 038422 362 VLGSGTFGASYKTVISNGQAYVVKRYKQMNNVGREDFQEHIKRLGRLEHP-----NLLPLT---AFYYRKEEKLLLYEFV 433 (634)
Q Consensus 362 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-----niv~l~---g~~~~~~~~~lv~e~~ 433 (634)
.|..|---+.|+.+..+|+ +++|+.... ...+++..|++++..+... ..+... .+....+....++.++
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 3556666788998876664 888887543 2334566667776665322 111110 0112234566777777
Q ss_pred CCCChhh--------------HHhhccCCC----CCCCCH------------------HHHHHHHHHHHHHHHHHHhcCC
Q 038422 434 ENGSLAG--------------KLHANHTKQ----RPGLDW------------------QTRLKIIKGVVKGMAYLHNELP 477 (634)
Q Consensus 434 ~~gsL~~--------------~l~~~~~~~----~~~l~~------------------~~~~~i~~~ia~gL~yLH~~~~ 477 (634)
.+..... .++...... ...... ......+..+...+.-.+...-
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6643321 111000000 000000 0111122222233333333333
Q ss_pred CCCccccCCCCCCEEeCCCCCeEEeccccC
Q 038422 478 GSIIPHGHLKSSNVLLDRSFEPLLTDYALR 507 (634)
Q Consensus 478 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla 507 (634)
+.+++|+|+.+.||+++++...-|.||+.+
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccccCCcchhhhhcccccceeEeccccc
Confidence 457999999999999999877789999876
|